[CLS]physicalmapping220k##bcent##rome##richumandsequenceanalysis43k##bsegmentincludingring##1##6##4gene[CLS]end##oadd##uc55 8##r##r 88ars9##dc##load##ditionsubstitutedc2c3doublebondachievedch##em##odi##aster##sel##ecway##uin##one1##dpresence##b##r2[SEP][CLS]d##naelementrecognizingn##fy##1regulatemulti##dr##ugresistancegenepromoter[CLS]radiogoproblemspecific##ity##ity [SEP]patientrandom##3049##6048topic##al30di##lo##fen##ac2500 5gdaily3060dayrespectively[CLS]ata##tdramaticallyincrease1geneexpressionpresumablyregulatedlate##ntstatemayalsoactivatedmitc##lardifference##rkii##rkii23proteinexaminedbinding##ro[SEP][CLS]conclusionsystemicfactorincreasebonemineraldensityappearinvolvedpath##ogeno##ssilongitudinalfactormayactivatedmiddleageage [SEP][CLS]thusfurco##xequivalentcomprisestwogeneseparatedgenometwogenepptscomplexid1##hid##hseemhumanho##mo##logue##smouseid1id2respectivelypotentialen##code154135aminoacidproteinprotein [SEP][CLS]characterizationinsertionmutationsa##cc##har##omy##cesc##ere##vis##iae##1##2geneevidenceseparatemitochondrialnuclearfunction[SEP][CLS]transcriptionfpromoter##ran##ferfusiongenebasesubstitutiononerichsequence##ivo##it##rorevealedbasesubstitutionrichsequenceresultreductionpromoteractivityalthoughdownstreamg##cbox##c##dplayprimaryrole[SEP]m##or##phologicalco##ugainternalelasticlavesseloftenobservedvehicleprominent##lnhealthycontrolag##trichsequencebindingtranscriptionfactors##1crucialhighhuman##iico##lla##1##bro##era[CLS]eachreceivedreceived 20m##lonethreetestsolutionle##vocontrolle##vo##any2microm##lle##vo3microm##lthe##rgeneya##rrow##olyinal##kalextra##cellularpro##te##ase[CLS]conclusionannualratedeno##voan##eur##ysformationrelativelyhigh089cumulativebecomes9yearyear [SEP]##14##0bindprimarily##kregulatorysubunitbetaid##iodetectionmuscleinvolvementpreviousanalysismotifla##oseper##me##asea[SEP][PAD] [CLS]combinedch##em##otherapy26b##c##nure##current##current mamalig##liooperationi##rra##diation##diation [SEP]likei##schi##1containsnterminalbirepeatcterminalringfingermotif[SEP][CLS]effecttermrestm##od##roidfunctiontestprofileprofile [SEP]donor10in##com##tiblein##com[CLS]alternatives##licinghumanse##rot##onigeneinterestingbasalmap##k##af1activitycon##utiveenhanced##ak##1defhecell[CLS]thisreportdescribestreatmentpatientperiod##ont##osistheaimorganizechemicalclientserverenvironmentusingdatabasemanagementsystemwebfashionclientinterfaceinterface [SEP]c##er##ume##nmanagementtetexadistrictprogram##ct##ate##vateactualvalue##nousbloodnewborncalffocusgeneralapproachagentagent [SEP]##letr##b##canimallabeled51##r99##trespectivelyrapidlyinjectedrightatbloodsampled##ort##a[CLS]comparisondelta##met##hreffectlo##com##otoendstrongeg[CLS]protectionlevel33336370achievedgroup100020kc##er##car##ia100010k##er##car##ia200040kc##er##car##ia200060k##er##car##ia[CLS]intypeiiicap##illa##rywallbecamethinner##illa##ryl##ume##n##isi##ablethusp##rimavpromoterselect##ivitymediatedt##b##ptacomplexlikelysubtledifferenceindividualsubunitleads##pec##iespecificpolymer##aseitranscriptioncompetitivenm##daantagonist##k80##1alterrepeatedrestraintstress[CLS]geneconversioninitiateddoublestrandbreakd##b##hom##olo##godpresentendmustremovednewdsynthesisinitiated[SEP][CLS]inre##con##stitutedsystemrii##ar##btrans##cribed##h##f##rpromoter[SEP][CLS]thecloneen##pt##ide65aminoacidb##hl##hbasichehedomaincharacteristictranscriptionfactorper##rn##tsidomainterminalhalfregion[SEP]ft##ffunctionc##lar##ificationmembershipmainl##rbonemineral##m##ddualdincreased06368148weekmhrespectivelyresponsehhighermanmann##n w##hits##yne##rgy##fergammatumorne##rosistranscription##alactivationmediatedcooperationsignaltransacttranscription1factor115magneticsecondarystructuretertiaryfoldes##chercod1a##a##bri##l2dlibrary##l3vectorfurther##kl##cbrbraloneinhibitor##9##80##9##01activationlbrlethal[CLS]the##ole##ster##ol##al##pha##ydro##atranscription##allyregulatednumberfactorincludinghormone##leaciddi##urn##alrhythm[PAD] [CLS]c##nsprevent##ivetreatment##ali##rra##diationeffectiveallpatientpatient [SEP]additionallymemberstrongsequenceho##mologylargerterminaleffect##orbindingo##go##mer##izationdomain[SEP][CLS]##parsweetsoftdrinkmanyfoodfood [SEP]therat##ocusedposts##ynastudythepresentationreviewknowledge511e##ico##sat##o3effect##idmetabolisma##1cloneencodedmember##obgeneidentifiedasasbetaho##mo##oclone##dp##b##cripts##kexpressedes##cher##ichik12containl##o##cam1serumdeterminedel##isamethod[CLS]thehighestt##t##x100nlives##cens[SEP][CLS]on##podi##uremayaccompaniedde##pletotalbodyconsequenceconsequence [SEP]##athred##ucactivityliverkidneylungbrainaffecteddiet[CLS]heredescriben##uc##leo##tiden##tsequenceg##eno##micorganizationi##bi##pio[SEP]##comteto##xinstooldelayeddeathdeath [SEP]solublefi##bri##nmon##omercomplexth##rom##boe##mbo[CLS]comparisonm##uriho##mo##loguemoleculerevealshighdegreeconservationproductonegenef##cgammar##ii##bmbetageneprimarysequences##p##licingpatterntissuedistribution[SEP][CLS]acid##osis##osis provoked30co##2##2 i##rre##vers##versiblyb##dr##thowevertchanged[SEP]othersexample11labeledfattyhorizon[PAD] [CLS]theprogression116s##d90[CLS]80b##psurroundingsitetranscriptioninitiation[SEP]ultra##structureto##xin##rdipculture##dpresenceem##tlocalizedchromosome##3132regioncontainsgeneseveralfactorwellearlyactivationgeneparticularlyinvolvedhem##ato##po##ietsystem[CLS]t##b##xmapchromosome7appearlinkedknownmutation[CLS]kaer##updiseaseittestedyetextentdamagebetterreferenceplane12importbetamediatranss3[CLS]theencodedproteincontainsaminoterminalp##d##zdomainfollowedpredictedcoil##edregionp##estdomaincar##boxterminalsadomain[SEP]usingpinvolvesre##share##fraincreasedhoweverage243ma##ximal##hra55ma##ximal41663cm[CLS]severalstudydemonstratedco##rt##ico##troreleasingfactortest##rfusefula##eti##ologicaldiagnosis##shingsyndromediseaseopposede##ct##opact##hsecretsyndromeh##y##pot##hala##mus##uit##aryad##rena##lhp##aaxisstillstimulate##rf[SEP][CLS]transcriptioninitiationregionalsodetectedv##ivoclone##dr##rnageneclusterpresentmulticopy##mi##d[SEP][CLS]theresulttranstranss##1bindingelementlocatedcoreregionposition641alphainintepromoterplayessentialrolealphainintepromoteractivitydown##re##gu##b[CLS]principalcomponentanalysis##ych##osofactorwomanshowedtwops##ych##oso##cialstructureesecondprincipalhighso##chighlifestylelowstress4thprincipalcomponenthighsupernatural##l##chigh##c##c [SEP]expressionregiongeneposition69510b##pmediatedserum##ness[CLS]interactionvre##lproteinn##fdbindingsite[CLS]thisincreaseresultalterdepositioninhaledparticlebroughtvolumerestrictionrestriction [SEP][CLS]appropriatecaresexsex [SEP][CLS]tosystemtranstransad##ipconstructcontainingg##ly##yd3de##hy##dr##ogen##asegap##dhspromoterfusedgenereportercat[CLS]in##omoe##uga##oscellulardivisionreadilys##hrdarkcycle[SEP][CLS]s##gconcentrationwomanhighert2t3t1value[CLS]si##vas##tatl##dl##ster297t13644 alphato##ol##ol 1616 25##ol1022000##1increased##dl##ster##ol7000##1seruminsulin00theseverec##rflikelytotalhlowtheygrowthintbeta[CLS]to##ivorole##ime##ricbproteinontransformationdirectedl##ymph##oidcompartmenttransthisneedrefunction##ainduceder##kactivation[CLS]infectedtranslationm##1proteinreduced20translationneither##1interfere##s##1translation##alstimulationm##1protein[SEP][CLS]somecellexcitedothersin##hibit##eddirectional##lysensitiveop##tom##oto##rstimulusstimulus [SEP][CLS]l##tbetatranscriptionma##ximalthy##micme##du##llas##plewhitepulpmutantcellulartransformation[CLS]interactiondetectedfulllengthh##1smallsubunitgammat##fi##iawe##1intrinsicse##rinekinase[CLS]ashortconservedmotifrequiredre##press##ordomainfunctionmy##elo##idspecifictranscriptionfactor##aa##tenhance##rbindinge##ps##ilon[SEP]and##rogen##bla50year[CLS]##3regulate##sj##monageneviadirectinteraction[SEP]alsoabsence##isegmentheatseed[CLS]theoreticalmechanismh##yper##uri##ce##mia##f##3en##codesput##ativeper##ip##micctypec##och##romemolecular94000dacontainssevenchem##ebindingmotifshowsequenceho##mology##1[SEP][CLS]do##zomaximum##rinarate101m##l3m##lrespectively021m2m##bo##bo [SEP][CLS]h##poxdecreasedratespontaneousimpulseinitiationsanod##alfiberdecreasingslopedi##ast##olicde##pol##ari##zation[SEP]backgroundplate##letpath##ogen##way##yper##res##poas[CLS]t##ferfoundmanytissueadultratrelativeconcentrationt##fet##fe##3rvaryconsiderablydifferenttissueunlikecase##1genefunction##sp##ablenormaldevelopment[CLS]studygammagenereporterconstructca##cboxdel##eti##onrevealedca##cboxsequencegammagenepromotermedia##tesactivationgammagenef##k##lf[SEP]recommendmake[CLS]animaldividedequalgroupfollows1oraldrughem##od##utioniivdrugsa2oralhem##odisa3oralhem##odiivprop##rano##l4oralhem##odiivprop##rano##l55 oralprop##ranohem##odiivsa6oralprop##ranohem##odisa##line[CLS]first##ata1motiffoundbindnuclearfactorpresumably##ata1factorpresentcellextractlivingkcell[SEP][CLS]b##p##nexperimentalin##che##alinmicro##or##gan##ismhighconcentrationvent##ila##p##ila##abolunginjury[CLS]amouthas##ym##metrystudy[CLS]additionallyimportantimp##licationunderstandingmechanism1late##ncyreact##ivation[CLS]in##hibitionduecompetitionvirusipresent##atrans##criptwellexpressionpro##te##oly2##ro[SEP]somemayaffectfoldingpathwayaffinity[CLS]dietim##bal##ance##sis[SEP][CLS]4835507lr##3pp 00 05050h##992##423p##rvv [SEP][CLS]effecteffect fil##trpromoteractivitydelnuclearfactorbindingsiteexaminedldel##etimutant##lace##lt##ran##s##fergeneseriessequencefragmentplaced5##ty##lt##ran##s##fercatreporterabilitymediatranscriptioncatresponsegammal##pstudiedtrans##roplikeraw2647apartlargedu##landscooperative##edial##ysstagere##naldiseaseresidualre##nalcould04weekdial##ystherapytherapy [SEP]module2rlackbetakred##uc##rdomainonemodule33 apparentlyinactive##phbindingmotifsimilaronefounder##kseight##rdomain##ffunctional[CLS]cellf##p##gsexpressioncontrolledtwopromotershowefficiencyleastcontextreportergene[SEP][CLS]th##ia##zidi##ureh##yperinsulindependentdiabetes##lli##tus##tus [SEP][CLS]reduced##athwithinbloodserange101228##gramsearea[SEP][CLS]susuc##roseproducedsourceleafpredominantcarbonsourcedevelopingsinktissuehigherplant[SEP]apersonalviewfuturetrend##assreviewreview [SEP][PAD] [CLS]in##na##rb##orclassificationobserved12i##a2132ci##b3514cii##a25427ii##b4977 [SEP]numerousgenefamilyidentifiedanimallargestnumberfound##tecontainsbindingsites##h##2domainsubunit3mapped##31presentsequenceye##am[CLS]4motorne##urons##pec##ifieswildpatternpre##sy##napinput[CLS]significantdifferenceobservedcompositionnucleartranscriptionfactorboundc##ielementwithinl##dhcpro##ximalpromoterregionso##matic##er##mcell[SEP][CLS]abovetransitionantagonistlowerf##mpronounced##ly[SEP]1986describedopnervede##gene##rationpatiental##z##heimerdiseasesaddropre##tinagang##lionrange3060onemediaresponsibleresponsible alalirathercomplexinter##playexistsdiversepro##in##matcomplementproductc##yt##oc##ainch##em##oc##ain##soxygensproduct1medias##osoextractfractionsecondsteps##licingfactor[SEP][CLS]contrastradio##graphymethoddocumentpu##dc##fduo##den##al##uc##osatypicallyappearsnod##ulardistortedpoor##uc##osa##lfold[SEP]similarbindingmutationsiteincludingmimic##ose##bol##ishbindingpresumablydueeither##fa##vor##ables##icinteractionconform##ationalchange[CLS]abrass##acloneencodingbi##function##alh##ydro##idkinaseth##iam##inphosphateinvolvedth##iam##inbio##hesis##ptmotherchildaffecteddownsyndrome[CLS]differentialdecay##cist##ronices##cher##ichicotrans##criptinitiatedr##eedependentend##lyprocessing[SEP]defectr##t##6expressioncoincideincreasedsuinsulindependentdiabetes##lliauto##mudisease[CLS]bydetectioncorrectionpossiblecausegoaltherapeuticachievedh##ydrodeeffectin##ot82##12the101s1r##ok1genedistinctsetregulatordifferentiation[CLS]temporallobee##pileinter##ict##fflu##oro##de##cospetthreeconditionrestingemotionalspeechperformingrecognitiontasktask [SEP][CLS]s##1suppress##oryeast1identifiedmulti##copysuppress##or1subsequentlyfoundidentical##3r##napolymer##aseitranscriptionfactor[CLS]newlyhatchf##1n##ympha##iolth##ab##rfedfoodtreatedvariousconcentrationh##l##l2c##d##c##lendadultlife[SEP][CLS]ne##uron##alactivity58do##pa##mine##rgda200do##pa##mine##rgdane##uronte##al##tamonkeyrecordedcorrelationbarpressfeedingsensorychangemotivationinvestigatedbothsequenceanalysisrestrictionfragmentlength##mor##phismhighdegreesequence97ho##mologystructuralsimilaritycommonoriginrecentpenetrationd##na[SEP]threenovelbindingpreviouscrystal##log##raphicanalysisinde##cosupad##ip3##3l##1ad##ipu##31[CLS]elevatedin##osphosphatee##pialpha##9expressionsimilarobtained##bachactivationm##1##car##ty##choreceptor[CLS]dtemplateprobed##eiexperimentdeterminesiteproteindinteraction[SEP]wetestedhypothesisreduction##rsympatheticnervessaltwarresultb##m##k119contentde##polparameterv##max##d##psimilart##t##xdifferent##2[CLS]incelladjacentmatrixseveralcharacteristicfi##bro##car##til##ageincludingch##ond##ro##tes[SEP]manbaseo[CLS]allex##onintro##ns##p##licejunctionfollowg##ta##grule[SEP]glucoserepression##rb##1transcriptionmediated##k##1##4genec[CLS]comparisonencodeder##3##d##mproteinho##mo##log##ousmousemanstrongaminoacidconservation71identityespeciallydbindingregionsevenhe##licadomain[SEP]p##yr##ido##st##igin##hibitrecovered100mum1o##xiexperiment[PAD] [CLS]inmoderateb##uc##calclassiitendency55m##olarclassirelationshipevaluatedlwhereas45belongedmild1stdegreeclassiim##olarrotationpresent81casecase [SEP][CLS]mutationonuclearlocale##1dreplicationintactgenome[CLS]serumpro##ct##ino##rad##iolleveldifferentpub##ertydurationvar##ico##cel##eperseaffectdseminallevel[CLS]##ricresponsedo##padi##iodimensionalecho##card##io##allsdetailedcomparisonex##rinepatientlesn##ysyndromecontrol[CLS]enzymedistinctknownknown e##3##sincludingincluding e##3alpha##r##1##1 e##3betabeta e##6a##p[CLS]thisevidenceabilitycar##box##ylterminalcodingsequencestartingb##hisitecomplement##1##1##pcontainstwodomainseparatelyexpressedformfunctionalprotein[SEP]zinctumorne##rosisinter##le##uki1il1innegativelyregulatefactorka##fka##ppadependentgeneexpression[CLS]adistinctmuscularh##yper##tromdoublem##us##c##lingoccurshighbebel##giablue##d##montbreedme##lanii##i##i iivdifferencesurvivalrate2greater200##1thoughlevelatcomplexeliminatednuclearextractbroadreact12proteinthustranscriptionfactorrecognizes12motif[SEP]mutantbetaad##renetpsubstitution350displayagodes##ens##zationrecruitmentactivationroledistinctmitpathwaycooperationet##s2atu##rok##inastype##min##ivainduction##le1proprotedigin##tramatureextraenvelope##d##rproteinpresentsurfacesurface etypeiimembranetopologyabsentassociatedessentialfunctionendd##bs##ivocomplementalphalackyetfunction##ych##op##ath##getvitalhourhour [SEP][CLS]resultin##ulinclearancele80m##lmin1mcutserumc##rea##tin##ine115mum##ollitermen90mum##olwomanwoman [SEP][CLS]thesedatamayred##unda##ncymemberngn##r##1nor##1subfamilycouldexplain##hen##otypicdisturbanceyetfoundmousenggeneinactivatedsampleadditioninternalstandarddirectlyte##tra##cyregulatedsystem##oso##stethus##lmediasuppressionimpairedsphaseprogression[CLS]ta##agsiteservefunctionallatepromoterfoundmediatranscriptioninitiationbasallevelcontextgenomelatepromoteractivationspecificwithin##idae[SEP][CLS]stability125ilabeledinsulinradioinsulininsulin [SEP]inlevel1000mustscreenedorderssn##morganicpath##ologyassociatedassociated [SEP][CLS]##elcausedrapidtransincreasecj##hterminalkinase##nkactivityproposedmediastressactivationpathway[CLS]theseresulth##risuperhormonereceptoriimayregulatemmh##cclassigenealsogenecontainingcontaining er##erelatedsequencecoursech##em##otherapy##b##c##da##dgainpainre##currentbonemeta##stamanagedmainlyadministrationbestsupportivecarecare [SEP][CLS]##1##pbind3had##omenovelmet##hyl##asewhosepossiblesubstratediscussedresultlateral##amedial0000001[CLS]conclusionurban##isationprevalencerateriskbehaviourbehaviour [SEP]howeverwholerequiredunderstand##r##hsignalingcontexthormonecyclehumanseruman##gio##gen##indiabetes##lli[CLS]thisdu##plicate##dg##eno##micregionalsolinkedtightlyd##zgeneticmarkercontaining##oly##morphic##rtandemrepeatconsistingunusual40b##pre##iter##atedsequence[CLS]at##f##6basic##uczipperproteinisolatedbindingparticulartranscription##alactivationdomain[SEP][CLS]c##1sequencefeatureexpressedre##tro##pogenelackintro##nopenreadingframeinterruptedstopco##doncodingregionflankedpairdirectrepeat[SEP][CLS]thelargestoneprobablycorrespondsprecursorformps##2eco##li[SEP]theas##gillgeneproductho##mo##log##ousyeastr##ad##18##uro##sp2[CLS]onmaximumestimatewithinoneordermagnitudemaximumdosetested##1formproteincomplexinteractionterminalregulatoryregion##2domain##1##osmanner[CLS]theoriginallyem##b##ryogamma##binlodu##plicate##dacquirednovelf##etalpatternexpressiontimeperiod5540millionyear##rima##hyl##ogen##y##y [SEP][CLS]c##los##tri##diumb##ot##ulinmarinesediment[SEP]b##lotanalysis##r##37revealedmain33 8k##bmleabundantabundant 8kexpressedbraintissueparticularlycall##osme##du##ame##tenucleus[CLS]indicatesingletransactingfactorabsolutelyessentialenhance##ractivityenhance##ractivity##rimediatedviacomb##inatoradd##itivemechanism[SEP]w##i##38cellcell e##1##b19genesubstantial500foldhighert[CLS]toel##uc##ida##temechanismho##rmon##aleffectstudiedregulatoryregion##kgenetrans[SEP][CLS]consequentlyevolutionma##mmal##k##a##a4genelineagerecruitedbio##ct##ose[CLS]furtherdisruption##r##1reducedexpressionf##b##p##1glucosere##pressgenenegativelyregulatedsolution125ian##kyfoundn##dpage##3enhances##pectselfassociation10foldtranscriptionanalysise##cor##idregionauto##aca##fo##rn##rosisearly4##ilo##baser##naencodingessential##3gene##eri##os##rot##rona##ry[CLS]5in##ven##ous##id##ilohdecreaserestingblood##ricareaincreasepulseratevirtuallyeffecte##jectionfractionfraction [SEP]instudysub##cellularlocationdomainstructurebio##chemical##xinthehumancclone##dsequence##dshownopenreadingframeencoding29##6aminoacidproteincouldfourp##eptidepreviouslymicrose##quencingproteinca##bradmethodchemicalanalysis##gene##dia##bet##istadi##abe##krat21precisionerrorredetermination26study[CLS]fluxre##ticactivate##stranscriptiongene[CLS]thepreferencethirdbaseco##donypositionproalpha##ico##lla##bri##llarco##llatumorcontributionelectron[CLS]de##ton##ationtraumaticloadmilitaryserviceinswayforceclosed[CLS]so##ggysperm##atospecificgenelie38k##bupstreamanti##po##daltea##d2transcriptionfactorexpressedbeginningdevelopment[SEP][CLS]##ratofactor[CLS]resultstudysuggestmedicineusepopulationdependsregularsourcecarechin##esemedicinewellpreferencemedicinetwopredict##oruseuse [SEP][CLS]thegreatest##terr##upmembranepp##rom##ter##mdelivery[SEP][CLS]discussionhigherabsolutekneeextensionstrengthsimilarextensionstrengtho##besmightexplainedtrainingeffectbearingsupportlargerbodymass[CLS]residuesr38##28oxygenanaloguebodytissuefedr38##28dietthegoalexperimentdeterminewhetherlaan##ruswouldprolonged48hfastday13ppeffectcouldreversedproteinle##pt[CLS]pit##uit##3cellvitamindincreaselevel##rltrans##criptstimulate##rlpromoter[SEP][CLS]howeverelectronmicrorevealed##4cella##ulatesecretve##si##cle##31cellaa##ber##rantgogol##gistructure[CLS]methodweretrospective##lydata20patientgate##d##oride##cos##d##gpetpet equilibrium##gio##na##na [SEP][CLS]howeversuggestedslowlydig##estedstar##chyfoodmaypositivehealthbenefit[CLS]northernb##lotgenetrans##cribedseparately[SEP]completeactivationsignaltransact1s##tat##1requires##70##1conservedpmsequence[CLS]overhalfchildinitially##res##poinmen##ingsubsequentlyanti##body##body [SEP][CLS]itunderstandet##iologyhitdevastatingconsequenceconsequence [SEP][CLS]fivesequencevariantidentifiedidentified [SEP]the##arelatedharboract##inbindingdomaininteract##odr##pas[CLS]weanticipateds##nfunctionc##vaas##ym##metricselectedhypothesisbilateralsymmetrics##rlateamplitudei##rrestimulationrecording[SEP][CLS]##pate##ctmeta##static[CLS]adoptiontwistedstructureimportbetaessentialinteractionrequirednucleartransport[SEP][CLS]thepresenceshort70b##pintro##nnearnterminusat##xgenepredictedcontainscanonicalg##t##t adin##tide##s53s##p##licingjunction[SEP][CLS]morehybridproteincomposedppval##factivationdomaindbindingdim##eri##zationdomainractivatedgeneexpressionrrecognizesdenhance##rv##ivoconsequentlyrfunctiondbindingsitedependentre##press##or[SEP][PAD] [CLS]t99brains##pectcomparedcseizure[CLS]wecentral##con##dregionsubunitessentialfunctionlikelyactspace##rconservedncterminalregiontransport125r##ti55bindingpronouncedreduction##netmembraneparallelinabilityhigherpool[CLS]showupstreamregionbetagenegene 55##18249##0relativetranscription##alstartsitedirectedhighleveltranscription##alactivitystabintegratedextra##ch##romtrans[SEP][CLS]d##nas##eiprotectionanalysiswello##leo##tidecompetitionexperimentbindingsequencespecific[SEP]p##las##mi##d##64containsreadingframeframe eorderstudyproteincoupledtranscriptionrabbittranslationsystem[CLS]transtransl##uc##ifer##asereportergenedriven1k##b5flankdthreecalmgenepromoteractivitycorrelatedend##ogencalmtranscription##alactivity##latedregionincludedconstruct[SEP]thesep##1##1 effective##v##ftransplantcondition##pa##ticc##ir##cula##toryimprovementwouldlimitedfirstdaytransplant##ation[CLS]theder##ep##ressedexpressionfix##nobserved##hmutant[CLS]nearly15million##eric##anmen65oldero##ste##op##oro##sisanother35millionrisk[CLS]bothexpress##afonproductgagfusion##inonviasub##omi##omicm##rna[CLS]conclusionda##ximprovedp##har##co##kin##eticprofileda##bictolerate##dregimefront##logtransplantrapidresponse[CLS]encodedencoded es##xerestrictedse##rineboxexhibitet##slikedbindingspecificelectro##oremobilitytranstranstrans##act##ivateetpromoterelementincludingfound[SEP][CLS]areaca##1hip##po##camnumberne##uronincreased1114fold##k80##101[CLS]temporalchangeatconscious##eri##ove##nousfisthighoutputheartfailure[CLS]thereendstudyshowedgoodcomplianceproposeddietschemechildpoorcompliancefamily[CLS]thedeltagvalueregionhigheresecondarystructuralelementfewert##irgeneco##li[CLS]twocloselyrelatedgrouptrans##cript##1##2controlledcirca##dianrhythmisolatedspecimen##pecmainlypatientc##d##d4extensive##zoexposurethesefinding##ife##ainteractionessential##if[CLS]threesimplemethoddetectma##ln##utritionwardward [SEP][CLS]compared##med##icastatesmoothhigherratecorrect##iveletimeengagedtrackingtasktask [SEP]##okiialphareblockedproteinsynthesisinhibitor##hedevelopment##inipneumoniastagesubdisease00 20x109l##3##d##4theeffect##os##inadministrationfeed400mginjectiondisease##tetemgbodycomparedthoseparticipatinginvestigationcenter79computerdiskcontaining5099##m##t##cd##astudystudy [SEP][PAD] [CLS]path##ogenfeverfever [SEP][CLS]twofulllengthclone##1##2isolated[PAD] [CLS]##birth[CLS]theendbarrelcappedshorthe##lix[SEP][CLS]nonfingercodingmoduleconservedamongzincgenedescribedmgenomefingerassociatedboxf##axdomainhumangenomegenome kboxdomain[CLS]thiscombinationfact##iti##oush##yper##ins##ulin##ism##ism [SEP][CLS]comparison5flank##ingregionmousejka##ppaelementincludingconservedput##ativere##comb##inationtargetsequenceshowobviousdifferencevariationre##comb##ination##alefficiencyconcludealthoughconsensushe##pta##mer##ame##rsignalmaysufficientidentifyre##comb##inationsiteprobabilitysiteuseddependsdepends alsode##ter##termina##nt[SEP]me##langrowths##ti##latorregulated##x##l##1con##it##utiveexpressedhighinflammationprogressionme##lanmamali##lignant[CLS]geneticanalysis##43upstreambranch##1signallingpathwaysince##43mutationsyntheticlethal##1delwhereas##43defectcouldrescuedhighcopyencodingdownstreamprotein##1pathwayunlikewhosedisruption##3mutantresultedgrowtharrestg1growthdefectobserveddouble##43##3mutant[CLS]twelve92showedcognitived##ysimp##airmemoryattentionaffect##ivedisturbanceanxietydepressioni##rri##ta##bilitypoorfrustrationtolerancetolerance [SEP][CLS]c##lar##ifymechanismregulatetranscription##t##pc##dr##olaigenegeneratemultiples##pec##iem##rnaisolated##eno##micdclonehumanmouse##t##p##dr##olaigene[CLS]thereforestructuralinteraction##al##aistabassociation##alphotos##ys##temicore##ctorse##ptic##rino##tens##hra[CLS]thepresentstudyscreening11oppathfunguscan##dial##ansnegativem##od##1pro##co##llageneskin##brotranscription##al##fer[CLS]ho##mologyexaminedrolecre##lcontrollingil##ralphatranscription[SEP][CLS]expression##b##30##0potentmediatedtrans##act##ivation[SEP]werapidbacterial##oddomain##od##ulincolumninvestigatedppppk##cinteraction##od##ulins##a[CLS]accordingpenetrationca45microsection[CLS]h##l##hes##izeddirectlyh##dllip##idmetabolismtissuecellularlip##idmetabolisme##ps##rexexerttrans##act##ivatingfunctioninteractionre##combsignalbindingr##b##mo##mologue##ros##opsuppresshair[PAD] [CLS]mad##uro##cosititaly##aly [SEP]twogroupinew##ptiith##rom##be##cte##pt##raft##raft [SEP]thethe authordescribestechniquedetailpatient10menmen 15il##eo##stodrec##ro##hndiseaseil##ealo##bss##a##a [SEP][CLS]increasedsu##ptdistract##ortaskrecallverbalcommandcommand [SEP][CLS]lastingpara##ple##giacausedlossl##rspinalcordinter##ne##uron##sratdirectcorrelationmotorne##uronloss[CLS]universalspecificmechanismactionfactoruponlivingtissuebaseddelreactionsuggested[SEP]r##v714m1min1001c0590mcalculated1ratiodeltadelta95153p63delta195037flowwestabledo##ubtranscell10carryingch##rom##oso##malintegratedp##te##tetoreportertekprotein[CLS]electricalstimulationnratobservepress##orrapidapproachscreeningne##uro##se##cre##toryfunctioncentralneuralintegrationrelease##as##op##in[CLS]tostudyadaptiveprocess##structure##d##tainterviewdailybasis30yeardivorcedmalefirst3initialcomprehensivein##patientrehabilitation[SEP][CLS]me##lio##idosideer##er##vunienter##ob##ius##rm##icularegg##artakenposteriorfor##ni##x##natogetherresult##b##pgeneralcooperationpartner##elo##moncell[CLS]medicalaidsoughtfalsehistorygiventruenaturechildillnessheatstrokedetermineddeathdeath [SEP][CLS]bothd##2d##3closelylocalizedchromosome5##q##21correspondinghumanchromosomechromosome 4##q##21sacrucialhighlightnovelalternatives##dvarianttranscriptionfactor##al##phaolens[CLS]fi##1##p##p fi##plikelyactcellsurfacesurface fi##1betagalbetafusionproteinlocal##izeperipherymatingcell[CLS]crystaltriplemutant##42##dd##47##p##6##3##lstabledayo##xi##dizedformgrown##moncellconstantb343c111111 8abelongingspace##321[SEP][CLS]neverthelesspinfluenced##rodrugavailabilityconsiderablyincreasingdrugso##lubdissolutionrate[CLS]normalreplicationdstill##c##3##fmutationfoundextractplant[CLS]suchsat##urationseveralrecordingsweepsignaleyeblinkrejectedrejected [SEP]muscleliverbioan##oma##lywithoutbranchingenzymedeficiencyliverliver [SEP][CLS]possibilityindependentlyadministeredcenter[CLS]airborner##abien##pha##litdemonstrationr##abihumancentralnervoussystem[SEP][CLS]t##1t##2valuecalculatedbrainv##ivo05tt [SEP][CLS]automajorsitey##12##35up##re##gukinaseactivityreceptorincreasingv##maxp##ot##ferreaction[SEP]clinicalinter##le[CLS]c##longeneencodingben##zen##ede##gradenzymefoundstrainj##15##0alsocarrygenetoben##zen2##oo##xy##gen##ase[SEP][CLS]associationt##ptaboxmayregulateddirectlyindirectlysubstrate##f##1##g[PAD] [CLS]itdifferedcue##drecallinstructiondirectedsubjectawaymemoryaspecttestcompletethreelettercuefirstwordcamemindmind [SEP][CLS]realtimedimensionalecho##card##io##ralaxisviewobtained10normalsubject[SEP]damageyearonset33 8y##r[CLS]itshown##iantiexpressionregulatedsystemsimilar##csregulatorysysteminvolvedcoacid##cher##ichico##li[CLS]themapbasedreferencep##ig##ree4000newg##eno##typepreviouslydata29all##elesystemversiondatabaseconstructedusingprogrampackage##rimap[SEP][CLS]ho##mo##rom##some13severalsetcloselyspacedprime##rdesignedbasedc##asequenceusedamhuman##eno##micd##r[SEP][CLS]mg##2extentdes##ta##bil##rnagreaterappearsconfinedinternalregionaccept##orps##iche##lixevidencedselectiveenhancedexchangerateproassociatedbasepair[SEP]study26patientpatient [SEP]serumalphaam##ylatrytrytotalpro##te##ase##cre##atictissuestudiedindicatorflu##oroelectrocum[CLS]1theeffectdos##ire##tanidi##urechemicalchemicallyrelatedf##rus##em##ideb##ume##taniseverere##nalins##rea##tin25m##lminsynthesisod##3analogueeffectgal##4operates##4consistentlargepocketr##bbindingii250largepocketdomain##0ablebindii250##ivo[CLS]50n##uc##leo##tideintro##na##a[SEP]theeducationalprogramfactorinfluencedchangetrajectoryrerecurrentre##currentfactorinfluencedchangepamphletgroupgroup [SEP]##p4##21q##rgeneindependently##rone[CLS]activationreceptorinducere##tp##lationleadsurvivalpromotingeffect##oobtainedindicatedma##ximal##o4reached[CLS]thispaperdescribescoursetherapy##rappatientpatient [SEP][CLS]kineticmodelusedidentifymajorchemicalreactionpathwayinvolvingp##ahafter##burne##r[CLS]hehen##ry##lerbroughtactualxraytreatmentd##r##r [SEP]criticalreviewtesth##banti##gendetectiondirectinitial60year##ral9closedmit##ralcom##rotd##41dominantsuppress##or##4nexchangeproteinaid##4##pfunction[CLS]thesemonitoringhighriskpregnancy[CLS]thesitepredict##ricrestexerciseanteriorimpairedinferior111113patient9898 produced##bm##l##l [SEP][CLS]theinteralphail##ralphachaingenecontainssequencesimilar##ppaenhance##rnka##ppabbindingsitecomparisonderivedaminoacidsequence##9##9geneproductreveals348identityoverlap66aminoacid[CLS]although##del##tacellyeasttobaccop##pch##eraimport##p##1##preportergrowacidconsistentobservationintroductionssitet##f##bet##1##ftargetgenecon##ferscooperativecooperative t##bet[CLS]inanalogyhuman##d##70##d##70trans##criptlevellevel stronglytrans##lyregulatedl##ymphactivationlinerole##d##27##d##70receptorpairearlyimmuneresponse[SEP][CLS]serumi##g##mlevelshowedhighlyincreasetypebraint##umourcontrolbeyondfirstyearre##naltransplant##ationi##ol##rdca##dall##og##raft##raft [SEP][CLS]##k##k8##k##k##1##krear##rang##ementencodedrespectivelchainvregionregion [SEP][CLS]nursingdeeplyrootedhumanhuman conditionclinicalfindingplaqueindex##ig##ing##ival##ibleedingprob##oppudischargepupro##bingdepth##dppt01sitemeasuredeveryvisit4week[CLS]oneelementresemblesbindingsitepreviouslyidentifiedcellulartranscriptionfactor[SEP][CLS]##ralso##mihostcellactivationvectorcontainingl##uc##ifer##asereportergene[SEP]plasmat##ibi##abreakingpercentaget##ibi##aashincreaseddiet##arypresence39##1cacok##1##1 h##4[CLS]infungusne##uro##sp##t2majornitrogenregulatorygeneactivateexpression##linkstructuralgenespecifynitrogencat##ab##olicenzymeconditionnitrogenlimitation[SEP]thematrixc##bscontainsdiagnosticco##zedattachedembeddedbs##osocontainss##psduringobservation12weekha##lvingate##nomeandose82mg41mgs##ys##todi##astblooddi##astblood95leobservedcomparativevolume##tricanalysisdifferencecorpuser##hrperipheralblood##v##bdiurine##vupatient33hiinfected##ido##vuserumr##nalevel20000mc##d##4count50400cellmm##3[PAD] [CLS]withinyearwwwgrownenormous##ly##ly [SEP][CLS]these##rfbehavioralact##ivatingan##xieffectleastpartincreasingactivitynor##ad##rene##rgne##uron[SEP][PAD] [CLS][CLS] oncaseauthordifferentclinicalpicturecausedcardiactoxicity##fu##fu [SEP][CLS]thesequence##1##pcontainstwoput##ativezincbindingringmotifzincfingermotif##edmotif[SEP][CLS]cardiacoutputdecreasedslightly##fhem##ody##namchangedue##funlikelyaccountobservedfall##ao##2##2 [SEP][PAD] [CLS]anti##o1##bodypresentpresent [SEP][CLS]thefirstop##eron##f##1##1 to##raironregulatedgrowthironregulatedexpression##bop##rlfusionlatelogphase[SEP]auleakdetected15samplein##bate##bated4weekleakin##bate356week[CLS]weexaminedcontributioncry##pticp##mi##d##r##4##bnod##ulationsatstrain##r##4##zo##bi##lotlaboratorypre##rena##renalacutere##nalfailurefailure ee r10unpredictableunpredictable factworsepro##gno1057death1010 48deathdeath [SEP]##ple##ao##icballooncounter##pu##ls[CLS]##t##p##d##p##paffectresponseresponse [SEP][CLS]usingfluorescentproteinfusiondemonstratess##xss##xproteinnuclearprotein[SEP]theanunderwenttransplant40monthperiod##apupuert##a##a dehi##er##roreviewed[CLS]respiratorydistress[CLS]thesedatasuggestedmutantps##1maycausediseaseresultreductionps##1function[CLS]theanalysisorganizationsequencehuman##b##pdagenereveals24k##ilo##basemessengerr##natrans##cribedtwocloseoriginidentifyingpro##ximalpromoter[SEP][PAD] [CLS]mostion##izationtechniquestage471yearsurvival##1##0comparedt##2##n##0286t##1##11919 44 [SEP]investigatesteps##osoassembly##pactused##atgelelectro##ores[SEP][CLS]internalfragmentu##24met##hylguides##nor##naencompassingupstreamantielementdcboxmotifsupportsitespecific##hylr##rnared##ucshowsphasespecificexpressionconsiststwoidenticalsubunitproteinr##1largesubunitr##2smallsubuniteffectde##hasdevelopmentradiation##ph##roprat##k##1r##k##1##exes##cher##ichicorecognized##bodyraisedkinase##enostarstar anti##ot##os##bodyidentification##cevidencerelatedyeast[CLS]##ktmemberactivatedviap##i3kinasesignalingpathway[CLS]sobackr##ado##ntransformr1correctresultat##uation##uation [SEP][CLS]beforefl##eca##iniinm##or##phologicalidenticalspontaneous##lyoccurringa##rr##hy##th##mia##mia [SEP][CLS]anadditionaldose2025g##ydeliveredsiteoriginalinvolvementimp##lantfeasible[CLS]theprominentfracture75yearhipfracturetypeiio##ste##op##oro##sis##sis [SEP][CLS]theexpectedproductclone##db##phgeneexceptb##3observedeco##li##it##rotranscriptiontranslationsystem[SEP]it##oc##aguprolongedbleedingtime##letcount##agufactornormal[CLS]resultanalysis##earcorrelationshowedhighers##smdrumrotationfollowinghigherr076higherratiospectralegg49cycledrumbase00 63chigherspectralfrequency04hbase##3r029##4r031higherratiospectral04hdrumbase##3r031ehigherskinbase030saltfourmedium[CLS]theconsensusconsensus maerstresselementelement er##seconservedpromoterconsiststrip##art##itestructure##aan##9nstriking##lyg##crichregion9b##p[SEP]acutetoxicityins##tarto##x##or##nchs##plem##os##quitoadult##icidesma##hi##onre##rinpositivecorrelationlevel##9##cbindingdifferentiation##ro[CLS]effectacuteexposurecoldawakeratwhenlabeled99##m##td##tserumsuperior99##m##twithoutattachedd##t##pa[SEP]unlikecs##3domainh##ylal##ydmotifabsentamechanismindefenseinfectionevaluatedevaluated [SEP]8837373743objectiveto##mina##nt##urosevere##ares##rist##em##otherapy[CLS]themediansurvival18monthhem##or##rp##har[CLS]itpstronglypotentabilityactivatetranscriptionf##opromoterte##rna##rycomplexassembledf##oserumresponseelement[SEP][CLS]f##us##3##p##1togetherincreaseexpression##ln##3##lgenepromoteb##uddin##1##pin##hibit##smapkinase##de##de [SEP]consistentobservation##p1bindingcontributeco##act##ivationobservationactivationpu1blocked##o[SEP][CLS]apossiblecorrelation##di##bula##rgrowthre##tar##dation##alac##le##ftingdiscusseddiscussed [SEP][CLS]timedependencepotentat##rium[CLS]4highlyconservedregion##90exclusively27acidconservedamongdiffering##90alpha##90betasequencecharacterizationt##leotandemrepeatcontainingtrans##criptobtainedspinalclibraryfilterhybrid##izationwepresentcompleteprimarystructurehuman##33variantkidneyautocausinghey##mann##ranog##lo##mer##hrratrat [SEP]membraneiireceptorinhibitorusedhigh##rona##ryusedused approximatelyonethird##rona##ryinterventionunited##pe##pe [SEP][CLS]conscious12oxygennitrogen##erial44750pre##nat##aldiagnosisgeneticdiseasedisease [SEP]protectiongas##tro##est##inal##uc##osa##l[PAD] [CLS]readymadeproplacedexternalsideribverticallybr##idfl##ailedchestsegmentfixedfirstupperfirstlowerintactribwellmobilesegmentaffectedribrib [SEP]designcasestudy##adiataskclassification22 [SEP]sitedirected##uta##4endgenerole##ys130[CLS]aminimalp##omoinductiondomaindel##atedresidue301335s##pdependent##omomitpathwayinductionactivity[CLS]librarythususefulselection##sm##idclonecarryc##d##cgeneyeastcomplement##ingfirstvector##ialyeastgene##1##yr##idaux##ot##d##cstrainrespective##dwildgenetemperaturesensitiveall##ele[SEP][CLS]thesemutantrleaderl##igate##d##adaexpressioncassettetransformedch##op##lastcre##in##hardtee co##li[SEP][CLS]inactivatedr##al##dlikefactorstimulatec##y##cd1transcriptione##factivityacts##rgy##i3kinase[CLS]frompresentconcepthormonedependent##ractivationrequiresdirectindirectin##cularinteraction##dlb##d[SEP]likedunlikeclassiigenegene zgenecodetwoc##ys##teinresiduemightinvolvedformationdi##sul##fibondalpha1domaindownregulationid##1m##rnacorrelatedmit##ogenq##escellfactoractivatereceptorreceptormitsecret##og##rani##niis##isecret##ptlargedensecore##uro##end##uroncell[CLS]conclusionresultstudys##d##bevensindependentlyassociated##yper##tens##ionwomanelectronspinsuperdspinadd##ucstronglyinc##geninhibitoret##od##ola##olacdependentmanner[CLS]b##k##k##ofwellcon##it##utivedifferent##ozevidenceroledi##gly##olsensitive##csalphae##ps##ilon##ksignalingtoward##k[SEP][CLS]em##b##ryomortalitymortality [SEP]leadacidh##ydro##laseanimaltissuecharacterization##aencodingtwounusualee244 ee2abilitygenehybrid[CLS]interestingunlike##k##1containsmall##pasr##ac##1c##d##cbindingdomainbind##1suggesting##k##1activation##ac##1##dindependent[SEP]theresultfindingpairfedtreatedcontrolgroupne##rosispersystemiccirculationhoweverplasmafi##bri##noshowedstatisticalpositiveassociationimgroupwithoutteamhope##etalsurvivalmortality80100100 [SEP][CLS]analysisdel##eti##onsubstitutionmutation##r5ex##ondemonstratesunusuallylargesizeex##onplayimportantroles##p##licingregulation[SEP]studysignalingpathwayregulate##os##kel##etalrear##rang##ementl##ymphsetcon##gateformation##ur##katcelleffect##orlate##xbecoated[CLS]re##ex##d1revealedadditiondefect##iveonsetsphasedefect##iveg2mtransitionreleased##uresphasearrestall##pt##idecontaining26##3residuederivedcterminusp##13##0##gaeresidueresidue 92##0118##zy##oskinase[CLS]astructuralmodel##puproposedmembraneanchorpre##cederegiontwoalphahe##lixopposedpolarjoinedstronglyturnpro##tr##udesc##op##mcontains##ksite[SEP][CLS]there##combcontainingfulllength##hed##rinleadersequencegavelevelm##rnacomparable##rna[CLS]immune##ob##illacid##opas##ththus##b1associatedfactorrepresentsfirstcardiacrestricteddownstreamregulatorygene##obgene##k##x5pathwaymayservenegativeregulator##f1dependentpathway##ric##ularmusclegeneexpressioneachreceptormustengageuniquesubsetavailablesignalingelementleastselectionproteinshodomains##h##2protein[CLS]amethodsscomplexstructurebuiltinvestigates##especificallyrecognizessubstratef##racex##polimitonederivedallauthorbased##ogramj##ul[CLS]##rona##ryarterydiseasered##but201##thalcardiacre##jectionseverely##cheviablemy##oc##ard##iumparticularlyusefulpro##gnopatient[SEP]howeverrecoverycurver##2componentblinkpatienttensionheadachegroupgroup [SEP]whenre##ehecellprobe##ot##osdim##eric##eform130k##dasurface[CLS]transformingfactortbetain##hibitcellcycleprogressionpartregulationgeneexpression##21##1##1cycleinhibitor[CLS]theresultsuperficialdeepco##rt##icalve##nousdrainagekidneyre##nalre##ninrelease[SEP]conclusiondetectionre##currentcancerfeasible##d##dgpetpet [SEP][CLS]theredifferenceincidencefracturedz##ona[CLS]d##pincreaseslowwavedeltasleepsleepe##egpredictacuterejection[CLS]7ni##tro##zoselectivene##uron##alni##tricoxides##ynthn##nosinhibitorin##nea##llyadministered30minuteonsetlocalan##ox##ia[CLS]mutationextendspecificend##uc##lea##seactivity##daterm##inas##e[SEP][CLS]genesetmitochondrialgenomesubsetre##lino##monaam##ericam##oe##bo##idpro##zo[SEP]anevaluationplate##letneutralactivatedth##romthepror##nabinding##kmemberalphatypepro##so##malgenefamilysinglecloneperfectho##mologyeightrodesequencetagusedtemplate53rapidam##p##aends##picesystempolymer##asechainreactionam##p##lification##aendreactionobtain36k##b##bank##19##5encodingde##duced##pt96##3acid[SEP]thesetinyprematurereceivedsignificantlylongerperiodtimelongerin##ole##stadeveloping[CLS]thes##mspecificselectionex##on2resultinex##on33 [SEP][PAD] [CLS]presentdiscreteorigininsertioninsertion [SEP]medicalstagebreastcancercancer [SEP][CLS]fivegirlturnsyndromeyearshowedshowed lvalue5014i12hupperslightlypath##ological##ly2222 43i12hf##sh##sh [SEP]##it##rodeathtransover##exdel##etiis##ofbetagal##os##idasreporterfollowing1nbindingdomainactnegativeregulatordef##cap22 lrepresentsput##ativecon##it##utive##ly##ly activeinduce##ra##pop3killingin##hibit##hibitableaso##oro##etongaso##oro##etondef##capinpatient9kidneyirrigationsolutionre##nalperformeddissolutioninfectiousstonestone [SEP][CLS]theusesi##gma54promoterknownrequire##gnatebindingcouldfineprovidestemporalordering##ellagenetranscription[SEP]##9##4##75##3##9do##c[CLS]knowledgetranscriptionfactorexhibitand##rogenexpression##pid##idy##mis[SEP][PAD] [CLS]focalregional820h##ze##pile##ptpar##yseitherhip##po##cam##pus10patientam##a1patient1patientprecededinitialmotionlessmotionless staringstaring [SEP][CLS]thelack##tero##gopositionposition essentiallyonedataanalysisdetectionnewall##ele[CLS]e##pitspecificactivationachievedcooperativeinteractionapparentlyu##bi##quito##ustranscription##alfactor[SEP]b##19geneexpressionviralppromoterb##19##prestrictedhumanhem##atoundergoinger##hr##oiddifferentiationpath##ogencorrectdisorder##idat##osenter##ososectionusuallysingleholegridsimpledevelopedcry##otherapyre##tinopre##mat##urityha##lvedtreatmentbionormalcell[PAD] [CLS]bleedingpreventedi##vdes##mo##press##fi##bri##not##ranelocalgcompressiontechnique[CLS]he##teroo##mer##izationspathwayrestricteds##madessentialsmediatedtranscription[CLS]thisfragmentcontainstwocompleteend##obeta11 4g##can##aseencodinggenedesignated##cc##c##g[SEP]onelimitedinteractioncommoncerebralcortexcortex [SEP][CLS]analysis53terminustrans##criptproducedv##ivopuop##eronrs##erodelta34##8420threetrans##cript05906464 263k##ilo##base##slackinginter##cist##ronicterm##inatorstructureidenticalcorrespondingtrans##criptderiveds##ero41fourtrans##cript05006607171 27##ilo##base##sshowingtrans##criptbeginendsite[SEP]theop##ticoolingrater##t5degreeresultingmaximumsperm##atofound051degreer##tsubsequently##2##2 [SEP]the##ere##bella##rco##rt##icalvesselcomparedcerebralvessel[CLS]##hageecho##card##ioriskfactorstroke##vu##larat##rial##bri##lla22##net##oregion[CLS]prevent##ivehealthcounselingtailoredneedgroupbeneficial[CLS]strainlackingfunctionalgenegrowrapidlywildtypewhereasallgrowslowlytype[CLS]neon##ata##lh##yper##thy##roid##ism##ism [SEP]afterhybridtwo##x##31trans##cript2218k##bdetectedtotalrkha##cattrans##cript219k##btotalrtranscellinf##r##3signalingpathwayutilizestwo##rbcontainingcomplexs##rbso80##kh##rbsocomplexmayalternativelylink##3kinase[CLS][CLS] inidentifyfactorinvolveder##hr##oidregulatoryisolatede##kgenesystematicallyanalyzedpromoterregiontheirmainrepresentative##ericdiagnosticmentald##smii##irevisedversiondii##irnew##d1010 [SEP]anyopchestradio##graphwidedifferentialdiagnosisdiagnosis [SEP]chloride20##hlargerareausedsignificantlyrate900##h##z[CLS]intorpedosingletrans##criptseenexpressseveralm##rnaencodingdifferentis##of##orms[SEP]fourfamilyho##mingendidentifiedincludingla##glic##ysbox##i##y[CLS]convergencet##em##inalinput##al##hren##icinput##rima##1c##2spin##oth##ala##mictractne##uron[CLS]involvedregulationgas##sisynthesis##hilarch##aeidentifiedtranscription##alact##iva##torpromoterlocatedupstreamgeneencodingmajorgas##sistructural##pa[SEP][PAD] [CLS]no##so##graphicproblemproblem [SEP][CLS]inearlymid##gesem##b##ryoexpressedte##pha##licdie##phame##pharegionday1175##esta##estationexpressiondisappearsdorsalte##ce##pha##lonconfineddie##nce##pha##pharegionregion [SEP][CLS]thetrainingprogramduration30day5dayweekperformedmotordrivent##read##millphylogeneticanalysisneighborjoiningalgorithmclosestsimilarityhorsem##uchainencodingconstantregiongenehumandogsequence[CLS]usingproberegionrear##rang##ementidentifiedninecase821am##lexaminedexamined [SEP]c##lonn##uc##leo##tidesequenceanalysisrevealsbenho##mo##logd##1alsocalledn##almare##pressbasaltranscription[SEP]##2ho##mologyhyeastsa##har##visespeciallyregion[SEP][CLS]earlierdatas##1bindingr##1alphabetaregioncouldconfirmedsuggestingr##1in##iti##atorelementmayfunctionindependent##1[SEP][CLS]inreducedmetabolismco##tinprom##papparentlyresponsiblesustainedplasmani##cot##inelevel[SEP][CLS]activationhi1requiresbindinghostcelltranscriptionfactorc##ielementpro##vir##allongterminalrepeatl##tr[SEP]theyeastmitochondrialh##70##1##pfunctionm##d##j##1##pd##jho##mo##mologue##1##pho##mo##mologuetdbindingleadtrans##actco##rrelinability203##5increase##p1[CLS]thericegeneconsistsfourex##on##on [SEP][CLS]howevergene##ifics##yne##rg##isticeffectcatactivity##p13elementfoundco##lla##ase3genepromoterfoundequationmeantnumberpassedtestt##bwwiappearedappeared limitedmethodlimitingca##x##per##iment##alinpost##mit##oticne##uronpossessedextremelylevele##f##1proteinassessedelectro##ph##ore[CLS]rehe##pa##ys##tpartialexdrainagecomplicatedfist##ulaformationc##ysduo##den##um##um [SEP]reversal##quin[CLS]possibleconsequencebind##erdistributionpowderaggregatediscusseddiscussed [SEP][CLS]thehumancontainsput##ative##lationsignala##ata##aa13n##leo##tideupstream##lationsite[CLS]thedeltams##vtumordblineagetumortypicallyrear##rangedimlocontainedcontained gger##m##m lineline configurationtreceptorbetagenegene [SEP][CLS]theexperimentalresultequilibriumcomplexformationoot##c##pmainlycomplexvinjectedproductcombinedinjectionformulationformulation [SEP]##fles##ionsecondaryin##muscontaininglongtermlocalimmunereactiondetectedpatientsystemic##pt##omappeared##ation##ation [SEP][CLS]examineeffectcampsignaltranspathwaytranscriptiongeneencodingcat##alyticsubunitglucose6##pas##pas##fercatfusiontranstransliverderivedhe##p##2kidneyderivedline[CLS]whereassequencealphaact##ininow[CLS]bycontrastc##lon##id##ine1micro##gramkgelimmediateprolongedfallbloodheartrategiven##brain##ven##ously[CLS]theshiftcomplexicomplexiiseen##m1suppressed##los##poraa [SEP]f##er##ritvaluehigh47mgresultkitcomparef##er##ritgreater300castdoubtcontroversialserumf##er##ritmeasurementironover##load##load [SEP][CLS]post##p##bsuperiorgroup3903v[SEP][CLS]erbetalepotenteralphaact##ivatinge##2er##elactivity4v[CLS]theexpressionpattern##xchangeddramatically##b##ryoexpressionseeninitiallyentireneuraltubeme##so##der##msecond##arilydown##re##gu##latedsecond##arilyc##alnervegangc##rani##of##ialme##sen##me##me [SEP][CLS]disruption##lsub##cle##ardomainacidic##1c##irmediatedinteractionmaym##od##ulateringfingerdependentcry##ptictrans##act##ivafunction##l[SEP][CLS]further##moreg##crichsequencecouldcons##1dependenttrans##act##ivationhe##ouspro##ctminimalpromoter[SEP]twelvepatientle##p##ros##hrwithoutart##hr##itisim##mu##munologicalparameterlikereactiver##idfactorassertpro##ct##inaffectdelta5delta4pathwayeffect3##bet##ah##ydro##ster##oidde##hy##dr##ogen3oh##s##dthe##pt##ide24contains16c##ys##tein##eresiduearrangedfourclustertypicalco##ofsuperhasuz##ono##rolauthorauthor trans##l##l [SEP]p##60boundfast##cesswildi##pilackingcar##box##ylterminal24aminoacidilackingcar##box##ylterminal40aminoacidwhereascellularproteinpr[SEP][CLS]stress##all201my##oc##ard##ialimagingan##ginheartfailureidentifyclinical##lysilentareais##che##micmy##oc##ard##iumdistinguishscarre##vers##iblyis##che##micmy##oc##ard##iumcauseakin##esivent##ric##ularwallsegment[SEP][CLS]thecommunityacquiredb##act##eremainlydueeco##li[SEP][CLS]y##1y##2y##4pp##1##1 [SEP][CLS]plasmaglucoseresult##ptcon##itaseveraldiversediseasedisease [SEP][CLS]developmental##lyregulatedinteractiontranscriptionfactorcomplexcontaining##d##pcutearlyhis##3genepromoter##rch##rchintetetrachangech##roma##tinstructuregeneexpressionprocedureperfectmethodmethod [SEP]shiftdegreemutant1##91lostrim1cellcellbecomecluster##ed[CLS]themproteinexpressedallcell##ur##katdesignatedhug##1ho##x##11upstreamgenegene [SEP][CLS]thestssequence149##20factderived3regionhumangene[CLS]itconstructcatgenedrivenh##k##b5enhance##rregionh##2##t##f##1##b##f##1sitecomparable##catcarryingstrongrl##trenhance##r##3appears##mo##loguewellpro26regulatorysubunitthegene##usniniduen##codes73##9aminoproteinsimilarity##35##pdadal##l8##1##p##psalittlehonouredstatuerecognitionrecognition ed##ward##enne##rm##d[CLS]p##har##kin##eticinteractionl##35##47##40di##az##amleadinglevelfreedi##az##amdemonstrateddemonstrated [SEP][CLS]thepromotermet##hyl##fer##asegenelackidtaboxcharacterizedc##p##gislandbeginapproximately72##3n##leo##tideupstreammajortranscription##alstartsiteextendsex##on1firstintro##n[SEP][CLS]nopromoteractivitycoulddetectedvariousfl##i1promotercatconstructcontaining600b##p5flank##ingregioncompleteex##on15endintro##n1##tro##all##trsequence[SEP][CLS]thediscoconservedfourregionknownimportantggt##pbindingcontainedcterminalca##ax##amotifsharedrprotein[CLS]an81n##ttandemdu##plicationcterminalcodingregionlocatedadjacentterminationco##donc##yi##ii##bgenepotentialre##licslipped##air##ingreplicationevent[SEP][CLS]only53injury125injuryinvolvedchildcontrast1950searly1960syoungadultappeargreatestrisk1980s1980s [SEP]themethod48h##r##oc##ardin##farsoperatedcontrolherepopulationgammatransadultstructurecry##gsgene[CLS]theslopeq##dversusfourtubenearunity[SEP][CLS]theextento##don##to##blastprocesshumanden##tin[CLS]mac##ropbetasubunit##d##11##a##r##3complementreceptormac1en##acshowntolerateconvenientgo##hoe##a[CLS]weassessedcard##iovascularvariablebloodo##2contentordero##2##readexercise[CLS]thefindingdiscussedreferencepossiblemechanismparasitedevelopmentmightcontrolled[SEP][CLS]the80k##bprecedingexpressionsitefunctional##fscontains50b##prepeating##ire##tro##tra##ns##polikeelementnovel412k##brepeatfoundnearte##lo##mere[SEP][CLS]thepredictedproteinstrongho##mologya##baingrichmaizeem##bma##mmal##mmalianrbinding##1he##tero##genecomplexpre##rnas##licingincreasecaeffect##amir##ad##ad [SEP]wecomparedpollentraptrap f##eb##rua##p##ril19881989[CLS]##b##lsignalingmoleculemultiplefunctionaldomain##hdomainbind##ot##osresidueringfingerdomainact##igaproprolinerichregionse##rfdock##ingsite##3containing##ot##osservedock##ingsitecontainingprotein##lsubunit##i3kinaselocalsignal[CLS]surprisingly##pois##o1c##och##romeabsentc##c##3strainalthoughis##o2##och##romepresentpresent approximatelylevelho##lois##o2c##och##romefoundc##c##3strain[SEP]analyticalp##doneorderparametertemperaturephase2dx##ymodel[CLS]the##ric##ulardemandpace##makerimpthreeyear##aircardiacperformanceperformance ase##quentialpace##makerd##ddusedrestoreat##rios##ync##hr##oni##sation##sation [SEP][CLS]itpredicteds##tro##optaskwouldtriggergreaterconsumptionicecreamfearfulfilmeffectwouldpronouncedbin##geeat##ernonbin##geeat##er##er [SEP][CLS]linehypothesis##ffunctiongrowthcellcycleregulatedte##ther##ingfactor##1basictranscriptionmachinery[SEP]therepositivecorrelationchangebase##line##iet##allobematter##osoch##olin##ech##olin##rea##tineratiocognitiveperformancemeasured##z##heimerdiseasecognitivecolonizationincreasedlevel9independentapartmentapartment 60acutehospital0000001isecondgene##har##vis##iaeendomainho##mo##log##ousg##pasact[CLS]ex##on##1en##codesregion[CLS]coopera##ti##vityfunctionaldomainmusclespecifictranscriptionfactor5[SEP][CLS]##rea##tinc##rea##tine##oki##nas##p##k[CLS]incellresultarrestcellg##14##ndcontentpseudo##1[CLS]thesealter##ationoccurredm##rnaproteinlevelaffectsub##cellulardistributionfouris##of##orms[CLS]ggly##lyox##ysp##id70k##daco##tyencodedsinglegene[SEP][CLS]suspectedend##osis31##1tweightedspinechoc##sealonecombination##1weightedfatsuppressed##1##fs##adoenhanced##1##fsg##d##1echotechniquetechnique [SEP][CLS]se##ro##con##version##pa##ation[CLS]acasebilateraltest##er##mtumor23yearmalereportedreported [SEP][CLS]totalbodyb##m##dr0300202 f##em##oral##m##dr03900002positivelycorrelatedweightbearingactivityweightbearingactivitytheeffectcast##oroilalonewellcombination##2in##acgas##tro##int##est##inalfunctionratcheckingcompliancen10f##kconcentration0ngmanalyzedanalyzed [SEP][CLS]k[SEP][CLS]thehem##ato##po##ietformtrans##criptinitiateddownstreampromoterseparated7k##bfirst[CLS]theresidualsmallr##rnap##okappearsynthesizedviaupstreampromotermissing3744n##leo##tide5endindicatingeitherpre##rnaprocessedabnormalabnormal5runstable[SEP][CLS]extradosedueextra##4missionmeasuredboardt##ldsystemsystem [SEP]unconventionalm##rnaprocessingexpressiontwo##of##ormsdi##yo##liumthede##ducedaminoacidsequenceopenreadingframesignificantlyho##mo##log11 ulul4##95geneproduct##9containspotentialsignalsequencetrans##ranedomaincharacteristicmembraneprotein[SEP][CLS]stimulation##ome##pha##chia##b##r##inch##olin##ergicdrugelectricitypotentpainsuppressionant##agonop##iateantagonist##xon##e##afactorknownre##mo##del##romastructureconcertn##somere##mo##delfactor##f##ros##b##ryoss15##0extract[PAD] [CLS][CLS] alsoliketubwiderpatterntissueexpressioneithert##ulp##1t##2##2 [SEP]nine##f##rspontaneous32m##lmin173m##yper##tens##ion##ion [SEP]first##deldifferdisruptionupstreamsignalingelementee gsste##4##delsste##te20##delsste##delsste##te11##delsste##te7##del##3##del##1##delclearlyretaincapacityins##3##pherede##yop##53proteinlevelreceptorblock##eta##nsema##ximal##hra##hralpressurehealthy40withoutreducingbloodpressure[CLS]thusseemslikelyaffectcommonpathwaydownstreamsignalstudybg##bras##tra##mineoutdoorcondition[CLS]theelectro##card##iota##chy##card##ia##ia [SEP]identificationput##ativech##rom##osoreplicationoriginhe##lic##ob##act##yl##or##usinteractionin##iti##atorproteind##a[SEP][CLS]theprimarystructure##ol##eradisplayedho##mology##asealthoughput##ativelip##idinter##fa##cialrecognitionsitesite gxsxgpresent##ol##erasequence[SEP][PAD] [CLS]essentialquestionhe##pacc [SEP][CLS]thetranscription##alinitiationsiterag##1localizeda26b##pupstreamput##ativetranslation##alinitiationco##donat##gprime##rextensionass##ay[SEP][CLS]##rona##ry##eri##ulo##graphcorresponding27##4consecutivepatientj##anu##ary1975o##obe##r1978co##rona##ryles##ionreviewed[CLS]visualphaseresultednumberyeastcellexhibitingsmallb##udsontruemorphologyc##ysles##ionclearlyc##tson##com##plicate##dhe##pa##ticc##ys##tdiagnosisdiagnosis [SEP][CLS]proteinkinasetransactivated##tero##mernmetchannelindependentsdomainconsensussite[SEP][PAD] [CLS]yearstarted##yper##em##esis##ra##aru6weekadmissionadmission [SEP][CLS]similaritydetectednterminalregion##30##enaproductanothergenegene##alocatedupstreamace##efl##p##dop##eron##rputtranscription##alre##press##or##lu##cona##teop##eron##ill##ussub##til##is[SEP]##it##rodbindingelementidentifiedspecificallyinteractc##s1[SEP]advantageconventionalindex##urtsquareb##1b##2##back##back [SEP][PAD] [CLS]theythey elsimilarregionalcerebralblood##c##b##fpatterneventhoughsignlanguagedependentspatialinformationinformation [SEP]si9predictedcontainthreeextradomaincompriseterminalsetdomaintwo##2setdomaintransregionctailcontainingtwoput##ative##ative t##osbasedsignalingmotif[CLS]determinationl##d5030infantperiodgrowthperiodperiod [SEP]availabilityprogram##noncarrymatrixcalculationtheintroductiongivehistoryresearchprogramme##z##viimplementationregion[CLS]thef##eca##lex##cre##tiononethirdmeasuredurine[SEP][CLS]theco##rbio##sy##syntgeneclusterp##yr##80encoded32k##bregioncontainsstructuralregulatorygeneneededco##rsynthesis[SEP][CLS]modelexperimentsingledosinsect##icidelherb##icidete##ut##rynmineralfungi##cidh##c##b[PAD] [CLS]inposteriorwallneo##xconsiststissueflapformlateralwall[CLS]thecommonhosthost e##quin##quine31##ov##ovine25r##ac19asingleh##dsession##ulosmembranewatercontentforearmlowerleg[CLS]bothc##larcarmon##oc##ist##ronictrans##criptleveltrans##criptdeclinedrapidly48##hcomplexmediumlowsustainedtrans##criptobserveddefinedmedium96##h[SEP][CLS]c##larcarsignificantlymutantdisrupted##argeneregulatorygenecontrolpositivelyc##ula##nicacid##cinbio[CLS]whereasmutant##4specifiedwildtypep##olproteindetectedfulllengthp##olprotein##4extract[CLS]thehe##pais##ofp##of##ct##o2kinasekinase f##ru##ct##ose26bi##k##ru26##pastranscription##allystimulateg##co##cor##ticwhereasinsulinblocks##ti##latoreffect[CLS]beinginsuling##kgeneregulationcommontranscriptionfactori##1s##t##tf1p##d##x1likelyessentialrolemaintainingnormalbetacellfunction[CLS]thethe ca##eno##r##hab##ditel##egan##egans22involvedcomb##inatoractivationgeneexpression##ge##almuscleem##b##ryocellc##5##b##l##btransformede##1e##1##bgene##1[CLS]thelargestageadjustedmenlownormalmoodah##43##1##m##co55 8[CLS]restingt##l201s##tidetectionco##rona##ryarterydisease##ur##lersyndrome[SEP]##rm1proteinbindlit1v##ivo##rm1activatelit1proteinkinaseco##extissuecellcell [SEP][CLS]resultprimarytumorpositive##m##5extractse##rt##olicelleboxshiftstimulatedifferentiateculturebasalconditioncondition [SEP]##ir##raddayabsorptionp##ob##ar##bit##onesu##pha##razme##cam##ylaabsorptionq##uin##idis##onia##zi##dstillre##tar##ded[CLS]trans##act##ivation##rs##1sitefused##rpromoterl##uc##ifer##asel##ucreportertrans##roscell##ch##ider##ider 2containss##p##1s##1likefactor[SEP]wedeterminedhopt##42contains##yssubstitutionamino69##6##9##k[CLS]the[CLS]resultstudyindicatebindingbio##tinproteinresultprotectionregioncentraldomainvicinityactivesitecterminaldomainchemicalc##lea##vage[SEP]the##3genesharehighdegreestructuralsimilarity##3[SEP][CLS]imp##airno##cturnalsecretrelated##hsecretpatternalsomm##sescorescore [SEP][CLS]thusanti##bodyclassswitchappearsdirectedinductionaccess##ibilityasstranscriptiontranscription g##er##mchgene[SEP]inhibitorsuppressed##1deltamutationh##yper##act##ivationm##p##k##1pathwaytoxiccell[CLS]thechickengenomecontainstwofunctional##alle##licbeta##1##1 4gal##lt##ran##s##fer##asegeneer##hr##emocancer##mo##di##mersrip##60replicationinitiationregionextractbindtwoat##trichsiteor##ibe##tafosterformationtwisted720b##pdloop##ro[SEP]end##od##ontform##olam##putationmethod[CLS]somephysiologicalresponseregulatedviaactivationtranscriptionfactoract##iva11[SEP]totestrole##bmemberprogressioncellcycle##roi##n##jectedserumdeprived##csoverallg##raft33375respectivelyrespectively [SEP]la##c##9dbindingregulate##stranscriptionla##osegalgalact##ose##gu##lonk##y##yver##ceslalact##is[SEP][CLS]wedeterminedcompleten##leo##tidesequenceelementpresentforklo##ros##op##1all##elethehighdegreesequenceho##mologyfdip##losalphabetasequence8577respectivelyfoundn##uc##leoaminolevelresultcomparison[SEP]de##cu##bit##usulhumander##malfi##broico##llader##malmatrixdem##roelectric##ogenfieldwound[CLS]groupfactorknownact##ivatingtranscriptionfactorat##ffoundbindlatterrelatedsequencefoundupstreamearlyadpromoterinducede##1##afactorhighlyho##mo##log##ous##bprotein[SEP][CLS]incasepatientwhighmicro##fi##lar##emiane##uromanifest##ation##airleastoneweektreatmentveverte##bra##bratetranscriptionfactortcellfactorfactor lelenhance##rbindingfactorinteract##hes##izedmedia##lesswsignaling[CLS]somedproteincomplexpresentlowerlevel##ns##formedpossiblecellularfactormechanismregulationmediatedade##1##a[CLS]##po##ceusuallydueeitherdisturbancepara##roidhormonesystemdisturbancevitamindmetabolismactivityhowevertwocomponent[PAD] [CLS]solvedisplacementduememoryrequirementchancelevel3problemproblem [SEP][CLS]77 8newwavepath##km##bprofile##rop##oni1047##gram34125000001##1 iii[CLS]mineral##izedbonenod##uleformation##rocellpopulationyoungadultal##ve##olarbonemousedisplaynonemotif[CLS]##az##rilh##ydro##oth##zialonecombinationshown##az##ril20mgdailyeffectiveeffectivedi##ast##olicbloodh##ydro##oth##zi##de25mgdailycombination##az##ril20mgh##ydro##oth##zi25mgmg possiblys##yne##rg##isticeffectdi##ast##olicblood[CLS]the132b##p##pfragmentconnectedposition2815upstreamregionla##czfusedgenecouldsensep##isignalv##ivo20b##psynthetico##gon##uc##leo##tidesequence54##4##5##pdcould[SEP][CLS]1988[CLS]sequencewithin##aselement##ogeneboundsecondproteincorrespond##eda##b##fiautonomous##lyreplica##tingsequencebindingfactorprotein[SEP]##mi##dsub##lone##lonesre##combpla##da##15complementes##cher##ichicocoli##bse##s##banmutant##phg##ama##tes##ynth##asestraincomplement[CLS]thesequence##z##32##1matchedr##b##1transcriptionfactorbound##are##spelementr##redifferentsequenceisolated##z##32##1[SEP][CLS]level##rm##rnameasured##ropj##7##74##eknowncellsurface[CLS]basal2050##gastopcoreplacedrespectivelyecotranslationterminate##sefficiently##ga[SEP][CLS]disc##rim##inafunctionanalysisauditidentifysatpositivesatnegativepatientanalysisaccounted425variancecorrectlyclassified846sample[SEP][CLS]co##rona##tine##rp##mi##dencodedp##xinsynthesized##ova##monas##yr##e[SEP][CLS]both53##latedregionalsoshowsimilaritygene7970sequenceidentityrespectively[CLS]onepatientexhibitednonsensemutationco##don38##8changed##lut##amineco##donca##gstopco##dontag[CLS]thetranscription##alp45011betagenestudied##rotranscriptionsystemnuclearextractb##ovad##rena##lcortex[SEP]re##nald##ys##p##lf##ormstudy9casecase [SEP]thisb##udmorphologyleastcellcycledelayimposedc##d##c##pinhibitor##ykinase##1[CLS]eleven12ex##oncompletesequenceho##mology##b##m1sequence[SEP]copyright1998presspress [SEP]##aroexamination1yearenlargedwalledfluidfilledu##inesegmentc##almid##uso##cc##lusionsiteanimalthethreeproteincouldco##d##1##d##2##2 [SEP]fractionstructurelit##hium35di##io##dos##ali##late1t##ritom##rea[CLS]foralsog##eno##micsequenceredlgenepresented[SEP]eliminationbrushborderwellg##lo##mer##ular##tra##ven##ousinjection##smocmi##op##ami##do37083m##os##mkgme##g##lumdi##at##riz##oat76210##0m##os##mkgscattering##o##2singlecrystalstudycombination##emcancer[CLS]makingsenseoxygensensorsensor [SEP][CLS]base##b##fincreaseobservedauditcortexbilateral##lyrightsuperior##iet##alrightdo##rs##olate##ralfrontalright##moto##rregionm##od##ulationfunctionattention##alconditioncondition [SEP][CLS]##it##rocsp##latedf##akt92g##athstransfer##ase##ase fterminaldomainwhereasf##ak[SEP]methodandtheeffectprolongedni##tratetherapyday6weekin##farparameter##ric##ularre##mo##delscarexpansionscarthin##ric##ulardi##lationh##yper##troas##rgyakin##esisplusd##ys##kine##jectionecho##card##iohem##ody##nam##morcomputerplan##imegeometricmapradioco##llacontent##rolrandom##izeddayanteriordescendingco##rona##ryl##igavariousnifirst212trans##der##mal##tro4trans##der##mal##troplus6mgsustainedreleaserelease oral##tro333 oralis##oso##rbdin##it##rate30mgmg 84is##oso##rbdin##it##rate10theessentialoilmedicinals[PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD][PAD]assessmentee2##borconclusionm##cratiopredictionpoorcombined##st[SEP][CLS]evaluationmaterialtech##nicsvascular111inthec##laus##tro##cor##ticalconnectioninvestigatedinjection30h##rpthreesubdivisionauditcortexabstractt##runcatedat400wordapplyingmentioned4metausedcompositevcavityfreshlyextractedhumanteeth[CLS]the##1mutationinducedinsertion12k##bpelement5transregionpro##ximalgeneclinicalsensoryinteractionccts##ibfunctionalreachorientedmobilityproblemupg[PAD] [CLS]genometimelineinitialcomputersimilaritysearchhumanre##tino##blastbinding1##b1##ros##op##hilme##lan##ogamalespecificlethal3mms3polar##3##pcomponentyeastyeast nhatcomplex##arhem##ody##nameffective##ificespaspabsuperiors##tencounterpartespeciallysize[CLS]serumpro##ct##inrapidlyinstitutiontreatmentactualnormalle20ngm3rdmonthmonth [SEP]weall##ei##eicsiblingsibling b##mtransplantmm1990therapytherapy [SEP]healingin##31##9functionalsite70inter##dom##ainbregionthese##rrapromotionvascular##izationtissuetransplantresearchdesignandid##d##mrandomgrouponegroup##bo##bo n363yearb##mi24511mgroup15mgl##isidailydaily n342yearb##mi##mi 24409m##2previouslyencodingprotein3##3l##1adlibrarysequence##dexpressionhumancomplementreceptortypetype 2##r##d##21primarilyrestrictedmaturebcellf##oll##icularden##itic[CLS]the65k##b##eno##micfragmentcontainscompletecodingregion##oddistributedthreeex##onplus23k##b5##co##dingsequence14k##b3##co##dingsequencesynthetic##anderivativewit##tireaction[CLS]theapparentbindingthyd168xm1##ropsgivevalue1851##hen##otypicscreeningmutation##1yeastsecretrevealsresiduecriticalselect[SEP]molecularc##lon##ing##aencodingalphasubunitbindingregulatoryrevealedexistencenines##pec##iealphasubunit[CLS]notrans##actpromoterp##lov##tatatemplatecontrolobservedproconselectivein##ox##asedual##oxinbetterone[CLS]year52##1majorco##rona##rydiseaseeventoccurred261fatal260fatal[SEP][PAD] [CLS]theet##iologyestablished7376895casem##or##ph##test##inepig[CLS]serumzinccopperurinecopperconcentrationmenlowerwomandifferenceserum##rinazincageh##defoundexclusivelytargetedper##ox##issystem[CLS]gene##cal##lingsuccessfuldetectmembercomplexmetabolicpathwaynovelgeneeithercoincide##ntal##lyregulateddirectlyinvolvedpathway[CLS]transformationcircularp##las##mi##dslowlyirregulargenetic##inresistantmy##cel##ium1nucleuscontainedp##las##mi##dsequenceconclusioncontrol##ricresponse##ba##virpace##rio##vent##ric##ularmodifydrugpaceleadexercisedurationlifelife [SEP][CLS]theregionincludepotentialbindingsitetranscriptionfactorat##f##1##aa##tbindingprotein[SEP][CLS]both##h##rdgeneconstitutesingleop##eroncore##gu##latedexpressionpu##rinepu##rinegene[SEP]thepatientdemographicdefollowsyearninemalethreefemaleii153diagnosis912patientpneumoniapneumonia [SEP]sithybridrevealsstrongsignalmc##ere##bell##umo##lf##actor##ybulbmoderatesignaldetectedhip##po##cam##puscortex[SEP][CLS]t##n##falphaeffecteliminated2b##psubstitutionmutationn##fkab##1bindinghalfsite##fkabc##ielementcrosslinkingcomplexrepresentonetwomoleculead##r##1boundd##naaalreadyavailableknownmemberenzymestructuralfunctionalfeaturehumanl##ymphprop##rote##inconvert##ase##c[CLS]themphaseinduction##d##c##c2in##hibitwe##e##1t##d##c15[CLS]n##uc##leo##tidese##quencingrevealed207basepairopenreadingframeencoding69aminoacidprotein[PAD] [CLS]butpossibletwohemispherehemisphere differdiffer mannermakesemanticlefthemisphereselectiveselective mannermanner appropriatespecifictaskrighthemispheredi##ff##use##use globalglobal mannersupportivetherapyx##eno##genmeta##static##em##otherapymodifiedprotocolrandom##izedstudy[PAD] [CLS]thepregnancyterminated1912weekg##estasinglesubstitutionthreehighly##yla1527substitutiononehis##tihislocatedwithinput##ativerbindingsiter##p12abolishednuclei##cbinding##b[CLS]thecaseterminalforcevent##ricactivationdirectiondeltawavesuperior##lyleft60degreeinferior##lyright120degreeformingsingledef##lect012secondresultdelayedactivationanteriorposteriorleftbundlelongdelaydelay [SEP][CLS]thegeneencodingcar##otee##o##13cluster##ed7k##bdfragment[CLS]theresultshowlargerp##pt##idesubstratecarryingh##d##13##csiteprocessedefficiently##ptsubstratecarryingp##olzsitec##lea##vagesyntheticp##eptidesubstratecontainingtwoc##lea##vagesiteoccurredsimilarefficiency[SEP][CLS]usingtransdetailedanalysis##xa7enhance##rdirectedem##b##ryo[SEP][CLS]la##czexpressionfirstdetectedall##oisday7pcme##so##der##me##ct##ode##rmdayday 8##esta##tionaner##p##60likefi##lar##ialparasitedir##of##ila##ilaria##ria im##mittransdi##sul##fiis##omer[CLS]atpromoterinitiate1g##ggtr##naps##ynth##zesladderp##olyproductresultslip##pagetrans##criptthreecresiduetemplatestrand13[SEP]serumlevel##gio##tens##inconvertingenzymemaintainedmaintained [SEP]theul##3##f204aminoacidshowho##mology##3nuclearp1625353 [SEP]onproteinmislightlyslowers##dpage##xon##in1[CLS]forsophisticatedadjustmentchesspulseneededmethodmethod [SEP][CLS]the10eyeinjectedr##pecellshowedstage2le4weekweek [SEP]thisestablisheseffectho##mo##gosickgrowthpatternchildhoodapparentyear[CLS]theremaining77n##uc##leo3domainiidomainii##i65n##uc##leo##tide##tide iiv77n##leo##tidepresentdi##sser##nathebiologicalactiono##yteclearlydistinguishdualspecificshowninhibitoro##oc##ytepresence##o##quinsa##liva21daysingle600mgoraldosedrug##roma##pect##ros##p##41ptfused##j##j gloopsymmetryrelated##sts[CLS]comparisonbio##rea##ctivegas##tri##n[CLS]alsoppt##xeffectdependentactivationj##nk##nk [SEP]iidiseasewetestedgrowthregulatoryseabilityrestoret##1[CLS]weanalyzedcontributionthreetypemitmap##k##kactivationpromoterhighdegreesequenceconservationabilitydirecttransportbio60subunitcharacterizationnucleardef##orm##ed##ed e##pid##gu1deaf1relatedn##ud##rtranscription##alregulatorprotein[CLS]here##1geneclone##dhighcopynumbersuppress##ormutation##3ablesuppressdefectconferredmutationgeneha##m##di##ehnenefi##z##odzz19611219m##r##azarbi##liod##jes##r##rad##b1984besidesbesides greatcontributionbi##liographygivend##r##jo##rproprof[CLS]d##r[CLS]thelongest##ainsertidentified2k##bencodedentire46aminoacidopenreadingframerat##gaincluding18aminoacidh##ydrosignalp##eptide[SEP]wesystemic##to##to##xidrugam##ikainducetotalcohair##cellloss##chiprofounddeaf##ness[CLS]co##tra##ns##fectcc e##b##bet15foldco##tra##ns##fect##b##bet1individuallye##3allowedexpressionpatternsimilarobservednaturallybencon##masmediated##1block##1arrest##d##kinhibitor##p##1##1cannotbypassbypassedinee2membermember [SEP][CLS]inone##3all##3d##t##ph##1elementinserted30b##pupstreamtranslationstartwithoutin##act##ivatinggene[PAD] [CLS]casene##ph##rot##icsyndromecausedgoldpreparationpreparation [SEP][CLS]toinvestigateroleb##hl##hm##3##3t##3##3 e##1o##ste##obundergodevelopmentalsequence##roanalyzedtranscription##alcontrol##stegenetrans##fectpromoter##uc##ase##ime##ric##37##ucassessedroleeboxc##iactingelement##stepromoterdbinding[SEP][CLS]intreatmentrelatedeffect##ph##roprelevanthumanhealth[CLS]inshowsbind##f1sitepromoteractivate##stranscriptiontranstrans##pherespectively[PAD] [CLS]gas##tro##int##est##inalaccumulationin##dium111labelledreactive##itis##itis [SEP]into##xic##yper##hrn##rd##c149[CLS]wetranscription##alact##iva##torc##remhighlyexpressed##mei##oticcell[SEP][PAD] [CLS]nointeractione##pidinlateo##obe##r1974s##operinfectionrecorded##ulaoperation[CLS]twentycalf##oa##blaorderestablishcompletecardiacden##er##vationourcurrentaimc##lar##olartargetingnamely##i##1alphac##rc[CLS]theeffectdef##ero##xa##minebbloodsugarbehaviorin##ven##ousglucoseloadingperson[CLS]inremediatedc##lea##vageum##udanotherroleresom##utaprobablyact##ivating##udm##utafunction[SEP]settingphysicianhealthrandom##ized##pi##otesmalephysicianthe##uria##rrange15150min1overnighturinesample395iinterval19400 [SEP][CLS]reproteinknownbindrerecognitionr##rs##sinvertedterminalrepeat##rsppromoterpreferredintegrationsitehumanchromosome19called##1lipdipcharacterizedgroundglassat[CLS]thelevelt##1mdramaticallyregulatedre##gene##ratinglivernormaladultlivercopyright1999theal##zoenhancedspecific##zoreceptorreceptor [SEP][CLS]southernhybrid##ization##rtransformp##mi##dintegrationoccurredfrequentlych##rom##osolo##cusgeneconversionhe##tero##log##ousre##comb##inationobserved[SEP]theanalysiseffectsignalingmoleculemolecule tex##prevealedexpressionact##iv##in##ct##ody##sp##las##inexpression[CLS]intwohighaffinitybindingsiteapparentdi##sso##ciationconstantk##d50100mapped5et##supstreamearlyprer##rnaprocessingsite[SEP][CLS]singleobliqueviewma##ographyperiodicscreeningbreastcancerwoman[SEP]r##adiacorrectionl##2decay[CLS]thisdel##eti##ondisrupt##s1etdomain[CLS]insufficientamountt##rarapparentlysensitivecellularfunctionrequiringr##nas##ed[SEP][CLS]thepredictedproductexhibit91aminoacididentitymgate##d##17re##polmembrane[SEP][PAD] [CLS]beanprotein##uostoragecellco##tydynamice##47ho##mo##di##mer##izehe##tero##di##mer##odidta##1bloodsample30m##lcollectedviacatrestminute1328exercisedeterminatione##piserumfatty##faserumg##ly##olg##lybloodglucoseg##lublood##atelala concentrationamongfourpatientaidsyndrome42individualhihivcarrier[CLS]subject73maleemployeex##erojoininghealthfitnessprogramprogram [SEP][CLS]over##exp##50transco##tra##ns##fectpro##ximalc##rppromoter1259linkedl##uc##ifer##asereportercaused3foldincreasel##uc##ifer##aseactivityce##b##bet##aovercaused18foldincreasesimultaneousovertranscriptionfactorincreasedl##uc##ifer##aseactivityactivity approximately600fold[SEP][CLS]whiledifferentialexpressiontwotrans##criptfoundpromotercontrollingl##t##1l##2transcriptionregulatedcellcycledependentmanner[SEP]s##cho##ttbarriertt##2ntypesi100surveychildh##bs##agmarkerrelated##bmarkermarker [SEP]##mukiller##kifgammain##fusion[CLS]f##etalrecoverynigroup[CLS]geneticanalysisdominantmutant##iactingre##cessmutantdefineminimumthreecomplement##ationgroupdefectseveraldifferentgenerestorehigherexpression[SEP][CLS]rat##ole##ster##olsidechain##ochgenehis##top##athdisplayings##po##ng##iformchangematterne##uron##allossat##rog##lio##re##utz##feldj##ak##obdisease[CLS]##apromotercatconstructactiveconstructassc##lonnewzincdefinesclosely##rup##peltranscriptioncomho##mologysearchsimilarity##3##21##21 activated##akactivated##d##acbloodlossinjection45range310[CLS]inacoustic##alpropertyresponselatedischargepatternfrequencytuning##au##ralinteractionhabit##uationdifferentiation##belectro##siomeanmean [SEP]these8od##ylaho##1humanm##1mho##mo##log##ousyeast##1[CLS]thechproteinincludesconsensusatbindingdomaincharacteristickinasedisplay3442identicalalignedaminoacidresidue##d##c##c2relatedkinaseconsiderablylongerterminus[SEP][CLS]conclusionresultinteractingcellulartranscriptionfactor##fa##ctor##fmaym##od##ulateexpressionearlyinflammatorygenepotentiallyder##eg##ulateimmunesystem[SEP]howeverpatientnormal##tresultlatterareacerebralactivityan##ato##miccorrelated##uroles##ion##ion [SEP][CLS]we##3centralinitiationme##iosviaeffect##2[CLS]thecar##boxpro##ximalregion##p##1containlowaminoacidho##mologydisplayedevidenceconservationstructuralfeatureh##ydrohighlybasicdomain[SEP]##fer##imayregulatedinter##ferstimulateresponseconsensuselement5uex##onsimilarmotifconservedcorrespondingpositionrelated##elodifferentiationabstract##runcatedat400word[CLS]designarandom##iseddoubleblind##botrial[CLS]gene##alog##icalanalysismainlymotheroffspringtransmissions11 [SEP]thesebackmutationledkinasetumor##igechickenunexpectedtransformingcell[CLS]thelimit50ngm##lp##hthp##phindividualinto##x##olocontinueoccuralwaysrequiredpatientcardiacrespiratoryd##ys##functionexposedbetaantagonistantagonist [SEP]pre##toriafeasiblecondition[CLS]inpresentt##gala##czconstructlackingtt##aspace##rregionanalyzeeffecttsynthesisbehaviortranslatest[SEP]t##zoderivativecauseder##mat##cos##edcan##di##dia[CLS]restrictionanalysis##eno##miccloneend##ogen##oussequencea##but##ting3end94a94ktrans##geneseparatedle20k##bstrongsupportsingleintegrationmodel[SEP][CLS]serumshowedincreasebirth6agedecrease6month1yearagefemalew##ista##rratalcohol5##ation##ation n7normalcontrolfedfed adl##ibi##ibitumcomplementary5endp##k##cm##rnasequenceco##llalatticestimulatealpha1mlevel[CLS]hi##f1##al##phadel##eti##onbasicdomaincar##boxterminusblockedreportergeneactivation##ogen##oushi##f1##poxcell[SEP][CLS]weh##hes##gatedest##rogencontain##as##oaest##rogen##iccompoundfavor##ablyinfluencev##as##omo##chomenmen [SEP][CLS]inexperiment2levelam##p##rolet##aba##te02sa55mgkgmon##ens##in99mgkg##cid110mgkgresiduecrucial##ainteraction##d##p##t##pexchange##r[CLS][CLS] 4[CLS]serumstar3##t##3cellr##afincreasedm##dr##1promoteractivity10foldshiftcontrol[SEP]searchinghumanddatabasesequencetagestrevealedpartialsequencesimilarprotein[CLS]undercontrolpresence3##mo##rma##ximaleffectnor##ad##renareached01##mopresence10##moreacheddose1##moitaffected34transcriptionfactorcomplex##1##6effectivesuperdi##utaer##yt##hrstagein[CLS]twodifferentgene##bdpolymer##aseclone##dorganism##rusingde##generate##dprime##rbasedtwoconservedmotifmotifab[SEP][CLS]theeffectsurvival##vanttreatmentincludingpre##opersystemicin##erialch##em##otherapycurrentlyevaluationstructureregulation##utehormonereceptorgenethediseaseprocesstransplantseenfrequentlygas##tro##enter##ology##ology [SEP][CLS]methodsinglephotos##cot##opflickerflicker errecorded30##ila##teralccr##vo[CLS]howeverencouragecontactinsbeneficial##smanpresentcowins##inated[SEP]modellingclassclass analogysi##rspectrumexpharmaceutical[CLS]organfailuremmajortraumaoccursresponseper##fusionpersistentinflammatoryfocuspersistentfocusdeadinjuredtissuetissue [SEP]westernp##gac##lea##vageproductppderivedgaggagprespectivelyc##ef##min##ivoactivityexpectedsafety[CLS]conclusionhighm##fer##gseemssensitivem##fer##g##g [SEP]35foldincreaseereceptor##istimulationnextregulationmechanism##dinteraction##dcomplexfoundcontainsr##d##pdi##sso##ciationinhibitorregulator##t[PAD] [CLS]theresultshowedgroupeffecttasktask [SEP]onday72135birderin##ven##ously[CLS]todeterminec##iactingelementcontrollingratb50gap43geneexpression##eno##micdencodingex##on15flank##ingsequenceisolated[SEP]inmeasured1year##pid##emnutritionexaminationexamineeffectoverco##rona##ryheartdiseaseyearyear [SEP][CLS]through##eno##miclibraryscreening##rbased##eno##micwalkingclone##det##mo##dgenewhosecodingregionspanapproximately60##k##bcontainingnineex##oneightintro##n[SEP][CLS]t##falphastimulatechangepartincreasingtranscriptionstabr##guereceptorldirectlyincreased1616 ec##lin[CLS]thedataobtained1meanfrequencyabnormal##elinfiberupperlimit952meandensitytotallarge##elin##elinlowerlimit95decadefusiongaldbindingdomainfullm##3[SEP][CLS]none19probabler##a100116definiter##acriterion[CLS]theinitialoraladministration12mgkgdosen##ox##imo##necentralhem##ody##namparameterapparentprefer##entiallimbvascularau##gmentbloodregionperipheralsystem1reditingreactionr##naeditingthefulllengthclone##dsequence##din##ferredaminoacidsequenceproteinnamedc##ys##tat40ho##mologyhumanfamilyfamily 2c##ys##tatsimilaroverallstructure[SEP]42ndannualmeetingam##ericacademypathbag1growtharresti##rra##eno##tointerferingaccumulationproteinp1expressionthesidepulmonaryfi##bro##sisoccurs2030drugdrug [SEP][CLS]theselargersizepredictiondsequencep##olgene[SEP]primary##di##gent##gent [SEP][CLS]n##0diseasefavorablen##1##1 n##2diseasedisease [SEP][PAD] [CLS]inserialrecalltermmemoryrepeateditemrecalledrecalled wellrepetition##ilirepetitionin##hibition##hibition ranransch##burgeffecteffect [SEP][CLS]inin additiontwoc##iactingelementdirectfirstz##gotexpressionk##rstripedsub##pa##tterwithincentralregionblast##ode##rmem##b##ryo[SEP][CLS]hundredpatient217femalemedianageage 24year07366malemedianageage 20yearrange7572examinedtheroberobertwood##oh##ohnsonfoundationbillionforceuniquem##t##3ccode##of##t##3fifthidomaincomparisonpro##to##tyform##53mutationapproachstudyoriginmutationcancer19931993 8949999 [SEP]desdesar##roll##o##o demodelmodelomateproprocesf##er##ment##ati##ativosc##inet##ica##ica dede##grad##ac##ae##ro##bia[CLS]particlebombardmentbar##uronbb22##el##8promoterbetag##lu##ron##idasconstructpromoter3k##bactivedevelopingbargrain[CLS]changeb##hr##rrelchangelevel24hmeanso##2no##2smoke48hmeanno##2smoke24hlano##2effectaccounting10var##iabilitywithinb##hrvisitvisit [SEP][CLS]thenterminalsequenceis##of##ormsbetae##ps##iloncontainp##estregioncouldinducerapidin##tra##cellulardegradationis##of##ormsbetadelta[SEP][CLS]characterizationregionfi##bro##nectbesides##rggas##paracidsequencerequiredad##hesivebindingdomainsitedirectedm##utaeffect##p##roa##roaterelateddifferentialm##od##ala##mo##cor##ticalex##ci##bilityelementregulatingcellstagespecificexpressioncel##egan##egans##od##mo1ananalysiskit5flank##ingregionbacterial##lt##ran##s##fer##asegenecatasserend##ogenmhighshowedregion18022importantexpressiongeneafter5daystimulationg##f10##gram1##lblooddrawnkept##ro##cess3day##in##fused24h##em##otherapyobecomerecentyearparticularly##guhoweverrelativesubstratespecific##3differed##of##orms[SEP][CLS]subunithuman##bcomplexdistinctrolemultiplestagemediata##tactivationhi1transcriptionel##ong##ation[CLS]correspondingo##gon##leo##tide##sscreenratliverc##alibraryconstructedp##las##mi##dc##lon##ingvectorp##d##v[SEP]selectedduct##al##cinfoundmarkedtumor##alinflammatoryin##fi##lt##rate02per##ino##daltumor##alin##fi##filt01sin##uscat##ar##rf##icularh##yper##pmixedpatternl##ymphnodeyearcorrelatednodemeta##sta##sishighhis[CLS]cap##illa##ryto##rt##uofunction##omer##elengthanimalrelationshipchanged##pox##iaso##x##x8mapcomplexchromosomehuman3regionassociated##ph##thal##ara##ctsyndrome##malphath##sse##tar##dation##r16directionalgrowths##cticsinterfacealongforbiddenorientation[SEP][CLS]thet##rbetaenhance##ractiveminimalpromotert##rbetavariablegenepromotert##ralphabetat##rgammadeltatcell[SEP][CLS]uu [SEP]##letderivedp##dbetareceptorstimulationvariousin##hibittranscriptionalpha##1##dalpha##1alpha##1##rresultingreducednor##ep##phs##cgrowthsouthernb##lotanalysisreversetranscription##rshowedb##rexpressedtissueexceptlivers##ple##enwidedistributionb##ractivityde##ducedplongtermre##nalfunctionheartbeatingdonorkidneytransplantsinglecenterexperienceexperience [SEP][CLS]studypaineexhaustexhaustiveinfluencevariouslocalstimulusdependentgeneralfactorfactor uponthresholdvaluewellstudiedrelationintensityintensity [SEP]vaccine8080 e##icaappearedprotective[CLS]thecent##romedo##de##casatellite##rosformalteredd##nastructurev##it##ro##rinerichstrandgstrandformstablefoldbackstructurecomplementarycstrandremainsun##structure##d[SEP]diesend##osvisualmodifieddi90diameter##oroadvancedc##d##4lower21934pre45167studiedpro##lifeunchangedthesystem015mmbagbag looselyfilled1mmsphere[CLS]mean24h##rina##ryex##creobservationhowever4assuredthreecourse##em##otherapyunusualphaseistudyj##n[CLS]thertrpolymer##asefrees##ter##icinteractionte##rna##rycomplexavailablestructureformationleast10baseawaysitepolymer##ization[SEP][CLS]thes##1lo##cuslocatedcloseleastgeneinvolvedr##nas##p##licing##3s##41[SEP]ani##culengthstayshorter24hrelatedgroupcerror[CLS]shipcat##aly##zesconversionp##hos##oi3##i##3##kproductp33 45t##ris##3p34bi##phate##phate [SEP]likep##thi##xen##ec##ro##he##pta##dineantagonist##dymprocedurefractiong##cos##idebeseparatedsisugarclonegeneticde##ter##minaobiologicalthewebgene152hodependentat##pas[SEP][CLS]evidenceat##1activatetranscriptionfactors##9##1relatedprotein[CLS]there91con##cor##dancesr##d##i##i l##rd201##tlrsnn ininfre##vers##ibility##ibility [SEP][CLS]twocomplexdetectedsimilaractivationkineticuponil4stimulationresultda##lut##cor##pore##alcirculationtheseprefer##ential##altypeexpressionb##bregulatorypregnancyassociated##ale##pitgeneexpression[SEP][CLS]s##penknownhome##otic##pbindingmotifindicatess##licingtransportrregulatorystepinvolveddivers##ificationsegment##almorphologymorphology [SEP]longtermfollowkidneydonorlongitudinalstudystudy [SEP]##oly[CLS]conclusionthepresentstudyshowedpossiblemodifieds##tro##optaskmeasureimp##licitprocessingalcoholstimulusstimulus [SEP]patientpatient 24developedse##psisonesurvivedsurvived [SEP][CLS]none10sequencehit##herrecognizedpart##53signalingpathway[CLS]thepro##mptpraiseconditionsuperiortwoconditionencouragingparticipationlowinterestrecreationalactivityactivity [SEP][CLS]themajorityhumaniheavyiregionlo##cusclone##dmapped[CLS]weanalyzedrightsizefunction##tldeterminerelationship##tl##to##yper##tens[CLS]thetranscription##alstartsitei##a2genemapped5rapidam##pc##aend97b##pupstreamtranslation##alstartsite[SEP][CLS]theraggeneencomponentre##comb##inasessentialassemblyassembly antireceptorgenebl##ytetheladen##saalwaysinterruptednumeroussmallgapareabasementmembranecouldidentifiedlongdistancecharacterized21mutationco##llagene##1fi##bri##l1515 unrelated##cess##cessived##ys##tror##b[CLS]thedatausedstimulatecollectioninformation##ena##natnonethelessdescription3mortalitytrenddifferencetwoperiodexamined19841989conservedthreeabsentonesubstrater##s##bt##i##z##bbearoneterminaldomaintheregoodoccurrencecontractintrinsictone106m[CLS]bothat1100litrelitre 1la##nos1501enhancedrelease3##hnae##vokedfieldstimulationh##z24stimulusaffectrestingreleaserelease [SEP]168p00##1[CLS]the15dbindingdomaincomprisesthreezincfingerseparatedunusuallylonglink##ersequencewouldexpectedinterruptspecificdsiterecognition[SEP][CLS]replicationregionplantpaths##yr##mi##dsimilarco##le##2relatedre##p##ons[SEP]theretoxicityrepeated5finsair##way[CLS]twentymalevolunteeral##moin##fusionaimingplasmaconcentrationc##p##l2050100150nm##oll[SEP]in##hibit##1dbinding##ro##delmutationincreaselevel##l##1proteinpromoterelementv##ivo[CLS]theresponsesequencelocalized6730siiie##9##4promoterupstreamposition9##6##68promoter[CLS]somech##opc##bhe##tero##di##mersapparentlybindalternativedsequencetherebyregulatetranscriptiongene[SEP]determine##pgal##os##idas[CLS]b##lotregulatedexpression14gene[SEP]typicalrepresentationdu##barothersspecificadditionn##h##411s##lator10mg11level##e50no##3medium##iovasculardrughospitalat##tri##buttypediabetes[CLS]thearrangementaminoacidhe1he2regionquitesimilarm##ximaddifferentee2##f1d##p1[SEP][CLS]theycontainlarge09x103188x103basepairintro##nmiddlegeneinterruptedclose5endgene[SEP]thepresentemphasizesestablishingdoseresponsecurvecorrectlyassrelativecontributionregions##idhormonereceptoractivation[CLS]defaultre##evalhomevisitma##ximaldrugcompliancecompliance [SEP][CLS]dlongc[CLS]by##a11deleted##d##flargerdeficiencyexaminedgenecloser150k##b[CLS]accordinglycon##it##utivedown##re##gu##lationexpressionaccess##orymoleculemmh##cclassipathwayrevealdifferencedifference hclassiallantipresentationencounteredexpressionlevelaugmented[CLS]an##ovapparentlynormalbloodpro##ct##inleg##ione##lla##bodyanimaldifferentialscreeningxlibraryisolated2111b##pc##acorrespondsmaternalmmrnaspecificallydeadf[SEP]similar##mudisturbancepatientexaminedlater6monthmonth injurythisflu##oso##l##utad##oto##vas##cular[CLS]electricalanalogpresentanalysiscalculationparameterwellcornerfrequencynetworkf##1withoutsimilarassumptionassumption [SEP]weexaminedinteraction##akc##opdomaininvestigation[CLS]these##fcomplexpresentg##1celllowlevelelevatedcell[CLS]therelittlesimilarityamongsequenceupstreamcapsites##pec##2geneexceptta##taconsensussequencerepeatingt##uc##leo##tidea##ac[SEP][CLS]thusdelta##3care##nefourtimepotentsensoryi##rriibetapinedifferenceialphapine##ne##ne markedsensoryi##rrialphapineinactiveinactive [SEP][CLS]##conr##napolymer##asealphasubunitexaminedresponsetranscriptionactivationcamp##rp##b##1upelement[SEP]drugcombination##in##blast##inecc##nusingleagentt##zin##ateda##tum##oractivitypatientpatient advancedre##nalcellcancer[CLS]result##4containstwoactivationdomainsimilarfunctionindependentlypromotehighleveltranscriptiontargetgene##3##4diagnosedaffect##ivedisorderdisorder n96accordingdcriterioncomparedaffect##ivesuicideattempt##er161161 [SEP][CLS]taxdemonstratedinteractdirectly##b##1proteinincluding##b##2##xi##rinpatient##per##fusionkidneycurrentstatusfuturedirectiondirection [SEP][CLS]dialtransferfactorfactor [SEP]##rb##1mutantre##fra##ctor##ycellcycleintactintact ee1##abindingpropertyre##press##ae5080fold##rb##1subgroupanalysiset##os##idepatient##elodiseasediagnosticsubgroupthei1bindalphabetaformhe##panuclearfactor33##foldrelativeaffinity[CLS]fragmentshownaggregatenucleusc##opcelldeathexpressedcellleadingproposalpa##ggsteppath##esis[PAD] [CLS]itsuggestedpresentationtailtipnenec##rosiskitdiagnosisneon##ata##l##l is##rol##ysisconsidered[CLS]micro##scopiccartmarkedstunt##eddi##ganizedend##och##ond##ralo##ssi##fication[CLS]differentials##licingextraregiongenegeneratesreceptorvariantdifferentl##igan##dbindingspecific##ity[SEP][CLS]su##c##rosespecificsignallingre##press##estranslationtranslation a##idotranscriptionfactorgene[SEP]wolfhi##rsch##hornsyndrome##lf##orm##ationsyndromehem##iz##godel##etidi##stalchromosome44##pouraimcheckdadministrationserumlip##asechangesimultaneouslyserumam##yla##ylaseactivityreasondetectedchangechange [SEP]alongtermfollowpsychiatricdaytreatment[CLS]se##quencingrestrictionenzymeanalysissinglecopygenecontains11ex##onspan95##9basepair[SEP]m##dl7297conventionaltherapyconsensusexistscon##dict##ory[CLS]theeffectnm##dareceptorantagonist##ppconditionedreflexactivationopera##ntreactionbrainelectricalselfrat[SEP][CLS]cellseveralt##fscoexpressed[CLS]constructcontainingfragmentupstreamregion##otagenefusedpromoter##lessgene##ran##fertrans##lytransem##brodefinefunctionalpromotersequence[SEP]weinvestigatedpatternevolution##gaipatientrelationno##com##ialpneumoniapneumonia [SEP][CLS]mortalitypatient##bstillhighdeclinedwithinlastdecadedecade [SEP][CLS]mutationaways##p##licesiterecognitionsequencemightc##im##od##ulatealternatives##licinggoatalphas##1case##intrans##cript[SEP]settingabasedfertilityprogram[CLS]promoters##p##lice##dleadercodingsequencebi##p##4largestimmediateearlyb##ov##ovineher1[SEP][CLS]thelimbdefecto##go##da##ct##yl##ys##yn##da##ct##yl##ytracedimp##roperdifferentiation##picale##ct##ode##rmalridgea##ershort##eningant##ero##eri##orlimbaxisz##fh##dclass##odproteinmayestablishmentcharacteristicexpressionpatternc##4##casegenetherecorrelationplate##let##gglevel##letlevelin##mentplate##letcountwhetherw##t##1s##licevariantlackingincludingthreeaminoacidk##tinsertionthirdfourthzincdbindingdomaincouldre##pressi##rpromoter##ro[SEP]o##go##mersynthesizedregionho##mologyproducedtwodproteincomplexonuclearprotein[CLS]thede##ducedaminoacidsequenceexhibit953761identityca##dsequence##mssq##can##as[SEP][CLS]trans##1gogol##giobserved##1co##ex##pressedn##smalthough##smstillgogol##gi##gi [SEP]sincesiproteinbindregulatoryfactorproteincomplement##1defectearlygeneactivation[CLS]repressionpromoter40fold2aminoacidsequence##rs##47reportercontaininghe##xa##mer##iceboxsiteused[SEP]similar##utatransco##tra##ns##v##1shearbondsystemlower17m##pa400b##pfragmentb##p33##971##d##22promoterregionsub##c##lone##dppge##m##ty##lt##ran##s##fer##asevectortrans##fectcellactivetcellresultdifferencemeanserumratiohemhemmightaffectserummaternalagegb##mi##estahem##atobloodgroupdifferentsampleiir##64iirseed##ertotalde##hy##dr##ogen##asesugar##yl##osecontenttranselectro##orerpeitherpro##ific[CLS]thuswideart##erialdimensionresultobtainedestimatel##umi##nalareadiameter##r70system1yearpredict[CLS]werevieweddifferentcaseacutehighdose##uro##xidifferentunderlyingmechanismdrugtherapydirectedreducingamountdi##ff##icico##lonpromotingnormalin##test##inalfloratheincidenced##pgrouppatient[SEP]levelpulmonary107028rightat102028peripheral112023peripheral11400 38f##moman##gin100032##mom101029##mom[CLS]dosedependentp##har##co##kin##eticsemphasisphaseimetabolismdtop##ois##omeralphageneexpression##53tumorsuppress[CLS]activationhigenecellularprocesstriggeredddamagegenerationfullgeneresponseresponse [SEP][CLS][CLS] 4[PAD] [CLS]pereasilymi##ter##p##retder##mat[CLS]lipd##mi##dmaintenancesuppliedseveralsubtogetherformactive##oso##rome##re[SEP]insecondclinicalpapergeneticfeaturecase##ph##thalsheep##na##ardiscussedgreaterdetail[CLS]revealsconsequence##hesionsignalingregulationcellactivation##yt##okipromanycontrolled3aurichelementthegapkn##irmedia##nchdirect##ros##op##b[CLS]familyhistoryobtainedparentparent [SEP][CLS]theddirectionuniformsampleddiffusionelsurfacesurface [SEP][CLS]##d##40receptorstimulationprimarybcellresulttrans##act##ivationenhance##r[SEP][CLS]thisproductive##lyrear##rangedimgenewell2genehighlevelcomparableactivatedsbcell[CLS]therelationship##s##f##mat##ost##atiperipheralthy##roidhormoneaffect##ively##batreatment[CLS]bothrgeneclone##dmulti##copyp##las##mi##dablesuppresstemperaturesensitivestraineithermutationencodedproteincouldinteracttreatmenttwoad##ren##oc##ort##ico##tro##phiact##hpreparationgivenin##tra##mus##cular22 uonepreparationin##mus1##ptte##tra##cos##rinco##ropgivenin##ven##gramkg[CLS]changeduemechanicaleffectin##jecth##ypersolutionm##t141rate70130m##ldogdog [SEP][CLS]itit wellwell knowngiant##ericausefatalcom##plicationduer##upa##ort##ican##eur##yscerebral##oc##ard##ialin##far##ction##ction [SEP][CLS]pcontainstwotwo l##x##llsignaturemotif[PAD] [CLS]basal##rina##ry17h##ydro##cor##ticoh##csvalueelevated912patientdosede##hassuppressionfavouredcu##shingsyndromesyndrome 89patientlikehumangened##ros##opgeneenleastthreefulld##ysd##dl##1d##dl##2d##m##dl##3regulateddifferentpromoterlocated5endgenesmallerproductregulatedinternalpromoterd##d[CLS]accordinglyinfectionhes##3cell##3##ldef##del##3level##r##al##phathegoalworkdeterminethresholdhereditarymotor##uroi[CLS]influencediet##arysupplements##tre##cim74br##oilbodyweightfeedconversioncharacteristicin##test##inalmicro##bialcolonization[SEP][CLS]theresultrevealpreferenceparticularin##iti##atingn##leo##tideat##p##t##p##t##pc##t##pstartingpositiondownstream##bbox768910trim##yl##chita##ratet##m36##35##1dailymouthpatientpatient mal##ymph##ymphoma[CLS]genetrans##criptdetectedtissuebliverkidneylungbrainbrain [SEP][CLS]assessmentam##moniau##reabloodcontentmetabolicacidbasedisorderrat[CLS]theimmediateremotesurgical##nal##eno##cin##oma##oma [SEP][CLS]ironha##emgenelinkedonetwosetset ton##bex##bbex##b##dgene[SEP][CLS]thepredictedaminoacidsequenceincludesnterminalsignalsequence27aminoacid27aminoacidproregion251aminoacidcat##alyticdomaintypicalseserinepro##te##asetry##ps##inlikespecificcterminalterminal hextensionpredictedfunctionmembraneanchor[SEP][CLS]examinebio##chemicalmechanismtax##1trans##act##ivationdeveloped##it##rotrans##act##ivationasstax##1ablespecificallytrans##act##ivatepolymer##aseiipromoterupstreamtax##1element[SEP]interestingpro##te##olysubstantiali##3[CLS]thustherapyanti##ox##idaeffectincreasing##dactivityr##abloodcellreducinghighlyreactiveoxygenformreactiveme##socellusuallyseenexconsistentlystronglypositivealpha1##chy##ryvar##iablyalpha1##oz##ymepropmutationonethreethreeinhibitorprop##eptidethehighestobservedal##oly100followedpara##vial3434 67fur##nismimic00 8[CLS]acutem##or##phineincreaselo##com##oto##ractivitymousewithdrawn1daywithdrawal3dayincreasesimilarcontrol5dayincreaseclearlylargercontrol[PAD] [CLS]t##b##yt##okiserumifgammail6il1010 [SEP]isolationproperty##ros##op##hil##lan##oga##ritmolecular##lonenonesubunitlocal##izationgenethirdchromosome[CLS]f##oregulate##simmediateearlygenec##oe##r11 e##r2mit[SEP]linkalter##ation##letderivedregulation##ni##thin##ede##car##yla##cmaconversioncirculatingimmunecomplexdeterminedmethod[CLS]thehuman##igenememberinter##ferinmousehumangenecloselylinked##yn##tenchromosome1[CLS]inmodelelimination##amc##yt##op##las##micdomainincreaseddevelopmentalalterat##tri##but##ampro##te##oly##ticactivity[CLS]di##abeo##ste##op##athyathird##3k##0##08##46activated##1##1 sharedsequenceho##mologycalciumdi##gly##olactivated##s##1##2quantitative[CLS]comparisondefect##iveh##vipro##viruspredictmodeorigininternallydeletedgenomereversalbi##liaspadoseg##lu##ca##gonoperative##ola##io[SEP][CLS]shown##1generequireds##por##ulationexpressionme##ios##isspecificgenesa##cc##har##cesc##ere##vis##iae[PAD] [CLS]comparisonacquiredimmunedeficiencysyndromeaidhomosexualspinend##oth##eliabnormalreme##ido[CLS]ininjectionvolumealphaad##renagox##yla##zinec##lon##idc##er##vic##alregionspinalconscious##rainsheepdosedependentanal##gesfore##limmeasuredmechanicaldevice[CLS]secondc##acontainingsequenceplaced88deltammtcatreporter##mi##dconferredinsulinretumorpromoterinf##ogeneexpressionf##oproteinappearsreplacedproteinf##o##ra11 at##fat##fa[SEP][CLS]thedo##pad##1do##paantagonists233##90dosedependent530micro##gramant##agons##ti##mu##lantlo##com##oto##reffectdrugprevent##im##mo##bilityeffectbehavioraldespairtest[SEP][CLS]theresultobtainedshowexpressiongenelow23degreecinducedrapidly37degreecc [SEP]characterizationch##omorerein##gotspecificenproteincontainingandomain[SEP][CLS]ad##eno##mauppergas##tro##est##inaltractfoundpatientv##ater12duo##den##umninegas##tricant##rumseven[CLS]##on##mentsdominatedc##ob##eriab##p##chigher77 8dominatedl##ichel5555 [SEP]atotal64##plicate##dtypedi##abeindividualhighermiddleclassrichstudiedstudied [SEP]dropace##tatevehicleconstituentdi##sse##ssectedplant##arnervepro##ximals##ti##mulatingelectro##derecordingcontrolresponsefibrevols##cianervecfibrefibre eevokedreflexdischarge##ex##orm##oto##uron[CLS]basicheacteboxwithinserumelementf##opromoterhormonepromoteractivationse##rt##oli[SEP]usingyeasttwo##3interactingfactorc##iaconcentrationcocummnsemilk11helpinstrumentalradio##chemicalneutronactivationactivation analysis[CLS]gal##lston##eformationattributedbi##ole##ster##ol[SEP]patientmaintenancehem##od##ial##ysdial##ys##ropmembrane1switchedsecondweek[CLS]geneexpressionpartcontrolledch##roma##tinre##mo##delfactorstate[SEP]513further##more##a##a gexchangefactor##1primarilynterminal##3domainre##pis##odl##ymphimpairedcellularimmunityimmunity [SEP]after3monthinterventionphysicaltraining1level[CLS]thirtyelevatedt##iter120di##lution##4dominant##lyinheritedricegenegene con##fersresistancerace1bacterialb##lightpath##ogen##ogen xor##za##zarice[SEP][CLS]##raesimilarmaximumserumconcentrationfoundsingle75mgkgi##vdosetheeffectbutsub##sodi##sul##fid##s##rot##ox##icit##mic##paexaminedmouse[CLS]allpreviouslymappedstructuralproteinencodinggenepllhincludedsequence[SEP][CLS]whenlonger71##478fragment##dpromoter70mutantstilldisplayer##hr##oidactivatedh2enhance##r100mutantcompletelyinactiveabsencepresenceenhance##rsurprisinglyadultsu##pra##basd##r##x##ralphaabilitytstimulate##iffk##erabasallayere##pid##er##misinmanycontract##ilegenecardiac##ofexpressedearlyskeletalmuscledevelopmentlaterre##pressed[CLS]1995[CLS]for##raformedtwoex##onwhereas##rbdistinct##ut##rnaformedalternatives##p##licing11ex##on##oc##ardremainslifethreateningdiseasesubstantialm##or##bidmortalitymortality [SEP]thegeneencodingcell##ula##se##lasec##el##1s##omy##cesre##tic##ulianalysisdomainfromsequenceatnovelsubfamilyseser##r##ksplantplant [SEP][CLS]of23136due##ibupper##ib19##ib44 [SEP][CLS]theemulti##loc##ular##gol##ersystemreplacenaturalcan##idhostnewin##fectegganalyzeparasiteinteractioninteraction [SEP][CLS]e##1recognitionsequenceorigindreplicationinteractionhalfsiteinvertedrepeatwesecretch##iti##no##lyenzymelmajorparasitein##hibitbloodhem##ogenzymeapparentlyabsentbloodfedinfectedcardiacvalveappearsund##ama##gedpatientm##uc##inoc##ysca125##ys##ticlevelend##oma##omasder##mollt##t 005sat##b##1interact##ed##ddbindingdomaindemonstrated##athstransfer[CLS]plasmapro##ct##in##ale##cteme##lat##oni##n##alintactemaintained24hourphoto##per##io##dittargetedper##ox##is##ome##sexpressed##mmalyeast[CLS]thetranscription##alstartsiteidentifiedprime##rextensions##1##uc##lea34n##tupstreamtranslationinitiationco##don[SEP]##linear##ities##r##ydro##dynamicelectronicstructureopticalb##12##o##2crystal[CLS]s##po##ng##iosregeneration##ip##orechamber[CLS]predicted53trans##criptdeterminedsize##3message[SEP]this##acorrespond##ed##ed fbindingsecretbindbasicbasic fm##ulateactivity[CLS]analysisreplica##tiveintermediate##mi##dcontainsch##rom##oso##malreplica##tor##rs##1initiatebid##ire##ctionalreplication100b##pregionwithinsequencerequiredautonomousreplicationv##ivo[SEP][CLS]suchresultsuggestdifferenceb##m##rageweightmatchedasinmaletropicalpopulationam##eric##an[CLS]rewardpropertymet##ni##datese##iti##zationpriorexposuredrugeffectdo##pa##mined##1dreceptorantagonistantagonist [SEP]similarobservedputmutant##ug90reductionr##po##spromotermutantcouldcomplement##edr##po##spromotergeneprovidedtransmutantpseudo##monas##ielostinducer##po##sexpressionstationaryphaseretained##rumautotherole##ativec##2domainne##dd##4el##uc##idated##7specificallybind##1##1elementhigher##1elementincreaseth##rom##box##aneevidencedmajormeta##bol3din##ort##hr##omb##ox##anebo##ec##tomgroupgroup [SEP]##varlog##isticreshowedbloodglucoselevelfirst2day00##2o##besity00002independentpredict##ordeepwoundinfectionhoweverprecisefunctiond##kddoublestrandbreak[CLS]newreceptorreceptor to##rthy##muscloselyrelateddbindingdomainl##igan##dbindingdomain9053respectivelyr##oralphar##z##ralphaclustertworeceptor##z##rbetaphylogenetictreedbindingdomain##igan##dbindingdomainsequencereceptorcompared[SEP]inexaminedwhetherp##1effecttransformationinduced##21##0##r##b##bl[CLS]s##1n##uc##lea##seanalysisrnumberl##dclonesimilarresultl##dpopulationcomposedvirussimilaridenticaldel##eti##onend##point[SEP]associationsl##ymphenhance##rbindingfactor1specificfactormediacooperativesignalingtransformingfactorpathwaypathway [SEP][CLS]thethreegeneflankedmarker##i106cd##22##9##3te##lcontainedwithinthreesetoverlappingco##sm##idclone22patientfoundpositivehiscorpusm##uc##osaonepatientelevatedcirculatingi##gghp##yl##or##usgroupcin##hibitactivationmapresponseresponse activated##afeffectuponc##afactivityactivity er##kactivation##k[CLS]quasi##dia##tom##icstudyl##yalphaproducingh##2necollisionk##evenergy[SEP][CLS]then2terminusthreeproteincontainsp##ozdomainconserved120aminoacidmotifinvolvedtranscription##alrepressionproteindim##eri##zation[SEP][CLS]theisolation262additionalall##ele##1##17suggestsdirectlyblockingdreplicationprovideddamageresponse[CLS]mutantshowdefectbasallevelexpression##r##1la##czreporterconstructgwe##lystudiedserumpro##ct##in##rlseizurepatienthoweverp##eptide1496387boundalphabetabinding[CLS]valuek##1v##dincreasedt##umourtissue[SEP][CLS]mutationpreferlimitcomparedtotalproteinsynthesistranslationgenedependsfive##gaco##done##dac##ire##press##orgene[CLS]fiver##natrans##cript121##base##smappedgenomeinsecti##ride##scenttypechi##ridecgenomecoordinate0830withine##cor##idfragmentf[CLS]othersimilarpatientmustfoundestablishedco##llo##idc##ys##tpartne##vo##idbasalcell##cin##omasyndromeportion3coding3##ns##latedregionfoundmissing7244 8k##b##om##rnaanalysisine##48##48##9removedalonghe##lixne##gli##gibleeffect##t##p##d##pexchangeasspotentialrole##apathwayleadinger##kp##t##p##d##pexchangecomparison[CLS]##hen##otypictrio##bcooperateregulatinga##xonout##groem##b##ryo##niccentralnervousc##nsca##sp##asetypicallyes##chercosystemattendantactivationpro##te##ase[SEP][CLS]thegeneencodingratp##ept##idy##glyalphaamid##asecontains26proteincodingex##on[CLS]thisbound3##h##op##ros##thighstimulatecampexposedago##nist##nist [SEP][CLS]structureconnect##ives##trom##ae##idyz##eb##uproteinsdeficiency##che[PAD] [CLS]inseriespaperstagingsystem##lan##comingidentifiedidentified [SEP][CLS]reproductionmaternalresponseratth##iam##ineintakelimitedlimited [SEP]me##so##oreranged00000400 08cm##3103369mm21respectivelyaccounting33betsurface[CLS]n##fka##ppap##100l##yt10p##9p##9generatespro##te##olyprocessingk##dasubunitbindkamotif[CLS]conclusionthebio##dis111isimilar99[PAD] [CLS]based29determinationsinconditiontotalg##cos##latedetermination94873receptorsethorganizedtwodistinctclassknowniiibasissequencesimilaritytransformingbeta##1in##hibitionpromotermappedinhibitor##yeffectatatfsitepresentifgammafunctionaltrans##fectin##hibitionpromoterdespitemutationatycelement[CLS]ther##smamutantlikeparentn3o##ohho##mos##erila##cton##eh##lstarvationcelldensitysensingsignalrequiredextra##cellularenzymeproduction[SEP][CLS]theinactivexall##elehowever##met##hyl##uk##ytepresumablyreflectingearlyxin##act##ivationeventbecomeimportantgenedos##ageexpressinglineageintensivetherapyhe[CLS]alsorrv##wh##yper##troh##yper##trohighpressureiivmayrelatedhighe##fabnormalchamberinpgroupgroup bbv[CLS]analysisdbindingtranscription##alactivationfunctionhumanfl1protein[SEP][CLS]thispatternexpressiondifferentialprocessingrolein##k##1aspects##dphoto##per##io##dicinducedfloweringmorningglory[SEP]progressivei##gadeficiencydeficiency [SEP][CLS]r##m##rpositivelycorrelatedtetefr061##301netnet tetefr06464800l##ute##alf##icularphase##rspectrum##3##6singlecrystaldynamic##ahntell##ereffect[CLS]theterminalex##on##1ho##mologyacidlevelng##fibma##mmalho##mo##logue[SEP][CLS]thispaperdescribeslongitudinalstudyclinicalparameteras##par##tateamino##tra##ns##fer##aseas##ival##vic##fmonitoredbi612month97siteperiod##ontpatient[CLS]observation33 ilileelementcompositeenhance##rfunctioncombinedinteractionleastfiveregulatoryelementco##gnatebindingfactorthreefoureboxmemef2sitememef3site[SEP][CLS]theanalysis1fittingfirstauto##re##ressmodel##r##1##r##22obtainingspectrumdatafour##iertransformtransform [SEP]112175withinrbinding##170##kproteincrosslinkedg28u30stemloopirespectively[CLS]k##ud##zuextractshowmode##ratingalcoholabusefurtherim##otoconsiderablepatientpatient [SEP][CLS]b##c##vm##rna51appearusedsynthesis1279k##daproteinrespectivelypatternexpressionstriking##lydifferent[CLS]disaster[CLS]thelongests##1s##2intervals##2failedcaptureeffectivere##fra##ctor##yperiodlonger555 8m##se##ctwice00 0505 le00 10553m##se5timestimulationbasicdriveextra##st##im##ulideliveredseparatesitesite [SEP]so##maticcellhybridyacon##ti##gte##lo##merd##3##floregiondeletedlungcar[CLS]experimentwithoutpolar##ization##ho##dican##od##icpolar##izationads##or##bent[SEP][CLS]chronicactivehe##pa##r##hosliver[SEP][CLS]regulationmediatedkinasepspecificresiduedifferentdomain##53molecule[CLS]theseprocessingspecifictargettrans##criptpelementm##rnaregulatedfunctional##iu##1##rn##pinteraction##ros##op[SEP][CLS]effectdimcoolingrate##rainrat[CLS]incalfgivengiven ha##emon##chuscon##tor##tortusla##rvaserump##sin##ogenconcentrationrosequicklyreachmean35it##yr##osday14infectiontheseresultstrongly1infectionin##hibit##shostcells##licingaction##27[SEP]##o##2related##co##co2079194##o951212 44 07[CLS]transformationem##bfi##brogagfusionproteinresultelevationtpspecificcellularproteinmolecular13000011000070000p##0p##70respectivelyeventcorrelatedcelltransformationtransformation [SEP][CLS]u##reaseactivityjudgedamountam##moniau##reacouldmeasured25ngpertubesn15beanmealu##rease[SEP][CLS]directevidence##iotdefectcausedeither##re##kactivity##re##latedran##1kinasedueinabilityinducetranscriptiongenerequired##iotinitiation[SEP]opticalrotationharmonic##tinab##eri##or##homon##omerb##dge##ttfilmevidence##p##lana##rre##tina##lstructure##sonreplace##hr##ographykbi##cist##ronicvectorselection##l##chifoldhigherm##dr##1geneproduct##41stringm##dr##1selectionsystemefficientgeneinhealthbehaviorinvestigatedyear98##1yearthree##ost##ttsi##ic##ut[CLS]ouranalysisgenecorrectionmechanismoperatingh##bbschromosomekeepbetabetaevolvingconcertwhereas##bb##dchromosomebetaddiver##gedconsiderablybetad##j[CLS]structureregulation##d##2structuralgeneyeastdi##hy##drtrans##lase[CLS]inde##dratadegreecte00##1normallyh##ydstatemeasured39902degreec00 84009wkg1respectively[CLS]y##y##1recognitionsequencewithindresponseelementv##dreo##ste##algenecritical##1dependentrepressiondenhancedpromoteractivitybackgroundfactorwithdrawaltypeevaluationmodeh##b##vtransmission[CLS]pointmutations##tat##3withininteractingdomainblockedphysicalinteractions##tat##3cjcooperationil6transcriptiondirected##rogenhance##r[PAD] [CLS]threepatient##riz##zitypeiisyndrometwopatient##zitypeisyndrome##aro##scopic##ally##ally [SEP][PAD] [CLS]s##ync##hr##ono##usmulti##centricgiantt##umourreportreviewliteratureliterature [SEP][CLS]fromcomparisonnodboxsequencebra##dy##zo##bidiver##gentnodbox##zor##zo##bica##ulin##odaproposemodularbuildnodboxsequenceatc##9gatbindingtargetnod##dnod##dbox[SEP][CLS]the##xgeneadjacent##qprovidespromoter##bexpression[SEP]methoddisc##rim##inafunctionpredictseizureseizurecomseparatelyn79rightright nn 62temporallobe##ct##tlrat[CLS]itlikelyrecordingincompleteactualnumberactivatedne##uronestimated300acutese##ns##iti##zedpreparation[SEP]thepossibilitydiagnostic[CLS]geneticanalysisrolehergkinfectiouse##g[CLS]aconventionalnterminalsignalsequencedetectednod##oprotein[SEP][CLS]dynamicexpressionbroadcomplexis##of##ormsmediatemporalcontrol##c##stertargetgeneonset##ros##opmeta##mor##ph##osisthestudycarriedb##sirecommendation##ora##ivo[CLS]##ysanalyzedl##uc##ifer##asebetagal##os##idasactivity[CLS]##yt##okis##idhormoneusedifferentsetsignaltrans##ductionpathwayseemunrelatedunrelated [SEP][CLS]thesefindingpro##s##uohatevolvedparallele##cterprocommonancestralgeneunderwentgenedu##plicationfunctiontransactingdominantregulatortranscription##alinhiterminalrepeatcontainstwopotentialn##fbindingsite##bolintrans##d##4deltamutant[SEP][CLS]inmeasurementshield##elds##in##xcontaining99##m##t##clabelledradiocarriedcarried [SEP]thistesto##2criticalcomponent##oc##ard##ialprotection##c##p[CLS]bio##massgrowthco##currentbio##fi[CLS]thisalternatives##p##liceaccept##orsitealsousedbiologicalpro##virusefficiencyapproximately5comparedupstreamsite[SEP]homuchhigher6428k##daproteinregionregion stronglyconservedse##rinepro##te[CLS]weisolatedstructural##lycharacterizedg##eno##micdsequenceencoding##ulos##e15bi##box##ylaoxygen##asercar##box##ylaact##ivabar##rdelexpressionput##ativecon##it##utive##lyactiveformd##d##k##1##d##1backgroundbackground capableleastpartiallycomplementaggregatedefectabilityactivateg##yl##ylc##c##laseslowingmedianulmorphologymap##pobservedcasemonth[CLS]more##overmutationleaddramatictransition##romastructured##ei##senregionreplacedtwostablesequencepositionedn##some##s[SEP]duringchronicca##ci##ton##pha##rina##ry##rol##ine50pagepagetdisease[CLS]187200becausestructuralsimilaritynewgenetermed##2experience##yadistricthospital[CLS]the23x103base##12trans##criptcontainsopenreadingframesufficienten88x103m##rprotein[SEP][CLS]co##rt##icalso##mat##oseemediannerverevealedsignificantlydelayedpeaklate##ncyn##20pp20pp25##26althoughlate##ncynormal[CLS]familyrateadaptivepace##makeraccomplishcirca##dianratevariationmodelingpatientsleepwakecycletimedayclockinsidedevicepropresentfuturefuture [SEP][CLS]bi##ru##binredcellmetabolismrelationneon##ata##l##ndi[SEP][CLS]materialmeanthreedifferentplacementtechniquebulkpackhorizontallayer##ingverticallayerclassiicavityextractedhumanm##olar[CLS]thispathwayfunctionanotherand##rogenpromotershowntumor##tcatreporter[CLS]stressinducedsuppressionpro##ct##inafternoono##ctest##rogentreatedno##cturnalpseudo##p##gnantaccompaniedincreasemedianem##inendi##dracidconcentrationer##go##read7562respectivelym##or##ph##gicre##nalca##xp##viscontrolu##ret##ericactivityrabbitchildprotein##uriahigherpath##olo##gic##ye##ram##ram [SEP][CLS]par##ph##ost##rong##ylo##do##eired##es##cribedwormcollectedtypehosto##dohem##ionco##bianca##fo##rn##iawellmaterialexperimental##lyinfectedm##uledeeroo hhemal##a[CLS]thecar##box##ylg##bula##rdomainfoundencodedex##onappeardel##atestructuralsub##dom##ain##s[SEP]expression##bmutation##bplasmamembranepm##37##3[PAD] [CLS]thusintegrationhostfactorrequirednormaltype1fi##riaphasevariationeco##li[SEP][CLS]insulintherapyexpandedhumaninsulinmodeinjectionincludinginsulinpumppump [SEP]becauselevel##o##2##dir##o##2similargrouppooldatase##ptic[PAD] [CLS]furtherintervention##ph##re##rect##xre##sectionl##igaca##va##va 1##xre##sectionreplacementrevein1##x##x [SEP][CLS]objectivethepresentstudytestedhypothesiss##ti##mulatingcentralnor##ad##rene##rgsystemnor##ad##renaup##takeinhibitorre##eti##newouldresultdosedependentenhance##mentmemoryemotionalmaterialman[SEP][CLS]wemechanismtwodifferenttypephotocgammaradiationactivatetranscriptionfactor##f##ppa[CLS]howeverco##liga##tiongammar##b##1cellareceptor##rin##hibit##rmediatedsignalingmechanismrecruitmentp##pha##tases1s2##2containingin##os##taseshipp##latedgammar##b##1im##ec##or##or t##osbasedinhibitor##ymotifmotif [SEP]usingstandardfull##q845yearsensitivity54score33 [SEP]11580##18##3proteinco##loc##ali##zes##11proteinc##osoface##uomembranethispatienttreated19641978ageyearrequired##9generator[CLS]brcearlygenedirectlyactivatelategenetranscriptioninteractinglategenec##iactingregulatoryelementinteractionresponsibletemporallink##ageearlylateegeneexpression[SEP][CLS]specificlimitdetection002micro##gramm##l0010125##gramm##lf##antemeta##bol##iterespectivelyrespectively sufficientlyhighcharactertimecoursedrugplasmaoraladministrationtherapeuticsheep[CLS]identifiedgeneencodingsigeneticscreendesigneddesigned is##olatetransactingmutation##bol##isheitherh##po##hp##3twopromoterrecognizeduniquelysicontainingr##napolymer##ase[SEP][CLS]c##yt##oki##net##ics##bscar##cin##oma[SEP]througheffectivelaboratorytestingdatabasepossibleawayanal##yticqualitycontrolfarsystembasedevaluation[CLS]thesepatientdevelopedseveredi##abe##tics##ym##pt##omglucoseinto##lerweightlossimpairedenergyu##til##izationnervebraindisorderinsulininsulin [SEP][CLS]onepromoter##53##1located100250b##pupstream218b##pnon##co##dingfirstex##onsecondstrongerpromotermapwithinfirstintro##n[SEP][CLS]bothgeneproductcontaincar##box##ylterminalsequence##lsimilarput##atives##k##lper##ox##issortingsequencego##uldsthelikelihooddeath3timehigheramongeragroup3829514899 84bar##ium##uc##osa##lcoatingjudgedmembermasu##7immortaldip##lo##idwwt##avtargetedintegrationch19[SEP][CLS]thecorrespondingte##tra##pe##pt##idesequences##dsat##dhumane##ps##ilonrespectivelyunusual##sp##ase3[SEP]the##haribindingsecretclass1acutewhosegenetranscription##allyactivated##rf##tat3##okiinprotein[CLS]t##ritfounddeterminedwithin25[CLS]thisregioncontainconsensusest##rogenelementerbindingdsequenceobserved[SEP][CLS]proteincalledvsspecificlo##cusvsgeneexpressionsiteethes##ng##ulatedin##test##inalpath##ologyhorseaccompaniedlocalactivationne##utrevealedt##ularen##zy##matic##matic activityactivity genzyme##elo##per##ox##idas##idase##po[CLS]del##etianalysis##as##1promoterin##os##olinelementmotifregionn##leo##tide760850responsibleremainingactivation[SEP][CLS]herefabricsinglemoleculetrans##istbasedindividualc##60moleculeconnectedelectro##dethehome##odtranscriptionfactor##dcutinteractcellcycleregulatoryelementhisgenepackaged##some##stheyproteinwhosecoreregiondisplaygreatsimilarityashahaha##peknownhaho##moorganism[SEP]further##moreco##gnatebindingproteinpresentrathumanhe##lanuclearextract[SEP][CLS]transco##ns##fectcooperativeassociationil8promoterresults##rg##istictranscription##alactivation[SEP][CLS]heartratebehavioralavoid##ancetestshownsusceptibleexperimentaldemandstudyshownapproachbehaviorinfluencedinfluenced [SEP][CLS]functionretainedonecopysequencepresentsequencerepresentsessentialelement[SEP][CLS]decreased##th##rom##binii##iassumedonemajorfactorunderlyingh##yper##gustate##ph##rotsyndrome[CLS]no##2roadfrequentlyexceededbrunionairparticlelowerlower [SEP][CLS]co##tra##ns##fect247##3constructcontaining247##3basepairhiupstreamsequencelinkedl##uc##ifer##ase##odtranscriptionfactorooct##1o##2br##4##1##1##iresultstrongsuppressionbasalpromoteractivity[SEP]8772##70[CLS]i[CLS]trans##criptin##iti##atingca##gtmotifpro##ximaltransabolisheddel##etipro##ximalta##taboxlocated29relativeca##gt[SEP][CLS]##eno##micdb##lotanalysisl##2lo##cusclusterlikeorganizationsimilarl##1lo##cusilo##cusseveralfish[SEP][CLS]althoughenergyd##ftaffected##rote##ren61156017jdecreased3716jthirdstagein##40##31##rote##renbase##line##rote##rengolength412cmdynamicinteractionretention3##b##utgroupgroup 20##rks35s1##r3##r##par3han##estinjectedinn500##ci30minhe##par##brollerpumpooxbent0mm2##2 abent00 25m536lmin3##r[CLS]theregionimmediatelyfollowingpromoter5##f##1potentialtranscriptionterm##inatorsequence[SEP][CLS]studyre##rrenceg##ivalh##yper##ppreface[CLS]c##lon##id3micro##gramproducese##dationcomparabledi##az##am02mgin##tub##ationresponseincidencecom##plication[CLS]##cre##aticexpressiong##lu##ca##gongenedependsmultipletranscriptionfactorinteractingleastthreed##nacontrolelementg##1upstreampromoterelementg##2g##3twoenhance##rlikesequence[SEP]##3followingorderplate##let##3breakclusterregionlikeshowbindbound##dconclusionmen##hrperipheralbloodpro##life##kp##didentified1794diagnoseddepressione##pwoman78b##diiiidentified10##ychoftenwishelementothers[CLS]singleaminoacidsubstitutionshownresultmutation##dr##12##30##i##dr##13ff8##15##s##dr##16k##30##q##177 p##29##298##1##1 88 l##10##36whereasin##trasuppress##ormutant##1100deletedaminoacidacid ll53##53[CLS]bothgeneconsist40##8b##por##fcoding135aminoacid[CLS]##nio##ticfluidion##icresponsef##etal##as##opin[CLS]thesliceimage##dthreetimesequencespatialpre##sat##uration##uration [SEP][CLS]molecularc##lonalpha##bintranscriptionfactor##2[CLS]thedi##stalactivesitet##igaex##cision66b##pintro##n[SEP][CLS]##at##oresddgg##esequenceanalysis##4majormemberfemalema##ryg##landsub##illa##ryla##ry##malgsexcounterpartmaleliver##agufound##1allpossessedcut##aneousre##ceptivedi##stalsegmentdigit234[CLS]seseedalsoconsideredcauseall##ergicreactiondrug##etic##etic [SEP]l##igan##dbindingreceptorhem##ato##ietresultrapidactivationt##os##t##kdependentsignallingmoleculep3##i3kinasekinase [SEP][CLS]theu##as##breactortreated##famixtureace##tate##ate##yra##teratio532co##dbasisace##tatesolesubstratedifferentcosu##ateratio[SEP]specific##againvolvementdiagnosisex##ti##rpmildoperativecoursecourse [SEP]nowpleasure[CLS]thisarticlereviewcurrentconceptpath##op##siosum##mar##isesclinicalfeaturenaturalhistoryavailabletreatmenttreatment [SEP]previousdatasubtleincreaseserumptimewithout##hreduces##rwomanoiiv##fstudycompared##rrecipientsharedoprogramaccordingdonorlevel[CLS]ad##eha##ldatransformationcomoo2manman [SEP]mm adfour##netcapassociation##ys##tein##cheheartdiseasela[CLS]radio##logicalimagingseriesc##tscanarriveaccuratediagnosisdiagnosis [SEP]architectureh##1domainclosedomaint##1##1##p##b80encodedaminoacidlocatedimmediatelyetjunctionfoundtranslationproductprosetcellularproteinprotein 646260k##darelated##eptidepredictedproteinproductsecondm[CLS]becausecontrolledreleaseni##acseemspotentcrystalni##acproductsubstitutiondoseadjustmentavoidedavoided [SEP]interagreementnot##tinghis##to##radingscheme##fi##lt##ratingduct##cin##omabreast[SEP][CLS]thisdose##3##ratesuggesth##po##emiaeventhoughacid##ratede##x##troniformulaformula aaac##didenticalconditionreduceleveltotalcalciumserumcon##comnumberreactiondonorlate##xgloveballooncondomdirectlyboundbound iigepatient[CLS]##6##9cnewbornearlylateproteinstimulatecellularpromoterthusexexertratherbroadactivationpattern[CLS]southernb##lotanalysis##eno##micdalteredc##pmet##hylwithinintro##n1dbnormalmortalhuman##rye##ct##bet##a##1expressionup##re##guk##erar##troalthoughfunctionalclear[CLS]anincreasedincidenceat##n##los##pora[CLS]##pdependentbr##ef##eld##in##it##ro1bindingassdeterminedparameter1bindingreaction[CLS]theoverallratebio##hy##dr##ogen2143hdeclined12haddedsubstrate[SEP][CLS]plasmaenter##og##lu##ca##gonmeasuredthreehourstandardmeal##trepatientsuspectedco##eli##acdiseaseat##ropin##test##inal##ucma##bs##or##ptionninecontrolsubject[SEP][CLS]aftermasstraitanxietypredictdi##ast##olicbloodpressurewoman[CLS]regulationhumanstressgene##ad##d##15##3expressionrole##1##i1geneproduct[CLS]##4sa##cc##har##omy##cesc##ere##vispart##4##6componentm##rnasapparatus[SEP]132var##ixl##igaperformed44separateseparate eevsession[CLS]herer##f##xx##b##pdcomplexformedclassiiis##otype##sregardlessabilityxboxregionbindeitherfactorindividually[SEP][CLS]theps##iz##etagenenonsensemutationex##on1identicalpromotersequencerprocessingsitez##etageneraisingpossibilityps##iz##etaz##etatranscription##allyactive[SEP]prospectch##em##ost##eri##lantgeneticcontrol##ntserum##rladministrationnormalwomanh##yper##rol##act##inenormalsell##apatient##no##roa##omawithoutsu##pra##sel##larexpansions##se##se [SEP]theid##4proteincontainshdomainhighlyconservedamongd##ros[CLS]thecodingregion##fadeterminedtranslation##alla##czfusionsitedirectedm##utaidentifyfourframeau##gco##donused[SEP]##eptidecompetitionlocalizedc##y##c##linainteractionsitel##ys##38##1##38##2##3##4sequencewithinterminalnegativeregulatorydomainhumanp[CLS]he##tero##di##mer##ization##rfailedalter##p##drdistributionactivityliket##rop##oni##od##ulin##kcontainsfoure##fhandbindingmotifathirdgroupn10assignedcanal##ithre##positionmaneuverwithoutmast##oidvibration[CLS]upstream##fa3genecluster1k##bregionfound96identicalre##ibsequenceoneenter##otoco##mi##30commonancestorp##mi##d[SEP]thecatstage2l##ymphtestnegativebesttreatmenttreatment [SEP][CLS]h##hesact##ivaspecificallyinteractmultiplecomponenttranscriptioninitiationcomplexlikelydramaticfunctionals##rgyexhibitedclassactivationdomainv##ivo[SEP]twomodifiedcombinedhole163##pir1##rradiusonehole1971his##to##logical##notrevealedlargecelll##ymphbcellonetcelltwosmall##ave##dcelll##ymphbcellfivebcell##ymphthreethree f##icularmixed##ymph##oma##oma [SEP][CLS]thede##viationsiteequivalentex##on1ex##on2s##p##licesitemousecsubunit[SEP][CLS]determinationdi##ace3##ed##ione##to##inperformedtwostep[CLS]theremayo##smochallenge##uc##osa##lcellfunctionevidenceddifferentreactionrate[CLS]##9prototypeem##b##ryoexpressionh##stgenepositivelyregulateddownstreamo##ame##rmotifenhance##r[SEP]readingachievementdisabilityreadinginstructiondi##starprogramstudentusingbasalreadermaterial[CLS]twoput##ativeatbindingdomainidentifiedoneaminoterminalhalfa##rgaencodedproteincar##box##yterminalhalf[SEP][PAD] [CLS]childchild [SEP][CLS]halflife25hreduced15minadditionm##olarpc##op##las##micregionp[SEP][CLS]thistransformationsuppression##bshownduetranscription##alrepression##uusingr##bexpressingeffect##orp##mi##d##upromoter##lora##l##ty##lt##ran##s##fer##asereportergene[SEP][CLS]therapystartedbonealter##ationcouldobservedtypicalpage##tdiseasebonebulk##yt##ec##eincreasedre##mo##dellsurfacegianto##ste##oc##lasttin##festdel##pont##ei##ei t##rovso##rdi##da##da tv##icein##id##ip##ro##fa##ciaterminalmutationdisturbmit##osisproducecell##rapproachisolatedput##ativeho##mo##logue##4cell[CLS]11 [SEP][CLS]bio##chemicalstudyililt##yr##osactivationinitiatecomplexsignalingca##sca##de[CLS]backgroundperipheralreceptorago##nisttherapeuticapproachtreatmentd##pefourteen389developeddedefect13time[CLS]theyeastgenomecontainssingle##d##1generesideschromosomex##ithesystemunit##m##cat[CLS]nterminalsequenceextra##cellulart##vas194198withinor##f[SEP]##olatebb##dorfhumanrodeidam##mini##disbb##dorfdifferentmajorproteinidentifiedc##lon##atabindingregulateend##oth##elin1geneexpression##oth##elicell[CLS]thesgene##1encoding##1located11k##bdownstream##bb##codes##ys##80##op##in[SEP][CLS]dimensionalecho##card##ioaxisviewgradedbleedingrapidwithdrawalbloodart##erial##nu530bloodvolumeraterecovery##co##bagrowthmg##itbi##phase##ptch##ekbasedog##awamedium[CLS]ain##palphap##mi##dop##erontrans##cribedbid##ire##ctionalpromoterregionconsistingttop##eron##apt##b##pt##rbop##eron[SEP]conclusionstructuralstudyth##rom##busselfsustainingsignificancepath##opmechanismabdominal##ortan##eur##ys##m[CLS]thebbh1ul##24ul##25ul##26ul##265trans##criptterminatedcommon3sitevariedsignificantlyrelativeabundance[CLS]electro##oredcomplexformedproteini##3combinationsuper##shis##p##1s##p##1bindingsite##dpromoterformspecifici##3re##onsdproteincomplexcontainss##1transcriptionfactor[SEP]distinctdbinding##rarho##mo##di##mersse##x##r##rarmolecularmechanismunderpath##l[CLS]theanalysisshowedmorningactivemaindividualroseearlierwentearliereveningactiveactive e##aindividualformerlongersleeplengthlatterdaymorningshiftoppositetruetrue afternoonnightshiftshift [SEP][CLS]thiser##drecordedcon##tral##ater##alcentralregionregion [SEP][CLS]del##eti##onmutationconstructedremovingresidue230316061904978nterminalc##opdomainwellmiss##ensemutationdi##ucmotif[SEP][CLS]k##ylab##uddinrelated##vissubstrateshowlesensitivityglucoserepression##vis[SEP]lowaffinitye##2bindingsitemediadown##motrans##actpromoter##tra##formed3##t##3cell19k##bho##x13r##cho##lant##hrentransformedm##b##6##t##k3##t##3transformedons##olevel[CLS]althoughanalysissimilaritykcoreproteinshowho##mologyrevealedidentityfiveaminoacidresidueinvolvedformatione##pitrecognizedre##bodysubsequente##pitbindingproteinu##reaseshownidenticalenzymefi##romadoelectrocorrelatednickelcontentatomicabsorptionanalysisde##ridsuppressionma##rrowculture##cyan##mia##mia [SEP][CLS]finallyp##eptidecorrespondingmutantproteinactsubstratep##rthesepssponsoredtoxicprogramrootsurfacecar##iesinv##iscoav##iscoplusdiffer[CLS]theseresultdemonstrateentire##3##lgenerequiredpath##ogen##esismodel[CLS]thedevelopmentvariouspath##ologicalles##ionthy##muss##ple##enl##ymphnodebonema##rrowfrequentlyobservedobserved [SEP]microcellbrainmac##rop15receptor[CLS]weanalyzedroleproteinininvert##asassemblyenhance##rlocatedvariablecloseonere##combsite[PAD] [CLS]themodeactionoftensuggestedexplanationdifferentslopeconcentrationeffectcurvecurve [SEP]exampleprincipleprinciple lele [SEP]wideconservationgenenatureevidenceparticipatemobironsulfurnitrogen##asespecificironsulfurclusterformationproductgenecouldgeneralformationrepairironsulfurcluster[CLS]transferglucosesu##natemamedium##ratemediumces##cher##ichicostraindelay3648hgrowth[SEP]resultresistancedo##xcellduedifferentmechanismtop##ois##omermulti##dr##ugresistance[PAD] [CLS]j##valbb [SEP][CLS]thepatternexpression##i##26##33promotereregioncontainsc##iactingsequenceactivatetranscriptionsilencetranscriptionleaf[SEP][CLS]spontaneousco##rona##ryarteryspa##rona##ry##gioexercises##tsegmentelevationelevation [SEP][CLS]fournewborngroupbecameh##bs##agcarriercarrier [SEP][CLS]effectivelyupstreamhouse##keepingtypepromoterresponds##kpositivelyregulate##sdownstreamsi54typepromoter[CLS]kwe##imm [SEP]newt##bre##sp##irachoicecostcost [SEP][CLS]electro##oreo##gon##leo##tide##sderivedsitedemonstratedspecificdproteincomplex[SEP][CLS]a##8##9n##leo##tidelonge##cor##ifragmentgenomegenome the##oto##ritcrosshybrid##ization##ization l##11##11 l##1##1 l##10##10 l##12genesequence##cher##ichicoclone##dsequence##d[SEP][CLS]backgroundreductionvariousagentprominenteffectd##tin##1well99##m##td##t##pabio##dis##tribution##tribution [SEP]reductionp##racontributedhem##ody##nampeakii##ipinhibitor[CLS]thefollowingparametermeasuredonsettimetimeintervalinjectionmamaximaltotalblockt##1275time##1reach2575totof##70toratioreach70heartrateblood[CLS][CLS]premature##lyin##act##ivating##kextractresultedcorrespondinghas##ten##ingfirstmit##osis[CLS]theuse##adactivitye##pleadsuggestedsuggested [SEP]bindingc##b##psthree233re##press##orsitealthoughratherweakconfirmedelectrorevealinteractionlivernuclearprotein##ro[SEP]cycleregulatoryconservedhoweveror##th##olo##gsneither##k##1##sk##1s##pec##iedate[CLS]inclone##dfulllength##4racerapid##pendrmin##6cellinsulincellline[CLS]k##oh##tzjj [SEP]hencegap##1geneencharacteristictypicaltransl##igancellularmembrane[CLS]thepro##en##zyprocessingessentialsecretp##2pcontainingmutationaffectabilityprop##eptidec##lea##vagesitefoldwithincat##alyticpockettransferredbeyondearlystagesecretpathway[SEP][CLS]theseresulttranscriptioninfluenceaspectgeneconversioninitiationstrandinvasionmm##rimportantpro##gno##sticfactorresult##sioc##lau##dicationfinallysampledrugderivedprobearchivema##rrowcellbreak##pointoccurredm##dr##1sequence5001000k##bte##lo##mer##icm##dr##1randomch##rom##osorear##rang##ement[CLS]applicationmethod11yearmicro##sei##smicrecordrevealedsystematicspatialtemporalchangesliprates##ync##hr##ono##usearthquakeactivityindependentmeasurefaultzoneslipslip [SEP][CLS]p##c##12cultureprimewayaccelerateddifferentiation[CLS]onecloneen##codesx##enon##athem##oltenimpcasehigheyeeye [SEP]the10ngmintermiminterim[PAD] [CLS]in912##monaco##agus##ta15se23sau16cocoryn##ebs##pecotherssevenisolatedisolated [SEP]stampcard[CLS]factornuclearextractpotatotubefoundbindspecificallyn##uc##leo##tidelocated135105suggestingregioncontainsimportantc##iregulatoryelement[SEP][CLS]zipperatalsosimilar##p1jtranscriptionfactorwhosedbindingsitediffersatbindingsitesingleposition[SEP][CLS]r##26##0mutantexpectedsupportm##rnasynthesis##it##rotranscriptionre##con##itutionreactionwelltranscription##ivomini##genreverseapproach[SEP]higherid487326vucontractionbeganlateminalphawomanuactivityunchangedhypothesiscorrectrequirement##4##rrel##atedegreem##rnasecondarystructureinphysicianrealpath##ologyinpopulationco##lo##mbwellknownknown [SEP][CLS]resultdemonstrateb##vcoatproteinsoletranslationproductg##eno##micrbetawhereassbeta1se##rfmessengertranslationbetabproteinprotein sbeta2functionmessengertranslationbetacbetanewlybetaprotein[SEP]retrospectivestudy##zaelectro##phaabnormal##zopatientpatient [SEP][CLS]theconceptdevelopedmine##reynext10yearyear [SEP][CLS]betagal##os##idastranscellnormal##ized##11transappropriatecontrol##40earlyregionpromotercon##it##utiveresultpromoterregiongenecontainsinformationnecessaryinitiationtranscription##6cellspecificmanner[SEP][CLS]existsthreedisc##ernformsteadyunderform100k##dasolublec##oso##latedformk##dapdeformk##da[SEP][CLS]thepitcompelledcomplexbindactivate##ss2turnde##ph##latesship##cprobablysubstrate[SEP][CLS]when##rusedam##p##garcultureexpressfi##riaswitchregionoff[SEP]mechanismactionlocalan##aestudenthealthhealth [SEP][CLS]we##rmutationimp##airfix##ation##cre##tconsequentlyprevent[SEP]differentapp##icitnormalapp##ixsan##ore##xia[SEP]propose##3involved##hylghuman28r##rna[CLS]atstartperformancerideplasmaglucose4200 25201570mm##oll1conch##o##o021respectivelydifferent0505 [SEP][PAD] [CLS]thereforeproee2characterizedrelationproalphaalpha strongerueffectivenesseffectiveness alsoinfluencecard##iovascularsystemsystem [SEP]copyright1999[CLS]##lionc##ysfrequentlyoccurproximityjointjoint [SEP]##ystransmodifiedableh##ydro##lyte##aal##aasth##io##zy##erb##aass##ltrans##mo##difiedinactive[CLS]protein##b12bindtwothreepromoterelementtry##omose##ym##our##i##i [SEP]expressionmedicalefficiencyrational##tilbudgetfund[CLS]thepresentstudytryassociatecausehotis##emiaagonycorpsedonorevaluatemaycausedsympathetice##fferenceremovalremoval [SEP][CLS]theenzymeencodedclone##dfragmentequallyactivep##vateh##ydro##vateindicatingenzymedla##ct##atedg##ly##atede##hy##dr##ogen##aseactivity[CLS]noises##t##matommovingtunnelspacespace [SEP][CLS]thehumansequencecontainselementt##ctalsofoundmr##areenhance##r[SEP][CLS]thereoverallfunctionalf##opromotertranspromoterdintacthecellm##od##ulatesfunctionhe##teropromoterconstruct[SEP][CLS]enhanced##ydrofattyth##rom##box##aneincreasedreleaseex##ci##tataminodecreasedtissuema##gnesiumlevelworse##nsecondarytissuedamagedim##uroinjuryacutealcoholinto##xi##cation[SEP][CLS]trans##criptenactiveenzymetransem##b##ryoex##cisionass##racoco injectedrtrans##cribed##it##roc##atemplate##mi##ddharborelementdel##etitrans##pocodingregion[SEP]theobjectiveresponse##r50952971includingcompleteresponseresponse eightpartialresponseresponse [SEP][CLS]relativelysmalldel##eti##onaffectsegmentcontaining3genegene importantregulatoryfunctionlossleadal##hen##otype[SEP][CLS]twos##h##2domain##12##0##a##pasactbinds##yne##rg##istic##ally##0[CLS]p##12##0g##pasactgapregulator##afunctionkeyrelaypointsignaltranspathwaycontrolcellproliferation[PAD] [CLS]ho##mo##loguemaper##kkinasegeneexpressedveveget##ativefemalereproductivepethybrid##a##a [SEP][CLS]itpro##gnot##12oner##r29p##10[CLS]iten##codessequencespecifictranscriptionfactorcontrolconcertgeneproductdifferent##iapathwaytissue##rexpressed[SEP][CLS]conclusionddetectregional##lyh##y##pop##er##fusedmy##oc##ard##iumagreementm##b##ffattyupde##ter##ior##ateseffectabsorptionbio##tamcomposite[CLS]transcriptioninsertedgenepredictedsub##omi##cmr##nabhybridanalysisencodedproteindetectedenzyme[SEP]theseresultpan##ret##inalphoto##coa##gueffectivedealingearlymoderatelyadvancedcaseangleneo##vas##cular##ization[CLS]n##bs##iiessentialstimulateactivitysixteen25rejection95monthrange163[CLS]alal##aniamino##fer##bhem##ogpredictefficacythe##op##hyl##idt##idbidq##d##d [SEP]areport24hourdosreleasethe##op##hylemphasisanalysisdataobtainfooddrug##o24##brotransformedactivityextra##cellularsignalregulatedterminalmoderatelyincreaseddeltainhibitorjalleviate##d[CLS]timeactionhe##nis[CLS]es##cher##ichicocellmutantgenecon##it##utive##hen##otypeimp##licationmechanismunderlyingm##uta##ut##cm##utaeffect[CLS]24hleveltargetspecific##2alteredadditionappropriateterminalextensionthusselectsystemherec##lon##inghemgene##ero##biccop##rop##or##rinoii##io##dases##cher##ichicofunctionalcomplement##ationsa##harc##vis[SEP]thisstudyundertaken##bul##ized##oso[CLS]theatop##icskinreactionreaction i##bodytetcbr##ty##choexaminedfollowingthreegroup11 20adulthistoryas##thsfreefree 4y##r22 20currentas##th33 20healthy[CLS]previousstudyshowedp##ali##nd##rom##icsequencelocated159basepairessentialinductioncut##inasgenefsof[SEP][CLS]s##ematype##ihcut50k##danuclearbindpromotercontainselementthisregionalalterbrainopdependencewithdrawalweconcludebelongnovelclasshere##bydesignatedka##ppasubunitgenedesignated##1humangenecalledcalled h##1[CLS]based##rstrategyexpressiong##eno##micorganizationf##ut##bgene[SEP][CLS]thepresentdemonstratesproon##cocjre##press##estranscriptionhumanalphabetapromoter[SEP][CLS]cjre##pressedalphapromotercanonicalcampresponseelementcknownbindjmemberbztranscriptionfactorfamily[SEP]pulsemonitorout##patientdentalan##ae##hesia[CLS]previousstudypartialsequencesuggested26largesubunitp##hyl##ogen##yre##tri##evaltax##miclevelinvestigated##a[SEP][CLS]thesensitivity99##m##ti##ggs##tiranged71100100 [SEP][PAD] [CLS]theindexpatient10yearboypresenttypicalsop##dtypeitogetherbowboneabnormalth##oraxspinalcolumncolumn [SEP]thecause##pactivephaseremainsdetermined[CLS]ag##eno##micclonerepresenting5partmessagealsoisolated[SEP]anti##biotic##d##camediaessential##omatherapythemainside##elom##os##itis##urocommonoftenseveresevere [SEP][CLS]thecolumndensityfrozenhydrogen##hanininferred25x10183019respectivelyrespectively [SEP]similarlycatexpression##l##cat##oaobserved##21cell1p##1424127determinedblooddonor146imdisorderc##lonse##quencinginchainregulatedexpressiondevelopmentskeletalmusclecontractoproalphacombinedhuman##ro[CLS]these1sub##c##lonpromoter##lesssu##dfragmentdownstreamla##cpromoterm##102precises##p##licingsucodingregionefficientat##perib##osobindingsiteexpression##oi##ucpromoter##50##3vector[SEP]mutationpreventf##k##bbinding##rhybridsystem[CLS]transcriptione##ukatgenedependentabboxinternalcontrolregioni##c##rsupstreamtranscriptionm##od##ulatoryregion[SEP]failuremajorinflammatoryto##olsupplementi##udayresultam##io##dar##oneprevention##ox##ys##fe##quiattributeddifference##ox##ys##fhighlevelexpressions##bwellsclone##dexpressionvector##j##70changegrowthmorphology##rys##ns[SEP]##po##9tumorne##rosisreceptorinduce##pop[CLS]in##oes##hageecho##card##iovariationwallthicknesschangegloballoadingconditionbasalmid##wallcompartment[CLS]wedogspontaneous##lybreathingroomairin##hala##tiongasmixturecontaining10co##2209oo2691nn2determinerolehisse##rot##oniacid##aeh##yper##tens##yper##cap##nia[SEP][CLS]se##quencingfragmentshowed##rpcodingregions##pec##ifies##4aminoacidbasicproteincalculated##r3736##6[CLS]viralcomplementary15sm##rnadirectssynthesisproteinhybrid##izespredictedngenedidentifiedcellextract[SEP]##orediprotection##piboundtranscriptionfactorpu1s##pi1[SEP][CLS]##trocellpopulationcellcloneclone established##rvectorcapablehighvectort##iter105##8##rcm3##t##3[SEP][CLS]howeversitegenomee##ccellpermitmm##v##odeltapro##vir##alexpression[CLS]increasinginsulintypeidi##abepossibilityg##lu##co##cor##tic##oiddeficiencyhoweverdifferentialu##til##izationde##ter##minamediar##ar##x##rhe##tero##di##merbindingd##r2d##r5rare##s[SEP][PAD] [CLS]gal##actor##r##hoerarepresentationsell##asyndromesyndrome [SEP]his##statransratedetectiondisease[CLS]severaldrugmanagementmacdruginteractioninvolving##yt##och##penzymesystem##erialcompliance##kespatientisolateds##ys##to##yper##tens9029patientessential##yperdi##astblood##ote##nsratherblanketcharacterizationid##io##mcom##psecondarymanifest##nis74##00preventing##urodgroup##5174##00bettervehiclepreventing##urod[CLS]thewomanintermediatecalciumgroupgroup approximatelymeanb##m##dvaluelowcalciumgroup[SEP]##em##olyconditionpresentstudymeantcontribution[CLS]thetransitionexpressionearly##iotgeneexpressionmiddles##porgeneoccurscellexitform##iosispin##dle##dle [SEP]n##fdproteinbinding##cam1promoteractivityenhanced1##beteffectint##ph##ost98##0##5##9203##urocherryred##lonsi##ali##dostypeiusinghybridadditionalcomponent##tbindingfactor[SEP]my##bproonproductc##btranscription##alregulatorexpressiontightlylinkedentrysphasedsynthesisboth##38kinaseinhibitor##20##38kinaseil1##betstimulationpromoter[CLS]clinicalfeaturey##r##ra##vidvparapara 0presentedan##aeconsultationclinic37##estadisc##usoptionlabourdeliverydelivery [SEP][CLS]thetahahaei##l##pstoolgeneticanalysis##r##2effect##f##popresultstronglyrolep##k##pop[CLS]cognitivemeasures##tro##opcontrolledoralwordassociationtestusinglettercc flcow##at##f##lversionversion [SEP]##x##1belongsexpandingbi##co##idrelated##bra##obgene[CLS]effectdiet##ary##idwholebodyretentiondistributioninmercurymouse[SEP][CLS]differentialtranscriptionp##omeencodedgeneme##so##llbundlech##opmon##oc##ot##yle##don##ous##d##penzymetype##4plantmaizeso##rg[SEP]##quentialdetect##24classtransformedindeedwildtype[CLS]tissuespecificgeneregulationlargelarge extentmediatedtranscriptionfactorinteract##enodsequencesequencespecificmanner[SEP]enhancedcorrelationboundhighersoeffectboundsodrasticallyenhancedsothecompromisedfi##bri##nocontributingfactordevelopmentth##rom##bospatientl##guthe##egreaterbeecalculatedenergyexpenditure[CLS]resulte##60##10treatmentco##rona##ryo##cc##lusion[CLS]relationshipexpressiononinstabilitycellactivatedhumanhar##acontrolbacterialla##oseop##eronregulatoryelementchange##hotdi##of##olatered##ucd##f##rgeneam##p##lificationfollowingmutanthar##ainductiononvarietyfrontchronicbacterialat##her##os##cle##rosiscom##plicationan##gin##oc##ardin##far##ctionstrokestroke [SEP]longtermresultcu##rative##teralre##f##luxend##osinjection[CLS]inspectionxtropical##ismousehumandupstreamsequencerevealedpresenceta##taboxwellpro##ximalenhance##ro##ame##rmotifelementcontained##rnagenetrans##cribedrpolymer##aseii[SEP][CLS]characterizationunusualt##rnalikesequencefoundinsertedne##uro##spre##tro##mi##d[SEP][CLS]repeatedtimecoursepatientreabsoluteconcentrationshowedvariationvariation [SEP]thepresentrelativeblood##test##inalf[CLS]thehumanpgenegeneratesleastfivedifferentalternativelys##lice##dtrans##criptencodingdifferent##of##orms[CLS]theseshows##1s##3transcriptionfactorup##re##gu##fpromoteractivitybindings##p##1bindingsiteposition31##8303b##p##fgenepromoter[SEP][CLS]1hresttreturnbasesubjectrepeated5minprotocolfollowedfinalm##rim##r##r [SEP][CLS]thecellarrestg##1cyclegrowprojectiontowardsoneanotherformings##hm##ooprojection[SEP]ma##mmalho##mo##mologue##s##combgroupenhance##rmediagenesi##ros##ophe##tero##chte##lowithshow##lannod##almeta##sta##siss##lnhis##tologyreflectivehis##tologyremaindernod##albasinconservatives##lnbiostagenod##allypatient##lan##omatheresultobtained##30##4rstructuralchangeecorvicinityhe##lixdistortioninfluencecat##alytic##zy[SEP][CLS]c##lon##ingcharacterization5flankregionhumanat##ratel##yasgene[SEP]##bulmaintenance##od##ialrelationhe##painfectionthes##3proteincontainsdrepairprocessingprocessing 8odvia##yla##id##yasactivity[CLS]25patientreceived20mgh##cinen##ylbr##omi##derest5mgprop##ino##tevplusdi##az##am[CLS]westatisticaltechniqueidentifysequenceelementmayresponsiblecycleregulation[CLS]comtoc##tfinding##cre##aticduct##alad##eno##cin##omastudiedcombinedmethodearlyenhancec##thighdoseenhance72##cin##oma[SEP][CLS]notrans##criptdifferentlengthcoulddetectedprolongedexposureabsencee##1##a##4triggeroperateindependentlyknown##vacayet##ter##izedmechanismusedsuper##shi##fts##teropromoterproteincomplexgelshiftexperiment[CLS]then##uc##leo##tidesequenceest##rogenreceptorgeneore##och##romau##reuso##ae##rindicateshormonebindingedomaincomposed4ex##oninter##spersedshortintro##n01813k##b[SEP][CLS]theexpression##1mph##1wellcorrelatedtissueem##b##ryo##ryo [SEP][CLS]thengene##9rear##rangedseveral##uketrans##locationwithinregionweisolatedsequence##dsequencecorrespondingtwonovelgenemap##q##28adirectdirect hem##rina##hcomparedserum[CLS]diffusionepidemicin##cu##bationc##ris##s##crossdynamicdynamic [SEP][CLS]c##eri##pinteractioninteraction [SEP]theencoded##ido##3foldedsecondarystructuresimilar##3r##zo[PAD] [CLS]therapyprevention##rre##versibleshockco##rt##ico##ster##oid##oid [SEP]##rate01m##l2##h##5finternal00 05m##l100mgmg lextractedextracted to##xitubeto##roma##pect##rome##rometry##try [SEP][PAD] [CLS]positiveeffectradioactivetherapy[CLS]thel##tbetageneexpressedl##ymph##oidcellorganlittleknowninregulation[SEP][CLS]##ro##fattainedpeakserumconcentration12mglserumhalflife34min[CLS]d##dcloneen##codesp##pt##ide33aminoacid82identitymy##od41aminoacidput##ativehe##lixloophe##lixregion100identity13aminoacidbasicdomainproposedcontainessentialrecognitioncodemusclespecificgeneactivation[SEP][CLS]identificationo##ste##al##cingenepromotersequencebind##p##1treatmentbased##ngadrugn##ys##tatam##oterk##le[CLS]mutation##bolma##lkfunctionresulttransport##lt##osealsocausecon##it##utiveexpressionma##lt##osere##lon[SEP][CLS]d##roscase##inkinased##cki##icomposedcat##alyticalpharegulatorybetasubunitassociatedalpha##ahe##tero##te##tra##mer[SEP]thethe aimstudyexamineexamine whetherwhether eresearch##l##30alonedistinguishgroupdesigndefinedgasgastricvariablevariable [SEP]##gio##po##flesalmostsizelightareadarkcenter##co##idles##ion[CLS]wepercentageo##3up##take30adults##pra##gueda##wleyratnose1h##r030610o##3[SEP][CLS]thesignalnoiseratio##rcalculatedt##2weightedsequencesequence [SEP]kinase##3##klackingclusterkinaseregulatorydomain[CLS]threedistincthumanh##da##csho##mo##log##ousr##d##3yeasttranscription##alregulator[SEP][CLS]the4n##tsequencerot3tefarshortestsequenceenhance##rknownstimulatetranslation[SEP][PAD] [CLS]objectivevassociatedne##bro##mat##matosistype##2wellcharacterizedexpression##em##okirequiren##felementadditionalregionca##atenhance##rbindingproteince##belementil8promoter[CLS]hopehealthillnessillness [SEP]assessmentdirectscreening##rinap##or##ph##ob##ili##vationperipheralblood##opefirst##po##cellularma##rrow##ratetherapydose##racc exexertmainmain activitysuppressionle##uka##emratherdifferentiationcellcell [SEP]allde##pressiveshowedimprovederrortreatmentt##ria##xialproneutron##osoo6symmetryapplicationa[CLS]thebestsequencestudyexperience##rshortt##rspinechot##1weightedimagespinecho1200t##rt##2imageimage [SEP][CLS]cellcoinfectedsimultaneouslyiib##bvrecontainingdr##nasequencesecondrexpressingexpressing tr##napolymer##aseinitialexpressiondrtrans##criptsubsequentlyrescuedhelp##eri##b##v[SEP][CLS]seasonalvariation##d##miumcontent##d##miumpoll##utedenvironmentresultrelation##of##ormldiversitytissuecell[CLS]doctorgivenin##hot##xa##te20standardneedleusedthe11 recruitedreleasedgogol##gimembranetreatment1mt##risre##in11 recruited##utive##1##1remainsbound[CLS]theformationtumor##likeles##ioncockanalblock##agefinetangledp##iliha##emdunovelclassp[CLS]weremarkabledifferenceexpressionpatternm##t##b##rnatwohybrid##rna5##k##b##b 8k##bhumanbrainprimarybraintumorcomparedcompared [SEP][CLS]twored##oxcenterf##ad##ad 4##4##s21clusterpresent64k##damon##omerthegeneggt##pasbelonging##ptr##abexpressionregulatedmediated##rome[CLS]car##ot##idbodych##em##ore##ceptoractivityrecorded##ros##algang##lioncathuman##otoseserineproprotesub##siteth##io##estersubstratein##oly[CLS]explorerolecar##boxterminaldomaindeterminingcellcycle##d##c##c34characterizedgeneencoding##sincorporatingsequence##drelatedfunctionaldistinctdistinct ee2##ad##2[SEP][CLS]map##k##kkinase##kpactivatedownstreamproteinkinasemap##kkinase##kturnactivate##k[CLS]k##ond##oeffectcuf##efilm[CLS]howeverad##ar##1relatedde##ami##nas##ar##2showedexpressionregionbrainexaminedincludingcortexhip##po##cam##puso##lf##actor##ys##tri##at##um5##t##rm##rnaextensivelyedited[SEP][CLS]toinvestigatetranscription11k##base##s5flank##ingsequencefusedl##uc##ifer##asereportergene[SEP][PAD] [CLS]influencecopperaddition001inchflow##iredosignal[CLS]##os##ulf##atesoxygen##etonc##19s##tero##idadulthumanurine[SEP][CLS]an##ae##ro##biccondition50dayexperimentorganismde##graded1515 18te##m##m 2025al##kanin36368##9109##34##342168##64##3determinehemlethalfurtherreviewevaluationsurvivalrate9262patient198119961996 [SEP]36initialexamination[CLS]co##rt##ico##tro##pinreleasing##rfinjectedcentralsuppressionpunishedpunishedrespondingconflict##hesrolemediabehavioralresponsestress[SEP][CLS]temporalrecruitmentmmsin##3core##presscomplexet##sdomaintranscriptionfactorfactor el##k1[SEP][CLS]theclustermappedn##uc##leo##tide46##443##4relative##leo##tideainitiationco##dong##eno##micd##na[SEP]in##r##1showcon##it##utiveppositiveregulatortranslationp##70##6kinasepin##hibit##3kinasem##tortargetinhibitor[CLS]thethe authororbitalcavern##oushem##ang##iodiagnosedt99r##b##cs##pect##pect [SEP]##ro##flevelserum##erenddosinterval8hsuperiorsuperior almostsuperiororganismpseudo##mona##inoanti##biotic##hyl##ax[CLS]identifiedclonech##omo##eno##micdrescuedcaca 2dependenta##xon##ema##l##ulesedefect##1thesechangefirstweekweek [SEP][CLS]##yper##liprecentlychild##graalter##ationbasediseasedisease [SEP]plasmahem##ope##xinhome##ostacutephase[CLS]re##press##orelementrareexamplenaturallyperfect##nd##rombindingmotifn##fka##ppa##ltranscriptionfactor[SEP][CLS]try##ptinductionpreventsr##hodependenttranscriptionterminationleaderregionop##eron[SEP][CLS]remainsphysiologicalproblemonealwaysforemostm##orintrinsicregulationbrainactivityseparateactiondifferentarousalsystembroughtwholewhole [SEP][CLS]thegenecomprised17ex##onspan36k##b[CLS]theimmuneresponseseemspartiallyprotectiondestructiveconsequenceinfection[CLS]resulthe##pah##yd##dos177patientpatient [SEP]c##rea##tinep##hos##oki##nasreleasepatient[CLS]themajorityput##ativetmutationfounds##poradicratherlinkedfamily[SEP][CLS]m##am1encodedsinglecopygenespanning13k##bstructural##lyorganized14ex##on13intro##nsimilarhumancounterpart[SEP]biospecimentakenfrontalbranchrightsuperficialsegment##alin##tithickconsistentin##tifi##bro##ptype##m##dhisthusstudy##it##rodirectlyevaluate##phe##nousrespond##as##oc##ons##tric##eriallevel[PAD] [CLS]wefound##20geneidenticalyeast##rm##1gene##ks##pra##gue19891989 [SEP][CLS]basaljmap##kspecificallydelta##rcorrelatedincreased54k##daproteinobserveddelta##rcelldel##eti##onanalysisdistinctfunctionaldomain##f##1line1[CLS]##asimilarresultinductionwwt##p##1jpromotercatp##mi##dsmaller[SEP]##th##rom##binii##iatii##i[CLS]one##fextendsn##uc##leo4151620en##codes40aminoacidprecededrib##osobindingsite[CLS]glucoseconsumptionhumanbraininfluence##ven##ousin##fusionglucoseg##lu##ca##gonglucoseinsulindhug##hesf[CLS]del##eti##clethalresulteddumb##bellshapedterminalmorphologynucleusalmostdividedstillconnectedthese##afoundderived3region3metgene[CLS]aduringoo2is##cheextra##cellularkchangesub##ep##rdi##umsignificantlylemid##oc##ard##ium[SEP]thegenerationdo##rs##oventralpolar##ros##op##b##ryoregulatedaction1212 maternalmaternallygeneproductdorsalgroupgroup [SEP][CLS]ul##ti##mo##nch##ialbodypara##roidg##landfreshwaternanatrip##catresponsed##3administration[CLS]theseobservationsuggest##f1region##phapartiallysilence##dcore##press##orproteinmightinteractp##lationdependentmanner[SEP]authortitletitle twodrugnamename twoc##ir##cum##stanceconditiondatadialdimsvariationasspro##te##aseenzymeexhibitedsubstantiallevelpro##lyis##omer##aseactivity520wildrevealingmutationcon##ferpro##te##asedig##estclassic##it##roasspro##lyis##omer##asemisleading[CLS]testhypothesispredictedalteredclassigeneproductbetaknockoutbetawoulddevelopover##load[CLS]n##uc##leo##tidesequencegaggenegagp##oljunctionf##elin##uke[SEP]based1r##nalevelbasedcomplete##irosuppressiondescribesresulttrialtumor##bcombination##id##d##p5flu##oro##rist##ine[CLS]onbasisphysicalinteraction##x##l##fpresentmodel##x##ls##licingregulation[SEP]skin##foldant##hr##oplimitationder##ivingtotalbodyfatfat t##b##bfpossibilityproblemmightrelatedden##siaddressedaddressed [SEP]differenceintermediategroup11f##em##oral11l6totalb##m##dsweclone##db##hiffragment##4##131sab##hisiteorderstructuralanalysis##1##aregion##4wereviewed81patientdem##entauto##psyfindingal##z##heimerdiseaseadidentifypatientseizure##oc##lononsetdem##ent##ia##ia [SEP]backgroundlungex##pi##ratorslightlyhigherp##xair##waycorrespondinglowerin##fle##ctionlipins##pi##ratorpcurvemeasuredrecommendedrecommended [SEP][CLS]33 [SEP]rawcellmicroe##octwoifgammaactivatedtranscriptionfactors##tat1##al##phai##rf1bindgasi##rfelementrespectively[SEP][CLS]thermalchangeb##ovu##ter##usfollowingadministrationest##rad##iol17##bet##a[CLS]thestartingdosedose 8madministeredin##veni##vshortin##fusiondaily5dayrepeated3doseadjustmentdependingtolerancetolerance [SEP]safesatisfactoryresultresult [SEP][CLS]in##hibition##oam##ineo##xi##xidas##gy##line10mgkgveffectt##yra##mine1000##graminjectedhe##papotenthe##lenatrigger##d##9death##lxl##l2of##cusin##alinvasiveneo##p34952149including9lowhighsqinles##ion1ad##eno##cin##oma##er##x3ad##eno##cin##x2ad##eno##cinend1ad##idbasalcar##cin##er##x[SEP]thed##3##1genehighover##ex##pressedtranscription##allevelbreastcancer[CLS]theorganization##bgenesimilararrangementgeneho##mo##log##ouspulmonarysurf##actalthoughoneintro##npositionshiftedsingleaminoacid[CLS]hipfracture[CLS]theseresultindicatepatientsevidenceexercises##tsegmentdepressionmaydecreasedmy##oc##ard##ialoxygensupplyduehem##og##lo##binlevelincreasedmy##oc##ard##ialoxygendemandelevateddoublecomparedsubjectexercises##tsegmentdepressiondepression [SEP]althoughdisplaydisplay approximately75sequenceidentityrat##rreceptordisplaydifferentp##harprofileespeciallyrespectanalogue20199##5specificreduction##aupeakechoelatecomponentobserved[CLS]em##boe##ur[CLS]usingo##gon##leo##tideprobeprobe 8k##ilo##basehind##ii##ifragmentg##eno##micdisolatedsubjectedsang##erdid##eodse##quencing[SEP]130132167itop##ois##omerfourck##4##15identifiedmatchoneg##eno##micclonematchconfirmed##leo##tidesequenceanalysis[CLS][CLS] 2prevalence##p##rideprohispro##ramrelaxproee1##1##osmenart##eri##ogenicimp##otedi##abeimp##ote##nousleak[CLS]prime##rextensionexperimentd##pdifferentiated##9##37singletranscription##alinitiationsite[SEP][CLS]iniishowedimprovementpeakv##o##2rate##vdelayfixed##vdelay05effectfamilyvisitbloodheart##rona##ryunit[CLS]sequenceanalysiselectro##oreexperiment##nseelementinteractregionregion g##atarelatedfactorrespectively[SEP][PAD] [CLS]cok##12strainco9##und##ii111 ec##aca##aca 2##art[CLS]wild##k##k##1enhancepromoteractivityactivityin##hibitdominant##k##k##1##k##1##3##kc250302[PAD] [CLS]thestudyshiftimmunitysystempath##ogenchronic##tum##orousdisease##idg##land##land [SEP][PAD] [CLS]co##ex##istturn##ersyndrome##chi##zophrenia##zophrenia [SEP][CLS]anpromoterfragmentdosecontainsequenceresemblingoshiftedfusionprotein[SEP]conflictdrinkingtestrateffect##sel##ecbetaad##ren##ept##orblock##erpin##do##lo##op##olobind##t##1##a##1receptorselectivebeta1betaad##ren##orantagonistbeta##x##oloi55##1##1 respectivelyrespectively ne##treceptorreceptor [SEP][CLS]althoughsignalcontaintandem##lyoccurrings##h##3##2domainfunctioncloselyspaceddomainwellunderstood[SEP]bio##har##cesc##vis##29##eli##1defectinitiationchainformationconclusionul##cerco##litincreasedpromptlyparent##eral##teroi##rre##spectiveoutcome[CLS]thedurationna##xon##eappearsdoserelatedstatisticalapproximately15h##r[CLS]butequal##izesupperlimitnormalcommon95specifict##umourindicating199clearly##pass[CLS]thesemotionfoundncterminaltailsegment3335formturnbetastrands##1s##2residue4752locatedlongloopprecedingstrands##3[SEP][CLS]##eno##micsouthernanalysisreveals1015hybridfragmentmaizecontainssmallgenefamily[CLS]custommadeor##th##oseachievingwidetherapeuticgoalimprovingfunctionpinchstabindividualjointpreventingposition##alcontract##urejointtraumaintrinsicmusclecorrectjointtissuecontract##urecontrollinginflammationinflammation [SEP][PAD] [CLS]ispatientc##ro##hndiseaseenvironmentalfactordevelopingdiseasedisease [SEP][CLS]thez##1##rotranslationbindconsensustargetsiterecognizedprotein[SEP][CLS]the##100c##iactingpromotercon##it##utivemutationdu##plicationcomprisestwog##atasitesuppress##esareazincmutationalleviateneedfunctionaluareaprotein[SEP][PAD] [CLS]pit##uit##arythy##rot##enoassociated##gen##italh##roid##ism##ism [SEP][CLS]regionun##fa##vour##ableduemalariapastpast [SEP]indeedsingleoraldoserolemagocomponentantitram##ado##lappearsminoranaleffectat##tri##but##able##op##io##idparentcompoundchiefend##ol##umipro##sta6##eto##1alphath##rom##boxpate##ccoverage[CLS]so##matic##cer##alinputthspinalcateffectbi##lia##rysystem##2high##cher##ichicosyntheticgene[CLS]##fect63presulted10foldinductionhumanre##nintranscription##alcontainingnativeconsensusc5foldactivationcontaining##function##al##re[CLS]wewe undertookstudyexaminerelationshipsystemicoxygendeliverydo##2tissueoxygent##po##2##vowhitecaselikely1995c##i10355 [SEP]methoddeficitad##h##d28subyearrandom90immediatereleasemet##ni##datei##rmph3dayt##iddose##devery4hourhour n97##osmphdayq##d##d n9528day[CLS]im##mutolerancerat13weekin##hala##tionexposure##elli##ide[PAD] [CLS]theycausedisabilityinvalidmortalitygreatpartsignificantlydamagingcountrycountry [SEP][CLS]c##lon##ingsequenceanalysisch##otproprote##aset##po##neden##tic##ola[CLS]andq##t##dj##t##dinterval39childlongq##tsyndromecompared50normalagematchedchild[SEP][CLS]vv er##bbmediatedcomplexformationtransformationshownoccurindependently##aactivation[SEP]bothparameterdeterminedion##ron##oro##otoexcluded[CLS]organizationex##onsuggestssimilarhumangenealternatives##p##licinggenerates120164188aminois##of##ormspredictfourth##of##ormcorresponding##20##6electron##sco7tsextract10v##oncomplex##ed##oso10bound##osoconfirmingo##galeast##coat##ed[CLS]thesequencecontainedfiverepeath##heticalzippermotifonenterminalg##bula##rdomainfourcentralalphahe##lica##lstalk[SEP][CLS]post##he##parlipfatemsubstrategreaterfemaleratmaletheauthorpainfulwristrelated##ieumuscledorsalhandhand [SEP]g##eno##micorganizationhumanmulti##dr##ugresistancem##dr##1geneorigin[CLS]theresponseni##tro##cerintactinitial##per##fusionpressure[CLS]del##etianalysisrevealedtdomainrequiredgogol##gitargetingtargeting [SEP][CLS]inadditionput##ativebindingsites##h##3s##h##2domainpresentaminoterminalhalfmolecule[SEP][CLS]sincenearlytransformhome##olo##go##usdcarriedsinglere##combp##mi##dpmpmstrainstablehe##tero##du##plexdappearslelikelyho##mo##log##ousd[SEP]rightright reserved[CLS]onenew##f##r##0##4detectedcodingprotein91##8aminoacidacid [SEP]sequenceready3m##bcon##ti##gbreak##points##iri##daregionhuman##13themapkinasekinasekinasem##lkcolocal##izesalong##tub##uleassociatekin##esimotor##3[CLS]bones##tiexcellentscreeningtestboneles##ion##a67s##titooldetectinflammatoryles##ion##ion [SEP][CLS]spontaneousfractureta##rsa##rsalbone2casele##ros[CLS]theytrans##ducedtc##op##lasportionc##olo##opscterminaltailreceptortransferred##op##lassignalingmoleculegprotein[SEP]serumal##kal##pha##rea##tineincreased##raefeddecreasedna##o##4pig[CLS]thisgroupshowedpresencebacteriain##fi##ratedden##tina##ltub##uleco##rona##llyrootcanal[SEP][CLS]sevenzchallengetimehoweverscatteringrateta1plan##ck2##pitaapproximately6##tperpendicularimplyingbedt##t2##cun2meetcriterioninter##layerin[PAD] [CLS]theeffectkidneylengthlength considerablyprolongedeffectchainlinked29implicatedtargetingpro##as[CLS]di##abeo##steknownchroniccomdiabetesalter##ationcalciumvitamindend##rinesystem##ro##af1kinasel##af1kinaseactivitycellrawcellr##af1kinaseact##ivatingcomponentlsignalingpathwayregulating1promoteractivity##ag##t##pasactgap##9##3fformationfcomplexviadomaindependentmechanism[CLS]g##ivalre##tractionclassvrestorationmethodhem##ogoxygen##perl##ymphflow##lincreased433 83m##l30##ymphratiounchanged06l##ymphproteinincreasedincreased 266 46m##l30datamicro##vas##cularper##me##ability[CLS]usa[CLS]re##tppt##con##co##genegeneratedch##rom##osorear##rang##illathy##roidcon##it##utive##lyactivatedversionpro##toreretgenecodingreceptortypetype t##oswhosel##igan##dstillunknownunknown [SEP][CLS]p##cc680##3mutantimpairedc##yt##och##romecmat##uration[SEP]studyobjectivecharactergasma##ximalcexercise[CLS]instudyshowact##ivatingeffectmutationresultcreatingex##onics##licingenhance##res##edisrupt##ingput##ativesecondarystructure[SEP][CLS]thekinasedomainencodedco##ohterminal##ety94conservednterminal##oi65ho##mo##log##oussuggestingregionmayen##codesequencecon##fer##ferringdifferentialregulationtwokinase[SEP][CLS]inratc##d30levelpara##roidhormone##roid##x1alphah##le##fer##ol1alphaohd##3showedalmostpatterncontrolratresponsecampinfluencedcontinuouscontinuous oraladministration##d[SEP][CLS]thegoalinvestigationdeterminewhether##miupdifferentiateviable##oc##ard##iumscartissuesoon##rona##ryth##rom##bol##ys##oc##ardin##far[SEP]therethreetypeproblemproblementersbodyacceptproblempenetrationdrugbodyabsorptionbarriercrossingdurationactionproblemrelatingtherapeutictargetselectivelocaldeliverydelivery [SEP][PAD] [CLS]inshockse##psis##psis idcauseacid##osisseverean##emiahem##og12dappearedet##iolfactorfactor [SEP]transplant##los##porliverdiseaseadultadult [SEP][CLS]northernb##lotanalysismusclefat##uit##aryrd##dshowmajortrans##cript43##basek##bthreeminortrans##cript00 81732k##bcorrespond##rcopyright1999concentration##roit##umourevidencere##gressiondrugthe##9geneen##1proteinmajorpartnerrang##t##pas[SEP]studydesignretrospectivereviewreview [SEP][CLS]sequencedivertransformation10foldfold [SEP][CLS]studysuggesthe##licaassemblyproteinresponsibleloadingt##4gene41he##licaspecificallyreplicationforkbindingsitearmmustholdsix12##tide[SEP][CLS]during1stweektreatmentreceivedeither##ans##eri##n30mgc##mi##pra75mgdailyc##b##dexplorationpatientnormalthehumanpro##ximalpromoterpromoter analyzedd##nas##eifoot##printfunctionalfoot##printregion##1##6withinpro##ximalpromoterstudiedhehe[CLS]wedocrosscross e120degreec60relative4degree90relative##readexercise1kmhdegreemeasuredf##etallaebodytemperatureabdominalradio##emmutationvariantwithinclosecodingregionex##on1hgeneex##onexpressedsolely##quito##of##orm[SEP]approachdeterminationstructurefunction##4isolatedfiftyall##4generandomsitedirectedm##utaanalyzed##henmany[CLS]overfivetrainingsession25daylearnedbreathenumberstimulusreceivedsessionfirstsession[CLS]the5flank##ingregiongeneapproximately11k##b##plongknownregulatoryelementtranscriptiong##ccc##aa##tbox[SEP][CLS]f##3##pk##1##pcontrol##1arrestmultiplefunctionoperateparallelfar##1[CLS]tagexpression##pop##rye##pitlatepregnancythecompositionre##nalstoneanal##ysinfrared##pect[CLS]149x109l1equalcc##ivaluehigherbedsidefilteredp14195vv [SEP][PAD] [CLS]insecondhe##pa##cin##omayearfirsttumortypereportedreported [SEP]thetimedependentchangemeasuredfacilityout##outappearedresultgradualdissolutionh##idascomponentbarrier##ousouteyethefactordefect##ivegroupc##ii##tac##xdidentified24unitedkingdom247##uga##ltransmission7amongho##mobisexualamongin##jectdrugamonghe##teroonapproximatelyd##f##1millionannuallyfirst40yearprevent##ativestrategystrategy [SEP][CLS]bydel##eti##onanalysisidentifiedregioncjencodingtransformationtrans##act##ivationfunction[SEP][PAD] [CLS]surveylatedetectedcasec##dhyear19707474 presentedpresented [SEP][CLS]totestpromediatedactivationtranscriptionyeastreporter##mi##dconstructedtransformyeastcellpc##1##creceptor[SEP]fl##i1rear##rangedtumorthreedifferentre##trocabrefm##v##1[CLS]ion##iccompositionnana kca2mg##2##ere##brofluidfeedingbehaviorsheep[SEP]materialm##or##phological##iot##nnmedium[CLS]conclusionfindingimplyspinalcordsimplecommandcarryingmediumbrainlimbimpliescomputationalactivitytakeplacespinallevellevel [SEP]the101##stannualmeetingj##nesesociety[CLS]theresultphysiologicalfunction##oa##om##tel##icitcellmaylightse##quentialactiontranstrans activefactorregulation##anogene[SEP][CLS]stransformedgaphe##tero##mer##iccomplexnotablyhighlypk##da##2[CLS]astudyas##th##ns##nsiticatdogall##er##gen[SEP][CLS]p##prapidlytrans##ient##lyactivatedextra##cellularsignalregulatedproteinkinase##ktypecell[SEP][CLS]coharbor##10##zy##maticc##lea34meo##leocontainingsinglesingle 8o##xopposite##os##ine##ine 8o##xc[SEP]est##rogencast##ratedalsoshowedmy##oc##ard##ialbloodbetaest##rad##rona##rydecreasedbase##line1h200dose1690611410##h##zdi##ast##olicco##rona##ryresistanceincreased01comparedtime5115compared39##zre##nalveinth##rom##bosall##og##pp[CLS]severald##nacloneobtainedprocedureoneclone18reportedcharacterized[CLS]longrangemappingfieldgelelectro##oresthreem##drgenecloselylinkedg##eno##micdsegmentapproximately625k##ilo##base##s[SEP][CLS]thesesequencetestedpresenceenhance##relementabilityactivatereportergeneconsistingcatgenelinkedgamma##lo##bingenepromoterpromoter er##yt##hrker##hrhecell[SEP][CLS]twosi##bidenticalfeaturedwarf##ismnormalskullfacenormalintelligencedescribed[SEP][CLS]thisdescribesprogramresulted75reductionfiveyearintervalfurthercomparativeanalysispara##log33identity46similaritygenebelongnovelfamilyninezincmotiffollowed##obdomain[SEP]allpatientma##rrowidenticalsiblingdonorunderwent##elo##abregime##tre##atcharacteristiccharacteristic [SEP][CLS]in##adb##ufb##uffeedingdifferentrate##revaluen044metabolismgrowthk##j##j11 [SEP][CLS]methodpatientdeveloped##er##vic##elo##adimanipulationtherapyher##niadiscc##4c##5c##6respectivelysub##lonestabalpha##1alpha##1##balpha##1##d##rcontrolpromoterhighreceptordensityisolatedcharacterized[SEP]analysiswwt##1targetgenetranscellline[CLS]solubler##isolublecalphaassociate##roactivatedcam##p[SEP]i##risgasdformednumberspecificcomplexcon##it##utivefactor##b##b [SEP][CLS]simulationbasedpresentedmodelexperimentaldatatypecm##utsliterature[CLS]t##reexercise35wdegreeccorrelatedr70v##o##2##max080exerciseheatheat [SEP]electro##oreextract1celltranss15indicates##3formcomplexmigration##ogentbetaspecificcomplexobserved##broextract[SEP][CLS]then##fkaenhance##r##r t##aa##att##ccboundt##n##falphaappearskeyelementrapidtranscriptioninduction##falphattrans##act##ivationelementre##pressedbound##co##cor##ticreceptor[SEP][CLS]ourresultshowedh##ydro##try##ptahcontentplate##let1increasedsubgroupantisocialalcoholic2trans##ient##lydifferentlyalteredalcoholiccomparedopadd##ict3lowereddrinkingalcoholicnormalalcoholicdrinkingwellsmokingoccurviavia mamaobin##hibitionsmokesmoke [SEP]in3336detected6levelle25mgd3thep##pt##ideencodedcontainedaminoacidcalculatedmr5205showedho##d22[CLS]correlationalphaactivityfrontalo##pit##alcortexcortex [SEP][CLS]sitlocal##1trans##criptrevealedspecificallypollenlatebin##lea##tetstagedevelopmentrathertape##tumpreviouslytakenprincipalsourcecoat[SEP]##fo##ido##foc##os##ino[CLS]thes##pec##iecompositionabundanceglassenaturalin[CLS]howeverh##19iliewithinlargerimprint##eddomainspecific##19e##pi##mupersistentquestion[CLS]herec##lon##ingeitherp##eptidesesequencehumanc##dn##ere##vis##iaegene##1##2##3##4##5itintereststarvationnutritioncat##ast##rophepastincludings##r##vyvitamindeficiencyresultinglackfruitbe##ber##ib##1deficiencyconsumptionpolishedriceforgottenhistory[CLS]thissequenceinteractleastproteinfi##bronuclearextractbindinget##sserumresponsefactorlike[SEP][PAD] [CLS]ath##rom##binbypasspro##th##rom##binactivationfragmentf##12##rom##bin##rom##bincomplexshowingfactorx##iinecessaryth##rom##bingenerationgeneration [SEP][CLS]moleculareventunderlyingspecificreceptorregulatingnativeunderstood##1hehairheresponse##hylddamagesa##ere##vis##iaetreatmentheinter##ferexperiencewesterncountry[CLS]severalcloneisolatedencodedcterminal253aminoacidputrhe##lica##sedeadboxproteindesignatedd##d##x##3[SEP]k##erstakemedicaleducationeducation [SEP][CLS]bindingn##f##50ho##mo##di##merbindnuclearbsiteproteinsgamma3tandemrepeat[CLS]ininitiallyexpressedcharacterizedexpressionpairedboxgene##3##3 [SEP]at##her##ogenicstimulationco##llael##ast##insynthesis[CLS]theseresult1##x##r##rhe##tero##di##mersplayrolebasaltrans##act##ivation##ivation t##3suppressionnegativelyregulatedgene2##x##rsincreasedominantnegativeeffectmutantmutant t##rsspecific##res[SEP][CLS]mutantincludingex##o##1##rs##ad##5##dh##4strainrolere##comb##alrepair##j[CLS]furtherinductionc##yt##och##rome4501##a##1observed##rm##oranindicatesreceptormediatedprocesst##c##ddrelatedchemicalchemical exexertmanytoxicityactivated[SEP]sastudy34na##fareace##tate14740bus##ere##tatelongiiv##fprotocol6846##fare##tate35639bus##ere##tate4shortshort iiv32##fare##tate55030bus##tatei8760na##fare##tate8161bus##ere##tateshortiprotocolthis##easpotential##geneb##mt##x##elo##ma##ma [SEP]5366r##per##idodeterminedsequenceeightv##ir##fbindingsitefourdifferentgenedi##ydrofoot##print[CLS]il##9##rgenegene approximately90identitynonecopyen##codesfunctionalreceptornonecontainssequenceho##mo##log##ous5flankregionex##on1il##9##rgeneremaining##fsinactivatedvariouspointmutationdel##on[SEP]typeiine##uro##pta##geso##dons##ato##logy##327##42##0##9put##ativeper##isproresponseelementpresent47[PAD] [CLS]whilereviewinggas##tricspecimen215##abfounddi##ff##usegiantm##uc##osa##lfold2specimenmultiplegiant##uc##osa##lnod##uleanother33 [SEP][CLS]toinvestigatewhethertwo##gboxmediamediatetranscriptionactivationl##46##24genetwoexperimentalstrategyfollowedc##longenemulti##copyvectorconstructionfusiongene[SEP][CLS]whenopantagonistadministered24h##rterminationsinglemultipleexposurerestraintincreasebasalplasmal##hatchronic##allystressedratstressabstractt##runcatedat250wordthe##cialfeatureselfignitionsuicidesuicide[CLS]thistrans##act##ivationfi##brotranstransbeta##lo##binreportergeneabsencepresence##k##lf##aconstruct[SEP]colonysanalysis[CLS]thusadditionpreviouslycharacterizedf##abindingfactor1interactingin##os##olinelementmotifsecondmotifcommonpromoterregionfgenecouldidentified[SEP][PAD] [CLS]reconstructionx64matrixmatrix approximately45trans##axsliceslice [SEP]sequenceanalysis##aass##alikedomainterminusband41j##efdomain##rb10adapt[CLS]patientreceivedb##p##busingb2mg1adrenaline1000eitherwithoutwithout h##yal##uron##idas3000iiuvolume0m##lper254heightheight [SEP][CLS]##hino2proprote##asefootmouthdiseaselpro##te##aseusedanalyzeassociatione##if##4e##if##4##ae##if##if4e##if##3hundredclonesequencer##t##ksidentifiedwellr##t##kssekinase[CLS]rollerpump##rona##rysucard##iotfurther##bextendedne##uri##tesresponsee##pid[SEP][CLS]levelp##53substantiallyincreasede##1##aexpressioninfectionin##sulprolevel##static1400 8##gramll [SEP][CLS]healthysubjectreceivedfollowingregime##ndose##dsteadystatet##af300mg24hc##ro##f400mg12ht##af300mg24hplus2g12hc##ro##f400mg12hplusc2g12hinin emediatedkinase##ba##ktmit##ogencterminalfunctiondownstream3##i3kinase##osp##latedformmit##ogenicpathwayproteinsadditionrmitpathwayactivated##deffectmediatedactionupstreamc##y##ce##d##kvianeutral##izationrather##d##c##c25[CLS]bi##lere##f##lux99di##so##in##in [SEP][CLS]nuclearimportrant##4closelylinkedn##f##2transportsteprant##4[PAD] [CLS]almostimageappearstherapysessionrevealssymbolicsymbol##gupositionoriginateddifferentareainvestigationmentionedmentioned endingdescriptiontraitaccordingwriterwriter best##owsymbolicimageimage [SEP][CLS]the##ych##omo##tar##dationvariedmildseveresevere [SEP]botho##leo##tidecrosscompetitionsuper##shiexperimentestablisheddoublestrandbindingproteinequivalents##1[SEP]hasynthesisabnormal[CLS]althoughf##kh##2redundant##kh##1controllingpseudo##hy##pha##lgrowthgenedifferentfunctionsi##ra[SEP][CLS]molecularanalysisin##act##lexpressioneverynullcloneresultedapparentdel##eti##onrear##rang##ement5flank5codingsequencebreak##pointsconsistentlymappingwithin550b##pg##crichregionex##on1middleintro##n2[SEP][CLS]howeverc##bbetastimulatetranscriptionprimarilycampre##spelementc##remapposition77945bindingsite[SEP]he##lio##lioxpu##ls##doxex##pi##ubapatientsevereas50foldincreaseion##rnsheatingconfinement##orto##ka[CLS]howevermolecularmechanismspecificc##itransactingfactorcontrolpro##dy##phipromoterclearlydefined[CLS]finallymediated##k1decreasedinsulinincreasedpro##ct##ingeneconfirmedrequirement##k1insulinincreasedpro##ct##ingeneexpressionsubstitution##11leddominantlethal##itythreemodernhem##atoanalyzed##yn3000co##ulters##t##ks##ys##mene800throughdifferentialcapabilityprotocoldesignedteaminjectedant##ec##ubi##ubital7mgkgsodium25solutionmeasurementtaken1h##r##in##jection457re##tina[CLS]##ftwalllinedhighlyresidue##pboundalongonewall[SEP]c##ac##lonse##quencingchromosomemappinger##hr##oids##pect[CLS]##rtranscriptionregulatedrugmeta##bolenzyme##presste##ratocellspecifich##yper##pcertaintypema##gnatoxicity[PAD] [CLS]19961996 jj [SEP]definemolecularmechanismregulating##r1geneexpression##lifemy##ob##lastmit##oticmusclefiberisolated##r1gene[CLS]morefactspecificallyinteract##leo##some##sh##bdim##erindicatingmaypromoting##somedi##sse##mb##lyupontranscription[SEP][CLS]measurese##dationdelta##bisabsolutechangebipainfulstimulusmemorydrugconcentrationobtainedtargetdrugconcentrationerd##rcorrelated1l0105respectivelyrrit##dte[CLS]linearcorrelation01206801maximumplasmaconcentration03401minimumplasma05501eliminationt##12r04601##ressedage[PAD] [CLS]psevidencegivenexistencetwodistinctsystemhumanvisionfastsystemextract##ingcon##tourslowersystemassignsurfacecolorcolor [SEP]peripheral##ovcenterparticipatedtrialtrial [SEP][CLS]theprogrammy##ogenicdifferentiationsubjectnegativecontrolfactorproductmutation##allyactivated##aon##genepersistentactivatein##tra##cellularca##scanormallytriggeredspecificfactor[SEP][CLS]te##traben##zodi##sso##cia##tesse##dation##zoactivityactivity [SEP][CLS]thedifferenceeffecttwodoselevellevel zz [SEP][CLS]mutationdi##stale##fbindingsite##d##cpromoterpromoter abolishedrepressionwhereasmutationpro##ximale##fsitesite e##2siteeffect[SEP][CLS]p##mi##dppnk##21205k##bsequencecoveringregionencodingni##tri##laseplacedcontrolla##cpromoterdirected##pen##zyni##tri##laseresponsedth##rano##cher##ichico[SEP]toxicityneutral##izer##bial##llan[CLS]expressiondecreasedinclusionregionupstreamexexting##uishedinclusionfirstintro##n[SEP][CLS]staticdynamic##rinormalpath##ologicalflooridensitycalflowerobtainedpro##ximalsitelengthdependfiberloss##urotheseresultspecificassociationsihi21t##rz##eta[CLS]insertionalternativelys##lice##dex##onw##bm##rna##atoresultp##oly##cist##ronicren##codestwonovelinternallytranslated##bre##press##or##of##ormscalledi##bsconsistingcar##box##yterminaldbindingdomaindevoidtrans##act##ivationdomain[SEP][CLS]acontinuousflowbisystemconsistshighcsystemreservoirbag##umaticcontrolledmembranevalveex##pi##ratorlimb[CLS]olderfemale0613t##b1111b##m##dzscoregreater0p00##1##1 [SEP]smoothgainpercentagetotaleyeduevarious##dicsub##typecom##cucomputerpatternrecognitionsoftware[CLS]fractionmmgp##40proteinpt##os##ine[SEP]consistenthypothesisalpha##1##xpreventsc##lea##vageotranslationp##53del##etimutantdeltaprolackentireprorichdomaindeletedamino91createdcharacterizedvarietypfunction##ort##icth##rom##busdeficiency[CLS]ourresultsuggestbr##1sinfluenceexpressionm##bs##bdrivengeneexpressionb##uddinyeastperhapsincludinggeneinvolvedcellwallmetabolismviatwocomponentsignaltrans##ductionpathwayactivate##sbr##1responseunidentifiedsignal[SEP][PAD] [CLS]19921992 jj [SEP]aconstructedphylogenetictree##1member##2##s##letfactor4levelpatient##rona##ryarterydiseasefunctionalcharacterised##1interaction##oto##xin##mbalsointeractionsmall##1yeasthybridsystem[PAD] [CLS]abackwardlookinfectioninfection [SEP][CLS]##r##14##bstronglyimpairedbaral##binoinvolvementp##id##ialfactorcontrolgeneexpression[SEP][CLS]m##rdifferentiationfollowingmeta##bol5patientnaceas##a##rea##tinep##reap##chog##op##chobetagammag##lu[SEP][CLS]overallfree##lor0310mgshowedlowerhe##tero##troplatenumberwithout##lor##ine[CLS]s##1n##uc##lea##seprotectionmappingprime##rextensionanalysisuproposeresiduelocated19b##pupstreamtranslationinitiationco##donsitetranscriptioninitiation[SEP][CLS]variousstimulusin##act##ivatei##kaalphatriggernterminalresiduese##r##32se##r##36[SEP]daycure64regimeconfirmed##eno[CLS]insuggestnregiondiversitydjjunctionwithinrear##rangedlointroducedgenerationragcat##zedd##nadoublestrandbreakedendjoiningphasedjre##comb##inationreaction[SEP][CLS]99##m##t##9##1marker##oc##ard##ialvia##bilityacute##per##fusion##fusion [SEP]threepatient##ph##otersinglecoursewellmultiple##nga##il##ba##mire##sedmonth##gen##ital##lau##op##hillostoneeyedueha##em##or##r##tomhospitalhospital [SEP]andhospitaltumorhohoust30year19441974minimumyearmajorpro##gno##sticfactorsurvivalnodewec##aininvert##rate##rch##b##ryo[CLS]tostudystructuraldiversitythreeho##mo##loglo##1like##ob##xa##idwheatgenomeisolatedclonec##alibraryyoungspikej##nesecommonwheatnor26[SEP][CLS]novelrepeatedsequencethroughoutsregioninvolveddisease[CLS]thusregulate##s##ot##ossignallingeventcomplexe##ct##ode##rmalme##seninteractionregulatema##mmalb##uddin##gm##or##ph##ogen##esis[SEP][PAD] [CLS]m##oya##mo##yaintriguingcontroversialsyndromesyndrome [SEP]howevereliminationkinased##k##1detecteffect##ulepolymer[CLS]wethusclone##dtwoyeastho##mo##log##sma##mmal##0[CLS]theglucoseeffect##vategenere##versant##agonagentincreasingincampanidentical##pt##idedetectedk##1##f##on[CLS]patientpshowexcessivedaytimesleep##inessins##nia##nia [SEP][CLS]##bbinding##b##30##0##p132add##itiveeffectpromoterdemonstratedphysically[SEP][CLS]itbelievedoperationeffectivecutspin##oth##ala##mictracts##ttprimarypathwaycarryingno##ciinformationspinalbrainhuman[CLS]##alakeyanti##ero##bicorganismtoxiceffecthydrogenpercasepost##ir##ulefactorrecoveryrateenergylevel##trastimulation100##h##zobserved30##h##zexhaledno##em##olaircavitysufficient##alae##co77analyzerecentstudyfactor##rfso##mat[PAD] [CLS]newconcept##ina##inatachildthisfirstduef##etalka##bachpre##nat##allydiagnosedsonbloodsamplingsampling [SEP]ace##to##tatede##car##yla##c##c##4114c##los##tri##diumace##to##yl##ic79first25nterminalaciddetermined[SEP]transferpromisesaysequence127residuem52strikingstrikinglysimilar##iprotein##ula##ulatus##tus especiallyput##ativeha##embindingmotifabstractt##runcatedat400word[CLS]catass##x##ral##phaconferredbestr##aresponse9c##ir##apotenttrans##ain##fgene[SEP][CLS]forrotatingpresenteddominanteyeclassne##uronrespondedbestrotationworldaxisorientednearhorizontalplaneapproximately45degreea##zi##th##th [SEP]nonepatientdevelopedclinicaleventdisappearancedependentinhibitorco##agu##lation##lation [SEP]invard##d##9##5regardbodyweightrecovery##musthreegroupcomparable[CLS]westudiedparametergoverningpromoterreporterincorporatedtype1[SEP][CLS]relationr##oe##genlungfunction##bropulmonaryx##13##3eachfusionleadprinciplere##tt##yr##osunstringphysiologicalregulationreplacement5enda##ber##rantactivated5fusedgenethy##ro##cynormallyrerett##yr##os##osinekinase[PAD] [CLS]hecomplainedfeverrighth##po##cho##ndra##ndral##gia2monthoperatedapp##icit[CLS]inpredictedaminoacidsequence##1sequenceho##mo##log##ouscat##alyticdomainproteinkinasefound[SEP][CLS]##cin##omarelatedproteinmaymay playedroledevelopmentobservedre##nalles##ion##ion [SEP]thesestrongevidenceconserved##icalpackinginteractioncorede##ter##minahi1entry[CLS]la##gphase1489hour07713hour05050 2020 22hour07676 2000079respectively##oth##eli##dloxidationadult122f##etalsacrificed##esta##casanalyzedvarietygrowthparameter[CLS]o##gon##leo##tide##scontainingc##4##tsequencecon##ferheatinreportershowpresencetwoelementadd##itiveeffectinduction[SEP][CLS]thee##1e##2proteinalongcellularfactorrequiredreplicationgenomegenome [SEP][CLS]theobservedalter##ationlungfunctionindividualheavyexerciselikelyaffectedlowero##3levellevel [SEP][CLS]end##oto##1in025##gramkg1xmin1begunpulmonarycard##iovasculard##ys##functionclosermimicusethemaintidalp##oinsteadins##pi##rator##ocontrollercap##noso##staproportionaldifferencetidal##co##olikehumaner##hr##4er##oc##4containsregionstriking##lyho##mo##log##oustranst##gasproteinalthoughlikelylackt##gas##e##linkactivity[CLS]itspanspan 20k##ilo##base##sconsists7ex##on6intro##ncontainsta##tamotif24n##leo##tideupstreamtranscription##alstartsite[SEP]nine##bs##aglevel94i1msegeometricmeani1ninepatientpatient [SEP]##ros##rdifficultmethodmethod [SEP]postsynthesis##ido##glylayeraffectedanti##ab##olim##oreffectstrikingc##acadi##so##etaplusld##raprecognizedc##d##9furtherel##idasubtle##cha##incorrelationrevealdetailedatomicstructurelowtemperaturetemperature 8##x[CLS]controlo##go##mersscrambledsequenceidenticalbasecompositionineffectivet##fore##comb##inationseencontroll##t##kcellcarryingotherwiseidenticaldualt##kgeneconstructlacking30b##p##purtargetsite[SEP][CLS]to##uantnormalcouplingpattern##da##verspecimenl##1s##1used[CLS]onec##op##las##mictargetreflectsfunctionalstatep##idproteinkinasec[SEP]thesethreechromosomesharetransfer##ringenet##os3gene##3gene##h[CLS]severalrib##osoproteinsynthesizedsubstantialexcessexperiencewouldhomenutrition##alsupportdiseaserelativelystablemajororganfailurepresentpresent [SEP][CLS]basedsequencedata##olateexcluding##1en##codet##runcated49a##ap##aframestopco##donalthough##1##olateen##code202##a[CLS]inpresentstudy##lysideeffect12patientfirstadministrationdoseok##t##30mgtwicedailyinductiontherapy10patienttreateddoseok##t##3dailyacuterejection203sensitivemapkinaseinvolvedmediatedincreasedbindingtrans##act##ivation[CLS]togetherresultindicate##ts##1bi##function##alproteinactives##licingproteinsynthesis[SEP][CLS]o##s##cillaflow##esta##illa##ry##ere##illa##ryve##nousinterface[CLS]4oneeightknowngenecodingla##rva##rvalsecret##iond##ros##op##hilme##lan##oga[CLS]althoughg##3sequencecontainstwoproteinbindingmotiforganizationg##3enhance##rlikeelementbi##par##tite[SEP]human##otod##kmembernovelclass##domsizeshapevarietyorganism[CLS]thehumanbr##1promotercontainsconservedee2##fsitesimilarlyregulatede##f##1r##b[SEP]thetranslatedsequence##ilassociatedflapproteinrepresenteddatabase##ster##darl##ymph##p##hyl##axoppulmonaryinfectioninfection [SEP][CLS]inrespectpromoterstructureco##xgeneresemblemanyhousekeepinggene[SEP]##ro##oki##poxregulationexpressionassociatedr##t##c##pop[SEP][CLS]thesite##tmappeddouble##ysmotifhighlyconservedregion49##k##k##q54basicrbindingmotiftatat[CLS]theseresult##btherapysufficientcurecaseelementbulk##ymeta##sta##sis[SEP][CLS]thekmeasurementshowtwomodelgiveimprovementsignalratioapproximately7d##bdi##ff##usesoundfieldfield [SEP][PAD] [CLS]indirectdeterminationma##ximalo##2consumptionmanman [SEP][CLS]usingun##id##ire##ctionalp##risolated36##1b##p5promoterregiondelintro##nicex##onicboundaryincludenoncodingex##on1singleintro##ncodingex##on2structuretypicalgenersuper##family[SEP][CLS]whensevereh##poxacute##lyproducedventilationlowoxygenmixtureexperimental##ao23717to##rrcontrolanimal##ao26310to##rrplasmainsulinresponseresponse markedin##hibit##ed##ed [SEP][CLS]uprequireddifferentdomainton##bmaroundresidue160coidomaincloserend[SEP]dwhenxcombinedtprolongedcentraltreatmentimprovecareflwholefedlevel515compared15menoiltypicallayerratio[CLS]itlabelsecretsincerequirementdefenceton[CLS]thecompleten##leo##tidesequenceo##to##umrings##pot##y1strain##eno##micr##na[CLS]anenhance##mentbenlivertumortumor##igec##f##1male1756testeddose400v[CLS]cellcocotra##fected##mi##dappropriaterespond##erp##mi##dc##lon##iesselectedbasisresistancegenetic##invianeo##my##cos##ide##ot##ran##fer##asegene[SEP][CLS]thiscterminaldomaincontainsseveral##x##xilmotifreminiscent##aput##ativet##ra##fbindingsite##1[SEP]o##mitexperimentalnoderiveddistancerestraintviolationlowerrfactorstructural##m##d##fine[CLS]cardiacles##ionex##oto##xishock[CLS]riskfactorat##os##rosisrelatednutritionh##teroh##yper##gly##ce##miadiabetesh##yper##tenso##besityhighintakeexcessivealcohol[CLS]mutationabsenttbeta##iproteintumortissuescanboxgene##bankdatabasealso##rup##pelzinclackingadomainzinchoweverresistance##olo##nej##osa##cint##yl##os##inseventyninechildscreened91010d##ic[CLS]normaldogeither101530gxraysinglehemispheregrosshis##ath##gicchange##ly[CLS]ya##csselectedcon##ti##gstartingpointc##lon##ing##dgenetherebyestablishbiologicalbasisformmusculardrelationship##ir##dlemusculard##ys##cc##1detectgroup1group4x##pextract[CLS]inma##lateextensionrouting##bo##dies##dies sincecontainsper##ox##is##oma##omaltargetingsignalse##r##yterminus[CLS]op##ti##mizeddbindingsitediffern##leo##tidebordering##ot##ideboxdi##sp##lace##lace e##4factorcompetitionefficiencyefficiency e##4site[SEP][CLS]screeninghumanclibrarytwodifferent5terminusalternativelys##lice##dformhumanfl##i1gene##i1##bpossibleexistencetwoindependentpromoter[SEP]arateas##by##lradicaldirectlyo##radabruptfallsuperdi##uta##utaseswitchingradicaldependentmachineryformation##ct5hthermalcarryingrun##awayre##combp##bs##1proteinb40proteinfractionfraction cell[SEP][CLS]aregulatoryelementemptys##rac##obcomposedthreedistinctconservedregionbindregulatoryprotein[SEP][CLS]peakreactiveh##yperm##lmin11determinedforearmimmediately12weektrainingtraining [SEP]suit##44##1effectivepro##dr##39##4##oro##zor##iv##iz##orstereoinhibitor##romaend##oceffectistudy[PAD] [CLS]incombinedse##ns##iti##zationsaltparticularlygoldsodiumth##ios##ulf##ateg##st##adichloridep##d##cobserved[CLS]genestructureprecursorprocessingprocessing [SEP]thecontentmon##oammeta##bolhacidhi##aa##moh##vapatient##eredeterminedone13129248329normalserumt##4310remainedh##yper##ro##xin##emh##ro##xin##em[CLS]thesefindingt##3##rre##pressactivatetranscriptionte##ther##edlb##dgal##4##x##rhe##tero##di##mer##izationoccurv##ivowithoutstab##ilizationhormoneresponseelement[SEP][CLS]mosteffect##or##mi##dcontainingi##p##27genelittleeffecttwodifferentmarkedeffectdependingtargetobservedi##p##27combinedi##p##4##0[PAD] [CLS]re##nalveinth##rom##bossimilarpatternacutetub##ularne##c##rosisfoundr##ive##noto##1enmemberhedomain##3growth[CLS]##eno##micclonecontainingcbr##aegenegene ablecompletelyrescue119transcel##eganmutant[CLS]therapiddecreaseplasmafirsttwohourstandardh##dcausemembraneh##yper##pol##zation[SEP][CLS]regionspecificenhance##rneartwomahome##oboxgenedefineadjacentr##ost##ro##ca##uda##ldomaincentralnervoussystem[SEP]inc##lonse##quencingoverlappingc##aencodingencoding approximately41k##bhumanho##mosub##typeresponseelementdependentdifferencetrans##isalphagammam##rivisual##ogdecartin##ven##ousadministrationg##dd##t##pa[CLS]wedevelopedartificialchromosomecon##ti##gregion[CLS]inductionif##napromoterregionrequirescooperationalphaf##1bindingproteini##rf1[SEP][CLS]hybrid##12genespecificprobe##ugrevealedpresence##12ho##mo##log##oussequencewithininvertedrepeats##rod##ela##op##lastdfragmentb##am##hiv[SEP][CLS]toinvestigateeffecth##yper##roid##ismpatterntimecourseo##2up##take##otransitionrestexercisepatientsubjectcycleexerciserate##r1818 20wrespectivelyrespectively [SEP]however##rodel##eti##onmutant##dreported[CLS]re##comb##inationoccurredcorrespondingl##trlo##cusquasis##pec##iepresent##olatedescribed[SEP][CLS]instabtrans##fectedmutantdel##eti##onsecondzincfingerdbindingdomaindomain ehhtdifferenteffecteffect e##pgeneexpressionexpression e##bb##pregulationregulation ee dramaticallyreducedeffectaugmented[SEP][CLS]geneatsubunit6mitochondrialf##0atcomplexnormalog##uramales##adi##oporderdetermineattranscription##aldifferencecouldc##yt##op##mics##ter[CLS]whensingleaminoacidmutationdirectlyintroducedparental##b##agenomech##ime##riclargewildlikepatternobtainedtransobservationdemonstratingpointmutationalonedrasticeffectgrowth##b##4ch##ricvirus[SEP][CLS]gagvariantefficientlylocalizedcellnucleus[CLS]##r##1formtogetherth##2##1th##2th##ocomplexcontroltranscriptionel##ong##ationgenomestabilitysa##vis##iae[SEP]up##relementpresentergeneyeast##r##2##pma##ian##9functionanalogousmanner##b##2[CLS]theobjectiveresearchdeterminedetermine er##got##amine##amine er##go##pt##kalneo##ty##ph##odinfectedgrassassociatedtoxic##oselivestockalteredhormone##icularhecowproimp[CLS]acutespontaneoussub##du##ralha##ema##a##a [SEP][CLS]straincarrying##1mutationunablegrowsu##rosegal##act##osema##lt##ose##bio##fer##mentcarbonsource##til##izationcarbonsourceregulatedglucoserepression[CLS]2dependingstructurecertaincompoundse##ered##eapresumablys##trom##aformreleasesystemanteriora##que##ousneuralnetworkdensitymaskthreshold750300hradio[CLS]mechanismregulatorysubunitm##od##ulate##i3kinasesignalpossiblysublocal##izationcat##alyticsubunitinteractionadditionalsignalingmolecule[SEP][CLS]theseresult##btherapysufficientcurecaseelementbulk##ymeta##sta##sis[SEP]rightsided##leg5yearoccurredremainingcasecase [SEP]##mi##dsub##lone##1containinghind##iinfragmentfragment examinedreplicas##po##do##rug##9cellstimulatetranscriptionlinked##i39##kgenepromoter##ron##idasfusioncocotraalongp##mi##d1containinggeneencodingtransactingfactoriie1[SEP]##fectchainlossvariantcomplete12k##bconstructtermed238##roresultedsecreti##gpairing238##dalchainhowevertransilackedauto##reapath[PAD] [CLS]diver##gentregionposteriorlefthemispherehemisphere usedde##co##dingstorageinformationemergedworkingmemoryversuscontroltaskcomparisoncomparison [SEP][CLS]normalcellstimulatelil4newcomplexappearbindce##b##p4elementrespectivelylocatedwithin125101region[SEP][CLS]crystalstructure25aresolutionfragmentin##ter##ousresidue49286containingconservedcat##alyticdomainm##od##ulatorydbindingdomaincdomain[CLS]vector##card##io##rona##ryelectro##card##iosegment##1lead[CLS]theb##dic##rg##srdfragmentfragment end##osy##ions##pec##ie##phipromoterco##liranged6135observedcomparabledfragmentcocolir##b[SEP][CLS]there##8re##8regulatory##ioteffect##orcellulardreplicationcellulartransformationcellularon##mo##molog##terogeneexpression[CLS]rolecc##aa##tenhance##rbindingalphatranscriptionfactor##cor##ticstimulationp##1##1genepromoteractivityarrestedhe[CLS]longterm##bulaco##2##cotestdirectlycooccurrencepanic##yper##ilationnaturalcondition[SEP][CLS]thehighlyconservedregion##rnastructuralsimilaritycat##alyticdomainstrandsatelliter##natobaccoringspots##vsuggestinghighlyconservedregion##rnaformcat##alyticcenteronesuppress##orsuppress##cdel##eti[CLS]cell10mint##falpharesultedactivation##44map##k##38j##nkthisdescribes##combcloneencodingfourthmemberfamily[CLS]inpulmonaryabnormal1carriercarefuldeterminingdetermining whetherpulmonaryinvolvementinvolvement et##iol##iological##ogicallyrelated1infectionmitderivative208##3[CLS]excessre##combppt##bsq##uels##licingswitchre##esta##lishex##onskippredominants##licingpathway[SEP]childchild presumed21h##ydrodeficiencyformcon##gen##italad##rena##lh##yper##pstudiedextensivelyinfantinfant [SEP]sixanniversary##gio##tensinabilityni##ac##ivo##yper##ox##ro##so##idper[CLS]m##da46cellstab##lytrans##fectedp##mi##dpromoterdrivenbeta##bingenep##mi##dpromoterdrivench##ime##ric##ad##d##45ubeta##bingeneentire##ad##d##4512929845b##psub##fra##gment##ad##d##45uutr1055positionedendbeta##bingene[CLS]theuniversitynorthcar##olincar##iesriskassessment198619895000childinitially15##orisite##olinmain##e[CLS]e##rkc##rkproteinbecametp##latedwithin1min[SEP][CLS]b##r##bcrossresistancemultiple##eno##to##candrugin##hibition##popddamageassociationcyclearrest##2mrestrictionpoint[CLS]resultlavarapiddecreaseart##erialp##aoincrease##acoanimalanimal [SEP][CLS]conclusionelevationt##bardecreaseshowpresenceo##xi##da##f##dhem##od##fis##3[SEP]oz##oneup##takeawakespontaneous##lybreathing##scher34##4s##pra##gueda##wley##vanha##rt##leydatados##ime##3smalllaboratoryanimalercp[PAD] [CLS]importantadvancediagnosisdiagnosis [SEP][CLS]del##eti##onanalysis35##k##bdfragmentrevealedregion1251containingsingles##1bindingsiteessentialtranscription##bi##gingene[SEP]resistanceclassifiedlowminimalinhibitorm##lhigh512mdegree[CLS]extra##ada##lend##ode##rmalsin##ustumorneckrare[SEP][CLS]les##ionkindresemblevitamindef##icientchickenfirstinducedexcessvitamine[SEP]essentialfattydeficiencychildhoodchildhood [SEP][PAD] [CLS]inhibitor##3activation##bolin##hibit##hibitedeffect##k78effecteffect eactivityactivatedf##r##3predominantlyinteract##rbsocomplex90k##daproteindesignatedprotein80##khtherateco##lla##genconstant6monthmonth 20yearinitialwoundh##yper##trok##eloinitiallyapproximatelytwice23yearwoundlevelscarevidenceroleschickcardiacdevelopmentresult8369987majorityvar##icocomplexinvolvedinvolved [SEP]mutation##alanalysisyeast##1fourfiveconservedmotifessentialcapenzyme##ivo[CLS]wediscoveredyeargirlpresentingan##ae##mia##mia [SEP][CLS]thel##ifappearedreleasedperipheralbloodl##ymphculture##doptimaldosprop##rano##lo##lselection[CLS]coexpression##1co7celltwo##ksubunitalphabetaassociation##1kinasebetasubunit[SEP][CLS]forcapsulecontainingdrugvaluet##50increasedparticlesizedrugdecreaseddecreased [SEP][CLS]the##ecmean94logcincreasedslightlyholdingtimefindpossiblepredict##orexpressionprogression##j##mevaluaterelationship##j##mcomdependentdiabetes##lli##p##rre##nalfailuretransconclusionl##h##bsimpleeasytechniquecapableupperperpressurepressure [SEP]northernanalysisconfirmend##ogenalpha##acgene4cellsuppressederemovalc##y##cdependdependantkinase##d##ks##kextractmatrixseverelyin##hibitsphase[CLS]analysisrevealreveal f##lthy##roidcellnuclearextractformspecificproteindcomplexregionpreventedt##t##f1bindingelementelement tpromoternuclearextractt##t##f1formcomplex[SEP][CLS]thes##1kinasestimulatevarietystressconditionincludingo##smoo##dastressheatshock[SEP][CLS]noviralr##nareplicationcoulddetectedcelltransmutantr[SEP]##d[CLS]comparisongenecodingmousehumanp##36an##nexiimouserathumanan##nexipigeon##p##35an##nexirelatedstrongg##eno##micstructuralconservationsupportinghypothesisgenecommonancestor[CLS]in##batein##fectla##rvapenetratedskinnormalimmunecellattachedla##rva##rva absenceserumserum [SEP]31year##elo##fi##broinitiallyreceiveddose##racc [SEP][CLS]collectivelysuggestmajormit##oticgrowthpathwaymayabsolutelylinkeds##9##1signalingtranscriptioncomplexcomplexpreviouslyreported[SEP]stableg14day##ogd##ysnon##sui##cid##almortalitylatelifedepressiondepression [SEP][CLS]fewt##rieruserreceiveds##ltcounselingdendespitehighdentalu##tilraterate [SEP][CLS]however##vresistancerestoredcellremainsensitivegammaradiation[CLS]o##lateo##dasresultmeanreferenceintervalo##xa##lateex##crecomparablecomparable isdi[SEP][CLS]inm##rna##0resultedre##versiontransformedcelllinestar##cheffecteffect [SEP][CLS]ma##ximalex##piflowrateex##pi##rrate255075vitalma##x25mamax50mamax75forcedex##pihalf75measured##3healthysmokingadult144male129aged1563yearlivingmad##ras##ras [SEP][CLS]theaminoacidsequenceproteinencodedm##sk##1ho##mo##log##ousyeastc##opl##ys##yl##rnas##cgenerecentlysuggestedcodees##cher##ichicoenzyme[SEP][CLS]similardbbeproteinfknownrbindingmotifsuggestingtyperinteractionoccurcore[SEP][CLS]theseobservationsuggest##r##4##ik##1mustassembly##ptranscription##allysilentin##cess##iblech##roma##tinstructurefi##romerequiredspin##dle##uleensurechromosomesegregationcharacterizationdeadboxat##lica##idoth##alia[CLS]amplitudelatesurfacep##2n##2depthbccomponentdecreasedpatientshiftedsi##vpincreasedpw##2##2 [SEP]ode##tidederivedinter##callink[CLS]vectorapplicablecharacterizationnewopenreadingframefoundgenomese##quencing[SEP][CLS]subjectpatientand##roido##besitymenmen 13yearmassb##miranging3205252 2mratiogreater10nouniversallyacceptedstandardizedsystem##garexistsalthoughneedbloodsampledetermination##bri##noimmediatelycompressionapplicationstock[CLS]neithers##ym##ptviralr##nadetectplantin##ocmutantmutant##hi##ftmutationcoatgene[SEP]thecumulativelengthgenomeincluding56251n##t[CLS]riskratiodecreasedincreasingageincreasednumberbreastbiofamilyhistorybreastcancerest##rogentimescreeningcomparisonprevious##mm##ogramradiotendencycall##ogramabnormalabnormal [SEP][CLS]theat##1expressionprofileu##birootstemleafflowersi##lique##lique approximately17k##btrans##cript##cript approximately50k##dagreaterlevelyoungertissuedevelopmental##lyactive[SEP][CLS]theo##ssi##ficationlocatedsidec##344 [SEP][CLS]atcutk##isa100280281participant996correctlyclassifiedclassified [SEP]followingreplicacontrolramprepeatedpresenceni##russ1micro##mp##to##lam1alpha1ad##ren##ept##oreffectrespectively[CLS]behavioraleffect##zo##dial##igan##ddependentdi##az##amdependentdi##az##amwithdrawn##ab##oon[CLS]thispaperreportestimatere##tar##dationfactorbasedpopulationsurvey9yearchildgreaterka##aki##stan[CLS]thusincreasela##ct##ateobservedal##kaltherapyworsemetabolicpicture##cticacid##osis##osis [SEP]adjusting##faridosedependsvaluefactordoseneedadjustedsingle##rslightlyrangealtertotaldose52020 [SEP][CLS]allregionpartprominentc##p##gislandmayactingextendedenhance##rindependentpromoter[SEP]comparisonheal##vis[PAD] [CLS]largevolumebonema##rrowmayrequiredtypeauto##log##ousbonema##rrowtransplanttransplant [SEP]further##9locryneo##formstructuredefinedforcedexpressiondescriptiongene[CLS]wes##pecenhancingeffectglucose##act##osef##ct##oseabsorptiondueactivationf##ru##ct##osecarrier[SEP]##iro##lthedproteinreceivingspatialcueguidet##hea##lcellout##gro##wththeexperimentincidencesolidtumorma##rrowtransplantmaystillrisedecadedecade [SEP][PAD] [CLS][CLS] patientadoptnewsetbasedbased partlyoriginalpartlyid##iosconcernconcern [SEP]n2##of##ormsresolvedp##ivalue55threegroupunevencomposedleasttwoproteins##pec##ie##ie [SEP]prevalenceruralwesterninwho##arcop##cor##dstudyni##dutransformsecrethigh##icomparisoncharacterizedni##gertransformp##act##uron##ase##chighlevelni##dutransformedsub##lone##dgene[CLS]thisinteractionleadre##tar##getn##fp##50nucleusc##op##las##m##fgeneproduct79characteristicsimilarta##ttrans##act##iva##tor##gu[SEP][PAD] [CLS]medicationtreatment##bia##bia [SEP]elevatedtotalserumcalciumlevel1190mgd00##1developed1ohd##3groupday42daypriorpronouncedstructuraldamageday7r##acr##pashighly##elo##idregulator##d##pho##dascomplexkinase##vilputsignaltranshighspecific##43ma##ximal##f[SEP][CLS]effectinfant##ileunder##nut##ritadultsu##c##rosesolutionconsumptionrat[CLS]indescribedidentifiedtwopotentialet##sbindingsite##bs##1##1 e##bs##2conservedinterenhance##r[SEP][CLS]ka##fhem##ebio##syenzymem##rgaalsoinducedentrystationaryconditionironmangalimitation[SEP][CLS]##25substitutionobservedumconservativepossibledistinguishmutation##oly##mor##phismregionshow46identity##od##ulinbindingregionbraincaca2##od##ulindependentii32identityregion##oskinase[CLS]theper##rateds##pgivesuperiorresultvirtuerequireremovedpurposeh##ygienethussatisfactoryresultevenpatientfailfail grasptechniqueremovalreplacements[CLS]itcontains31ex##onhighproportionclass0intro##nalternatives##licingresultlevelvarianttrans##criptmaintainoriginalopenreadingframem##rpm##rna[SEP]issuemm##fscalequestionresearchhomosexualitydifferencehe##tero##sexualhomosexualsuba##urationhomosexualadjustmentclusteranalysist##pol##ogyhomosexuality[CLS]abriefdiscussionrelationshipamongformulagivengiven [SEP]la##vu##dinetherapyhe##paperipheralthesenm##dareceptorblockade##eli##orad##ys##kincomlongterm##vo##do##patherapybeneficialeffectpark##oniasign[CLS]further##moresecondarystressresponsepronouncedimpairedexposed##x##posedfish[CLS]distinctspatialpatternexpressionunusualaminoacidsequencedbindingdomainparticularroled##te##f1cellspecificgeneregulation[SEP]ausualtest##halisensiblel##m##wusedussyndrome1##1con##italconditionmanifestprofoundabsence##ib##ularfunctioneventualre##tina##lde##gene##rationimp##lant##icasevered##p##lasiarecentlyvarietyxlinkeddeafdef##icientbonefund##usinternalauditmeat##us##us [SEP][CLS]over9k##bdsequenceobtainedoneclone##1totali##glength124k##b[CLS]s##raxenhancedexpression##gg##re##cangenenormallyexpressedhighlevelo##ste##obcellthisdemonstratesexposuresumustresultand##rogenh##y##r##hfirstnormalinjurynew##opercomrelatedsurgicalstressresponse##rinemetabolicinflammatorychangechange [SEP][CLS]fourmulti##can##nuho##lsinitialb##416xx 4lalatinsquareinfluencesupplementforintakesiteextentdig##estnut##rientdormantbluesrangerange for23c##p[SEP][CLS]patientriskfactorwithoutriskfactorfactor [SEP]der##mat##phicpatterndemosdemostratedi##stalt##ri##rad##ius##rlabnormal##ity[PAD] [CLS]thetermka##rtasyndromesyndrome appliessyndromeaccompaniedinde##x##tro##cardsitin##vers##us##us [SEP][CLS]finallytestedactivationfactordependentcomponentsagacomplexcomplex [SEP][CLS]eight17se##rop##ospatientfaileddetecthewithinthreemonththirdinjectioncomparedonese##rone##gatpatient01[CLS]the##bialinitialprop##hylasexposed##hra##hracisc##ro##f500day60day[CLS]e##if##if4transformscellmutation##if##if4arrestg##d##cmutant[CLS]ben##zy##lalcoholadministrationneon##ate[SEP]repressionheralphagenegenei##4withincontextgenomeconditioneddistancestereo##axalignment##4dbindingsiterelativetaanticipatedin##cellular##bet##aactivation##c##l2blockedmapspecific##3##1[CLS]relationimmunecomplexserumf##rithem##os##ider##osisdifferentet##iology##iology [SEP]r##p##ls48patientrerecurrent##current ietfailure179120groupwomanwoman [SEP]manymetaboliceffect##zidite##boro##xinew##oroadd##uctech##netdibat##ofavorablecharacteristic[CLS]totalareabloodglucosecurveinitialalteredhtreatment209##b##nontreatmentexcessivebleedingbasedalgorithmpointtestingbloodpro##th##rom##bin##rom##par##lot##lotting##letcountcount [SEP][CLS]inlargefractionalbecameins##ubstomaching##est##ion##ion [SEP]to##gio##tensconvertingenzyme##ala##prandom##os##indesigned##ensfirstdaytreatmenttreatment [SEP][CLS]glucosemayreduceslightlypoolaminonitrogenavailablealbum##inu##reasynthesisdiverinproteinsynthesislivermuscle[CLS]backgroundbackground [SEP]isolation[CLS]resulteuropro##stratotalg##erseasonanationwiderecordlink##nishtwinco##horstudyhospitaldischargemedicationpresented[CLS]consideringfactvase##ctmayleadpro##statictumordiseaseclaimnearly22000lifeyearunitedstatealone[SEP]memberjf##otranscriptionfactorshow##tar##dationlikefactorcomponent##32specificcomplexshesevere##pan1yearhospital##is##olopulsetherapysuccessfulsuccessful [SEP][CLS]relftransfer##aseenzymecontainsdetect##ablercomponent[SEP]cordformation##h##12mediumrapid##su##mpt##cotuberculosiscomplex[CLS]moresitespecificintegration##rflankeddalsodetectedp##ram##p##r##s##1junction##bro##blasto1##bi##quito##quitous##uslyregulatorygenefamily[SEP][CLS]instudystageexposuretreatmentinjectionvaccined##ys0371428togetherdoser##abi##quinhumand##0[CLS]3withexceptionant##ero##eri##ordirectionlayeriiii##ime##dio##late##raldirectionlayerlayer iivverticalconductcortexalwaysgreatereitherhorizontalconduct[CLS]ourstudyinvestigatedhypothesiscombinationhigh##ldietsocialisolationstresswouldincreases##ys##tobloodsend##ogensodiumpumpl##igan##aba##in##c##rino##fatherelationshipdestruction[CLS]suggestedlossweightdecreasefoodintakeincreasebrainmso##4inducedc##mireflectpossiblean##ore##cticdrug[CLS]resultpatient30showeds##tsegmentdepression##em##em 3449ex##t[CLS]thevirusmustprogresspastimmediateearlyexpressgeneproductactivationc##y##c##lineexpressionin##1livercontained3folds##teroelementbinding2m##rna[CLS]ad##eno##cinlargeworsepro##cint##1##n##1##1 t##n##1subsetsubset [SEP]ipain2681patientpositiveth##all20120patientabnormaleectimean##ginpatienttranseecchangechange [SEP]prototypestructureon##cologyinformationavailableinternetresourcemaintaineddisposaldisposal [SEP][CLS]bindingto##rrregulatorc##iactingdirectrepeatactivate##sto##rop##eronexpression[SEP][CLS]forparta##ero##bicmicro##bialdegradationsystemfar[SEP]##emiadaily##rona##ryarterydiseaseredundantredundant [SEP][CLS]thisconsensuscase##inkinase##ki##isiteshowmain##isitebodyterminalcomplexformingregion[SEP]inii##isinglestudydesigncontrolledrandom##izeddoubleblindphaseiivrequiresdifferentdesignmanydifferentquestionquestion [SEP][CLS]treatment##sininduceexpressionc##reresultedcompletedisruption##rn##tgeneloss##tmessengerrm##rnaexpressionliver[SEP][CLS]physicalmapgenomeson##chusr##dogeneconservedgenejunctionsequence[SEP]tub##ulard##nallit##hiacauseconsequencetoinvestigateoveralltub##ulardsubgrouppatient##rol##iasfollowingparameterre##naltub##ularfunctionfast##ingmorningurine124malestoneformerformer ex##cre##ys##oz##amtrans##idasgammaggtfraction##alexglucose##atetheoreticalphosphate##r[SEP][CLS]interactiontobaccodbindingactivity##b##f1promoterelement##ba##cter##cteriumt##ume##fatdgenetcco##rrel##ate1directedgeneexpressionmultipletobaccotissuetype[SEP]aexpected##olsnlowercorrelationphysical024000##pt00 2000##1highermental00 52000000 [SEP][CLS]then##1pamplitude##epdecreasedincreasingmuscularinner##vation##vation [SEP][CLS]s##n38re##boundmanycourse051hourendvin##fusionenter##ohrecycling[SEP]sequenceanalysisrevealedenproteincontainingthreethree g##2zincfinger[CLS]inp##18##1p##mi##din##act##ivationin##iti##atorre##p##cproteinoccursattachmento##leo##tideactivet##osresidue[SEP]x##poanti##bioticsi##issif##o##5##6##2extraextracellularregulated1##kauthenticdualspecific##hr##hr [SEP]treatmentdosecap##top##ril[CLS]ht##run##cationhipnterminusresultedapparentlosshipho##moo##go##merretainedassociation##70receptorcomplex[CLS]thebiologicalbasischangec##nap##sproduced##s##2investigation[SEP]alargeppclalanbasishospitalinformationsystem[CLS]tragic##allyhighlightedyeardentalnursetakingsingle1gtabletsodiumni##tri##te[CLS]thehumanproteinencoded900basepairlongm##rnag##ulare##pitcellend##umc##yclicmanneradditionfound##uc##osa##lefall##optube[CLS]inre##nal##cin##omaexperiencedvent##ric##ularta##chy##cardundergoingtreatmenthighdoseb##ol##usil22 [SEP]fouranti##nga##ph##oter##tosmi##cona##zo##lek##cona##letheregulatorygene##xclone##d##exes##cher##ichico[SEP]examination##oma##ssiestainedgelcaps##idlikeparticlecomposedn##11##1containhostderivedhis[CLS]conversionn##fka##bg##ab##pbindingsitelikelyoccurredalsoworldwidehi1noticedl##trmodificationsubeis##olateth##ail##andproteinbinding##1##1extractder##epre##pressedcouldexcess##re##1[CLS]weisolatedfulllengthcodingregionhumanb##1geneexpressedsequencetagreversetranscription##asechainreactionrapidam##p##lificationc##aend[SEP][CLS]authorpresentan##ato##mic##alvariationcourse##sent##ericarterybranch62humanf##etus##etus [SEP][CLS]the72k##be##cor##ifragmentclone##dn##uc##leo##tidesequence##rincodingregionflank##ingregiondetermined[CLS]11 [SEP][CLS]theinmedianplasmasecret##in163064pm##olx11secret125250500##mo1corresponding15minbi##car##bon##ate28##344143##morespectivelyrespectively [SEP][CLS]theresultingthresholdelevationcurvefellsmallnumberdistinctgroupdiscretespatialfrequencymechanismhumancentralvision[CLS]because##bentranscription##alact##iva##torviadbindinglikelyc##bexexertbiologicalactivityregulatingtranscriptiongenerequireddsynthesiscycleprogression[SEP][CLS]therest3##latedsequencecommonclone[CLS]co##exc##lcombinationat##f1##b##2at##f1##blead##rgtrans##act##d##28reporter##mi##es##katcell[SEP][CLS]conventionaltoxicsuggestadversehealtheffectincreasecoalcombustione##ff##luewouldgreatestperunitcoalareaheavilyhighestpre##ex##istlevelgas##erocomplex[SEP][CLS]genechromosomeinvolvedtrans##locationidentifiedtranscriptionfactorencodinggene##3##rconductedsuppress##orin##os##otyeast[CLS]##est##hesiadrop##eri##do02mgkg1f50##gramth##iam##yla##l150250mgsu##cho##line1mgkg1maintained##tro##uso##26733supplementedrepeatedvdosfwithin15micro##gram1complexityhostpath##ogeninteractionactualinfectiondifficulty##ivothisnovelgenecouldcandidategenegeneticdisorderbi##polaffect##nd##romhereditarydeafknobsyndromeho##lop##nce##phamappedregion[CLS]para##dox##icallyloop3##im##1##carma##ximalin##hibit##r##hcampaccumulationp##rlrelease40effecteffect mediatedactivationprotein[CLS]wepatientpresentedunusuallylarge##ucc##ys##tmeasuring38x25mmuncommonlocal##izationright##llar##y##y [SEP]acousticpropertymeasurementsuper##conductor##b##1x##bi##x##o##3resonancemethodinmen1diedsuddenlyfunctionalareamy##oc##ardsin##oau##ric##ularareasub##end##oc##ardlayer##ricne##c##rops3hpreparedelectroni##filevelchildautism4malemeanage33 8years##d11levelcontrolparticipantmalemeanage33 8yearin##cthi##fupatientpro##phn102determined[CLS]threehigham##ylricei##r##42iir##36##6##62similarchemicalcomposition##yl##osecontent26cooked##itdig##estwellbloodglucoseinsulinhealthyhumanvolunteerslowlyadapttypei##chan##oredischargefunctiondynamicforcedynamicdisplacement##broskinsquirrelhand[CLS]usingbeta1##rl##uc##ifer##asereporterdeterminedimportantbeta1##rgeneticelementcontrollingexpressionwithinc##6g##liocontainedwithinregion39##629##9relativetranslation##alstartsite[SEP][CLS]f##ac##sanalysismreachedmiddlelateg##1phasecellcycleprogressiontime##pointhoweverhisserumf##rote7monthagere1yearyear [SEP][CLS]analysistobaccom##b##aprobe##bpresenttissueexaminedhighesttrans##criptaccumulationoccurredstemtissue[SEP][CLS]corevealed##gata4##23stimulationnecessaryil5promoteractivation[CLS]expressionk##rabdomainsuppressv##ivoact##ivatingfunctionvariousact##ivatingtranscriptionfactordemonstratekdomainspecificallysilencepromoterwhoseinitiationdependentpresencetabox[SEP][CLS]adultonsetappearedseveral##af##fectedmemberd##rdsuggestingadditional##otypic##alexpressiondiseasedisease [SEP]wetested##ngadrug##di##ro[CLS]theenter##oc##olipath##ologicalmicro##bialflorastoolchangeco##lon##uc##osaabsentabsent [SEP][CLS]result##ivointeraction##kigammagammacouldinvolvedsignalingpathwaydownstreamr##t##ks[SEP][CLS]correlation##idmetabolicratcooledconditionalteredgas##eousenvironmentreact##ivationreplicationrareeventnaturalhistoryhebb [SEP][CLS]aminimalregionstimulateoriginfunctionmapped50aminoacidwithincterminus##1##p[SEP][PAD] [CLS]cut##aneousme##lan##omabilateralre##blast##oma##oma [SEP]treatmentj##leinduce##b##l##bp##ory##lationwell##d##28activate##ddependentactivityan##aph##asepromotingcomplexmethodaftereligibilitypatientrandomlyallocatedonefollowinggroupm##nis##olo30mgkg11hourfollowed4mgkg1h123hourhour nni##mo##di001mgkg1h12hourfollowed003mgkg1h17daymmnp[CLS]theamountoverlap##fie##f##v##fvalueamongclinicalgroupconsiderableconsiderable [SEP][CLS]after5850c##14b##pdecrease##rstandcouldattributedfiresuggestedstrongincreasebet##uladelayedexpansionpinc##em##bra[SEP]assl##uc##ifer##asereporter##mitranshe##pcellshowm##uta##tedbindbfunctionil1alphainenhance##rwhereasm##utabindb##cr##4requiresath##ydro##lysis##hboxs##licingfactor##r##2[CLS]severalsequenceresemblingbindingsiteliverfatbodyspecifictranscriptionfactoridentifiedwithin1k##bupstreamdownstreamgene[SEP]bptissue[CLS]itshowedaminoacidresiduewouldcontactextendedtaboxbrecognitionelementevolutionaryconservationt##b##pt##bdcomplexorientationarch##ae##alorganismdifferentoptimaltemperaturegrowth37100degreec[SEP][CLS]studywithoutatmediumperformedmy##oc##ard##iumdefectcountratiodefectsizedualis##otos##pectimagecompared##oc##ard##iumdefectcountratiodefectsizesingleis201##tl99##m##ts##pectimageimage [SEP]comparisongeneavailabledatabaserevealsho##mologyfactor1probablenearclonefactor##fpatiente##ales##ales diseasese##rousma##gnant##oro##gende##viation##viation [SEP]copyright1999[CLS]the1m##bregionco##sm##idminimumoverlapset52##sm##idassignedbin9con##ti##gssimilarlybetaad##renblockadeachievingconpatient[CLS]est##rogenpositiveeffectsexualtargetcognitivefunctionfunction mayet##iologyal##z##heimerdiseaseactingpreventam##ylplaqueformationo##xi##dade##ter##ior##ation##olin##ergicne##uro##mitsystem[SEP][CLS]theseinsulin##bmapkinasedeno##votviasimilarpathway[CLS]effecthe##ob##ar##bit##alratt##rie[CLS]suchte##tra##otcommonpromoterregionparticularlyact##ivatingtranscriptionfactorcam##presponseelementbindingat##f##beboxmotifsuggestingpmaym##od##ulatetranscriptionmanygene[SEP][PAD] [CLS]bloodcellbinding99##t1316120respectivelyrespectively [SEP]inhibitorterminusdependentdependent activation##p##amapkinaseabilitycomplexactivatedactivated ereceptorbrainse##za##1##z##2region##yper##ote##nss##mbind##itsuggestingsequencestructurespecificminteractionmightmediasspecific##ity##ity [SEP]receptorfeatureallowsunderstandingevolutionuniquegroup##rs##ida##igan##dsignalingmechanism[CLS]sequenceessentialprocessings##naslackcanonicalterminalstem[CLS]theusehassociatedf##eca##lflu##oriex##credecreasenetabsorptionflu##oriregardlessintake##oricalciumma##gnesiumthighctreatedctreatedcontrol[CLS]k##ramha##urg##b33 92##9075s##yn##dr##omadaydayshiftingfeatureman##icde##pressiveseveralmixedtimestructurestructure 25patientstudiedpaperpaper [SEP]##ainvolvementsignaltrans##ductionse##rot##onireceptor[CLS]analysisex##on2factori##xgenetmutationco##don10prop##eptideregionresultingsubstitution##ne##ne[SEP][CLS]theredirectproportionalrelationshipspiralarteryflowpressurespiralarteryam##niofluidpressure##onafound13mmh##g[PAD] [CLS]m##l1min824##k##pa11 [SEP]threeput##ative##fsho##0##9##6##68newmemberlargese##peryeastmembermember l##13##13new##btransportho##mo##log##ousyeastca##dresistance##1##phumanmulti##dr##ugresistance##1terminalpartpart l##13##1325presentsequenceho##mo##log##ousflyfly abdominalsegmentformation[CLS]celldenselyc##iliatedcshowingtypical92##larpattern[SEP]imalpha##isi##gma##ibeta##isi##gma##is##pect##osalpha##iibeta##iis##pectco##locssh##3bindingextracancer##phar##ii##bet##asubunit[PAD] [CLS]detection##us##oidg##ratingpatternspecificdetectorevidencecorrelationprinciplehumanvisionvision [SEP][CLS]thisbboxpresent##1##2##2 ppea##3pu1proteinunableformte##rna##rycomplexcomplex s##rlcc ffo[CLS]mad##sboxgenediversetranscriptionfactorinvolvedregulatingprocessparticularly##emorganidentityfloraldevelopmentdevelopment [SEP][CLS]elevated##ys##tobloodhighpost##lu##cosseruminsulinshowedindependent##ricmassdi##abesubject[CLS]thisstudyinvestigatedat##rialat##rialfi##bri##llaflutter##ffthirtydisease##ian##emiad##atocon##gen##itablack##fandiamonder##hr##ob##lastgth##rom##bas1o##ste##ope##tro1disease1viralproteinu##puencoded1hi1promotesdegradationreceptorc##d##4enhancereleaseparticlecell[CLS]variation##bo##dra##tehumanmilksmallsimpleapproachwould##bo##draestimateenergycontentleveliimosaic##ism09c##vme##sen1am##nioculturegeneral##yt##ogenfollowstudystudy [SEP][CLS]bio##l[CLS]i##v[CLS]sleepingpositionsuddeninfantdeathsi##dseffectinterventionprogrammeavoidpronesleepingsleeping [SEP][CLS]c##senstimulate##dtranscriptionvarietypromoterincludinghumangrowthhormonethy##mi##dinekinaser##ouspromoterch##car##cinlineline be3he##lacellratso##mat##ola##otg##cskint##rain##hibitinductionjproteinconsequently1cjproteininvia##cription##almechanismsincetininduction[CLS]thus##pophem##atoendresultconflictdeathsurvivalsignalrathersimpledeathdefaultdefault [SEP][CLS]effectageglucosereducingsugarplasmabloodmilkfedcalf[CLS]conclusionresultstudysuggestmalefemalesoldierdiagnosedrelativelyhighriskre##in##fect2020 [SEP][CLS]duringseedmat##urationtranscription##alactivitynapgeneregulateddevelopmentalsignalinvolvingtranscription##alact##iva##tor##bi##3##bs[SEP]designin##der##malinjectedsqgrown80mm##3ati##rra##dia75cm75m24hourininjectionsip##ci##v10mgkg[CLS]thisresultsecretconsequentlydecreasedresistanceinfectioninfection [SEP][CLS]theabsolutec##d##4countpatientdeno##voi##b##d210700m##ltimei##b##dcat##rissub##structuresectionallowsanaldisplayedseparatelyseparately [SEP][CLS]tostudymechanismsignalingpathwayinvolvedi1##rpromoterreporterconstructtranstrans##fectedch##oat##1cell##gio##tensat[CLS]withstudytotal13operatorg##pre##gu##loncharacterized[SEP][CLS]na##tlj##agon##adependentstimulationk##da##ati##atinaspromoterdrivenreporter[PAD] [CLS]patientmalehomosexual##op##hil##romrelatedcomplexcomplex [SEP]however##x##ralin##hibitbinding##l##phar##x##ralhe##tero##di##mersco##x##ral##agonper##ox##ismediatedr##x##ralv##ivo[PAD] [CLS]theresultsummarizedfollowsfollows [SEP][CLS]acasehe##tero##top##icgas##tric##uc##yl##origwallgal##l##bla##dderreported[SEP][CLS]thesefindingmechanismrib##osoframes##msignaldifferentonedescribedsimultaneousslip##pagemodelstringfourad##eno##sinrepresentsslipperysequenceinvolved1psiteslip##page[SEP]c##t##d##k##1c##d##kdifferproteinsubstratespecific##itythiscommunicationclinicalmassiveprecentconfirmedlungpersinglevdose30mglp##mins##accomparable1500000sfollowedsystemiche##par7day[CLS]alaboratorymanual2ndeded [SEP]engineeringtemperaturesensitives##h##3[PAD] [CLS]##1increasedprogressionre##tinoassociated[PAD] [CLS]alldetectdetect [SEP][CLS]at1minpostal##fen##tani##ln##2##ocausedrigid##ity100oo2[CLS]thepre##par##ativeregimefraction##atedtotalbodyi##rra##diationt##bic##mi##dec##y[CLS]ngalsoinducedpromoterrepeateds##p##1sitelinkedcorepromoterp##mi##dregulatedch##ime##rictrans##act##iva##torgal##4dbindingdomainfuseds##1trans##act##ivationdomainindicatingtrans##act##ivationdomainregulatedng##f[SEP]##lle##mbo##olsfi##metstudiedsoilsu##atedifferentperiodintroduction##lle##mboeffectagingcontaminationtoxicitythesevereconheartfailurekillii##i##i iivadmissionearlypresentationlatepresentation307la##atelasolutionshowednetlasolutionpeaked2hdecreasedsignificantly4h6thethe gtumor##do##mentation##ssyg##t##dsdiseasespecificsystemrubberlate##x[CLS]co##trafragmentsinretainings##3bindingsiteone##oscontainingmotif##rcactivationmeasuredtranscription##alreporter[SEP]relatedtumorsuppress##or##0alsoeffectp##10levelphase[CLS]pinductionedbindingobservedprimarilysphasecellcoincideincreaseproteinlevel[CLS]bothfl##avred##uc##tasemediaelectrontransferresultingna##dhdependentreductionper##eneh##ydro[SEP]transcription##alregulationkgene[CLS]furthercellco##tra##ns##fectedpromoterl##uc##ifer##ase1935##uflreportergeneb##bexpressionvector2foldhigherlactivity##nsreporter3[SEP]e##vashostimmunityimmunity to##x##occanin##fectla##rvamediatedne##matsurfacecoatshedresponsebindinganti##bodymoleculeeffect##orcellcell [SEP][CLS]f##rankvector##card##io##gram1530houro##cc##lusioninagreementarch##aelacke##if##5e##if##b##ysrichbindingdomainfactore##ifho##mo##log[CLS]##ep##ressionr##arsignalingdominantcore##pressresultedem##b##ryoexhibitedp##hen##otypesimilartreated[SEP]05bacterial##m##ns[CLS]last##lyseveralrestrictionlengthp##oly##mor##phismidentifiedmappedwithin1k##bregionlocatedimmediatelyupstreamcluster[SEP]radio##graphicspatialessentialdiagnosisin##ntinter##ro##ximalles##ion[CLS]promoterregionhumanalphaad##renegene[CLS]19821982 [SEP][CLS]99##ys##teindim##erstable6##hcontributeddevelopi##ct##alstudyevaluatelocationpartialseizureseizure [SEP]l##if##if the##oldoschip1eyeskinthy##roidclothesbreasto##varyfemaletest##iclemalepatientpatient [SEP][CLS]thus##ivofunction##pstrictlycoupledshortg##bswithin##plinkmmrnatransportfactorp##ored##m##tbindad##oh##cyconform##ationm##tased##m##tsharesequencestructuralfeaturem##tasetrans##met##hyl##ase[CLS]thestructurem##urid##t##kgenedetermined[SEP][CLS]showednuclearimportoccursviadirectinteractionimportbetadomain[CLS]in##pameans##d143046m##l[SEP]inclone##d##1b##uke##h##3library[CLS]patientyearyear terminal##ej##uno##stowithinfirstmeter##un##umtreatedinelementaldietdi##stalbow##eli##edd##s##b##b [SEP]s##tend##ples##bro##matdigitalradioheart##ortpulmonaryvascularregulation##21activatedkinase##awrepeat##1[CLS]otherclinic##ath##ologicalfeaturedefiniteinfluencesurvivalexpect##ancy##ancy [SEP][CLS]thesetandemalphahe##lixlocatednearcterminusmembranebindingextraction##lines[SEP][CLS]strikingsimilaritypreference##tchedweaklypairedn##leo##tidebindingex##cisionfunctionalrelationshipbindingc##lea##vagereaction[SEP][CLS]interestingactivationdefectmutantsegregatedtwoclass1unableformdim##ercouldstillformhigherordero##go##merstransformcell2defect##dbindingtransformationin[CLS]patientshowedlowyetlevel##em1m##rnabonema##rrow[CLS]conclusiontheresultshowin##nas##alchallengefluinduce##schange##ytehis##taminereleasesystemicimmuneinflammatoryresponse[CLS]activationstimulategas##trigeneexpression##crichelementcalledg##ere[CLS]crichsequenceresemblingc##pislandassociatedmanyimprintgeneoftenparentalspecificmet##hylcouldactcommonimprint##ingelementthe##rea##tinekinase##ric##ularfi##bri##llata##chy##cardwithinfirst24hourdeathcon##tiveheartfailurewithin30dayfollow30day##rice##jectionfractionfraction [SEP][CLS]preventiongris##zation##zation [SEP][PAD] [CLS]re##lapwithinfirstyearconfinediidiseasefoursiteinvolvementinvolvement [SEP][CLS]presence##k##cdependentpathwayfunctionindependentlymapactivation[CLS]thisinterestingex##onjunctionresultednovelde##ducedaminoterminalopenreadingframecompletelyframesequencelocateddownstream[SEP]singleaminosubstitution##boxterminalas##d##2incapableavidregulation##rsignaling##atreatmentelevationcamplevelutilizescommonstructuralelementregulating##d##2avid[SEP][CLS]12perobservedte##tra##cy4e##pian##hy##dr##otedos1000100##gamem##b##ryorespectively[CLS]presentinvestigationundertakenel##uc##ida##tep##har##co##kin##eticparameterexperimentcouldpredictablehumanbetablockingagent[CLS]theat##pareadingendfourtandem##gaco##donoverlapfourtandemtandem auco##donin##iti##atingunidentifiedreadingframe##f##21##4[CLS]transhe##plackc##b##palphao##bpromoterweaklyactive[SEP]##as##od##ila##ensis##omerni##card##ip##c93newca##2antagonistbetween1988199534##1##ltreated##10##10 [SEP][CLS]##teropromoterconstructcontainingthreerepeatconsensuss##1siteclone##dupstreamsinglecopyz##iic##b##p##1elementb##1promoterlinkedbeta##lo##bin##taboxexhibited##bol[SEP][CLS]ni##cotreceptorantagonistme##cam##yla##mine051mgkghe##xa##met##hon##ium510mgkgreducedresponseinducedni##cot##ine025mgkg[CLS]app##l[CLS]thuspredictedm##3##ffunctionalgeneenabundantsecretproteincandidateinteractinghostcellularreceptor##yt##oki##neproteinmetabolismdisorderburn[CLS]thecumulativedoseweektreatmentdependentmobilityestimated00 08m##sselfcaring63m##stotally1840##b##qgroupaa [SEP]j##ca##house##yxdata##ine##levent[CLS]show##bttrans##cribedupstream##bbgenepromoterm##rnatargetsequence##bb##1function[SEP][CLS]totestc##dexposurewouldincreasecareleasebonela##ct##ationrelationet##iolmechanismmechanism it##ai##ai it##aidisease45pre##la##belskeleton##cionerounddef##icientdietcontaining00 525c##d2532dayconceptionday14o##5##25showho##mologyproteinanotheryeast[CLS]principlethy##roidhormonetreatment[CLS]significancees##op##ha##go##card##iacreflexinth##ora##cpain[CLS]thefateo##rato##xinma##lt##ingbrewingmethodmeasuredmethod[CLS]messengerr##naad##2dbindingdsequenceencodingfirstleaderhe##tero##genm##rna5end[SEP][CLS]consistenthypothesisstimulationa2rpenhancednuclear##p##cactivity[CLS]at##rialdi##sso##ciation##ciation [SEP]thegenesequencepredict##s15082m136##3nterminalhsignalsequence17acid19linkedlinked gsitehsequenceapproximately17aminoacidnearterminush##teinrichterminus35acid[CLS]howeverdependingpromotercontextobservedcooperativeinteractiontwodomaincon##ferhighdbindingaffinityspecific##ity[SEP][CLS]aresultrelativebiological##be2322 7straightlinegivenmodifyleastcurvean##omaf##etusimp##lantem##bi##rra##dia120r##adc##f252252 80220r##adco60dayday 8pregnancypregnancy [SEP]sample1gextracted05##c##l70##hanm##ldi##lut##edsubsequentlygivefoldfoldstepwisedi##lutioncontaining00 05t02tb##saknowledge108eat##blae##ct##op##icfocussuccess[SEP][CLS]followingimhybridmoleculeisolatedbcelldcontainedtransre##comb##inedend##ogen##ousilo##cus[SEP][PAD] [CLS]itextra##py##ram##idaldisturbancenearlyeverysubjectcommonaka##thiseverecaseoneindividualacuted##ys##ton##ia[CLS]northernb##lothumanm##urigeneen##codeapproximately6k##btrans##cript[SEP][CLS]transformingfactoractivatepromoterc##ydependentinhibitorpp15##1consensussite[CLS]co##xproportionalhazardanalysisdial##ysm##oda##litypredial##ysle1000m##lm24hriskfactorsurvival[SEP]the##yperlinkedpresencenumeroussingleme##lan##osop##oly##mel##ano##somekleveleder##malfactorx##ii##iaden##dr##ocytes[CLS]possibledefiniteneglectabuse36correlatedd##b##hactivityactivity [SEP]twosproteineformhe##tero##di##mer##iccomplexcellthealpha##b##1gene##ifies268aminoproteinacididentityho##mo##mologue##i##f##1[CLS]##hylinterferencef##ojproteinbindsequencespecificmanner##p1sitewithin##drebox[SEP]##rinachestxpe##c##ghem##atoexaminationr##b##c##b##ch##lt##rbio##chemicaltestasalalgamma##t##dh##p##pkch##olttb##rgcac##rpbothinactivedomainiilacking91243leinhibitorduereducedabilityinitiationfactoralpha##ivo[CLS]allpatientstudiedpregnantwomandeliveredchildchild [SEP][CLS]currentbodysizew##t##2di0000005mad##3##4interactingtranscription##al##presssuppress##cdependenttransformationexpressedneuraledifferentiation[SEP]conclusionattain##bmon##otherapychangetest[CLS]theregulatorylo##cusfoundrequiredinductiongenewithinre##gu##lon##b##d##c##i##j##f##em##otaresponsebacteria##romaticcompound[SEP][CLS]furthermajoropenreadingframer##f##423k##bessentialactivationshownn##fkas##1taboxmotifl##trrequiredfullinductionpromotertrans##act##iva[CLS]howevermutationcrichelementdisruptedg##cboxlocatedinversestrandeliminatedgelmobilityeliminatedbinding##1[SEP][CLS]t##ib##dralsointeractdirectlyfactors##rgmediatrans##act##ivation[SEP][CLS]bothalgorithmimplementedscanlargea##xial30degreealsoe##cat##re##cat##rscan##ner##ner [SEP][CLS]thewelltrainedmeasuredre##spirationchamber36haccordingprotocolsa##mar##ium153##vas##rra##diationtherapyfilledballoonrest##eno##sistermrest##enoonlyviablebacteriahighpuomediumculturepositive58day4[CLS]urinepregnancy[CLS]transferflikep##las##mi##dregulated##opsystemcontrolexpressiont##rajpositiveregulatortransferop##eron[SEP]1memberhitshownsequenceidentityorganismconversionglucosephosphate##cglucosepassagebrain##ivosimpletechniquesectionco##cci##diano##ysreported[CLS]it21stdayc##ime##ti##dineadministrationserumgas##tri##nlevelelevated[CLS]dualsignalp##eptidemediasignalrecognitionse##cindependentinsertionthy##lak##oidmembrane##by[SEP]scorealloweddiseaseeffectivelyutilizedseecorrelationseverityco##rona##ryart##erialdiseaseca##dindividualriskfactorriskmarkerong##uan##id##ineb##ot##uli##smelectronicstructuresi111##si##2111typebtypeinterface[SEP][CLS]indevelopmenttumorposteriorsideprolackim##eapresencem##uc##ino##usg##landsometimesend##allikelike couldoriginem##b##ryomremnantprou##tricratheru##italsin##us[SEP][CLS]ma##rangthresholdinitiallystationaryflowbecomesquicklytimedependentdependent [SEP]theresultshoweddifferentialactivationregionverbalmemorytasksideside activatedshifteddependingdepending naturetaskemployedincrease##b##f##us##us associatedreretri##evalstrategynonmatchingincrease##b##fright##us##us associatedreretri##evalstrategymatchingmatching [SEP][CLS]maternalacquiredthroughoutfirstyearlifedemonstrationchangef##etalliverer##hr##opecho[CLS]theactualplacementles##iondeterminedmapping##pimicro##re##cor##dingstimulationidentifysensor##imoregionso##mat##otoorganizationorganization [SEP]effectproee2at##her##os##rosis[CLS]bothart##erialve##nousth##rom##busclearlydisc##ern28hinjection99##t##c##z5151 [SEP][CLS]effected##asfur##ose##mi[CLS]howevermalariavectoran##op##helan##biabecomeabundant1970s1980s##por##oz##oitpositivespecimenfound##es##bro3foldhigherkinaseexaddedliver40rib##osopr##s##l##ra[SEP][CLS]ingeneencodingmajorp##idexpressedpartiallytotallys##p##lice##dtrans##criptrespectively##1[SEP]inhibitorcharacterizedpresencecharacteristicsequenceknown##eptt##osbasedinhibitormotifit##im##optail##g##cses##op##hage##alvar##ixsettingh##yper##dynamicportalcirculationacceptableliverfunctionfunction [SEP]candidatefactoridentified##cor##tic1cellcouldreproducedvaryingcellularlevelco##act##iva##torstranscription##alinterintermediafactor2t##ifs##idreceptorco##iva1s11 amamplifiedbreastcancer1##ib##1com##od##ulator##bbinding##b##pcore##press##orsi##lenmediare##idthy##roidhormone##mwithoutcon##com##ita##itantincreaseg##r[CLS]act##ivafunctioncoincideselectiveremovalcterminaldomainc##t##dh##napii##oalongn##2[SEP][CLS]then##uc##leo##tidesequencegeneencodingproductdeterminedaminoacidsequencede##duced[SEP][CLS]at9monthserumft##4ft##3levellownormal8011 7##olrespectivelyt##shraised00 4m##ull [SEP]resultthreepatientmedicationmanagedtreatmenttype2his##tamineblock[CLS]itconsideredthereforetreatingdi##abepatientperipheral##uroassumediabetescausecasecase [SEP][CLS]t##ii##bassembleautonomous##lyupstreampromoteryeast##rgenev##rointeractiontsubunitconsensustatataboxlocatedbasepair30[CLS]mutation##alanalysisrevealstwocriticalsequenceelementgcrichsequencecalled##rs##1previouslyidentifiedmany##iotnewlyelementtt4##csitefoundsubset##iotgene[CLS]molecularanalysisman##toop##eron##los##tri##diumace##to##icencodingp##ot##ran##s##fer##asesystemput##ativepm##od##ulatedregulator[SEP][CLS]resultshowcombinationpex##oprime##rextensionstep##ram##p##lificationstepdanalysisddamagemappingl##r[SEP]effectt16tencapsulefi##brotissueculture[PAD] [CLS]est##rla##czintprobes##plelibrarytranstrans##fectedanti##genisolatedcloneallowedmmh##ccomplexend##oto##xe##miab##erese##psisintensiveunitunit [SEP][CLS][CLS] earlyattemptmodifygrowthfunctionannualvariationdatingback2decadeapplicationshowingratherdifferentdegreeapproximationareductiontotalcellularpproteinlevelmoderatereductionpm##rnaobservedchangec##d##kregulatoryoccur[CLS]geneticlink##agemapping##a##1geneencodingch##ole##ster##olsidechain##0sclose##1##1genedd15##20##4chromosomechromosome 15##2233##23region[CLS]geneticphysiologicalexperimentcloserelationship##d##c##cgenekeyregulatormit##osisyeastalsocell[SEP]thestudy100##r##iculateextra##ne##oussource[CLS]theclone##dop##erontrans##cribed##it##ro##rifiedr##napolymer##asees##cher##ichico##li[SEP]##ftestedtested 24oxygen08403424001##olmins##d##d nn 8[CLS]thesequencegeneupstreamcapsitecontainscharacteristicr##napolymer##aseiipromoterbindingsiteput##ativetaboxposition29s1bindingsitesite g##gg##agaposition48[SEP][CLS]thekinetic##cngblooddosefollowed[CLS]theseclonecontainex##onc##y##c##lindexceptex##on5[CLS]one48hourcycle24hourcycleactioncould##agon##llincompetitive##1##rino##ceptor[CLS]evidence##r##1##p##r##pinteractionpresentedsupportedisolationmutation##r##1##psuppress##rassessedgrowthenzyme[SEP]keyusedidentifyings##pec##ieus##r##tan[CLS]promotermutationp##tresequenceselectiveselectivelyabolishedbindingeitheronecomplexexexert##ertedoppositeeffecttranscription##alactivity##psg##bia##biae##e a##ede##edes##s a##ptcellline[SEP]there##8protein##avcontainsaminoacidsequencemotifcommonrollingcirclereplicationr##c##rin##iti##atorproteinplasmapro##ct##inpatient##ec##talcancerrealitypreparation[CLS]theextent##oc##ard##ialis##che##rona##rysin##usstudy##rona##rydiameterpro##ximalmiddlesegmentram##usinter##ric##ular##isanteriormiddlesegment##us##fle##x00 87p02[SEP]planeorientation##al##bfilmgrownun##id##ire##ctionalphoto##rizsubstrateconsiderablyintrinsicsurfaceorientationsubstrateweakalignmentlayer[CLS]nucleartranscriptionc##ys3sulfurregulatedtranscription##alcontrol3transcriptioncon##it##utivesulfurcontrollernegativeregulatormutant[SEP][CLS]rreplicationsuggestseithertertiaryinitiationnovelmodeinitiation[CLS]p##har##kin##eticsskinpenetration[CLS]further##moreregulationconferredreportergened##ros##opthreecloselysequencedemonstratesevensubtlesequencechangewithineboxflank##ingbasedramaticconsequenceoverallrepertoireproteinbind##ivo[SEP]bus##pi##ronetherapytypebehaviorhostilitystresscardiacpatientpatient [SEP]detailedanalysisspecificne##uronpopulationaffectedmutationrole##ro##x20segment##ationphysiologicalin##ivation[CLS]as##pec##iecomparisonsequenceisolation##eno##micclone[SEP][CLS]in##oamomamaot##ran##yl##romvolunteergivenincreasingdos10152025mgday4weekperiod[CLS]del##eti##utapromoterpositiveregulatoryelementprelikelyexistdownstreamul##9##4m##rnastartsitenegativeregulatoryelementn##representupstreamtabox[SEP][CLS]expression##liodetectedearliesthem##ato##po##ietsiteem##b##ryohem##ato##ietstemcelladultsubsequentlyrestrictedsubsetcelltcelllineagelineage [SEP]meta##chiatermbornnecessitydesignhit##heruninterface##ia##sticeffectnegativep##ime##sonbonema##rrowcell[CLS]probecontainingc##b##pbindingsiteingenerevealedbindingdifferentcomplexstronglyincampalsoil1##bet##a[SEP][CLS]thep##isignalconveyed##ho##8binding##ho##4proteinregulatoryfactorpromoterregion##ho##ho8##pinfluence##horegulatorycircuit[SEP][CLS]thusendlinear##izeddfragmentinitiatenewdsynthesisbi##rnewlysynthesizedddisplacedsubsequentlyformcirclen##j[SEP][CLS]wouldseemvalueindex##ntalfunction[PAD] [CLS]acaseacquiredimmunedeficiencysyndrome19801980 [SEP][CLS]thesemultiplegeneticre##comb##inationamongb##act##eri##opdifferentimmunitytookplacegenerateprop##1##kai[SEP]##1##b1900019##k##popcooperate##1deshormonekinasekinase 2##ak2transsrequiressynthesistwoseparatespecimen##livaindividualyear76year37yearyearexaminedconcentrationconcentration i##gafunctionvolumetotalcontenthtransformationrequirestransactivationdomaindomain ee2##ucdim##eri##zationdomainh[SEP][CLS]twoadjacenthighlyho##mo##log##ousend##og##can##asegenec##eldc##elefi##bro##basu##no##geneseparatedatrich223n##leo##tideinter##genicregioncharacterized[SEP]sedifficultj87##9##9 30[CLS]screenedth##alialibrarywhoseinsertcontrol##act##oseingal##10promoter##aenabledgrowrestricttemperaturesignatureo##leo##tide##s##dr##3##r##plifiedkaproduct##yn##ov##ium##b##lspatient##b##lss##pleindividualwithoutrdisease[CLS]onemajortrans##cripten33##9aminobproteinho##mo##logjf##otranscriptionfactorclasscompetitivenm##dareceptorantagonistexexem##4##9candidate[CLS]anem##endeddiagnosist##yl##ocexcludingfeaturealongdistributiontestpre##ova##rianfieldc##cum##med##ull##arydistribution##llin##ef##icle[SEP][CLS]inductioninter##fer##phageneexpressionrequiresinducedactivationtranscriptionfactori##rf##3##rf##7methodjwestnidendenden 2testdetermineinfectionvirusvirus [SEP][CLS]moreintegratedtransformingdalteredlostexpression##b##csa##ada##b##csgeneappearsre##pressed[SEP]done##how[CLS]tendencyho##mo##tero##di##mercomplex[SEP][CLS]furtherliverdiseaseleddifferentialalter##ationc##yt##och##romeregardproteincontentactivity[PAD] [CLS]apparentbus##ch##kelo##ew##ensteint##umourpenispenis [SEP][PAD] [CLS]thiseffectstrongermultiplepre##dos##rt##ralim##ram0ininfinityincreased396868 respectivelyrespectively [SEP][CLS]mutation##r##1##c##r##4r##po##nencodingsi##4influencex##dhgeneexpression[CLS]wepropose##rtruehumanho##mo##logmph[SEP][PAD] [CLS]s##warmm##orax##ella##ella [SEP]bio[CLS]inv##relstrongcterminalgeneactivationfunctionsincele##xafusionproteincontainingcterminalv##relsequencealoneweaklyactivatedtranscription[SEP]crystalstructureyeastt##phete##rna##rycomplexthe##rm##usaquaticeef##d##ptdeterminedrepresentativegeneraldisc##rimcomplexformation[SEP][CLS]##ovsuse##rone##gatcowinfectedherdexperimentalinfection##apmarginal##e[SEP][CLS]becausegutf##er##mentationsubstantialportion1680nabsorbedam##monian##h##3##n[SEP]quantitativemeasurementfactornecomparisonlatelatexwarosetestthedensityranged239##7ne##urimmskinwithoutpsmall[CLS]zoo##notcoinfectionsandbecomecoinfectedindividual[SEP]##th##rom##binii##iatii##i[CLS]thekineticer##omy##air##nalsinglein##ven##ousdosedose [SEP][CLS]basesubstitutionwithinn##l6siteresultedvirtualeliminationlinducedil1betagenetranscriptionmortalityrate##i##200 02##9##98thema##ito##fexperimentprovedsuperiorg##cexperimentregardbaseresolution##satacidacid [SEP][PAD] [CLS]modernaspectshockburnofaccreditedau##gus199540participatedparticipated [SEP][CLS]a##ros##op##hilsub##ob##sg##eno##micfragmentcontainingex##onlateearlypro##moto##rs##lgenedme##lan##ogaisolated[SEP][CLS]collectivelyuniquemechanisminvolvingappearsregulatetypespecificactivationdependentexpression##m1gene[SEP][CLS]thesensitivitycentraldo##pareceptorassessedhormoneresponse##mor##phineapplication[CLS]oralbasalbodytemperature##btdonorins##ute##iniestablishfeatureassociatedoptimalcycle[SEP][CLS]ourresultadmitrib##oso##mescanningmechanismm##pgeneexpressioni2s##rnaoperatesconcurrentlyconcurrently [SEP][CLS]thethreedimensionalstructureco##li##rdomainsequenceconservationlikelyresultconservedstructuralmotif[SEP]o##tosmon##oz##got##ictwinclinicalgenetic##alanalysisanalysis [SEP][CLS]adfragmentcomplementmutationsub##lone##dmonitoringabilitytransformmutantresistance[SEP][CLS]thehumanhuman lbonproductgnexchangefactorspecificallyactivatersmallbindingthusresultingbiological##tboundturnmediaactc##os##etalreorganizationgenetranscriptionentrymitmitoticsphase[SEP][CLS]insulinauto##phspecificsitetdomainreceptorbetacorrelatedkinetic##allyactivationkinasecatpmodelsubstratereducedcarl##ys##ozr##caml##ys##oz##yme[SEP][CLS]criticalobstaclemodelingdisorderlimitedinformationoriginunderlyingneuralmechanismmechanism [SEP][CLS]backgroundallr##hinocommondisorderaffectingpeoplesocios##tra##tum##tum [SEP][CLS]theresultstudy1structuralho##mosimplesimplexsuggeste##pitcontainingterminalaminoacidsequencesequence her##pesundergoneextensiveevolutionarydiver##gencecterminalsequencesequence [SEP][CLS]withinfinal11aminoacid5a##romatic2basicresidueproposedresiduestackelectrokin##keddsite##id##inedim##er[SEP]bycontrastfoot##printiiposition125he##3extract##lies15basepairsequencefoundmemberhormonesignificancedeterminationtondifferentialart##eri##os##rotlesheartvesselelderlyperson##bri##lla##rr##ththegeneresponsibleend1men##1her##ita##itable##dist##umouridentifiedidentified [SEP][CLS]toxicdiet##arymail##lardreactionproductrat[CLS]as##tactivity##nssignificantlylowapproximately2observedhp##lf##sspecificallyengineeredtwoch##ime##raterminallobe##h##1domainc##bswapbio##chemicalanalysisrevealednor##ep##phreducedsignificantlycortexhip##po##cam##puso##lf##actor##ybulbregiondo##pase##rot##oni##nlevelalteredbrainregionexamined[CLS]thecontainsreadingframe145aminoacidproteinlack##gaco##donfoundreadingframemousem##cpresumeden##codese##ys##teinaminoterminalde##ducedaminoacidsequencetheseresultsuggestrepetitiveg##aasequenceenhances##licingbindingcomplexcontainingsequencespecificr##nabindingproteingenerals##licingact##ivaturnrecruitadditionalsprotein[SEP][CLS]letterde##hy##drateststripdetectionyeastcellsinfectionmoderndiagnosis[CLS]highlyconservedregioncalledsho##mology3##3comprisingaminoacidresidue88250believedm##odtpresentcar##boxterminalhalfs##rcprotein[SEP]interestingalteredinteractions##licingcomplexbindingtightly##35co2separate1in##ductorypathway1##al##phat##osserumsignalingpartiallyoverlapactivatedmitpathwayleadingjho##mo##di##merbinding1[CLS]##11##31mutationdistinctdefect##iot##ic##ination##ination [SEP][CLS]##11reslowlyultimatelylehalfwildlevel##31h##yperre##sectme##iotdoublestrandseveredefectformation##203endm##ol##1genecodingsimilarstressinf##30nanatgeneen##codesmet##hi##oni##nen##lt##ran##fer##ase##35##30genecoding##30##r##1encodingr##arelated##ys##ys4genec##ys##tat##oni##nebetas##ynth##ase##70identicallocatedclose##ys##4##3##1##oencoding##tra##fer##70##01##r##r1genecodingsignalrecognition[CLS]transcription##alanalysisgeneclusterperformeddetectpresencem##rnaspanningadjacentgenewellpromoter##lessla##czreportergenefusedsevengenecontainedtoop##rllo##cus[SEP]serumidecreased[CLS]his##top##athkilledhigh##ciigivenoral##lydi##ff##useh##yper##emialiverde##gene##rationkidneytube##pit##iumed##emaem##phylung[CLS]theeffectspaceradiationpartiallyknownknown astronautmuchremainsdiscovereddiscovered [SEP]effecteffect gal##11##ktranscriptionmust##ku##aspresumablypartactivationcomplexwing##lesswsignalingdirectscellfatechoiceem##b##ryodevelopmentdevelopment [SEP]##nasreveals10foldexpression##d3##3l##1pre##adidifferentiation[CLS]totranscription##x##rcontrolledmechanismcontroltranscriptionregiondiverdoccompared##r##xcdointerregion[SEP]member##quito##usrodehumanimpmajorrolethe##rm##ogencopyright1998presspress [SEP]parentalvectortrans##fcellsensitivegrowthinhibitorexhibitedexhibited at##radependentre##artranstrans##re##pthe83co##it##usstoppedpregnancypregnancy [SEP][CLS]basedratioareaconcentrationtime##fserumoverallpenetrationr##ici013042median00 22[CLS]thedifferentialmineral##idol##ymphnodereactionradiodiseasediscussed[CLS]withzsufficientdiet##3ed##ta##ed##taabsorption##rina##ryretentionzlesserlesser extent[CLS]99##t##clabelled##idal##bur##esradius250##coradius25usedtestsubstancestudykineticvascularclearancerestimulation##qcjhe##tero##di##mersbind##p##1likesequence##qpromoterregionaffinitymuchgreater##q##qho##mo##di##mers[CLS]moreeffectm##kmapadditionaldi##stalcampdependentinhibitor##ymechanism[SEP]thesefindingtransdominantfactorfacilitategrowthlinespecificmanner[PAD] [CLS]pseudo##tum##orformpulmonaryno##cardinfection##cardno##naltransplant##ato##letcountliverfunctiontestdeterminedstandardprocedure##ryo##rt##icallayerpyramid##al##binoratthreevariousfixclinicalexperiencegained##c##f##chy##thermedicalradio##ramgeneralizedtheteamphysicianconditioningathletesportstatementinterrelationshipanchoro##go##mer##izationse##rot33 tsi1del##eti##40onelackinghhi##ngelackingadjacentregionconstitutedcoilaimtheaimstudystaticdynamicbonechangepatientr##ick##ets##ets [SEP][PAD] [CLS]thelawch##iro##pra##practor##ctor [SEP][CLS]in##exd##bweakexpressiontargetgeneun##ressedconditioncausedgrowthre##tar##dationtransplant[SEP]maym##or##ph##olo##rrel##atetumorrepre##oper##oto##xi##em##otherapymeantotalho##mo##stein##cy2119##molmedianconcentrationconcentration 19##moll [SEP]efficacypro##bioticfeedaddguidemicro##or##gandogcathorsepro##biotic##or##ganfeedadd##itiveanimal[PAD] [CLS]lungtransplantwarrantstable##iladependentrecipientrecipient [SEP][CLS]sitedirected##utasitethroughoutialtercontrolib##pbindingreflectingfactfoot##printib##pentire[SEP][CLS]approachrandomintegrationlargedfragmentplantoneseveralsitespecificre##comb##inations##rsystemc##relo##x[SEP][CLS]neon##ata##lma##cu##lini##zationaffectmaternalbehaviorsensitivityfemaleratrat [SEP]##t##11##alytictowards12e##pox##y3##troni##trodi##chinlandmarkfavoredx##ero##raddegreenon##let##hal##111mutationmutation eliminatese##3##pcomplex[CLS]sequencedel##eti##onanalysisre##combenhance##mentgenere##fb##act##eri##opp##1evidencepromoteroperatorat##uaanti##ter##minacontrol[SEP][CLS]t##b##cthusthus suggestedindicatorpersistenthe##painfectionfoundrarelyse##rone##gatpatientchroniche##paalcoholicc##ir##r##hosalcoholicliverdisease[SEP][CLS]adapt##ability##pp##ost##rongbra##si##vas1914leadcontaminatione##phmembranee##phcellinteraction[CLS]disc##uspossibilitydproteininteractionho##mo##logn##leo##tidesequencelikeidentifiedp##iipartregulatorygeneca##sca##departicipatestiminggeneexpressioncc##rescellcycle[SEP][CLS]post##con##trasimagealsoacquired##git##talsixpatientco##rona##lthreeplaneplane [SEP]nature##rm##opbi##conductorto##ut##rops##m##fdosemicro##gramc12h##han##ol00 15mb##ora##tebuffer80cat##ech##olomet##hyl##tra##fer##aseactivitymightass##ito##nifree6weekpet[CLS]theaminoacidresiduesub##dom##ain##simportantdbindinghormonebindingdim##eri##zationtrans##act##ivationmostlyconservedamongs##pec##ie[SEP][CLS]trans##criptappearinitiatedupstreampromoterp##1locatedfronttmet##1genethreeinternalpromoterp##2locatedimmediatelyfronttgene##10nearbeginningl##1l##10inter##genicspace##12endl##10genesequence[SEP]basedde##ducedaminoacidsequenceidentity##1##2groupi97identical##3##4groupgroup ii994identicalidentical [SEP][CLS]casefunctioningpara##roidcar##cin##omah##yper##tens[CLS]finallygelshiftass##fablebindpromoterfragment56##688##8criticalgeneralresultresult [SEP]fattyinduce16foldincreasetranscriptionactivitywhereasre##presso##1transcriptionmuchfold[CLS]this##pt##ideincludesfirstthreezincfingert##fidbindingdomainanexception##l6geneencodingtranscriptionfactorfoundm##uta##tednormalhumanmemorybcell[CLS]33 [SEP][CLS]achestxrayfilmshowedin##fi##rativeshadowrightmiddlelowerlungfieldchestc##tscanabnormallungdensityrightlowerlobelobe [SEP]inliverpan##cre##aticis##letg##lu##co##kin##asein##hibitionregulatoryprotein##r[CLS]m##rimeasurementbrainbrain [SEP]similarly67revertedad##ome##d##c[CLS]ofhighune##x##plain##vamong##f##ricaam##ericwomanalsoextremelyhigh##terbirth[CLS]theusebent##oni##tecompound##ydro[CLS]co##tra##miproteinkinaseinhibitorinactiveproteinkinasepcat##alyticbetasubunitin##hibitfor##sko##acaactivationch##rom##ogtranscriptionrevealing##acatransactivationhighlydependentp##ka##hrapidt##ospproteinapproximately93k##dafi##bro##lotsspecificrevealeds##tat##5activationp[CLS]themethod##bbearingc##hal##ometricdiagnosis9091con##cor##dance##d##9temperatureall##elesc##ere##vis##iaedisplayedcelldivisioncyclearrestlargeround##ddedcellmutant[CLS]thec##yan##ob##erialp##is##omecomplexlocatedphotos##ynth##eticmembrane[SEP][CLS]onedayinjection48injectedactivityskeleton93liver3kidney44restorganorgan [SEP][CLS]objectivetoasslaboratorypracticeexaminationbloodfilmmalariaparasiteparasite [SEP]backgroundthoroughunderstandingma##gnantfi##brohis##hsubleadhis##tospecificprotocol[CLS]sequenceanalysisrevealedpartial94##1b##p##aencoded313aminop##pt##ide[SEP]further##b##30##0stimulatebetatranscriptions##4##4dependentfashion[CLS]sequencewithinflank##ingh##yper##sen##sitivesite32beta##lo##binlo##cuscontrolregionrequireds##yne##rg##isticadd##itiveinteractione##ps##bingenepromoter[SEP]sequenceanalysis100ho##mologyderivedp##tenfragmentnormal##fwell##en##banksequenceaccession##9##30##51174233247he##n##row##troincludinghumansicontain##uczipperlikerepeathighlyconservedregionexternaldomaintranst##in[CLS]functionalproperlyfoldedsurfaceloopcoveringcat##alyticcenter[SEP][CLS]thefrequentabnormal##ity##hdeficiencycasefollowedgo##trofourcaseco##rt##is##olfourcasecase tonecasewhereaspatientshowedhighserump##rlvalue[CLS]re##combexpressbbact##eri##opt##3r##napolymer##aset##3##pol##pol esescherlalacre##press##orlalacicontrolearlylatepromoterpp75constructed[SEP][CLS]internalcontrolvolumemilksuck##ledappearinfantrat2weekagetimegas##tricdi##stenmilksystemicde##drain##test##testinalhormonech##ole##kinisuppressmilkintakederivedsuck##ling[SEP][CLS]shieldneededpace##maker##maker [SEP][CLS]concerningpracticalapproachsettingpointeddiseaseinfectionconsideredtestingheanti##bodypositiverindicated[CLS]##fow##idistributeequallyexpectedwmutanttwocterminalresiduehowevereasyestablishdiagnosisth##orammf##h##h [SEP][CLS]typeinsulinleddependentassociationpi##rs1sdomainregulatorysubunit##i3kinaseincreasedamountp##ikinaseactivitydetected##rs1##pit##atestheul##m##rsystemmicro##dial##ysbio##senglucoseunite##cul##msend##ertransferringglucoseconcentrationreceivingthexan##nexlackhighly##osposition23siteonproteinnoatdetected##uofraction[CLS]##las##mi##dbearingps##tip##tipitis##3gene##rs##2element30000transform##antsper##gramp##mi##dd##na[SEP]he##pargivendose03mgxkg1b##ol##us03mgmg x1xh1in##perlowerre##lusion[SEP][CLS]thescorethreefactorcorrespondrecognizabledimensionde##pressiveillnesscorrelatedr##c##b##f##f [SEP][CLS]c##lon##ingsequenceanalysisexpressiongeneencoding##dedi##utapseudo##monaputf##6##1[CLS]howeversalvageserum##alevel9111ngmr##psalvager##tgroup0000001[CLS]##tedig##est##somesegment3sufficientstablemembraneanchorindicatingsegmentmayspecifytrans##ranedomain##b##inthetimel##r0monthrange31945month490monthrange32090monthmonth respectively[CLS]agene##r1identifiedwithinfourco##sm##idcon##ti##g##cdexpress48k##bmessagehumanbrain[CLS]detailedcomparisonsequence##p##35iisubstantialsequencedi##ssi##mi##lar##itydomainencodingaminoacidresidue2040includespsitehumanmoleculealongresiduepossiblephysiologicalsignificance[SEP][CLS]ex##ogenheartstresslogcirculatingneconcentrationriseheartrateloadusualrelationshipobservedstresspreservedpreserved [SEP][CLS]theimp##licationanalyzedtranstransexperimentcon##it##utivevdominant##17mutant[SEP][PAD] [CLS]alternativeimmune##bulpreparationstandardimmuneserum##bulavailableavailable [SEP][CLS]plasmainsulinresponseglucose##em##oralhe##pa##tic##aticdog[CLS]bio##con##versioninexpensivesubstratevaluableintermediate##hal##os##porde##to##pordaeliminatingagitationaddingde##cane[CLS]elevatedpotassiumstimulationgalmmrna##rna completelyblockedpit##uit##aryad##en##yl##ylc##cact##ivatinghishistaminestimulationblocked##he##deinl##y##zo##zyperiodicgroupyoungest##oa##l[CLS]##b##f##1m##rnapresentlightdarkgrownleafwellrootroot [SEP][CLS]weidentificationanalysistranscription##alactivitymediatedthreec##iactingsitewithin90b##pportionrenhance##rdesignatedm##odregion[SEP]adi##ff##usea##xon##alinformationphysicalearlier##it##rotissuestudyco##rrel##atehisradio##xon##alinjurypredictedregionanalysissamplemeasurement[CLS]atransinductioncf##ocmtobservedcellpopulationpopulation togetherassociatedsuppressionm##rnaf##etalratca##var##ialcell[SEP]video##anaballisticcharacterinitialphasereachingmovementmovement [SEP][CLS]is##omer##izationpreexistingclosedcomplexopenpromoterformjudgedlocalden##atpromoterdrenderedsequence510reactivetowardskm##4shownfullydependentni##fa[SEP][CLS]ma##rcontextdependenttranscription##alenhance##ractivatedexpressionondependent##rom##osointegrationpositivelyselecttumor##igecellmulti##ste##pet##iology##alcancer[SEP][PAD] [CLS]socio##logicalanalysisfamilyfamily [SEP][CLS]thisenhance##relementfunctionedpositionorientationindependentmannerp##n##rp##0promoter##tero##ous##mi##dinekinasepromoter[SEP]thesemmtpotentwhereas##icit##ifereffect[CLS]multi##var##iantstudy##uitad##enotwolog##isticre##gressionequationauxiliarysupportdiagnosistumortumor [SEP]bi##lesaltho##rmon##alcontroldisadvantagenumberwarmhigherratefiringthermalgraduallyincreasedgrowthgrowth [SEP]suchuniquerecognitionalter##ationc##dr##3loopt##r[CLS]toeffectsurveymaximumdelaystreamguaranteedimensionalclass##gin45minutehot##limtropicalconditioncondition [SEP][CLS]gene1m##rona##9en##codesapproximately800k##daproteinproductwithintwooverlappingopenreadingframeor##fs1##a1##bforinteractionterminalpart##1terminuse##f##1domainpresente##f##3absent[CLS]biological##f1regulation##ghgeneexpressionattributefunctionalreceptorinduced1proteindirectlinklink imediatedsignalling3enhance##ractivationactivation [SEP][PAD] [CLS]onactivationreretdetectedthysyndromesyndrome [SEP]c##d##4degradationmediatedrequireerca##ex##independentintactsystem[CLS]thematernalgenesegregationcellfatespecificationactivityearlyearly ca##eno##r##hab##ditel##egan##egansem##b##ryo[SEP]effect##agonadministration12met##ho##l42p##raz05mgkgppurposetoeffectpu##lsbro##cillarotatingbraoralbultraplaqueremoved##9plaqueremoval[CLS]detailedanalysispredictedaminoacidsequencerevealedsequenceelementconservedmanydr##napolymer##ase[SEP]subinhibitoranti##biotics##yer##hr##omysau[CLS]thec##d##csystemappearsfirstpro##karexample##tero##di##mer##ic##b##ctransport##ptcontainsh##ydroatbindingdomain[SEP][CLS]thesinglecopyu##20sequencelocateddstrandn##linm##rna[SEP]shiftsouthwesternexperimentnuclearprotein43k##da30k##dafishcellrespectivelybindspecificallyspecifically tinvolvementbindingproteinprotein act##ivatingtranscriptionfactorlrelatedp##eptidecampresponse[SEP][CLS]thecodingsequenceratkinase1##k##1determinedmultipleindependentc##dn##aclone[CLS]inbetterquantitativeestimateregionaldistributionbonema##rroworganinfantchildvariousan##ato##mic##aldatadevelopeddeveloped [SEP]wecomparedresponsehatch##lingadultpohpopulation[CLS]onmutant##fectisolatedgeneher##pes##ximmediateearlygeneproducti##p##4knownpositivelyregulatetranscriptionviralearlylategenenegativelyregulateexpressionpromoter[SEP][PAD] [CLS]infantisolated##com##pa##ric##oc##arddevelopedvent##ric##ularta##chy##ar##rdescribeddescribed [SEP][CLS]recenthighlyvisiblereviewsubjectclearlypointedlittleknowncellularmechanisminhaledas##besfibercauseknownde##bil##itatinglungdiseaseas##beseinter##st##iti##alpulmonaryfi##bro##sisthespecificdomainpit1essentialsequencespecifichighdbindingddependentpit1pit1interactioninteraction [SEP]alsoplace##de##pressedtreatmentoutcomedepressedpatientobtainingkidneycellpuppy##p##b1establishment##op##vation[CLS]theseresultessentialrolebinding44factorbetaaasitebasaltranscription##alactivation##3genelivercellitit enenvis##agedwho##q##olbr##efusefulrequireexamplelargee##pid##em##iol[CLS]restrictionmappingtworep##mi##dsharede##cor##ifragment89k##b[SEP][PAD] [CLS]##cor##ticheartfailurefailure [SEP]thech##rom##oso##mallocation##cs##chi##mer##icnature[CLS]afterfirststrandc##asynthesis##etalbrainm##rnashortfragment##as##f##asynthesizedtwostepam##p##lificationsystemusemodifiedde##generateo##gon##uc##leo##tideprime##dshuttlepolymer##asechainreactiondo##pshuttlep##rmethod[SEP]ex##citationpathblockwall##chapro##fiiiiipresenthumansuggestingmathreepro##fi##ormstwohybridsystemisolated83aminoringfinger##3##4zinct##1beta1specificallyinteractdomainzincfactork##1##10thethe authorex##ere##ye##ricsmallkidney##arosurgerysurgery [SEP]proteinproductdiettherapyre##nalins[CLS]une##sta##lished##ob##troonorderinvestigatemechanismoninterfereterminaldifferentiation[CLS]earlydetectionsignhe##pa##to##ang##ios##aamongworker[CLS]reducedexpressioncausedmulti##mer##ization##as##2nativepromoterobservedpresence##r##1[SEP][CLS]##4differential##lyregulate##st##ra##fsignalingdi##sen##ga##ging##nkactivationdirectingn##fka##ppaeffectrotspecificcellularresponse[CLS]3rdis##che##miakidney30minstructuralcomponentwallg##lo##mer##ularart##erifi##ltrationre##ab##ptionbarrierundergoundergo certainultra##st##ructuralchangetimetime el##ap714daygraduallyawaycellh##yper##troprocessincrease[CLS]rag##1proteinover##excoexpectedc##lea##vagecombinedrag29##3##3tcell[SEP]194949preventinghe##terohiformidablepublicchallenge[CLS]more##ata1s##1s##rg##izedistancedesignedmimicarchitectureg##lo##binlo##cuscontrolregiondownstream##lo##binpromoter[SEP]##ovininssoalternativegame##tein##fall##iantransfergiftcontrolledcomparativetrialtrial [SEP]chromosomeendcontainlongarrayt##tagrepeatcomplex##edte##lo##merespecificproteint##tagrepeatbindingfactort##rf##1[CLS]##eno##typep##otypecorrelationmalepatientpartialnull##is##omyxchromosomechromosome suggestedonelo##cusinvolved##r##xx##p3[CLS]meandispositionconstants##dobtainedindividual##izedfitv##1039398033kgv##dar##ea25300 72kgalpha0316029294min1beta0000020##204000##26##262min1k##2003030##05001##01min1[SEP][CLS]thegenein##iti##atorsitecontainedwithin13244base##pair##scontains19ex##on[SEP]c##lot##ron##ronc##tpet##os##ronemgas15##o11##c##o##2##oetcetc [SEP][CLS]c##lot##ronroomtransportationpipeshieldreducep##os##it##ronan##ni##hil##ationradiationmaco##ohterminuscentralcellbindingdomainfi##bro##nectwellwell corresponding##s##1##dresult##umi##nalportionprecursorcerebralbloodflowmeasuredi##vmethod133x##b##fdetermination##domeasured##erial##nousoxygendifferencedifference [SEP]activationmitmap##kpathwayenhancelongrangetrans##act##ivationbeta##lo##binlocontrolregion##rwsithybridwholemountem##b##ryo##xrexclusion##xem##b##ryo##nicdevelopmentthreepatientelectrocharacteristicat##rio##vent##ric##ularconduct##ionpreventeddemonstrationdifferencedifference [SEP]humanrelikeiiii [SEP][CLS]33 [SEP][CLS]newstrategypreventco##rona##ryre##th##rom##bospatientminimalat##her##os##cleth##rom##bol##oc##ardin##farthei##ckt##osc##d##4c##dr##3loopsignaltrans##ductionin##hibit1transcriptionprogrammedper##nealava##uracom##foulstomach[CLS]del##eti##onanalysis73k##b##atapromoterregionrevealed11k##bdsequencecriticalexpression##atane##uron[SEP][CLS]themodelpredict##s1linecalculationair##waydeadspaceendexpiredlungvolumeadditionoxygensin##ewavepercomponentmeanfi##o##22q##tmeasuredoxygenperwaveexpiredgas##erial##nousindependentbloodoxygensatvalueconsistent##h##5##8disappears##7cellabsent##less[CLS]thefusiongenecassetteplacedcontrol##aearlypromoterclone##dhostrestricted##poxvector[SEP]##oriatumor[CLS]f##ul##mina##nthe##pa##ticfailurecasecouldcould characterized1rapidserumaltransalleveldiscoe##car##azi2prolongedj##au##ndi##cedespitee##car##azi3highan574his##tofindingextensivehe##pa##to##cellularne##c##rosisrangingbr##id##gingne##c##rosismassivene##c##rosis##rosis [SEP][CLS]thesesecrett##runcatedreceptorencoded26k##bc##bbtrans##criptbindtalphagrowthregulatory##ro[CLS]local##izationenzymeconsistentelectronhe##tesacloseho##mo##mologuegenenamed##balsoisolated##idolibrary[CLS]thusratefactorreceptorend##osiscon##quent##uo##larturnoverdependavailablelevelcell[SEP]approachshownh##firebinds##lator##yproteins##1##3addition##b##f[SEP]specific##muabnormaldetected8lookedlooked [SEP][CLS]usingcombinedp##har##co##kin##eticp##har##co##dynamicimpactfactoreffectivebio##ava##ila##bilityest##imationin##tra##ven##ousoraldoseratiorequiredarearesponsetimecurveacuteadministrationexploredexplored [SEP][CLS]conclusiontheronecommonbestcharacterizedrbindingmotifthecdependentkinase##d##kassociatec##c##linsd##1sphasetransitionma##mmal[CLS]m##ol##ol [SEP][CLS]theterminalgagencodedregionp##0containsp##ot##osresidueadditionnormalgagsiter##ad##18requireddrepaircheckresponseyeast[CLS]alecommonper##plexc##ir##cumoccurspatientestablishedyearchronicpulmonaryinvolvementd##ys##p##nea[CLS]2426to##lue##ned##iamh##ydro##ly##lysedplasmaurinetestchamberhuman242to##lue##nedi##is##yana##te[SEP][CLS]further##ioscoincide##ntalgeneralphenomenon[CLS]after1daynoneer##hr##ocdetected[CLS]thissubstratec##lea##vedefficientlytransproprote##ase3derived3##cprecursorprotein[SEP][CLS]thegamma##yltrans##idasserumproblemdrink##er[PAD] [CLS]patientend##oc##ardvascularfrequently##com##p##rom##isedolderacuteqfeverfever [SEP][CLS]effect##lateproductden##tinesurfacese##minvestigationthetechniquesystemtransexternalincreaseresistancebreathing[CLS]we99##m##mt##ds##pectcomparing##c##b##fimagepatientspin##bellades##d##d [SEP]##pt##yl##olo7daystrainb##al##bc##b##li##gh##ad##ba##ba2r##fc##einla##cztrans##criptsynthesiswayyieldlittlebetagal##os##idas##e[SEP]sixhumanho##mo##loggeneknowns##pec##ienamelyh##1r##vis##rnas##vischromosome[CLS]theth##ala##mics##dregularlytriggeredshort002005highhe##iet##alco##rt##icalsurfacesurface [SEP]allthrees##vtransformedcellgeneproductp##44psecrettightlysurface[CLS]itmechanismin##test##inalabsorptiond25hdiffermanabsorptionpossiblyledependentbiacidelevatedf##akexpressione##4##9o##leo##tidereducef##ak[CLS]ittendshigherf##raz##ion##icommunitycommunity[SEP][CLS]thebrlgene65##3n##tlengthderived##pt##ide216##atostudyt##tliverdiseaseinitiatedeffectpro##in##f##matmediatumornenec##rosis##falpha##tcell[CLS]availabilityledietch##owfollowingdietresultdiminishedca##lor##icintakebodyweighto##besityh##yper##ins##ulin##emiabyc##ifailedaffectil9responseandepic##ardmapelectricaldogacutegroupselfdogchronicgroupsin##usrhythmat##rialpacing3dogcontrolgroupgroup analyzedcreatinglinearradioa##blales##ionat##riumeliminated[CLS]inresponse##hos##phoruslimitationfungusne##uro##spcnumberenzymefunctionbringphosphatecell[SEP]theeffectinsizemediumtemperaturedurationsuas##gill##gatinvestigatedbr##oth##rodi##lution[CLS]weanalyzedfunctionput##atives##lstructurertranslation##lora##l##ty##lt##ran##s##fer##asecatflanked53terminalsequencedomainrgenomeseveraldel##etiderivativesequence[SEP]##iar##osar##nalvesselbloodblood [SEP]despitebio##chemicalestimateboneturnovertermstimulatebonemetabolismo##ste##op##orobonemineralpro##ximal##em##ur[CLS]compressionpulmonaryarteryright##ric##flowtractan##eur##ysascending##ort##a##a [SEP]patientd##p##xoccurrenceassociatedconditioncondition [SEP]pressurelongtermdi##urebetaad##ren##ore##ceptorblockingdrugsixteennineteenpatientmoderate##yper##tens[CLS]howeverf##os##blf##os##b##b sdiffertransregulatorytransactivation##xtcatreporterconstructhe3##t##3cellfoundf##os##bform[SEP][CLS]mutation##b##r##1##c##r##4nencodingsi54influencegeneexpression[CLS]disruptionin##p##53related##51generesultedalphafactormatdefectexexace##rb##atedalphafactordefectcombined##c##152##1impact##yt##okigene##mor##phismoutcome##rona##ryarterybypassgsurgery[CLS]regardlessmuscletensionmatreatmentaging24hh t##1##1 t##2##2 t##3lowershearhotbone##dt##4##4 t##5##5 [SEP]bloodwholebrainmercuryconcentrationpup0birth21we[CLS]sub##tract##ivedifferentialscreeningclone##d12sequence2c##o##ro##x24[SEP]s##tivalue3434##estadifferencelslb34##bstimulatebasalalphaico##llapromoter93fold##ath##ionered##uc##ob##erian##aba##cc71[PAD] [CLS]additionalinteractionspatialstimulusdurationeffectadaptationpropertyresidualtraceopposedper##sistence##sistence [SEP][CLS]fraction##alcaretentionmeasured72h##dos##b##rdivided##b##rtime00 [SEP]methodtheacuteco##rona##ryacute##oc##ardin##far##gin##ectorpatient##gin##ector75[CLS]furtherrub##bodyneverdetectedwomanha##inegativelapositivepregnancypregnancy [SEP]diseasefreegreaternode##100007##7 tpresentation[CLS]5del##eti##ons##tatbindingsiteabolishedpromoterreporteractivityresponsep##rl[SEP]atreateddepartment19601991891superficialt##1diseaseremaining9presentedinvasivediseaseplasmabetath##rom##bo##bulbetabeta t##let##vas##cularplate##letde##gra[PAD] [CLS]j##ohw##ort[CLS]designsettingandsubjecttheanalysisdatacollectedfirsttworoundnationallyrepresentativeg##hanasurveyheld198788g##lsi198889##lsiisurvey3000householdhousehold [SEP][CLS]thed##nabindingproteinwithouteffecttranscriptionp##mi##dlackingbindingsitebindingsitelocatedupstream[SEP]gas##tro##est##estinaltumor##itsprotocol##i71random##ized197519801980 followingstageb##2re##ct##alfour1therapy2ch##em##otherapy3radio##ther##ap4radio##ther##ap##em##otherapycombined##oda##lity[SEP][CLS]ther##ti##40genespan35##basepaircontains6ex##onleast6idrepetitiveelement[CLS]thedelementelement e##b3activate1promoterincludess##pi1s##pibbindingsitepreviouslycharacterizedimportante##b2responseelement[SEP]d1d2enmaternal##lytrans##criptexpressedearlydevelopmentdevelopment [SEP][CLS]further##moredel##eti##ontwopotentialsste##11recognitionsitef##us##1promoterregionabolishedtranscriptionexpressioncouldrestoredinserteddifferentsste##11sitemat##1ppromoter[SEP]howeveranalogous##yladerivedyesalsoinhibitor[CLS]theoralmovementoccurha##ltreatedratslowernormalfinallyanimalmutationconvertbi##function##alproteinu##1specificproteinviable[CLS]thesesequencedifferencereflecteddifferencegeneexpressionthreecellline[SEP][CLS]pathwayreportedmedia##di##merregulatorbad[CLS]##utabase142151a##bolformationcomplex##iipartiallyin##hibitcomplexiivproteinformingcomplexbindneighboringsegmentd##na[SEP]d##faslidepreparedthin##pd##fasampleendsm##be##mitoleratealternative##de##presslongtermefficacymethodauto##capdevicepace##sett##rre##rpace##settsosolns##tero##utiepic##ardpacing##dteepi103##6##dtmmnimpchildchild [SEP]##rmon##alreplacementtherapypersonalhistorybreastcancercancer [SEP]recentlyalsodirectlyassociate##3##l##oz##ntranscription##alre##pressinvolvedpath##ogenho##d##g##kin##ymph##oma[CLS]usingreportergeneconstructdrivenc##d##4promoterreporth6efficientlytrans##act##ivategeneticelement[SEP]characterization##aencodingpredict##sstructuralthree##ucmotifseveraldomaindomain exhibitinglimitedho##mology##os[CLS]pre##formeds##b1##pdcomplexbound##bcontainedterminalportionc##b##p[SEP][CLS]##ido##st##ig##attwodosanti##docombinationt##mbconsisting005mgkgat##rop224mgkgt404mgkgben##act##zinefollowingthreeseparateexposureexposure 10l##d##50so##manta##1proteinp##latedexclusivelyseidentifiedse##r##12substratemit1rapidgas##roma##toanalysis8met##hohumanplasmaifc##ysliverlesexcluderefuse##em##otherapy##ben##zo[CLS]co##tra##ns##fectedhil##trcatc##v1cellp##d##41##d##41clonetransactivatedl##tr[SEP][CLS]inductioncomposite##ktags##ktagtrans##dra##terichdietliversimilarend##ogenl##kgenepatientpatient advanced##ian##cinii##iiivrandom##ized##emdo##x##or##ubi##p##xa##apexitmit##osisd##ros##ops##ialem##brequirespro##te##olyc##y##c##lindegradationassociatedlocalizedde##lation[CLS]coughc##p##rdeeprhythmicforce##fulcoughrepeated3060timeminuteeffectivere##sustechniqueemergency[CLS]todramaticeffectexaminedlocal##rprotein##35shiftedc##op##lassky##1##del##tayeastalthoughphenomenonobviousasnuclearimport##rproteinmaydifferential##lyregulated[SEP]##biotic##bioticsreducingsalmon##ella[CLS]oncontraryadministrationca##tonin##tra##lor##icpressureviav##aga##lnerveat##ropgal##lamanimalpresencefattymediumtranscription##19directlyregulated##p##1##p##r##1[CLS]gasexchangemeasuredbreathbreathwepremature##las##minthusdefensein##tra##ve##olarfi##bri##ndepositiontraumareducedreduced [SEP][CLS]analysisn##tsequencecarriedthree15regionpresentmousegenomestudyreaction##och##romecco##rt##ico##ster##oid[CLS]however##arr##x##rspecificl##igan##dincreaseca##skinumber20[SEP][CLS]alsopatientmy##ddecreaseart##erialp##o##o2seatedposturesu##pineposturewithoutchange##erialtheprimarystructurehuman##bcell##r##b##1f##olatereceptorhuman##r##rproteincellular##olatede##ducedc##asequencegeneralrarec##lea##vagemappingwelllimitationdiscusseddiscussed [SEP]investigaterole##rtranscription##alsignalingwildhuman##rcat##alyticdominant##rprebl70##z3[CLS]selectiveupperabdominals##ym##tomincreasedbasalacidoutputrateffectstimulate##dacidoutputserumgas##tri##nconcentrationgas##tric##uc##osa##lhis##ti##dinede##car##box##yla##ylaseactivity[SEP]reasonpresentedsupportcontentionincreasepartrealpatient##hal##othin##tra##ven##ouslyprocedureadditionaldos[CLS]inbup##takedirectlyproportional##i671activitynumbermit##osetumortissue[PAD] [CLS]heatingeffectforcedeclinerelaxation##uingcontraction[CLS]bindingtransformedreceptorcomplexditranscription##alenhanceevidencetwodistincthe##tero##mer##icdbindingform[SEP][CLS]interesting##drablebind##shighfullyactivatetranscriptionintactyeastcellpresencere##tino##idreceptorr##x##r[SEP]manti##bioticinfection[CLS]afinestructureradiationhybridmapregionextendsdd8##20di##staldd8##9pro##ximalpreparedfollowedconstructionsingleintegrated##cb##accon##ti##gintervalproteincontainss##haaminoacidsignaturemotifsecond##blikerepeathighlyconservednumberrelatedthusdefiningclassdbinding[CLS]i##vshownre##ninsecretstimulateend##othdiscoveredpstrongv##as##oc##ons##trics##ti##mulatingeffectre##ninsecretherec##lonnovelhumangenepredictk##elproteinho##mo##log##ousigenepreviouslyk##elmember[SEP][CLS]theencoded260aminoh##1i240##1##pttypicaltrip##art##iteorganizationanimal##1cterminaldomainflank##buladbindingdomain[SEP]insteadlargedifferencesbindinglosshe##xa##mer##izationabilitysuggestingformin##tra##xa##mers##rg##ismco##oper##atibindingsitewithinhe##xa##merleadhighobserved##aseenfoundgroupdegree##operde##ior##io##ry[CLS]thep##kdomainshowedpair##wise##robindinginteractionpseudo##asehis##rsctermdomainadditionally##rsdomaininteract##edtermregion[SEP]effecter##hr##osred3benred105##roid##ec##tomdevelopmentthy##roidtumormalew##ista##rratbi##trod[CLS]theam##yispecific3characterizedabsencei##rsequencepresenceput##ativea##ata##aa##lationsignal[SEP][CLS]toinitiateanalysisfactorrequired##if2alphaexpressionselectedcappro##ximalelementshown##ivomet##hyl##ationprotectionanalysispotentialregulatoryfactor[SEP]furthern##fyasubunitrestorere##versiblepressuream##orsolid##70##anphoto[CLS]alternativeroledmotifact##ivaearlym##rnatranscriptionin##iti##atorelementlatem##rnatranscriptionexplaingeneregulatedl##yticgrowthprovidescellulartranscriptiondevelopment[SEP][CLS]s##p##1bindingsitefunctiondistinctt##fbetaelementt##fbetamediatedpromoterexpression##p##1persemedia##teresponse[SEP]effectbr##omo##cript##ramserumpro##ct##inlevel##yo##trophaseistudy##oro14daycirca##dianin##statictheresultstudydemonstratereleasesinglerepairtendareaglidingex##cursiontend##onreducedresistancemotionrepairedtend##onprovidesupportpartial##2pullinrepairarea##ey[CLS]heartrateoxygenconsumptionincreased754b##pm26311 4m##loo2xmin1su##pinerestingrespectivelyrespectively [SEP]effectth##rom##boxblockade##letreact##ctoran##gin04##6600mgdaypadministeredpatientre##gintherapytherapy [SEP]pro##longpro##th##rom##bintimeduededependentco##agu##lationfactormanifestfi##bri##noduepresence##bri##nofi##bri##n##mon##omer##d##pcomplex[CLS]effectg##ly##co##genliverin##test##inalmicro##f##loramouse[PAD] [CLS]acasereportreport [SEP]mutationk##3##rfmajortarget##ro##fersstrongsyntheticdefectonv##3valuedegreet##rem##orse##bor##r##heaillnessillness [SEP]patient##alevel01ngm##l[CLS]intrans##act##ivationmediatedet1##renhance##rsequencespecificallyin##hibit##k##rtranstrans[CLS]treatmentaceinhibitor##oc##ardin##far##ction##ction [SEP][CLS]con4##ime##raisolated##z##3b##c##l##6b##t##bp##ozdomainnearlyefficiententireproteinintranscription##alrepression[SEP][CLS]newmy##oc##ytespecificenhance##rbindingfactorrecognizesconservedelementassociatedmultiplespecificgenedi##lo##fen##acsodiumbloodconcentrationslowreleasemetabolism[CLS]thelgenepromotersequenceho##mology##mology es##ichicocolipromotersequenceterm##inatorsequencecapableformingstemloopstructure[SEP]wesyntheticimaging[CLS]eithers##1p##btranstransactivated##gapromoterdosedependent##lycotranscriptionfactorresultedaddadditive##gapromoterresponse[SEP][CLS]##ga9264b##pcomprisings##1e##r1sitec##remotifconferredgas##tri##nthy##mi##dinepromotersystemthereforefunctiontrueenhance##relement[SEP][CLS]togetherregulationcampresponseelementm##odm##rnaproteinlevel##bregulation##bbetacompensationwithin##b##b at##ftranscriptionfactor##bdelta##balphaabsent[SEP][CLS]thedataobtainedcellularrcelldemonstratedtranscriptioninitiated89##1baseupstreamtranslationstartsitep##lationsitelocated550basedownstreamstopco##don[SEP][CLS]finallyrecognitionpivotalb##preduction##allpressurerelatedcard##iovascularcom##plicationevenamonghighpersondiabetes##llire##nalins[SEP]individualcombinedeffectf##onib##1presentfmonculturematerialdi##to##ci##cirp##rato[CLS]ith##y##hesoccursant##agon##ism##aralphaaction##ukecell[CLS]1396##196##91993tcouldmediatranscription##alactivationinteractionta##tabindingproteinwellupstreamboundtranscriptionfactor[SEP]##rbs##3cbindingregion##ab##1ho##mologyregionadapt76inter##ferre##nalpro##te##ase[CLS]activation##otapromoter##obcontaininggenegene eev##x1[CLS]conclusioninterpretationincreasedhipfracturewoman75yeartypeidiabetestypeiidiabetesdurationduration [SEP][CLS]maternalbehaviorassessedobservation##altechniqueratpp8discoveredstrongactivation##asacutephase##atil##vcomplianceslopeenddi##ast##olic##vedvv [SEP][CLS]achelevelacutepoisoninglimitedlimited [SEP]##as##odheart[CLS]theco##lli##cularlabelfoundinjectionwithinm##stareaexhibiteddistributiondeeps##csubdivisionwhereassparedsuperficiallayerdeepso[SEP][CLS]aloneintroduceddeltalungmoderatelyincreasedsuggestingfur##acouldregulategeneinvolvedpath##ogen##esisthec##az##olinii##i##ricdifferentstudied##abacontentg##ad##abatbrainstem[CLS]sub##lone##sr##15revertedka##ppalightchaincontainedg##eno##micdel##eti##onr##15##nssurroundingintro##n[CLS]thedisorderaccompaniedre##versibleelectro##ence##phachangechange [SEP][CLS]thedelayedactivationpro##ynthpromoterg##ranassociatedregulationupstreamsfactor2trans##amimissingreexaminepro##tractedhe##palate##ncy296amongins35among43he##tero##genegroupvarious464##building4945151 7amonghistorydomesticas##bespeopletradetrade [SEP][CLS]thestrategyusrl##igaadddo##leo##tidep##rim##ingsitersubsequentreversetranscription##rrl##igareversetranscription##rr##lr##t##r[SEP]weanalyzedeffecttub##ulinm##rna##idor##nagelb##lothybridprobe[SEP][CLS]morel##igan##dactivatedinsuliniireceptorp##late##cprotein##it##roindicatings##cproteincoulddirectsubstrateinsulini##fireceptor[SEP][CLS]ch##ime##ratransil4signalbindingdramaticallyenhancedtypetype 2responseil##it##rot##c##rstimulation##ivoantichallenge[CLS]adistinct5sequenceclonealternativeupstreamtranscriptioninitiationsite[SEP]twohumanbeta16##cos##ran##s##fercore2##canbranch##gn##tii anti##gnho##mo##logthreeregionregion cat##alyticdomaincgeneresidelochromosome9bandq##21bi##zenmfmat##te##imgf##uku##dagenededev46##8471993[CLS]higherlevelvitamincat##ala##se##get##arianc63686mum##oll149131m##lmalefemalerespectivelycompared##get##ariansc4133 54mum##ol##ol l119108m[CLS]cuttingin##tra##bit##alnervere##tri##evalimp##air##mentin##disinlid##oc##aineinjection[CLS]developmentalregulationexpressionma##lates##ynth##asegenetransplant[SEP]inlevel##53activationm##d##mproteinp##53observed##ms##1cellexposure[CLS]day1350r##ishowedfallbodyweightrespects##lamaintained[CLS]transcription##alactivationpro##op##io##mel##cor##tingeneam##pelementbinding[CLS]then##f##1memberinteract##edoverlappingsequenceliielementwherein5halfsitecriticaln##1binding3siteimportant##4binding[SEP]rapshownusefulvaccinetargetsiteripinhibitortherapeuticauinfectioninsulindi##abe##ticlevelh##ba##1[CLS]thela##ofgenepromoteractivehumanend##umcar##cin95cellrat##6cell[CLS]the1year2yearsurvivalraterate patientn##03exceededn##4patientpatient [SEP][CLS]measurementspectralsensitivitysensitivity erthushelpdiagnosisthreehereditarydiseasedisease [SEP]##r##1distortiond##pomonitoredsystematicallythreegroupgroupuniqueincorporatedrepeatedexposuretone[CLS]lungvent##ilated##2##oofi##o03endtidalco##2presentan##est##b##f##xetencounterfivecerebralhemispherehemisphere [SEP][CLS]thischangeall##er##gyb##c##g##g [SEP][CLS]analysis1m##bpublishedsequenceregionconserved##yn##tenhumanchromosome##31q##33identified45genecandidateincluding35expressedgenehumanil##yt##okigenecluster[CLS]thereindicationexperimentlink##erhis##tonebindfundamentaldifferently5sbulk##some##s[CLS]kmvalue##lglucoseranged0525mmordermagnitudehighernormal##l[CLS]c##yt##och##romeb##dbio##syes##cher##ichicocolisequence##c##dgenesuggestencomponent##b##cmembranetransport##er[SEP]##k##kkinase98##0##9kinasedefmap##ksactivatedbasal##r##h##rlactivity[CLS]theinfluencegascompositionaircellplivermetabolismem##b##ryochick[SEP]historicallyfirstabilitybindim##mu##nos##pressiveagent##c##los##porc##idyprotransis##omer##ecat##alyfoldingo##ptprop##romayfolding[CLS]thuso##rmutantlocked##43expressionwhereasmutantlocked##43expression[CLS]araret##rnaccregulatet##1elementrib##oso##malframes##ftingessentialt##1re##tro##ns##positionsa##har##cesc##ere##visseveral35mmslided##trosectionmy##of##ibersection##alareatechniquesettingimagecapturesystem##cho##ydrotrans##locationnewselective##ech##ol##ferdiseasefurtherfurthermorelearninglearning theorydepressiondescribeddescribed [SEP]laserexfi##bri##no##alc##lot##tingburstingwe##ast##omoresult##rok##inas##bri##nocrosslinkingintensityvariationt##rremoveddatacorrelationlateral##izedstimulusstimulus [SEP][CLS]routineimagingtotal79meta##sta##sis##sis [SEP]anal##ges##or##phinehem##or##r##hage##eu##erssire##cshock293001986s##tatrelatedfactor##9##3##43extractappearsabsentb##ovfi##bro##blastifgammatumornealphacell[CLS]p##9##3appears##allyrelated##9##1pem##1nekinaseundergodifferentmit##oticresponseeeg##f[CLS]inin additionaddition f##ce##ps##ilonr##1linkingactivate##i3kinasekinase [SEP]whensinglepointmutationintroducedg##cboxe##b##tbox##93foldcatactivityobservedc##8cell[CLS]associationkinasetranslation##alact##iva##4genesa##harc##ere##erevis[SEP][CLS]treatmentaffectmediatedimmediateeventtp##ak##1##ak##3insulinreceptorsubstratei##rs1i##rs2pdbindings##tat##6[CLS]thuss##t##k##1likelyhumanho##mo##loguemmo##15[SEP]backgroundsequencealignmentk##dabelongs##aaclassat[CLS]when##b1proteinsolelylocatedc##op##las##mlocal##izenucleus[SEP]consistentexperimentcompoundcocainepotentgroup[CLS]thesignificancechangerelationcontrol##hos##phorusbalance##umidiscussed[SEP][CLS]trans##fectfirst600b##pupstreamn##uc##leo##tidesequenceindicatedregion75120necessaryal##dhgeneexpressionespeciallyn##f##p##1bindingsite9296##aa##tboximportantexpressiongene[SEP]thisdistinctbio##chemicaldifferencessactivateds##tat[CLS]theresultshow##in##fected3##t##3cell##varo##lcause50reductiongrowthratehighconcentration296##miiaccumulatedc##op##mclosenucleusnucleus [SEP][CLS]bloodco##agufactorxactivatedformfactorxplayessentialrolemid##lot##de##de [SEP]theex##onsequencedetermined##eno##micdse##quencingdifferencepublishedratg##lut##2##a[SEP][CLS]in##tra##cularinteractionbelievedresultformationm##xamon##omerwhereasinterinteractionmayinduceformationlargem##xao##go##mers##mers [SEP][CLS]thegeneend##1proteinphotos##ysiisynthesizedhighratelightorderreplacephoto##damprotein[SEP]thethreeslowermis##bbandobservedresponsecontainresidue[CLS]themaximumreporterproteinattainedtransformedprolonged17totalcellularprotein[SEP][CLS]specificallydemonstrate25basepairregionmedia##tesregulatoryeffectbetaco##l##1##apromoteractivityallowsantagonist##icalphaalpha tbetaeffect[SEP][CLS]sin##4##10componentspecificr##napolymer##aseiisubcomplexrequired##6t##1repressionactivityfoundrequired##1repressionfunctionfunction [SEP][CLS]translationm##oktightlyregulatedso##krso##krthusregulate##shohoktranslationindirectlym##ok[SEP]dependingbodypositionc##s##fpressurevaried20##h##oerect15##hsu##pineposition[CLS]onehour##3##2personalmeasuredsample##rdevelopedlaboratoryshorttermpmpm25cov##oc##sexposuremeasuredcurrentlymonitormonitor [SEP]theset##rfamilymemberunlikeothersdateidentifiedwithin##eno##micdatabase[CLS]weh##y##pot##hessubjectwouldp##karhopsteppingp##karcentral##lyadaptationgeneral##com##ototrajectoryspecific##com##otionusedrotatingdiskdisk [SEP][CLS]instudytranscription##alfusionconstructedx##c##ppx##rgenela##czreporter[SEP][CLS]mechanisminsulinreceptor##3##t##3transreceptoronech##ricreceptorcomposedextra##cellulardomainhumane##greceptorc##osodomainhumaninsulinbetasubunitsecondkinasedefinsulinreceptorpath##ogen##eticproved##th##romii##iconcentrated##ag##gat##bro##nect##ras##yl##olcomplex##oper[CLS]stimulationend##ost##ealboneformationratemainlyimpairedddepletedresultingt##rab##ec##ularbonelossdmotherratassociateddecreasedboneashtotalbonecalciumhem##atopro1##k##1membermit##ogenmapmap4##kupstreamupstream act##ivaterminalterminal kinasesignaling[CLS]we##ico##l##ty##lt##ran##s##fer##asecatreportergenesystemstudyeffecttterminalrepeatl##slargehumanend##ogen##trolikesequencer##lh[SEP]toinvestigatepossibilitysplitvisualstudymanipulatedstimulussetrecognitiontaskexposuredurationduration [SEP]effect##rinestresse##pidan##estfinallyconservationresiduesensitivemutation##9##4##9##9##53##11ho##mo##logresiduedomainplayimportantrolestructural##chan##isticaspectcommonproteinbasedrequirementc##rem##rr##ad##bproteinsperm##ato##genesisdeterminedexpression##d##c##c34##ad##ris##of##ormss##1subunit##l1##l2associatedactivitytest##iculardevelopment[CLS]theen##igmaagingbonelossloss [SEP][CLS]transcriptionfactorii##ict##fi##iirequiredassemblypre##tiacomplexrtrgenecontainstwose##ablecomponentt##fi##ii##1ttfi##2recognizingkeycomponentreceptorpathwayincludingereceptorp##dreceptorbeta##rs1[CLS]thesetwoenhance##relementalsoenhancedtranscriptionfusedseparatelybasalpromoterregionchickenv##iment##ingene[SEP][CLS]whenexposedintermittentschedulepunishmentfixedintervalfi120fi300si##b1participantincreasedlevelsimilarobservedbase##line##line [SEP]deepbitec##liididiv[PAD] [CLS]patientbin##ularpatientbalancedbin##ular##ulatelosswithoutrap##dpatientmonpupilagematchedcontrolcontrol [SEP]proteinse##quencingelectro##4##4748membernuclearfactor3##3transcription[CLS]p##4belongssubfamily##n##f##3beta##4748bindingincludes##f##3gammaincrosscontrolledmalevolunteerdonatedoneunitredoneunitwholebloodmanual3monthapart[CLS]promoteractivitytranstransl##uc##ifer##asereportercontainingnest##eddel##eti##onupstreamsequence##pecell##40wells28he[SEP][CLS]thissystemexploitlatetranscriptionterminationsignalsufficientlyweakallowmanymulti##gen##omelengthprimarytrans##criptrepeatingintro##nex##onp##olysite[SEP]plan##llarregionaccordinglit##tmanmethod312##ecchronic125agerematcheddiskphotograph[CLS]althougheliminateddel##pcomponentdownstream##pgrowthm##orabnormalcell##r##1##prescueddelknownp##omoresponsepathwaycomponentsouthernhybrid##enodwll##b##ryospecificrear##rang##ementnear##1lo##cusnorthernr##nab##lotr##t##revaluation##1##1mwllem##bin##dis[SEP]inin addition##171combinationmutationaffectingmitochondrialcauseddefect##ivep##hen##otype[CLS]expressioncharacterizationg##eno##mic##ak##1kinasegene[SEP][CLS]significantlypgeneseveralfeaturefoundhumangene[CLS]fluorescentsithybridfishanalysisregioninvolved##k##brear##rang##ementoriginated##q##34thusimplyingoccurrence710q##34q##24re##p##ro##calch##rom##oso##maltrans##location[SEP][CLS]transexpressionsub##lone##iglocalizedtransactivefactor30k##ilo##base##ba##ifragment[SEP]mg##fmember##okiregulatedtranscriptionfactor##hdomain##rsproteinfunctiondominantin##hibitinsulinsignaling[CLS]a29425k##bsegmentarmyeastcontainstwicemanyunknownknownopenreadingframe[CLS]##rra##ngedka##ppagenetranscription##allysilentstructuralfeatureka##ppalo##cuscontributetranscription##alefficiencyrear##rangedkagene[SEP][CLS]thefirst270b##ppromoterregionsequence##dcontaincat##aaboxrathertatata##aboxseveraldmotiffoundactivationgene[SEP][CLS]cg##bracellcontaining##b##f##1geneinfluenceshutpromoterte##choarrestedgrowth5hcultivationdrugdo##cline[CLS]##1utilizesma##xikho##mology##mology ma##xi##hdomainrecognitionstrandedb##psrequirescooperativeinteraction##licingfactor##65boundadjacent##idtractpphighbinding[CLS]anxlinkedzincgenemappingx##q##211q##213closelyrelated##xz##fypossibleorigincommonancestralgene[SEP]validityformq##ifcorrelationmotorusinganalysisvariancemotorlevelmotorgroupinggrouping [SEP][PAD] [CLS]juvenilean##gio##bro##mascommentcriticalbehaviorbinarymixtureproteinthepine##alhormoneme##oni##nm##ltableon##cos##tatactionamount##12##0specific##pasgapassociated##0additionaltrans##ec##neliminatedremainingsi##g##mo##idalcorrelationmapr##s##naincreaserestingmapr##s##na[PAD] [CLS]pregnancyensued4casegroupii [SEP][CLS]the13k##bdplacedupstreamch##lora##lace##ty##lt##ran##s##fer##asegeneshownfunctionalactive[CLS]controversyregardingnaturallifecycleparasitewells##pec##ieidentityopsa##rc##oc##ys##tis[SEP]themean66mmlasergroup63mmcontrolgroupp##os##inhighbloodpressure[CLS]5##3antagoniston##dan##set##ronreducedalcoholintakemediumhighalcoholratdos00100 16mgkg[CLS]oralh##gly##ce[CLS]11 [SEP][CLS]insystemenhance##ractprimarilyincreaserapidefficienttranscriptioncomplexformationinitiation[SEP]relationshipdonorb##tra##nshe65surgery[CLS]byse##quencingex##on##uc##leaii##idel##eti##oncloneopenreadingframe405n##leo##tidefoundcodingprotein135aminomolecular15k##da[SEP][CLS]the##igeneover##exes##cher##ichico##litreatment##terorejection##t##3[CLS]theleveltranscriptionact##iva##torgreaterlevelindividualfactorphenomenontranscription##als##yne##rgy[SEP]conservationzincfingermotifyeasthumanimpliesfunctionalimportance[CLS]thisnuclearorgan##ella##rgenetransfereventstrikingsimilarexperimentalaccessiblenuclearintegrationintroduced##log##ousd##na[SEP][CLS]resultdatasetsinglesamplemodelconfirmedgiveexcellentest##imationmgm##lxmin093xc##3##h00 47m##pe##pe 44 4r##ms##mse##e 899 [SEP]s##3##acompetes##3domain##rbbinding##1inter##sect##inm##1complexcomparisonrtherapeutictechiidivisionimm##alo##cc##lusion[PAD] [CLS]thisshiftc##1c##2effectco##llapronouncedma##ximal##1##2134##pma##ximal##1##279[SEP][CLS]weexercises##tsegmentelevationhistory##oc##ardin##far##rican##eur##yscausedco##rona##ryspa##smmajorco##rona##ryvesselvessel [SEP][CLS]x##r##3transcription##allyactivatedwsignalinggas##tr##ulationx##enoem##b##ryo[SEP]forfor economicalcouldsendquestion##naire3577##9individualbasedinvestigations4000mens##tra##ti##fiedhighrisklowriskgroupgroup [SEP]severalwave##mat##osen##20n30##20##0brainseiiiii##i idemonstratedshorter005late##ncygrowthre##tar##dedf##etusnormalsizedf##etus##etus [SEP]effectch##olinma##rispro[CLS]sequencetwoknowntailgenerstemperatebbact##oppp2sequenceadditionalopenreadingframeor##f30locatedsdetermined[SEP][CLS]thehighat##rialse##pta##ptaldefectte##tralfall##otcitedpossibleanalogyright##ric##ularpressurehighrightcompliancelowbirthbirth [SEP][CLS]thestress1resultedmildrespiratoryinfectioncalfdifferenceobservedtreatmentgroup[CLS]solutionbolt##zmanequationrandommagnetic##hsignalinteractingreceptor[CLS]##linkexperimentelementbrevealedspecificbindingtwoproteinapproximately4380k##da[CLS]resultatshortdwelltime##re##ctedwholeduhighercorrectedplasmavalue57599 [SEP][CLS]therecoveryx##nin759averaged41coefficientvariation25theextraordinaryhighsubstratespecific##putogetherenzymegoodcandidatestar##ch[SEP]relationship##mu##munologicalchangediseasestage3##h##mi##dineincorporation9stagediseaseex##ace##rb##ation2088stagere##missioncomplementtreached46645280unitm##l##l [SEP]dos##d##d pageband22k##da[CLS]consistenteffecttranscriptionp##21localizednucleustranscell[CLS]analysispseudogenesegmentre##comb##inationproductrevealsbiasdgenesegmentreadingframeu##til##ization[SEP][CLS]plasmapro##ct##in##bation25823ngm##ldecreasedbaselevel10819ngmwithin24h##rnest##boxremovalremoval [SEP]30weekam##if##osttherapym##dswitched##m##llikeappearance##if##ost1monthmonth excludeexclude possiblesideeffect##if##ost##ine[CLS]heartdiseasedisease [SEP][CLS]anewbcellspecificenhance##relementidentified33 e##4o##ame##rl##ikemotifenhance##rconclusionexperiencemiddletermefficiencyg##kstreatm[CLS]casepoisoning##con##vatorigindescribedgeneticmutationlosstreceptorfunctionshownl##ymphbreastcolor##ec##ectal##p##1##oest##erdesignedcombinedo##culardeliveryde##xa##hassodiumphosphate5release[CLS]wedescribecell##inbetasubunit##ak##bcontaining96base5##tra##ns##latedsequencesequence 64##5baseopenreadingframe1832base3##tra##latedsequencetwoconsensussignalsequencetwostretch[CLS][CLS] br##omepolymer##aselike2##adirectedend##oprehe##licalike1##a[CLS]diagnosticimportancedetermining##ucamino##fer##cre##ati[CLS]therapeutici##od125##yper##roidspecialradio##bioeffectf##oll##icularcellcell [SEP]maintenancemeta##bolenergyenergy me310k##calkg[PAD] [CLS]thisfindingimportancecompletecompletes##s explanationcentralnearlocationerrorpartialreportbarprobetasktask [SEP]dbindingidentifiedbindtwotargetlikesequence5flanksitebreak##pointchromosomechromosome 8patienttl##ymph##uke14q##24q##11rear##rang##ementiichromosome1threefive114pq##11rear##rang##ement[CLS]ne##do##rom##ilshiftedearlyall##ergicreactionearmean34869in##hibit##edlaterreaction3000 4the##r##1proteincontainskmotiffoundrbindingr##r##1bindspecifically##r##2r[SEP][CLS]resultobtainedt##rit##iumtestdirectchemicalanalysiscompared[SEP][CLS]wean##estparalyzede##pdependentdeltacpatterntransitionendingcontrastlevellevel [SEP]experimentclinicalbio##chemicalhis##to12dayperiodz##osagiven[CLS]directsat##urationanalysisanalysis [SEP][CLS]fromas##ympreviously##4interact##valentpossiblyoverlappinghalfsiteatatdifferentaffinityfurtheral##dos##tero##nes##tisodiumdietchildsevereprolongedvomitchildsyntheticactchildstudiedmodifiedmethodmethod [SEP][PAD] [CLS]acasecontrolstudy12182pairhe##paa##p##ril19881988 [SEP][CLS]themutantstraincarrythreetandemcopy18b##psequencedu##plicate##d##di##6##6mutation[SEP]althoughc##aencodinghumanform##ylbinding##ou##laytambr##chov##aisp3##t##3##brohigh##rbearingdel##eti##onregionrichacidicaminoacidacidicregionil##rbetachaininducetpmapkinasewellexpressionthree[SEP]moleculeilinhibitorsuppress##k##r47##3##r308site[CLS]thecar##cincontainshybridgenedeltagagm##htcon##ti##guousopenreadingframe26##8basepairwellmy##cahelp##errelatedsequencedeltagagpartialre##alcoreproteingenevm##htcelldrive##dsequence[SEP]theresult##tre##atedpatientdemonstrateprimarybulkreductioninitial##aro##tom##y[CLS]of38##41serumsamplereceived##ness##eestatediagnosticlaboratory19911992113##0positivepositive to##x##opanti##body[SEP][CLS]theseexcludedfactorproteinlikelylocatedalonglengthna##scenttrans##criptgrouppatient939i##ulsexhormonebinding##bul549nm##olconcentration7111##u##u l2600 70nm##olrespectively[CLS]wecompletedprimarystructure##bri##ucex##onintro##norganizationgenederivedphysicalmapgeneticlo##cusb##c##lp##ozdomain##ozdomaininteractcore##press##orn##rs##m##rt##oki##cam##1##oth##eliutilizesinteraction##tero##di##mer##ic##rf1[CLS]m##fmalereceivingeither50mgkgc##d##pdose30mgkgr##odoseexploredobjectoftenmmmalemale abstractabstract t##runcated##runcated at250word[CLS]insightnovelcheckcharacterized##vilo##cussequencesimilarity##hesion##goimplicatedprocess##elinquestionlocalizedbi##uda##lcenproteincontainingkdomainrbindingmotif##r##1##2encodingmembermamaf##k##g[CLS]indigenousmicro##bialfloralargein##test##ineta##d##polecopyright1998associationbehaviourbehaviour [SEP]intissue##tro##nathy##roidrespectively##4diversetissueincludingoovarytestad##renaplace##ntathy##musspinalcord##roidwhereaswhereas lmuscle##ntaspinalbrainsubstantiallyreducecasehe##paframeworksuccessfulintroductionfutureadolescentau##lia##lia [SEP]techniqueidentificationphasecontainedpolymerblendpaperradioactivehem##ody##namni##russs##n##p##tronntdeepen##f##ranecontrol[CLS]theircentralprojection##xonfourt##emsub##i[SEP]the##kact##ivamixedlineagekinase3m##3transforms3##t##3cellfashiondecisionsupportsystemnetworkcorereachingdiagnosisoptimalreachdiagnosisdiagnosis [SEP][CLS]indreplicationsubstitutionlargepreventcomplexformationh##70##bprotein[CLS]toexploreeffectpersistentcard##io##gal##y##iovascularnewbornratinhaled500pp##mco33daydevelopmentcontinuedambientair[CLS]bandwidthauditunit##bra##infieldl##vcomplexmeasuredis##oint##enstonestimulus[CLS]members##idhormoneregulatetargetgenetranscriptionviarecognitionassociationspecificc##iactingsequencedcalledhormoneelementh##res[SEP][CLS]indeedde##xenhancedr##adependentincreaser##ar##bet##am##rnamanner[CLS]thehighestconcentrationmineralfoundoverhaultruckas##besinsreachedvalue5fcm##3totaldustvaluevalue 80m##3em19day##ryo##ortblood[CLS]c##51##1965identicalhuman##51codingsequenceinterruptedintro##nsixframestopco##donresultingpointmutation[CLS]weachedecreaseindividualsampledtanksa30temperatureincreasethree##40differabilitybind##aeffect##or##al##0subunit##i3n##rcellmutanttransform3##3[CLS]matingresponsefcorpuslsizeg##esta##estationlengthratela##mb##ingratelabirthrecordedrecorded [SEP]membraneadifferencedistributionanti##bodythy##rog##bulthy##roidper##ox##idasfoundsubgroup2heret##r##d##48##d##28##imls3##3[SEP]##3##gamskeletaltissuedroveinvestigatedifferentiationin##obshowedincreased##aexpressiondifferentiationinduction[CLS]therateii##ica##ftherapy6153252littlehighertwotwo [SEP][CLS]theseresultinduceput##ativeta##taboxin##iti##atorinvolvedpromoteractivity##it##rone##ct##inpromoterlacktaboxin##iti##ator##cboxinteractiontrapcandidateproteinbind##opregion##rtrans##rane##aseisolated##aencoding286##1aminoproteintermedtriocontainsthreeenzymedomaintwofunctionalfunctional g##efdomainproteinseth##kdomain[SEP]weisolatedtwo##19econtain##f##4correspondincompletecopyunique23k##br##nacombined##it##roeffectethanol##ih##lonep##ob##ar##bit##al##zodi##sul##fi##rambrainmicro##sobeta##1ininte##tegstimulationcellbind##0##cas[CLS]earlierlocalizedmutationaffectprocessingtransporther1regionlocatedgenespecifybmajordbindingbeta8[CLS]theseresultb##p##aen##codesfunctionalf##elinlbktypeexpressedcellviag##ly##canlink##age[SEP]tweightchoicerecognition##c##rosis##unate##unate [SEP][CLS]analysishe##tmutations##pstrain71##20##licasecondarymeta##bol##iteregulationhe##tero##stspa##cing[SEP][CLS]herecomponentrmap##kpathwaycon##it##utiveltransformedim##matthy##mo##s[SEP]putilizes##rbadapt##ormediaactivationp##21##athy##mo##blastlinepromoting##cproteincon##utiveinteraction##rbre##8##10##11genegene fiyeasts##chi##zo##sa##cc##harspecific##iot##icre##comb##8requiredchco##mopairing[SEP]basedresultanalysispredictb##uddinyeasta##rsen##ateresistance##r##3pcat##alyticsimilar##c[CLS]firstininjection375mgproservedinjectedcon[CLS]weh##vachievevalueco##2eliminationcloseestimatedmetabolicco##2normal##int##ubasubjectshortperiodtime[SEP][CLS]thep##ho##5geneactivated##4##ptranscriptionfactornegativelyregulatedproductp##ho##80[SEP]althoughauthoritativewaydetermineeffectdiet##hfeedingprotocolmeasuring##rina##ry[CLS]analysisdsequenceupstreamgeneen##codessecondni##trateresensortransmitterproteines##cher##ichico##lirevealedopenreadingframe##fwhoseproductshowhighdegreesimilaritynumberironsulfurwellbetasubunitsubunit g##ama##tes##ynth##ase##dco[SEP]##oth##eli##alpu##rinecontent[CLS]suggestresponsetypeiiico##lla##gencausedcrossreactiontypeii##ico##lla##genp##eptide##eptide [SEP]possibilityl##imlaboratorydiagnosisr##abi##esthe5halfegenefused3regiongeneencodingdbindingdomaintranscription##alregulatorincludingat##f##111 erhumantumorp##dstimulatec##d##kme##sang##ialdecreasedlevelp##1inhibitorprotein##po95theinfluencedifferenttemperaturedegreecdegreec##agu##rostudied##lottimetime[CLS]onr##c##lvalue23controlregionstudiedgreatestdifferenceposteriorbrainregionassociationcortexprimarycortex##iet##alcortexth##ala##mus##mus [SEP][CLS]thustrans##geneexpressiondirectedhumanr##bpromoterrestrictedsubsettissuer##bnormallyem##b##ryo##genesis[SEP][CLS]thustax##1activate##smediatedtranscriptionwithoutmitsignalinteractionbindingfactorp##s##rf[SEP][CLS]inexperiment1subjectrequireddisc##rimmalefemalefacehem##is##phericas##ymfoundfound [SEP][CLS]membranede##polcriticalelementne##uronsignaling[SEP][CLS]thetranscriptionstartsitelocalized224b##pupstreamat##gco##donr##nas##eprotectionprime##rextensionmapping[SEP][CLS]allco##gnategenecloneconstructedusingeitherp##rproductam##plifiedg##eno##micdgaprepair[SEP]rising##troonechildi##g##mserumserum [SEP]effect##ob##arielectro##card##io##yper[CLS]althoughr##ad##17##ad##24##3requiredcellcyclearrestsphasein##hibitcontributeyeastcellpossiblyrequiredddamage[CLS]##aimportantintermediatedegradationsynthesiswellfunctionregulationinter##media##rymetabolismgeneexpression[CLS]##1la##czstudyp##1spatial##lylocalizedpre##stal##kanteriorlikecelltypetype [SEP][CLS]whentranslatedframe##kz##etastopco##donlocated28aminoacidtowardsterminusdiver##gencepointinter##veningsequencelackexpectedin##iti##atingps##i##kz##etafunctionaltermproteinsynthesis##lotdirectedcterminuszrevealproteinsmallersyntheticpsrfailedsupportproteinsynthesistranslationsystem##ro[SEP]w##usteroo [SEP]electricalundcompetitionconvection[CLS]thesequenceimmediatelyupstreamtranslationstartsitegcrichgreater75containedconsensus##aa##tsequencedespiteabsencetabox[SEP][CLS]theseconditionmaydetermineincreaselevelindoor##utatobaccosmokegascoolingetcderivedmitdomesticcock##roach[SEP]neverthelesslowerdosaloneactivity100250mgkgb##1b##6125mgkgb##12pdosedependentpotentantidi##lo##fen##ac[CLS]foro##3correlationweak##estwinterresidentialmicro##on005strongestsummeroutdoor##on091changeelectrocontentbrained##emaacutedrug##yper##tens##bino[CLS]likere##bb##d##3bindmon##omerdsequenceconsistsspecificatrichsequenceupstreamconsensushe##xa##mer##ichalfsitespecifiedpboxdbindingdomain[SEP][CLS]inho##lod##t##fi##ialbindt##b##phighaffinity[SEP][CLS]over##exwildse##scmutantth##ior##ed##ox##inred##uccorolese##ys##teincat##alytic[SEP][CLS]biolesrevealedginflammationnumerousse##pta##teh##y##pha##pha [SEP]westernpre##b##ulatesspecificallyg##h##3cellnucleus[CLS]twogenefamilyencodingclone##dsequence##danalyzedse##rinekinaseactivated##1##d##hsdependentautorelated##65##20[CLS]thede##ducedgeneproductsequencesimilarityyeastpro##karr##napolymer##asesubunitinvolvedsubunitassembly[SEP]maximumho##lo##zyachievedinclusionp##las##mi##dtenu##rop##or##rinoii##imet##hyl##tra##fer##aserequiredsynthesissir##emco##fahem##op##in[CLS]enhancedand##rogen##co##tic##teroreceptordependenttrans##actalsobasaltranscriptionsregulatedpromoter[SEP][CLS]thehumanproteinbindstronglyssh##3domain##b##lprosuinmethod[CLS]t##ospaffectinteraction##c##rmultiplesignaling##rreceptor##ostrans##duction##duction [SEP]weshownhumancellcloselyresemblesproteincompositionfractionprofileprofile [SEP]1985patient##cinmit##omy##cin15mm2flu##oro750mday15f##u750mgmalonedayday 25radiationtherapy3000c##gyday728forgivenagehighstressed##aristend##onhigherfatiguelowstressedex##tens##ortend##oninin addition##k##1tbetastimulateactivity[SEP]foam##sexpressgagproteinprecursormolecularmass74k##da##r##7##470k##dac##vedproprote##ase[CLS]resultsuggestleastch##lor##opliketgenewheatm##ttrans##cribedtrans##criptundergoingprocessingposttranscription##almodification3##aadditionproducematuretmayparticipatemitochondrialproteinsynthesis[SEP][CLS]ifhowever##oc##ard##ialstunningsevereinvolveslargel##vthusimpglobal##vfunctionreversedin##ot##ropicprocedureprocedure [SEP]##8[CLS]differenttype##rbrear##rang##ementpatternimp##rbasedc##lon##ality##rbaseddetectionresidualdisease##rbgeneanalysisanalysis [SEP][CLS]undercondition##atlit##hium7daymodifyh##yper##omo##tionproducedam##phe##tamine[CLS]sixpatientunderwentelectro##phy##siostudy[CLS]ratmultipleoraldos##ageregimegiven13dayadministrationb##ol##usdose14##cday14multi##varanalysisanalysis t##wacorrelatedagel##vfunction00002occurredoften##rio##rmibonema##rrowfi##bro##sisserialpro##co##llaii##iserumanalysis[CLS]as##thdiagnosisaccordingasguide##line[PAD] [CLS]ch##ar##cotjointjoint [SEP]ideal##izedrealizedoveralltreatmenttimetime [SEP][CLS]nonsuppressedthy##roid##alradioactivei##odrthy##rot##oxphasecasesubthy##roid##itis##roids##ti##bodyt##sa##b##b [SEP]ultraimagingusuallysimultaneous18ffd##dgt99studystudy [SEP][PAD] [CLS]bilateralre##nalon##adogdog [SEP][CLS]ungeneactivity##romastructurepromotermutationin##act##ivatetranscriptionyeastgenewithouteliminatingfreeregion[SEP][CLS]ec##y##cd##1proinledre120k##daform##cc##d##kprecedingre##sumptioncycleprogressionunliketrulyspecificnaturala##re##pitle##gene##oussuitabletargetselective##ap[CLS]becausemutationmappedpreviouslyvicinityetalphareceptor##rgenechromosome11h##hes##hen##otypedefecteitherexpressionactivityactivity e##r[CLS]regioniincludestwoc##ys##teinc##teinzinccomprisedbindingdomaint##pi##fiessuper##familysouthernzoob##lotanalysis##23conservedgenomemas##pec##ietestedyeastrde##ter##minarequiredl##4mediatedat##uation##10ropes##cher##ichico##po##do##rug##9cellprovedsuitablecellsystemstudy##r##3showcelllineline t##op##lusninit##b##14highfivecellallowslargefunctional##comb##r##3[SEP]intervention##operdeterminationbio##chemicalmarker##k##km##b##t##card##io[CLS]atfirstphase143m##m##mn110ml##nh##y##pot##hala##micco##rt##icalresponseresponse completelyin##hibitformation##cresponselightstimulusstimulus [SEP]6320mm##300##586ininmatecount000mm##3compared1400000001thereuncertaintyresultobtainedexperimentlandscaperegionalgeneralecosystemtypeprocess[CLS]thef##ili##tationstartedprecedingonsetelectro##mymass##etermusclemuscle [SEP][CLS]therecruitment##it##utive##uactivatedmitproteinmembrane##fiinteractionsitephysicalmodelintegratingassemblymit##ogenictransmissionsignal##os##etondel##etiacidresidue267##1postinteractp##30##0##binhibitor##1whereasdelresidue120140effect[CLS]quantitativet##l201analysisviablemy##oc##ard##iummildmoderate5185i##versible##l201defectdefect [SEP]pointmutation316##38analogous##kextra##cellularsignalregulated##makermutationbinding##p1substantiallycompromiseseffectcat[CLS]jca##usalcombinetheoryresearchinterpretationdatapossibletheoryadvancingspecificpracticepractice [SEP]intrans##fusionhetreatedl##ymph##ob##lastinter##fer5mmthreetimem##o3mm##2threetime410m##oderivedr##aresistantn##t##2d##1r##1def##icientactivitycoresistant##is##p##lat[CLS]b##r##b##leltransformation##brohem##ato##poblocka##pop##okide##p##ri##vationfactordependentcell##letsequenceanalysisregionshowedcontainedfivepotentialcopys##tero##lregulatoryelementelement s##re1sroos##bornegg [SEP][CLS]mutationsa##har##omyc##ere##visblockme##iotprop##has##hasechromosomemetabolismcyclearrest##yte##yteneidentifytwonew##iosspecificgene##1##3isolationcharacterizationhumanor##th##olo##gs##4complexsubunit[SEP][CLS]thusleaderproteingeneproductunknownfunctionhighlargeintermediatetimeinfectionabstractt##runcatedat400wordword [SEP]conclusionla##tano##p##rosadministereddailyreducingi##op##op##ros##toneadministeredtwicedailypatientoh[CLS]thedynamicinsightconform##ationalflexibilityanalog[CLS]in##fainsectcausedmortalityevaluated[CLS]thereforeagerelatedchangeserumle##pt##inlevelrelationshipad##ip##osand##rogenlevelgroupcommunitydwellingmen[CLS]injectionp##dsolution1362238gliterglucosereduceding##est##ionsu##c##rose4233611 respectivelyaffecting##estproteinprotein [SEP]areacorrectionbio##e##qui##valence##trasvarclearancesuspected[CLS]expressione##2proteinrapidrepressionexpressionfollowed12hlaterprofoundin##hibitioncellulardsynthesis[SEP][CLS]plasmare##ninstagekidneydisease[SEP][CLS]##nob##lot##ot##osmanyyeastproteinincludingpp34##d##28kinasebecameptcell##rc[SEP]##nalco##omb##shem##olyth##rom##ph##re##rect[CLS]pre##tre##atratdifferentdoselevel##l##4resultedpro##longt##mohalflifeincreaseareacurvecurve auaucdecreaseclearanceclearance apparentvolumedistribution##ddecreaseddecreased [SEP][CLS]cohighlevel##38map##k##k##k##3together##38##ksignificantc##y##c##lind##1expressionauto##gra##grafted##r##1related154rerelaprri583653yearyear [SEP][CLS]administration##r34##23##ort##icbloodincreasedcardiac##est##ero##idco##rona##ryo##cc##lusion[CLS]theprimaryconditionacceptablehospitalexhaledvolumemonitoringpatiento##2monitoringperformedsettingfi##ocontinuouslyfi##olevelcriticalthe##ho##1geneho##momar##agbindingyeastsa##har##ere##erevis[SEP]aregardshortstatureprovedsyndromerelatedlevelso##mat##m##c[CLS][CLS] 2[CLS]men##ru##allunarcycle[CLS]h##bo##bo markedeffectenzymelungso##dincreased47##p##xactivitydecreased33brainlung[CLS]s##cticordering[SEP][CLS]phylogeneticanalysisyeast##vert##ratemultiple##mmal##ofgenedu##plicationlikelyoccurredearlymeta##zolineageproteinproductdifferentlo##cusrelativelydiver##gent##gent [SEP]hard[CLS]thushirarerepresentsnewtype##aresponseelementrolem##od##ulationexpressionm##h##cclass1familygene[CLS]wefoundmultipletranscriptionstartsitelocatedwithin15basepairregion205basepairupstreamtranslationstartco##don[SEP][CLS]duringthreedaymeanurineo##smou##os##mfreere##ab##ptiontseetexttext [SEP][PAD] [CLS]thestructuralin##test##inaldefectpresumedresultdefect##iveco##lla##gensynthesishereditaryconnect##ivetissuedisorderdisorder [SEP][CLS]rerevalthoughin##dom##acrolec##lo##ox##gen##aseproduct##thresponseconsideredasincidencebetathcarrierdeferglucose6de##hy##dr##ogen##aseairarea[CLS]both##bc##bbindspecificallydeltae##3an##ato##mic##alconsiderationtrans##oidh##sectinteractiontwopairinvolvedassociationz##2##cf##1##otwhereasoneionpairfreecomplexinvestigationas##ym##metric##alinducedyield90s##r90##ybetai##rra##diadl##ani[SEP][CLS]an##1nullmutantviableshowedslightreductiongrowthstrainserumlevelall##ergicsubjectsubject [SEP]##gebinding##oc##op[CLS]productcanonicalla##gli##gli dadintegrationend##learecognizecutinsertionsiteoptionalsequencefurtherb##mi##1proteininteractinteract [SEP][CLS]indeede##ct##op##4a##ero##biccellresultedpartiallycon##it##utiveda##1[SEP]weelectro##myrelationshipcagedi##aph##rag##bs##truct##pchainmhybridprobe[CLS]identificationput##ativeinrpm##i##ltop##eronflankedlonginvertedrepeatmy##co##pf##er##ment##ansin##co##gnistrain[PAD] [CLS]standardized##an4710year33 410year1970s##i22 81##urotoxicityflu##dar30mgmday##os##ino##side##rac00 5gmm2hour26hour5daynew##uke##lasia[CLS]evaluation##oc##ardin##farlossp##rb##10bindinglosstransforming[CLS]theanalysisresultse##rop##valencel##ymeb##rel##iosdogk##os##iceregionne##gli##gible[SEP][CLS]insulinglucose135114423120mrespectively3exhibitingpeakleveli##risbindinginfluencehigh3##idper##ox##idathepro##ilo1label##uroradioresultidentificationtwomajornovelst##osp##lationsitey##23##9##24##0[CLS]dominant##f##1mutationisolated##ro##uta##genesis##mi##dcontaining##f##1gene[CLS]thetens##ilestrength##hesive##uti##sin##aviaex##ovden##tindecreasedzincion##top[CLS]highlyconservedconserved lxxlfsequencenearcterminusp##6domaingagprecursormajormotif1##r[SEP]down##re##gu##lateinter##fer##re##guproliferationn##f##3##b##3domainmass3446##cos900goodnlinkedsiteaverage210##0[CLS]wespectrumpchestsoundcontainedentirelywithinrot##ocnoisethehumancaca11geneappearslocatedsecret##ortypealpha1##uc##osy##lt##ran##fergeneclusterf##ut##1##1 f##ut##2##2 f##ut##pdsitebindinggene##bchromosomechromosome 193[CLS]anan##oe##r##xiama##zin##do##lsuppress##esfoodintake1s##ti##mulatingbetaad##rene##rgreceptor2in##hibitfeedingcenter3s##ti##mulatingsat##iet##ycenterh##y##hala##mus[SEP][CLS]thesesegmentmayrepresentpseudo##gene##s[CLS]thefusion##1m##ds##1frameadd127co##doninterrupted##1[SEP]inanti##bioticr##n##ae##ro##bicfungusneo##cal##lim##astfrontalr##k21examined[CLS]w##b##cdifferentialse##gbandl##ymphmon##oe##os##as##ousuallyshowedlognormaldistributiondistribution [SEP][CLS]o##go##mer##izationdependentsubunitfolding[SEP][CLS]chromosomespecificsts##s27te##loidentified196t##ya##cssecond##11suppress##1miss##ensemutation##1##32##1##f##1delcalculationenergylevele##1transitionparviolationinterventionphysicaltreatmentcreatewoundtissueenvironmentcon##vehealing[CLS]thisk##daproteincontainstwos##h##2domaininters##h##2domain##al##phas##h##3b##rho##mologydomain##al##phareplacedunique6aminoacidsequence[CLS]##ydrode##duceda##4sequencerevealedfourput##ativemembranespanningalphahe##lix[SEP]trial##al##cona##zocsuperficial[CLS]studydoseconmplasmahormonechangerelationcirculatingdnor##ges##tre##rad##iolconcentration[CLS]here##withcps##accoulddiagnosedpositivesample##lo##fen##ilpro##ct##insecretreo##est##rad##iollevelmightreducedth##rom##boe##mbo##lisbr##omo##criptin##hibition##ation[CLS]relationshipso##manin##itationat##rd##zat##rs##c##pdos##age[CLS]thebrainbi##sect##edt##1t##2relaxationtimedeterminedrightlefthemispherem##rs##pect##rosdi##sse##ction##ction [SEP]simulation##ort##icitcertainstressdisplayedinteractioninteraction [SEP][CLS]inpresentstudyreportentireg##eno##micstructure##1consists19ex##onspanning400k##bchromosome##p##15northernr##nab##lothybrid##ization##ization analysis1specificsequencesequence rexperimentcorrespondingmmrnaexpressednormals##ple##ennormalthy##musvarioustlline[PAD] [CLS]investigaterecognitiontasktwostringletterpresentedse##quential##ly##ly [SEP]k##ettimodularfizdiscregioninsect[CLS]##zychemicalstructurepromainlyconservedterminalparttermed3cdi##9##c3ucontainingdistinctivermotifestablestemloopsinearr3terminusconsiderablylestablestemloopsiiformportion3c[SEP][CLS]thisreviewchroniclechronicle characteristicdeliberateaccidentalmasspoisoningoccurredworldwariiib##hop##alhistoricalcaseincludingmodernwarwar [SEP]theeffect4week##los##por##in7mgdayc##yasurvivalvascular##ochgstraindadonor##wirecipientpresencesignificanceimmunetolerancegm##od##ation##mu##nos##pressexamined[CLS]incorporatings##ten##tpostp##ivo##tbase10expansioncom##surerealizedcom##pressivecom##ralstress##ing250150k##pa[CLS]1meanz##r0946group2meanz151727normalkidneymanmann##n w##hit##neytesttest [SEP]hospitalhospital serviceservice [SEP]freefractionatmeasureddial##ysattreateddepressedpatient5499 82699[CLS]differenteffectre##ox##genelectrical##ric##ularmuscle[SEP]meta##statict##umourboneni##ger##ian##ian [SEP][CLS]##in##conxdemonstratestranslation##alrepressionabsenceconsensusrbindingsequencesequence f##2presencef##2recognitionelementwithinmpotent##iatetranslation##alrepression[SEP]class00 obtained33##42classii iifindingbelonged##1patient7676 79509classifiedhihii##i i2classclass vv [SEP]however##pleremovaladjustmentriskfactordetermineddetermined [SEP][CLS]virginpildetectedurine52child##ye##ph##ritcompared00##1determinedcompletec##asequenceratoverlapping##11clone[SEP]settinghospitallaboratoryunitedsubmitis##olate##d##co##ct##obe11991se##pt##em301992[CLS]theterminalsequencesequence hergenomecontainspromotergenelocatedrepeatsequencelcomponent[SEP]indo##kdo##klack##x##pmotifcterminusbind##aproteinupon[CLS]theseobservationk##rcapablemapkinaseactivationtargetpthusnovelmechanismm##od##ulating##amapkinasesignalingpathway[SEP]g##f10startedday1withinmedianday12102210x109lmedianday10180##let##let 2000 x99 ll iplate##lettrans[CLS]ahigherchildcerebralmalaria40cerebralmalaria29control20serumf##rit100inflammations##t##tf##r73mgll [SEP][CLS]duringburstperiodapproximately510minlocalbloodh##2##oconcentration##ant##hineo##xi##dasactivityr099##9[SEP][CLS]previous2172b##prepeattranscription##alcontrolelementenhance##40dreplicationvprovidedeitherrepeatlocatednearendcorereplicationorigincontaining17b##patcontainingsequence[SEP][CLS]crosslinkingsouthwesternanalysisk##p##1dbindingproteinclearlydistinct##pproteinmayresponsiblebasalkspecificexpression##1gene[CLS]complexrational##econservedresiduesubstratespecific##itysubstratebindactiveconform##ationst##osunlikeunlike at##fabindinactiveform[SEP][CLS]regionhighhocontainstypean##leo##tidebindingsiteconsensussequenceat##pas##esufficientbinddcontainingspecific##tchedresidue[SEP]copyright1999[CLS]nickelrelease##wedmarket[CLS]sphasepromotingc##ydependentkinase##d##kskinased##4actinitiatereplicationn##f##bpartiallymediae##rlatemembrane1activationbcell[CLS]f##erexhibiteddistributionconstantk##dbetaest##rad045nmnm [SEP][CLS]thelongterminalrepeat59##0b##plengthu##3regioncontainingconsensussequencelikelyinvolvedviralgeneexpression[SEP][PAD] [CLS]incorrectresponseprevioustrialtrial enhancedcurrenttrialleft##v##f##f [SEP][CLS]p##eptidegenerated##osotrans##locacrossmembraneend##opretransport##erassociatedprocessingtap[SEP][CLS]itcompetesbrings##osthereforedrop##os##inecomparisondataclinicalhem##ody[CLS]serumcollected19731975305##3resident12selected##ask##an##kimvillagetestedevidenceheinfection[CLS]injection##radper##idas##ere##bella##rfl##culusratemployedidentifyne##urona##b##censnucleusprojectfl##culus[CLS]toass##aysequencecouldpotentiallyregulatex##enopro##en##ke##phatrans##fectedconstructcontainedupstreamg##eno##micsequencelinkedcatreportergenevariouse##ukacellline[SEP][CLS]ratioil6il10injurytrauma##binducedassociationtumorne##rosistreceptor1tfactormediaactivationreprotein[CLS]amajorfeatureg##eno##micsequencepresencefirstintro##nil215b##plonglocated48b##pdownstreamtranslationstartat##gco##don[SEP][CLS]experimentalstudyclinicalplasmaradiokitwithoutextractionprocessprocess [SEP][CLS]in##vicenlocatedmiddlepartla##iila##ii##iaccounting25totalne##uronnatureincidenceconditionedresponse##had##onepopulationcomparisonnaturalist##icstillautomaticallyrefusepositivemedia##ino##scointerventionn##2analyzedanalyzed [SEP]demonstratedpro##ukegeneinvolved1517trans##locationtransformationsuppress[CLS]asharptransitionchaoticcorrelatedturbulentcofoundbecomeslargercritical##acc approximatelyequalx107define##e16##al3133crucialproteinsbindingeffect38##al39hybridinteract##1##1 er##ral##pha##1[PAD] [CLS]nuclearexportplantplant at##1exportreceptorrichexport##idoth##alia[SEP][CLS]thus##r##2##oss##eessentialfunctionbesidesbindingbinding [SEP][CLS]auto##psyfinding5remaining23expiredpatientleg##ione##llapneumoniaseemedsuccessfullytreateddiseasebacterialpneumoniaputendpatientpatient [SEP]ni##tro##cerg##ly##oamo##xi##xidasinhibitor[CLS]highdose5f##uactdprotocoleffectivedrugresistantcase##aprotocol[CLS]stimulationbeyondthe##tarangethreephenomenonoccurredshiftburstfrequencyhigherlowerharmonicstimulationcomplexinteractionbasicbackgroundfrequencyrhythmstimulationbeatingreturnbackgroundthe##taburstspitestimulationescapeescape [SEP][CLS]conclusiontrans##onaairboundgal##act##osecarriersafecontrastagentnative##raniinvestigationkercellstab##lytrans##fectedconstructcontaining##gam##ma##binpromoterlinkedenhancedreporterwithouthanalyzedanalyzed eexpression[CLS]gas##tri##nstimulatetranscriptionhumanhis##ti##dinede##car##box##ylah##d##cgenebindingcoupled##ole##cy##stogas##tri##nreceptor[CLS]isolationnewspin##dlecheckgenemph##1##1##plikeho##mo##logfifissionyeastyeast s##chi##zo##ccrequired##pointactivationresponsespindefect[CLS]mph##1functionupstreammad##2previouslycharacterizedcomponentspin##dlecheck##pointessentialgrowthdevelopmentvarioustissueliverhoweverpath##op##sioassessmentimmediatelyi##vo##xu##til##izationreduced##th##rom##biniiiii##minproteinproteinpatientassociatedeitherth##rom##bosl##up##guthefirstdecisionmanagementcard##io##versionachievedi##canti##ar##r##hydruglikefl##eca##ini##deprop##af##eno##ne##ne [SEP]structurech##rom##oso##mallocal##izationhumangenep##otp##taseact##iva##t[SEP][PAD] [CLS]rchestwallmaximum356##2##ol1se##c122se00 2h##z10m##ldecreasedincreasing##talthough##teffectdiminishedhigherff [SEP]m##od##uli##z20local##ph##rol##retj##ho##ritemany[CLS]thesetrans##criptdirectedsynthesisthreeproteinvirustransact##iva##torta##tencodedor##fs##1proteinencodeds##2envelope##in##in [SEP]##alratiodeltadi##abepatientcontrol[CLS]trans##mura##lmetaboliche##tero##gene##ityhighcardiacworkstate[SEP][CLS]weinvestigatedwhetherpromoteractivityt##r##hgenedirectlyregulated##atranstrans##fectass##v1cell[SEP]spinalinjurymultipletraumapatientpatient [SEP]theunusualen##igmakdiscussedstatisticalaspectrelationradio##p##oederivativeanalogc##ere##bella##rfunctionalcompensationcompletedestructionneo##p[CLS]therwhether##ozr##ptamustefficientlytrans##cribedstab##ilizedrapiddegradationfoldedcorrectlydirectedpartcelleffectiveweisolateddeterminedcompleten##leo##tidesequenceanotherop##eron##denlink##er##mers##bil##is[CLS]th##aliac##ys##tat##onibetal##yasexhibit22sequenceidentitycorrespondingenzymecontains70nterminaladditionalsequencecomparedbacterialprotein[SEP][CLS]theenzyme##cco##xi##dascat##alylaststepetethyl##enebio##syplantconverting1amino##ane1acida##ccetethyl##ene[SEP][CLS]a99bonescanfocalareaincreasedup##takesitemassca##l##cane##us##us [SEP]##nal24patient21men3yearsurvived##gnantphase##yper##tensperiod196919791979 [SEP]guide##lineclear[CLS]##mi##dinekinasedefcell3##t##3cellc##b##phadetectedproteincomplexbindee2##fbindingsitefoundpromotergeneee2##f1di##hy##dr##of##olatered##ucd##r[SEP][CLS]memberc##rebindingproteinc##re##bact##ivatingtranscriptionfactortranscriptionwellmemberjf##oshownbindsequence[SEP]c##skcterminalskinasekinasetailresultingdown##rememberroledoublerdependentproteinkinasemedia##yper##con##iancomplement##fergammagamma tumornenec##rosisr[CLS]##iovascularabnormalfrequentlyneglectedalthoughassumedassumed [SEP][CLS]highprop##of1001th##io##al50m11 markedrelaxation##of3249th##io##al23[CLS]dosedependentactivityl##ys##ase##egmightmanadministrationni##cot##inemutationhumangene[CLS]##ylapparent##ylreceptorabundantamountin##test##inenorthernanalysispolymer##asechainc##lonad##rena##lg##landair##wayecellbraino##lf##actort##rac##hea##l##uc##osainpresentstudyusedsouthernb##lotanalysisdemonstratetsinglecopygenehumanms##iereactionsupossessingfree##oi7ch##lor##o4ch##ome##rinaffordedseriesn##o##o 4##rin##yl##hylderivativein##ozawellvariationcap##illa##rysizedensity##ricf##etalneon##ata##lperiod[CLS]##combinvolvedmaintenance##dstateseveraldevelopmental##lygene[CLS]uncertaintyexistsfunctionpotential##of##orms##b##fa##1gene[CLS]when##edapostshockrhythminitiallydisplayedsignalhepack##ardx##las##ys##to##lep9humanc##d##38eect##oe##nzegeneni##cot##mi##dead##eni##nedin##tideconvertingstructuralho##mologybonema##al1##pad##p[CLS]itnoteworthyphysiologicalconditionmimic##kingcellular##d##p##tratior##afenhance##efstimulate##d##texchangeha##aagreementse##a##t##af##af [SEP]terminaldifferentiationdifferentiation app##rogcomplexlostconventional##p1dbindingbecamebecame evidentparticularlyas##tro[PAD] [CLS]fromde##ducedaminosequencemolecular3854##9calculated##hsubunit[CLS]thehigherca##lorincreasedintake##bo##dra##te[CLS]simplealgorithmfittingdatamoving192##irsourceproposedproposed [SEP][CLS]ta##f1activate##stranscriptioncon##it##utive##lymappedfirst32aminoacidaregion[SEP][CLS]forfirstshorttermconcurrenttataltwodifferentflavor##edstimuluspresentedtimeoneassociatedsimultaneousin##gas##tricadministrationa##vers##iveproduct##ypersa##line[SEP][CLS]thegreatcardiacveinflowbecamezeroduecardiacarrestremainedzeromomentdeadtimeinitiationre##per##fusion##fusion [SEP]internetliterallydatadialoguerightfinger##tip[PAD] [CLS]attentiondevotedparticular##rm##ore##gunervousho##rmon##almechanism[CLS]themaup##rmediatedc##iactingerstresselementconsisting19n##t##aa##t##n9##gpartconsideredprovidespecific##ity[SEP][CLS]theformationdloopessentialstepddoublestrandbreakre##comb##ination[SEP][CLS]thepredicteden##pt29aminoho##mo##logyboxinverted##aa##tdbindingtranscriptionfactor[SEP]towardcultureco##loncancerr##kotranscription##ally##boltreatmentsitedirectedm##utaconservedc##ys##teinresidueto##m##1##32##ahedomainsupposednecessaryth##io##esterbondfunction[CLS]thetwoyeastp##omoalphaalpha factormanyfunctionalsimilarityreceptorcoupledownstreamsignaltranspathwayreceptorundergofeedbackregulationincreasedterminaldomainresponsel##igan##dchallenge[SEP][CLS]moreformationcomplexi##roperatorpromoterregionfoundimpaired##oe##vate##tateco##a##vate##zyshownextractd57consistsunchangeds##44##53thereforemainpartnercon##gatedproduct[CLS]theexpressionpatternreportergenecomparedend##ogenp##d##f##agene[SEP][CLS]thetwos##h##3domainseparated54aminoacidlink##erregionwhoselengthhighlyconservedx##enochickenchicken ma##mal##rkiiprotein[SEP][CLS]thiscomplexeliminatedmutationhalfsiteupstreampromotertranscriptionfactorcoupt##f[CLS]the##z12genewidelyexpressedrattissuehigheststeadylevelm##rnakidneyliverheartu##uso##vary[CLS]f##z12m##rnalevelgreaterneon##ata##lcorrespondingadulttissuetissue [SEP][CLS]theseresultindicatechangepatientthy##roidscanrat##tri##butt##b##b [SEP]the##oa##cmethoddi##lutionheatingaddition##rccharcoalcar##rez2pvaluedirectanalysistreatmentcontrolc##yt##ochultra##ructuraltet##rem##ato##dememegal##od##is##custemper##atusinhe##tero##mer##iccc##aa##tbindingfactor##b##fmajorcomponentc##1bindingfactor##1##fhumancell[SEP][CLS]40foldstimulationace##ty##lt##ran##ferfourtandemscouldinducedwithin2h250within6hd93appearedlikelytrueproteinkinasemediatedsignaltranseventratherdifferentiationresponse[CLS]thisincreasedinfectionexcessmortalitymortality [SEP][CLS]del##etimutanthumanchpromoteridentifyregioncomprisingn##uc##leo##tide75104requiredcon##it##utiveerstressexpression[SEP][CLS]thedurationalphaelevationwellpeakinfluenceddaycycleproposeen##picalplasmafunctionalexpressionsodiumchannel[CLS]electro##siop##harepic##ard##ialend##oc##ard##ialmcell[CLS]terminalrbindsinglestrandedrformhaltedcomplexmuchlowerlevelwenzymecomplexstabpresencen##tstrand[SEP][PAD] [CLS]ac##hal##oth##ora##codi##mme##mmetrocalfbrainc##alibrary##11screenedassociationtwopositivecloneencodingt##osp##taseisolateddi##sor##gan##izationh##yper##trozonetbone05diett##ibi##alabnormal##itylinear00001zeronormal[CLS]repressionstrictlydependentpresenceupstreamo##ox##1bindingsitereportergeneconstructfunctionnterminalregiono##ox##1preceding##od##in[SEP]on##dan##set##ronthusline##em##eticchild##em##otherapyradio##ther##apsurgery[SEP][CLS]toel##uc##ida##temolecularmechanism##asignalingpathwayactivate##scelltypespecificgeneusedpit##uit##aryspecificratpro##ct##rlpromotertargeton##a##af##4pit##uitcell[CLS]thehumanr##f##c1genediffersha##msgenetermtotalnumberex##onregardalternativeex##on1en5endhe##tero##ity[SEP][CLS]typecunitsum##materesponsetonestimulusshowlittleinhibitor##yinfluenceinfluence [SEP][CLS]hincreasedc##y##c##linac##y##c##ling##1nucleartranscription##alfactorn##f##ka##bproteinexpression[CLS]sincebloodse##rot##oni##nprimarilyperipheral##lyresultaspectperipheralse##rot##oni##nmetabolismabnormalmajordepression[CLS]althoughseverallargewater##borneoutbreakoccurreddecadesmallcommunitycommunity [SEP][PAD] [CLS]##ogenmix##te##ryomosaic##im46x##x46x##yratioratio 8020[SEP][CLS]the16k##b285aminoobtainedbetagal##os##idasfusionbacterial##lyc##abounddfragmentcontainingseveralcar##gboxmabilitycomplementgrowthtemperature##23##pertemperaturetemperature [SEP]inreviewevidencesmokinglungcancerlaincludingunpublishedtechnicalreport[CLS]the##r##0delta##lo##idcellgavemicro##co##lon##iescomprising2050cell[CLS]despitehighinitialratetranscriptionpromoterconstructlalatl##trableremaintranscription##allyactiveestablishmentlate##ntstate[SEP][CLS]twomutantmappinghind##ii##isiteconsensussequence##10##1te##tapromoterstudiedmama2corresponds4b##pdel##eti##onposition1215b##30bear44b##pinsertionctata 21ghind##ii##isite[SEP]1r##ct[CLS]s##cieffecttime##pidbr##omi##b##cho##lineragent##ty##choneo##st##igneo##stgas##tricduo##den##albloodflowdistribution131##irabbittheseextra##rom##osocopyisolatedclosedmoleculelengtharound3##mu[CLS]comparisonfoot##printpatternmousehuman##rtgenedemonstratedv##ivobindingregulatoryproteins##pec##iegenerallyconservedidentical[SEP]threedimensionalstructureenzymees##cher##ichico##lide##ter##minedrefined20aresolution[SEP][CLS]northernsouthernbanalysisclearlygenemayinvolvedtumordevelopmentconsideredcandidatetumorsuppress##or[CLS]##iva##ivaxmalariathissetgeneticphysicalinteractionroleyeastrbindingtranscription##alregulation[SEP]populationandpatientfollowedmale8756101st3rd6th4th##giomonth[CLS]allc##ys##tshowedun##ilo##cularpurelyc##yspatternho##mogeneousfluidalthought##2relaxationtimefourles##ionoverlapo##donk##sts[SEP]geneticdiagnosisrespiratorydisease[CLS]thecjdeltadomainin##hibitne##uro##endpromoteractivitydsequence##uit##aryspecificmannercrosssection##alstudythemedicalpro##gnote##tanspeciallytimeseveritydiseasecharacteristictherapydeservete##tan[CLS]differencefoundco##lonse##m[CLS]increasingheight##garcolumnoverlysfabricfabric diminishedinhibitorsmicro##bialgrowthneitherrawre##tro##gradedstarfast##ingserum##ster##oli##em[CLS]5[CLS]he##pamarkerla##ashiofficerintwogrouppvariationserumpro##te##aseobserved[PAD] [CLS]maximumstructureanalysist##runcated[CLS]asingledose##efadministeredin##ven##ouslypatientautodiseasevaryingdegreere##nalimp##airgroupi##l##c##rle50m##lmingroupii##l##c##rgreater50mmin[SEP][CLS]theliverspecificsequencecontainsuniqueconsensussitep##lationcam##pdependentproteinc[SEP]effectfunctionalstate##ye##ph[CLS]theyphysiologicalpatternarithmeticstandardde##viation##viation [SEP][CLS]the##al##bet##adomaincanonicalfeatureknownt##rdomainincludingresiduebeginning##r##2end##r##3prefer##entialrepairrepair explaineddefectrepairgeneraltranscriptionunclearpresentpresent [SEP][CLS]thisstudyexamineslebiographicalcontext[CLS]dip##etal##onea##can##th##och##onedid##els##p[CLS]nhowevermii##igroupii[CLS]whileimagerycommonneuralsubstratefactdfshowintactimageryfacemassivedeficitformchallengetwoprocessshareinputpathwayearlyvisionvision [SEP]anethnicanalysis89##47caseprimary##nstumorpathwashing1985theexactfunction##p30yetknowngamma##ferreactioncocellassessedactivitymetaboliclabelfollowedspage[SEP]in##rs##2formcomplexnterminal##2domainpresponsestimulation[SEP]it##p213replacedoralcapsulerecommendedinitialdose100130mgmm2given5daycourseevery2128dayddconfigurationreplacedposition377 815181921showing[CLS]theseresultestablishd##nafragmentisolatedcontainsinter##le##okimayinfluencepromoterviaactivateds##tat##s[CLS]whentargetedgal##1promoterpromoter f##usinggal##4##pdbindingdomains##1##pact##6t##1##pdependentre##press##orregulated##smostress[SEP]unexpectedprevalencecalphatub##ulinsphaselibrarynorthernanalysisr##naphases##ync##hr##ono##uscellcell [SEP][CLS]promotesurvivalbadresultingdi##sso##ciationb##c##l2##c##lxlassociation1433##u[SEP]radical##ph##re##rectt##1t##2les##ionidentifiedidentified [SEP][CLS]sufficientlystrongcrush##ergradiente##pipulsesequencetemporalvariations##f##pdisturbancesuppressedduediffusiondiffusion [SEP][CLS]howevercaseeitherd##qalphad##qbetachainexchangedmajoralter##ationreversalpatterninteractionobserved[SEP][CLS]onlynativestructureer##krecognizedinactivatedsecondorderrateconstant40000m11[SEP]from19981999largecommunityacquiredrespiratory##olate##trepneumonia##6ha##emin51##3mmorax##hali15centreau##oresouth##f##rica##wan##ry##bial[CLS]diet##hyl##dit##ar##ba##mate##phestereo##typebehavior[CLS]we##mo##biltemplatebasedassexaminetranscriptiontermination##a##1##s##lal##uclassii##itemplateroletrans##criptreleasep##olii##iterm##inatordependentin##hibitionprocessingb##1altrans##cript[SEP]anovelzincfingercontainingrbindingconservedfruithumanhuman [SEP]##k1##ps##3trans##act##ivationse##r72##k##9##80##9hing##estday1day14t##x##1##rit12425##rid##3biologicaltracemonitor##ogenmeta##bol##iteisolationjointdemonstratingthick##ov##iaeinvasivediagnosticspecificbetam##ylresultdependexperienceb##or##relb##dorfserum##bodyresultgthesizepredictednterminalsequenceproteinexperimental[CLS]nuclearrunoffcomplementrestore##1stimulateearlygeneexpression[SEP][CLS]yetilgammaindependentlyregulateddifferentialexpressioncertainsubsetregulatoryelementtwogenemustdiffer[CLS]025mgdoset##zocounter##actinducedsleepdisturbanceinducechangee##egspectrumtypical##zoreceptorago##nist##nist [SEP]anh##c##2breadresisttransition##stal##ba##2##cu##scopichighhisidenticalseenpatientbonema##rrowfunctional3spathway##gnant##uke1transformedentrymediac##cpreviouslyknownp##olioreceptorrelated1##1##1 herherpesreceptorhihig##rbfifidereceptoremployedemployed her12studystudy [SEP]4h##rolco##lla##gencontentcombination##11finegativesurfaceclassim##h##callowedclassi##hpopulationsorted[CLS]although##rs11 24similaroverallstructurestructure i##rs33 approximately50shorterdiffersrespectsitet##os##lation[SEP][CLS]interactionproteinsystem##tubcriticalcellular##elleinmappedput##ative##1bindingsiterdemonstrated##rs##1bindingsiteco##rrel##ate##rfunction[PAD] [CLS]sailcopyright2000presspress [SEP][CLS]thiselementrequiredbasalactivatedexpressionexpression almostcertainlyfunctionta##tabindingproteininteractionsite[SEP][CLS]in##ps##b1m##rnaprecursorproteinlevel9reconfirmingend##ogen##ousl##x##rr##x##ractivationinduce##ogen##ouss##b1expression[CLS]##ria##varanalysisyearsurvivalrespectfollowing6565sexdepthinvasion##uc##osa##lsub##cos##altumorlocationuppermiddlelowerthirdgrossgross appearancetypeii typeiiii typeii##isize15cm15cmpresenceabsencel##ymphmeta##sta##sishis##to##tologicaltypein##test##inaldi##ff##use##use extentl##ymph##nectlimitedlimited extendedtypegas##tre##trecttotaldi##stalsub##to##tal[SEP][CLS]thisintegrationresultproduction##t##vm##dr##3fusiontrans##criptoriginate5l##trpro##virus[SEP][CLS]inresultexerciseperformancebasedheartrateresponse##max##ima##lexercise##o##2170##pmindexcapacityheartrate##ilasequencecomparisonpw##oese##iggt##pbindingstrikingrelatedsequencee##uba##cter##ialftmarginal##lysimilartub##ulinbacterialftprotein[SEP][PAD] [CLS]four15patientpatient r##2case##body##body i##gaclassclass [SEP][CLS]phosphatecompoundperheartp##hvariationduechangeextra##cellularp##co##2##bon##ate[SEP]vd##b##lmembersharesequenceidentityapproximately250aminoaciddomaindesignatedd##bho##mologydomain[CLS]serumusefultumormarkermonitoringresulttherapythepossiblepossible eequimultipleaffectadrevisedmar##cker##ubi1985studiedco##rrelformma##lrstatetraits1995affectbalancebra##d##burn1969sensationseeking##cker[CLS]dataprocessingtimefunctionintensitymodifiedre##tinaalsolaterprocessingsiteidentificationmaskedto##xinex##otos##taund##lperexistencemaskmechanismunlikela##1la##2##rolresponsepatientc##dmeasuredhybrid##izationhowever##lation##almodification##ar##2proteinappearessentialnormalr##rna[CLS]hereanalyzedinteraction18rprcorrespondingisolatedpp4pdomainnmitochondrialsubunitrintro##n[CLS]thede##ducedaminoacidsequence##r154acidresidueshowedho##mologysmallregulatoryproteinl##rp##k##dr##nc[SEP][CLS]yeastcellreachlate##1simultaneouslystartbinitiatedsynthesisactivatetranscriptionsetgeneincludes##1c##y##lins##ln##1##ln##2manydsynthesisgene[SEP]functionalpetcerebralart##eri##ove##nous##lf##orm[CLS]inin addition26##9ms##p##retxc##b##l6##jf##1xc##b##jinter##spback##crossordermarkerlo##cuscalculateinterdistanceregionaccordinglysuper##ptmaterialreadilydetectedextract##uopreparationdefcellblockadetactivationsurfacelinkedsinglechain##a4##d##15##2three##pect[CLS]4mutationthreeextra##cellularc##ys##teinresidueg##karbetaindicatedtwoconserved##ys##teinresiduec##30##5##38locatedtwotrans##ranesegmentformsolventaccessibledi##sul##fi##debondinxomatreadabilityneneutpp18participateparticipate ereceptorcommontranspathwaythestudiedne##uro##tro##phinervegrowth##fmajorsurvivalfactorsympatheticsensoryne##uronpromotesdifferentiationsystem##c##12cellactivationalpha1m##car##olin##afbeta##ct##17##kinhibitorblockedndelta[CLS]transcription##alanalysishumantfunctionpoorlypromoterrecognizedrpolymer##aseiii##ip##oliipromoterlackingconventionaltaelement[SEP]level##d##k##d##k##afd##1reducedcellline[CLS]mapping53terminuste##drindicated##trou##3rstructuralorganizationcapabledirectingsynthesistrans##criptpotentialsubstratereversetranscriptionintermediatetrans##position[SEP]duelectro5fixedsound90##d##b##l33 [SEP][CLS]detectedanti##bodynterminus##3##3 f##2pro##genyse##gatings##3ha##p##lotexpresseds##3ha##p##lot##ype[SEP]bloodrapididenticalfastafollowed16h##tra##umaticcourseprocessedltevisual##rp[CLS]totalbodydistributionspacewomanvariousbodyweight[CLS]threeexperiment20hmet##hyl6##zo##idoh##hipperformedinducemutationdi##hy##dr##of##olatered##ucd##f##rgenehem##iz##go##ms##ocell##21[CLS]thismediatedvascularre##mo##delactiveprocessresultchangebloodvessel[CLS]separatefactorfourregulatorycon##it##utivefactor1probably##1##1 expressedthy##mostageiiinncomplexbinding##d##28elementelement activatedthy##moincludingcellc##d##d4##d##d8##rl##owundergoselectionii##iinfactorat11 activatedmature##d##d4##d##d8##r##hi##ghim##mat##ure##d##d4##d##d8##rthy##moaliketransitionalcell##d##d4##d##d8##rl##owsubjectfactorcontaining##b##b activatedthy##modevelopmentalstageculturerequirespecificinduction[SEP][CLS]thus22m##drespondedoralp##la##c[CLS]posterioro##ste##op##hy##tearoundposterioredge##rte##bra##lbodyresultedinter##vert##ralins##iciencycorrespond##edh##yper##tro##phicspuro##ste##och##ond##rosis##rosis [SEP]systemicinfectioncan##di##vadministration[CLS]offour##cgeneexpression##c##bet##agenereportedtissuespecificdevelopmentdependent[CLS]fusiondbindingdomaingal##4fullactivityrequiresentirebbhalphatalthoughaminoterminusdisplayactivity[SEP][CLS]theinduction##has##3##a##1differsclassical##ticgeneregulationpartg##co##cor##tic##oidanti##tic##no##lone16alpha##ril##ninduce##3##a##1transcription##algeneactivation[CLS]more##bodybindingde##mina##ntalsoin##hibitz70s##h##2domainboundz##etachain2##pyit##am##am [SEP]specimenun##fer##til##izedeggalmostflatflat [SEP]f##etaltransplantrescue##xialmusclerepresentationm##1cortexneon##atatrans##ecdevelopweightsupport[CLS]weexaminedcontributionmmenhance##rtranscription##alactivitypath##ogenconstructingl##tr##scontainingenhance##relement[SEP]theremajor##opercom##plicationfollowpatient1026monthoperationsatisfactorysatisfactory [SEP]the##th##rom##binii##iincreaseanti##th##rom##binii##iinsda3weeksupplementdietm##ldailycoliveroilconcentratenorthernb##lot##ts1regulatedmeta##phy##sea##l1435folddi##aph##ys##eal42foldbone1h1returnedlevel24h[CLS]thetranscription##altrans##act##iva##tortasiaugeneexpressiondirectedpromoterterminalnewlydiscoveredinternalpromoterlocatedwithinengene[SEP][CLS]incaseflu##ox##eti##ne##junctbenefitsideeffecteffect [SEP][CLS]del##eticonsensuselement##popromoterabolishedtranscriptionresulteds##por##ulationdeficiency[SEP]##emmutationbetagal##osgeneresultl##osodisorder##1gang##dosm##qui##osyndromeresultindicatedhobbymobilitytransportrelationshipenergythingsloweraspectrelevantpatient##ol##ol [SEP][CLS]transflystrainmutationaffectingspecifictis##of##ormsinvestigateindividualroleregulatingalternativeprocessingdoubles##exextprem##rna[SEP]theho##mologyimmediateus##1herho##mo##log##s##ice##6##3##quin##quine##e her##f##4[CLS]thesestudydefineclassdelementmodeaction##fodescribedinteractioneffect##bul[CLS]chestxpabnormalshadowupperlobelobe [SEP]specimenlargenumbersectiongoodm##or##phcharacteristicmaymay producedproduced [SEP]##oxreceptorantagonistinhibitorg##amareleasecalciumchannelblock##amineantagonists##ynth##aseinhibitorcan##binome##onivitamin12[CLS]aseriesmutationwithinwithin eopenreadingframedel##etevariousregionconserveddbindingtrans##act##ivationdomainwellinternalhi##ngeregion[SEP][CLS]c##rk##ii##lcon##utiveformedcomplexexchangefactor##3unwellppdcell[SEP]inbiologicaldproteininteraction##rao##leo29##1245provedorientation##ferin##mi##dinegenepromoter##ur##katcell[CLS]plasmas##tero##idlevelin##fusionrateequallevelsubjectb##c##ppprotocolachievedcompleteresponse75responsedisplayed50responseresponse [SEP][CLS]the##31geneencoding##31subunitsa##har##cesc##ere##vis##iaer##napolymer##aseii##iisolatedstartingcterminalfragmentclone##d##dalibrary[SEP][CLS]electro##oresequencewithinregionbindmembers##1transcriptionfactor[SEP][CLS]thepactivesitelocatedwithin36##737##4[SEP]oneyear##rgon001k##olmtreatedgroup[CLS]furtheraimcharacter##izingtransactingfactormedia##tespatialtemporalexpressionho##xgeneem##b##ryo[SEP]##eno##sin##edruginteractionarticlearticle [SEP][CLS]asideeffectsic##yl##ru##ria##ria amicro##scopic##at##uriaelevationgot##pt##1pobservedonerespectivelyserumc##3measured128childabnormal19801997[CLS]twomeasuresensoryin##hibitionemployeds##2s##1x100amplituderatios##1s##2amplitudedifferencedifference [SEP]computeranalysisrevealedhumanp##1sequencecorrespondingaminoacidresiduewithinterminalrbindingdomaindisplayhighho##mologygreatergreater 54identity6194similarityrbinding##3##lrot##p##p2unknownmrot##34likelyrbinding[CLS]de##ter##minareisischa##emiare##vas##cularth##rom##bol##ys##min##ivaco##rona##ryo##cc[CLS]forlargebreast70mmxrayiiged##mautomaticallyselectbeambreastresultedlowerdoscomparedmanualtubepotentialselectionselection [SEP][CLS]experimentalstrainindicated##ulentcomputersystemtrain##horequirementrequirement [SEP]finallytrans##rbgenespecificmutation##hdomaina##pop##tco7cell[CLS]comparisondosevolumehis##to##gramrevealedfieldplansparedheartwhereaswhereas 8fieldplansparedlung[CLS]demonstratedput##ativeho##xco##fa##ctor##x##1##aparticipatescooperativedbinding##xa1def##orm##edgrouphohox##d4the##l1c##t##f1geneproductsa##har##ere##vischromosometransmissionnormalcellcycleprogression##2m[SEP]##tero##tri##mer##icgbindingfunctionsignaltranshormonecellremovedremoved 6886m##difirsth744hhd##ddrpacingautomaticmodeswitch##ysat##rialfi##bri##llaa##vnod##ala##blatherehighlydecreaseserume##ospatient##ga[CLS]sequenceanalysisrevealedbelongslargefamilyf##addependentglucosemet##han##ol##olino##xi##dor##ed##ucsharesequenceidentity67alcoholo##xi##das##hyl##ot[SEP][CLS]itrequiredcorrectexpressiongenegene [SEP][CLS]inhil##trregiondemonstratedpositivenegativeregulatoryeffecthigeneexpression[SEP][CLS]acomparisonat##ctedtransmissionemissions##pectimageobtainedt##l201ca##dpatientpatient [SEP][CLS]accumulationamperlung[CLS]sincenecessaryresortth##ora##cotfinalstepdiagnosissimplersimpler capableprovidinginformationinformation [SEP][CLS]bothcontrolm##n510timemliversimilarlysmallinde##phcampdependentproteinppkap##blivernuclearextractaretrospectiveanalysisdata21de##mber1989se##pt##em1991investigationxex##rona##gioelsystemintervention##rvin##rvine##e caperformedpresentlychainpairswitchch##ime##ricsitemutantgammadeltat##rstrans##fectedt##rmutant##ur##katexamineeffectt##rgammajunction##alregionsequencereact[SEP][CLS]f##ojboundn45foldreductiondbindingdactivatedk##i##asuppressactivation##hterminalco##lonelectro##mo##bilityshifto##leo##tidepro##ximaldi##stalbed##p1bindingregionselectivetrans##act##ivation##d##2signaling##pm##c[SEP][CLS]thepresentshowc##iactingelement189175b##pbindthy##roidtranscriptionfactor1t##f1involvedactivity[SEP]increasedplate##letderived##ti##malthickda##rongmodel[CLS]despitedegreesequencesimilarityfiver##f##cgeneessentialcellproliferation##ere##vis[SEP]more##overe##ct##12##roplineresultinductionmanyblineagegeneincludingincluding eeb##ral##pha##darag1abilitychainresponsemitalsohi##12##0##d##d4##link1015foldlevel##i3##i4##d##d4##ate1infectionin##ven##ousdrug##du67##du322 55557oneor##fsmet##hanjgenomehighsimilarityma##eo##bauthenticah##as[CLS]more80appropriateleverrespondingestablished273844dailytrainingsessiond232di##az##amptrainingdrug[SEP]wemagneticstructurerkissinghair##pincomplexformedhi2ta##rhairloophaircomplementaryloopsequence[SEP]resultinmenweightheightsatisfactoryindexstrongcorrelation##riceskin##giblecorrelationheightheight [SEP]##20relatedstructurefunctionr##cc##1genema##1genes##chi##zo##sa##cc##harappearregulateentrymit##osischromosomecon##den[CLS]noconsensusbindingsequencecoulddisc##ernefragmentboundfactorrapidequilibrium##bound##bound [SEP]selectivetranscription##alinductionsystembasedbased galgal4est##rogenfusion[SEP]kinaserereactproteinelectro##phdo60k##daliver##oso##rprotein##ose##ad##ificinstead##r[CLS]##os41##6##y##miincreaseppst##osp##lationdominant##rac##1in##k##29##3wellmetabolic##tra##ben##azi##ych##ot[PAD] [CLS]readingtwintwin [SEP]theseresult1##ainteractindependentlyerrkeyorganizerrreplicationcomplexassembly[SEP][PAD] [CLS]similar##c##lyer##sin##sinia[CLS]effecthighsugarintakemetabolicregulatoryindicatormenmeatin##fusionbr##othsuitable##emgalgallina##linarumb##eri##n[CLS]theresultindicateexpressioncodirectedtwopromoteronep##2characterizedearlierworkerstartsitetranscription60n##leo##tideupstreaminitiationco##donfirststructuralgeneprop##1situated250n##leo##tideupstreamproprov[SEP]ma##ximalriseplasmaadrenalinesimilarthreegrouplowerplasmaglucoserequiredstimulateho##rmon##alresponseunawareplasmaadrenalineconcentrationlowertimereactionreaction [SEP][CLS]throughinteractionprem##rnac##t##ddomainpolymer##aseiis##rproteinshownregulatealternatives##licing[SEP][CLS]onechildrecentlyfedvomitsmallbreastmilkshortcryapparently##gos##passhownsuddendropp##t##co##2levelwithoutdiscomfortdiscomfort [SEP]changesizeorganisationbrainmanancestorancestor [SEP]onlys##ta##taphyx##yl##os##x##6##3strainhighad##herenceactivity[CLS]itn##h##2terminuscorrespondsequivalentterminusprocessedmatrixformsimilaralpha##1x##ichainthusphysiologicalsignificance[SEP][CLS]transmissionm##utasinfanttermi##od##fsolutionmotherden##ti##tion[CLS]expression##x1m##x2studieddevelopmento##ste##obroleddl##xcontextregulationboneexpressedgeneunknownscalpbloodflowrecordedincorporatedtrans##oelectro##de[CLS]designact##ivating11ta##tinducedtranscriptionjhybridta##tjexpression##mi##dreportergenecontained##p1bindingsiteupstreamratpro##ctta##aelementhi1l##trconstruct##p1bindingsitereplacedelement[SEP][CLS]my##co##ba##ctertuberculosisin##hibitif##ngammatranscription##alresponsein##hibitactivations##tat##1[CLS]rabbit##1r##b##k##1rat##1r##t##1clone##dscreeningkidneyratbrainclibraryho##mo##logc##aprobe[SEP]##40reducedwatercontentrighthip##po##cam##puscon##tral##ater##alsiteinjury[CLS]g##hstimulate##dactivitypromoterfragment5endn##uc##leo##tiden##t2001n##t65##31927foldc##d##ktargetsitedefmutantops##25s##38blockcelltransitionproteinpromotesdstrandtransferlineardoublem##19dsingleviralm##19disolatedeco[SEP]thebrainprocessedaccordingte##tra##zi##dinet##mbprotocolme##sul##am78studieddark[CLS]seizurere##r13095001##epdrug##r00138influencemortalityraterate [SEP]oneday##operbetama##ximal45en##f##rane53ne##uro[CLS]theserumlevelco##rt##is##olpro##ctinssuspensionex##udashowedlowervaluecontrolconditionnasalinsfoodinenzymeelatoponeall##ergicdisorderas##thr##hin##itiseeczufourmouthgas##troinintest##testinalsatopvariousclinicalsreeczoneumouthgas##troin##test##testinalcordbloodseruminner##ticsheepgoat[CLS]bio##chemicalstatuser##yt##hr##ocenzymebloodlevelsexualadvent##urihighbehavior1se##ro##con##version##hor19841992pen##rosproteincycledependentnuclearlocalrequiredproliferation[CLS]para##dox##icallydecreaselevelsolubleabetasecretcellsignalingmit##ogenkinaser##acrdueffect##askeletalmy##ogen##esisinternalpro##ctinvolvenucleartransmaexpressionneo##2neoconstruct##zyindependentlyelectro##poratedyinrestrictedrestricted ilil 2##otowhenes##cher##ichico##lidisplayt##osspecificp##tase[SEP][CLS]thestructureel##uc##ida##tioni##rid##oidcompound23discusseddetail[SEP][CLS]theresultstudyinvestigateinvestigate effectivenessprop##oliscontainingmouthin##hibitiondeno##voplaqueformationpresentedeffects##hos##ai##koto##alherb##almedicinalmixturerestrainttheregionsurrounding##f3##p##21particularregionchromosome3frequentlyinvolvedrear##rangdel##etitumorincludinglungre##nal##cin##oma[CLS]inpromotermanyimmediateearlygeneincludingcf##o##gdregulatoryelementmedia##tebasalcon##it##uit##iveexpressionrapidtransseruminduction[SEP]re##conrpolymer##ase##ivoco##tra##ns##fect##1##onlikerencodingcatgeneco1celliicompleteactivity[SEP][PAD] [CLS]trans##ientthy##rot##ox##ico[CLS]weunableconstructinsertionmutantrme##li##lotwhereasmutantinsertionoutsidegenereadilyreadily obtained[CLS]b##lotrevealsc##jun##bfamilymember##bbetaphysiological##lyrelevanttranscriptionfactorwhoseexpressioncorrespondsm##dam##rnaexpression[SEP][CLS]##lfodorelrapidtranscampresponseterminatedconcert##edprocessrequiresrequires actiontwoppkareceptorspecifickinase##rk##3ssch##le##iche##oe##kh##offi[SEP]##a##ylayeastyeast essentialenzymefactorinvestigateroledomainincorporationsienseriessienmutantsmallframedel##eti##onwithinc##yt##op##lasdomain[CLS]computeranalysissimplecorrelationhypothesisdistribution1degreefreedomrevealedcorrelationverticalrootfracturetechniqueinstrumentationo##bt##5length05existence[CLS]minuten##183krequiredcelltypeinvolvedmultipleprocessnecessarypropagationpropagation [SEP]t##d##xass##los##pormeta##bolbloodsamplehp##cr##iamethod[CLS]howeversequencem##rarbeta3regionadiffersm##rarbeta1additional27cterminalaminoacidencoded81n##leo##tidelongput##ativeex##ons##p##lice##dex##onencodingabregionm##rarbeta1[SEP]##d##dregulatoryinteraction##if##ifsuppressmutationisolatedgenedecreasesu##pt##if##binhibitor##ifimp##aircat##alytic##iftranslationinitiation[CLS]the3regiontrans##criptcontainedfullyconservedcorrectlys##lice##dt##ralphacregion##lated3end[SEP]these##tal##pharegulateddomainthreealphaherepeatmixtureiilast57residue[CLS]sortinginformationch##op##lasticinnerenvelopecontained##2pro##ximalpartmaturei##11##0110##n[SEP][CLS]mostelementadjacenttypexte##lo##mer##icrepeatregionflankfourfivecharacterizedspara##doxinsertioncarryautonomous##lyreplicasequence[SEP]1989totalregional##cinradio##ther##aprrtregional##yperhhtdivisionradiationonuk##ennenorcancerhospital##fo[CLS]thearedefinedfiven##tidesequenceembeddedrichregion[CLS]lackchangemilkproductionmilkcompositionacuteincreaseso##mat##ot##rop##incon##com##itaincreaseinsulinsufficientstimulatesynthesismilkmilkcomponentestablished##ation[SEP][CLS]materialcutdiamondsawx103mmupperpolishedsi##o##2t##itaclayer33micro##menhancedvapor[CLS]i##oma##zensincrease##zo##diareceptorupco##rt##icalregionexcepttemporalcortexboth##ye##pi##zo##oticsituationau##jedisease##falongdensity[CLS]sinceregulatereceptoractivitymacellspecificallyregulateco##act##ivationmediated1proposeindirectlyregulatereceptor##factivitycompetitionco##act##iva1di##cfi##bri##nomayaccount##agusyndromesyndrome [SEP][CLS]acasechickenho##mo##mologuetwo##rformaboriginatetranslation##alinitiationau##2co##don165##1respectively[SEP][CLS]flu##ctmeasurede##c##fenergyrelatedcorrespondclinicaleventpresumablyinvolvingh##y##poxis##che##miausinglaserdi##abefurtherzinc##alnaturalactivation[CLS]cellstab##lytrans##fectedalpha2alpha3gene5flank##ingsequencefused##flyl##uc##ifer##ase##areportertemporal1015foldtranscription##alactivationgeneoccurredcellularpolar##ization[SEP]conclusionresulthis##taminereceptoractivationmechanismmayinvolved##operil6synthesisregimedopluss##tre##ptdor##ifgoodel##appainhospitalshorterdopluss##tre[CLS]fi##bro##sisadjacentmy##oc##ard##iumseenfivecasefoursimilardegree74120foldreductionratereactiono##6##zy##ninereductionnotedvertical##rfnewexexert000##92003038##3stancephaseant##eri##orexexert000##95000stance##bula##th##oticdeviceidentificationkatencodedb1[CLS]itsuggestedbi##lia##rysecrett##b##z##b##zmeta##bol##itemaycontributerecycling[SEP][CLS]duringchord##oto##nalorgandevelopment3enhance##rdirectsexpressionprone##uralclusterwhereassuccessivemodularenhance##rlocated5regiondrivetissuespecificexpression##oto##nalorganprecursorem##b##ryola##rva##llegwingantennaimdiscdisc [SEP][CLS]themeasuredblooddrug##didaymorningevening[CLS]n##uc##dstructurethe##rm##ostn##uc##dpolymer##asecomplex[SEP]vascularcomponent##oteshownmanagementmanagement [SEP][CLS]resultmamaximalearlyas##th##erplace4sese 44webweb 208##6##6 18944 44 [SEP]##xin##ate[CLS]usefulcomputerto##mohem##od##ial##yspatientpatient [SEP][CLS]theaimstudydetermineexercisetrainingvent##ricdi##ast##olicfillingrestexercisepatientis##che##iochangedi##ast##olicexercisetolerance[SEP]p910di##hy##dr##o101met##hyl4##rid##yl##iden##e99 ant##hr##olwahisse##rot##oni[CLS]methodologyacasecontrolstudysurvivor##esta281000data##ata##atalintensivedatabase[SEP][CLS]theretworegulatoryregion##3##6transcriptionunit[SEP]databasesearchrevealed5063similarity34identityseserinepro##te##asetry##psproproteincludingprogammagamma e##ivaincludingtissuep##min##ivahumanheact##ivasuper##id##osee##insgasex##citation##cillab##osee##insgasdependent[CLS]4706##mo##lkg1[CLS]min1changedtrainingtraining [SEP][CLS]l##ymphss##hs##3domaincontaining##rbsubunit3associate##utive##bvias##h##3[SEP][CLS]z##tahat##b##pmacell##b##p[SEP]patientsub##to##tal##illoat##rop917patient53patientpartialat##roppatient15normal##illo210patient2020 [SEP]howeveropcom##pressivereachedvalue40higherccsampleexpressionho##x4959l49l59regulatehohomgeneexpressioncel##egan##eganst##r##xgened##ros##op[CLS]l4959trans##geneexpressedwidelythroughoutthroughout cel##egan##egansanimal[SEP][CLS]inter##le##uki1increasednor##ad##rena##linerelease[CLS]magneticinfluencecentralnervoussystemfunction3patient##uka##romrandomdonorplate##lettranshighdosetwogene##ienho##mo##logue##senergycouplingenzymeip##oe##no##vatedependentsugar##ot##ran##fer##asesystempreviouslyes##cher##ichicochromosome[CLS]eightsuppress##orcomplement##ationgroup##1##2[CLS]thesetranslation##als##ter##icall##ericcontrole##kfunctionimportantdbindingabilityinteractfullyestablishcorrectstereo##sp##ificarrayleadingswitchingbeta##bintranscriptiondevelopment[SEP][CLS]o##latedig##estivetracthoweverin##ven##ousinjection##d101markedimprovement##pt##om[CLS]westernb##lotexperiments70k##daproteinmayc##lea##vedactive34k##danterminalp##pt##ide[SEP]thea##etimanagementdi##abeimp##otewelleffectdiabetessexualitycleartreatmentdiabetesre##tina##tinalcom##plication##plication [SEP][CLS]activatedg##co##cor##ticformcomplexs##tat##5enhances##tatmediatedtranscription##alinductiondemonstrate##6##3memberfamilytrans##act##ivaprotein[CLS]forpresencetworelatedgenebb##ob##act##erisuggestsat##ps##ynth##asecomplexnine##pt##idesinglecopyrelatedbproteinrathertwocopyidenticalbsubunitfoundenzyme4[SEP]livers##6kinasekinase specificallyspecifically im##ates##plabeledinsulins##6c##rk##ls##3##3adaptonemajor##uke##utcm##l125acceleratedhealingace##ticacidinducedduo##den##alul##cerwellf##amo##tir##atiace##tateidentifyresidueresponsiblemutantneutral##izedm##h##vreceptorsincemutantexpectedmutationaminoacidresponsiblereceptorbinding[CLS]itsman##son##ic##er##car##iapenetrationma##mmalhostskinprobablydueexhaustionenergyreservereserve [SEP]especiallynumberdimensionsamplelargesaidb##p##nbetterknclassificationsir##4##pinteractingrap##1##ppartitionle##xa##4##pfusionnineindividualstable1monththerapylowdosrandom##izedtherapylowhighdosonefourhighdospartialresponsenonefivedosmanifest##edresponseresponse [SEP]backgroundm##p##ropresistancegeneit##y##g[CLS]incaseidentifiedins##uliaffected23is##letcontaininginsulinaffected1is##letinsulindef##icientthusins##uli##tis##mu##munologicaldestructioninsulinsecretbcellcell [SEP][CLS]4expressiondifferentsitecentralnervoussystemdrivense##par##ableelementwidelydispersedthroughout8k##b3gene[SEP]investigatepossiblerole##plateer##hr##oiddifferentiationexpression##pohem##og##biner##hr##uke[CLS]theendclustercontainedhumantypei##20kgenelo##cus[CLS]an115k##bintro##nfoundendtrans##ranerestorex##on3arelessonlesson learntlearnt [SEP]e##cinenteredmet##hyl##ami##f800mm2i##vdaily5dayevery4weekkinaseplayedregulating##uri##teout##grogrowthconem##otcellautoessentialy[CLS]howevertranstranst##run##cationlittle15n##r##1co##ohterminalaminoacidtranscription##alactivationb##1##a##mi##dinekinase##lora##ico##l##ty##ran##ferreporter[SEP]sonurseninepiginmicro##scopicintactalterconcentration##ronicaciddifferents##rahighehehf##rend##oc##rinesystemseriesh##yperprocess##umcharacterizationhumanact##ivatingtranscriptionfactor4transcription##alact##ivainteract##smultipledomaincampreelementbinding##bbinding[SEP]effectconstantmagneticdifferentcar##cin##ogen##esis[CLS]in##p##roeffect##ab##1##ab##2mediael##k1inductionmoleculesimilarextra##cellularregulatedactivationeitheron##co##agrowthfactorstimulation[SEP][CLS]thisresultexpression##70genet##uce##imainlycontrolledpost##tra##ns##cription##alleveladefinitionbiasconceptstudybasebase [SEP]##romatrans##mientirecodingsequencecr##ab##phi##3insertedantiorientationinsecretcoexpressedapproximately30serumfullspottest##mer##ieu##genanenvironmentalinvestigationsub##op##tifoodstoragetemperaturerestaurantfoodmaycontributedlowat##tri##but##ableidentifiedre##os[CLS]evidencefourareasensoryde##ri##vationenvironmentnervoussystemplastic##itysensitivene##uro##de##vel##op##mentsensorystimulationprogrambeneficialspatient[SEP][CLS]studyelevatedlevelserumiobserved[CLS]withexercisegradualincreasebloodla##ct##ateconcentrationlaboccurredwhereasrateaccumulationdeltalabdecreaseddecreased [SEP][CLS]aphysicalgeneticmapcoveringentire##p##12candidategeneregionconstructed[CLS]thesinglecopyfl1genelocated##p##213mmh##cclassiregionconsists13ex##on15k##b[PAD] [CLS]anatformjuvenilesevereem##ac##iationmuscleat##ropopbulb##arsignjointcontract[CLS]v##ivoresponse##clikede##came##rsexternaldependentstatusregulatedact##iva##tor##rim##10##1##pho##mo##log##ousninidu##cregulator[SEP][CLS]electronmicro##scopicvisualpopulationactivegeneflygreatmajoritygeneseemednormaltermco##ns##cription##alrprocessingeventabnormal##ityrareex##onskip##pingevent[SEP]havingproperlocal##odb##uddinyeastexaminedlocal##izationfusion##od##ssion##odmethod[CLS]serumnewborn##estaweekradiosg##btypei##ai##biiii##i##i [SEP]infrozensectionappearbluelabelledne##uronbrilliantredne##uron##essurroundedreddishtissue##scope##scope [SEP][CLS]thepercentagedistributiontypefixdi##sp##aritycurvestudyhigherprevalencetypeicurve643followedtypeii286typeii##i71curvecurve [SEP][CLS]b##ursetset 20minitsecond[PAD] [CLS]datacontextpath##ogendifferential##ec##ec [SEP][CLS]seminalpro##ct##inlevelsignificantlyelevated##fermale[CLS]northernb##lotre##tinaspecifictrans##cript30k##brodgalpha26k##bconealpha[SEP]##riafixeddependent##var##iatemanyvariableprogressiont##4cellcounttratioblastmitserumserum i##gaappearancedevelopmenthairy##1##lio##blastin##hibitsphaseentryrecruitment##pe##d##kcostanalysisframeworkframework [SEP][CLS]c##y##c##linc##cassociatedcharacteristicsphaseinductioncharacterizationton##bp##ho##agenefusionaminoterminal41aminoacidton##bsufficientpromotepresumablyton##bwell[SEP]bi##ru##bina##tecrystalseen##l##bla##dderbi##lewallscraping8tcontrol00001thisdomainencompassesregion##rp1coupt##icorrespondinghe##lix312crystalstructurereceptor[SEP][CLS]differentclinicalvariantemptysell##at##casyndromedemonstratedvariantresultsubstitutiontherapythy##roidh##po##functiondo##paago##nisttherapyh##yper##p##rol##act##ineh##gon##adi##smradio##ther##aph##sea##lad##eno##ma##ma [SEP][CLS]bothgene##ro##3##ro##4stronglyregulatedgeneralcontrolregulatorysystem[CLS]polareffecttrans##poinsertionm##rnaarosesinglepromoterregiontranscriptioninitiated80b##p5ni##f##h[SEP]j[CLS]importantlysinglebasechangefifthpositioncf##osequence##ga##ccgggt##ca##gaproducedelementboundest##rogenreceptorconferredest##rogendependenttranscription##alactivationreportergene[CLS]measuringdim##lat##oni##nonsetdusefulpracticalwayasscirca##dianphasepositionhumancoexpressiongagt##ral##phafusiontransformed##igander##ep##ressesca##iitranscriptiontranscription [SEP]thei##bgeneapprovedsymbolmapcontains10codingex##on[CLS]transcriptionstartsite##l##rgenedeterminedlie3024b##pupstreamrespectiveinitiationco##donseparated78n##leo##tide[SEP]123##phainteractingchainassociated70kinasebasedactivationmotifessentialmembranerecruitment##av[PAD] [CLS]wecarriedtwoexperimentinvestigateproblemproblem [SEP][CLS]whenlinkedlinked her##dineminimalpromoterfragmentactenhancingelementr##chog##ccell[SEP][CLS]ama##mmalproteincalledr##f##xxbindxboxx##1boxpromoternumberclassgenedirectedm##utainvestigatefunctionalelement3minusstrandterminalsequence3cc##aucontainsstrand3endsequence311 22 auaufoundcar##mor##na[SEP][CLS]thevarfree##atotal##aratioearlydiagnosispro##statecancer[CLS]##b##1##b##pcouldmediahighrater##vl##trenhancedtranscriptionb##urs##all##ymph##omacellmanycelltype[SEP][CLS]instudentgiventrimsu##zo160ts##m##x800mg38t35##bogivenbfiveday[CLS]developmentalslotbmmrnacorrespondingthreel##hmtrans##cribed##hasme##iosi##sp##orestagenorthernanalysisrevealstape##tal##lyexpressedcorrespondtrans##cript500b##p[SEP][CLS]hundredmenmatchedagestudycenterlengthtimeblooddraw100men##bo[CLS]thecontributionresidueoutside##abindingdomain##afr##af##rb##d##ar##afinteraction##adependent##afactivation##res##ol##ved[SEP]otherrecommendationenhancing##plate##letvarietyprovidedprovided [SEP]resultattendedrepeatco##ytoneyear[SEP]change##mentmousedifferenterinsoughtdeterminespecificeffectproprote##aseweight[CLS]howevermassivene##c##rosisre##naltub##ulefound15##m##gd##smadministrationadministration [SEP]thecharacteristicsimpleapparatustypicalemissionemission [SEP]obtaininformationfunctional##ac##1##asignalingeffecttranscriptiondifferentiation[CLS]thecosteffectivenesseducation11 [SEP][CLS]theatcsitealsoessential##d##4promoteractivationfor##skoact##ivaad##c##lase[SEP]##0##31##cessentialgenerestrictedexpressionnovelat##onal##iff##nti##atedneuralprecursor[CLS]since1900sgenetichypothesissuggestedsuggested [SEP]weg##eno##micorganizationmousestructuralmemberfactor##9s##dpartialkinase20compared[CLS]thestructureexpressiongenecolonysevidenceu##tilalternativepromoter[CLS]thussearchgeneticacquiredsu##ibility##tub##er##cu##lousmy##co##basearchsufactor##bopportunityrecognizeend##ogenpathwayexploitedtherapeuticliverdisease##vinfectiontransplanthedonordonor [SEP]afterdial##ysonlinela##ct##ateconvertedla##ct##ateo##xi##das##bilglassde##pleoxygenregisteredc##kelectro##de[CLS]thede##ducedaminoacidsequencematureenzymeho##mology204identityknownp##lyenzyme##tate##yas##sa##hari##yas1[SEP]hecell##opextractg##athstransfer##ase##afpresenceatreleasedactivencouldelectro##orelossye##1stillablecomplement##1mutationenred##ucdomain[CLS]crosss##pec##iecharacterizationpromoterregiontransrevealsmultiplelevelregulation##idxnecessary161794infectedvisiblyillxththighinsurvived304468alone0000001[CLS]thepredictedvon##coproteinsequenceexhibitseveralmotifreminiscenttranscription##alfactor[SEP][CLS]thep##har##co##kin##eticsbestdescribedtwocompartmentopenmodelgivingdistributionhalflife031h153heliminationhalflife697h603ho##x##olinacido##terespectively[SEP][CLS]predictremotelysensedmapbasedn##d##vidataappearsbetterforecast##lim##aticdatadata [SEP]confirmedexperiment##oc##ardsamplesample approximatelyfollowsp##oisdistributionadequateconditionhe##pa##bulhi##vanti##bodythisgenedividedsixex##onspanning3##k##ben##codesaminoprotein4052identityrere##rating[CLS]p##3sequencefeatureacidicdomaincharacteristictranscription##alactivationfactorwellsequenceblockdisplayinglimitedsimilarityposition##allyequivalentregionsi##gmafactor##ubarelatedmit##och##ond##rion[SEP]##rda##17abbreviatedcontainingfragmentse##rineth##onirichdomainl##dlreceptorl##rplacedaderivedsethrichsequenceanchored[SEP][CLS]thuspathwaypathway f##ps##ilon##ri##k##k##kactivationactivation apparentlybypass##af1201##allo##ldetectdetect childhoodtumorchild100 18yearphotocoms##pect##pect t1311 8min##ven##ouslyfollowedpatientpatient tech99min##ven##ously##ously [SEP]ft##zhandinfluence##zf##1activityinteracting##f2domainmannermimicnuclearreceptorco##act##iva[CLS]successive5del##eti##on32##620typepromoterindicatedregionupstreamposition195in##hibit##stranscription##foldhecell[CLS]fortypatientrecent##yper##roid12s##tra##ti##fiedrandomlyallocatedcar##bi##ma##zoneo##tom##izcar##bi##zoplusdosec##t##ls##r100i##uday2dayweekcar##bi##ma##zoplushighdosec##t##ls##r100##uday14daymonththec##lonshowedcorresponds##01en##codes14transsegmentcontainingseveralput##ative##cossite[CLS]howeverstraintwohighlyrelatedgened##d##pi##k##1d##d##pi##kdisruptedshowedgrowthdevelopmentaldefectdoubleknockoutd##d##pi##k##1d##d##pi##k##3d##d##pi##kd##d##pi##3appearlethal[CLS]thismechanismseemsinvolvedinduced##rlgeneregulation[CLS]competitionmet##hylinterferenceassshowedbindingsitenovelfactorlimitedn##tide3half##ppasitethesepromptedinvestigate1expressioncopattern1##dr[CLS]concentrationinsulinmaternalplasmahigherethanol[CLS]thestronglydbindingp##50subunitshowedweakinductiongeneexpression[SEP]theresultobtainedapp##lica##romae##1##atransformedem##b##brohighcon##it##utivedbinding##p1dim##eraltered[CLS]minorchangewithintrans##ranedomaint##msometimesproducedmajoreffectdrasticchanget##ma##bla##tedsurfaceentirely[CLS]nuclearlocallikeputhe##licadependentnuclearlocal##izationsequencelocatedterminalregion[SEP]##eas##r##1chstrategytargetingcomplementin##hibitionuseparticularspecific##ity[CLS]m##or##phologicalfunctionalstatused##ent##ulous##di##bleselectionselection effectivemethodfunctionalimpressiontakingtaking [SEP]seas0mm##2[CLS]tarest406decreaseddecreased 2441071h##z18100 4h##z##z [SEP][PAD] [CLS]investigate211childininc##clone1990checked1991sitebra##tistownvaryingso##2dust##inessdust##outinfluencetypecoursererelaprespiratorydiseasedisease [SEP]statisticaldifferencecapratiocarbonsurfaceenergydifferentheat[CLS]dim##4promoterregiondifferential##lyprotecteddependinguponho##lo##zybound[CLS]in##1terminalaminoacidn##1##aentirerbindingdomaindeletedcar##box##ylportionn##1##aproteinfunctioneffect##ordomain[CLS]overallpre##nat##alexposureand##rogenbasedproexexert##ertedma##cu##linidef##eminfluencehumanbehavioraldevelopmentwhereaspre##nat##alnaturalpro##teroprobased##emdem##as##cu##liniparticularlyamongsubjectsubject [SEP]thetest##isspeciment##rit##rm##oracollectedmonth1987processedelectron##scomicro##scotest##osteronetfollowing##cavidbioper##idascomplexmethod[CLS]m##t##xtherapy##a67uplivertumormuscle[PAD] [CLS]instageihis##to##chemistrycopper1121casecasecase t12casecase oo 2casecase tt r[CLS]ensodiumfludyerelease[CLS]prime##rextensionanalysissub##c##lon##j##ho##afusionindicateace##tos##yr##ing##oneinpromoterliedirectlyupstream##jstructuralgene[SEP][CLS]genecontainzincfingermotifhumanbrainc##alibraryscreenedo##gon##leo##tidecomplementaryconservedlink##ersequenceadjacentzincfinger[SEP][CLS]18##bresponse##oc##ram01subject5day200me##qsodiumintakeday10##qsodiumintake[CLS]##ivoscreeningfirstidentifiedgeneappearedinterferehisp##orehp##tdomainreceiverdomaino##rprovidedgeneproductmulti##copy##mi##d[SEP][CLS]##d##1emergedanti##genpresentingsystemdistinctiiimoleculethepredictedaminoacidsequence##1##phighsequencehosin##3proteinknowninteractionde[SEP]q##az##onestudynitrogencontainingcompoundremovaldramaticallyl##ymph##oid##urodefectseenb##mi1defindicating##acritical##ivotarget##mi1[CLS]r##x##r##drtrans##activatedselectivelinkedtemplateexclusivelyhe##tero##di##mer##iccomplexreceptoralonetranscription##ro[SEP]nasal##irom##rsaeithernoseeffect##iroera##dication[CLS]of1070##970##1chemistryspecimenparticipatinglaboratorydataperiod37208035rejectedpriortesting[SEP]earlycomplementcomponentc##1##q##gasecretpieceabsentadministrations##4groupresulteddecreaseal##adactivityincrease##pudominant##3transcription##alactivation##ch##ne##ider##pha##3interactiondefinepathwaypathway ee2in##hibitionmechanismdecreased##2[SEP][CLS][CLS] fromsu##ospossibleconnectionsyndromesyndrome ee g##ucregionalcerebrald##ysaudittahall##ucinvestigatedsorientedstudytech##net9999##aos##pectcomparednormalcontrolcontrol [SEP][CLS]lackchronicdepressed##b1dayquickstructuralrepairend##oth##eli##umin##uc##ida##idatepossiblemechanismactionemexaminedeffectdrugexpression##ut##hesion1tissueexpansionpreparetissueclosurefollowingdifficultclub##footcorrectioncorrection [SEP][CLS]thetranscriptionstartsiteidentifiedprime##rextensionanalysis800b##p5flank##ingdsequence##d[SEP][CLS]thereportergenetwocopywildtyperepeat23sequencetrans##cribedactivelys##tero##ldeprivedcellre##pressed80s##tero##lpresent[SEP]changetensionisb##asi[PAD] [CLS]15monthboy##ifersyndromesyndrome describeddescribed [SEP][CLS]however##12cellcloneexpressedp1increasedlevelre##gufashionresponsede##hasisolatedin##i3##d##d4complexjudgedpresence##i3##d##d4theclinicalpictureelectronhis##todescribedcasefi##brotendsheathhoweverstabilitylowalreadyso##dent##alis[CLS]insitep##d##finducedt##osp##lationmappedt##yr138s##h##3domain138exposed##h##3p##eptidebindingsurface[CLS]theresultstudysuggestpatientsyndromex##oc##ard##ialis##chefrequentlydevelopsdailylifesilentis##che##miaimportantcomponentsyndromeincreasedoxygendemandpresenceimpairedco##rona##ry##as##od##ilacause##oc##ard##ialis##che##mia##mia [SEP][CLS]weidentifiedd##nafragment10k##b##pupstreamfirstcodingex##onhumanwhosesequenceconservedgenome[SEP][CLS]falsepositivefractiondecreasedcountdensityincreaseddifferencef##pffoundchangeles##iontrace##rconcentrationconcentration [SEP][CLS]theseeventweaklystimulateactivatedp##dalphareceptor[CLS]humanp##last##ingene[SEP]bus##eremedical##cinpro##stateaparto##rogen[CLS]cc e##b##pdeltan6betadetectedcomplexextractil1t[SEP]reduceduppergas##tro##est##inalul##cercom##conovelco##xmoret##5geneundergeneticmanipulation##ru##zi##rofindgenefunctionatstraincouldstrategy[CLS]ins##pect##rostissue700400cm1region##00##3alsotermed##d##1ho##mo##mologues##chi##zo##sa##cc##har##cesr##ad##21essentialgeneimplicatedddoublestrandbreaknuclearorganization[PAD] [CLS]bio##art##ificdisadvantagedisadvantage [SEP][CLS]thethe objectivestudystudy 1##ifycomparativestructuralstaticfatigueshoetoeboxbox 2evaluatepreferredshoecharacteristicdeterminedsurveylocaldancerdancer [SEP]in##operte##tral##ogyfall##ots##oma##ric##ulara##rr##hy##thconcludedelectro##ucepisodeanti##ar##rsmallnumber##ric##ularprematurecomplexaloneelectropro##gnoimprovedtreatmentresultpreventioninductionright##rich##yper##tensdrugtreatmenttreatment [SEP][CLS]indicationtherapyusingma##oinhibitorinhibitor [SEP][CLS]theabsorbel##uen##uentmonitored[CLS]detailedstudyaimedidentifyinggenegeneresponsiblerapidgrowtharrestobtainedhumanchromosome9foot##print18enhance##rshowfiveprotectedregionho##1##p##1eefitranscriptionfactorbindingmotif[CLS]insulinbindingalphareceptorstimulatereceptortbetasubunitseveral##ogenproteinsubstrateincluding##0##0 ha##4liverspecific20000m##ot##iliserumlevelmeasuredonehour[CLS]therolep##lationreceptordes##zationreceptormutantcellha##mslungfi##bro[PAD] [CLS]firstaidaid [SEP]improvementpharmaceutical##lo##fi##bra##te##de##x##tricomplex[CLS]thedetectionmixedel##uen005013mglseveraltimesinglekel##uenearlydiagnosisearlysurgicaldivision##ry##cre##aticductrecommended##b##d[CLS]weanalyzedherefourdifferentpprotein##3##xalpha##1##xbeta##b##p##1##3s##tatmediatedtranscription##alactivation[CLS]comparisonpredictedaminoacidsequenced##ros##irigeneshowseveralblockaminoacidsequencehighlyconserved[CLS]analysisfocusedtwop##yr##hinenews##pec##iecall##ith##rixj##chusbrownpaired##eli##elicgammalo##cus5gamma1gamma3iim##dcooperativeoral##racanalogue##cresistantc##idde##nastumorroutefoundlevel##sterl##ster##olinter##le##it##utivehicellcelltranstax[CLS]unlikeactivationactivation er##kactivationmappedspecificregenesegmenter##kactivationactivationtriggereddifferenteventvirushostcellinteraction[SEP][CLS]despitedecreasemapr##sat30minpropinrespectskeletalmuscleexaminedeffectmutationmuscletwoinfantinfant ho##mo##pect[PAD] [CLS]appearsun##tre##atedpatientstageiiiii n##hldefiniteradioabnormalabnormalradioextra##oraspreadtreatedpatientquestionableradio##graph##graph [SEP][CLS]b##1fusionyeastgal##4dbindingtranscription##alactivationdomaininteractsynthesizedyeast[CLS]becausela##9contactposition678plus##asseparatedoneturndhe##lixtwistwaydthusprotectingbroadregionminorgroovemajorgroovecontact[SEP]onop##aclego##na##dalaxiscontrolmalephaseo##test##lug##rio##limca##fo##icussubstitutionch##olindrug##z##heimertypedem##ents##da##dathit##her##to##to successfulsuccessful [SEP][CLS]n##leo##tidemiddleanti##done35suppress##orefficiencydisplayedc##yt##op##lastt##yr[SEP][CLS]therootmeandebondidealvalue002a[SEP][CLS]jetlame##lat[CLS]ininteractionconsequentlymechanismgoverningtranscription##alactivation##fdistinctmediadreplication[SEP][CLS]ata##aa##tasequencepresent26n##tupstreammajorcapsitewithin5flank##ingregionseveralput##ativetranscriptionfactorbindingsite[SEP][CLS]versionbriefs##lam##psimilarcorrelationtargetvariablefulls##lam##p[CLS]enzymebinddaffinity20foldintacttop##o##70[SEP]treatment##p45retumorgrowthaccompaniedwellbloodpicturebioparameter[PAD] [CLS]is##tan##bulturkey[CLS]optimaltranscriptiong##dgenedependsinteractioni##4multiplebindingsiteacrosscellularfactorrecognizespecificsequenceelementpromoter[SEP]identifiedfamilycave##olinrelated##olintermed##olin1rolezincfingers##1##26##r1transcription##alregulationhumans##yna##pt##ob##regenehumanhuman fgammareceptorgenegammar##let##utpre##isondtreatmentoccuradded##isonbasestartcombined##isoncalciume##ulosconfirmedpatient20616casefindingpro##tos##co##ceshookninedetection##ulos##5##5 [SEP][CLS]theeffectstimulationen##topnucleuse##pjawopeningreflexj##orstudiedcatan##est##he##tizedsodiumpen##to##bar##bit##al##rusyndromelate##utedisorderdiicriterionidentified6woman[CLS]firstmutationif##ngaactivatedsequencegaseithermulti##mer##izedcontext17k##bi##rf1promoterfailedmedia##rlresponseshowingi1gastarget##rlsignaling[SEP][CLS]02##5##5 [SEP][CLS]resultpetrevealedwidevariationc##b##fregionis##of##lu##raneparticularlycomparisonprop##of##olr##c##m##ro##2decreasedgloballydosedependentmanneris##of##lu##raneprop##of##ol[CLS]selectivesq##uelgriminteractessentialcomponentr##napolymer##aseiitranscriptionmachinery[SEP][CLS]thisfirstdescriptionininte##gro##nlocatedcompositetrans##po##son[SEP][CLS]theninesubjecttreatedrandomsequence##ime##ti##dine00 810goneday##bocapsuleproteinover##exes##cherpuho[SEP]identificationcharacterizationyeastgeneencoding##2[CLS]a360b##pdfragmentlocated500b##pupstream##f##ltranscription##alstartsiteusedd##nas##eiprotectionspecificbaseboundco##rr[SEP]takingcertainconditionfrequentfeedingsupplement##aryfeeding46monthmethodabsence##st##ru##ationlalamrelied1year##umcontainsclassicalironelement3##ns##latedregionconirondependent##rnastab[CLS]likewisee##pid##uralm##or##phinemodifyin##opermetabolicho##rmon##alresponseresponse [SEP]conclusionpost##barpu##ncheadachemaymay mediatedreleasesubstanceptriggeredl##r##ncpatientpre##dis##posedhsubstancepart##erialbloodsamplingbased##spusedquantitative##c##b##fmeasurementm##uta##ted##b##f##1sitedisplay##f##1functionalreplace##1##1sitegivenrapidinductione##r1molecularmechanismunderlyingm##odinjurynationwidesurveyten##foldvariationcounty##sif##n##b[CLS]infirstaccountchroniclehomelessjersey1980s1980s [SEP]re##ct##altemperaturewalk00##1si3987degreecbin3946degreecdominantmutationreceptormapextratrans##ranesegment[CLS]suchsimpleinjuryaccompaniedfarreachingconsequencethisfirstclearlyprovedc##easynthesish##cc[CLS]screeninghumantestc##alibraryprobecontainingppea##3domainisolated22k##bclonecontaining510openreadingframeaurichelement3regionnew##uc##rucon##fersm##odtranslationefficiency[CLS]these1r##hodependentc##os##kel##etalreorganizationclusterspecificarchitecturenecessarypersistentcellactivationchronicdisease[SEP][CLS]changetest##iculartest##osteronetest##isaccesssexinductionvar##ico##cel##erat[SEP]mappsd[CLS]thesedataweightgainincreasedca##lor##icintakecontrastlargeeffectperipheralthy##roidfunctionfunction relativelylittleeffect##nst##r##hactivity[SEP][CLS]##fap##hos##phorusreleasekinetichighbacterialp##hoscontamination[SEP]quantitative1alphaace##ado##lprincipalmeta##bol##iteion[CLS]clinicaltentativesuggestionpossibleadditionalriskcigarettesmokingbavoid##anceve##no##graphycavoid##ancevar##ico##seveinsurgerysurgery [SEP]in##hibition116is##opcirculationorganmetabolicsky[CLS]insa##cc##har##vis##iaeactintro##nsilentbranchpointlikesequenceu##aglocated7n##tupstreamcanonicalsequence[SEP][CLS]therequirementessentialinteractioni##4##lexplanationobservedrestrictiontranscriptionterminationearlyviralgene[SEP]significantlyhigherincreaseincrease i##ga##ga i##praserumtaken36monthgroup122 i##ga##ga iserumtakenshowedincreasegroup[CLS]relationchangebonedensitylevelbloodcalciumblood##pmetabolismstudied[SEP][CLS]theseresultho##mologysequenceamongika##m##m linegene##ibexpressedphylogeneticresponseselfantipartselectionprocessautoresponseregulatedinshowedtotalbilaterals##tri##ate##ct##omirequireexecuteaccurateguidedreach[CLS]comparisonsequencealphalikedpolymer##aseincludingcodpolymer##aseiishowedninehighlyconservedregionconstructed##rootphylogenetictreedpolymerbaseddifferenceconservedregion[SEP][CLS]before612monthh##yl##or##usera##dicationfast##inggas##trine##miap##ep##sinibasalpeakaciddetailedhis##toincludinge##c##lcellpro##lifepattern[CLS]fourexperimentexaminedrolech##olinprojectionse##ptverticallimbnucleusdiagonalbandbr##oc##d##bacquisitionperformanceconditionaldiscrimination[CLS]transactivationhi1l##tr1tatathitaxproteinmediateddifferentc##iactingsequence[SEP]defect##ive##avasuppressionban##croftfi##lar##ias[CLS]fordetailedmapping##9cellcontaining##fsderivedhumanchromosomechromosome 2tag##t##odifferentregion##31q##ter##ricinsrequiresspatient81pcentcent [SEP][CLS]howevercowfailadequate125di##hy##dr##indonset##ationacidiccar##boxterminaldomaingeneprotein##act##opproteinproteininteraction[SEP][CLS]##rra##ngedka##ppagenetranscription##allysilentstructuralfeatureka##ppalo##cuscontributetranscription##alefficiencyrear##rangedkagene[SEP]a1076##3men33 118studied9789respectivelytraced3616dieddied [SEP]n##d##1containssetdomainmultiple##h##dfingerem##gbasedmeasurefatigue##uaexerciseweintroducedchangeyeastttgenedemonstratedtactefficientambersuppress##or##ivothisass##ga##ga i##g##m##yt##oi##ob##ar##bit##al[CLS]theseresult##rainvolvedtriple##trepeatinstabilitycellamongfactorinverseincomeakinaseinteractingidentifiedregulatorydomain##kbetaibaitconclusionthe##jacountryintermediateintermediate positiononerepeatingdomain##b##1consistingaminocloneco##ela##r67ability##rkpmembranemembrane incorporatedreceptorsubstratedramaticallyat##betmediatedactivationenzyme[CLS]methodc##d##4cellcountdatasurveypatientattendingcommunityhospitalbasedhiout##patientclinic[CLS]bio##l##ogenc##d##kdominantc##d##k##r##44##r##4##90##r##r4##9effect##r##5##1##3domainbacterialthe##tafragmentspecifically##da##kat##ateshis##to##logicalvariablelossmotorne##uronlimitedinjectionsitethisnorthernlargestepidemic28year[CLS]s##ptskin##rickenvironmental##tsalttotalserumserum ilungfunction##chia##chial##res##postandardprocedureprocedure [SEP][CLS]bindingsitemappedfactorcomplementarydlibraryliveroim##matscreenedho##mo##log##ousera##l##phaprobe[SEP][CLS]thebindingp##t##bantagonist##icbindingenhance##rlocated##idtract[SEP]ininte##p1inducetissuefactorexpressionmechanismmit[CLS]howeverstudypromoterdemonstratedl##1transcription##allyactivate##s##20genec##iactingka##ppasite[CLS]southernb##lotanalysis##kencodedsinglegene[SEP][PAD] [CLS]surgicalmethod##hino##phy##az##oly##6##p##ddeficiencyfinallyalthoughdbindingdomain##brequireddifferentiationblockshiftcellcycle##atreatmentp##inkinasemitposition111253##brespectivelyactivation##fdependentreportertranscription##1##apotentsuppressed##1##b##b 19k##da19##k[CLS]ourresultshoweddirecten##anti##omer##icseparation##to##in##ira##iral##rycolumnretentiontimesr##to##in25526minrespectivelydetectionlimitle50ngm##l##to##inmy##elozincgene1##1chzinctranscriptionregulateg##ran##ulo##po##iesregulatorycellularproliferationon##co##genesis##genesis [SEP][CLS]snailinfectedthreefivemi##id##iaproducedmeta##cer##car##iaeinfectedsingle##id##ium##ium [SEP]##1formho##mo##teroo##go##mersviad##hdomainmutation##alino##go##mer##1associatedimpaired29##3cell##1mediamediatesleastpathway##afactivationoneconmainlydependentonesignalcooperateauaugment##a[CLS]fortargetstimulusp##3amplitudelatecorrelatedtightlycoupledfrontalcentralrightmediallateralrecordingsitesite [SEP]mit##ox##roneplus##racombinationtherapyam##l[CLS]inre##nalcortexs##pledi##stalco##lonil##eumgal##l##blastomachbodyregionalo##2deliveryhem##odgroupashortaccountkato##utolifehistoricalconceptgiantcellcurrentinterpretationnatureunit##arianview##oly##kar##yonfavoredx##asgiantto##utocharacteristicdemons##idc##op##m[CLS]chronicactivehe##papregnancypregnancy [SEP]ininducedn##fdependentgeneexpressionproteininvolveso##xi##daradicalactivationikinasetheseobservedchangefoundlevel[CLS]re##versibletopologybi##functiontransdependsuponchargebalancearoundtransdomain[SEP]kinase##cactivationtreatmentne##uro##blastcell##afoundenhancetranscriptionhumando##pabetah##ydrod##b[CLS]thesecondcontrolgroupcasediagnosedh##si##yt##ology[PAD] [CLS]theill##umi##nat##oruslightadjustbulbholderfashionedbentpaperclipclip [SEP]##ime##imexn##ymph##gorstar##vedcentralsecuritywardcolonygroundelhetogether27##6serumsamplerecruitwardtheg##eno##micorganizationregionsimilarsimilar neuralrestrictedmember##1##1 el##l##2m##hu##d##d el##4##4 [SEP]s##yne##rg##uke##9br1##asd##re##gumap##k##sca##dewithpartiallyoverlapping##mat##oussu##turedifferentre##nalsegmentde##vi##tal##ized[CLS]promoterelementtranscription##alcontrolmouseace##ty##cho##lines##teragene[SEP][CLS]thecumulativeudose65cmcm2patientreceived200cm##2[PAD] [CLS]ma##lf##ormopte##ctla##gy##ptb##ufregular[CLS]thesem##or##phologicalchangemarkedinductionp##45##0##mgeneexpression[CLS]theim##mu##p##fiadultpatientpulmonarytuberculosisstudiedcontrolve##nousrelatedreadilydiagnosedcomparingsimultaneousbloodsampleviaperipheralvein[CLS]theroleas##xiamechanismiiacutedrowninghanging[PAD] [CLS]processinglargebitmanipulationmanipulation heavymemorystoragerequirementrequirement [SEP][CLS]thus##rl##iga##tioninitiate##i3##kt##sk3signalingpathwayc##ac##lontranscription##alpropertyg##cboxbindingproteinb##b[CLS]thisactivitycreates4b##pstaggeredcut3ohover##hangwithinspecificsequence21r##rnageneo##gastrain[SEP]thetwoorreplication##mi##dp##k##12th##io##ba##llusinter##med##iusco##ie##2related##mi##d[SEP][CLS]inssfg##mil3inducedtpgammaplcgamma[SEP]phaseicombination##hot##omyreplacement##al##20##21dim##ericr##iibetaproteinbind##p##75approximatelyavid##lyr##iibeta[CLS]thetemporalexpression##b##psimilarphoto##re##ceptordifferentiationcomplete[CLS]i[CLS]intwosignalpathwaycriticalinter##leproductionproduction [SEP]replacement##6domain##1##a##paracidfoundc1##k1nette##rna##rycomplexformation60effectdirectdirect actionda##zo##lend##osisinin[CLS]then##fre##ltranscriptionfactorparticipateactivationimmunesystemregulatorygeneviralearlygeneincluding1terminalrepeata491childexaminedquestion##nairesat##is##fa##factorcompletedrelativeguardianusuallymothermother 465##1##1 [SEP]c##ac##lon##ingrevealstwoinintetrans##criptdistinctc##op##las##micdomainresultalternatives##licing[CLS]earlier##opportionfilmcontained##uc##us[CLS]objectiveto##mar##marisequantitativeassociationmoderatealcoholco##rona##ryheartdiseasepredict[CLS]likeknown##dgene##d##14##d##15probablyrequiredgeneraltranslationinitiationadditionrole##4specifictranslation##alcontrol[CLS]highlycorrelatedfrequencystrongmediumfrequencypatterngeneratoroperativebeyondneon##ata##lperiod[CLS]thisgenenamed##x##1humanno##menclaturecommitteedifferentiation##orsimple##roma[PAD] [CLS]hi##v2spa##in##in [SEP]noeffecteffect 4betaobservedexpressionhpatientexternalframecum##bers##omedtheat##1genegene s##chi##zo##sa##cc##har##ces##omb##ombeb##zi##ptranscriptionfactorstrongho##mologymafactorat2[SEP]theeffectsourcecommercialratiohumor##alnewnewcastledisease[SEP][CLS]multipleattemptaimeddisruptionch##rom##oso##malfgeneunsuccessfulprimaryt##j##rsdegree##ste##rosis[CLS]radiationi##rra##diah##pox##iap##min##ivatissuesectionmodifiedtotechniquecomplexityreportv##acopposedest##rogentrue[CLS]thusmutantdef##icientoanti##genpolymer##asetermed##cmutant[PAD] [CLS]up1988145casereportedliterature32casecountrycountry [SEP][CLS]focalg##lo##mer##ulos##cle##rosislikedisease##ph##rotsyndromehorsehorse [SEP]##hy##pert##ensdi##ureinter##con##version##sha##eri##doreducedha##eri##do##chi##zo##rensteadystudytheeatingdarkmeatfishpositivelyserumedo##3serumseffectfoodhem##ody##nam##icsd##44##3substitutionact##ivatingmutationrenderresistanth##cho[CLS]centralheartrate##o##2localmusclebloodla##ct##atead##eno##sintrip##rea##tine##nasg##ly##co##gencuehighlightedcomplexityeffortneedbetterunderstandingphysiologicalcomponentuponbased[CLS]thegenepredicteden##code88aminoproteincontainstwoc##hzincfingernuclearlocal##izationsequencetwotranscription##alactivationdomain[SEP][CLS]examinationbase##linefactorwelleffectchangemile##ageoccurrenceproblemoccurrenceanotherhealthproblemrate##out##out [SEP][CLS]micro##uriamarkersystemicdisease[CLS]regulationact##ivatingtranscriptionfactor1campelementbindingproteinprotein caca2##od##ulindependentproteintypeiiiiiv[SEP][CLS]##rona##rybiotissue307639formedstudygroupserum##yl##adiseaseam##yl##hrat##os##pacellimplicatedpath##ogendisease[PAD] [CLS]p##ace##ph##rit##is[CLS]wedigitalflu##oroimagingsystemreplaceportalfilmverifypositioningradio##ther##aptreatmenttreatment [SEP]thehumanpgenespanleast75k##bcomposedthreeex##ontwoen##codepprotein[CLS]serum##rea##tinkinase780017500umakingacutemuscledamagelikelyprobablyr##hab##dom##yo##lysis##lysis [SEP][CLS]highlyspecificeventmerelyconsequencedecreasedstabilitye##clikem##d##d##x##x ablebindin##hibit##53trans##act##ivationhowever##d##m##xde##grade##53yetexamined[PAD] [CLS]purposeseconds##m##mnsrareoccurrencesuccessfultreatmenttreatment childhoodcancercancer [SEP][CLS]recentgeologicalstudyfocusingda##viefracturezonem##oz##am##bi##quechannelresolutionsituationpresencelandbridgemide##ocene##oceneintervalmatchage##rgroup[CLS]then##uc##leo##tidesequence##ram##plifieds##m##t##3##eno##micdfragmentidentical##t##3##aabsenceintro##nproteincodingregion[SEP]mutantp##53dcloneco##loncar##cin##atransformingcomparisonhotspotmutantgas##romadischargetrim##eth##yla11samplefishodorsample[CLS]standing##bo11479b##ht93##3926767 [SEP][CLS]i##x##odes1971showfollowingtrendhpu##tata##tata rtt##ickpreferpreferably##si##tisincreaserelativeshare[SEP][CLS]thesegeneclone##dsequencepredict994k##daprotein45sequenceidentitybetacop[SEP][CLS]studyf##etalmaturitymaturity [SEP][CLS]f##etalart##erial##git##talsinbase##o##2oxygensatdecreasedhydrogen##co##co2increasedas##phy##xiaaloneas##phy##xiaplusis##of##lu##raneoxygen[SEP]thereforeappears##nkinasefunctionstimulate##d##lation##allyaminostar##vedcell[SEP][CLS]##elalone##38##kactivationsubsequent##d##9##80##9dramaticincrease##38##k[CLS]in35patient##n##rt##j##rjunction##albeatservedtriggerre##entry##entry [SEP][CLS]thethreerespectivetimecontrolgroupcinjectedsasolution[CLS]sequenceanalysis##acloneencodinghumangammarevealedopenreadingframepredictprotein29##9aminoacidapproximately32k##dahalfsizeb##ov##ovinegammasubunit[CLS]apositive##b19##mtestindicatesnecessitytreatment[CLS]ourdatasuggestdefectobservedbwr##tsconsequence##rainre##comb##ination[SEP][CLS]thepromoter##as##ynth##asecontainstwobindingsites##teroregulatoryelementbindingproteins##b##ps[CLS]thesedatach##romaticprocessingareav##1##2normal##4les##iontogetherbehaviourareasufficientbasicbasic aspectcolourperceptionperception [SEP][PAD] [CLS]thecurse##hara##haraohco##var##iate##s##trerangesensorycharacterizationtargeteddisruption##1p##orecomplexp##1member##ydependent##d##kinhibitor##y##d##kcomplexincatresponse##ifer[CLS]p##1regulated##cription##almechanismincludingsublocal##izationtherefore##1proteindg##cos##ylal##yas[PAD] [CLS]onepatientd##ph##oria##oria onetoxic##a##a [SEP][CLS]al##ve##ol##uscap##illa##rydiffusion[SEP]mutationsin##4r##3##8##9##10##rb##11twonovelgenenut##1nut##2relieverequirement##pexpressionreporterreporter [SEP]ca##culahp98##45hp85##aforthe##rm##usstrainz##o##5di##hy##dr##otad##ho##aseencoded##chighestsimilarityidentityd##ho##asesca##ldob##ussub[SEP][CLS]precisiondatamodelsodiumkinetichem##od##ial##ys[SEP]thesefi##bri##nogammaregion##0##20functionminimalrecognitionsequenceininte##teg##d##d11##18[CLS]atserumco##rt##is##olresponsefoundpatientdespiteact##htestisolation##to##xin##t##12##32pointmutatione##17activesitesite a##bolen##zy##maticn##t##12##43nonsensemutationresultdel##eti##oncterminal25##23##stoptoxicity##zo##yl24##rich##raz##amimeta##boltwo##spspidermitlivermon##oam##ineo[CLS]screenmutantwhosegrowthdependshighgenegene [SEP]thegeneexpressedem##b##ryoz##etaf##etaladultstagealphaalpha1modifiedpointmutationaffecteitherprocessingtranslationmake##idechainextremelyunstable[SEP][CLS]in##oremainpulmonarytuberculosisreceived2monthdailytreatmentsr##ami##defolloweddailyis##dreither##amis##z##rzwithouts##z##rallocatedrandom[CLS]##f##50geneproductcontainscterminalactivationdomainactivategeneexpressionviaspecifictargetsequence[CLS]n##sai##dmicro##rcstomach[CLS]theefficiencynormalrelativenetamountp##mi##dactuallytranscelldeterminedmodifiedsouthernhybridprocedure[SEP][CLS]##eno##micsouthernbhumanha##p##idgenomecontainssinglegalphagene[CLS]evaluationeffectch##ela##tiontherapytimes##tron##tiumexposuremouse[CLS]inpresentstudyfound##d##34down##re##guhem##ato##po##iesoccur##edleveltranscription##alinitiationall##erstimulate##d##d2##456146146867##9##isonlikewisehehete95llte##te45454 20915151 15hehete##te 6325[CLS]foreignd##nainsertcontainedwithinf##poxsequencetransferredviralgenomeho##mo##log##ousre##comb##inationoccurringcellinfectedf##poxtemperaturesensitivemutanttrans##fectedwildviraldp##mi##dd##na[SEP]althoughevidenceconeratiodeterminecolourappearancemanyconditionsitesitecomfurther1formspecificslowlycomplexpu##fbinding##m##fpromoter1sitesite [SEP][CLS]severalcomponent##yt##okisignalingremainunidentifiedthisfirstdemonstratingspecific##itylevelenergycouplingp[CLS]instemloopstructure2343domainshowedgreatvariationsizesequencestructure[SEP]s##pect##hotmicro##det##er##mination##ate[CLS]resultfollowed1earlycancerlikeadvancedcancerconsistedles##ion128les##ion962p##ept##icul##cercancer##ousles##ion73les##ionactivestage55les##ionscar##ringstagestage [SEP][CLS]effect##ae##all201red##butnormalcanmy##oc##ard##ium[SEP]1404p150precognized95##j##10per##le##can24404p##cher##ichi[CLS]theancardiacsurgeon[CLS]togaininsighteventalpha3geneminimalpromotercharacterizedfound67basepairupstreammajortranscriptionstartsite[SEP][CLS]f##d##p11in##cor##onainjectionco##lla##teralflowreducedsystemicarteryresistanceco##rona##rys##ys##toin##far##ctedregionareain##far##ctiondecreaseddecreased 2891315312pp 00 01nn 66 [SEP][PAD] [CLS]path##op##siomechanismunderlyingspatialdi##ient##ationpatiental##z##heimerdiseasedisease [SEP][CLS]manymacelllackmet##hyl##thi##ospm##penzymeactivity40minis##cherecoveredtrans##mura##lconduct##ionblock##1group4minle005##223min##runcated250word[CLS]thenovelgenespan167k##bg##eno##micsequenceformed11ex##on10inter##veningintro##n[SEP][CLS]gboxbindingfactor##b##fsconstitutedbindingbindboxmotifregulatoryc##ielementpresentmanygenep##nd##romdmotif##gt##g[SEP][CLS]conclusionacutecanl##c##xco##rona##rys##tenc##f##rimpairedis##che##micremote##ische##micregionassociationmildmoderateis##che##micinducedregionalmy##oc##ard##iald##ys##function[SEP][CLS]athirdorderp##oly##lfitshowedgoodcorrelationparameterqm##ttwhereastsi##maxfoundpoorcorrelationcorrelation [SEP][CLS]lateresulttreatmentu##rot##rc##ulos[CLS]changefrequencyxch##romawomanpre##dn##isontherapyothertoxicity11de##hy##dranauseavomitas##the##nia##nia [SEP]proceedinginfluenceha##lothe##3##ukeresulthighdose05resultam##niofluidsamplestoredstrictchangeoccurinprogressioncertain##p1transcription[CLS]thepatternnetrexpressionadulttissuedifferent[SEP]spin##op##hilnebrainextract##1##gam##ma1##1##a[PAD] [CLS]thethe authorpatientma##gnanttumorroutinexraystudy##rto##mo##graphypatientinvestigatedwaypluscct##t [SEP][CLS]reductionp##53proteindetected1daytreatmentreachedma##ximalsuppression1020control3dayh##39##2240control4day##f7cellassociationst##osoccurstwo##os##osbasedactivationmotifh##y##hes##izedlassociateassociate ye##eaacidmotif##os112##11##2##cor##tic##nos##pressnoticeablelevelt##3er##c##f##f [SEP]four##brocloneinfected##trocontaining##aencoding##odpuselectionmarker[CLS]serumest##rio##llevelbetareceptoragothirdtrimpregnancy[CLS]ininvestigatedmechanismtaxactivategeneexpressionconjunctionmemberat##f##bfamily[SEP][CLS]four12patient33initiallydiagnosedben##igndiseasefalsenegative[SEP][CLS]howeverobservedstoragetimeaffectedbio##chemicalchangeoccurringconstituent##rotgammai##rra##diation[CLS]suppression##1deltamutantp##hen##otypeoccursinteractionc##b##1defect##iveencodedcat##alyticsubunit[CLS]themediancumulativeincidenceratefound34##1permale29##6femalefemale [SEP]th##omasimilarlyt##fbetaii##go##de##leo##tidemicroresulted58increasebranching##sma##tchedsequencecontrolt##fbetamproteinexpressionlevelsuppressed84respectivelysecretcutdome##dcellleadhoney##comblikestructuregivesuperficialwarlikemit##oticcloneadultadult [SEP][CLS]takenresultipu1criticalelementil18geneexpression[SEP]basedresultconcludedi##sapromotehealingprocessa##vas##cularzonetornmen##is##cusrabbitsystemicvasculars##yn##ov##ium##is##cusessentialhealingoccurna##sa##r122##3[CLS]themagnitudefourparameterincreasedex##po##nent##ialfashionincreasing400x106e##culatewestudiedhis##to##logicalfindingkidneyin##fimac##roponehourtransplant##ationkidneybioonehourbiobiopatient[CLS]anadditionalstimulationd##1receptorgivings##38##39##330minalmostcontinuouspatternjawopeningleclosuremovementrestpositionopeningaccompaniedfrequenttonguepro##trusion##trusion [SEP][CLS]controlheart[CLS]the000 2di##ff##ractionhacrystal##lfibershowedaround60archanglech##sfibershowedaround10degree[SEP][CLS]during4oventilationbase##linepulmonaryvascular##rdi##lators##n##pgreaterlunglung [SEP]determineroletrans##ranehfusionhproteinbiologicaltonurse[CLS]transtrans45##51##1catconstructcontaining5regulatoryregionrat1geneactivated##phacotrans##fectdosedependentmanneractivationpotent##3realphasynthesis22th##zo##kan##eb##zi##zoant##minhuman##r##2restrictedcellulardistributionexpressedl##ymphden##drs##ge##ale##pitcelllowlevel##ymph##yte[CLS]##r##1extractmadeglucose##epbound##1dsimilargreatlydifferentactivate##h##2geneexpression##ivo[SEP]furtherago##nist##t##1receptorantagonistaction##treceptorappearcontributeanti##de##pressd##rl72schedule[CLS]geneput##ativefunctionpreventionddamageincludecompletebaseex##cisionpathway##ildg##cos##yla##leadpolymer##asebetana##ddependentdl##iga##sephoto##rea##ivationpathwayc##lo##but##anep##iddim##erphoto##lyalinetypereversetrans##cript##asemho##mo##loguethreegroupm##oddischargemotoriitransitionalphasespara##dox##icalsleepii##irapideyefollowingelectrical##brare##ularformationm##rf##rf [SEP][CLS]likewiseconsensussignalbelievedinvolvedterminatingearlygenetranscriptiont##tt##ttevident3boundaryn##2m##1or##fssuggestinggenemayearlygene[SEP][CLS]thisradio900b##pam##p##lichybrid##izationscreenc##alibraryconstructedr##naisolatedinducedtaxcellfulllengthtranssequenceobtained[SEP][CLS]lowtemperaturetemperature 8degreecimp##airsecretindependentlyphoto##per##io##dselected[CLS]##ricco##rona##rysin##usfist##ula##ula [SEP][CLS]instructured##nasequencetranscription##alcontrolregionhumanw##ista##rsinglefunctionalculture[SEP]ma##gnesiumcontentcouldmedium[CLS]thesequencethreerevealedpureca##gstretchstretch [SEP][CLS]furthermutationelementiiresultchanger##nastructurenearelementii##iconsistentlongrangeinteractionmaypromotetranslation[SEP]althoughq##tdurationhigherbeatbeatvarintervallowerdomaindecreaseddedomaindecreased00004chaoticdomaintightercluster[CLS]theratsurfao##go##mer##idesubunitderivedsinglegenedependentintactdi##sul##fibond##1mutant##ivo1114nterminalaminoacidalteredviables##ym##pttypicalwildinfection[CLS]thistakenuclearcompartmentnormal##is##licingproceedsybranchedintermediateanalogousla##riaformeds##licing[SEP]##b##d##paloneth##rom##bol[PAD] [CLS]chronicremulti##foo##ste##elimaximumbar##oreslopecurvereducedat##her##os##cle##rot4253472##130spike62000 8spike[PAD] [CLS]apath##ogen##eticrelation##ise[CLS]co##rona##ry##as##oc##triccausedend##oth##elin1enhanced##che##pernor##ep##ph##rinepresentconcentrationtypicallyobservedneon##ata##atal[SEP][CLS]located3transs##lice##dleaderaccept##orsitetranslation##alinitiationco##don##6##3geneareaconserved##ot##idedirectrepeat##t##c##ccvarynumberaccordings##pec##ie[SEP]##lukplasma##raw10h[CLS]insulinsecretis##lett##umour##cre##as##as [SEP]disruptionreconstructionnarrativeinsightillness[CLS]theresultposteriorwallcom##pliantanteriorwalldifferencetrans##mura##lpressurelocalsegmentlengthchangeposteriorwallgreater[SEP]pdieselexhaustde##pjc##edarpollenall##er##ain##llypartialcharacterizationcc##aa##tboxpromoter1geneinteractionnegativelyactingtranscriptionfactorde##cid##ual##ized##als##alcell[CLS]transcriptions##d##1##d##2generecellulars##tero##llevellevelnuclear##b##1transcription##alinductionrequiresthreespatialconservedc##ielementbind##by[SEP][CLS]threetranscription##alcontrolelementwithin300basepair5flank##ingregionratg##lu##ca##gongeneinteractregulatorycellularproteindirecttranscriptiong##lu##ca##gonproducingis##letcell[SEP]arolep3regulationbeta1ininte##d[CLS]relationshipageassociatedend##rinedeficiencymuscleelderlycrosssection##alstudystudy [SEP][CLS]insequenceessentialtranscriptiontranscription eeft##1localizedregionstartat##gstopco##don##17geneterminate##s26##7n##tupstreamstrand[SEP][CLS]exposurer##aftcultureact##iva##bolresultinductionlategeneexpressionwellv##iri##onassembly[CLS]acase2cancerco##lon##lon [SEP][CLS]theggre##ggphenomenon##oc##ardfunctionoxygenconsumption##voincreaseco##rona##ryper##fusionenhancedwithinautorangerange [SEP]mappedspecificdomainwithinproteinresponsibleinteraction[CLS]instudiedtypetwoc##d##pcutbindingsite##moverlapknownpresumedbindingsitereplicationin##iti##atorproteine##1[SEP]reducedcellnumber72hins##no[CLS]h##ydroradical##printdcomplexetdomainpu1comparisoncrystalstructureatformulatedpro##th##rom##binpfi##bri##notransformation##rrepresentationth##rom##bin##bri##no##gbloodplasma[PAD] [CLS][CLS] lpin##af1interfere##af1activation##ksubstratebinding##henmolecularpartialchromosome21##osoenabledudefineregionspanning24m##bd##21##s##19##0d##22##6associated##pore##tar##dation##yper##tonseveralfacialan##oma##ly##ly [SEP][CLS]theclassics##tero##lregulatoryc##ielements1##dlreceptorpromotermedia##tessregulatoryelementbinding##b##pbindingeffectinsulin##letderived##d##f[CLS]theca##2concentrationserumin##gas##tric##allyf##rim##oladministrationdos140120110l##d##505dayinvestigatedinvestigated [SEP][CLS]co7celltrans##1campaccumulationhighest##rfutilized100[SEP][CLS]##yk##noto##ste##ocincreased12h012day00##1is##che##miatherightratca##uterdrop15nh##c##130oneservedcontrolis##op##rote##reninheartrate30beatminbase[CLS]thisprobablyv##ivobacteriaperhapsdormantformentirelydependentuponu##reasesurvival[SEP][CLS]thesystemconsists##com##puteanalyze##rbloodgasanalyze##rflamephoto##meteriont##ratorbloodsugaranalyze##rhem##ogsat##urationmeterhis##tobio##ificoneconcludedfrontalbiohighpro##gnoclaimedreport[SEP][PAD] [CLS]abdominalpainhem##atofallfall [SEP][CLS]fusionc##d##d8classirestrictedb##51##47thy##moin##var##d##d8hybrid##omartrans##cribed##d##d8alphalgeneund##ete##able[SEP]plasmaact##hpatientgroup[CLS]forptrans##criptpgorientationfullterminationactivityrequiredregioncontainingstemloopstructureupstreamsequence[SEP]developmentneuralcontrol##iment##arymotor##te[CLS]cellexpressedthree##rrelatedmtrans##cript253010k##b[CLS]these##1##cc##op##las##miccomponentmachineryresponsiblereturning##1kinasebasallevelre##esta##lishingglucoserepressionhoweverblendmeta##niii11resultedd##150value288min[CLS]themajoritycellalso##4positivehelp##erinduce##rminoritypositivesuppress##or##oto##xi##yteaimpost##he##cha##emoxygenmetaboliceffect##oc##ardviain##hibitioncar##ni##tine##tra##fer##ase1##empatientsevere##orts##ten##osis##osis [SEP]theif##narchaininteract##sifalpha2betademonstratedcrosslinking[CLS]toclonecbetasubunitaminoacidsequencedatafirstobtaineddesignredundanto##leoprime##rusep##r[SEP][CLS]wec##lon##ing##1gene44k##b##3##ainsertyeastshuttlevector##5[CLS]ni##mo##di##pine5micro##gramfollowedin##fusion075minbloodpressure##ote##ns##yperdosescheduleni##fe##di##pinemap##it##rostudymayrelevantpath##ogenal##ve##olidustinducedlungdiseasetheatoptimehigherratioratio 70951631101influenceage[CLS]aselect##ablemarkertransformationconstructedtranscription##alfusion##tilmaymaydisheatgenepromoterh##ot##ran##fer##asegenees##cher##ichico##li[CLS]thestructure##ror##fconfirmedsequenceanalysisfragmentobtained##ram##p##lificationtestc##rspecificprime##r[SEP]theaimstudydetermineresponsehumancortexch##romaticmagnet##oe##phatherole##1regulationnitrogenmetabolismdiseaseprocesspath[CLS]thesethreephase##c##romadiverse##cc##d##kinreplicationblockingre##re##plicationallowingre##settoriginmit##osis[SEP][PAD] [CLS]##ortrelatedder##mat##thinter##le##leukiilacquisitionilil 2[PAD] [CLS]enter##oto##xin##rance##rance [SEP][CLS]measurementgiven##ranoin##hibitincreaseqi##batindicateddecline##batat##tri##butqratherrather increasingsat##urationup##take##take mechanismmechanism [SEP][CLS]plasmal##hpro##tero##nelevelsinglemultipleinjectionsyntheticsynthetic lran##oes##tro##usecomparisonlevelo##rouscyclematerialandand method[CLS]butmate##dmalebuiltnestabsenceyoungtlevelhigherconditionthoughearlybr##ood##ood [SEP][CLS]prime##rdevelopedspecificam##p##lification98##0##4genefragmentinteract##1in##hibittrans##actepromoterpromoter [SEP]mutantretainedparentalparticipateinterco##aghumanoralact##inospecific##itymutationin##traco##ag##s[SEP][CLS]thesa##cc##har##omy##cesc##vistargetrap##r##1to##r##2signalactivationcellgrowthresponsenut##rientavailability[SEP]biologyan##op##helconditioncentralfl##dacorresponds##ti1vaccineth##rom##bol##ys##oc##ardin##fart##iiirandom##ized333patientininv##v n168##1conservative1typep##las##min##ivar##oc##ardin##far##ction[SEP][CLS]inin additionmutationwithin##b##xunitex##onknownbehavenullall##ele[CLS]takens##3s##4complexleastse##ablenuclearfunctionformrapidyettranssequencespecificdbindingcomplexpotent##p##1dependenttranscription##alactivation[SEP][CLS]whenp##hen##ter##minemixedrema##oinhibitorinhibitor ee gpseudo##ep##rinee##drnorest##rad##iolben##zo##atedegreema##oin##hibitionadd##itive##itive [SEP][CLS]herepointmutation##b##dbgenetranssuppress##ab7##hen##otypepairingdependentmannerthusrepresenttypetrans##ve##ction[SEP]438newmotherexaminedretrospective##ly##ly enzymeelcm##vpregnancy[CLS]alsoresidue27##3287identicalsequence15acidsegmentnearcar##boxterminussitranscription##alact##iva##findependentlyenhanceminimalact##ivaregion[SEP][CLS]analoguecalciums##tron##tiums##r89rapidlyclearedbloodvinjection[PAD] [CLS]effect##um##operdi##sse##minationscarimp##lantabdominaltumorcellninedscoreobserved##itapark##ins##oniawhereasfullparkakin##dladministrationadministration [SEP]altert##rm##ccontactrecognitionclassimmh##csingsubstitutedvarianttwopatientpatient e##wingre##lap##sed1localdistantfailure26diseasefreebodyi##rra##diation##em##otherapy##otherapy [SEP][CLS]thec##lonhuman##po100providedinsightstructurep##po100facilitatefactorm##od##po100bio##sy##synt##hesis##po100genepatientd##ys##gio92patientprimary##gioaccepthomemonitoring[CLS]repeatedinter##ferbetaif##nbetasilence##rbmotifl##ozsilence##r1motiffound##d##9geneapproximately16001100respectivelyaction##riochoo1to##xchemicallemonpatientchronicphotos##itider##matact##inire##ulo##idhightotalserumiconcentrationconcentration [SEP][CLS]thesequence25k##dachainalphasubunitfound##acloneaminoacidsequencede##duced##aestablishescompleteaminoacidsequence25k##dachain[SEP]characterizationchromosome19break##pointregionrevealedtranscriptionfactorencodinggeneaffectedtaxactivetaxmutant##1arresteffectco##rrelalteredlocal##izationnuclear##53disruption##53dcomplexpatientadmittedwithinoneweekonsetdarkurineurine 45hahavwhereasspecimenadmittedweekcontainedvirus[CLS]bio##chemicalidentifiedcellularelementencodeddbindingtermedinvertedrepeatbindingi##rb##pspecificallyinteractouterhalf31b##pterminalinvertedrepeat[SEP][CLS]three##foldobservedmenhighestintensityhighestheavyriskrisk [SEP]spontaneouslevellowernormalhighercontrol[CLS]wesequence79##41b##pdfragmentarmchromosomev##viscontainsfouropenreadingframeor##fsgreater100aminoacidresidue[SEP][CLS]a40k##bnmessagealsopresentem##b##ryo##genesisdetect##abledaye##10##10 [SEP][CLS]promotingfatu##til##isationreducingcar##bo##dra##tefatratiot##preducesradicalsimilarfatexclusionexclusion [SEP][CLS]cellinfected##vstructuralcoree##1e##2d##d##x##3coreco##loc##zeddistinctspotper##rregionc##op##m[SEP][CLS]m##utasequenceeliminatedcomplexformationmarkedbasalcampdependentpromotertransreportergene[SEP]thelowestp##acolowermfwddgroupcontrol[CLS]thetranslation##alproductul##265infectedcell35if[CLS]thetapgenemapped70##baseh##2kcent##romeendmouse##c[CLS]duesignificantho##mologycterminusm##utatrans##po##saalternativegeneproductnamedtraptrans##poassociated[SEP][CLS]nonethelessmajoritylocatedwithinthreeshortsequencenterminusmiddlecterminusphylogenetic##allyconservedknowne##cter##ialch##op##lastversionprotein[SEP][CLS]thec##af1procellularho##mo##loguer##afonacute##lytransforming36##11##v[CLS]##tar##dationfourbindingsiterap##1##pidentifiedwithinpromoterrap##1geneinextractpotentphoto##tasuppressionalcoholabusetreatmentresistanceskindisease[CLS]themeanserumc##dt5s##dul16s##dulp00001[SEP][CLS]subsequentanalysisrevealeduniquemodularstructureconsiststerminaldeathdomainsimilarin##tra##cellularsegmentt##freceptor11 f##acterminalregionrelated##op##las##micdomaind##ros##opm##or##ph##ogentoll1receptor[SEP]r##t##ranalysis3mpresences##p##licevariantex##on78deleted##x##rom##osorear##rang##ementleadfusiongrowtharrestddamageintranscriptionfactorch##op##ad##d##15##3p##eptidefragmentencodedt##lgene[CLS]showmma##oe##nseisolatedenvironmentmaysourceinfectioninfection [SEP][CLS]theadministeredcommonleadis##otomixrate1300##gramkgwwtdayage10monthstartstudyup##re##gum##tanti##rodlimbregenerationcharacterizedmmtanti310325k##da##roicoreprotein285300k##da[CLS]analysis##v1##po##1revealedhighaminoacidho##mologycorresponding##ptvar##iolvirus[SEP][CLS]theeffectdo##pado##padreceptorblockha##doactivity##otch##em##orestudiedstudied 24an##est##tizedvent##ilatednewbornkit017daypatientabnormal##s##f[CLS]control##ychgaveremarkablyresult[CLS]patienttreatedeithereither 44 8millionunitpro1##ne##cid3545g1##ne95te##cygiven4day[CLS]theresultstudyimprovedcrestcompletelongerripbrsuperior05inter##p##ro##ximalpenetrationgumco##gatetotaloralbadvantagebrush[SEP]cardiacnehigherbasehealthyre##nal##nal wholebodynesimilar##letfactor4healthyhighnewbornplasmare##ninactivityessential##erialh##yper##tensobservedincreasedg##rafthalflifeera2pnproteinencodedgenecalledproteinparticipatedcomplexshow60identityconserveddistributedproteinreferred33protein[CLS]pits##rebeta1proteinsuperrelatedmastermit##oticprotein##c[CLS]ma##ximalexercisedurationpeakoxygenconsumptionchangedchanged [SEP]inn##fbactivationobservedcellstimulationp##t##din##s45psynthesishandmoderatelyaffectedeven##1##del##tamutantprocedureaccurate##ii##iinhibitor48patient##orabloodsupplybasedr##adi##loslowestt##12secondhigheronett##10serumc##3valueobserved11childstageillnessthebroughtho##ustlaboratorymeasuredanalyzedl##ign##inproteincontent##ylaam##monial##yasper##idasactivityp##ax6lackingcterminalactivationdomainre##pressedbeta##b##1crystalpromoteractivityeffectivelyfulllengthproteinalone##ax##as##p##licevariantalteredpaffectingdbindingspecific##ity[CLS]are##gressionanalysisshowed86varianceweightpredictedtwoleadingindicatormiddletreatmenttreatment [SEP][CLS]objectiverespiratoryrelatedelectro##mysuperior##al##ricanalyzedearlystageforcedbreathingbreathing [SEP][CLS]thepredictedaminoacidsequencecontainedconsensusregionsad##enomet##tra##fer##asespresented26identitysa##cc##har##cesc##ere##vis##iaed##bmet##tra##fer##ase##ase 38identityratproteinwellbacterialbacterial es##cher##tra##ns##ferencoded##ggeneletterball##ist##oc##ard##io##graphytheintroduction##1promotesdegradationi##kaconcertikinaseresultingnucleartrans##f##ppa##bf##osbloodpressure101h149patientdi##asth##yper##tens8615180patientisishalthough##b4is##olateleresistant##lor##b##olate1000mincontact001inputinfectiousinfectious [SEP][CLS]thesu##deat##ropuppersympatheticblockadetoth##rom##busgrowth##ret125fi##bri##noauto##logth##rom##buspre##formed##ugrabbitrabbit [SEP][CLS]th##all201s##cin##tidipinlowlevelexerciseexercise [SEP][CLS]kineticmodel99##m##t##cd##aratrat [SEP]crudedrugplant[CLS]yettest##osteronepredominanttypeiimalem##or##phneithercourtnestnest insteadinstead para##sitypeimalesneaksatellitespatactictactic [SEP]comparisontherapeutic##phereterminal##mor##phismbetaad##reneagoregulatory[CLS]henceperhapsnecessaryperformspinalpu##ncpurposedetermine##fserumratio[SEP][CLS]##mi##donecontainingterminusfuseddbindingdomainyeasttrans##act##ivagal##4containingnfusedfused hertrans##act##ivatransco1cellalong##ran##fer##asecatreporter##mi##dcontaininggal##4dbindingsite[SEP][CLS]bio##chemicalexperimentgenomese##quencingshowndespitepro##kar##yocellgenomeorganizationbasaltranscription##alelementmemberdomainarch##aeeta##taboxlikesequencer##napolymer##asetranscriptionfactort##b##ptt##fi##ise##ryotype[SEP]humor##alimmunityaltereddroplevel[CLS]forsecondphase125wwkr##ir10w##lmalewhereasr##irw##lfemale[CLS]modified##cottquickstain##umcar##ini##iadditionallyv##ah##softenfatalim[PAD] [CLS]result##rot##rotisingf##ci##erialp##orose7fold##erialincreasedslightlyexposure55 absoluteatmosphereatmosphere atoxygen[CLS]we43oldmalebr##choc##ysdi##stales##opmi##diama##gnantes##op##hage##hagealtumorbasedpreleveltumormarkerca199ca125125 [SEP]10051p[CLS]aplasmacellrichin##fi##lt##ratepresentconnect##ivetissuecorep##illa[CLS]duringnorm##oxexerciseo##2up##take##o##o240lminal##mit##rineincreasedart##erialp##o05##o##o201vedecreasedart##erial##co##co201affectingpulmonaryhem##odyventilationperdistributiondistribution [SEP][CLS]gene##r51localizedradiationhybridchromosome9481c##rw##i86##8##4markerpro##ximalhereditary1lo##cus[CLS]outcomepatientu##m##tmainlyinfluencedinitialstagetypeecomponentcomponent [SEP]regulated246s##dpageb[CLS]otherfi##scher34ratalso1h##r0006ppo##3computer##izeddatabaseveterandischargedmilitary1967selectedcontains50totalv##ieterapopulationreasonably##biamethodtwin[CLS]toexaminefunctionalrelationshipdistinctc##iactiveelementwithindi##stalenhance##rregionratp##rlgenedel##eti##onalmutation##alanalysisregiontranstrans##3##uitcell[SEP]theentirecodingregionregion oend##alo##cinc##rsub##lone##d##40majorlatepromoterexpressionvector##jtransco7cell[CLS]alcoholstomachdisease[CLS]theseop##eronen##codesubunitphotos##ys##temi##aiips##bc##yt##och##rome##fcomplexpetp##id##dphde##hy##dr##ogen##ase##dhunidentifiedopenreadingframe##f##9[SEP][PAD] [CLS]thepptransfernewnew originaltransfer##pde##uter##ce##teasor##za##zae[CLS]transcription##alm##odantib##lxpairedboxtranscriptionfactor##3##3##r[CLS]thelevelp##deproteinmonitoredtwospecificcamp##al##bodypactivity[CLS]b##lotin##testrhybrid##lot##box##bprobesingle15k##bhybrid##izationbandhybridterminalprobeprobe producedtwohybrid##izationband15k##bsince##udproteinpro##te##olyprocessedactiveform##udredependentfashionaminoacidho##mology##mology umexaminedwhethersimilarlyprocessedcellla##czfusion[CLS]influencelongtermz##ime##lidl##s##dinducedbehaviour##aleffect[CLS]wedeterminedmolecularorganizationtranscriptionstarttgeneencodingthy##mi##dinekinase[SEP]togethernumberiiies##caldos##bo##p##latfactorsupportincreasedoseintensityachievedit##testargumentconventionalbetaad##renunwantedmetaboliceffectcountercardiacbenefit[CLS]genetic##mor##phism5flank##ingregionchangetranscription##alregulationhuman##yt##och##rome##e##1gene[SEP]##ric##ulare##ct##op##icactivityhigher00##1co##rona##ryheartdiseasedisease 8690compared12[CLS]increasedt##ecspa##cingoccurs##ste##op##ororeducesspatialfieldthuspro##longt##2shown##it##ro##ivo[CLS]healthy##ter##mg##esta2629showedmaturepatternperbirthfollowedperiodenhancedper34life[CLS]thesereveal##remtissuespecificfactorregulatedpredominant##remtrans##criptenre##press##or##r##rcapablein##hibitexpressionin##hi##binalphasubunitgene[SEP][CLS]theb##th##1genemaycorrespond##idoth1gene[SEP][CLS]thepatternfiringseensa##cca##delightcompletedarknessdarkness [SEP]chronichese##roltesthebecomesbecomes availableavailable [SEP]a##can##tham##osikinasep##osiincreasing##inactivatedatactivity[CLS]mutationh##3elementpromoteractivity##pwhereaselementisolationconferred##3promoter[SEP][CLS]mitochondrialt##osy##rnas##etapod##os##poran##serbi##function##alenzymesynthesisrs##licing[CLS]cell1con##dictobservationsystem1activelineline [SEP]thetgenees##cher##ichicok12factorfonenumerousproteinrequiredcon##gat##ivetransfer##mi##d[SEP]mi##be##fra##dir##o4059##6##di##hy##drantagonist[CLS]howevertechnicaladvanceshownlimitationtesttest##mpositiveresidualspecific##mevensubjectfreeacuteinfectionexistencenaturalinterferinginterfering i##m##m [SEP][CLS]##cinground##nutmealcontainingrat1991##bojj [SEP][CLS]wetranstransmutationanalysiselectro##motesthypothesisexpression##phagenecontrolledpartbindingthreetransactingnuclearfactors##p##1##2##3[SEP][CLS]am##p##khe##tero##tri##mercomposedcat##alyticsubunitalphatworegulatorysubunitbetagamma[SEP][CLS]theevolutionarysimilarityintro##nsecondarystructureopenreadingframen##d##34atgenediscussedincludingpossibleseparateevolutionstructuralcodingsequence[SEP]##cle##arreactiveserumcon[CLS]thedestructionme##some##sometri##umlengtho##rouscycleconcentrationplate##letni##tri##tetotalni##trateni##tri##tedeterminedsensitiveni##trateni##tri##te##oro[CLS]powerbrmodeledschemebased##aus##rataccommodatedepositionratewhosespatialvariationhighly##uni##form[CLS]thesulfurs##peccouldwithinle4minc##ze##yrelectro3550[CLS]propose37mayregulated4[CLS]##enocellin##hibit##edtranscriptionp##oe##no##vatecar##box##inas##p##c41132##ckgenevirtuallyeliminatedtranscription##ime##ricgenecontained##ckpromoterlinkedstructuralgeneace##ran##fer##asecat[PAD] [CLS]landspositivepositive [SEP][CLS]thesecondintro##nsmallestintro##n116b##p[SEP][CLS]expressiongeneencodingtranscriptionfactorcad##eno##sin3campresponseelementbinding##bregulationf##icles##mulatinghormoneinducedcampsignalingse##rt##olicell[CLS]efficacy24patienteightreceivedr##d16s##d[CLS]asi##licabasedflu##orifreeplace##bocontaining##ppcontainingsi##licabased##pasusedpositive##pasrespectively[PAD] [CLS]theoverallresponserateincludingc##rp##r2341717 [SEP]highpath##ai1##otestdefect##ivefi##bri##no##lydueinhibitor##yeffect1##minactivation[CLS]duringhe##xa##ami##mbadifferentiationer##hr##ole##ukeceller##hrtranscription##allyactivatedc##bseveralregulated[CLS]##stoextra##cor##pore##alfi##ltration[SEP]to##rs##ioncon##tral##ater##altest5year##ope##xy[SEP]frequencymedianyearrange21[CLS]ch##olin##fer##hisre##tro##gradetransport##radper##idasre##tic##ularme##dio##dor##salth##ala##micnucleuscatreceiveimportantinputch##olin##ergicch##olin##ergicne##uronsub##iainn##aadjacentstructurebasalfore##bra##in[SEP][CLS]thech##ime##ricgeneconsistingcoding5##tra##ns##latedleaderregiont##kgenefusedportiondomainalphagene0extendinglargelyupstreamsiteinitiationtranscriptionalphagene0regulatedfashionalpha4alpha27t##kch##ime##ra[SEP][CLS]ethanolpreferencestrainratselective##lybredbehavioralcharacteristiccharacteristic [SEP][CLS]foral##binos##t##1s##t##2spatialpeakaround03cyclede1curvedisplacedconsiderablyspatialsidenormals##t##2spatialresponse[SEP]nuclearproteinbound##d5575elementcycledependentelectro##mospecificma##xblockeddbindingdifferentgrowthregulateddcomplex[CLS]thus##mo##difiedthposition169##28importantinteractiong##1##c##lins[CLS]additionalgeneticanalysis##b##1componentmorphologycontrolbranch##asignalingca##sca##desppomb##ombepositivelym##od##ulates##1function[SEP]methodpreparationcoffeecountrycountrych##rom##osoco##sm##idlibrarys##rgm##t##mclonecocosar##7isolatedho##mologyact##iii##iregionss co##eli##colors##tr##trde##mgene##usininvestigatedwhetherc##lea##vager##rmotifmgogol##giassociatedfur##in##in analogousenzymeactivationmechanismobserveds##ely3[CLS]coc##balphacellspecific##ity##mformulatraditionalcornmmctblendcontaining38mmctsmmctgroupfatblenddesignedresemblehumanmilk6mmctslgroupthirtythreesmallg##lotcar##cint##1smallt##2u##ic##c1978examinedmagusingusing 8factorsystemproposedj##obetal##ylat##os##ami9glucose55infantgiven##ami##yr##oslimittargetrange[CLS]wewe soughttestprolongedinma##gnesiumsu##lf##atemg##so440mm##ol24hournormalq##tintervalvarcompensateheartfailurefailure [SEP][CLS]es##cher##ichicostraincarrying##30all##eledramaticincreasesodependentspontaneousm##utaactivity[CLS]outlookoralcut##aneous##oma[CLS]wereportcompleten##uc##leo##tidesequencegenealong155basepair5175basepair3flank##ingsequence[SEP][CLS]howeverlooselyassociatedassociatedviralparticle[CLS]##17alternativelys##p##lice##denm##rnausings##p##licedonors##p##liceaccept##orpairlocalizedwithinenopenreadingframeor##fnormallyusedgeneratebellbettrans##criptderivedinternalpromoterwithinenor##f[SEP][CLS]##17##0expressedlevel3050precursor##0##0 [SEP][CLS]inmarkedhumanc##d##6sequencemousesequencepredict##slongc##optailcloselyrelatedproteintwoprorichmotifcontainings##h##3domainbindingconsensussequencethreeproteinkinasep##lationsitemotifninecase##inpsitemotifsethrichmotifrepeatedthreetime[SEP][CLS]et1limitedelectro##card##iosub##end##oc##ard##ial##che##miacontract##iled##ys##functioncompareds##tenco##rona##ryeventhoughla##ct##atefluxsimilar[CLS]resultconsistent##f##1mutationleadingt##reaco##llin##hen##otype##otype [SEP][CLS]experimentalsyndromeanalogoush##yd##ram##nioratf##etus[CLS]crosselectronscatteringco##2moleculeenergyrange4005000e##v[CLS]thuscognitiveperformanceelderlysubjectcouldtrainedlargeextentextent [SEP]partialal##bin##ism##de##em##opma##lastone[CLS]residueaffectplc##betadoppositesidecentraltunnelplcad##yllikealphamakemanycontacttopsurface[CLS]thedynamicpro##to##zogroupr##nfistbasaldietm##olal##ib##af##fgiven618gweightthe##bs1genemappedhumanchromosome10##p##12marker85##3547##24tightlylinkedtwomarkerd##s##17##178##9d##55##0[CLS]bloodam##moniasignificantlyhighermale708090v##o##2peak[SEP][CLS]valuebones##cin##ti##9##9##d##pearlydiagnosismob##ilizationtotalhippro[PAD] [CLS]you##uf[CLS]thedip##perr##on##fb##p##r1022 [SEP]inpresentinvestigatedeffects##d##z71##3spatiallearningdeficit[CLS]materialanddomainperform##rmeasurementbreastpre64yearya##csb##ac##sco##sm##idsts##sdefinedaidgene[CLS]##v##rld##vasd##co490to[CLS]me##ftranscription##alact##ivatype[SEP][CLS]thef##ricup##takeregulationgeneproductparticipatesregulatingexpressionmanga##neseironcontainingsuperdi##utagene##cher##ichico##litodate6ma##mmalg##rksidentifiedmolecular##lonop2##cuprotectioncalphaheinter##dom##ainhi##ngebetastrand27theaimpresentstudyinvestigateterm##ousadministration##id##rodu##so##dr##ha##rz##ntwicedailydosedose 200mgcontinuous4hourinm##l09arto##cc##lus##aospecial##porlo##pclasspolymeriitransgenelackin##tracontrolregioni##relementhattrans##pofamilymaizeact##iva##cdiscoveredlarges##ie[SEP]judgech##rist##d##biprotocol##b##ryo##ryo [SEP]correlationcoefficients##fthickness##ropticalreading94o##d##1950##d##2r030subr067bi##cepso##d##1r039aaxi##llar00 68bi##cepso##d##2plcinsstimulation##letderived##d##f[CLS]analysisdomaindel##etimutantdemonstratedstrongs##yne##rgy##rmcentralde##generater##rmrepeatbindingr##na[SEP][CLS]sequenceanalysiscatintro##nseveralsequencepresentappearsimilarimportanttranscription##alregulatoryelementfoundwithinintro##nhigher[SEP]31di##ioh##yper##tro##io38##oc##ardin##far##gin##ectordisease100however##32mutation##hen##otypeinduced20spro##asmutation##ept##idy##am##eptideh##ydrofulfillrescuefunction[CLS]whereass##pra##gueda##wley##sdisplayedlightlightpeaking##estiveactivityminority34##4##sdisplayedconsistentlightpeaking##estiveactivityresult35##1patient24differentregime##ndrop##eri##do##l[CLS]the##roop##eronflankedho##lli##daystructuredhe##licaho##mo##logupstreamtwo##fsrepresentingpu##rineho##mo##15characterizedgeneencodingmembranedownstream[SEP]wenineconsecutivecase##boccurredmalefemaledetected11159routinespiral##texaminationchestperformed199419981998 [SEP][CLS]insearchmutationmulti##copygenemightinsequencedatareportedc##aclonedetermineintro##nex##onboundary1gene[SEP]989398[CLS]studyex##cre##tionse##lenurinef##ec##esdistributionorganratmethodradio##actmeasurement[SEP][CLS]usetwop##har##co##kin##eticparametert##12c##lt##pdrugeliminationabilitydiscussed[CLS]gas##tricsecretin##hibitionthreemetproee2administeredin##gas##tric##allymanbyr##t##rdifferentlevele##75expressiondetectedenervecordeyes##tal##kearlymshrimp[CLS]vicinitylarge##bbconcentrationusuallytwicehighka##to##hip[CLS]fortydoseex##cre##tedmet##hyl##do##paopposed18normallyseenoralmet##hyl##do##pados##age[CLS]noc##vage##p130observedanalogouschase##bfi##broper##creplicationprocessnative##bmolecule[SEP]phylogenetic32s##pec##ieshoweddifference##bm##rnasequence##bm##rna31s##pec##ro[CLS]thefivewithins##romayentrancepointc##loncandidategenene##uro##blast##oma[CLS]sugaranalysisalphainvestigatepossiblebio##sy##heticmechanismparttimep##gsp##ediatrichandlecarecare [SEP]theseund##ef##ined1##d##1##d##2##d##3codingunknownfunctiongeneencodingnew##rup##pelput##ativetranscriptionfactorflyho##mo##mologue##sma##mmalmitochondrial##ri##function##alenzymeth##iol##ase##rdbinding43first##ratemembertransgenenew##odgenegenecodingnuclearbinding##bho##mo##log##ousmale##lesscoplikeelement[CLS]t##fpreviouslydemonstratedactivatetranscriptionfactornuclearfactorn##f##kacjterminalstressproteinkinase##p##kpathwayturnstimulate##stranscriptionfactorfactor act1##p##1mainlyviapjcomponent[CLS]apro##car##yoregulatoryfactorhis##1likecar##boxterminaldomainc##lon##alvariationrepeatwithingeneinvolvedregulationm##uc##oid##y##mona[SEP][CLS]thehosththoughtprimarilydeterminedsurfacemoleculefunction##olioreceptor##rsinceshowntranssensitiveintroducinghuman##rgenegenome[CLS]humanalcoholde##hy##dr##ogen##aseexistshe##tero##gene##ousgroup##oz##ymeo##xi##di##hatalcohol[SEP][CLS]thecontrolhumana##roma##tasecomplexseveralpromoterdrive##tasetissuespecificmanner[SEP]inre##nalsympatheticactivitymeasuredseparaterat[CLS]thisin##comrequiresglobaltranscription##alre##press##or##or##btargetin##ccmediatedin##com##or##bbindingsiteob[SEP][PAD] [CLS]bodilyreferaffectaffect [SEP][CLS]theeffectnegativeregulatoryelementne##gatedvirali##e##2proteinl[SEP]r##x##ral##phar##tero##di##mersho##mo##di##mersbindd##r1motifelementbi##4[CLS]evidenceinvolvementproteinh##ur##po##stranscriptionproop##eron##cher##ichico##li[SEP][CLS]howeverlesserlesser extenteffect##p##gnantseenrat[CLS]m##or##phineadministrationacute##lyreducedplasmaclearancesu##lf##ob##rom##op##haleb##spmouseincreasedhe##pa##ticretentiondyebll [SEP][CLS]in##tras##pina##lmedia##inalfore##gu##tc##ys##tcom##pressingcord[SEP]nut##race##uticalspecific##rogenfattyriskreductionprogramcharacterizationuniqueproteincomponentyeastrm##rpr##nabindingzincclusterdomainthepresentstudyhighdose5regimeshowactivity##cre##aticseems[CLS]likenuclearin##tra##ardoublemembranelame##lladefinedc##isterinterruptedp##oreunlikenuclear##orelacked##c[SEP]22orbitalflightco##smos60bio##ellifollowediner##yt##hr##ob##last##osisalter##ationmorphologyme##ga##karstimulation##elo##po##is[CLS]ano##d650greater015rapidreliableindicator##etallungmaturityportn##2t##umourclear[CLS]r##x##rgammaterminaldifferentiations##cctumorsuppress##orfunctiontranscriptionfactor[SEP]residuesubsequentlyidentifiedsedess##imdegradation[CLS]theinfectionm##olo##neymmmcauseincreasespecificcellulargeneproductincludingmmh##cclassii anti##gen[CLS]theseo##singenetranscriptionregulatedtissuespecifictemporalregulatedmannerclearlyo##sinproteinexpressioncoor##dina##dinatedprimarilytranscription##allevel[CLS]##oc##ard##ial##ial tech##net99##boroup##eno##sin##yperdogcriticalmildco##rona##rys##tencomparisoncomparison th##all201regionalbloodflowflow [SEP]ucriterion35although##rpan##emia##emia obviouslyimprovedhem##og##lolevelincreasing44 8d8d##lsideeffecteffect [SEP][CLS]di##k##zans##arexperiencer1surgicalsu##urawound[CLS]atd##2814938patient49episodeautomaticmodeswitchpromptedat##riala##rr##hy##th##mia##mia [SEP][CLS]togetherresult##licaf##al##1##p18r##rnamat##urationpathwayrathertranslationinitiation[CLS]mostdifferencetwole##porlocatedte##lo##mere[CLS]weragr##wallhaydosragextractinvestigaterelationshipearlyerlatelate l##rrereaction##c##rsnasalchallengechallenge [SEP]expressionsecondproteininvolvedcalciummetabolismmoderatelydo##x##or##cincell[CLS]thecentralregion##rc##omer##ecoincide##ntmlineselectivelabeled##bodycterminalform[CLS]despitedepend##encyhoweverbj##aponfix##kmutantp##hen##otypiccharacteristicbj##aponfix##lfixmutantmutantneitherfixs##ym##bio##sissoplantdefect##ive##ive an##ae##ro##bicre##spirationni##trateterminalelectronaccept[SEP]an##l75##35theq##csappearscomparablemm##sequickeradministeradminister [SEP][CLS]weultracharacter##ndiant##ralex##cursioncharacteristic15healthyvolunteercopyright1998presspress [SEP]human##3##lioprou##usal##iment##arytract[CLS]e##pitcellabnormalacceleratedex##foliaresultedmulti##fo##cale##ialdefectdefect [SEP][CLS]tightbindingbandstructurecalculationbetam##nxm##rxc##lbrmh##fxc##l##rc##ly2c2br2reported[SEP][CLS]screeninghumanfoe##talbrain##enodlibrarye##cor##ie##cor##ifragmentcontaining6k##b5flank##ingopenreadingframe4k##b3flankregion##4gene[CLS]##osoapproach##hr##osis[CLS]theratedecreasere##monsetest##rahalflifesuggestsre##monset##ationre##ninproductionproduction [SEP][CLS]similarlyinterfering##k##klieupstream##1dominantvectorreduced##p9promoteractivityconcentrationrangere##pressed##p1thy##mi##dinekinasecatreporterconstruct[CLS]thereserumtransfer##rinlevelprelevelgroupfedearlydesirablecontrolgroup15825mgd##l28938mgdv1800 20mgd##l25939mgd##l[CLS]therepeathighlyconservedwithinelementwelldifferentle10diver##gence[SEP][PAD] [CLS]utility##all201s##tiright##ric##ulard##ys##functionem##bol##ism##ism [SEP]conclusionsystemdevelopedstudydetectairtrappingtrapping t##gi##gi [SEP][CLS]thecar##box##ylterminal75aminoacidtwoproteincontainb##hl##hmotifdifferthreeconservativeaminoacidchangeaminoterminalportionmarkeddiver##gent[SEP]ratmodelassessed##bbchangemeanquantitative##calphaamino##ob##yric[PAD] [CLS]poll##ino[CLS]b##lotred##ucmsteadylevelseeddevelopmentincreaseenzymeactivityphasestorageregulatedlevelgeneexpression[CLS]timetestleoneyearaffectcorrelation##piresponsesetvariablelfkfkk [SEP][CLS]differencebindingk##da##ppincorporationextensionkinetico##x##od##pd##pincorporationtemplatetemplate 8o##o##ucpolymer##asefioverallgeometrywa##tsc##rickbasepairreflectsas##metryenzymeactivesitethisconstantprofilem##3au##1s##rem##bfi##broretransformationm##3##alimitingfactorregulationsuperfunction[CLS]thesequence1035relativetranscription##alstartingsiteshowedho##mologyconsensuses##cher##ichicocolisi##gma70typepromoter[SEP]theresult23autointo##ani##oidmethodde##utsdiabetesdial##ysrandomhypothesisat##tatred##uccard##iovascular##fa##fatal##oc##ardin##fardiabeteshem##od##ial##ys[CLS]therecorrelationserumam##io##dar##onedes##eth##mio##dar##oneleveldos##age##io##dar##onetheeffectmon##ralmiddledestruction##nat##aldevelopmentmouse##culusunusualbehaviourmayexplained18aminoacidlongc##dr##3coulddesignsingledomainanti##bodyquestionmustmortalityrisk##rom##bol##yselectro##card##io##farinitiatedearlyonsets##ptregime##can##alipat##far##ctparameterl##ptreatmentsbcellatresultdecreasemencodingalphaclassamongst53##opert##4n##0n##1tn##2n##3case510positivescandoubtfulscan[SEP]anti##biotic83##7as##pi##rinisconventionalspermanalysisuseuse [SEP]thecomputer##isedrecord86coupleinvestigatepro##gnose##menvolumem##otmorphologymorphology [SEP]musclein##fari##p242pre##ische##m##k212groupcontrol422bindingsdomainsfpossibilityproteininteractionvariousmembercp##t##kfamily[SEP][CLS]mutation##alanalysisput##ativeeffect##ordomain##pbinding##1proteinyeastspecificregulationnovelgapactivity[SEP][CLS]interactionobtainedd##b##mscorequalifiedthreeinteractionlimitedpatternparticipanthigherselfdeceptiondeception [SEP]t##yr##steinp3##ort29##40##400##0222 4m##or##ph##olin##yl##yl 8##yl##h1##zo4blockedad##eno##sin##3map##k[CLS]surprisingly##1bindeboxv##1proteinfunctionaltranscriptionactivationdomain[SEP]ex##rformhe##tero##di##mersend##ogen##rresultobtainedfunctional##rtakencaution[SEP]##atspecificlip##ase##airfatabsorptiontherebyreducingfatup##takemetal##rote##inasmediac##lea##vage##vage specificallyin##hibittissueinhibitormetal##rote##roteinas33 t11 t[CLS]relativeindependences##ync##hrrhythmictissuelevelinfluencehigherregulatorycenter[SEP][CLS]itcon##ceelevatedinsulinmaycauseh##yper##tri##gly##cer##miapossiblyabnormal##itylip##idmetabolism[CLS]flickerthresholdmeasured140h##zverticallinetargetasthresholdthreshold [SEP][CLS]thec##r##1lo##cusregulateexpressioncry##pticmatingtypelo##cusfiyeast[SEP]useelelisadiagnosiscanatop##y##y [SEP][CLS]aclinicalstudy[CLS]method[CLS]instead##xshownactivatec##y##c##linpromoterinducec##y##c##linac##ydependentkinasecomplexpromotecyclinggrowtharrestedcellg##1pathwayinvolvingactivationkinase[CLS]growthhormoneexexerteffecto##ianf##icularcycledirectlylocalproductioninsulin1i1thethe aimstudytypeiinsulindependentdiabetes##llithesubjectstartedin##ac25mgth##ricedaily[PAD] [CLS]ab##udd##his##tviewabortion##erialbloodmeasuredmethod##estanimal15minhem##or##r##hagestar##ved45minstrikingdifferenceobservedde##cid##ualt##ho##blastpro##ct##incharacterizationgenestructurecellspecificexpression[CLS]flu##oressithybridinvestigatephysicaldistributionrevealedre##tro##tra##ns##pofamilypresentsugarbeechromosomelargelyexcludedch##rom##oso##malregionharbour##ing##ing 185825r##rnagene[SEP][CLS]plasmanene eincreasedsignificantlyhigher15minyoung168018vv [SEP][CLS]aninsertionsequenceelementis##11##70identifiedupstreamni##m##cgene[SEP][CLS]organ##elles##zesetf##esproteininitiategenerationextra##mit##och##ond##rialf##esprotein[SEP][CLS]##c##dcomplexma##ximalactive##1stransition##cdecreasetakecomplete##1entersphasephase [SEP][CLS]##eno##micclonechickeno##steencodingopisolatedfoundorganizedfollows##lated5ex##onsignalprecognitionsequencepcase##inkinasedomaincontainingpossiblelink##agesiteg##cos##tionsecondcase##insiteex##oncontainingthreefunctionalregionassequenceconsecutiveresidueresidue r##g##dininte##tegrecognitionsiten##agesiteg##coslargecterminalex##onalsocontainsn##agesite##coshoweverneitherssf1alonebindingmon##omertranscriptionsatisfactorycorrelationresult[CLS]structuralorganizationhumanel##k##1geneprocessedpseudo##gene##gene el##k##2[SEP]o##cc15304590min##murabio##cheanalyzedad##eni##reaultra##ructuralchangethe##cularad##nex##alssignificantlygreaterhairbaybrown01[CLS]patientwithouts##yn##dr##omi##omicdiagnosisdiagnosis [SEP][CLS]inr##1r##2feedrestrictedwith##holdingconcentrate345m##orespectivelyrespectively [SEP]in##1required##ivo##ifalphaextract##1deltastraincontainedwildtypelevel##ifalphakinaseactivity[SEP][CLS]s##co##f1localizednucleusbinddirectlyeithercrepeatde##dracda##bareelementelement a##brec##iactingdregulatoryelementpresentco##rgenepromoter[SEP][CLS]onbasisacceptpbindtransfer##asebetalikeconform##ation##imateresiduechains##ter##icinteractiondeterminingextentgivense##rth##rg##cos##yla##ted[SEP]theconcentrationvitaminb##1b##2b##6996992301mgrespectively240mgcapsulepowderstandardnameduedue secrecypurposepurpose [SEP]##oly##mor##phism##rgene##f##ricamouseaminoacidinfectionsi[CLS]furtherdetect##2threeoverlapping##cscontainonemarkerlinkedd##f##9m##co##b##2geneticallymappedchromosome12regionho##mo##log##ous##yn##ten##yhuman##q##11contains##1audioseizurelomouse[CLS]absenceni##tro##soformation14##c##hom##ylni##tri##testomachcondition##b##1mutationcreateproteinisolatedpreviouslygene##6twonewss##2amamt9610ssbt##l##l911 10sst##t 13bbnt##nt 14c##pt11 03b##dt##dt 1919 033 3333 [SEP][CLS]antidoseresponsecurvedrawncumulativedoserequired35reductionspecificair##waycalculateddesignatedpro##vocationdosep##d##35[SEP][CLS]crosstalktranscriptionfactorn##fc##btranscription##alregulationgene[SEP][PAD] [CLS]elect##ivereplacementrootma##rf##ansyndromesyndrome [SEP]complexo##xi##di##zesca##lda##riel##uin##olhighratecompletelyin##hibit##oloanaloginhibitor##uin##olo##xi##das##e[CLS]characterizednew##k6potentiallyencodingtobacco33k##dach##op##lastr##p##33ho##mo##logue[SEP][CLS]theregionencodingmatureprotein##aseclone##dexpressionvectorre##combproteinproducedes##cher##ichico##li[SEP]further##more##l##100suppress##es##12activationmapcellsystem##ytethex##eno##obgenetwinmediamediatesinduction##co##idestablishments##pe##pemannorganizer[SEP]19881994data3siterevealed35fold##de##pressattreatmentyear[CLS]the##ad##ropenreadingframeensubunithe##tero##di##mer##icvearlytranscriptionfactor##t##factivatetranscriptionearlygene##ro[SEP]se##rop##cc##lslikelymixedinfection[CLS]recognitiondsinglechainderivative43##4re##press##orhighaffinitybindingdependscontactedcontactedbasepair[SEP][CLS]thecallstandardizedquestionformatcentralizedmonitorchangeparametersexualbehaviour[CLS]##fbindonetwod##rosequence##rm##1promoterd##rosequence##rmpromoterspecificmanner[SEP]139##rrelaxationzdoeffectla##2##o##4[CLS]thegammaca##cboxbindingfactormedial##rgammainteractionnormallyenhancegamma##lo##binsuppressbeta##lo##bingeneexpression##etaler##hrcell[SEP]##ivoattachment21hacoatedo##ct##ame##rrecognitionmediateddomainstructuralmotiflikezincdefinestranscriptionfactor[SEP]alltest##osteroneplasmatest##osteroneconcentrationcontrolpreleveltest##osterone##yn##ovetest##osterone##yn##ove05[CLS]lifestylecharacteristicas##cer##tainselfadministeredquestion##naire##naire [SEP][CLS]themajorpromoterelementx##eno5rgenelocatedwithintrans##cribedregiongeneformbindingsitetranscriptioninitiationfactort##fi##ii##a[SEP][CLS]duringsteppulseino##ste##alresponse##igeneralparallelr046462inversecorrelatedr00 5656200003[SEP][CLS]thegammageneexpressedu##bi##quito##quitousinducedcoordinatep##uin##oneo##dor##ed##uc##tase1##o##1g##ath##ionestransfer##aseyayaresponseinterestingid##rt##olidetectcampcamp [SEP][CLS]wedeterminednterminalaminoacidsequencefoundp##pt##ideco##tt##ek##ecocot##f##a3145k##das##po##ivarespectivelyrespectively [SEP][CLS]theeffectbeta##hasduo##den##alcalciumabsorption125di##dr##yvitamind##3chick[CLS]furtherestablishedsep##lationstrans##act##ivationdomainviamap##kpathwaymeanmodifytranscription##alactivation[SEP]ecellgeneer##hr##oidtranscriptionfactor1disruptedmatureer##hr##oidcelleither##ivo##roconservedmotif##9##9##4##k##1seemedaddressing[CLS]itpredominantactionl##s##dcopmediatedincreaseddo##pa##minereceptoractivityactivity l##s##deffectmightm##od##ulateddecreaseddo##pa##mine##rgactivityactivity [SEP][CLS]therefore##drmediatedtranscription##alactivation125oh2d##3binding##dralter##sconform##ationl##igan##dbindingdomainengagesstronghe##tero##di##mer##ization##x##rfacilitate##drebindingiiinfluence##x##r##dbindingdomainresistantbinding9c##i##i r##aactiverecruitingco##act##iva##torii##ipresent##f2region##drco##act##iva##torassociation[SEP][CLS]750m##lsad##lcoco 801basedm1001baseal##dos##tero2901basere##nin01basehem##ato05baseincreasedcc 2001basewithout##pplit##1paternal##lyrwithin##1lo##cusposition##alscreeningapproachhumanmon##och##rom##osohybridaseriesdel##eti##onmutanttranstwo[CLS]thepredictedaminoacidsequence##ab##pt##ide92identicaltp##idfl##ab76identityn##leo##tidelevel[SEP][CLS]comparativeanalysis5peripheraldomainexhibit75b##plengthp##oly##mor##phismnearsequenceassociatedterminationhstrandreplicationthebowevenneedlongtermparent##eralnutritiongoodgood [SEP]thuscrossresistance##oroshownenter##rsa[SEP][CLS]the5endpgenem##rnaseparated109n##uc##leo##tidepaird##natemplate[SEP]usingcommunitydevelopmentapproach[CLS]bio##l[CLS]weclone##d##bhumanfrogyeastthreehybridsystemalong##arugroupgroup 2don3##ac##don15##ac##don##don ff ch##os##portypet##oth##enederivativesemi##tecoftenassociated[CLS]tbeta##1inducedss##3##1##lu##klungecelltherelittleaceinhibitor##topen##ala##rilte##rato[CLS]thusinductionrear##rang##1##agenetherapyunlikelytreatmentadvancedma##gnantdisease[CLS]althoughhybrid##izeseveralsimilarstructuralfeatureopenreadingframecomprises23trans##cript5un##tra##ns##latedregionregion extremelyggcrich3##ns##latedregionregion unusuallylongatrichidentification23k##dproteinzsad1992[PAD] [CLS]##una##ldonekindflap##faj##una##linter##positionflapwithoutneedneed complex##rger##y##y [SEP]inhighbindingat2lowbinding##bobservedextracttissuelowatoppositeextracttissuehighatlevel[SEP]activationt##yr##os##tero##tri##mer##icgenhanced29##3##ccell[CLS]the##ug##rip##uggenefragmentusedis##olategene##ugg##eno##miclibrary[CLS]##roglassstomachcontainingvariousvolumeh##ydro##chacid##c##lam##monn##h##4##c##lusedevaluateincreasinggas##tric##h##h##4##h##3transitionoccurs924[SEP]##lov##ir3otopic##allyonefivetimedayacuteo##cularh##vinfectiongavebeneficialresultreduction##ealinvolvementcon##iv##itis##rit##eal##ing[CLS]previouslyg##co##cor##tic##oidhormonem##odpost##lation##allocaltumormmmmt##tv##154##the[CLS]partialpro##te##oly##odbgmoleculegeneratesextremelysimilarpatternspotwithinha##p##lot##ypesettinguniversityresearchthere57reduction##fm##rna##9confluence##10[CLS]o##go##merscorrespondingregionm13enhance##rencompassesconservedsequenceboundme##fcompetedbindingm##ckenhance##r[SEP][CLS]similartissuespecificpatternobservedfusioncacauf##ufli3535srpro##moto##r##ugene[SEP][CLS]thisdifference1pduedifferentialup##takesincesince approximately100time2p##eptidecouldfoundc##yt##op##lasextracts1pexperimentradiop##eptide[SEP][CLS]onefunction##53regulatingcellcyclecontrolddamage[CLS]werelated##ricue##dspatialtaskdi##sso##cia##tebrainactivityrelatedattention##alcontroltargetstimulusstimulus [SEP]backgroundextractcontaining##ncontractioneffecthumangal##lbladder##poptriggered##hibit##rma##35##lx[CLS]theproductonegene##80singlediver##gentcopysequence149aminoacidapprox[SEP][CLS]the103##1b##pwildhit##1dcontainedopenreadingframeencodingprotein164aminoacid##gg##rgtgenecomplementhit##11mutant##hen##otypemutantp##hen##otypecauseddel##eti##ongene[SEP]eatingdisorder59lifetimeprevalence10i##rre##spectivetypediabetes41whole##olo##lcm##cusedopdrugpolymerrespectively[CLS]theseresultdiscussedcontextmodelmy##ogeniclineagebasedexpressiondes##min[CLS]identifiedtwopotentialpsitese##9se##3seemnecessary##f5[CLS]weconstructedseriesch##ime##ricgenecontainingpartfirstex##onincreasinglylonger5flank##ingsequenceo##d##cgenefusedeitherbacterialch##lora##lace##ty##lt##ran##s##fer##asecatl##uc##ifer##asereportergene[SEP][CLS]##vo##2satdetectbloodlossthegeneencodingneneisse##isserialalactii##idmet##hyl##tra##ns##fer##asemn##lai##iirecognizessequence##gclone##dexpressedes##cherco##li[SEP][CLS]thislattercomplexreactserumresponsefactorexhibitbinding##rf[SEP]patientin##ven##ousproalphapalphaalpha [SEP][CLS]alignmentrathumanwincomparison##eno##micsequencerevealedwindbindingdomainencodedfourex##ontwoex##on46alternativelys##lice##dgenerateleastthreeclassmtrans##cript[SEP][CLS]doggivenparent##eralroperationg##lotbloodcontainedrslightincreasein##hibition24hour93flowdirectblood##raldevised[CLS]hereinteractionlalalactlll##bintro##nend##leadtargetsitedfoot##printmodification[SEP][CLS]clinicalbringinformationp##hare##pid##em##iology##iology [SEP][CLS]inseveralstepconvertedre##idspecificresponseelementrebetapromoterdreresponseelementhumano##stepromoter[CLS]theimmediate5flank##ingregiong##crich3s##p1like2a##p2siteidentifiedcloseproximitytranscriptionstartsite[SEP]a##ktdependentfar##tra##fer##d##35##0091s##t##ks##3576s##t##ks73s##t##ksspecificcontrolo##vu##lationmareearlyo##iansproreasonsuggestingt##ljoincalciumantagonistagent[PAD] [CLS]##nouso##2satpulmonaryfatem##bol##ism##ism [SEP]twoprotein##rf12apparentlypro##te##oly##ticdegradationproduct1bind##ef##ficientunablec##c##1identificationdomainmediatranscriptionactivationrepressionin##hibitionpairedrelated##xmethodspatialcountinglocations##trapyramid##alesector##14controls##zmatched##morintervalwellwell 4mandem##dmatchedage[CLS]analyticalscanningscanning is##oe##ro[CLS]upstreams##ti##mu##lator##yfactor##fhumantranscription##alactivationfactorushehebho##mo##di##mer##izerecognizespecificsequencepromoterregionnucleargenetransr##napolymerii[SEP]4361401##3##ccsample##hl##hylmutation3##p##14pp21##hdiffer##p##p25pp26721825[CLS]sequenceho##mo##log##ousconsensust##ufbinding##asboxpresent5flank##ingregiongene[SEP][CLS]theanalysisserum##tinas##par##tatetrans##ami##nasreductionclearance[CLS]resultalthoughlow##ir##fm##rna8b##b##l1tumor120tetstimulateexpression##fgenetogetherprimaryl##yticcyclegene[CLS]centralprojectiongas##tric##fferv##againput[SEP]dsequenceul##6ul##20geneinfectiousla##ryn##got##itischaracterizationul##10geneproduct##cosprotein[CLS]colikelycontributemulti##mer##izationfunctionrequiredho##mo##mer##iccomplexformationhe##tero##mer##iccomplexformation##50associationp##65deltap##50evident[SEP]##ost##aticessential[CLS]ayeastmitochondrialtranslationinitiationco##donmutationaffectinggenec##yt##och##romeo##xi##dassubunitii##ico##x##3suppressedspontaneousnuclearmutation[SEP]only27kproteindetected##cos##ph##inmore##overstudiedrelationshipinitialma##rrowpro##sistheseresult##aseiinhibitorarrestg##0##1inducemannermanner ft##aseinhibitorinterferecycleeventmechanisminvolvesneither##p[CLS]weyearboyfirstacutein##vas##cularhem##oly##ph##oter##ici##bsubsequentlydelayedhem##olytransreactiondue##oan##body##body [SEP][CLS]temporalsequenceorganfailurelungc##lot##lottingsystemkidneyliverliver [SEP]thebiologicalstructuralmotifshared##r##5##r##3##r##b##rsdiscussedanalysisratbrainheartlungliverkidneyskeletalmusclerevealed##i##k##cz##etam##rnabraintheprovidebroadperspectivem##pasmanagementpatiente##wingreferenceneedachievelocalresultradiationtherapypatientlongtermsurvivalsurvival [SEP][CLS]furtherrapidlightmediated##rfproteintranscription##alinhibitorposttranscription##almechanismcontrol##rfaccumulation[SEP][PAD] [CLS]transplantse##rolreceived##viiggpositivedonorincidencediseasehighesthighest [SEP]sincecombination##lora##mb10mgdailyinitiallysixweekalternatingfort12weekinter##feralphasp2x106mm2threetimesubinjectioninjection 18weekrandom##isedalone##trestageii##iiiv##v f##oll##icularl##ymph##omatheb##dune##urontouchne##uronline##alsistera##blineage##a##bmotorneline##alsister##blineageweretrospectives##falone##emplus##d##34patient[CLS]serumconcentrationhormonepatientclassifiedccharacteristic##allyinclinedh##yper##ado##tro##rogen##ic##ic [SEP][CLS]c##er##vicc##trevealedirregularlowdensityperiphery##vic##al##brac##2##4level[SEP]incorporationinformationdatabroughtrevisedyearsurvivalestimatepercent[CLS]thesemotifco##gnatetranscriptionfactorappearactconcertpartialred##undadiscretemutationeffectivereducingtranscription##alactivity[SEP]weshowcinducebindingactivitytermedsisiinfactor[SEP]conservationturbulenttransport[CLS]expressionb##act##optt4dterm##inas##egene1617multipleprotein[SEP][PAD] [CLS]er##dheimchest##erdiseasedistinct##oidpartspectrumhis[CLS]er##dheimchest##erdiseasealwaysconsidereddistinct##oid##osisbasedclinicalradiocriterioncriterion [SEP]surfaceelectronicstructure1x2reconstructed110[CLS]p##mi##dcon##ferdrugresistancespecificallyl##mb[SEP][CLS]twop##har##ma##co##kin##eticmodelcomparedahighermedian##ro##chasiteo##cularinjuryan##est81girlcuredre5s##omap##ye##ph##rit3c##ys##titis##titis [SEP]theperformancetestpro##sta##atestdetectcancerproteinencodedgenesimilaritye##z##rinr##adi##xinm##mlink##os##etonpatient125s##omabacterial##nosis[CLS]inhealingtend##onrateco##lla##gensynthesisdecreasedrate##co##lla##genproteinsynthesisremainedunchanged[CLS]from##hansmallestsignalratiodeltasmindeltarobtaineddeterminesminimalcontrastgivenfilmpropertyfilmresponsesfilmgradientgammaamounts##cat##ter[SEP][CLS]howeveroneactivitybindprefer##ential##lygcrichpromoteranotheractivityappearsbindprefer##ential##lytwopromotertested[SEP]card##iovasculareffectin##ous##idhs92##65##pertcenterdiseasecontrolprevention[CLS]expressionc##acloneyeastcontaininglargeportionopenreadingframecampp##seactivityidenticalpropertyd##ros##openzymemutation[CLS]f##ds##rho##exf##ds##rcok##daho##mote##tra##merbindingf##dscontrolregionlocatedf##ds##rf##ds##ggene[SEP]zmmrangeh##ydro##tricradicaldependentmanner[CLS]theor##th##olo12subdisplayhighaminoacidsequenceidentitypighuman9294subdisplayidentity768787 [SEP]binding70notablehighco##oper##atitwos##h##2domainindividuallyaffinityinteraction##igan##d[SEP]##zo##onedrug##nal##otconsiderableproteinconcentrationairspaceinter##st##iti##altissueo##ederadiationsingle4m##jpulse##se##con##ddurationmeanarticulated##ir##conflu[CLS]perceptionsweetnesscannotusedaccuratelymetermeta##bolenergynut##ritfood[CLS]theleaderp##eptide##hesin##hibitrib##osoreleaset##nacstopco##dontherebyblockingr##hoaccesstrans##cript[SEP][CLS]responsepropertysingleunitaccessopdarkrearedcat[CLS]ex##crebreastmilkmilk [SEP]influenceh##uangcombination##uang##yt##hrofde##dr##ogen##asedeficiencyratobjectivetostudyinfluencecommoncombinationcop##hrde##ogen##p##ddeficiencyreceptorantagonist##hibitsulfurdioxidebr##on##con##ricpatientas[CLS]thissequencesufficientcon##fer##53dependentactivation##teropromoter##53capablebindingsequenceassessedgelshiftanalysis[SEP][CLS]theem##b##ryo##bra##lcolumnreviewedbrieflyoriginan##omac##2##bratracedonetwoearlystagedevelopmentfollows1formationme##sen##chyve##rte##bra2inductioncart##ge##ge [SEP]twothreegroup##pox##o005##5##o01thirdnorm##ox##o021groupgroup f##21environment[CLS]para##thy##roidhormoneam##pserum##bolreporter##ste##obum##r106cell[CLS]resultstronglyactivationbetaorigindistantreplicationenhance##relementrequiressmalltargetsequenceessentialin##iti##atorproteinmediatedd##naloop##ing[SEP][CLS]hm##rnato##tip##oteem##b##ryostemcell##ici##ty##choreceptormagnetictorque15tdi##lo##dgeresultper##c##f[CLS]l##1identicalr##dlgeneknowng##abareceptorsubunitgenedme##lan##ogawhereasl##3noveldsequencesequence exhibitedstructuralsimilaritymemberl##igangatechannelfamily[CLS]aincreasegas##tric##uc##osa##lper##me##abilityobservedsixsubjectinsethanol20vvusingsimulatedcougheffectaddingtensso##lphasesiclearancegelm##uc##ussi[CLS]firstaminoterminalregulatoryarm##dibindswitchiiidomainleadingin##hibition##d##pdi##sso##ciation##ph##ydro##lysis[SEP]combinationalternativepromoterusageex##ons##licingr##orgenegeneratesseveralis##of##ormsdifferterminus[SEP][CLS]electro##orerapidinductionproteinboundconsensus##ppamotif[SEP]analysislargerclonedemonstratesleasttwois##of##ormsdiffernterminalabhi##ngeddomain[CLS]multiplecopybindingsitefoundviralgenome[SEP][CLS]duringsubsequentcalonetrialresponsem##k80##1injectedexexting##uishedeasilysainjectedmouse[SEP][CLS]inde##via##tedi##ps##ila##teral##lycathem##ise##ction##ro##fle##xedtrans##ec##tion[CLS]themajoropenreadingframepredict##sprotein59k##d##ucsituatedadjacent##crelatedmotifproposedhe##lixhe##lixstructure[SEP]residuealthoughlocated55rather35terminalessentialundoubtedlysecond##par35motifmemberinin additiondigitidentityvarying##oly##da##ct##yl##ypro##ximalskeletalelementseverelyshortenedx##tl##ddouble##molimb[CLS]the##4geneisolated##eno##micdlibrarycomplement##ation3mutationgenehighdegreesequenceidentitymaad##rfbelieved##sishelleffectr##yd##kalscatteringshorttermgrowthrhythmchaosnoisenoise [SEP][CLS]associationdi##aph##raguseas##pt##omab##act##eri##uria[CLS]effectto##xi##rioch##ole##rae[CLS]theta##tproteincodedhistrongact##ivaterminalrepeatl##tristimewinewine trialtrial [SEP]thecoefficientvariation##roma58radio3coefficientvariationwithin##roma49radio9mac##ropm##od##ulatorimmunity##hterminalfragmenttestedsumodification##pha3male##pattachbiogroupc##ys##teinsu##yl##sproductionretrospectiveco##rot##11dieight25moderate##rot##ox1despiteseveralyear##ro[CLS]serumpit##uit##arys##tero##idhormonelevelmaleonevaluegoodmeanthreethree [SEP]sectionanti##oth##eli##ale##os##inmappingregion##p1required##1interactionshowedaminosubstitution##bol##1binding##it##roreduce1repression##ivo[SEP][CLS]theflank##ingopenreadingframe##2showedho##mology##rg##ini##nebiogene[SEP]promoteractivityproinc##rebindingintermethodlevel##rmeasuredsimultaneouslyplasma##uralfluid111##urale##ff##usionunknowncause[CLS]theg##isoftwareprogram##viewusedspatialanalysisdistancecalculation[CLS]ch##i##2testcomparedistributioncharacteristicmid##blockcollisioncollision [SEP]combinationpure##omer5alonge##bic##cre##aticcancerresult3weektherapyincreaseplate##letcountbase##line50008000##rma##ximallevel33##r[CLS]thespecific##itytranscription##alactivationis##3mediatedspecificelementtermedif##ns##ti##lator##yresponseelementis##relocatedpromoterregionifingene[SEP]k##b##ctestevaluation##fre##retlivingrelatedre##nalg6transplant[CLS]thesemutantinjectionxdel##im##itpromoter36b##pdupstreamcapsite73b##pun##nsm##rnaleader[SEP][CLS]upstreamtissueinhibitor1element1novelessentialregulatoryd##namotifhumant1genepromoterdirectlyinteract##s30k##danuclearprotein[CLS]theresultexperimentexperiment indicatedcharcoalim##berbeanredox##fs##fs 40##22dos##rc##1wouldusefulagentamountdie##rineliminatedviaf##ecdropping[CLS]thereceptor##f1##ste##ossintrinsictkinaseviarapidpselectedprotein[SEP][CLS]adaptiveeffectrepeated##mersexposurehumanbodybody [SEP][CLS]toendgenerateddetailedphysicalmap##eno##micregionspanningsequencetag##gedsitemarkerd##51##8d##51##6spin##op1bindingden##dr##iticspine[CLS]pro2initiallyformtwodi##sul##fi##deis##omerundergorear##rang##ementsingleconform##ationv##ivo[PAD] [CLS]whilewargasgas [SEP]formulatedha##berrulecxtconstantordertoxicity##hala[CLS]theexistencet##fi##iiassemblypathwayleadingtranscriptionnatural##ryotgeneabsencetinsightfunctionalflexibilitytgenetranscriptionmachineryevolutionancestralr##napolymerii##isystemrelyingupstreamtacenteredcontrolelement[SEP][CLS]e##ct##opx##brainducex##r1transcriptionindirectmechanismappearsprimaryactivationfi##bro##blastfactorsecret##ion[SEP]rapidmixingdevice##elareactsystem[CLS]themajortranscriptionstartsitedesignated1determinedracerapid##aendanalysishumanliverfoundlocated50b##pupstreamtranslationstartsite[SEP][CLS]theseresiduecorrespondco##don59108pd##h##f##ractivesitesimilarsubstitutionca59se108associated##yr##thamresistanceofya##rsyndromehigheststabilitydepressedscalescale [SEP][CLS]hereinvestigatemechanismtinduction##pgeneexpressionmeme 180##cccellline[CLS]betweenr##nainitiationsitecodingregiong##crichhair##pinstructurefollowed8tresiduelookliker##hoindependenttranscriptionterm##inator[SEP][CLS]conconverseratebio##avapatchreleaseratefastfirst24hleadinge##2peak8hcm##axaverage23hh [SEP]3progressfi##bri##no##lysisserialfluidsideearcase17casemuchactivityfi##bri##ndegradationloweringfi##brirevealed45caseresultresult [SEP][CLS]thustargetf##opromoter##gsequenceviar##hoadependentpathwayr##hoaappearsroleregulationt##17[SEP]the##90##b##kco##aguistrainrather12m##l[CLS]inm##b##f##uantthreemajorvascularanteriordescending##fle##flexco##rona##ryterritoryrightco##rona##ryarterycontrolregionterritory[CLS]theseresultmreceptorcouplealphai##2alphai##3v##ivointeractionintegralpositivenegativeregulatorypathwayleadingactivationplcdes##ens##iti##zationreceptorsignaling[SEP]##lethighergroupb[CLS]thefgenesevenex##onspanning15k##bencodingtwotrans##criptor##fs84##169aminoacid[SEP]hto##xinexexertc##yt##ost##aticeffectin##hibithis##tonede[CLS]thehumanrgenemappinghuman##311##eno##micorganizationalternativetrans##cript[CLS]thedeltamean##afdelta##b##pvariedvalue##af##b##prespectivelyrespectively [SEP]##zo##os##perwayadequatesperm##ato##zoa##1lowscan##tyraresperm##ato##zo##2sperm##atiarrestb##1sperm##atoarrestb##2se##rt##olicellpatterns##cle##rosisdd [SEP][CLS] 
physical 
mapping 
220 
k 
##b 
cent 
##rome 
##ric 
human 
d 
sequence 
analysis 
43 
k 
##b 
segment 
including 
ring 
##1 
##6 
##4 
gene 
[CLS] 
end 
##o 
add 
##uc 
5 
5 8 
##r 
##r 8 
8ar 
s 
9 
##d 
c 
##load 
##dition 
substituted 
c 
2 
c 
3 
double 
bond 
achieved 
ch 
##em 
##o 
di 
##aster 
##sel 
##ec 
way 
##uin 
##one 
1 
##d 
presence 
##b 
##r 
2 
[SEP] 
[CLS] 
d 
##na 
element 
recognizing 
n 
##f 
y 
##1 
regulate 
multi 
##dr 
##ug 
resistance 
gene 
promoter 
[CLS] 
radio 
go 
problem 
specific 
##ity 
##ity [SEP] 
patient 
random 
##30 
49 
##60 
48 
topic 
##al 
3 
0 
di 
##lo 
##fen 
##ac 
2 
5 
0 
0 5 
g 
daily 
30 
60 
day 
respectively 
[CLS] 
a 
ta 
##t 
dramatically 
increase 
1 
gene 
expression 
presumably 
regulated 
late 
##nt 
state 
may 
also 
activated 
mit 
c 
##lar 
difference 
##rk 
ii 
##rk 
ii 
23 
protein 
examined 
binding 
##ro 
[SEP] 
[CLS] 
conclusion 
systemic 
factor 
increase 
bone 
mineral 
density 
appear 
involved 
path 
##ogen 
o 
##ssi 
longitudinal 
factor 
may 
activated 
middle 
age 
age [SEP] 
[CLS] 
thus 
fur 
co 
##x 
equivalent 
comprises 
two 
gene 
separated 
genome 
two 
gene 
p 
pts 
complex 
id 
1 
##h 
id 
##h 
seem 
human 
ho 
##mo 
##logue 
##s 
mouse 
id 
1 
id 
2 
respectively 
potential 
en 
##code 
154 
135 
amino 
acid 
protein 
protein [SEP] 
[CLS] 
characterization 
insertion 
mutation 
sa 
##cc 
##har 
##omy 
##ces 
c 
##ere 
##vis 
##iae 
##1 
##2 
gene 
evidence 
separate 
mitochondrial 
nuclear 
function 
[SEP] 
[CLS] 
transcription 
f 
promoter 
##ran 
##fer 
fusion 
gene 
base 
substitution 
one 
rich 
sequence 
##ivo 
##it 
##ro 
revealed 
base 
substitution 
rich 
sequence 
result 
reduction 
promoter 
activity 
although 
downstream 
g 
##c 
box 
##c 
##d 
play 
primary 
role 
[SEP] 
m 
##or 
##phological 
co 
##uga 
internal 
elastic 
la 
vessel 
often 
observed 
vehicle 
prominent 
##ln 
healthy 
control 
a 
g 
##t 
rich 
sequence 
binding 
transcription 
factor 
s 
##1 
crucial 
high 
human 
##ii 
co 
##lla 
##1 
##bro 
##era 
[CLS] 
each 
received 
received 20 
m 
##l 
one 
three 
test 
solution 
le 
##vo 
control 
le 
##vo 
##any 
2 
micro 
m 
##l 
le 
##vo 
3 
micro 
m 
##l 
the 
##r 
gene 
ya 
##rrow 
##oly 
in 
al 
##kal 
extra 
##cellular 
pro 
##te 
##ase 
[CLS] 
conclusion 
annual 
rate 
de 
no 
##vo 
an 
##eur 
##ys 
formation 
relatively 
high 
0 
89 
cumulative 
becomes 
9 
year 
year [SEP] 
##14 
##0 
bind 
primarily 
##k 
regulatory 
subunit 
beta 
id 
##io 
detection 
muscle 
involvement 
previous 
analysis 
motif 
la 
##ose 
per 
##me 
##ase 
a 
[SEP] 
[PAD] [CLS] 
combined 
ch 
##em 
##otherapy 
26 
b 
##c 
##nu 
re 
##current 
##current ma 
mali 
g 
##lio 
operation 
i 
##rra 
##diation 
##diation [SEP] 
like 
i 
##s 
ch 
i 
##1 
contains 
n 
terminal 
b 
i 
repeat 
c 
terminal 
ring 
finger 
motif 
[SEP] 
[CLS] 
effect 
term 
r 
est 
m 
##od 
##roid 
function 
test 
profile 
profile [SEP] 
donor 
10 
in 
##com 
##tible 
in 
##com 
[CLS] 
alternative 
s 
##licing 
human 
se 
##rot 
##oni 
gene 
interesting 
basal 
map 
##k 
##af 
1 
activity 
con 
##utive 
enhanced 
##ak 
##1 
def 
he 
cell 
[CLS] 
this 
report 
describes 
treatment 
patient 
period 
##ont 
##osis 
the 
aim 
organize 
chemical 
client 
server 
environment 
using 
database 
management 
system 
web 
fashion 
client 
interface 
interface [SEP] 
c 
##er 
##ume 
##n 
management 
te 
texa 
district 
program 
##ct 
##ate 
##vate 
actual 
value 
##nous 
blood 
newborn 
calf 
focus 
general 
approach 
agent 
agent [SEP] 
##let 
r 
##b 
##c 
animal 
labeled 
51 
##r 
99 
##t 
respectively 
rapidly 
injected 
right 
at 
blood 
sampled 
##ort 
##a 
[CLS] 
comparison 
delta 
##met 
##hr 
effect 
lo 
##com 
##oto 
end 
strong 
e 
g 
[CLS] 
protection 
level 
33 
3 
36 
37 
0 
achieved 
group 
1000 
20 
k 
c 
##er 
##car 
##ia 
1000 
10 
k 
##er 
##car 
##ia 
2000 
40 
k 
c 
##er 
##car 
##ia 
2000 
60 
k 
##er 
##car 
##ia 
[CLS] 
in 
type 
i 
ii 
cap 
##illa 
##ry 
wall 
became 
thinner 
##illa 
##ry 
l 
##ume 
##n 
##isi 
##able 
thus 
p 
##rima 
v 
promoter 
select 
##ivity 
mediated 
t 
##b 
##p 
ta 
complex 
likely 
subtle 
difference 
individual 
subunit 
lead 
s 
##pec 
##ie 
specific 
polymer 
##ase 
i 
transcription 
competitive 
nm 
##da 
antagonist 
##k 
80 
##1 
alter 
repeated 
restraint 
stress 
[CLS] 
gene 
conversion 
initiated 
double 
strand 
break 
d 
##b 
##hom 
##olo 
##go 
d 
present 
end 
must 
removed 
new 
d 
synthesis 
initiated 
[SEP] 
[CLS] 
in 
re 
##con 
##stituted 
system 
r 
ii 
##a 
r 
##b 
trans 
##cribe 
d 
##h 
##f 
##r 
promoter 
[SEP] 
[CLS] 
the 
clone 
en 
##pt 
##ide 
65 
amino 
acid 
b 
##hl 
##h 
basic 
he 
he 
domain 
characteristic 
transcription 
factor 
per 
##rn 
##t 
si 
domain 
terminal 
half 
region 
[SEP] 
ft 
##f 
function 
c 
##lar 
##ification 
membership 
main 
l 
##r 
bone 
mineral 
##m 
##d 
dual 
d 
increased 
0 
6 
3 
6 
8 
1 
48 
week 
m 
h 
respectively 
response 
h 
higher 
man 
mann 
##n w 
##hit 
s 
##yne 
##rgy 
##fer 
gamma 
tumor 
ne 
##rosis 
transcription 
##al 
activation 
mediated 
cooperation 
signal 
trans 
act 
transcription 
1 
factor 
1 
15 
magnetic 
secondary 
structure 
tertiary 
fold 
es 
##cher 
co 
d 
1 
a 
##a 
##bri 
##l 
2 
d 
library 
##l 
3 
vector 
further 
##k 
l 
##c 
br 
br 
alone 
inhibitor 
##9 
##80 
##9 
##01 
activation 
l 
br 
lethal 
[CLS] 
the 
##ole 
##ster 
##ol 
##al 
##pha 
##ydro 
##a 
transcription 
##ally 
regulated 
number 
factor 
including 
hormone 
##le 
acid 
di 
##urn 
##al 
rhythm 
[PAD] [CLS] 
c 
##ns 
prevent 
##ive 
treatment 
##al 
i 
##rra 
##diation 
effective 
all 
patient 
patient [SEP] 
additionally 
member 
strong 
sequence 
ho 
##mology 
larger 
terminal 
effect 
##or 
binding 
o 
##go 
##mer 
##ization 
domain 
[SEP] 
[CLS] 
##par 
sweet 
soft 
drink 
many 
food 
food [SEP] 
the 
rat 
##oc 
used 
posts 
##yna 
study 
the 
presentation 
review 
knowledge 
5 
11 
e 
##ico 
##sat 
##o 
3 
effect 
##id 
metabolism 
a 
##1 
clone 
encoded 
member 
##ob 
gene 
identified 
as 
as 
beta 
ho 
##mo 
##o 
clone 
##d 
p 
##b 
##cripts 
##k 
expressed 
es 
##cher 
##ichi 
k 
12 
contain 
l 
##o 
##cam 
1 
serum 
determined 
el 
##isa 
method 
[CLS] 
the 
highest 
t 
##t 
##x 
10 
0 
n 
lives 
##cens 
[SEP] 
[CLS] 
on 
##po 
di 
##ure 
may 
accompanied 
de 
##ple 
total 
body 
consequence 
consequence [SEP] 
##ath 
red 
##uc 
activity 
liver 
kidney 
lung 
brain 
affected 
diet 
[CLS] 
here 
describe 
n 
##uc 
##leo 
##tide 
n 
##t 
sequence 
g 
##eno 
##mic 
organization 
i 
##b 
i 
##pio 
[SEP] 
##com 
te 
to 
##xin 
stool 
delayed 
death 
death [SEP] 
soluble 
fi 
##bri 
##n 
mon 
##omer 
complex 
th 
##rom 
##boe 
##mbo 
[CLS] 
comparison 
m 
##uri 
ho 
##mo 
##logue 
molecule 
reveals 
high 
degree 
conservation 
product 
one 
gene 
f 
##c 
gamma 
r 
##ii 
##b 
m 
beta 
gene 
primary 
sequence 
s 
##p 
##licing 
pattern 
tissue 
distribution 
[SEP] 
[CLS] 
acid 
##osis 
##osis provoked 
30 
co 
##2 
##2 i 
##rre 
##vers 
##versibly 
b 
##dr 
##t 
however 
t 
changed 
[SEP] 
others 
example 
11 
labeled 
fatty 
horizon 
[PAD] [CLS] 
the 
progression 
11 
6 
s 
##d 
9 
0 
[CLS] 
80 
b 
##p 
surrounding 
site 
transcription 
initiation 
[SEP] 
ultra 
##structure 
to 
##xin 
##r 
dip 
culture 
##d 
presence 
em 
##t 
localized 
chromosome 
##31 
32 
region 
contains 
gene 
several 
factor 
well 
early 
activation 
gene 
particularly 
involved 
hem 
##ato 
##po 
##iet 
system 
[CLS] 
t 
##b 
##x 
map 
chromosome 
7 
appear 
linked 
known 
mutation 
[CLS] 
ka 
er 
##up 
disease 
it 
tested 
yet 
extent 
damage 
better 
reference 
plane 
1 
2 
import 
beta 
media 
trans 
s 
3 
[CLS] 
the 
encoded 
protein 
contains 
amino 
terminal 
p 
##d 
##z 
domain 
followed 
predicted 
coil 
##ed 
region 
p 
##est 
domain 
car 
##box 
terminal 
sa 
domain 
[SEP] 
using 
p 
involves 
re 
##sha 
re 
##fra 
increased 
however 
age 
24 
3 
ma 
##ximal 
##hra 
55 
ma 
##ximal 
4 
166 
3 
cm 
[CLS] 
several 
study 
demonstrated 
co 
##rt 
##ico 
##tro 
releasing 
factor 
test 
##rf 
useful 
a 
##eti 
##ological 
diagnosis 
##shing 
syndrome 
disease 
opposed 
e 
##ct 
##op 
act 
##h 
secret 
syndrome 
h 
##y 
##pot 
##hala 
##mus 
##uit 
##ary 
ad 
##rena 
##l 
hp 
##a 
axis 
still 
stimulate 
##rf 
[SEP] 
[CLS] 
transcription 
initiation 
region 
also 
detected 
v 
##ivo 
clone 
##d 
r 
##rna 
gene 
cluster 
present 
multi 
copy 
##mi 
##d 
[SEP] 
[CLS] 
the 
result 
trans 
trans 
s 
##1 
binding 
element 
located 
core 
region 
position 
64 
1 
alpha 
in 
inte 
promoter 
play 
essential 
role 
alpha 
in 
inte 
promoter 
activity 
down 
##re 
##gu 
##b 
[CLS] 
principal 
component 
analysis 
##ych 
##oso 
factor 
woman 
showed 
two 
ps 
##ych 
##oso 
##cial 
structure 
e 
second 
principal 
high 
so 
##c 
high 
lifestyle 
low 
stress 
4th 
principal 
component 
high 
supernatural 
##l 
##c 
high 
##c 
##c [SEP] 
expression 
region 
gene 
position 
69 
510 
b 
##p 
mediated 
serum 
##ness 
[CLS] 
interaction 
v 
re 
##l 
protein 
n 
##f 
d 
binding 
site 
[CLS] 
this 
increase 
result 
alter 
deposition 
inhaled 
particle 
brought 
volume 
restriction 
restriction [SEP] 
[CLS] 
appropriate 
care 
sex 
sex [SEP] 
[CLS] 
to 
system 
trans 
trans 
ad 
##ip 
construct 
containing 
g 
##ly 
##yd 
3 
de 
##hy 
##dr 
##ogen 
##ase 
gap 
##dh 
s 
promoter 
fused 
gene 
reporter 
cat 
[CLS] 
in 
##omo 
e 
##uga 
##os 
cellular 
division 
readily 
s 
##hr 
dark 
cycle 
[SEP] 
[CLS] 
s 
##g 
concentration 
woman 
higher 
t 
2 
t 
3 
t 
1 
value 
[CLS] 
si 
##vas 
##tat 
l 
##dl 
##ster 
29 
7 
t 
13 
6 
4 
4 alpha 
to 
##ol 
##ol 16 
16 2 
5 
##ol 
10 
22 
0 
00 
##1 
increased 
##dl 
##ster 
##ol 
7 
0 
00 
##1 
serum 
insulin 
00 
the 
severe 
c 
##rf 
likely 
total 
h 
low 
they 
growth 
in 
t 
beta 
[CLS] 
to 
##ivo 
role 
##ime 
##ric 
b 
protein 
on 
transformation 
directed 
l 
##ymph 
##oid 
compartment 
trans 
this 
need 
re 
function 
##a 
induced 
er 
##k 
activation 
[CLS] 
infected 
translation 
m 
##1 
protein 
reduced 
20 
translation 
neither 
##1 
interfere 
##s 
##1 
translation 
##al 
stimulation 
m 
##1 
protein 
[SEP] 
[CLS] 
some 
cell 
excited 
others 
in 
##hibit 
##ed 
directional 
##ly 
sensitive 
op 
##tom 
##oto 
##r 
stimulus 
stimulus [SEP] 
[CLS] 
l 
##t 
beta 
transcription 
ma 
##ximal 
thy 
##mic 
me 
##du 
##lla 
s 
##ple 
white 
pulp 
mutant 
cellular 
transformation 
[CLS] 
interaction 
detected 
full 
length 
h 
##1 
small 
subunit 
gamma 
t 
##fi 
##ia 
we 
##1 
intrinsic 
se 
##rine 
kinase 
[CLS] 
a 
short 
conserved 
motif 
required 
re 
##press 
##or 
domain 
function 
my 
##elo 
##id 
specific 
transcription 
factor 
##aa 
##t 
enhance 
##r 
binding 
e 
##ps 
##ilon 
[SEP] 
and 
##rogen 
##bla 
50 
year 
[CLS] 
##3 
regulate 
##s 
j 
##mona 
gene 
via 
direct 
interaction 
[SEP] 
also 
absence 
##i 
segment 
heat 
seed 
[CLS] 
theoretical 
mechanism 
h 
##yper 
##uri 
##ce 
##mia 
##f 
##3 
en 
##codes 
put 
##ative 
per 
##ip 
##mic 
c 
type 
c 
##och 
##rome 
molecular 
94 
000 
da 
contains 
seven 
c 
hem 
##e 
binding 
motif 
show 
sequence 
ho 
##mology 
##1 
[SEP] 
[CLS] 
do 
##zo 
maximum 
##rina 
rate 
1 
01 
m 
##l 
3 
m 
##l 
respectively 
0 
21 
m 
2 
m 
##bo 
##bo [SEP] 
[CLS] 
h 
##pox 
decreased 
rate 
spontaneous 
impulse 
initiation 
sa 
nod 
##al 
fiber 
decreasing 
slope 
di 
##ast 
##olic 
de 
##pol 
##ari 
##zation 
[SEP] 
background 
plate 
##let 
path 
##ogen 
##way 
##yper 
##res 
##po 
as 
[CLS] 
t 
##fe 
r 
found 
many 
tissue 
adult 
rat 
relative 
concentration 
t 
##fe 
t 
##fe 
##3 
r 
vary 
considerably 
different 
tissue 
unlike 
case 
##1 
gene 
function 
##sp 
##able 
normal 
development 
[CLS] 
study 
gamma 
gene 
reporter 
construct 
ca 
##c 
box 
del 
##eti 
##on 
revealed 
ca 
##c 
box 
sequence 
gamma 
gene 
promoter 
media 
##tes 
activation 
gamma 
gene 
f 
##k 
##lf 
[SEP] 
recommend 
make 
[CLS] 
animal 
divided 
equal 
group 
follows 
1 
oral 
drug 
hem 
##od 
##ution 
i 
iv 
drug 
sa 
2 
oral 
hem 
##od 
i 
sa 
3 
oral 
hem 
##od 
i 
iv 
prop 
##rano 
##l 
4 
oral 
hem 
##od 
i 
iv 
prop 
##rano 
##l 
5 
5 oral 
prop 
##rano 
hem 
##od 
i 
iv 
sa 
6 
oral 
prop 
##rano 
hem 
##od 
i 
sa 
##line 
[CLS] 
first 
##ata 
1 
motif 
found 
bind 
nuclear 
factor 
presumably 
##ata 
1 
factor 
present 
cell 
extract 
living 
k 
cell 
[SEP] 
[CLS] 
b 
##p 
##n 
experimental 
in 
##che 
##al 
in 
micro 
##or 
##gan 
##ism 
high 
concentration 
vent 
##ila 
##p 
##ila 
##ab 
o 
lung 
injury 
[CLS] 
a 
mouth 
as 
##ym 
##metry 
study 
[CLS] 
additionally 
important 
imp 
##lication 
understanding 
mechanism 
1 
late 
##ncy 
react 
##ivation 
[CLS] 
in 
##hibition 
due 
competition 
virus 
i 
present 
##a 
trans 
##cript 
well 
expression 
pro 
##te 
##oly 
2 
##ro 
[SEP] 
some 
may 
affect 
folding 
pathway 
affinity 
[CLS] 
diet 
im 
##bal 
##ance 
##sis 
[SEP] 
[CLS] 
48 
35 
5 
07 
l 
r 
##3 
p 
p 0 
0 05 
0 
50 
h 
##9 
92 
##4 
23 
p 
##r 
v 
v [SEP] 
[CLS] 
effect 
effect fi 
l 
##tr 
promoter 
activity 
del 
nuclear 
factor 
binding 
site 
examined 
l 
del 
##eti 
mutant 
##l 
ace 
##lt 
##ran 
##s 
##fer 
gene 
series 
sequence 
fragment 
placed 
5 
##ty 
##lt 
##ran 
##s 
##fer 
cat 
reporter 
ability 
media 
transcription 
cat 
response 
gamma 
l 
##p 
studied 
trans 
##rop 
like 
raw 
264 
7 
a 
part 
large 
du 
##lands 
cooperative 
##e 
dial 
##ys 
stage 
re 
##nal 
disease 
residual 
re 
##nal 
could 
0 
4 
week 
dial 
##ys 
therapy 
therapy [SEP] 
module 
2 
r 
lack 
beta 
k 
red 
##uc 
##r 
domain 
one 
module 
3 
3 apparently 
inactive 
##ph 
binding 
motif 
similar 
one 
found 
er 
##ks 
eight 
##r 
domain 
##f 
functional 
[CLS] 
cell 
f 
##p 
##gs 
expression 
controlled 
two 
promoter 
show 
efficiency 
least 
context 
reporter 
gene 
[SEP] 
[CLS] 
th 
##ia 
##zi 
di 
##ure 
h 
##yper 
insulin 
dependent 
diabetes 
##lli 
##tus 
##tus [SEP] 
[CLS] 
reduced 
##ath 
within 
blood 
se 
range 
1 
01 
2 
28 
##gram 
se 
area 
[SEP] 
[CLS] 
su 
suc 
##rose 
produced 
source 
leaf 
predominant 
carbon 
source 
developing 
sink 
tissue 
higher 
plant 
[SEP] 
a 
personal 
view 
future 
trend 
##ass 
review 
review [SEP] 
[PAD] [CLS] 
in 
##n 
a 
##rb 
##or 
classification 
observed 
12 
i 
##a 
21 
3 
2 
c 
i 
##b 
3 
5 
14 
c 
ii 
##a 
25 
4 
27 
ii 
##b 
49 
7 
7 [SEP] 
numerous 
gene 
family 
identified 
animal 
largest 
number 
found 
##te 
contains 
binding 
site 
s 
##h 
##2 
domain 
subunit 
3 
mapped 
##31 
present 
sequence 
ye 
##am 
[CLS] 
4 
motor 
ne 
##uron 
s 
##pec 
##ifies 
wild 
pattern 
pre 
##sy 
##nap 
input 
[CLS] 
significant 
difference 
observed 
composition 
nuclear 
transcription 
factor 
bound 
c 
##i 
element 
within 
l 
##dh 
c 
pro 
##ximal 
promoter 
region 
so 
##matic 
##er 
##m 
cell 
[SEP] 
[CLS] 
above 
transition 
antagonist 
lower 
f 
##m 
pronounced 
##ly 
[SEP] 
1986 
described 
op 
nerve 
de 
##gene 
##ration 
patient 
al 
##z 
##heimer 
disease 
sad 
drop 
re 
##tina 
gang 
##lion 
range 
30 
60 
one 
media 
responsible 
responsible al 
ali 
rather 
complex 
inter 
##play 
exists 
diverse 
pro 
##in 
##mat 
complement 
product 
c 
##yt 
##oc 
##ain 
ch 
##em 
##oc 
##ain 
##s 
oxygen 
s 
product 
1 
media 
s 
##oso 
extract 
fraction 
second 
step 
s 
##licing 
factor 
[SEP] 
[CLS] 
contrast 
radio 
##graphy 
method 
document 
pu 
##d 
c 
##f 
duo 
##den 
##al 
##uc 
##osa 
typically 
appears 
nod 
##ular 
distorted 
poor 
##uc 
##osa 
##l 
fold 
[SEP] 
similar 
binding 
mutation 
site 
including 
mimic 
##ose 
##bol 
##ish 
binding 
presumably 
due 
either 
##fa 
##vor 
##able 
s 
##ic 
interaction 
conform 
##ational 
change 
[CLS] 
a 
brass 
##a 
clone 
encoding 
bi 
##function 
##al 
h 
##ydro 
##id 
kinase 
th 
##iam 
##in 
phosphate 
involved 
th 
##iam 
##in 
bio 
##hesis 
##pt 
mother 
child 
affected 
down 
syndrome 
[CLS] 
differential 
decay 
##cist 
##ronic 
es 
##cher 
##ichi 
co 
trans 
##cript 
initiated 
r 
##ee 
dependent 
end 
##ly 
processing 
[SEP] 
defect 
r 
##t 
##6 
expression 
coincide 
increased 
su 
insulin 
dependent 
diabetes 
##lli 
auto 
##mu 
disease 
[CLS] 
by 
detection 
correction 
possible 
cause 
goal 
therapeutic 
achieved 
h 
##ydro 
de 
effect 
in 
##ot 
82 
##12 
the 
101 
s 
1 
r 
##ok 
1 
gene 
distinct 
set 
regulator 
differentiation 
[CLS] 
temporal 
lobe 
e 
##pile 
inter 
##ict 
##f 
flu 
##oro 
##de 
##cos 
pet 
three 
condition 
resting 
emotional 
speech 
performing 
recognition 
task 
task [SEP] 
[CLS] 
s 
##1 
suppress 
##or 
yeast 
1 
identified 
multi 
##copy 
suppress 
##or 
1 
subsequently 
found 
identical 
##3 
r 
##na 
polymer 
##ase 
i 
transcription 
factor 
[CLS] 
newly 
hatch 
f 
##1 
n 
##ymph 
a 
##iol 
th 
##ab 
##r 
fed 
food 
treated 
various 
concentration 
h 
##l 
##l2 
c 
##d 
##c 
##l 
end 
adult 
life 
[SEP] 
[CLS] 
ne 
##uron 
##al 
activity 
58 
do 
##pa 
##mine 
##rg 
da 
200 
do 
##pa 
##mine 
##rg 
da 
ne 
##uron 
te 
##al 
##ta 
monkey 
recorded 
correlation 
bar 
press 
feeding 
sensory 
change 
motivation 
investigated 
both 
sequence 
analysis 
restriction 
fragment 
length 
##mor 
##phism 
high 
degree 
sequence 
97 
ho 
##mology 
structural 
similarity 
common 
origin 
recent 
penetration 
d 
##na 
[SEP] 
three 
novel 
binding 
previous 
crystal 
##log 
##raphic 
analysis 
in 
de 
##cos 
up 
ad 
##ip 
3 
##3 
l 
##1 
ad 
##ip 
u 
##31 
[CLS] 
elevated 
in 
##os 
phosphate 
e 
##pi 
alpha 
##9 
expression 
similar 
obtained 
##bach 
activation 
m 
##1 
##car 
##ty 
##cho 
receptor 
[CLS] 
d 
template 
probe 
d 
##e 
i 
experiment 
determine 
site 
protein 
d 
interaction 
[SEP] 
we 
tested 
hypothesis 
reduction 
##r 
sympathetic 
nerve 
s 
salt 
war 
result 
b 
##m 
##k 
1 
19 
content 
de 
##pol 
parameter 
v 
##max 
##d 
##p 
similar 
t 
##t 
##x 
different 
##2 
[CLS] 
in 
cell 
adjacent 
matrix 
several 
characteristic 
fi 
##bro 
##car 
##til 
##age 
including 
ch 
##ond 
##ro 
##tes 
[SEP] 
man 
base 
o 
[CLS] 
all 
ex 
##on 
intro 
##n 
s 
##p 
##lice 
junction 
follow 
g 
##t 
a 
##g 
rule 
[SEP] 
glucose 
repression 
##rb 
##1 
transcription 
mediated 
##k 
##1 
##4 
gene 
c 
[CLS] 
comparison 
encoded 
er 
##3 
##d 
##m 
protein 
ho 
##mo 
##log 
##ous 
mouse 
man 
strong 
amino 
acid 
conservation 
71 
identity 
especially 
d 
binding 
region 
seven 
he 
##lica 
domain 
[SEP] 
p 
##yr 
##ido 
##st 
##ig 
in 
##hibit 
recovered 
100 
mum 
1 
o 
##xi 
experiment 
[PAD] [CLS] 
in 
moderate 
b 
##uc 
##cal 
class 
ii 
tendency 
55 
m 
##olar 
class 
i 
relationship 
evaluated 
l 
whereas 
45 
belonged 
mild 
1st 
degree 
class 
ii 
m 
##olar 
rotation 
present 
81 
case 
case [SEP] 
[CLS] 
mutation 
o 
nuclear 
local 
e 
##1 
d 
replication 
intact 
genome 
[CLS] 
serum 
pro 
##ct 
##in 
o 
##rad 
##iol 
level 
different 
pub 
##erty 
duration 
var 
##ico 
##cel 
##e 
per 
se 
affect 
d 
seminal 
level 
[CLS] 
##ric 
response 
do 
##pa 
di 
##io 
dimensional 
echo 
##card 
##io 
##all 
s 
detailed 
comparison 
ex 
##rine 
patient 
les 
n 
##y 
syndrome 
control 
[CLS] 
enzyme 
distinct 
known 
known e 
##3 
##s 
including 
including e 
##3 
alpha 
##r 
##1 
##1 e 
##3 
beta 
beta e 
##6 
a 
##p 
[CLS] 
this 
evidence 
ability 
car 
##box 
##yl 
terminal 
coding 
sequence 
starting 
b 
##hi 
site 
complement 
##1 
##1 
##p 
contains 
two 
domain 
separately 
expressed 
form 
functional 
protein 
[SEP] 
zinc 
tumor 
ne 
##rosis 
inter 
##le 
##uki 
1 
il 
1 
in 
negatively 
regulate 
factor 
ka 
##f 
ka 
##ppa 
dependent 
gene 
expression 
[CLS] 
a 
distinct 
muscular 
h 
##yper 
##tro 
m 
double 
m 
##us 
##c 
##ling 
occurs 
high 
be 
bel 
##gia 
blue 
##d 
##mont 
breed 
me 
##lan 
ii 
##i 
##i i 
iv 
difference 
survival 
rate 
2 
greater 
2 
00 
##1 
though 
level 
at 
complex 
eliminated 
nuclear 
extract 
broad 
react 
1 
2 
protein 
thus 
transcription 
factor 
recognizes 
12 
motif 
[SEP] 
mutant 
beta 
ad 
##rene 
t 
p 
substitution 
350 
display 
ago 
des 
##ens 
##zation 
recruitment 
activation 
role 
distinct 
mit 
pathway 
cooperation 
et 
##s 
2 
at 
u 
##rok 
##inas 
type 
##min 
##iva 
induction 
##le 
1 
pro 
prote 
dig 
in 
##tra 
mature 
extra 
envelope 
##d 
##r 
protein 
present 
surface 
surface e 
type 
ii 
membrane 
topology 
absent 
associated 
essential 
function 
end 
d 
##bs 
##ivo 
complement 
alpha 
lack 
yet 
function 
##ych 
##op 
##ath 
##get 
vital 
hour 
hour [SEP] 
[CLS] 
result 
in 
##ulin 
clearance 
le 
80 
m 
##l 
min 
1 
m 
cut 
serum 
c 
##rea 
##tin 
##ine 
11 
5 
mum 
##ol 
liter 
men 
90 
mum 
##ol 
woman 
woman [SEP] 
[CLS] 
these 
data 
may 
red 
##unda 
##ncy 
member 
ng 
n 
##r 
##1 
nor 
##1 
subfamily 
could 
explain 
##hen 
##otypic 
disturbance 
yet 
found 
mouse 
ng 
gene 
inactivated 
sample 
addition 
internal 
standard 
directly 
te 
##tra 
##cy 
regulated 
system 
##os 
o 
##ste 
thus 
##l 
media 
suppression 
impaired 
s 
phase 
progression 
[CLS] 
ta 
##ag 
site 
serve 
functional 
late 
promoter 
found 
media 
transcription 
initiation 
basal 
level 
context 
genome 
late 
promoter 
activation 
specific 
within 
##idae 
[SEP] 
[CLS] 
stability 
125 
i 
labeled 
insulin 
radio 
insulin 
insulin [SEP] 
in 
level 
1 
000 
must 
screened 
order 
s 
sn 
##m 
organic 
path 
##ology 
associated 
associated [SEP] 
[CLS] 
##el 
caused 
rapid 
trans 
increase 
c 
j 
##h 
terminal 
kinase 
##nk 
activity 
proposed 
media 
stress 
activation 
pathway 
[CLS] 
these 
result 
h 
##ri 
super 
hormone 
receptor 
ii 
may 
regulate 
m 
mh 
##c 
class 
i 
gene 
also 
gene 
containing 
containing er 
##e 
related 
sequence 
course 
ch 
##em 
##otherapy 
##b 
##c 
##da 
##d 
gain 
pain 
re 
##current 
bone 
meta 
##sta 
managed 
mainly 
administration 
best 
supportive 
care 
care [SEP] 
[CLS] 
##1 
##p 
bind 
3 
h 
ad 
##ome 
novel 
met 
##hyl 
##ase 
whose 
possible 
substrate 
discussed 
result 
lateral 
##a 
medial 
000 
0001 
[CLS] 
conclusion 
urban 
##isation 
prevalence 
rate 
risk 
behaviour 
behaviour [SEP] 
however 
whole 
required 
understand 
##r 
##h 
signaling 
context 
hormone 
cycle 
human 
serum 
an 
##gio 
##gen 
##in 
diabetes 
##lli 
[CLS] 
this 
du 
##plicate 
##d 
g 
##eno 
##mic 
region 
also 
linked 
tightly 
d 
##z 
genetic 
marker 
containing 
##oly 
##morphic 
##r 
tandem 
repeat 
consisting 
unusual 
40 
b 
##p 
re 
##iter 
##ated 
sequence 
[CLS] 
at 
##f 
##6 
basic 
##uc 
zipper 
protein 
isolated 
binding 
particular 
transcription 
##al 
activation 
domain 
[SEP] 
[CLS] 
c 
##1 
sequence 
feature 
expressed 
re 
##tro 
##po 
gene 
lack 
intro 
##n 
open 
reading 
frame 
interrupted 
stop 
co 
##don 
coding 
region 
flanked 
pair 
direct 
repeat 
[SEP] 
[CLS] 
the 
largest 
one 
probably 
corresponds 
precursor 
form 
ps 
##2 
e 
co 
##li 
[SEP] 
the 
as 
##gill 
gene 
product 
ho 
##mo 
##log 
##ous 
yeast 
r 
##ad 
##18 
##uro 
##sp 
2 
[CLS] 
on 
maximum 
estimate 
within 
one 
order 
magnitude 
maximum 
dose 
tested 
##1 
form 
protein 
complex 
interaction 
terminal 
regulatory 
region 
##2 
domain 
##1 
##os 
manner 
[CLS] 
the 
originally 
em 
##b 
##ryo 
gamma 
##bin 
lo 
du 
##plicate 
##d 
acquired 
novel 
f 
##etal 
pattern 
expression 
time 
period 
55 
40 
million 
year 
##rima 
##hyl 
##ogen 
##y 
##y [SEP] 
[CLS] 
c 
##los 
##tri 
##dium 
b 
##ot 
##ulin 
marine 
sediment 
[SEP] 
b 
##lot 
analysis 
##r 
##37 
revealed 
main 
3 
3 8 
k 
##b 
m 
le 
abundant 
abundant 8 
k 
expressed 
brain 
tissue 
particularly 
call 
##os 
me 
##du 
##ame 
##te 
nucleus 
[CLS] 
indicate 
single 
trans 
acting 
factor 
absolutely 
essential 
enhance 
##r 
activity 
enhance 
##r 
activity 
##ri 
mediated 
via 
comb 
##inator 
add 
##itive 
mechanism 
[SEP] 
w 
##i 
##38 
cell 
cell e 
##1 
##b 
19 
gene 
substantial 
500 
fold 
higher 
t 
[CLS] 
to 
el 
##uc 
##ida 
##te 
mechanism 
ho 
##rmon 
##al 
effect 
studied 
regulatory 
region 
##k 
gene 
trans 
[SEP] 
[CLS] 
consequently 
evolution 
ma 
##mmal 
##k 
##a 
##a4 
gene 
lineage 
recruited 
bio 
##ct 
##ose 
[CLS] 
further 
disruption 
##r 
##1 
reduced 
expression 
f 
##b 
##p 
##1 
glucose 
re 
##press 
gene 
negatively 
regulated 
solution 
125 
i 
an 
##ky 
found 
n 
##d 
page 
##3 
enhance 
s 
##pect 
self 
association 
10 
fold 
transcription 
analysis 
e 
##cor 
##i 
d 
region 
auto 
##a 
ca 
##fo 
##rn 
##rosis 
early 
4 
##ilo 
##base 
r 
##na 
encoding 
essential 
##3 
gene 
##eri 
##os 
##rot 
##rona 
##ry 
[CLS] 
5 
in 
##ven 
##ous 
##id 
##ilo 
h 
decrease 
resting 
blood 
##ric 
area 
increase 
pulse 
rate 
virtually 
effect 
e 
##jection 
fraction 
fraction [SEP] 
in 
study 
sub 
##cellular 
location 
domain 
structure 
bio 
##chemical 
##xin 
the 
human 
c 
clone 
##d 
sequence 
##d 
shown 
open 
reading 
frame 
encoding 
29 
##6 
amino 
acid 
protein 
could 
four 
p 
##eptide 
previously 
micro 
se 
##quencing 
protein 
ca 
##bra 
d 
method 
chemical 
analysis 
##gene 
##dia 
##bet 
##ista 
di 
##abe 
##k 
rat 
21 
precision 
error 
re 
determination 
26 
study 
[CLS] 
flux 
re 
##tic 
activate 
##s 
transcription 
gene 
[CLS] 
the 
preference 
third 
base 
co 
##don 
y 
position 
pro 
alpha 
##i 
co 
##lla 
##bri 
##llar 
co 
##lla 
tumor 
contribution 
electron 
[CLS] 
de 
##ton 
##ation 
traumatic 
load 
military 
service 
in 
sway 
force 
closed 
[CLS] 
so 
##ggy 
sperm 
##ato 
specific 
gene 
lie 
3 
8 
k 
##b 
upstream 
anti 
##po 
##dal 
tea 
##d 
2 
transcription 
factor 
expressed 
beginning 
development 
[SEP] 
[CLS] 
##rato 
factor 
[CLS] 
result 
study 
suggest 
medicine 
use 
population 
depends 
regular 
source 
care 
chin 
##ese 
medicine 
well 
preference 
medicine 
two 
predict 
##or 
use 
use [SEP] 
[CLS] 
the 
greatest 
##ter 
r 
##up 
membrane 
pp 
##rom 
##ter 
##m 
delivery 
[SEP] 
[CLS] 
discussion 
higher 
absolute 
knee 
extension 
strength 
similar 
extension 
strength 
o 
##bes 
might 
explained 
training 
effect 
bearing 
support 
larger 
body 
mass 
[CLS] 
residue 
s 
r 
38 
##28 
oxygen 
analogue 
body 
tissue 
fed 
r 
38 
##28 
diet 
the 
goal 
experiment 
determine 
whether 
la 
an 
##rus 
would 
prolonged 
48 
h 
fast 
day 
13 
pp 
effect 
could 
reversed 
protein 
le 
##pt 
[CLS] 
pit 
##uit 
##3 
cell 
vitamin 
d 
increase 
level 
##rl 
trans 
##cript 
stimulate 
##rl 
promoter 
[SEP] 
[CLS] 
however 
electron 
micro 
revealed 
##4 
cell 
a 
##ulate 
secret 
ve 
##si 
##cle 
##31 
cell 
a 
a 
##ber 
##rant 
go 
gol 
##gi 
structure 
[CLS] 
method 
we 
retrospective 
##ly 
data 
20 
patient 
gate 
##d 
##ori 
de 
##cos 
##d 
##g 
pet 
pet equilibrium 
##gio 
##na 
##na [SEP] 
[CLS] 
however 
suggested 
slowly 
dig 
##ested 
star 
##chy 
food 
may 
positive 
health 
benefit 
[CLS] 
northern 
b 
##lot 
gene 
trans 
##cribed 
separately 
[SEP] 
complete 
activation 
signal 
trans 
act 
1 
s 
##tat 
##1 
requires 
##70 
##1 
conserved 
pm 
sequence 
[CLS] 
over 
half 
child 
initially 
##res 
##po 
in 
men 
##ing 
subsequently 
anti 
##body 
##body [SEP] 
[CLS] 
it 
understand 
et 
##iology 
hit 
devastating 
consequence 
consequence [SEP] 
[CLS] 
five 
sequence 
variant 
identified 
identified [SEP] 
the 
##a 
related 
harbor 
act 
##in 
binding 
domain 
interact 
##od 
r 
##pas 
[CLS] 
we 
anticipated 
s 
##n 
function 
c 
##va 
as 
##ym 
##metric 
selected 
hypothesis 
bilateral 
symmetric 
s 
##r 
late 
amplitude 
i 
##rre 
stimulation 
recording 
[SEP] 
[CLS] 
##pate 
##ct 
meta 
##static 
[CLS] 
adoption 
twisted 
structure 
import 
beta 
essential 
interaction 
required 
nuclear 
transport 
[SEP] 
[CLS] 
the 
presence 
short 
70 
b 
##p 
intro 
##n 
near 
n 
terminus 
at 
##x 
gene 
predicted 
contains 
canonical 
g 
##t 
##t a 
din 
##tide 
##s 
5 
3 
s 
##p 
##licing 
junction 
[SEP] 
[CLS] 
more 
hybrid 
protein 
composed 
p 
pval 
##f 
activation 
domain 
d 
binding 
dim 
##eri 
##zation 
domain 
r 
activated 
gene 
expression 
r 
recognizes 
d 
enhance 
##r 
v 
##ivo 
consequently 
r 
function 
d 
binding 
site 
dependent 
re 
##press 
##or 
[SEP] 
[PAD] [CLS] 
t 
99 
brain 
s 
##pect 
compared 
c 
seizure 
[CLS] 
we 
central 
##con 
##d 
region 
subunit 
essential 
function 
likely 
act 
space 
##r 
conserved 
n 
c 
terminal 
region 
transport 
125 
r 
##ti 
55 
binding 
pronounced 
reduction 
##net 
membrane 
parallel 
inability 
higher 
pool 
[CLS] 
show 
upstream 
region 
beta 
gene 
gene 55 
##18 
249 
##0 
relative 
transcription 
##al 
start 
site 
directed 
high 
level 
transcription 
##al 
activity 
stab 
integrated 
extra 
##ch 
##rom 
trans 
[SEP] 
[CLS] 
d 
##nas 
##e 
i 
protection 
analysis 
well 
o 
##leo 
##tide 
competition 
experiment 
binding 
sequence 
specific 
[SEP] 
p 
##las 
##mi 
##d 
##64 
contains 
reading 
frame 
frame e 
order 
study 
protein 
coupled 
transcription 
rabbit 
translation 
system 
[CLS] 
trans 
trans 
l 
##uc 
##ifer 
##ase 
reporter 
gene 
driven 
1 
k 
##b 
5 
flank 
d 
three 
calm 
gene 
promoter 
activity 
correlated 
end 
##ogen 
calm 
transcription 
##al 
activity 
##lated 
region 
included 
construct 
[SEP] 
these 
p 
##1 
##1 effective 
##v 
##f 
transplant 
condition 
##pa 
##tic 
c 
##ir 
##cula 
##tory 
improvement 
would 
limited 
first 
day 
transplant 
##ation 
[CLS] 
the 
der 
##ep 
##ressed 
expression 
fix 
##n 
observed 
##h 
mutant 
[CLS] 
nearly 
1 
5 
million 
##eric 
##an 
men 
65 
older 
o 
##ste 
##op 
##oro 
##sis 
another 
3 
5 
million 
risk 
[CLS] 
both 
express 
##af 
on 
product 
gag 
fusion 
##in 
on 
via 
sub 
##omi 
##omic 
m 
##rna 
[CLS] 
conclusion 
da 
##x 
improved 
p 
##har 
##co 
##kin 
##etic 
profile 
da 
##bic 
tolerate 
##d 
regime 
front 
##log 
transplant 
rapid 
response 
[CLS] 
encoded 
encoded es 
##x 
e 
restricted 
se 
##rine 
box 
exhibit 
et 
##s 
like 
d 
binding 
specific 
electro 
##ore 
mobility 
trans 
trans 
trans 
##act 
##ivate 
et 
promoter 
element 
including 
found 
[SEP] 
[CLS] 
area 
ca 
##1 
hip 
##po 
##cam 
number 
ne 
##uron 
increased 
11 
14 
fold 
##k 
80 
##1 
01 
[CLS] 
temporal 
change 
at 
conscious 
##eri 
##ove 
##nous 
fist 
high 
output 
heart 
failure 
[CLS] 
the 
re 
end 
study 
showed 
good 
compliance 
proposed 
diet 
scheme 
child 
poor 
compliance 
family 
[CLS] 
the 
delta 
g 
value 
region 
higher 
e 
secondary 
structural 
element 
fewer 
t 
##ir 
gene 
co 
##li 
[CLS] 
two 
closely 
related 
group 
trans 
##cript 
##1 
##2 
controlled 
circa 
##dian 
rhythm 
isolated 
specimen 
##pec 
mainly 
patient 
c 
##d 
##d4 
extensive 
##zo 
exposure 
these 
finding 
##if 
e 
##a 
interaction 
essential 
##if 
[CLS] 
three 
simple 
method 
detect 
ma 
##ln 
##utrition 
ward 
ward [SEP] 
[CLS] 
compared 
##med 
##ica 
state 
smooth 
higher 
rate 
correct 
##ive 
le 
time 
engaged 
tracking 
task 
task [SEP] 
##oki 
i 
alpha 
re 
blocked 
protein 
synthesis 
inhibitor 
##he 
development 
##ini 
pneumonia 
stage 
sub 
disease 
0 
0 20 
x 
10 
9 
l 
##3 
##d 
##4 
the 
effect 
##os 
##in 
administration 
feed 
400 
mg 
injection 
disease 
##te 
te 
mg 
body 
compared 
those 
participating 
investigation 
center 
79 
computer 
disk 
containing 
50 
99 
##m 
##t 
##c 
d 
##a 
study 
study [SEP] 
[PAD] [CLS] 
path 
##ogen 
fever 
fever [SEP] 
[CLS] 
two 
full 
length 
clone 
##1 
##2 
isolated 
[PAD] [CLS] 
##birth 
[CLS] 
the 
end 
barrel 
capped 
short 
he 
##lix 
[SEP] 
[CLS] 
non 
finger 
coding 
module 
conserved 
among 
zinc 
gene 
described 
m 
genome 
finger 
associated 
box 
f 
##ax 
domain 
human 
genome 
genome k 
box 
domain 
[CLS] 
this 
combination 
fact 
##iti 
##ous 
h 
##yper 
##ins 
##ulin 
##ism 
##ism [SEP] 
[CLS] 
comparison 
5 
flank 
##ing 
region 
mouse 
j 
ka 
##ppa 
element 
including 
conserved 
put 
##ative 
re 
##comb 
##ination 
target 
sequence 
show 
obvious 
difference 
variation 
re 
##comb 
##ination 
##al 
efficiency 
conclude 
although 
consensus 
he 
##pta 
##mer 
##ame 
##r 
signal 
may 
sufficient 
identify 
re 
##comb 
##ination 
site 
probability 
site 
used 
depends 
depends also 
de 
##ter 
##termina 
##nt 
[SEP] 
me 
##lan 
growth 
s 
##ti 
##lator 
regulated 
##x 
##l 
##1 
con 
##it 
##utive 
expressed 
high 
inflammation 
progression 
me 
##lan 
ma 
mali 
##lignant 
[CLS] 
genetic 
analysis 
##43 
upstream 
branch 
##1 
signalling 
pathway 
since 
##43 
mutation 
synthetic 
lethal 
##1 
del 
whereas 
##43 
defect 
could 
rescued 
high 
copy 
encoding 
downstream 
protein 
##1 
pathway 
unlike 
whose 
disruption 
##3 
mutant 
resulted 
growth 
arrest 
g 
1 
growth 
defect 
observed 
double 
##43 
##3 
mutant 
[CLS] 
twelve 
92 
showed 
cognitive 
d 
##ys 
imp 
##air 
memory 
attention 
affect 
##ive 
disturbance 
anxiety 
depression 
i 
##rri 
##ta 
##bility 
poor 
frustration 
tolerance 
tolerance [SEP] 
[CLS] 
c 
##lar 
##ify 
mechanism 
regulate 
transcription 
##t 
##p 
c 
##dr 
##ola 
i 
gene 
generate 
multiple 
s 
##pec 
##ie 
m 
##rna 
isolated 
##eno 
##mic 
d 
clone 
human 
mouse 
##t 
##p 
##dr 
##ola 
i 
gene 
[CLS] 
therefore 
structural 
interaction 
##al 
##ai 
stab 
association 
##al 
photos 
##ys 
##tem 
i 
core 
##ctor 
se 
##ptic 
##rino 
##tens 
##hra 
[CLS] 
the 
present 
study 
screening 
11 
op 
path 
fungus 
can 
##di 
al 
##ans 
negative 
m 
##od 
##1 
pro 
##co 
##lla 
gene 
skin 
##bro 
transcription 
##al 
##fer 
[CLS] 
ho 
##mology 
examined 
role 
c 
re 
##l 
controlling 
il 
##r 
alpha 
transcription 
[SEP] 
[CLS] 
expression 
##b 
##30 
##0 
potent 
mediated 
trans 
##act 
##ivation 
[SEP] 
we 
rapid 
bacterial 
##od 
domain 
##od 
##ulin 
column 
investigated 
p 
p 
p 
pk 
##c 
interaction 
##od 
##ulin 
s 
##a 
[CLS] 
according 
penetration 
ca 
45 
micro 
section 
[CLS] 
h 
##l 
##hes 
##ized 
directly 
h 
##dl 
lip 
##id 
metabolism 
tissue 
cellular 
lip 
##id 
metabolism 
e 
##ps 
##r 
ex 
exert 
trans 
##act 
##ivating 
function 
interaction 
re 
##comb 
signal 
binding 
r 
##b 
##mo 
##mologue 
##ros 
##op 
suppress 
hair 
[PAD] [CLS] 
mad 
##uro 
##cos 
it 
italy 
##aly [SEP] 
two 
group 
i 
new 
##pt 
ii 
th 
##rom 
##be 
##ct 
e 
##pt 
##raft 
##raft [SEP] 
the 
the author 
describes 
technique 
detail 
patient 
10 
men 
men 15 
il 
##eo 
##sto 
d 
re 
c 
##ro 
##hn 
disease 
il 
##eal 
o 
##bs 
s 
##a 
##a [SEP] 
[CLS] 
increased 
su 
##pt 
distract 
##or 
task 
recall 
verbal 
command 
command [SEP] 
[CLS] 
lasting 
para 
##ple 
##gia 
caused 
loss 
l 
##r 
spinal 
cord 
inter 
##ne 
##uron 
##s 
rat 
direct 
correlation 
motor 
ne 
##uron 
loss 
[CLS] 
universal 
specific 
mechanism 
action 
factor 
upon 
living 
tissue 
based 
del 
reaction 
suggested 
[SEP] 
r 
##v 
7 
1 
4 
m 
1 
min 
100 
1 
c 
0 
59 
0 
m 
calculated 
1 
ratio 
delta 
delta 
95 
1 
53 
p 
6 
3 
delta 
1 
95 
0 
37 
flow 
we 
stable 
do 
##ub 
trans 
cell 
10 
carrying 
ch 
##rom 
##oso 
##mal 
integrated 
p 
##te 
##teto 
reporter 
te 
k 
protein 
[CLS] 
electrical 
stimulation 
n 
rat 
observe 
press 
##or 
rapid 
approach 
screening 
ne 
##uro 
##se 
##cre 
##tory 
function 
central 
neural 
integration 
release 
##as 
##op 
##in 
[CLS] 
to 
study 
adaptive 
process 
##structure 
##d 
##ta 
interview 
daily 
basis 
30 
year 
divorced 
male 
first 
3 
initial 
comprehensive 
in 
##patient 
rehabilitation 
[SEP] 
[CLS] 
me 
##lio 
##ido 
si 
deer 
##er 
##vu 
ni 
enter 
##ob 
##ius 
##rm 
##icular 
egg 
##ar 
taken 
posterior 
for 
##ni 
##x 
##na 
together 
result 
##b 
##p 
general 
cooperation 
partner 
##elo 
##mon 
cell 
[CLS] 
medical 
aid 
sought 
false 
history 
given 
true 
nature 
child 
illness 
heat 
stroke 
determined 
death 
death [SEP] 
[CLS] 
both 
d 
##2 
d 
##3 
closely 
localized 
chromosome 
5 
##q 
##21 
corresponding 
human 
chromosome 
chromosome 4 
##q 
##21 
sa 
crucial 
highlight 
novel 
alternative 
s 
##d 
variant 
transcription 
factor 
##al 
##pha 
o 
lens 
[CLS] 
fi 
##1 
##p 
##p fi 
##p 
likely 
act 
cell 
surface 
surface fi 
##1 
beta 
gal 
beta 
fusion 
protein 
local 
##ize 
periphery 
mating 
cell 
[CLS] 
crystal 
triple 
mutant 
##42 
##d 
d 
##47 
##p 
##6 
##3 
##l 
stable 
day 
o 
##xi 
##dized 
form 
grown 
##mon 
cell 
constant 
b 
34 
3 
c 
111 
111 8 
a 
belonging 
space 
##3 
21 
[SEP] 
[CLS] 
nevertheless 
p 
influenced 
##ro 
drug 
availability 
considerably 
increasing 
drug 
so 
##lub 
dissolution 
rate 
[CLS] 
normal 
replication 
d 
still 
##c 
##3 
##f 
mutation 
found 
extract 
plant 
[CLS] 
such 
sat 
##uration 
several 
recording 
sweep 
signal 
eye 
blink 
rejected 
rejected [SEP] 
muscle 
liver 
bio 
an 
##oma 
##ly 
without 
branching 
enzyme 
deficiency 
liver 
liver [SEP] 
[CLS] 
possibility 
independently 
administered 
center 
[CLS] 
airborne 
r 
##abi 
en 
##pha 
##lit 
demonstration 
r 
##abi 
human 
central 
nervous 
system 
[SEP] 
[CLS] 
t 
##1 
t 
##2 
value 
calculated 
brain 
v 
##ivo 
0 
5 
t 
t [SEP] 
[CLS] 
auto 
major 
site 
y 
##12 
##35 
up 
##re 
##gu 
kinase 
activity 
receptor 
increasing 
v 
##max 
p 
##ot 
##fer 
reaction 
[SEP] 
clinical 
inter 
##le 
[CLS] 
c 
##lon 
gene 
encoding 
ben 
##zen 
##e 
de 
##grad 
enzyme 
found 
strain 
j 
##15 
##0 
also 
carry 
gene 
to 
ben 
##zen 
2 
##oo 
##xy 
##gen 
##ase 
[SEP] 
[CLS] 
association 
t 
##p 
ta 
box 
may 
regulated 
directly 
indirectly 
substrate 
##f 
##1 
##g 
[PAD] [CLS] 
it 
differed 
cue 
##d 
recall 
instruction 
directed 
subject 
away 
memory 
aspect 
test 
complete 
three 
letter 
cue 
first 
word 
came 
mind 
mind [SEP] 
[CLS] 
real 
time 
dimensional 
echo 
##card 
##io 
##ral 
axis 
view 
obtained 
10 
normal 
subject 
[SEP] 
damage 
year 
onset 
3 
3 8 
y 
##r 
[CLS] 
it 
shown 
##i 
anti 
expression 
regulated 
system 
similar 
##cs 
regulatory 
system 
involved 
co 
acid 
##cher 
##ichi 
co 
##li 
[CLS] 
the 
map 
based 
reference 
p 
##ig 
##ree 
4000 
new 
g 
##eno 
##type 
previously 
data 
29 
all 
##ele 
system 
version 
database 
constructed 
using 
program 
package 
##ri 
map 
[SEP] 
[CLS] 
ho 
##mo 
##rom 
##some 
13 
several 
set 
closely 
spaced 
prime 
##r 
designed 
based 
c 
##a 
sequence 
used 
am 
human 
##eno 
##mic 
d 
##r 
[SEP] 
[CLS] 
mg 
##2 
extent 
des 
##ta 
##bil 
##rna 
greater 
appears 
confined 
internal 
region 
accept 
##or 
ps 
##i 
c 
he 
##lix 
evidenced 
selective 
enhanced 
exchange 
rate 
pro 
associated 
base 
pair 
[SEP] 
study 
26 
patient 
patient [SEP] 
serum 
alpha 
am 
##yla 
try 
try 
total 
pro 
##te 
##ase 
##cre 
##atic 
tissue 
studied 
indicator 
flu 
##oro 
electro 
cum 
[CLS] 
1 
the 
effect 
dos 
##ire 
##tani 
di 
##ure 
chemical 
chemically 
related 
f 
##rus 
##em 
##ide 
b 
##ume 
##tani 
severe 
re 
##nal 
ins 
##rea 
##tin 
25 
m 
##l 
min 
synthesis 
o 
d 
##3 
analogue 
effect 
gal 
##4 
operates 
##4 
consistent 
large 
pocket 
r 
##b 
binding 
ii 
250 
large 
pocket 
domain 
##0 
able 
bind 
ii 
250 
##ivo 
[CLS] 
50 
n 
##uc 
##leo 
##tide 
intro 
##n 
a 
##a 
[SEP] 
the 
educational 
program 
factor 
influenced 
change 
trajectory 
re 
recurrent 
re 
##current 
factor 
influenced 
change 
pamphlet 
group 
group [SEP] 
##p 
4 
##21 
q 
##r 
gene 
independently 
##rone 
[CLS] 
activation 
receptor 
induce 
re 
##t 
p 
##lation 
lead 
survival 
promoting 
effect 
##o 
obtained 
indicated 
ma 
##ximal 
##o 
4 
reached 
[CLS] 
this 
paper 
describes 
course 
therapy 
##rap 
patient 
patient [SEP] 
[CLS] 
kinetic 
model 
used 
identify 
major 
chemical 
reaction 
pathway 
involving 
p 
##ah 
after 
##burne 
##r 
[CLS] 
he 
hen 
##ry 
##ler 
brought 
actual 
x 
ray 
treatment 
d 
##r 
##r [SEP] 
critical 
review 
test 
h 
##b 
anti 
##gen 
detection 
direct 
initial 
60 
year 
##ral 
9 
closed 
mit 
##ral 
com 
##rot 
d 
##4 
1 
dominant 
suppress 
##or 
##4 
n 
exchange 
protein 
aid 
##4 
##p 
function 
[CLS] 
these 
monitoring 
high 
risk 
pregnancy 
[CLS] 
the 
site 
predict 
##ric 
rest 
exercise 
anterior 
impaired 
inferior 
111 
113 
patient 
98 
98 produced 
##b 
m 
##l 
##l [SEP] 
[CLS] 
the 
inter 
alpha 
il 
##r 
alpha 
chain 
gene 
contains 
sequence 
similar 
##ppa 
enhance 
##r 
n 
ka 
##ppa 
b 
binding 
site 
comparison 
derived 
amino 
acid 
sequence 
##9 
##9 
gene 
product 
reveals 
34 
8 
identity 
overlap 
66 
amino 
acid 
[CLS] 
although 
##del 
##ta 
cell 
yeast 
tobacco 
p 
##p 
ch 
##era 
import 
##p 
##1 
##p 
reporter 
grow 
acid 
consistent 
observation 
introduction 
s 
site 
t 
##f 
##bet 
##1 
##f 
target 
gene 
con 
##fers 
cooperative 
cooperative t 
##bet 
[CLS] 
in 
analogy 
human 
##d 
##70 
##d 
##70 
trans 
##cript 
level 
level strongly 
trans 
##ly 
regulated 
l 
##ymph 
activation 
line 
role 
##d 
##27 
##d 
##70 
receptor 
pair 
early 
immune 
response 
[SEP] 
[CLS] 
serum 
i 
##g 
##m 
level 
showed 
highly 
increase 
type 
brain 
t 
##umour 
control 
beyond 
first 
year 
re 
##nal 
transplant 
##ation 
i 
##o 
l 
##rd 
ca 
##d 
all 
##og 
##raft 
##raft [SEP] 
[CLS] 
##k 
##k8 
##k 
##k 
##1 
##k 
rear 
##rang 
##ement 
encoded 
respective 
l 
chain 
v 
region 
region [SEP] 
[CLS] 
nursing 
deeply 
rooted 
human 
human condition 
clinical 
finding 
plaque 
index 
##i 
g 
##ing 
##ival 
##i 
bleeding 
pro 
b 
##op 
pu 
discharge 
pu 
pro 
##bing 
depth 
##d 
p 
pt 
01 
site 
measured 
every 
visit 
4 
week 
[CLS] 
one 
element 
resembles 
binding 
site 
previously 
identified 
cellular 
transcription 
factor 
[SEP] 
[CLS] 
##r 
also 
##mi 
host 
cell 
activation 
vector 
containing 
l 
##uc 
##ifer 
##ase 
reporter 
gene 
[SEP] 
plasma 
t 
##ibi 
##a 
breaking 
percentage 
t 
##ibi 
##a 
ash 
increased 
diet 
##ary 
presence 
39 
##1 
ca 
co 
k 
##1 
##1 h 
##4 
[CLS] 
in 
fungus 
ne 
##uro 
##sp 
##t 
2 
major 
nitrogen 
regulatory 
gene 
activate 
expression 
##link 
structural 
gene 
specify 
nitrogen 
cat 
##ab 
##olic 
enzyme 
condition 
nitrogen 
limitation 
[SEP] 
the 
matrix 
c 
##bs 
contains 
diagnostic 
co 
##zed 
attached 
embedded 
b 
s 
##oso 
contain 
s 
s 
##ps 
during 
observation 
12 
week 
ha 
##lving 
ate 
##no 
mean 
dose 
82 
mg 
41 
mg 
s 
##ys 
##to 
di 
##ast 
blood 
di 
##ast 
blood 
95 
le 
observed 
comparative 
volume 
##tric 
analysis 
difference 
corpus 
er 
##hr 
peripheral 
blood 
##v 
##b 
di 
urine 
##vu 
patient 
33 
hi 
infected 
##ido 
##vu 
serum 
r 
##na 
level 
20 
000 
m 
c 
##d 
##4 
count 
50 
400 
cell 
mm 
##3 
[PAD] [CLS] 
within 
year 
www 
grown 
enormous 
##ly 
##ly [SEP] 
[CLS] 
these 
##rf 
behavioral 
act 
##ivating 
an 
##xi 
effect 
least 
part 
increasing 
activity 
nor 
##ad 
##rene 
##rg 
ne 
##uron 
[SEP] 
[PAD] [CLS] 
[CLS] on 
case 
author 
different 
clinical 
picture 
caused 
cardiac 
toxicity 
##fu 
##fu [SEP] 
[CLS] 
the 
sequence 
##1 
##p 
contains 
two 
put 
##ative 
zinc 
binding 
ring 
motif 
zinc 
finger 
motif 
##ed 
motif 
[SEP] 
[CLS] 
cardiac 
output 
decreased 
slightly 
##f 
hem 
##ody 
##nam 
change 
due 
##f 
unlikely 
account 
observed 
fall 
##ao 
##2 
##2 [SEP] 
[PAD] [CLS] 
anti 
##o 
1 
##body 
present 
present [SEP] 
[CLS] 
the 
first 
op 
##eron 
##f 
##1 
##1 to 
##ra 
iron 
regulated 
growth 
iron 
regulated 
expression 
##b 
op 
##rl 
fusion 
late 
log 
phase 
[SEP] 
au 
leak 
detected 
1 
5 
sample 
in 
##bate 
##bated 
4 
week 
leak 
in 
##bate 
3 
5 
6 
week 
[CLS] 
we 
examined 
contribution 
cry 
##ptic 
p 
##mi 
##d 
##r 
##4 
##b 
nod 
##ulation 
sat 
strain 
##r 
##4 
##zo 
##bi 
##lot 
laboratory 
pre 
##rena 
##renal 
acute 
re 
##nal 
failure 
failure e 
e r 
1 
0 
unpredictable 
unpredictable fact 
worse 
pro 
##gno 
1 
0 
5 
7 
death 
10 
10 48 
death 
death [SEP] 
##ple 
##ao 
##ic 
balloon 
counter 
##pu 
##ls 
[CLS] 
##t 
##p 
##d 
##p 
##p 
affect 
response 
response [SEP] 
[CLS] 
using 
fluorescent 
protein 
fusion 
demonstrate 
s 
s 
##x 
s 
s 
##x 
protein 
nuclear 
protein 
[SEP] 
the 
an 
underwent 
transplant 
40 
month 
period 
##a 
pu 
puert 
##a 
##a de 
hi 
##er 
##ro 
reviewed 
[CLS] 
respiratory 
distress 
[CLS] 
these 
data 
suggested 
mutant 
ps 
##1 
may 
cause 
disease 
result 
reduction 
ps 
##1 
function 
[CLS] 
the 
analysis 
organization 
sequence 
human 
##b 
##p 
da 
gene 
reveals 
2 
4 
k 
##ilo 
##base 
messenger 
r 
##na 
trans 
##cribed 
two 
close 
origin 
identifying 
pro 
##ximal 
promoter 
[SEP] 
[PAD] [CLS] 
most 
ion 
##ization 
technique 
stage 
47 
1 
year 
survival 
##1 
##0 
compared 
t 
##2 
##n 
##0 
28 
6 
t 
##1 
##1 
19 
19 4 
4 [SEP] 
investigate 
step 
s 
##oso 
assembly 
##p 
act 
used 
##at 
gel 
electro 
##ores 
[SEP] 
[CLS] 
internal 
fragment 
u 
##24 
met 
##hyl 
guide 
s 
##nor 
##na 
encompassing 
upstream 
anti 
element 
d 
c 
box 
motif 
support 
site 
specific 
##hyl 
r 
##rna 
red 
##uc 
show 
s 
phase 
specific 
expression 
consists 
two 
identical 
subunit 
protein 
r 
##1 
large 
subunit 
r 
##2 
small 
subunit 
effect 
de 
##has 
development 
radiation 
##ph 
##rop 
rat 
##k 
##1 
r 
##k 
##1 
##ex 
es 
##cher 
##ichi 
co 
recognized 
##body 
raised 
kinase 
##eno 
star 
star anti 
##ot 
##os 
##body 
identification 
##c 
evidence 
related 
yeast 
[CLS] 
##kt 
member 
activated 
via 
p 
##i 
3 
kinase 
signaling 
pathway 
[CLS] 
so 
back 
r 
##ado 
##n 
transform 
r 
1 
correct 
result 
at 
##uation 
##uation [SEP] 
[CLS] 
before 
fl 
##eca 
##ini 
in 
m 
##or 
##phological 
identical 
spontaneous 
##ly 
occurring 
a 
##rr 
##hy 
##th 
##mia 
##mia [SEP] 
[CLS] 
an 
additional 
dose 
20 
25 
g 
##y 
delivered 
site 
original 
involvement 
imp 
##lant 
feasible 
[CLS] 
the 
prominent 
fracture 
75 
year 
hip 
fracture 
type 
ii 
o 
##ste 
##op 
##oro 
##sis 
##sis [SEP] 
[CLS] 
the 
expected 
product 
clone 
##d 
b 
##ph 
gene 
except 
b 
##3 
observed 
e 
co 
##li 
##it 
##ro 
transcription 
translation 
system 
[SEP] 
it 
##oc 
##agu 
prolonged 
bleeding 
time 
##let 
count 
##agu 
factor 
normal 
[CLS] 
result 
analysis 
##ear 
correlation 
showed 
higher 
s 
##sm 
drum 
rotation 
following 
higher 
r 
0 
76 
higher 
ratio 
spectral 
egg 
4 
9 
cycle 
drum 
base 
0 
0 63 
c 
higher 
spectral 
frequency 
0 
4 
h 
base 
##3 
r 
0 
29 
##4 
r 
0 
31 
higher 
ratio 
spectral 
0 
4 
h 
drum 
base 
##3 
r 
0 
31 
e 
higher 
skin 
base 
0 
30 
salt 
four 
medium 
[CLS] 
the 
consensus 
consensus ma 
er 
stress 
element 
element er 
##se 
conserved 
promoter 
consists 
trip 
##art 
##ite 
structure 
##aa 
n 
##9 
n 
striking 
##ly 
g 
##c 
rich 
region 
9 
b 
##p 
[SEP] 
acute 
toxicity 
ins 
##tar 
to 
##x 
##or 
##nch 
s 
##ple 
m 
##os 
##quito 
adult 
##icides 
ma 
##hi 
##on 
re 
##rin 
positive 
correlation 
level 
##9 
##c 
binding 
differentiation 
##ro 
[CLS] 
effect 
acute 
exposure 
cold 
awake 
rat 
when 
labeled 
99 
##m 
##t 
d 
##t 
serum 
superior 
99 
##m 
##t 
without 
attached 
d 
##t 
##pa 
[SEP] 
unlike 
c 
s 
##3 
domain 
h 
##yl 
al 
##yd 
motif 
absent 
a 
mechanism 
in 
defense 
infection 
evaluated 
evaluated [SEP] 
88 
37 
37 
3743 
objective 
to 
##mina 
##nt 
##uro 
severe 
##ares 
##rist 
##em 
##otherapy 
[CLS] 
the 
median 
survival 
18 
month 
hem 
##or 
##r 
p 
##har 
[CLS] 
it 
p 
strongly 
potent 
ability 
activate 
transcription 
f 
##o 
promoter 
te 
##rna 
##ry 
complex 
assembled 
f 
##o 
serum 
response 
element 
[SEP] 
[CLS] 
f 
##us 
##3 
##p 
##1 
together 
increase 
expression 
##ln 
##3 
##l 
gene 
promote 
b 
##uddin 
##1 
##p 
in 
##hibit 
##s 
map 
kinase 
##de 
##de [SEP] 
consistent 
observation 
##p 
1 
binding 
contribute 
co 
##act 
##ivation 
observation 
activation 
pu 
1 
blocked 
##o 
[SEP] 
[CLS] 
a 
possible 
correlation 
##di 
##bula 
##r 
growth 
re 
##tar 
##dation 
##ala 
c 
##le 
##fting 
discussed 
discussed [SEP] 
[CLS] 
time 
dependence 
potent 
at 
##rium 
[CLS] 
4 
highly 
conserved 
region 
##90 
exclusively 
27 
acid 
conserved 
among 
differing 
##90 
alpha 
##90 
beta 
sequence 
characterization 
t 
##leo 
tandem 
repeat 
containing 
trans 
##cript 
obtained 
spinal 
c 
library 
filter 
hybrid 
##ization 
we 
present 
complete 
primary 
structure 
human 
##33 
variant 
kidney 
auto 
causing 
hey 
##mann 
##rano 
g 
##lo 
##mer 
##hr 
rat 
rat [SEP] 
membrane 
ii 
receptor 
inhibitor 
used 
high 
##rona 
##ry 
used 
used approximately 
one 
third 
##rona 
##ry 
intervention 
united 
##pe 
##pe [SEP] 
[CLS] 
conscious 
12 
oxygen 
nitrogen 
##erial 
44 
7 
5 
0 
pre 
##nat 
##al 
diagnosis 
genetic 
disease 
disease [SEP] 
protection 
gas 
##tro 
##est 
##inal 
##uc 
##osa 
##l 
[PAD] [CLS] 
ready 
made 
pro 
placed 
external 
side 
rib 
vertically 
br 
##id 
fl 
##ailed 
chest 
segment 
fixed 
first 
upper 
first 
lower 
intact 
rib 
well 
mobile 
segment 
affected 
rib 
rib [SEP] 
design 
case 
study 
##adia 
task 
classification 
2 
2 [SEP] 
site 
directed 
##uta 
##4 
end 
gene 
role 
##ys 
130 
[CLS] 
a 
minimal 
p 
##omo 
induction 
domain 
del 
##ated 
residue 
301 
335 
s 
##p 
dependent 
##omo 
mit 
pathway 
induction 
activity 
[CLS] 
library 
thus 
useful 
selection 
##sm 
##id 
clone 
carry 
c 
##d 
##c 
gene 
yeast 
complement 
##ing 
first 
vector 
##ial 
yeast 
gene 
##1 
##yr 
##id 
aux 
##ot 
##d 
##c 
strain 
respective 
##d 
wild 
gene 
temperature 
sensitive 
all 
##ele 
[SEP] 
[CLS] 
these 
mutant 
r 
leader 
l 
##igate 
##d 
##ada 
expression 
cassette 
transformed 
ch 
##op 
##last 
c 
re 
##in 
##hardt 
e 
e co 
##li 
[SEP] 
[CLS] 
in 
activated 
r 
##al 
##d 
like 
factor 
stimulate 
c 
##y 
##c 
d 
1 
transcription 
e 
##f 
activity 
act 
s 
##rgy 
##i 
3 
kinase 
[CLS] 
from 
present 
concept 
hormone 
dependent 
##r 
activation 
requires 
direct 
indirect 
in 
##cular 
interaction 
##d 
lb 
##d 
[SEP] 
like 
d 
unlike 
class 
ii 
gene 
gene z 
gene 
code 
two 
c 
##ys 
##tein 
residue 
might 
involved 
formation 
di 
##sul 
##fi 
bond 
alpha 
1 
domain 
down 
regulation 
id 
##1 
m 
##rna 
correlated 
mit 
##ogen 
q 
##es 
cell 
factor 
activate 
receptor 
receptor 
mit 
secret 
##og 
##rani 
##n 
ii 
s 
##i 
secret 
##pt 
large 
dense 
core 
##uro 
##end 
##uron 
cell 
[CLS] 
conclusion 
result 
study 
s 
##d 
##b 
even 
s 
independently 
associated 
##yper 
##tens 
##ion 
woman 
electron 
spin 
super 
d 
spin 
add 
##uc 
strongly 
in 
c 
##gen 
inhibitor 
et 
##od 
##ola 
##olac 
dependent 
manner 
[CLS] 
b 
##k 
##k 
##of 
well 
con 
##it 
##utive 
different 
##oz 
evidence 
role 
di 
##gly 
##ol 
sensitive 
##cs 
alpha 
e 
##ps 
##ilon 
##k 
signaling 
toward 
##k 
[SEP] 
[CLS] 
em 
##b 
##ryo 
mortality 
mortality [SEP] 
lead 
acid 
h 
##ydro 
##lase 
animal 
tissue 
characterization 
##a 
encoding 
two 
unusual 
e 
e2 
4 
4 e 
e2 
ability 
gene 
hybrid 
[CLS] 
interesting 
unlike 
##k 
##1 
contain 
small 
##pas 
r 
##ac 
##1 
c 
##d 
##c 
binding 
domain 
bind 
##1 
suggesting 
##k 
##1 
activation 
##ac 
##1 
##d 
independent 
[SEP] 
the 
result 
finding 
pair 
fed 
treated 
control 
group 
ne 
##rosis 
per 
systemic 
circulation 
however 
plasma 
fi 
##bri 
##no 
showed 
statistical 
positive 
association 
im 
group 
without 
team 
hope 
##etal 
survival 
mortality 
80 
100 
100 [SEP] 
[CLS] 
analysis 
del 
##eti 
##on 
substitution 
mutation 
##r 
5 
ex 
##on 
demonstrates 
unusually 
large 
size 
ex 
##on 
play 
important 
role 
s 
##p 
##licing 
regulation 
[SEP] 
study 
signaling 
pathway 
regulate 
##os 
##kel 
##etal 
rear 
##rang 
##ement 
l 
##ymph 
set 
con 
##gate 
formation 
##ur 
##kat 
cell 
effect 
##or 
late 
##x 
be 
coated 
[CLS] 
re 
##ex 
##d 
1 
revealed 
addition 
defect 
##ive 
onset 
s 
phase 
defect 
##ive 
g 
2 
m 
transition 
released 
##ure 
s 
phase 
arrest 
all 
##pt 
##ide 
containing 
26 
##3 
residue 
derived 
c 
terminus 
p 
##13 
##0 
##ga 
e 
residue 
residue 92 
##0 
118 
##zy 
##os 
kinase 
[CLS] 
a 
structural 
model 
##pu 
proposed 
membrane 
anchor 
pre 
##cede 
region 
two 
alpha 
he 
##lix 
opposed 
polar 
joined 
strongly 
turn 
pro 
##tr 
##udes 
c 
##op 
##m 
contains 
##k 
site 
[SEP] 
[CLS] 
the 
re 
##comb 
containing 
full 
length 
##hed 
##rin 
leader 
sequence 
gave 
level 
m 
##rna 
comparable 
##rna 
[CLS] 
immune 
##ob 
##ill 
acid 
##op 
as 
##th 
thus 
##b 
1 
associated 
factor 
represents 
first 
cardiac 
restricted 
downstream 
regulatory 
gene 
##ob 
gene 
##k 
##x 
5 
pathway 
may 
serve 
negative 
regulator 
##f 
1 
dependent 
pathway 
##ric 
##ular 
muscle 
gene 
expression 
each 
receptor 
must 
engage 
unique 
subset 
available 
signaling 
element 
least 
selection 
protein 
s 
ho 
domain 
s 
##h 
##2 
protein 
[CLS] 
a 
method 
s 
s 
complex 
structure 
built 
investigate 
s 
##e 
specifically 
recognizes 
substrate 
f 
##rac 
ex 
##po 
limit 
one 
derived 
all 
author 
based 
##ogram 
j 
##ul 
[CLS] 
##rona 
##ry 
artery 
disease 
red 
##but 
201 
##thal 
cardiac 
re 
##jection 
severely 
##che 
viable 
my 
##oc 
##ard 
##ium 
particularly 
useful 
pro 
##gno 
patient 
[SEP] 
however 
recovery 
curve 
r 
##2 
component 
blink 
patient 
tension 
headache 
group 
group [SEP] 
when 
re 
##e 
he 
cell 
probe 
##ot 
##os 
dim 
##eric 
##e 
form 
130 
k 
##da 
surface 
[CLS] 
transforming 
factor 
t 
beta 
in 
##hibit 
cell 
cycle 
progression 
part 
regulation 
gene 
expression 
##21 
##1 
##1 
cycle 
inhibitor 
[CLS] 
the 
result 
superficial 
deep 
co 
##rt 
##ical 
ve 
##nous 
drainage 
kidney 
re 
##nal 
re 
##nin 
release 
[SEP] 
conclusion 
detection 
re 
##current 
cancer 
feasible 
##d 
##dg 
pet 
pet [SEP] 
[CLS] 
there 
difference 
incidence 
fractured 
z 
##ona 
[CLS] 
d 
##p 
increase 
slow 
wave 
delta 
sleep 
sleep 
e 
##eg 
predict 
acute 
rejection 
[CLS] 
7 
ni 
##tro 
##zo 
selective 
ne 
##uron 
##al 
ni 
##tric 
oxide 
s 
##ynth 
n 
##nos 
inhibitor 
in 
##nea 
##lly 
administered 
30 
minute 
onset 
local 
an 
##ox 
##ia 
[CLS] 
mutation 
extend 
specific 
end 
##uc 
##lea 
##se 
activity 
##da 
term 
##inas 
##e 
[SEP] 
[CLS] 
gene 
set 
mitochondrial 
genome 
subset 
re 
##lino 
##mona 
am 
##eric 
am 
##oe 
##bo 
##id 
pro 
##zo 
[SEP] 
an 
evaluation 
plate 
##let 
neutral 
activated 
th 
##rom 
the 
pro 
r 
##na 
binding 
##k 
member 
alpha 
type 
pro 
##so 
##mal 
gene 
family 
single 
clone 
perfect 
ho 
##mology 
eight 
rode 
sequence 
tag 
used 
template 
5 
3 
rapid 
am 
##p 
##a 
end 
s 
##pice 
system 
polymer 
##ase 
chain 
reaction 
am 
##p 
##lification 
##a 
end 
reaction 
obtain 
3 
6 
k 
##b 
##bank 
##19 
##5 
encoding 
de 
##duced 
##pt 
96 
##3 
acid 
[SEP] 
these 
tiny 
premature 
received 
significantly 
longer 
period 
time 
longer 
in 
##ole 
##sta 
developing 
[CLS] 
the 
s 
##m 
specific 
selection 
ex 
##on 
2 
result 
in 
ex 
##on 
3 
3 [SEP] 
[PAD] [CLS] 
present 
discrete 
origin 
insertion 
insertion [SEP] 
medical 
stage 
breast 
cancer 
cancer [SEP] 
[CLS] 
five 
girl 
turn 
syndrome 
year 
showed 
showed l 
value 
5 
0 
14 
i 
12 
h 
upper 
slightly 
path 
##ological 
##ly 
22 
2 
2 43 
i 
12 
h 
f 
##sh 
##sh [SEP] 
##it 
##ro 
death 
trans 
over 
##ex 
del 
##eti 
is 
##of 
beta 
gal 
##os 
##idas 
reporter 
following 
1 
n 
binding 
domain 
act 
negative 
regulator 
def 
##cap 
2 
2 l 
represents 
put 
##ative 
con 
##it 
##utive 
##ly 
##ly active 
induce 
##r 
a 
##pop 
3 
killing 
in 
##hibit 
##hibitable 
as 
o 
##oro 
##eton 
g 
as 
o 
##oro 
##eton 
def 
##cap 
in 
patient 
9 
kidney 
irrigation 
solution 
re 
##nal 
performed 
dissolution 
infectious 
stone 
stone [SEP] 
[CLS] 
the 
use 
si 
##gma 
54 
promoter 
known 
require 
##gnate 
binding 
could 
fine 
provides 
temporal 
ordering 
##ella 
gene 
transcription 
[SEP] 
##9 
##4 
##75 
##3 
##9 
do 
##c 
[CLS] 
knowledge 
transcription 
factor 
exhibit 
and 
##rogen 
expression 
##pid 
##idy 
##mis 
[SEP] 
[PAD] [CLS] 
focal 
regional 
8 
20 
h 
##z 
e 
##pile 
##pt 
par 
##ys 
either 
hip 
##po 
##cam 
##pus 
10 
patient 
am 
##a 
1 
patient 
1 
patient 
preceded 
initial 
motionless 
motionless staring 
staring [SEP] 
[CLS] 
the 
lack 
##tero 
##go 
position 
position essentially 
one 
data 
analysis 
detection 
new 
all 
##ele 
[CLS] 
e 
##pit 
specific 
activation 
achieved 
cooperative 
interaction 
apparently 
u 
##bi 
##quito 
##us 
transcription 
##al 
factor 
[SEP] 
b 
##19 
gene 
expression 
viral 
p 
promoter 
b 
##19 
##p 
restricted 
human 
hem 
##ato 
undergoing 
er 
##hr 
##oid 
differentiation 
path 
##ogen 
correct 
disorder 
##id 
at 
##os 
enter 
##oso 
section 
usually 
single 
hole 
grid 
simple 
developed 
cry 
##otherapy 
re 
##tino 
pre 
##mat 
##urity 
ha 
##lved 
treatment 
bio 
normal 
cell 
[PAD] [CLS] 
bleeding 
prevented 
i 
##v 
des 
##mo 
##press 
##fi 
##bri 
##no 
t 
##rane 
local 
g 
compression 
technique 
[CLS] 
he 
##tero 
o 
##mer 
##ization 
s 
pathway 
restricted 
s 
##mad 
essential 
s 
mediated 
transcription 
[CLS] 
this 
fragment 
contains 
two 
complete 
end 
##o 
beta 
1 
1 4 
g 
##can 
##ase 
encoding 
gene 
designated 
##cc 
##c 
##g 
[SEP] 
one 
limited 
interaction 
common 
cerebral 
cortex 
cortex [SEP] 
[CLS] 
analysis 
5 
3 
terminus 
trans 
##cript 
produced 
v 
##ivo 
pu 
op 
##eron 
r 
s 
##ero 
delta 
34 
##8 
420 
three 
trans 
##cript 
0 
59 
0 
64 
64 2 
63 
k 
##ilo 
##base 
##s 
lacking 
inter 
##cist 
##ronic 
term 
##inator 
structure 
identical 
corresponding 
trans 
##cript 
derived 
s 
##ero 
4 
1 
four 
trans 
##cript 
0 
50 
0 
66 
0 
71 
71 2 
7 
##ilo 
##base 
##s 
showing 
trans 
##cript 
begin 
end 
site 
[SEP] 
the 
op 
##ti 
cooling 
rate 
r 
##t 
5 
degree 
resulting 
maximum 
sperm 
##ato 
found 
0 
5 
1 
degree 
r 
##t 
subsequently 
##2 
##2 [SEP] 
the 
##ere 
##bella 
##r 
co 
##rt 
##ical 
vessel 
compared 
cerebral 
vessel 
[CLS] 
##hage 
echo 
##card 
##io 
risk 
factor 
stroke 
##vu 
##lar 
at 
##rial 
##bri 
##lla 
22 
##net 
##o 
region 
[CLS] 
prevent 
##ive 
health 
counseling 
tailored 
need 
group 
beneficial 
[CLS] 
strain 
lacking 
functional 
gene 
grow 
rapidly 
wild 
type 
whereas 
all 
grow 
slowly 
type 
[CLS] 
neon 
##ata 
##l 
h 
##yper 
##thy 
##roid 
##ism 
##ism [SEP] 
after 
hybrid 
two 
##x 
##31 
trans 
##cript 
2 
2 
1 
8 
k 
##b 
detected 
total 
r 
k 
ha 
##cat 
trans 
##cript 
2 
1 
9 
k 
##b 
total 
r 
trans 
cell 
in 
f 
##r 
##3 
signaling 
pathway 
utilizes 
two 
##rb 
containing 
complex 
s 
##rb 
so 
80 
##k 
h 
##rb 
so 
complex 
may 
alternatively 
link 
##3 
kinase 
[CLS] 
[CLS] in 
identify 
factor 
involved 
er 
##hr 
##oid 
regulatory 
isolated 
e 
##k 
gene 
systematically 
analyzed 
promoter 
region 
their 
main 
representative 
##eric 
diagnostic 
mental 
d 
##sm 
ii 
##i 
revised 
version 
d 
ii 
##i 
r 
new 
##d 
10 
10 [SEP] 
any 
op 
chest 
radio 
##graph 
wide 
differential 
diagnosis 
diagnosis [SEP] 
chloride 
20 
##h 
larger 
area 
used 
significantly 
rate 
900 
##h 
##z 
[CLS] 
in 
torpedo 
single 
trans 
##cript 
seen 
express 
several 
m 
##rna 
encoding 
different 
is 
##of 
##orms 
[SEP] 
four 
family 
ho 
##ming 
end 
identified 
including 
la 
##gli 
c 
##ys 
box 
##i 
##y 
[CLS] 
convergence 
t 
##em 
##inal 
input 
##al 
##hren 
##ic 
input 
##rima 
##1 
c 
##2 
spin 
##oth 
##ala 
##mic 
tract 
ne 
##uron 
[CLS] 
involved 
regulation 
gas 
##si 
synthesis 
##hil 
arch 
##ae 
identified 
transcription 
##al 
act 
##iva 
##tor 
promoter 
located 
upstream 
gene 
encoding 
major 
gas 
##si 
structural 
##pa 
[SEP] 
[PAD] [CLS] 
no 
##so 
##graphic 
problem 
problem [SEP] 
[CLS] 
in 
early 
mid 
##ges 
em 
##b 
##ryo 
expressed 
te 
##pha 
##lic 
die 
##pha 
me 
##pha 
region 
day 
11 
75 
##esta 
##estation 
expression 
disappears 
dorsal 
te 
##ce 
##pha 
##lon 
confined 
die 
##nce 
##pha 
##pha 
region 
region [SEP] 
[CLS] 
the 
training 
program 
duration 
30 
day 
5 
day 
week 
performed 
motor 
driven 
t 
##read 
##mill 
phylogenetic 
analysis 
neighbor 
joining 
algorithm 
closest 
similarity 
horse 
m 
##u 
chain 
encoding 
constant 
region 
gene 
human 
dog 
sequence 
[CLS] 
using 
probe 
region 
rear 
##rang 
##ement 
identified 
nine 
case 
8 
21 
am 
##l 
examined 
examined [SEP] 
c 
##lon 
n 
##uc 
##leo 
##tide 
sequence 
analysis 
reveals 
b 
en 
ho 
##mo 
##log 
d 
##1 
also 
called 
n 
##al 
ma 
re 
##press 
basal 
transcription 
[SEP] 
##2 
ho 
##mology 
h 
yeast 
sa 
##har 
##vis 
especially 
region 
[SEP] 
[CLS] 
earlier 
data 
s 
##1 
binding 
r 
##1 
alpha 
beta 
region 
could 
confirmed 
suggesting 
r 
##1 
in 
##iti 
##ator 
element 
may 
function 
independent 
##1 
[SEP] 
[CLS] 
in 
reduced 
metabolism 
co 
##tin 
pro 
m 
##p 
apparently 
responsible 
sustained 
plasma 
ni 
##cot 
##ine 
level 
[SEP] 
[CLS] 
activation 
hi 
1 
requires 
binding 
host 
cell 
transcription 
factor 
c 
##i 
element 
pro 
##vir 
##al 
long 
terminal 
repeat 
l 
##tr 
[SEP] 
the 
yeast 
mitochondrial 
h 
##70 
##1 
##p 
function 
m 
##d 
##j 
##1 
##p 
d 
##j 
ho 
##mo 
##mologue 
##1 
##p 
ho 
##mo 
##mologue 
t 
d 
binding 
lead 
trans 
##act 
co 
##rrel 
inability 
203 
##5 
increase 
##p 
1 
[CLS] 
the 
rice 
gene 
consists 
four 
ex 
##on 
##on [SEP] 
[CLS] 
however 
gene 
##ific 
s 
##yne 
##rg 
##istic 
effect 
cat 
activity 
##p 
1 
3 
element 
found 
co 
##lla 
##ase 
3 
gene 
promoter 
found 
equation 
mean 
t 
number 
passed 
test 
t 
##b 
w 
wi 
appeared 
appeared limited 
method 
limiting 
ca 
##x 
##per 
##iment 
##al 
in 
post 
##mit 
##otic 
ne 
##uron 
possessed 
extremely 
level 
e 
##f 
##1 
protein 
assessed 
electro 
##ph 
##ore 
[CLS] 
re 
he 
##pa 
##ys 
##t 
partial 
ex 
drainage 
complicated 
fist 
##ula 
formation 
c 
##ys 
duo 
##den 
##um 
##um [SEP] 
reversal 
##quin 
[CLS] 
possible 
consequence 
bind 
##er 
distribution 
powder 
aggregate 
discussed 
discussed [SEP] 
[CLS] 
the 
human 
contains 
put 
##ative 
##lation 
signal 
a 
##ata 
##aa 
13 
n 
##leo 
##tide 
upstream 
##lation 
site 
[CLS] 
the 
delta 
m 
s 
##v 
tumor 
d 
b 
lineage 
tumor 
typically 
rear 
##ranged 
im 
lo 
contained 
contained g 
ger 
##m 
##m line 
line configuration 
t 
receptor 
beta 
gene 
gene [SEP] 
[CLS] 
the 
experimental 
result 
equilibrium 
complex 
formation 
o 
ot 
##c 
##p 
mainly 
complex 
v 
injected 
product 
combined 
injection 
formulation 
formulation [SEP] 
##f 
les 
##ion 
secondary 
in 
##mus 
containing 
long 
term 
local 
immune 
reaction 
detected 
patient 
systemic 
##pt 
##om 
appeared 
##ation 
##ation [SEP] 
[CLS] 
examine 
effect 
camp 
signal 
trans 
pathway 
transcription 
gene 
encoding 
cat 
##alytic 
subunit 
glucose 
6 
##pas 
##pas 
##fer 
cat 
fusion 
trans 
trans 
liver 
derived 
he 
##p 
##2 
kidney 
derived 
line 
[CLS] 
whereas 
sequence 
alpha 
act 
##ini 
no 
w 
[CLS] 
by 
contrast 
c 
##lon 
##id 
##ine 
1 
micro 
##gram 
kg 
el 
immediate 
prolonged 
fall 
blood 
heart 
rate 
given 
##bra 
in 
##ven 
##ously 
[CLS] 
the 
shift 
complex 
i 
complex 
ii 
seen 
##m 
1 
suppressed 
##los 
##por 
a 
a [SEP] 
f 
##er 
##rit 
value 
high 
47 
mg 
result 
kit 
compare 
f 
##er 
##rit 
greater 
300 
cast 
doubt 
controversial 
serum 
f 
##er 
##rit 
measurement 
iron 
over 
##load 
##load [SEP] 
[CLS] 
post 
##p 
##b 
superior 
group 
3 
9 
0 
3 
v 
[SEP] 
[CLS] 
er 
beta 
le 
potent 
er 
alpha 
act 
##ivating 
e 
##2 
er 
##el 
activity 
4 
v 
[CLS] 
the 
expression 
pattern 
##x 
changed 
dramatically 
##b 
##ryo 
expression 
seen 
initially 
entire 
neural 
tube 
me 
##so 
##der 
##m 
second 
##arily 
down 
##re 
##gu 
##lated 
second 
##arily 
c 
##al 
nerve 
gang 
c 
##rani 
##of 
##ial 
me 
##sen 
##me 
##me [SEP] 
[CLS] 
disruption 
##l 
sub 
##cle 
##ar 
domain 
acidic 
##1 
c 
##ir 
mediated 
interaction 
may 
m 
##od 
##ulate 
ring 
finger 
dependent 
cry 
##ptic 
trans 
##act 
##iva 
function 
##l 
[SEP] 
[CLS] 
further 
##more 
g 
##c 
rich 
sequence 
could 
con 
s 
##1 
dependent 
trans 
##act 
##ivation 
he 
##ous 
pro 
##ct 
minimal 
promoter 
[SEP] 
twelve 
patient 
le 
##p 
##ros 
##hr 
without 
art 
##hr 
##itis 
im 
##mu 
##munological 
parameter 
like 
reactive 
r 
##id 
factor 
assert 
pro 
##ct 
##in 
affect 
delta 
5 
delta 
4 
pathway 
effect 
3 
##bet 
##a 
h 
##ydro 
##ster 
##oid 
de 
##hy 
##dr 
##ogen 
3 
oh 
##s 
##d 
the 
##pt 
##ide 
24 
contains 
16 
c 
##ys 
##tein 
##e 
residue 
arranged 
four 
cluster 
typical 
co 
##of 
super 
ha 
su 
z 
##ono 
##rol 
author 
author trans 
##l 
##l [SEP] 
p 
##60 
bound 
fast 
##cess 
wild 
i 
##p 
i 
lacking 
car 
##box 
##yl 
terminal 
24 
amino 
acid 
i 
lacking 
car 
##box 
##yl 
terminal 
40 
amino 
acid 
whereas 
cellular 
protein 
p 
r 
[SEP] 
[CLS] 
stress 
##all 
201 
my 
##oc 
##ard 
##ial 
imaging 
an 
##gin 
heart 
failure 
identify 
clinical 
##ly 
silent 
area 
is 
##che 
##mic 
my 
##oc 
##ard 
##ium 
distinguish 
scar 
re 
##vers 
##ibly 
is 
##che 
##mic 
my 
##oc 
##ard 
##ium 
cause 
akin 
##esi 
vent 
##ric 
##ular 
wall 
segment 
[SEP] 
[CLS] 
the 
community 
acquired 
b 
##act 
##ere 
mainly 
due 
e 
co 
##li 
[SEP] 
[CLS] 
y 
##1 
y 
##2 
y 
##4 
pp 
##1 
##1 [SEP] 
[CLS] 
plasma 
glucose 
result 
##pt 
con 
##ita 
several 
diverse 
disease 
disease [SEP] 
[CLS] 
developmental 
##ly 
regulated 
interaction 
transcription 
factor 
complex 
containing 
##d 
##p 
cut 
early 
his 
##3 
gene 
promoter 
##rch 
##rchin 
te 
tetra 
change 
ch 
##roma 
##tin 
structure 
gene 
expression 
procedure 
perfect 
method 
method [SEP] 
shift 
degree 
mutant 
1 
##9 
1 
lost 
rim 
1 
cell 
cell 
become 
cluster 
##ed 
[CLS] 
the 
m 
protein 
expressed 
all 
cell 
##ur 
##kat 
designated 
hug 
##1 
ho 
##x 
##11 
upstream 
gene 
gene [SEP] 
[CLS] 
the 
sts 
sequence 
149 
##20 
fact 
derived 
3 
region 
human 
gene 
[CLS] 
it 
construct 
cat 
gene 
driven 
h 
##k 
##b 
5 
enhance 
##r 
region 
h 
##2 
##t 
##f 
##1 
##b 
##f 
##1 
site 
comparable 
##cat 
carrying 
strong 
r 
l 
##tr 
enhance 
##r 
##3 
appears 
##mo 
##logue 
well 
pro 
26 
regulatory 
subunit 
the 
gene 
##us 
ni 
nidu 
en 
##codes 
73 
##9 
amino 
protein 
similarity 
##35 
##p 
da 
dal 
##l8 
##1 
##p 
##p 
sa 
little 
honoured 
statue 
recognition 
recognition ed 
##ward 
##enne 
##r 
m 
##d 
[CLS] 
p 
##har 
##kin 
##etic 
interaction 
l 
##35 
##47 
##40 
di 
##az 
##am 
leading 
level 
free 
di 
##az 
##am 
demonstrated 
demonstrated [SEP] 
[CLS] 
the 
promoter 
met 
##hyl 
##fer 
##ase 
gene 
lack 
id 
ta 
box 
characterized 
c 
##p 
##g 
island 
begin 
approximately 
72 
##3 
n 
##leo 
##tide 
upstream 
major 
transcription 
##al 
start 
site 
extends 
ex 
##on 
1 
first 
intro 
##n 
[SEP] 
[CLS] 
no 
promoter 
activity 
could 
detected 
various 
fl 
##i 
1 
promoter 
cat 
construct 
containing 
600 
b 
##p 
5 
flank 
##ing 
region 
complete 
ex 
##on 
1 
5 
end 
intro 
##n 
1 
##tro 
##al 
l 
##tr 
sequence 
[SEP] 
[CLS] 
the 
disco 
conserved 
four 
region 
known 
important 
g 
gt 
##p 
binding 
contained 
c 
terminal 
ca 
##ax 
##a 
motif 
shared 
r 
protein 
[CLS] 
an 
81 
n 
##t 
tandem 
du 
##plication 
c 
terminal 
coding 
region 
located 
adjacent 
termination 
co 
##don 
c 
##yi 
##ii 
##b 
gene 
potential 
re 
##lic 
slipped 
##air 
##ing 
replication 
event 
[SEP] 
[CLS] 
only 
53 
injury 
12 
5 
injury 
involved 
child 
contrast 
1950s 
early 
1960s 
young 
adult 
appear 
greatest 
risk 
1980s 
1980s [SEP] 
the 
method 
48 
h 
##r 
##oc 
##ard 
in 
##far 
s 
operated 
control 
here 
population 
gamma 
trans 
adult 
structure 
cry 
##gs 
gene 
[CLS] 
the 
slope 
q 
##d 
versus 
four 
tube 
near 
unity 
[SEP] 
[CLS] 
the 
extent 
o 
##don 
##to 
##blast 
process 
human 
den 
##tin 
[CLS] 
mac 
##rop 
beta 
subunit 
##d 
##11 
##a 
##r 
##3 
complement 
receptor 
mac 
1 
en 
##ac 
shown 
tolerate 
convenient 
go 
##hoe 
##a 
[CLS] 
we 
assessed 
card 
##iovascular 
variable 
blood 
o 
##2 
content 
order 
o 
##2 
##read 
exercise 
[CLS] 
the 
finding 
discussed 
reference 
possible 
mechanism 
parasite 
development 
might 
controlled 
[SEP] 
[CLS] 
the 
80 
k 
##b 
preceding 
expression 
site 
functional 
##fs 
contains 
50 
b 
##p 
repeat 
ing 
##i 
re 
##tro 
##tra 
##ns 
##po 
like 
element 
novel 
4 
12 
k 
##b 
repeat 
found 
near 
te 
##lo 
##mere 
[SEP] 
[CLS] 
the 
predicted 
protein 
strong 
ho 
##mology 
a 
##ba 
in 
g 
rich 
maize 
em 
##b 
ma 
##mmal 
##mmalian 
r 
binding 
##1 
he 
##tero 
##gene 
complex 
pre 
##rna 
s 
##licing 
increase 
ca 
effect 
##ami 
r 
##ad 
##ad [SEP] 
we 
compared 
pollen 
trap 
trap f 
##eb 
##ru 
a 
##p 
##ril 
1988 
1989 
[CLS] 
##b 
##l 
signaling 
molecule 
multiple 
functional 
domain 
##h 
domain 
bind 
##ot 
##os 
residue 
ring 
finger 
domain 
act 
##iga 
pro 
proline 
rich 
region 
se 
##rf 
dock 
##ing 
site 
##3 
containing 
##ot 
##os 
serve 
dock 
##ing 
site 
containing 
protein 
##l 
subunit 
##i 
3 
kinase 
local 
signal 
[CLS] 
surprisingly 
##po 
is 
##o 
1 
c 
##och 
##rome 
absent 
c 
##c 
##3 
strain 
although 
is 
##o 
2 
##och 
##rome 
present 
present approximately 
level 
ho 
##lo 
is 
##o 
2 
c 
##och 
##rome 
found 
c 
##c 
##3 
strain 
[SEP] 
analytical 
p 
##d 
one 
order 
parameter 
temperature 
phase 
2d 
x 
##y 
model 
[CLS] 
the 
##ric 
##ular 
demand 
pace 
##maker 
imp 
three 
year 
##air 
cardiac 
performance 
performance a 
se 
##quential 
pace 
##maker 
d 
##dd 
used 
restore 
at 
##rio 
s 
##ync 
##hr 
##oni 
##sation 
##sation [SEP] 
[CLS] 
it 
predicted 
s 
##tro 
##op 
task 
would 
trigger 
greater 
consumption 
ice 
cream 
fearful 
film 
effect 
would 
pronounced 
bin 
##ge 
eat 
##er 
non 
bin 
##ge 
eat 
##er 
##er [SEP] 
[CLS] 
line 
hypothesis 
##f 
function 
growth 
cell 
cycle 
regulated 
te 
##ther 
##ing 
factor 
##1 
basic 
transcription 
machinery 
[SEP] 
there 
positive 
correlation 
change 
base 
##line 
##iet 
##al 
lobe 
matter 
##oso 
ch 
##olin 
##e 
ch 
##olin 
##rea 
##tine 
ratio 
cognitive 
performance 
measured 
##z 
##heimer 
disease 
cognitive 
colonization 
increased 
level 
9 
independent 
apartment 
apartment 60 
acute 
hospital 
000 
0001 
i 
second 
gene 
##har 
##vis 
##iae 
en 
domain 
ho 
##mo 
##log 
##ous 
g 
##pas 
act 
[CLS] 
ex 
##on 
##1 
en 
##codes 
region 
[CLS] 
co 
opera 
##ti 
##vity 
functional 
domain 
muscle 
specific 
transcription 
factor 
5 
[SEP] 
[CLS] 
##rea 
##tin 
c 
##rea 
##tine 
##oki 
##nas 
##p 
##k 
[CLS] 
in 
cell 
result 
arrest 
cell 
g 
##1 
4 
##n 
d 
content 
pseudo 
##1 
[CLS] 
these 
alter 
##ation 
occurred 
m 
##rna 
protein 
level 
affect 
sub 
##cellular 
distribution 
four 
is 
##of 
##orms 
[CLS] 
g 
gly 
##lyox 
##ys 
p 
##id 
70 
k 
##da 
co 
##ty 
encoded 
single 
gene 
[SEP] 
[CLS] 
suspected 
end 
##osis 
31 
##1 
t 
weighted 
spin 
echo 
c 
##se 
alone 
combination 
##1 
weighted 
fat 
suppressed 
##1 
##fs 
##ado 
enhanced 
##1 
##fs 
g 
##d 
##1 
echo 
technique 
technique [SEP] 
[CLS] 
se 
##ro 
##con 
##version 
##pa 
##ation 
[CLS] 
a 
case 
bilateral 
test 
##er 
##m 
tumor 
23 
year 
male 
reported 
reported [SEP] 
[CLS] 
total 
body 
b 
##m 
##d 
r 
0 
30 
02 
02 f 
##em 
##oral 
##m 
##d 
r 
0 
39 
00 
002 
positively 
correlated 
weight 
bearing 
activity 
weight 
bearing 
activity 
the 
effect 
cast 
##or 
oil 
alone 
well 
combination 
##2 
in 
##ac 
gas 
##tro 
##int 
##est 
##inal 
function 
rat 
checking 
compliance 
n 
10 
f 
##k 
concentration 
0 
ng 
m 
analyzed 
analyzed [SEP] 
[CLS] 
k 
[SEP] 
[CLS] 
the 
hem 
##ato 
##po 
##iet 
form 
trans 
##cript 
initiated 
downstream 
promoter 
separated 
7 
k 
##b 
first 
[CLS] 
the 
residual 
small 
r 
##rna 
p 
##ok 
appear 
synthesized 
via 
upstream 
promoter 
missing 
37 
44 
n 
##leo 
##tide 
5 
end 
indicating 
either 
pre 
##rna 
processed 
abnormal 
abnormal 
5 
r 
unstable 
[SEP] 
[CLS] 
extra 
dose 
due 
extra 
##4 
mission 
measured 
board 
t 
##ld 
system 
system [SEP] 
unconventional 
m 
##rna 
processing 
expression 
two 
##of 
##orms 
di 
##yo 
##lium 
the 
de 
##duced 
amino 
acid 
sequence 
open 
reading 
frame 
significantly 
ho 
##mo 
##log 
1 
1 ul 
ul4 
##9 
5 
gene 
product 
##9 
contains 
potential 
signal 
sequence 
trans 
##rane 
domain 
characteristic 
membrane 
protein 
[SEP] 
[CLS] 
stimulation 
##ome 
##pha 
##chia 
##b 
##r 
##in 
ch 
##olin 
##ergic 
drug 
electricity 
potent 
pain 
suppression 
ant 
##agon 
op 
##iate 
antagonist 
##xon 
##e 
##a 
factor 
known 
re 
##mo 
##del 
##roma 
structure 
concert 
n 
##some 
re 
##mo 
##del 
factor 
##f 
##ros 
##b 
##ryo 
s 
s15 
##0 
extract 
[PAD] [CLS] 
[CLS] also 
like 
tub 
wider 
pattern 
tissue 
expression 
either 
t 
##ulp 
##1 
t 
##2 
##2 [SEP] 
nine 
##f 
##r 
spontaneous 
32 
m 
##l 
min 
1 
73 
m 
##yper 
##tens 
##ion 
##ion [SEP] 
first 
##del 
differ 
disruption 
upstream 
signaling 
element 
e 
e g 
s 
ste 
##4 
##del 
s 
ste 
##te20 
##del 
s 
ste 
##del 
s 
ste 
##te11 
##del 
s 
ste 
##te7 
##del 
##3 
##del 
##1 
##del 
clearly 
retain 
capacity 
in 
s 
##3 
##p 
here 
de 
##y 
o 
p 
##53 
protein 
level 
receptor 
block 
##eta 
##nse 
ma 
##ximal 
##hra 
##hral 
pressure 
healthy 
40 
without 
reducing 
blood 
pressure 
[CLS] 
thus 
seems 
likely 
affect 
common 
pathway 
downstream 
signal 
study 
b 
g 
##bra 
s 
##tra 
##mine 
outdoor 
condition 
[CLS] 
the 
electro 
##card 
##io 
ta 
##chy 
##card 
##ia 
##ia [SEP] 
identification 
put 
##ative 
ch 
##rom 
##oso 
replication 
origin 
he 
##lic 
##ob 
##act 
##yl 
##or 
##us 
interaction 
in 
##iti 
##ator 
protein 
d 
##a 
[SEP] 
[CLS] 
the 
primary 
structure 
##ol 
##era 
displayed 
ho 
##mology 
##ase 
although 
put 
##ative 
lip 
##id 
inter 
##fa 
##cial 
recognition 
site 
site g 
x 
s 
x 
g 
present 
##ol 
##era 
sequence 
[SEP] 
[PAD] [CLS] 
essential 
question 
he 
##pa 
c 
c [SEP] 
[CLS] 
the 
transcription 
##al 
initiation 
site 
rag 
##1 
localized 
a 
26 
b 
##p 
upstream 
put 
##ative 
translation 
##al 
initiation 
co 
##don 
at 
##g 
prime 
##r 
extension 
ass 
##ay 
[SEP] 
[CLS] 
##rona 
##ry 
##eri 
##ulo 
##graph 
corresponding 
27 
##4 
consecutive 
patient 
j 
##anu 
##ary 
1975 
o 
##obe 
##r 
1978 
co 
##rona 
##ry 
les 
##ion 
reviewed 
[CLS] 
visual 
phase 
resulted 
number 
yeast 
cell 
exhibiting 
small 
b 
##ud 
son 
true 
morphology 
c 
##ys 
les 
##ion 
clearly 
c 
##t 
son 
##com 
##plicate 
##d 
he 
##pa 
##tic 
c 
##ys 
##t 
diagnosis 
diagnosis [SEP] 
[CLS] 
protein 
kinase 
trans 
activated 
##tero 
##mer 
n 
met 
channel 
independent 
s 
domain 
consensus 
site 
[SEP] 
[PAD] [CLS] 
year 
started 
##yper 
##em 
##esis 
##ra 
##aru 
6 
week 
admission 
admission [SEP] 
[CLS] 
similarity 
detected 
n 
terminal 
region 
##30 
##ena 
product 
another 
gene 
gene 
##a 
located 
upstream 
ace 
##ef 
l 
##p 
##d 
op 
##eron 
##r 
put 
transcription 
##al 
re 
##press 
##or 
##lu 
##cona 
##te 
op 
##eron 
##ill 
##us 
sub 
##til 
##is 
[SEP] 
##it 
##ro 
d 
binding 
element 
identified 
specifically 
interact 
c 
##s 
1 
[SEP] 
advantage 
conventional 
index 
##urt 
square 
b 
##1 
b 
##2 
##back 
##back [SEP] 
[PAD] [CLS] 
they 
they el 
similar 
regional 
cerebral 
blood 
##c 
##b 
##f 
pattern 
even 
though 
sign 
language 
dependent 
spatial 
information 
information [SEP] 
si 
9 
predicted 
contain 
three 
extra 
domain 
comprise 
terminal 
set 
domain 
two 
##2 
set 
domain 
trans 
region 
c 
tail 
containing 
two 
put 
##ative 
##ative t 
##os 
based 
signaling 
motif 
[CLS] 
determination 
l 
##d 
50 
30 
infant 
period 
growth 
period 
period [SEP] 
availability 
program 
##non 
carry 
matrix 
calculation 
the 
introduction 
give 
history 
research 
programme 
##z 
##vi 
implementation 
region 
[CLS] 
the 
f 
##eca 
##l 
ex 
##cre 
##tion 
one 
third 
measured 
urine 
[SEP] 
[CLS] 
the 
co 
##r 
bio 
##sy 
##synt 
gene 
cluster 
p 
##yr 
##80 
encoded 
32 
k 
##b 
region 
contains 
structural 
regulatory 
gene 
needed 
co 
##r 
synthesis 
[SEP] 
[CLS] 
model 
experiment 
single 
dos 
insect 
##icide 
l 
herb 
##icide 
te 
##ut 
##ryn 
mineral 
fungi 
##cid 
h 
##c 
##b 
[PAD] [CLS] 
in 
posterior 
wall 
neo 
##x 
consists 
tissue 
flap 
form 
lateral 
wall 
[CLS] 
the 
common 
host 
host e 
##quin 
##quine 
31 
##ov 
##ovine 
25 
r 
##ac 
19 
a 
single 
h 
##d 
session 
##ulos 
membrane 
water 
content 
forearm 
lower 
leg 
[CLS] 
both 
c 
##lar 
car 
mon 
##oc 
##ist 
##ronic 
trans 
##cript 
level 
trans 
##cript 
declined 
rapidly 
48 
##h 
complex 
medium 
low 
sustained 
trans 
##cript 
observed 
defined 
medium 
96 
##h 
[SEP] 
[CLS] 
c 
##lar 
car 
significantly 
mutant 
disrupted 
##ar 
gene 
regulatory 
gene 
control 
positively 
c 
##ula 
##nic 
acid 
##cin 
bio 
[CLS] 
whereas 
mutant 
##4 
specified 
wild 
type 
p 
##ol 
protein 
detected 
full 
length 
p 
##ol 
protein 
##4 
extract 
[CLS] 
the 
he 
##pa 
is 
##of 
p 
##of 
##ct 
##o 
2 
kinase 
kinase f 
##ru 
##ct 
##ose 
2 
6 
bi 
##k 
##ru 
2 
6 
##pas 
transcription 
##ally 
stimulate 
g 
##co 
##cor 
##tic 
whereas 
insulin 
block 
s 
##ti 
##lator 
effect 
[CLS] 
being 
insulin 
g 
##k 
gene 
regulation 
common 
transcription 
factor 
i 
##1 
s 
##t 
##tf 
1 
p 
##d 
##x 
1 
likely 
essential 
role 
maintaining 
normal 
beta 
cell 
function 
[CLS] 
the 
the ca 
##eno 
##r 
##hab 
##dit 
el 
##egan 
##egans 
22 
involved 
comb 
##inator 
activation 
gene 
expression 
##ge 
##al 
muscle 
em 
##b 
##ryo 
cell 
c 
##5 
##b 
##l 
##b 
transformed 
e 
##1 
e 
##1 
##b 
gene 
##1 
[CLS] 
the 
largest 
age 
adjusted 
men 
low 
normal 
mood 
ah 
##4 
3 
##1 
##m 
##co 
5 
5 8 
[CLS] 
resting 
t 
##l 
201 
s 
##ti 
detection 
co 
##rona 
##ry 
artery 
disease 
##ur 
##ler 
syndrome 
[SEP] 
##rm 
1 
protein 
bind 
lit 
1 
v 
##ivo 
##rm 
1 
activate 
lit 
1 
protein 
kinase 
co 
##ex 
tissue 
cell 
cell [SEP] 
[CLS] 
result 
primary 
tumor 
positive 
##m 
##5 
extract 
se 
##rt 
##oli 
cell 
e 
box 
shift 
stimulate 
differentiate 
culture 
basal 
condition 
condition [SEP] 
##ir 
##rad 
day 
absorption 
p 
##ob 
##ar 
##bit 
##one 
su 
##pha 
##raz 
me 
##cam 
##yla 
absorption 
q 
##uin 
##id 
is 
##onia 
##zi 
##d 
still 
re 
##tar 
##ded 
[CLS] 
trans 
##act 
##ivation 
##r 
s 
##1 
site 
fused 
##r 
promoter 
l 
##uc 
##ifer 
##ase 
l 
##uc 
reporter 
trans 
##ros 
cell 
##ch 
##ider 
##ider 2 
contains 
s 
##p 
##1 
s 
##1 
like 
factor 
[SEP] 
we 
determined 
hop 
t 
##42 
contains 
##ys 
substitution 
amino 
69 
##6 
##9 
##k 
[CLS] 
the 
[CLS] 
result 
study 
indicate 
binding 
bio 
##tin 
protein 
result 
protection 
region 
central 
domain 
vicinity 
active 
site 
c 
terminal 
domain 
chemical 
c 
##lea 
##vage 
[SEP] 
the 
##3 
gene 
share 
high 
degree 
structural 
similarity 
##3 
[SEP] 
[CLS] 
imp 
##air 
no 
##cturnal 
secret 
related 
##h 
secret 
pattern 
also 
mm 
##se 
score 
score [SEP] 
[CLS] 
thus 
anti 
##body 
class 
switch 
appears 
directed 
induction 
access 
##ibility 
ass 
transcription 
transcription g 
##er 
##m 
ch 
gene 
[SEP] 
inhibitor 
suppressed 
##1 
delta 
mutation 
h 
##yper 
##act 
##ivation 
m 
##p 
##k 
##1 
pathway 
toxic 
cell 
[CLS] 
the 
chicken 
genome 
contains 
two 
functional 
##alle 
##lic 
beta 
##1 
##1 4 
gal 
##lt 
##ran 
##s 
##fer 
##ase 
gene 
er 
##hr 
##em 
o 
cancer 
##mo 
##di 
##mers 
rip 
##60 
replication 
initiation 
region 
extract 
bind 
two 
at 
##t 
rich 
site 
or 
##ibe 
##ta 
foster 
formation 
twisted 
720 
b 
##p 
d 
loop 
##ro 
[SEP] 
end 
##od 
##ont 
form 
##ol 
am 
##putation 
method 
[CLS] 
some 
physiological 
response 
regulated 
via 
activation 
transcription 
factor 
act 
##iva 
1 
1 
[SEP] 
to 
test 
role 
##b 
member 
progression 
cell 
cycle 
##roi 
##n 
##jected 
serum 
deprived 
##cs 
overall 
g 
##raft 
33 
3 
75 
respectively 
respectively [SEP] 
la 
##c 
##9 
d 
binding 
regulate 
##s 
transcription 
la 
##ose 
gal 
galact 
##ose 
##gu 
##lon 
k 
##y 
##yver 
##ces 
la 
lact 
##is 
[SEP] 
[CLS] 
we 
determined 
complete 
n 
##leo 
##tide 
sequence 
element 
present 
fork 
lo 
##ros 
##op 
##1 
all 
##ele 
the 
high 
degree 
sequence 
ho 
##mology 
f 
dip 
##los 
alpha 
beta 
sequence 
85 
77 
respectively 
found 
n 
##uc 
##leo 
amino 
level 
result 
comparison 
[SEP] 
de 
##cu 
##bit 
##us 
ul 
human 
der 
##mal 
fi 
##bro 
i 
co 
##lla 
der 
##mal 
matrix 
dem 
##ro 
electric 
##ogen 
field 
wound 
[CLS] 
group 
factor 
known 
act 
##ivating 
transcription 
factor 
at 
##f 
found 
bind 
latter 
related 
sequence 
found 
upstream 
early 
ad 
promoter 
induced 
e 
##1 
##a 
factor 
highly 
ho 
##mo 
##log 
##ous 
##b 
protein 
[SEP] 
[CLS] 
in 
case 
patient 
w 
high 
micro 
##fi 
##lar 
##emia 
ne 
##uro 
manifest 
##ation 
##air 
least 
one 
week 
treatment 
ve 
verte 
##bra 
##brate 
transcription 
factor 
t 
cell 
factor 
factor le 
l 
enhance 
##r 
binding 
factor 
interact 
##hes 
##ized 
media 
##less 
w 
signaling 
[CLS] 
some 
d 
protein 
complex 
present 
lower 
level 
##ns 
##formed 
possible 
cellular 
factor 
mechanism 
regulation 
mediated 
ad 
e 
##1 
##a 
[CLS] 
##po 
##ce 
usually 
due 
either 
disturbance 
para 
##roid 
hormone 
system 
disturbance 
vitamin 
d 
metabolism 
activity 
however 
two 
component 
[PAD] [CLS] 
solve 
displacement 
due 
memory 
requirement 
chance 
level 
3 
problem 
problem [SEP] 
[CLS] 
7 
7 8 
new 
wave 
path 
##k 
m 
##b 
profile 
##rop 
##oni 
10 
47 
##gram 
34 
12 
50 
00 
001 
##1 i 
ii 
[CLS] 
mineral 
##ized 
bone 
nod 
##ule 
formation 
##ro 
cell 
population 
young 
adult 
al 
##ve 
##olar 
bone 
mouse 
display 
none 
motif 
[CLS] 
##az 
##ril 
h 
##ydro 
##oth 
##zi 
alone 
combination 
shown 
##az 
##ril 
20 
mg 
daily 
effective 
effective 
di 
##ast 
##olic 
blood 
h 
##ydro 
##oth 
##zi 
##de 
25 
mg 
daily 
combination 
##az 
##ril 
20 
mg 
h 
##ydro 
##oth 
##zi 
25 
mg 
mg possibly 
s 
##yne 
##rg 
##istic 
effect 
di 
##ast 
##olic 
blood 
[CLS] 
the 
132 
b 
##p 
##p 
fragment 
connected 
position 
281 
5 
upstream 
region 
la 
##cz 
fused 
gene 
could 
sense 
p 
##i 
signal 
v 
##ivo 
20 
b 
##p 
synthetic 
o 
##gon 
##uc 
##leo 
##tide 
sequence 
54 
##4 
##5 
##p 
d 
could 
[SEP] 
[CLS] 
1988 
[CLS] 
sequence 
within 
##as 
element 
##o 
gene 
bound 
second 
protein 
correspond 
##ed 
a 
##b 
##fi 
autonomous 
##ly 
replica 
##ting 
sequence 
binding 
factor 
protein 
[SEP] 
##mi 
##d 
sub 
##lone 
##lones 
re 
##comb 
p 
la 
##da 
##15 
complement 
es 
##cher 
##ichi 
co 
coli 
##b 
se 
##s 
##ban 
mutant 
##ph 
g 
##ama 
##te 
s 
##ynth 
##ase 
strain 
complement 
[CLS] 
the 
sequence 
##z 
##32 
##1 
matched 
r 
##b 
##1 
transcription 
factor 
bound 
##a 
re 
##sp 
element 
r 
##re 
different 
sequence 
isolated 
##z 
##32 
##1 
[SEP] 
[CLS] 
level 
##r 
m 
##rna 
measured 
##rop 
j 
##7 
##74 
##e 
known 
cell 
surface 
[CLS] 
basal 
20 
50 
##ga 
stop 
co 
replaced 
respectively 
e 
co 
translation 
terminate 
##s 
efficiently 
##ga 
[SEP] 
[CLS] 
disc 
##rim 
##ina 
function 
analysis 
audit 
identify 
sat 
positive 
sat 
negative 
patient 
analysis 
accounted 
42 
5 
variance 
correctly 
classified 
84 
6 
sample 
[SEP] 
[CLS] 
co 
##rona 
##tine 
##r 
p 
##mi 
##d 
encoded 
p 
##xin 
synthesized 
##ova 
##mona 
s 
##yr 
##e 
[SEP] 
[CLS] 
both 
5 
3 
##lated 
region 
also 
show 
similarity 
gene 
79 
70 
sequence 
identity 
respectively 
[CLS] 
one 
patient 
exhibited 
non 
sense 
mutation 
co 
##don 
38 
##8 
changed 
##lut 
##amine 
co 
##don 
ca 
##g 
stop 
co 
##don 
tag 
[CLS] 
the 
transcription 
##al 
p 
450 
11 
beta 
gene 
studied 
##ro 
transcription 
system 
nuclear 
extract 
b 
##ov 
ad 
##rena 
##l 
cortex 
[SEP] 
re 
##nal 
d 
##ys 
##p 
##lf 
##orm 
study 
9 
case 
case [SEP] 
this 
b 
##ud 
morphology 
least 
cell 
cycle 
delay 
imposed 
c 
##d 
##c 
##p 
inhibitor 
##y 
kinase 
##1 
[CLS] 
eleven 
12 
ex 
##on 
complete 
sequence 
ho 
##mology 
##b 
##m 
1 
sequence 
[SEP] 
copyright 
1998 
press 
press [SEP] 
##aro 
examination 
1 
year 
enlarged 
walled 
fluid 
filled 
u 
##ine 
segment 
c 
##al 
mid 
##us 
o 
##cc 
##lusion 
site 
animal 
the 
three 
protein 
could 
co 
##d 
##1 
##d 
##2 
##2 [SEP] 
fraction 
structure 
lit 
##hium 
3 
5 
di 
##io 
##dos 
##ali 
##late 
1 
t 
##rito 
m 
##rea 
[CLS] 
for 
also 
g 
##eno 
##mic 
sequence 
red 
l 
gene 
presented 
[SEP] 
elimination 
brush 
border 
well 
g 
##lo 
##mer 
##ular 
##tra 
##ven 
##ous 
injection 
##smo 
cm 
i 
##op 
##ami 
##do 
370 
83 
m 
##os 
##m 
kg 
me 
##g 
##lum 
di 
##at 
##riz 
##oat 
76 
210 
##0 
m 
##os 
##m 
kg 
scattering 
##o 
##2 
single 
crystal 
study 
combination 
##em 
cancer 
[CLS] 
making 
sense 
oxygen 
sensor 
sensor [SEP] 
[CLS] 
base 
##b 
##f 
increase 
observed 
audit 
cortex 
bilateral 
##ly 
right 
superior 
##iet 
##al 
right 
do 
##rs 
##olate 
##ral 
frontal 
right 
##moto 
##r 
region 
m 
##od 
##ulation 
function 
attention 
##al 
condition 
condition [SEP] 
[CLS] 
##it 
##ro 
c 
s 
p 
##lated 
f 
##ak 
t 
92 
g 
##ath 
s 
transfer 
##ase 
##ase f 
terminal 
domain 
whereas 
f 
##ak 
[SEP] 
method 
and 
the 
effect 
prolonged 
ni 
##trate 
therapy 
day 
6 
week 
in 
##far 
parameter 
##ric 
##ular 
re 
##mo 
##del 
scar 
expansion 
scar 
thin 
##ric 
##ular 
di 
##lation 
h 
##yper 
##tro 
as 
##rgy 
akin 
##esis 
plus 
d 
##ys 
##kin 
e 
##jection 
echo 
##card 
##io 
hem 
##ody 
##nam 
##mor 
computer 
plan 
##ime 
geometric 
map 
radio 
co 
##lla 
content 
##rol 
random 
##ized 
day 
anterior 
descending 
co 
##rona 
##ry 
l 
##iga 
various 
ni 
first 
2 
1 
2 
trans 
##der 
##mal 
##tro 
4 
trans 
##der 
##mal 
##tro 
plus 
6 
mg 
sustained 
release 
release oral 
##tro 
3 
3 
3 oral 
is 
##oso 
##rb 
din 
##it 
##rate 
30 
mg 
mg 8 
4 
is 
##oso 
##rb 
din 
##it 
##rate 
10 
the 
essential 
oil 
medicinal 
s 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
[PAD] 
assessment 
e 
e2 
##bor 
conclusion 
m 
##c 
ratio 
prediction 
poor 
combined 
##st 
[SEP] 
[CLS] 
evaluation 
material 
tech 
##nics 
vascular 
111 
in 
the 
c 
##laus 
##tro 
##cor 
##tical 
connection 
investigated 
injection 
30 
h 
##rp 
three 
subdivision 
audit 
cortex 
abstract 
t 
##runcated 
at 
400 
word 
applying 
mentioned 
4 
meta 
used 
composite 
v 
cavity 
freshly 
extracted 
human 
teeth 
[CLS] 
the 
##1 
mutation 
induced 
insertion 
1 
2 
k 
##b 
p 
element 
5 
trans 
region 
pro 
##ximal 
gene 
clinical 
sensory 
interaction 
c 
cts 
##ib 
functional 
reach 
oriented 
mobility 
problem 
up 
g 
[PAD] [CLS] 
genome 
timeline 
initial 
computer 
similarity 
search 
human 
re 
##tino 
##blast 
binding 
1 
##b 
1 
##ros 
##op 
##hil 
me 
##lan 
##oga 
male 
specific 
lethal 
3 
m 
ms 
3 
polar 
##3 
##p 
component 
yeast 
yeast n 
hat 
complex 
##ar 
hem 
##ody 
##nam 
effective 
##ifice 
spa 
spab 
superior 
s 
##ten 
counterpart 
especially 
size 
[CLS] 
serum 
pro 
##ct 
##in 
rapidly 
institution 
treatment 
actual 
normal 
le 
20 
ng 
m 
3rd 
month 
month [SEP] 
we 
all 
##ei 
##eic 
sibling 
sibling b 
##m 
transplant 
mm 
1990 
therapy 
therapy [SEP] 
healing 
in 
##31 
##9 
functional 
site 
70 
inter 
##dom 
##ain 
b 
region 
these 
##rra 
promotion 
vascular 
##ization 
tissue 
transplant 
research 
design 
and 
id 
##d 
##m 
random 
group 
one 
group 
##bo 
##bo n 
36 
3 
year 
b 
##mi 
24 
5 
1 
1 
m 
group 
15 
mg 
l 
##isi 
daily 
daily n 
34 
2 
year 
b 
##mi 
##mi 24 
4 
0 
9 
m 
##2 
previously 
encoding 
protein 
3 
##3 
l 
##1 
ad 
library 
sequence 
##d 
expression 
human 
complement 
receptor 
type 
type 2 
##r 
##d 
##21 
primarily 
restricted 
mature 
b 
cell 
f 
##oll 
##icular 
den 
##itic 
[CLS] 
the 
6 
5 
k 
##b 
##eno 
##mic 
fragment 
contains 
complete 
coding 
region 
##od 
distributed 
three 
ex 
##on 
plus 
2 
3 
k 
##b 
5 
##co 
##ding 
sequence 
1 
4 
k 
##b 
3 
##co 
##ding 
sequence 
synthetic 
##an 
derivative 
wit 
##ti 
reaction 
[CLS] 
the 
apparent 
binding 
thy 
d 
1 
68 
x 
m 
1 
##rops 
give 
value 
1 
85 
1 
##hen 
##otypic 
screening 
mutation 
##1 
yeast 
secret 
reveals 
residue 
critical 
select 
[SEP] 
molecular 
c 
##lon 
##ing 
##a 
encoding 
alpha 
subunit 
binding 
regulatory 
revealed 
existence 
nine 
s 
##pec 
##ie 
alpha 
subunit 
[CLS] 
no 
trans 
##act 
promoter 
p 
##lov 
##tata 
template 
control 
observed 
pro 
con 
selective 
in 
##ox 
##ase 
dual 
##ox 
in 
better 
one 
[CLS] 
year 
52 
##1 
major 
co 
##rona 
##ry 
disease 
event 
occurred 
261 
fatal 
260 
fatal 
[SEP] 
[PAD] [CLS] 
the 
et 
##iology 
established 
73 
76 
8 
95 
case 
m 
##or 
##ph 
##test 
##ine 
pig 
[CLS] 
serum 
zinc 
copper 
urine 
copper 
concentration 
men 
lower 
woman 
difference 
serum 
##rina 
zinc 
age 
h 
##de 
found 
exclusively 
targeted 
per 
##ox 
##is 
system 
[CLS] 
gene 
##cal 
##ling 
successful 
detect 
member 
complex 
metabolic 
pathway 
novel 
gene 
either 
coincide 
##ntal 
##ly 
regulated 
directly 
involved 
pathway 
[CLS] 
transformation 
circular 
p 
##las 
##mi 
##d 
slowly 
irregular 
genetic 
##in 
resistant 
my 
##cel 
##ium 
1 
nucleus 
contained 
p 
##las 
##mi 
##d 
sequence 
conclusion 
control 
##ric 
response 
##ba 
##vir 
pace 
##rio 
##vent 
##ric 
##ular 
modify 
drug 
pace 
lead 
exercise 
duration 
life 
life [SEP] 
[CLS] 
the 
region 
include 
potential 
binding 
site 
transcription 
factor 
at 
##f 
##1 
##aa 
##t 
binding 
protein 
[SEP] 
[CLS] 
both 
##h 
##rd 
gene 
constitute 
single 
op 
##eron 
core 
##gu 
##lated 
expression 
pu 
##rine 
pu 
##rine 
gene 
[SEP] 
the 
patient 
demographic 
de 
follows 
year 
nine 
male 
three 
female 
ii 
15 
3 
diagnosis 
9 
12 
patient 
pneumonia 
pneumonia [SEP] 
sit 
hybrid 
reveals 
strong 
signal 
m 
c 
##ere 
##bell 
##um 
o 
##lf 
##actor 
##y 
bulb 
moderate 
signal 
detected 
hip 
##po 
##cam 
##pus 
cortex 
[SEP] 
[CLS] 
t 
##n 
##f 
alpha 
effect 
eliminated 
2 
b 
##p 
substitution 
mutation 
n 
##f 
ka 
b 
##1 
binding 
half 
site 
##f 
ka 
b 
c 
##i 
element 
cross 
linking 
complex 
represent 
one 
two 
molecule 
ad 
##r 
##1 
bound 
d 
##na 
a 
already 
available 
known 
member 
enzyme 
structural 
functional 
feature 
human 
l 
##ymph 
prop 
##rote 
##in 
convert 
##ase 
##c 
[CLS] 
the 
m 
phase 
induction 
##d 
##c 
##c2 
in 
##hibit 
we 
##e 
##1 
t 
##d 
##c 
15 
[CLS] 
n 
##uc 
##leo 
##tide 
se 
##quencing 
revealed 
207 
base 
pair 
open 
reading 
frame 
encoding 
69 
amino 
acid 
protein 
[PAD] [CLS] 
but 
possible 
two 
hemisphere 
hemisphere differ 
differ manner 
make 
semantic 
left 
hemisphere 
selective 
selective manner 
manner appropriate 
specific 
task 
right 
hemisphere 
di 
##ff 
##use 
##use global 
global manner 
supportive 
therapy 
x 
##eno 
##gen 
meta 
##static 
##em 
##otherapy 
modified 
protocol 
random 
##ized 
study 
[PAD] [CLS] 
the 
pregnancy 
terminated 
19 
12 
week 
g 
##esta 
single 
substitution 
three 
highly 
##yla 
15 
27 
substitution 
one 
his 
##ti 
his 
located 
within 
put 
##ative 
r 
binding 
site 
r 
##p 
1 
2 
abolished 
nuclei 
##c 
binding 
##b 
[CLS] 
the 
case 
terminal 
force 
vent 
##ric 
activation 
direction 
delta 
wave 
superior 
##ly 
left 
60 
degree 
inferior 
##ly 
right 
120 
degree 
forming 
single 
def 
##lect 
0 
12 
second 
result 
delayed 
activation 
anterior 
posterior 
left 
bundle 
long 
delay 
delay [SEP] 
[CLS] 
the 
gene 
encoding 
car 
##ote 
e 
##o 
##13 
cluster 
##ed 
7 
k 
##b 
d 
fragment 
[CLS] 
the 
result 
show 
larger 
p 
##pt 
##ide 
substrate 
carrying 
h 
##d 
##1 
3 
##c 
site 
processed 
efficiently 
##pt 
substrate 
carrying 
p 
##ol 
z 
site 
c 
##lea 
##vage 
synthetic 
p 
##eptide 
substrate 
containing 
two 
c 
##lea 
##vage 
site 
occurred 
similar 
efficiency 
[SEP] 
[CLS] 
using 
trans 
detailed 
analysis 
##xa 
7 
enhance 
##r 
directed 
em 
##b 
##ryo 
[SEP] 
[CLS] 
la 
##cz 
expression 
first 
detected 
all 
##ois 
day 
7 
p 
c 
me 
##so 
##der 
##m 
e 
##ct 
##ode 
##rm 
day 
day 8 
##esta 
##tion 
an 
er 
##p 
##60 
like 
fi 
##lar 
##ial 
parasite 
dir 
##of 
##ila 
##ilaria 
##ria im 
##mit 
trans 
di 
##sul 
##fi 
is 
##omer 
[CLS] 
at 
promoter 
initiate 
1 
g 
##gg 
t 
r 
##nap 
s 
##ynth 
##zes 
ladder 
p 
##oly 
product 
result 
slip 
##page 
trans 
##cript 
three 
c 
residue 
template 
strand 
1 
3 
[SEP] 
serum 
level 
##gio 
##tens 
##in 
converting 
enzyme 
maintained 
maintained [SEP] 
the 
ul 
##3 
##f 
204 
amino 
acid 
show 
ho 
##mology 
##3 
nuclear 
p 
1 
62 
53 
53 [SEP] 
on 
protein 
mi 
slightly 
slower 
s 
##d 
page 
##xon 
##in 
1 
[CLS] 
for 
sophisticated 
adjustment 
chess 
pulse 
needed 
method 
method [SEP] 
[CLS] 
the 
10 
eye 
injected 
r 
##pe 
cell 
showed 
stage 
2 
le 
4 
week 
week [SEP] 
this 
establishes 
effect 
ho 
##mo 
##go 
sick 
growth 
pattern 
childhood 
apparent 
year 
[CLS] 
the 
remaining 
77 
n 
##uc 
##leo 
3 
domain 
ii 
domain 
ii 
##i 
65 
n 
##uc 
##leo 
##tide 
##tide i 
iv 
77 
n 
##leo 
##tide 
present 
di 
##sse 
r 
##na 
the 
biological 
action 
o 
##yte 
clearly 
distinguish 
dual 
specific 
shown 
inhibitor 
o 
##oc 
##yte 
presence 
##o 
##quin 
sa 
##liva 
21 
day 
single 
600 
mg 
oral 
dose 
drug 
##roma 
##pect 
##ros 
##p 
##41 
p 
t 
fused 
##j 
##j g 
loop 
symmetry 
related 
##sts 
[CLS] 
comparison 
bio 
##rea 
##ctive 
gas 
##tri 
##n 
[CLS] 
also 
p 
pt 
##x 
effect 
dependent 
activation 
j 
##nk 
##nk [SEP] 
ii 
disease 
we 
tested 
growth 
regulatory 
se 
ability 
restore 
t 
##1 
[CLS] 
we 
analyzed 
contribution 
three 
type 
mit 
map 
##k 
##k 
activation 
promoter 
high 
degree 
sequence 
conservation 
ability 
direct 
transport 
bio 
60 
subunit 
characterization 
nuclear 
def 
##orm 
##ed 
##ed e 
##pid 
##gu 
1 
deaf 
1 
related 
n 
##ud 
##r 
transcription 
##al 
regulator 
protein 
[CLS] 
here 
##1 
gene 
clone 
##d 
high 
copy 
number 
suppress 
##or 
mutation 
##3 
able 
suppress 
defect 
conferred 
mutation 
gene 
ha 
##m 
##di 
##eh 
ne 
nefi 
##z 
##od 
z 
z 
1961 
1 
219 
m 
##r 
##azar 
bi 
##lio 
d 
##je 
s 
##r 
##rad 
##b 
1984 
besides 
besides great 
contribution 
bi 
##liography 
given 
d 
##r 
##jo 
##r 
pro 
prof 
[CLS] 
d 
##r 
[CLS] 
the 
longest 
##a 
insert 
identified 
2 
k 
##b 
encoded 
entire 
46 
amino 
acid 
open 
reading 
frame 
rat 
##ga 
including 
18 
amino 
acid 
h 
##ydro 
signal 
p 
##eptide 
[SEP] 
we 
systemic 
##to 
##to 
##xi 
drug 
am 
##ika 
induce 
total 
co 
hair 
##cell 
loss 
##chi 
profound 
deaf 
##ness 
[CLS] 
co 
##tra 
##ns 
##fect 
c 
c e 
##b 
##bet 
1 
5 
fold 
co 
##tra 
##ns 
##fect 
##b 
##bet 
1 
individually 
e 
##3 
allowed 
expression 
pattern 
similar 
observed 
naturally 
ben 
con 
##mas 
mediated 
##1 
block 
##1 
arrest 
##d 
##k 
inhibitor 
##p 
##1 
##1 
cannot 
bypass 
bypassed 
in 
e 
e2 
member 
member [SEP] 
[CLS] 
in 
one 
##3 
all 
##3 
d 
##t 
##ph 
##1 
element 
inserted 
30 
b 
##p 
upstream 
translation 
start 
without 
in 
##act 
##ivating 
gene 
[PAD] [CLS] 
case 
ne 
##ph 
##rot 
##ic 
syndrome 
caused 
gold 
preparation 
preparation [SEP] 
[CLS] 
to 
investigate 
role 
b 
##hl 
##h 
m 
##3 
##3t 
##3 
##3 e 
##1 
o 
##ste 
##ob 
undergo 
developmental 
sequence 
##ro 
analyzed 
transcription 
##al 
control 
##ste 
gene 
trans 
##fect 
promoter 
##uc 
##ase 
##ime 
##ric 
##37 
##uc 
assessed 
role 
e 
box 
c 
##i 
acting 
element 
##ste 
promoter 
d 
binding 
[SEP] 
[CLS] 
in 
treatment 
related 
effect 
##ph 
##rop 
relevant 
human 
health 
[CLS] 
in 
show 
s 
bind 
##f 
1 
site 
promoter 
activate 
##s 
transcription 
trans 
trans 
##p 
he 
respectively 
[PAD] [CLS] 
gas 
##tro 
##int 
##est 
##inal 
accumulation 
in 
##dium 
111 
labelled 
reactive 
##itis 
##itis [SEP] 
into 
##xi 
c 
##yper 
##hr 
n 
##rd 
##c 
149 
[CLS] 
we 
transcription 
##al 
act 
##iva 
##tor 
c 
##rem 
highly 
expressed 
##mei 
##otic 
cell 
[SEP] 
[PAD] [CLS] 
no 
interaction 
e 
##pid 
in 
late 
o 
##obe 
##r 
1974 
s 
##oper 
infection 
recorded 
##ula 
operation 
[CLS] 
twenty 
calf 
##oa 
##bla 
order 
establish 
complete 
cardiac 
den 
##er 
##vation 
our 
current 
aim 
c 
##lar 
##olar 
targeting 
namely 
##i 
##1 
alpha 
c 
##rc 
[CLS] 
the 
effect 
def 
##ero 
##xa 
##mine 
b 
blood 
sugar 
behavior 
in 
##ven 
##ous 
glucose 
loading 
person 
[CLS] 
in 
re 
mediated 
c 
##lea 
##vage 
um 
##ud 
another 
role 
re 
so 
m 
##uta 
probably 
act 
##ivating 
##ud 
m 
##uta 
function 
[SEP] 
setting 
physician 
health 
random 
##ized 
##pi 
##ote 
s 
male 
physician 
the 
##uria 
##r 
range 
15 
150 
min 
1 
overnight 
urine 
sample 
3 
95 
i 
interval 
1 
9 
4 
0 
0 [SEP] 
[CLS] 
re 
protein 
known 
bind 
re 
recognition 
r 
##rs 
##s 
inverted 
terminal 
repeat 
##rs 
p 
promoter 
preferred 
integration 
site 
human 
chromosome 
19 
called 
##1 
lip 
dip 
characterized 
ground 
glass 
at 
[CLS] 
the 
level 
t 
##1 
m 
dramatically 
regulated 
re 
##gene 
##rating 
liver 
normal 
adult 
liver 
copyright 
1999 
the 
al 
##zo 
enhanced 
specific 
##zo 
receptor 
receptor [SEP] 
[CLS] 
southern 
hybrid 
##ization 
##r 
transform 
p 
##mi 
##d 
integration 
occurred 
frequently 
ch 
##rom 
##oso 
lo 
##cus 
gene 
conversion 
he 
##tero 
##log 
##ous 
re 
##comb 
##ination 
observed 
[SEP] 
the 
analysis 
effect 
signaling 
molecule 
molecule t 
ex 
##p 
revealed 
expression 
act 
##iv 
##in 
##ct 
##ody 
##sp 
##las 
##in 
expression 
[CLS] 
in 
two 
high 
affinity 
binding 
site 
apparent 
di 
##sso 
##ciation 
constant 
k 
##d 
50 
100 
mapped 
5 
et 
##s 
upstream 
early 
pre 
r 
##rna 
processing 
site 
[SEP] 
[CLS] 
single 
oblique 
view 
ma 
##ography 
periodic 
screening 
breast 
cancer 
woman 
[SEP] 
r 
##adia 
correction 
l 
##2 
decay 
[CLS] 
this 
del 
##eti 
##on 
disrupt 
##s 
1 
et 
domain 
[CLS] 
in 
sufficient 
amount 
t 
##rar 
apparently 
sensitive 
cellular 
function 
requiring 
r 
##nas 
##e 
d 
[SEP] 
[CLS] 
the 
predicted 
product 
exhibit 
91 
amino 
acid 
identity 
m 
gate 
##d 
##1 
7 
re 
##pol 
membrane 
[SEP] 
[PAD] [CLS] 
bean 
protein 
##uo 
storage 
cell 
co 
##ty 
dynamic 
e 
##47 
ho 
##mo 
##di 
##mer 
##ize 
he 
##tero 
##di 
##mer 
##od 
id 
ta 
##1 
blood 
sample 
30 
m 
##l 
collected 
via 
cat 
rest 
minute 
13 
28 
exercise 
determination 
e 
##pi 
serum 
fatty 
##fa 
serum 
g 
##ly 
##ol 
g 
##ly 
blood 
glucose 
g 
##lu 
blood 
##ate 
la 
la concentration 
among 
four 
patient 
aid 
syndrome 
42 
individual 
hi 
hiv 
carrier 
[CLS] 
subject 
73 
male 
employee 
x 
##ero 
joining 
health 
fitness 
program 
program [SEP] 
[CLS] 
over 
##ex 
p 
##50 
trans 
co 
##tra 
##ns 
##fect 
pro 
##ximal 
c 
##rp 
promoter 
125 
9 
linked 
l 
##uc 
##ifer 
##ase 
reporter 
caused 
3 
fold 
increase 
l 
##uc 
##ifer 
##ase 
activity 
c 
e 
##b 
##bet 
##a 
over 
caused 
18 
fold 
increase 
simultaneous 
over 
transcription 
factor 
increased 
l 
##uc 
##ifer 
##ase 
activity 
activity approximately 
600 
fold 
[SEP] 
[CLS] 
while 
differential 
expression 
two 
trans 
##cript 
found 
promoter 
controlling 
l 
##t 
##1 
l 
##2 
transcription 
regulated 
cell 
cycle 
dependent 
manner 
[SEP] 
s 
##cho 
##tt 
barrier 
t 
t 
##2 
n 
type 
si 
100 
survey 
child 
h 
##bs 
##ag 
marker 
related 
##b 
marker 
marker [SEP] 
##mu 
killer 
##k 
if 
gamma 
in 
##fusion 
[CLS] 
f 
##etal 
recovery 
ni 
group 
[CLS] 
genetic 
analysis 
dominant 
mutant 
##i 
acting 
re 
##cess 
mutant 
define 
minimum 
three 
complement 
##ation 
group 
defect 
several 
different 
gene 
restore 
higher 
expression 
[SEP] 
[CLS] 
rat 
##ole 
##ster 
##ol 
side 
chain 
##och 
gene 
his 
##top 
##ath 
displaying 
s 
##po 
##ng 
##iform 
change 
matter 
ne 
##uron 
##al 
loss 
at 
##rog 
##lio 
##re 
##utz 
##feld 
j 
##ak 
##ob 
disease 
[CLS] 
##a 
promoter 
cat 
construct 
active 
construct 
ass 
c 
##lon 
new 
zinc 
defines 
closely 
##rup 
##pel 
transcription 
com 
ho 
##mology 
search 
similarity 
##3 
##21 
##21 activated 
##ak 
activated 
##d 
##ac 
blood 
loss 
injection 
4 
5 
range 
3 
10 
[CLS] 
in 
acoustic 
##al 
property 
response 
late 
discharge 
pattern 
frequency 
tuning 
##au 
##ral 
interaction 
habit 
##uation 
differentiation 
##b 
electro 
##sio 
mean 
mean [SEP] 
these 
8 
o 
d 
##yla 
ho 
##1 
human 
m 
##1 
m 
ho 
##mo 
##log 
##ous 
yeast 
##1 
[CLS] 
the 
ch 
protein 
includes 
consensus 
at 
binding 
domain 
characteristic 
kinase 
display 
34 
42 
identical 
aligned 
amino 
acid 
residue 
##d 
##c 
##c2 
related 
kinase 
considerably 
longer 
terminus 
[SEP] 
[CLS] 
conclusion 
result 
interacting 
cellular 
transcription 
factor 
##fa 
##ctor 
##f 
may 
m 
##od 
##ulate 
expression 
early 
inflammatory 
gene 
potentially 
der 
##eg 
##ulate 
immune 
system 
[SEP] 
however 
patient 
normal 
##t 
result 
latter 
area 
cerebral 
activity 
an 
##ato 
##mic 
correlated 
##uro 
les 
##ion 
##ion [SEP] 
[CLS] 
we 
##3 
central 
initiation 
me 
##ios 
via 
effect 
##2 
[CLS] 
the 
car 
##box 
pro 
##ximal 
region 
##p 
##1 
contain 
low 
amino 
acid 
ho 
##mology 
displayed 
evidence 
conservation 
structural 
feature 
h 
##ydro 
highly 
basic 
domain 
[SEP] 
##fer 
##i 
may 
regulated 
inter 
##fer 
stimulate 
response 
consensus 
element 
5 
u 
ex 
##on 
similar 
motif 
conserved 
corresponding 
position 
related 
##elo 
differentiation 
abstract 
##runcated 
at 
400 
word 
[CLS] 
design 
a 
random 
##ised 
double 
blind 
##bo 
trial 
[CLS] 
gene 
##alog 
##ical 
analysis 
mainly 
mother 
offspring 
transmission 
s 
1 
1 [SEP] 
these 
back 
mutation 
led 
kinase 
tumor 
##ige 
chicken 
unexpected 
transforming 
cell 
[CLS] 
the 
limit 
50 
ng 
m 
##l 
p 
##ht 
hp 
##ph 
individual 
into 
##x 
##olo 
continue 
occur 
always 
required 
patient 
cardiac 
respiratory 
d 
##ys 
##function 
exposed 
beta 
antagonist 
antagonist [SEP] 
pre 
##toria 
feasible 
condition 
[CLS] 
in 
present 
t 
##ga 
la 
##cz 
construct 
lacking 
t 
t 
##a 
space 
##r 
region 
analyze 
effect 
t 
synthesis 
behavior 
translates 
t 
[SEP] 
t 
##zo 
derivative 
cause 
der 
##mat 
##cos 
##ed 
can 
##di 
##dia 
[CLS] 
restriction 
analysis 
##eno 
##mic 
clone 
end 
##ogen 
##ous 
sequence 
a 
##but 
##ting 
3 
end 
94 
a 
94 
k 
trans 
##gene 
separated 
le 
20 
k 
##b 
strong 
support 
single 
integration 
model 
[SEP] 
[CLS] 
serum 
showed 
increase 
birth 
6 
age 
decrease 
6 
month 
1 
year 
age 
female 
w 
##ista 
##r 
rat 
alcohol 
5 
##ation 
##ation n 
7 
normal 
control 
fed 
fed ad 
l 
##ibi 
##ibitum 
complementary 
5 
end 
p 
##k 
##c 
m 
##rna 
sequence 
co 
##lla 
lattice 
stimulate 
alpha 
1 
m 
level 
[CLS] 
hi 
##f 
1 
##al 
##pha 
del 
##eti 
##on 
basic 
domain 
car 
##box 
terminus 
blocked 
reporter 
gene 
activation 
##ogen 
##ous 
hi 
##f 
1 
##pox 
cell 
[SEP] 
[CLS] 
we 
h 
##hes 
##gated 
est 
##rogen 
contain 
##as 
##oa 
est 
##rogen 
##ic 
compound 
favor 
##ably 
influence 
v 
##as 
##omo 
##cho 
men 
men [SEP] 
[CLS] 
in 
experiment 
2 
level 
am 
##p 
##rol 
et 
##aba 
##te 
02 
sa 
55 
mg 
kg 
mon 
##ens 
##in 
99 
mg 
kg 
##cid 
110 
mg 
kg 
residue 
crucial 
##a 
interaction 
##d 
##p 
##t 
##p 
exchange 
##r 
[CLS] 
[CLS] 4 
[CLS] 
serum 
star 
3 
##t 
##3 
cell 
r 
##af 
increased 
m 
##dr 
##1 
promoter 
activity 
10 
fold 
shift 
control 
[SEP] 
searching 
human 
d 
data 
base 
sequence 
tag 
est 
revealed 
partial 
sequence 
similar 
protein 
[CLS] 
under 
control 
presence 
3 
##mo 
##r 
ma 
##ximal 
effect 
nor 
##ad 
##rena 
reached 
0 
1 
##mo 
presence 
10 
##mo 
reached 
dose 
1 
##mo 
it 
affected 
3 
4 
transcription 
factor 
complex 
##1 
##6 
effective 
super 
di 
##uta 
er 
##yt 
##hr 
stage 
in 
[CLS] 
two 
different 
gene 
##b 
d 
polymer 
##ase 
clone 
##d 
organism 
##r 
using 
de 
##generate 
##d 
prime 
##r 
based 
two 
conserved 
motif 
motif 
a 
b 
[SEP] 
[CLS] 
the 
effect 
survival 
##vant 
treatment 
including 
pre 
##oper 
systemic 
in 
##erial 
ch 
##em 
##otherapy 
currently 
evaluation 
structure 
regulation 
##ute 
hormone 
receptor 
gene 
the 
disease 
process 
transplant 
seen 
frequently 
gas 
##tro 
##enter 
##ology 
##ology [SEP] 
[CLS] 
method 
single 
photo 
s 
##cot 
##op 
flicker 
flicker er 
recorded 
30 
##ila 
##teral 
c 
cr 
##vo 
[CLS] 
however 
encourage 
contact 
ins 
beneficial 
##sman 
present 
cow 
ins 
##inated 
[SEP] 
modelling 
class 
class analogy 
si 
##r 
spectrum 
ex 
pharmaceutical 
[CLS] 
organ 
failure 
m 
major 
trauma 
occurs 
response 
per 
##fusion 
persistent 
inflammatory 
focus 
persistent 
focus 
dead 
injured 
tissue 
tissue [SEP] 
western 
p 
##ga 
c 
##lea 
##vage 
product 
p 
p 
derived 
gag 
gag 
p 
respectively 
c 
##ef 
##min 
##ivo 
activity 
expected 
safety 
[CLS] 
conclusion 
high 
m 
##f 
er 
##g 
seems 
sensitive 
m 
##f 
er 
##g 
##g [SEP] 
3 
5 
fold 
increase 
e 
receptor 
##i 
stimulation 
next 
regulation 
mechanism 
##d 
interaction 
##d 
complex 
found 
contains 
r 
##d 
##p 
di 
##sso 
##ciation 
inhibitor 
regulator 
##t 
[PAD] [CLS] 
the 
result 
showed 
group 
effect 
task 
task [SEP] 
on 
day 
7 
21 
35 
bird 
er 
in 
##ven 
##ously 
[CLS] 
to 
determine 
c 
##i 
acting 
element 
controlling 
rat 
b 
50 
gap 
43 
gene 
expression 
##eno 
##mic 
d 
encoding 
ex 
##on 
1 
5 
flank 
##ing 
sequence 
isolated 
[SEP] 
in 
measured 
1 
year 
##pid 
##em 
nutrition 
examination 
examine 
effect 
over 
co 
##rona 
##ry 
heart 
disease 
year 
year [SEP] 
[CLS] 
through 
##eno 
##mic 
library 
screening 
##r 
based 
##eno 
##mic 
walking 
clone 
##d 
e 
t 
##mo 
##d 
gene 
whose 
coding 
region 
span 
approximately 
60 
##k 
##b 
containing 
nine 
ex 
##on 
eight 
intro 
##n 
[SEP] 
[CLS] 
t 
##f 
alpha 
stimulate 
change 
part 
increasing 
transcription 
stab 
r 
##gu 
e 
receptor 
l 
directly 
increased 
16 
16 e 
c 
##lin 
[CLS] 
the 
data 
obtained 
1 
mean 
frequency 
abnormal 
##elin 
fiber 
upper 
limit 
95 
2 
mean 
density 
total 
large 
##elin 
##elin 
lower 
limit 
95 
decade 
fusion 
gal 
d 
binding 
domain 
full 
m 
##3 
[SEP] 
[CLS] 
none 
19 
probable 
r 
##a 
100 
116 
definite 
r 
##a 
criterion 
[CLS] 
the 
initial 
oral 
administration 
1 
2 
mg 
kg 
dos 
en 
##ox 
##imo 
##ne 
central 
hem 
##ody 
##nam 
parameter 
apparent 
prefer 
##ential 
limb 
vascular 
au 
##gment 
blood 
region 
peripheral 
system 
1 
r 
editing 
reaction 
r 
##na 
editing 
the 
full 
length 
clone 
##d 
sequence 
##d 
in 
##ferred 
amino 
acid 
sequence 
protein 
named 
c 
##ys 
##tat 
40 
ho 
##mology 
human 
family 
family 2 
c 
##ys 
##tat 
similar 
overall 
structure 
[SEP] 
42nd 
annual 
meeting 
am 
##eric 
academy 
path 
bag 
1 
growth 
arrest 
i 
##rra 
##eno 
##to 
interfering 
accumulation 
protein 
p 
1 
expression 
the 
side 
pulmonary 
fi 
##bro 
##sis 
occurs 
20 
30 
drug 
drug [SEP] 
[CLS] 
these 
larger 
size 
prediction 
d 
sequence 
p 
##ol 
gene 
[SEP] 
primary 
##di 
##gent 
##gent [SEP] 
[CLS] 
n 
##0 
disease 
favorable 
n 
##1 
##1 n 
##2 
disease 
disease [SEP] 
[PAD] [CLS] 
in 
serial 
recall 
term 
memory 
repeated 
item 
recalled 
recalled well 
repetition 
##ili 
repetition 
in 
##hibition 
##hibition ran 
ransch 
##burg 
effect 
effect [SEP] 
[CLS] 
in 
in addition 
two 
c 
##i 
acting 
element 
direct 
first 
z 
##got 
expression 
k 
##r 
striped 
sub 
##pa 
##tter 
within 
central 
region 
blast 
##ode 
##rm 
em 
##b 
##ryo 
[SEP] 
[CLS] 
hundred 
patient 
217 
female 
median 
age 
age 24 
year 
0 
73 
66 
male 
median 
age 
age 20 
year 
range 
75 
72 
examined 
the 
robe 
robert 
wood 
##oh 
##ohnson 
foundation 
billion 
force 
unique 
m 
##t 
##3 
c 
code 
##of 
##t 
##3 
fifth 
i 
domain 
comparison 
pro 
##to 
##ty 
form 
##53 
mutation 
approach 
study 
origin 
mutation 
cancer 
1993 
1993 8 
94 
99 
99 [SEP] 
des 
desar 
##roll 
##o 
##o de 
model 
modelo 
mate 
pro 
proces 
f 
##er 
##ment 
##ati 
##ativos 
c 
##inet 
##ica 
##ica de 
de 
##grad 
##ac 
##ae 
##ro 
##bia 
[CLS] 
particle 
bombardment 
bar 
##uron 
b 
b22 
##el 
##8 
promoter 
beta 
g 
##lu 
##ron 
##idas 
construct 
promoter 
3 
k 
##b 
active 
developing 
bar 
grain 
[CLS] 
change 
b 
##hr 
##rrel 
change 
level 
24 
h 
mean 
so 
##2 
no 
##2 
smoke 
48 
h 
mean 
no 
##2 
smoke 
24 
h 
la 
no 
##2 
effect 
accounting 
10 
var 
##iability 
within 
b 
##hr 
visit 
visit [SEP] 
[CLS] 
the 
n 
terminal 
sequence 
is 
##of 
##orms 
beta 
e 
##ps 
##ilon 
contain 
p 
##est 
region 
could 
induce 
rapid 
in 
##tra 
##cellular 
degradation 
is 
##of 
##orms 
beta 
delta 
[SEP] 
[CLS] 
characterization 
region 
fi 
##bro 
##nect 
besides 
##rg 
g 
as 
##par 
acid 
sequence 
required 
ad 
##hesive 
binding 
domain 
site 
directed 
m 
##uta 
effect 
##p 
##roa 
##roate 
related 
differential 
m 
##od 
##ala 
##mo 
##cor 
##tical 
ex 
##ci 
##bility 
element 
regulating 
cell 
stage 
specific 
expression 
c 
el 
##egan 
##egans 
##od 
##mo 
1 
an 
analysis 
kit 
5 
flank 
##ing 
region 
bacterial 
##lt 
##ran 
##s 
##fer 
##ase 
gene 
cat 
ass 
er 
end 
##ogen 
m 
high 
showed 
region 
180 
22 
important 
expression 
gene 
after 
5 
day 
stimulation 
g 
##f 
10 
##gram 
1 
##l 
blood 
drawn 
kept 
##ro 
##cess 
3 
day 
##in 
##fused 
24 
h 
##em 
##otherapy 
o 
become 
recent 
year 
particularly 
##gu 
however 
relative 
substrate 
specific 
##3 
differed 
##of 
##orms 
[SEP] 
[CLS] 
subunit 
human 
##b 
complex 
distinct 
role 
multiple 
stage 
media 
ta 
##t 
activation 
hi 
1 
transcription 
el 
##ong 
##ation 
[CLS] 
corresponding 
o 
##gon 
##leo 
##tide 
##s 
screen 
rat 
liver 
c 
##a 
library 
constructed 
p 
##las 
##mi 
##d 
c 
##lon 
##ing 
vector 
p 
##d 
##v 
[SEP] 
selected 
duct 
##al 
##cin 
found 
marked 
tumor 
##al 
inflammatory 
in 
##fi 
##lt 
##rate 
02 
per 
##ino 
##dal 
tumor 
##al 
in 
##fi 
##filt 
01 
sin 
##us 
cat 
##ar 
##r 
f 
##icular 
h 
##yper 
##p 
mixed 
pattern 
l 
##ymph 
node 
year 
correlated 
node 
meta 
##sta 
##sis 
high 
his 
[CLS] 
cap 
##illa 
##ry 
to 
##rt 
##uo 
function 
##omer 
##e 
length 
animal 
relationship 
changed 
##pox 
##ia 
so 
##x 
##x8 
map 
complex 
chromosome 
human 
3 
region 
associated 
##ph 
##thal 
##ara 
##ct 
syndrome 
##m 
alpha 
th 
##sse 
##tar 
##dation 
##r 
16 
directional 
growth 
s 
##ctic 
s 
interface 
along 
forbidden 
orientation 
[SEP] 
[CLS] 
the 
t 
##r 
beta 
enhance 
##r 
active 
minimal 
promoter 
t 
##r 
beta 
variable 
gene 
promoter 
t 
##r 
alpha 
beta 
t 
##r 
gamma 
delta 
t 
cell 
[SEP] 
[CLS] 
u 
u [SEP] 
##let 
derived 
p 
##d 
beta 
receptor 
stimulation 
various 
in 
##hibit 
transcription 
alpha 
##1 
##d 
alpha 
##1 
alpha 
##1 
##r 
resulting 
reduced 
nor 
##ep 
##ph 
s 
##c 
growth 
southern 
b 
##lot 
analysis 
reverse 
transcription 
##r 
showed 
b 
##r 
expressed 
tissue 
except 
liver 
s 
##ple 
##en 
wide 
distribution 
b 
##r 
activity 
de 
##duced 
p 
long 
term 
re 
##nal 
function 
heart 
beating 
donor 
kidney 
transplant 
single 
center 
experience 
experience [SEP] 
[CLS] 
study 
pain 
e 
exhaust 
exhaustive 
influence 
various 
local 
stimulus 
dependent 
general 
factor 
factor upon 
threshold 
value 
well 
studied 
relation 
intensity 
intensity [SEP] 
vaccine 
80 
80 e 
##ica 
appeared 
protective 
[CLS] 
the 
cent 
##rome 
do 
##de 
##ca 
satellite 
##ros 
form 
altered 
d 
##na 
structure 
v 
##it 
##ro 
##rine 
rich 
strand 
g 
strand 
form 
stable 
fold 
back 
structure 
complementary 
c 
strand 
remains 
un 
##structure 
##d 
[SEP] 
di 
es 
end 
##os 
visual 
modified 
di 
90 
diameter 
##oro 
advanced 
c 
##d 
##4 
lower 
21 
9 
3 
4 
pre 
45 
1 
6 
7 
studied 
pro 
##life 
unchanged 
the 
system 
0 
15 
mm 
bag 
bag loosely 
filled 
1 
mm 
sphere 
[CLS] 
mean 
24 
h 
##rina 
##ry 
ex 
##cre 
observation 
however 
4 
assured 
three 
course 
##em 
##otherapy 
unusual 
phase 
i 
study 
j 
##n 
[CLS] 
the 
r 
t 
r 
polymer 
##ase 
free 
s 
##ter 
##ic 
interaction 
te 
##rna 
##ry 
complex 
available 
structure 
formation 
least 
10 
base 
away 
site 
polymer 
##ization 
[SEP] 
[CLS] 
the 
s 
##1 
lo 
##cus 
located 
close 
least 
gene 
involved 
r 
##na 
s 
##p 
##licing 
##3 
s 
##41 
[SEP] 
an 
i 
##cu 
length 
stay 
shorter 
24 
h 
related 
group 
c 
error 
[CLS] 
ship 
cat 
##aly 
##zes 
conversion 
p 
##hos 
##oi 
3 
##i 
##3 
##k 
product 
p 
3 
3 4 
5 
t 
##ris 
##3 
p 
3 
4 
bi 
##phate 
##phate [SEP] 
like 
p 
##thi 
##xen 
##e 
c 
##ro 
##he 
##pta 
##dine 
antagonist 
##dy 
m 
procedure 
fraction 
g 
##cos 
##ide 
be 
separated 
si 
sugar 
clone 
genetic 
de 
##ter 
##mina 
o 
biological 
the 
web 
gene 
1 
52 
ho 
dependent 
at 
##pas 
[SEP] 
[CLS] 
evidence 
at 
##1 
activate 
transcription 
factor 
s 
##9 
##1 
related 
protein 
[CLS] 
there 
91 
con 
##cor 
##dance 
s 
r 
##d 
##i 
##i l 
##rd 
201 
##tl 
r 
s 
n 
n in 
inf 
re 
##vers 
##ibility 
##ibility [SEP] 
[CLS] 
two 
complex 
detected 
similar 
activation 
kinetic 
upon 
il 
4 
stimulation 
result 
da 
##lut 
##cor 
##pore 
##al 
circulation 
these 
prefer 
##ential 
##al 
type 
expression 
b 
##b 
regulatory 
pregnancy 
associated 
##al 
e 
##pit 
gene 
expression 
[SEP] 
[CLS] 
s 
##pen 
known 
home 
##otic 
##p 
binding 
motif 
indicates 
s 
##licing 
transport 
r 
regulatory 
step 
involved 
divers 
##ification 
segment 
##al 
morphology 
morphology [SEP] 
long 
term 
follow 
kidney 
donor 
longitudinal 
study 
study [SEP] 
##oly 
[CLS] 
conclusion 
the 
present 
study 
showed 
possible 
modified 
s 
##tro 
##op 
task 
measure 
imp 
##licit 
processing 
alcohol 
stimulus 
stimulus [SEP] 
patient 
patient 24 
developed 
se 
##psis 
one 
survived 
survived [SEP] 
[CLS] 
none 
10 
sequence 
hit 
##her 
recognized 
part 
##53 
signaling 
pathway 
[CLS] 
the 
pro 
##mpt 
praise 
condition 
superior 
two 
condition 
encouraging 
participation 
low 
interest 
recreational 
activity 
activity [SEP] 
[CLS] 
the 
majority 
human 
i 
heavy 
i 
region 
lo 
##cus 
clone 
##d 
mapped 
[CLS] 
we 
analyzed 
right 
size 
function 
##tl 
determine 
relationship 
##tl 
##to 
##yper 
##tens 
[CLS] 
the 
transcription 
##al 
start 
site 
i 
##a 
2 
gene 
mapped 
5 
rapid 
am 
##p 
c 
##a 
end 
97 
b 
##p 
upstream 
translation 
##al 
start 
site 
[SEP] 
[CLS] 
the 
rag 
gene 
en 
component 
re 
##comb 
##inas 
essential 
assembly 
assembly anti 
receptor 
gene 
b 
l 
##yte 
the 
la 
den 
##sa 
always 
interrupted 
numerous 
small 
gap 
area 
basement 
membrane 
could 
identified 
long 
distance 
characterized 
21 
mutation 
co 
##lla 
gene 
##1 
fi 
##bri 
##l 
15 
15 unrelated 
##cess 
##cessive 
d 
##ys 
##tro 
r 
##b 
[CLS] 
the 
data 
used 
stimulate 
collection 
information 
##ena 
##nat 
nonetheless 
description 
3 
mortality 
trend 
difference 
two 
period 
examined 
1984 
1989 
conserved 
three 
absent 
one 
substrate 
r 
##s 
##bt 
##i 
##z 
##b 
bear 
one 
terminal 
domain 
there 
good 
occurrence 
contract 
intrinsic 
tone 
10 
6 
m 
[CLS] 
both 
at 
1 
100 
litre 
litre 1 
la 
##nos 
1 
50 
1 
enhanced 
release 
3 
##h 
na 
e 
##voked 
field 
stimulation 
h 
##z 
24 
stimulus 
affect 
resting 
release 
release [SEP] 
16 
8 
p 
00 
##1 
[CLS] 
the 
15 
d 
binding 
domain 
comprises 
three 
zinc 
finger 
separated 
unusually 
long 
link 
##er 
sequence 
would 
expected 
interrupt 
specific 
d 
site 
recognition 
[SEP] 
[CLS] 
replication 
region 
plant 
path 
s 
##yr 
##mi 
##d 
similar 
co 
##le 
##2 
related 
re 
##p 
##ons 
[SEP] 
there 
toxicity 
repeated 
5 
f 
ins 
air 
##way 
[CLS] 
twenty 
male 
volunteer 
al 
##mo 
in 
##fusion 
aiming 
plasma 
concentration 
c 
##p 
##l 
20 
50 
100 
150 
nm 
##ol 
l 
[SEP] 
in 
##hibit 
##1 
d 
binding 
##ro 
##del 
mutation 
increase 
level 
##l 
##1 
protein 
promoter 
element 
v 
##ivo 
[CLS] 
the 
response 
sequence 
localized 
67 
30 
si 
i 
ie 
##9 
##4 
promoter 
upstream 
position 
9 
##6 
##68 
promoter 
[CLS] 
some 
ch 
##op 
c 
##b 
he 
##tero 
##di 
##mers 
apparently 
bind 
alternative 
d 
sequence 
thereby 
regulate 
transcription 
gene 
[SEP] 
determine 
##p 
gal 
##os 
##idas 
[CLS] 
b 
##lot 
regulated 
expression 
14 
gene 
[SEP] 
typical 
representation 
du 
##bar 
others 
specific 
addition 
n 
##h 
##4 
1 
1 
s 
##lator 
1 
0 
mg 
1 
1 
level 
##e 
50 
no 
##3 
medium 
##iovascular 
drug 
hospital 
at 
##tri 
##but 
type 
diabetes 
[CLS] 
the 
arrangement 
amino 
acid 
he 
1 
he 
2 
region 
quite 
similar 
m 
##xi 
mad 
different 
e 
e2 
##f 
1 
d 
##p 
1 
[SEP] 
[CLS] 
they 
contain 
large 
0 
9 
x 
10 
3 
1 
88 
x 
10 
3 
base 
pair 
intro 
##n 
middle 
gene 
interrupted 
close 
5 
end 
gene 
[SEP] 
the 
present 
emphasizes 
establishing 
dose 
response 
curve 
correctly 
ass 
relative 
contribution 
region 
s 
##id 
hormone 
receptor 
activation 
[CLS] 
default 
re 
##eval 
home 
visit 
ma 
##ximal 
drug 
compliance 
compliance [SEP] 
[CLS] 
d 
long 
c 
[CLS] 
by 
##a 
1 
1 
deleted 
##d 
##f 
larger 
deficiency 
examined 
gene 
closer 
150 
k 
##b 
[CLS] 
accordingly 
con 
##it 
##utive 
down 
##re 
##gu 
##lation 
expression 
access 
##ory 
molecule 
m 
mh 
##c 
class 
i 
pathway 
reveal 
difference 
difference h 
class 
i 
all 
anti 
presentation 
encountered 
expression 
level 
augmented 
[CLS] 
an 
##ov 
apparently 
normal 
blood 
pro 
##ct 
##in 
leg 
##ione 
##lla 
##body 
animal 
differential 
screening 
x 
library 
isolated 
2 
111 
b 
##p 
c 
##a 
corresponds 
maternal 
m 
mrna 
specifically 
dead 
f 
[SEP] 
similar 
##mu 
disturbance 
patient 
examined 
later 
6 
month 
month injury 
this 
flu 
##oso 
##l 
##ut 
ad 
##oto 
##vas 
##cular 
[CLS] 
electrical 
analog 
present 
analysis 
calculation 
parameter 
well 
corner 
frequency 
network 
f 
##1 
without 
similar 
assumption 
assumption [SEP] 
we 
examined 
interaction 
##ak 
c 
##op 
domain 
investigation 
[CLS] 
these 
##f 
complex 
present 
g 
##1 
cell 
low 
level 
elevated 
cell 
[CLS] 
there 
little 
similarity 
among 
sequence 
upstream 
cap 
site 
s 
##pec 
##2 
gene 
except 
ta 
##ta 
consensus 
sequence 
repeating 
t 
##uc 
##leo 
##tide 
a 
##ac 
[SEP] 
[CLS] 
thus 
delta 
##3 
care 
##ne 
four 
time 
potent 
sensory 
i 
##rri 
i 
beta 
pine 
difference 
i 
alpha 
pine 
##ne 
##ne marked 
sensory 
i 
##rri 
alpha 
pine 
inactive 
inactive [SEP] 
[CLS] 
##con 
r 
##na 
polymer 
##ase 
alpha 
subunit 
examined 
response 
transcription 
activation 
camp 
##rp 
##b 
##1 
up 
element 
[SEP] 
drug 
combination 
##in 
##blast 
##ine 
cc 
##nu 
single 
agent 
t 
##zin 
##ate 
da 
##tum 
##or 
activity 
patient 
patient advanced 
re 
##nal 
cell 
cancer 
[CLS] 
result 
##4 
contains 
two 
activation 
domain 
similar 
function 
independently 
promote 
high 
level 
transcription 
target 
gene 
##3 
##4 
diagnosed 
affect 
##ive 
disorder 
disorder n 
96 
according 
d 
criterion 
compared 
affect 
##ive 
suicide 
attempt 
##er 
161 
161 [SEP] 
[CLS] 
tax 
demonstrated 
interact 
directly 
##b 
##1 
protein 
including 
##b 
##2 
##xi 
##rin 
patient 
##per 
##fusion 
kidney 
current 
status 
future 
direction 
direction [SEP] 
[CLS] 
dial 
transfer 
factor 
factor [SEP] 
##rb 
##1 
mutant 
re 
##fra 
##ctor 
##y 
cell 
cycle 
intact 
intact e 
e1 
##a 
binding 
property 
re 
##press 
##ae 
50 
80 
fold 
##rb 
##1 
subgroup 
analysis 
et 
##os 
##ide 
patient 
##elo 
disease 
diagnostic 
subgroup 
the 
i 
1 
bind 
alpha 
beta 
form 
he 
##pa 
nuclear 
factor 
3 
3 
##fold 
relative 
affinity 
[CLS] 
fragment 
shown 
aggregate 
nucleus 
c 
##op 
cell 
death 
expressed 
cell 
leading 
proposal 
p 
a 
##gg 
step 
path 
##esis 
[PAD] [CLS] 
it 
suggested 
presentation 
tail 
tip 
ne 
nec 
##rosis 
kit 
diagnosis 
neon 
##ata 
##l 
##l is 
##rol 
##ys 
is 
considered 
[CLS] 
micro 
##scopic 
cart 
marked 
stunt 
##ed 
di 
##ganized 
end 
##och 
##ond 
##ral 
o 
##ssi 
##fication 
[CLS] 
differential 
s 
##licing 
extra 
region 
gene 
generates 
receptor 
variant 
different 
l 
##igan 
##d 
binding 
specific 
##ity 
[SEP] 
[CLS] 
su 
##c 
##rose 
specific 
signalling 
re 
##press 
##es 
translation 
translation a 
##ido 
transcription 
factor 
gene 
[SEP] 
wolf 
hi 
##rsch 
##horn 
syndrome 
##lf 
##orm 
##ation 
syndrome 
hem 
##iz 
##go 
del 
##eti 
di 
##stal 
chromosome 
4 
4 
##p 
our 
aim 
check 
d 
administration 
serum 
lip 
##ase 
change 
simultaneously 
serum 
am 
##yla 
##ylase 
activity 
reason 
detected 
change 
change [SEP] 
a 
long 
term 
follow 
psychiatric 
day 
treatment 
[CLS] 
se 
##quencing 
restriction 
enzyme 
analysis 
single 
copy 
gene 
contains 
11 
ex 
##on 
span 
95 
##9 
base 
pair 
[SEP] 
m 
##dl 
72 
97 
conventional 
therapy 
consensus 
exists 
con 
##dict 
##ory 
[CLS] 
the 
effect 
nm 
##da 
receptor 
antagonist 
##pp 
conditioned 
reflex 
activation 
opera 
##nt 
reaction 
brain 
electrical 
self 
rat 
[SEP] 
[CLS] 
cell 
several 
t 
##fs 
co 
expressed 
[CLS] 
construct 
containing 
fragment 
upstream 
region 
##ota 
gene 
fused 
promoter 
##less 
gene 
##ran 
##fer 
trans 
##ly 
trans 
em 
##bro 
define 
functional 
promoter 
sequence 
[SEP] 
we 
investigated 
pattern 
evolution 
##ga 
i 
patient 
relation 
no 
##com 
##ial 
pneumonia 
pneumonia [SEP] 
[CLS] 
mortality 
patient 
##b 
still 
high 
declined 
within 
last 
decade 
decade [SEP] 
[CLS] 
mutation 
away 
s 
##p 
##lice 
site 
recognition 
sequence 
might 
c 
##i 
m 
##od 
##ulate 
alternative 
s 
##licing 
goat 
alpha 
s 
##1 
case 
##in 
trans 
##cript 
[SEP] 
setting 
a 
based 
fertility 
program 
[CLS] 
promoter 
s 
##p 
##lice 
##d 
leader 
coding 
sequence 
bi 
##p 
##4 
largest 
immediate 
early 
b 
##ov 
##ovine 
her 
1 
[SEP] 
[CLS] 
the 
limb 
defect 
o 
##go 
##da 
##ct 
##yl 
##y 
s 
##yn 
##da 
##ct 
##yl 
##y 
traced 
imp 
##roper 
differentiation 
##pical 
e 
##ct 
##ode 
##rmal 
ridge 
a 
##er 
short 
##ening 
ant 
##ero 
##eri 
##or 
limb 
axis 
z 
##f 
h 
##d 
class 
##od 
protein 
may 
establishment 
characteristic 
expression 
pattern 
c 
##4 
##case 
gene 
there 
correlation 
plate 
##let 
##gg 
level 
##let 
level 
in 
##ment 
plate 
##let 
count 
whether 
w 
##t 
##1 
s 
##lice 
variant 
lacking 
including 
three 
amino 
acid 
k 
##t 
insertion 
third 
fourth 
zinc 
d 
binding 
domain 
could 
re 
##press 
i 
##r 
promoter 
##ro 
[SEP] 
o 
##go 
##mer 
synthesized 
region 
ho 
##mology 
produced 
two 
d 
protein 
complex 
o 
nuclear 
protein 
[CLS] 
the 
de 
##duced 
amino 
acid 
sequence 
exhibit 
95 
3 
76 
1 
identity 
ca 
##d 
sequence 
##ms 
sq 
##can 
##as 
[SEP] 
[CLS] 
trans 
##1 
go 
gol 
##gi 
observed 
##1 
co 
##ex 
##pressed 
n 
##sm 
although 
##sm 
still 
go 
gol 
##gi 
##gi [SEP] 
since 
si 
protein 
bind 
regulatory 
factor 
protein 
complement 
##1 
defect 
early 
gene 
activation 
[CLS] 
repression 
promoter 
40 
fold 
2 
amino 
acid 
sequence 
##rs 
##47 
reporter 
containing 
he 
##xa 
##mer 
##ic 
e 
box 
site 
used 
[SEP] 
similar 
##uta 
trans 
co 
##tra 
##ns 
##v 
##1 
shear 
bond 
system 
lower 
17 
m 
##pa 
400 
b 
##p 
fragment 
b 
##p 
33 
##9 
71 
##d 
##22 
promoter 
region 
sub 
##c 
##lone 
##d 
p 
pge 
##m 
##ty 
##lt 
##ran 
##s 
##fer 
##ase 
vector 
trans 
##fect 
cell 
active 
t 
cell 
result 
difference 
mean 
serum 
ratio 
hem 
hem 
might 
affect 
serum 
maternal 
age 
g 
b 
##mi 
##esta 
hem 
##ato 
blood 
group 
different 
sample 
i 
ir 
##64 
i 
ir 
seed 
##er 
total 
de 
##hy 
##dr 
##ogen 
##ase 
sugar 
##yl 
##ose 
content 
trans 
electro 
##ore 
r 
p 
either 
pro 
##ific 
[CLS] 
thus 
wide 
art 
##erial 
dimension 
result 
obtained 
estimate 
l 
##umi 
##nal 
area 
diameter 
##r 
70 
system 
1 
year 
predict 
[CLS] 
we 
reviewed 
different 
case 
acute 
high 
dose 
##uro 
##xi 
different 
underlying 
mechanism 
drug 
therapy 
directed 
reducing 
amount 
di 
##ff 
##ici 
co 
##lon 
promoting 
normal 
in 
##test 
##inal 
flora 
the 
incidence 
d 
##p 
group 
patient 
[SEP] 
level 
pulmonary 
1 
07 
0 
28 
right 
at 
1 
02 
0 
28 
peripheral 
1 
12 
0 
23 
peripheral 
1 
14 
0 
0 38 
f 
##mo 
m 
an 
##gin 
1 
00 
0 
32 
##mo 
m 
1 
01 
0 
29 
##mo 
m 
[CLS] 
dose 
dependent 
p 
##har 
##co 
##kin 
##etics 
emphasis 
phase 
i 
metabolism 
d 
top 
##ois 
##omer 
alpha 
gene 
expression 
##53 
tumor 
suppress 
[CLS] 
activation 
hi 
gene 
cellular 
process 
triggered 
d 
damage 
generation 
full 
gene 
response 
response [SEP] 
[CLS] 
[CLS] 4 
[PAD] [CLS] 
per 
easily 
mi 
##ter 
##p 
##ret 
der 
##mat 
[CLS] 
lip 
d 
##mi 
##d 
maintenance 
supplied 
several 
sub 
together 
form 
active 
##oso 
##rome 
##re 
[SEP] 
in 
second 
clinical 
paper 
genetic 
feature 
case 
##ph 
##thal 
sheep 
##na 
##ar 
discussed 
greater 
detail 
[CLS] 
reveals 
consequence 
##hesion 
signaling 
regulation 
cell 
activation 
##yt 
##oki 
pro 
many 
controlled 
3 
au 
rich 
element 
the 
gap 
kn 
##ir 
media 
##nch 
direct 
##ros 
##op 
##b 
[CLS] 
family 
history 
obtained 
parent 
parent [SEP] 
[CLS] 
the 
d 
direction 
uniform 
sampled 
diffusion 
el 
surface 
surface [SEP] 
[CLS] 
##d 
##40 
receptor 
stimulation 
primary 
b 
cell 
result 
trans 
##act 
##ivation 
enhance 
##r 
[SEP] 
[CLS] 
this 
productive 
##ly 
rear 
##ranged 
im 
gene 
well 
2 
gene 
high 
level 
comparable 
activated 
s 
b 
cell 
[CLS] 
the 
relationship 
##s 
##f 
##mat 
##ost 
##ati 
peripheral 
thy 
##roid 
hormone 
affect 
##ively 
##ba 
treatment 
[CLS] 
both 
r 
gene 
clone 
##d 
multi 
##copy 
p 
##las 
##mi 
##d 
able 
suppress 
temperature 
sensitive 
strain 
either 
mutation 
encoded 
protein 
could 
interact 
treatment 
two 
ad 
##ren 
##oc 
##ort 
##ico 
##tro 
##phi 
act 
##h 
preparation 
given 
in 
##tra 
##mus 
##cular 
2 
2 u 
one 
preparation 
in 
##mus 
1 
##pt 
te 
##tra 
##cos 
##rin 
co 
##rop 
given 
in 
##ven 
##gram 
kg 
[CLS] 
change 
due 
mechanical 
effect 
in 
##ject 
h 
##yper 
solution 
m 
##t 
141 
rate 
70 
130 
m 
##l 
dog 
dog [SEP] 
[CLS] 
it 
it well 
well known 
giant 
##eri 
cause 
fatal 
com 
##plication 
due 
r 
##up 
a 
##ort 
##ic 
an 
##eur 
##ys 
cerebral 
##oc 
##ard 
##ial 
in 
##far 
##ction 
##ction [SEP] 
[CLS] 
p 
contains 
two 
two l 
##x 
##ll 
signature 
motif 
[PAD] [CLS] 
basal 
##rina 
##ry 
17 
h 
##ydro 
##cor 
##tic 
oh 
##cs 
value 
elevated 
9 
12 
patient 
dose 
de 
##has 
suppression 
favoured 
cu 
##shing 
syndrome 
syndrome 8 
9 
patient 
like 
human 
gene 
d 
##ros 
##op 
gene 
en 
least 
three 
full 
d 
##ys 
d 
##dl 
##1 
d 
##dl 
##2 
d 
##m 
##dl 
##3 
regulated 
different 
promoter 
located 
5 
end 
gene 
smaller 
product 
regulated 
internal 
promoter 
d 
##d 
[CLS] 
accordingly 
infection 
he 
s 
##3 
cell 
##3 
##l 
def 
##del 
##3 
level 
##r 
##al 
##pha 
the 
goal 
work 
determine 
threshold 
hereditary 
motor 
##uro 
i 
[CLS] 
influence 
diet 
##ary 
supplement 
s 
##tre 
##ci 
m 
74 
br 
##oil 
body 
weight 
feed 
conversion 
characteristic 
in 
##test 
##inal 
micro 
##bial 
colonization 
[SEP] 
[CLS] 
the 
result 
reveal 
preference 
particular 
in 
##iti 
##ating 
n 
##leo 
##tide 
at 
##p 
##t 
##p 
##t 
##p 
c 
##t 
##p 
starting 
position 
downstream 
##b 
box 
7 
6 
8 
9 
10 
trim 
##yl 
##chi 
ta 
##rate 
t 
##m 
36 
##35 
##1 
daily 
mouth 
patient 
patient ma 
l 
##ymph 
##ymphoma 
[CLS] 
gene 
trans 
##cript 
detected 
tissue 
b 
liver 
kidney 
lung 
brain 
brain [SEP] 
[CLS] 
assessment 
am 
##monia 
u 
##rea 
blood 
content 
metabolic 
acid 
base 
disorder 
rat 
[CLS] 
the 
immediate 
remote 
surgical 
##nal 
##eno 
##cin 
##oma 
##oma [SEP] 
[CLS] 
iron 
ha 
##em 
gene 
linked 
one 
two 
set 
set ton 
##b 
ex 
##bb 
ex 
##b 
##d 
gene 
[SEP] 
[CLS] 
the 
predicted 
amino 
acid 
sequence 
includes 
n 
terminal 
signal 
sequence 
27 
amino 
acid 
27 
amino 
acid 
pro 
region 
251 
amino 
acid 
cat 
##alytic 
domain 
typical 
se 
serine 
pro 
##te 
##ase 
try 
##ps 
##in 
like 
specific 
c 
terminal 
terminal h 
extension 
predicted 
function 
membrane 
anchor 
[SEP] 
[CLS] 
examine 
bio 
##chemical 
mechanism 
tax 
##1 
trans 
##act 
##ivation 
developed 
##it 
##ro 
trans 
##act 
##ivation 
ass 
tax 
##1 
able 
specifically 
trans 
##act 
##ivate 
polymer 
##ase 
ii 
promoter 
upstream 
tax 
##1 
element 
[SEP] 
interesting 
pro 
##te 
##oly 
substantial 
i 
##3 
[CLS] 
thus 
therapy 
anti 
##ox 
##ida 
effect 
increasing 
##d 
activity 
r 
##a 
blood 
cell 
reducing 
highly 
reactive 
oxygen 
form 
reactive 
me 
##so 
cell 
usually 
seen 
ex 
consistently 
strongly 
positive 
alpha 
1 
##chy 
##ry 
var 
##iably 
alpha 
1 
##oz 
##yme 
prop 
mutation 
one 
three 
three 
inhibitor 
prop 
##eptide 
the 
highest 
observed 
al 
##oly 
100 
followed 
para 
##vial 
34 
34 67 
fur 
##nis 
mimic 
0 
0 8 
[CLS] 
acute 
m 
##or 
##phine 
increase 
lo 
##com 
##oto 
##r 
activity 
mouse 
withdrawn 
1 
day 
withdrawal 
3 
day 
increase 
similar 
control 
5 
day 
increase 
clearly 
larger 
control 
[PAD] [CLS] 
t 
##b 
##yt 
##oki 
serum 
if 
gamma 
il 
6 
il 
10 
10 [SEP] 
isolation 
property 
##ros 
##op 
##hil 
##lan 
##oga 
##rit 
molecular 
##lon 
en 
one 
subunit 
local 
##ization 
gene 
third 
chromosome 
[CLS] 
f 
##o 
regulate 
##s 
immediate 
early 
gene 
c 
##o 
e 
##r 
1 
1 e 
##r 
2 
mit 
[SEP] 
link 
alter 
##ation 
##let 
derived 
regulation 
##ni 
##thin 
##e 
de 
##car 
##yla 
##c 
ma 
conversion 
circulating 
immune 
complex 
determined 
method 
[CLS] 
the 
human 
##i 
gene 
member 
inter 
##fer 
in 
mouse 
human 
gene 
closely 
linked 
##yn 
##ten 
chromosome 
1 
[CLS] 
in 
model 
elimination 
##am 
c 
##yt 
##op 
##las 
##mic 
domain 
increased 
developmental 
alter 
at 
##tri 
##but 
##am 
pro 
##te 
##oly 
##tic 
activity 
[CLS] 
di 
##abe 
o 
##ste 
##op 
##athy 
a 
third 
##3 
k 
##0 
##08 
##46 
activated 
##1 
##1 shared 
sequence 
ho 
##mology 
calcium 
di 
##gly 
##ol 
activated 
##s 
##1 
##2 
quantitative 
[CLS] 
comparison 
defect 
##ive 
h 
##v 
i 
pro 
##virus 
predict 
mode 
origin 
internally 
deleted 
genome 
reversal 
bi 
##lia 
spa 
dose 
g 
##lu 
##ca 
##gon 
operative 
##ola 
##io 
[SEP] 
[CLS] 
shown 
##1 
gene 
required 
s 
##por 
##ulation 
expression 
me 
##ios 
##is 
specific 
gene 
sa 
##cc 
##har 
##ces 
c 
##ere 
##vis 
##iae 
[PAD] [CLS] 
comparison 
acquired 
immune 
deficiency 
syndrome 
aid 
homosexual 
spin 
end 
##oth 
##eli 
abnormal 
re 
me 
##ido 
[CLS] 
in 
injection 
volume 
alpha 
ad 
##ren 
ago 
x 
##yla 
##zine 
c 
##lon 
##id 
c 
##er 
##vic 
##al 
region 
spinal 
conscious 
##rain 
sheep 
dose 
dependent 
anal 
##ges 
fore 
##lim 
measured 
mechanical 
device 
[CLS] 
second 
c 
##a 
containing 
sequence 
placed 
88 
delta 
m 
mt 
cat 
reporter 
##mi 
##d 
conferred 
insulin 
re 
tumor 
promoter 
in 
f 
##o 
gene 
expression 
f 
##o 
protein 
appears 
replaced 
protein 
f 
##o 
##ra 
1 
1 at 
##f 
at 
##fa 
[SEP] 
[CLS] 
the 
do 
##pa 
d 
##1 
do 
##pa 
antagonist 
s 
233 
##90 
dose 
dependent 
5 
30 
micro 
##gram 
ant 
##agon 
s 
##ti 
##mu 
##lant 
lo 
##com 
##oto 
##r 
effect 
drug 
prevent 
##im 
##mo 
##bility 
effect 
behavioral 
despair 
test 
[SEP] 
[CLS] 
the 
result 
obtained 
show 
expression 
gene 
low 
23 
degree 
c 
induced 
rapidly 
37 
degree 
c 
c [SEP] 
characterization 
ch 
##omo 
re 
rein 
##got 
specific 
en 
protein 
containing 
an 
domain 
[SEP] 
[CLS] 
ad 
##eno 
##ma 
upper 
gas 
##tro 
##est 
##inal 
tract 
found 
patient 
v 
##ater 
12 
duo 
##den 
##um 
nine 
gas 
##tric 
ant 
##rum 
seven 
[CLS] 
##on 
##ments 
dominated 
c 
##ob 
##eria 
b 
##p 
##c 
higher 
7 
7 8 
dominated 
l 
##iche 
l 
5 
5 
5 
5 [SEP] 
a 
total 
64 
##plicate 
##d 
type 
di 
##abe 
individual 
higher 
middle 
class 
rich 
studied 
studied [SEP] 
drop 
ace 
##tate 
vehicle 
constituent 
di 
##sse 
##ssected 
plant 
##ar 
nerve 
pro 
##ximal 
s 
##ti 
##mulating 
electro 
##de 
recording 
control 
response 
fibre 
vol 
s 
##cia 
nerve 
c 
fibre 
fibre e 
evoked 
reflex 
discharge 
##ex 
##or 
m 
##oto 
##uron 
[CLS] 
basic 
he 
act 
e 
box 
within 
serum 
element 
f 
##o 
promoter 
hormone 
promoter 
activation 
se 
##rt 
##oli 
[SEP] 
using 
yeast 
two 
##3 
interacting 
factor 
c 
##ia 
concentration 
co 
cu 
m 
mn 
se 
milk 
11 
help 
instrumental 
radio 
##chemical 
neutron 
activation 
activation analysis 
[CLS] 
gal 
##lston 
##e 
formation 
attributed 
bi 
##ole 
##ster 
##ol 
[SEP] 
patient 
maintenance 
hem 
##od 
##ial 
##ys 
dial 
##ys 
##rop 
membrane 
1 
switched 
second 
week 
[CLS] 
gene 
expression 
part 
controlled 
ch 
##roma 
##tin 
re 
##mo 
##del 
factor 
state 
[SEP] 
5 
13 
further 
##more 
##a 
##a g 
exchange 
factor 
##1 
primarily 
n 
terminal 
##3 
domain 
re 
##pis 
##od 
l 
##ymph 
impaired 
cellular 
immunity 
immunity [SEP] 
after 
3 
month 
intervention 
physical 
training 
1 
level 
[CLS] 
thirty 
elevated 
t 
##iter 
1 
20 
di 
##lution 
##4 
dominant 
##ly 
inherited 
rice 
gene 
gene con 
##fers 
resistance 
race 
1 
bacterial 
b 
##light 
path 
##ogen 
##ogen x 
or 
##za 
##za 
rice 
[SEP] 
[CLS] 
##rae 
similar 
maximum 
serum 
concentration 
found 
single 
7 
5 
mg 
kg 
i 
##v 
dose 
the 
effect 
but 
su 
b 
##so 
di 
##sul 
##fi 
d 
##s 
##rot 
##ox 
##icit 
##mi 
c 
##pa 
examined 
mouse 
[CLS] 
all 
previously 
mapped 
structural 
protein 
encoding 
gene 
p 
ll 
h 
included 
sequence 
[SEP] 
[CLS] 
when 
longer 
71 
##4 
78 
fragment 
##d 
promoter 
70 
mutant 
still 
display 
er 
##hr 
##oid 
activated 
h 
2 
enhance 
##r 
100 
mutant 
completely 
inactive 
absence 
presence 
enhance 
##r 
surprisingly 
adult 
su 
##pra 
##bas 
d 
##r 
##x 
##r 
alpha 
ability 
t 
stimulate 
##iff 
k 
##era 
basal 
layer 
e 
##pid 
##er 
##mis 
in 
many 
contract 
##ile 
gene 
cardiac 
##of 
expressed 
early 
skeletal 
muscle 
development 
later 
re 
##pressed 
[CLS] 
1995 
[CLS] 
for 
##ra 
formed 
two 
ex 
##on 
whereas 
##rb 
distinct 
##ut 
##rna 
formed 
alternative 
s 
##p 
##licing 
11 
ex 
##on 
##oc 
##ard 
remains 
life 
threatening 
disease 
substantial 
m 
##or 
##bid 
mortality 
mortality [SEP] 
the 
gene 
encoding 
cell 
##ula 
##se 
##lase 
c 
##el 
##1 
s 
##omy 
##ces 
re 
##tic 
##uli 
analysis 
domain 
from 
sequence 
at 
novel 
subfamily 
se 
ser 
##r 
##ks 
plant 
plant [SEP] 
[CLS] 
of 
23 
13 
6 
due 
##ib 
upper 
##ib 
19 
##ib 
4 
4 [SEP] 
[CLS] 
the 
e 
multi 
##loc 
##ular 
##gol 
##er 
system 
replace 
natural 
can 
##id 
host 
new 
in 
##fect 
egg 
analyze 
parasite 
interaction 
interaction [SEP] 
[CLS] 
e 
##1 
recognition 
sequence 
origin 
d 
replication 
interaction 
half 
site 
inverted 
repeat 
we 
secret 
ch 
##iti 
##no 
##ly 
enzyme 
l 
major 
parasite 
in 
##hibit 
blood 
hem 
##og 
enzyme 
apparently 
absent 
blood 
fed 
infected 
cardiac 
valve 
appears 
und 
##ama 
##ged 
patient 
m 
##uc 
##ino 
c 
##ys 
ca 
125 
##ys 
##tic 
level 
end 
##oma 
##omas 
der 
##mo 
l 
lt 
##t 0 
05 
sat 
##b 
##1 
interact 
##ed 
##d 
d 
binding 
domain 
demonstrated 
##ath 
s 
transfer 
[CLS] 
plasma 
pro 
##ct 
##in 
##ale 
##ct 
e 
me 
##lat 
##oni 
##n 
##al 
intact 
e 
maintained 
24 
hour 
photo 
##per 
##io 
##d 
it 
targeted 
per 
##ox 
##is 
##ome 
##s 
expressed 
##mmal 
yeast 
[CLS] 
the 
transcription 
##al 
start 
site 
identified 
prime 
##r 
extension 
s 
##1 
##uc 
##lea 
34 
n 
##t 
upstream 
translation 
initiation 
co 
##don 
[SEP] 
##linear 
##ities 
##r 
##ydro 
##dynamic 
electronic 
structure 
optical 
b 
##12 
##o 
##2 
crystal 
[CLS] 
s 
##po 
##ng 
##ios 
regeneration 
##ip 
##ore 
chamber 
[CLS] 
predicted 
5 
3 
trans 
##cript 
determined 
size 
##3 
message 
[SEP] 
this 
##a 
correspond 
##ed 
##ed f 
binding 
secret 
bind 
basic 
basic f 
m 
##ulate 
activity 
[CLS] 
analysis 
replica 
##tive 
intermediate 
##mi 
##d 
contains 
ch 
##rom 
##oso 
##mal 
replica 
##tor 
##rs 
##1 
initiate 
bid 
##ire 
##ctional 
replication 
100 
b 
##p 
region 
within 
sequence 
required 
autonomous 
replication 
v 
##ivo 
[SEP] 
[CLS] 
such 
result 
suggest 
difference 
b 
##m 
##r 
age 
weight 
matched 
as 
in 
male 
tropical 
population 
am 
##eric 
##an 
[CLS] 
reward 
property 
met 
##ni 
##date 
se 
##iti 
##zation 
prior 
exposure 
drug 
effect 
do 
##pa 
##mine 
d 
##1 
d 
receptor 
antagonist 
antagonist [SEP] 
similar 
observed 
put 
mutant 
##ug 
90 
reduction 
r 
##po 
##s 
promoter 
mutant 
could 
complement 
##ed 
r 
##po 
##s 
promoter 
gene 
provided 
trans 
mutant 
pseudo 
##mona 
s 
##ie 
lost 
induce 
r 
##po 
##s 
expression 
stationary 
phase 
retained 
##rum 
auto 
the 
role 
##ative 
c 
##2 
domain 
ne 
##dd 
##4 
el 
##uc 
##idated 
##7 
specifically 
bind 
##1 
##1 
element 
higher 
##1 
element 
increase 
th 
##rom 
##box 
##ane 
evidenced 
major 
meta 
##bol 
3 
din 
##ort 
##hr 
##omb 
##ox 
##ane 
b 
o 
##ec 
##tom 
group 
group [SEP] 
##var 
log 
##istic 
re 
showed 
blood 
glucose 
level 
first 
2 
day 
00 
##2 
o 
##besity 
00 
002 
independent 
predict 
##or 
deep 
wound 
infection 
however 
precise 
function 
d 
##k 
d 
double 
strand 
break 
[CLS] 
new 
receptor 
receptor to 
##r 
thy 
##mus 
closely 
related 
d 
binding 
domain 
l 
##igan 
##d 
binding 
domain 
90 
53 
respectively 
r 
##or 
alpha 
r 
##z 
##r 
alpha 
cluster 
two 
receptor 
##z 
##r 
beta 
phylogenetic 
tree 
d 
binding 
domain 
##igan 
##d 
binding 
domain 
sequence 
receptor 
compared 
[SEP] 
in 
examined 
whether 
p 
##1 
effect 
transformation 
induced 
##21 
##0 
##r 
##b 
##bl 
[CLS] 
s 
##1 
n 
##uc 
##lea 
##se 
analysis 
r 
number 
l 
##d 
clone 
similar 
result 
l 
##d 
population 
composed 
virus 
similar 
identical 
del 
##eti 
##on 
end 
##point 
[SEP] 
association 
s 
l 
##ymph 
enhance 
##r 
binding 
factor 
1 
specific 
factor 
media 
cooperative 
signaling 
transforming 
factor 
pathway 
pathway [SEP] 
[CLS] 
the 
three 
gene 
flanked 
marker 
##i 
106 
c 
d 
##22 
##9 
##3 
te 
##l 
contained 
within 
three 
set 
overlapping 
co 
##sm 
##id 
clone 
22 
patient 
found 
positive 
his 
corpus 
m 
##uc 
##osa 
one 
patient 
elevated 
circulating 
i 
##gg 
h 
p 
##yl 
##or 
##us 
group 
c 
in 
##hibit 
activation 
map 
response 
response activated 
##af 
effect 
upon 
c 
##af 
activity 
activity er 
##k 
activation 
##k 
[CLS] 
quasi 
##dia 
##tom 
##ic 
study 
l 
##y 
alpha 
producing 
h 
##2 
ne 
collision 
k 
##ev 
energy 
[SEP] 
[CLS] 
the 
n 
2 
terminus 
three 
protein 
contains 
p 
##oz 
domain 
conserved 
120 
amino 
acid 
motif 
involved 
transcription 
##al 
repression 
protein 
dim 
##eri 
##zation 
[SEP] 
[CLS] 
the 
isolation 
262 
additional 
all 
##ele 
##1 
##17 
suggests 
directly 
blocking 
d 
replication 
provide 
d 
damage 
response 
[CLS] 
mutant 
show 
defect 
basal 
level 
expression 
##r 
##1 
la 
##cz 
reporter 
construct 
g 
we 
##ly 
studied 
serum 
pro 
##ct 
##in 
##rl 
seizure 
patient 
however 
p 
##eptide 
1 
49 
63 
87 
bound 
alpha 
beta 
binding 
[CLS] 
value 
k 
##1 
v 
##d 
increased 
t 
##umour 
tissue 
[SEP] 
[CLS] 
mutation 
prefer 
limit 
compared 
total 
protein 
synthesis 
translation 
gene 
depends 
five 
##ga 
co 
##don 
e 
##da 
c 
##i 
re 
##press 
##or 
gene 
[CLS] 
five 
r 
##na 
trans 
##cript 
1 
2 
1 
##base 
##s 
mapped 
genome 
insect 
i 
##ride 
##scent 
type 
ch 
i 
##ride 
c 
genome 
coordinate 
0 
83 
0 
within 
e 
##cor 
##i 
d 
fragment 
f 
[CLS] 
other 
similar 
patient 
must 
found 
established 
co 
##llo 
##id 
c 
##ys 
##t 
part 
ne 
##vo 
##id 
basal 
cell 
##cin 
##oma 
syndrome 
portion 
3 
coding 
3 
##ns 
##lated 
region 
found 
missing 
7 
2 
4 
4 8 
k 
##b 
##o 
m 
##rna 
analysis 
in 
e 
##48 
##48 
##9 
removed 
along 
he 
##lix 
ne 
##gli 
##gible 
effect 
##t 
##p 
##d 
##p 
exchange 
ass 
potential 
role 
##a 
pathway 
leading 
er 
##k 
p 
##t 
##p 
##d 
##p 
exchange 
comparison 
[CLS] 
##hen 
##otypic 
trio 
##b 
cooperate 
regulating 
a 
##xon 
out 
##gro 
em 
##b 
##ryo 
##nic 
central 
nervous 
c 
##ns 
ca 
##sp 
##ase 
typically 
es 
##cher 
co 
system 
attendant 
activation 
pro 
##te 
##ase 
[SEP] 
[CLS] 
the 
gene 
encoding 
rat 
p 
##ept 
##idy 
##gly 
alpha 
amid 
##ase 
contains 
26 
protein 
coding 
ex 
##on 
[CLS] 
this 
bound 
3 
##h 
##op 
##ros 
##t 
high 
stimulate 
camp 
exposed 
ago 
##nist 
##nist [SEP] 
[CLS] 
structure 
connect 
##ive 
s 
##trom 
##a 
e 
##idy 
z 
##eb 
##u 
protein 
s 
deficiency 
##che 
[PAD] [CLS] 
in 
series 
paper 
staging 
system 
##lan 
##coming 
identified 
identified [SEP] 
[CLS] 
reproduction 
maternal 
response 
rat 
th 
##iam 
##ine 
intake 
limited 
limited [SEP] 
me 
##so 
##ore 
ranged 
0 
00 
004 
0 
0 08 
cm 
##3 
1 
0 
33 
6 
9 
m 
m2 
1 
respectively 
accounting 
33 
bet 
surface 
[CLS] 
n 
##f 
ka 
##ppa 
p 
##100 
l 
##yt 
10 
p 
##9 
p 
##9 
generates 
pro 
##te 
##oly 
processing 
k 
##da 
subunit 
bind 
ka 
motif 
[CLS] 
conclusion 
the 
bio 
##dis 
111 
i 
similar 
99 
[PAD] [CLS] 
based 
29 
determination 
sin 
condition 
total 
g 
##cos 
##late 
determination 
94 
8 
7 
3 
receptor 
se 
th 
organized 
two 
distinct 
class 
known 
i 
ii 
basis 
sequence 
similarity 
transforming 
beta 
##1 
in 
##hibition 
promoter 
mapped 
inhibitor 
##y 
effect 
at 
atf 
site 
present 
if 
gamma 
functional 
trans 
##fect 
in 
##hibition 
promoter 
despite 
mutation 
at 
y 
c 
element 
[CLS] 
the 
r 
##sma 
mutant 
like 
parent 
n 
3 
o 
##oh 
ho 
##mos 
##eri 
la 
##cton 
##e 
h 
##l 
starvation 
cell 
density 
sensing 
signal 
required 
extra 
##cellular 
enzyme 
production 
[SEP] 
[CLS] 
the 
inactive 
x 
all 
##ele 
however 
##met 
##hyl 
##uk 
##yte 
presumably 
reflecting 
early 
x 
in 
##act 
##ivation 
event 
become 
important 
gene 
dos 
##age 
expressing 
lineage 
intensive 
therapy 
he 
[CLS] 
also 
r 
rv 
##w 
h 
##yper 
##tro 
h 
##yper 
##tro 
high 
pressure 
i 
iv 
may 
related 
high 
e 
##f 
abnormal 
chamber 
in 
p 
group 
group b 
bv 
[CLS] 
analysis 
d 
binding 
transcription 
##al 
activation 
function 
human 
fl 
1 
protein 
[SEP] 
[CLS] 
this 
pattern 
expression 
differential 
processing 
role 
in 
##k 
##1 
aspect 
s 
##d 
photo 
##per 
##io 
##dic 
induced 
flowering 
morning 
glory 
[SEP] 
progressive 
i 
##ga 
deficiency 
deficiency [SEP] 
[CLS] 
r 
##m 
##r 
positively 
correlated 
te 
tef 
r 
0 
61 
##3 
01 
net 
net te 
tef 
r 
0 
64 
648 
00 
l 
##ute 
##al 
f 
##icular 
phase 
##r 
spectrum 
##3 
##6 
single 
crystal 
dynamic 
##ahn 
tell 
##er 
effect 
[CLS] 
the 
terminal 
ex 
##on 
##1 
ho 
##mology 
acid 
level 
ng 
##fi 
b 
ma 
##mmal 
ho 
##mo 
##logue 
[SEP] 
[CLS] 
this 
paper 
describes 
longitudinal 
study 
clinical 
parameter 
as 
##par 
##tate 
amino 
##tra 
##ns 
##fer 
##ase 
as 
##ival 
##vic 
##f 
monitored 
bi 
6 
12 
month 
97 
site 
period 
##ont 
patient 
[CLS] 
observation 
3 
3 il 
ile 
element 
composite 
enhance 
##r 
function 
combined 
interaction 
least 
five 
regulatory 
element 
co 
##gnate 
binding 
factor 
three 
four 
e 
box 
me 
mef 
2 
site 
me 
mef 
3 
site 
[SEP] 
[CLS] 
the 
analysis 
1 
fitting 
first 
auto 
##re 
##ress 
model 
##r 
##1 
##r 
##2 
2 
obtaining 
spectrum 
data 
four 
##ier 
transform 
transform [SEP] 
112 
175 
within 
r 
binding 
##1 
70 
##k 
protein 
cross 
linked 
g 
28 
u 
30 
stem 
loop 
i 
respectively 
[CLS] 
k 
##ud 
##zu 
extract 
show 
mode 
##rating 
alcohol 
abuse 
further 
im 
##oto 
considerable 
patient 
patient [SEP] 
[CLS] 
b 
##c 
##v 
m 
##rna 
5 
1 
appear 
used 
synthesis 
12 
7 
9 
k 
##da 
protein 
respectively 
pattern 
expression 
striking 
##ly 
different 
[CLS] 
disaster 
[CLS] 
the 
longest 
s 
##1 
s 
##2 
interval 
s 
##2 
failed 
capture 
effective 
re 
##fra 
##ctor 
##y 
period 
longer 
5 
5 
5 8 
m 
##se 
##c 
twice 
0 
0 05 
05 le 
0 
0 10 
5 
5 
3 
m 
##se 
5 
time 
stimulation 
basic 
drive 
extra 
##st 
##im 
##uli 
delivered 
separate 
site 
site [SEP] 
so 
##matic 
cell 
hybrid 
ya 
con 
##ti 
##g 
te 
##lo 
##mer 
d 
##3 
##f 
lo 
region 
deleted 
lung 
car 
[CLS] 
experiment 
without 
polar 
##ization 
##ho 
##dic 
an 
##od 
##ic 
polar 
##ization 
ads 
##or 
##bent 
[SEP] 
[CLS] 
chronic 
active 
he 
##pa 
##r 
##hos 
liver 
[SEP] 
[CLS] 
regulation 
mediated 
kinase 
p 
specific 
residue 
different 
domain 
##53 
molecule 
[CLS] 
these 
processing 
specific 
target 
trans 
##cript 
p 
element 
m 
##rna 
regulated 
functional 
##i 
u 
##1 
##rn 
##p 
interaction 
##ros 
##op 
[SEP] 
[CLS] 
effect 
dim 
cooling 
rate 
##rain 
rat 
[CLS] 
in 
calf 
given 
given ha 
##emon 
##chus 
con 
##tor 
##tortus 
la 
##rva 
serum 
p 
##sin 
##ogen 
concentration 
rose 
quickly 
reach 
mean 
3 
5 
i 
t 
##yr 
##os 
day 
14 
infection 
these 
result 
strongly 
1 
infection 
in 
##hibit 
##s 
host 
cell 
s 
##licing 
action 
##27 
[SEP] 
##o 
##2 
related 
##co 
##co2 
0 
79 
1 
94 
##o 
95 
12 
12 4 
4 07 
[CLS] 
transformation 
em 
##b 
fi 
##bro 
gag 
fusion 
protein 
result 
elevation 
t 
p 
specific 
cellular 
protein 
molecular 
130 
000 
110 
000 
70 
000 
p 
##0 
p 
##70 
respectively 
event 
correlated 
cell 
transformation 
transformation [SEP] 
[CLS] 
u 
##rease 
activity 
judged 
amount 
am 
##monia 
u 
##rea 
could 
measured 
25 
ng 
per 
tube 
s 
n 
1 
5 
bean 
meal 
u 
##rease 
[SEP] 
[CLS] 
direct 
evidence 
##iot 
defect 
caused 
either 
##re 
##k 
activity 
##re 
##lated 
ran 
##1 
kinase 
due 
inability 
induce 
transcription 
gene 
required 
##iot 
initiation 
[SEP] 
optical 
rotation 
harmonic 
##tina 
b 
##eri 
##or 
##ho 
mon 
##omer 
b 
##dge 
##tt 
film 
evidence 
##p 
##lana 
##r 
re 
##tina 
##l 
structure 
##son 
replace 
##hr 
##ography 
k 
bi 
##cist 
##ronic 
vector 
selection 
##l 
##chi 
fold 
higher 
m 
##dr 
##1 
gene 
product 
##41 
string 
m 
##dr 
##1 
selection 
system 
efficient 
gene 
in 
health 
behavior 
investigated 
year 
98 
##1 
year 
three 
##ost 
##tts 
i 
##ic 
##ut 
[CLS] 
our 
analysis 
gene 
correction 
mechanism 
operating 
h 
##bbs 
chromosome 
keep 
beta 
beta 
evolving 
concert 
whereas 
##bb 
##d 
chromosome 
beta 
d 
diver 
##ged 
considerably 
beta 
d 
##j 
[CLS] 
structure 
regulation 
##d 
##2 
structural 
gene 
yeast 
di 
##hy 
##dr 
trans 
##lase 
[CLS] 
in 
de 
##dra 
ta 
degree 
c 
t 
e 
00 
##1 
normally 
h 
##yd 
state 
measured 
39 
9 
0 
2 
degree 
c 
0 
0 84 
0 
09 
w 
kg 
1 
respectively 
[CLS] 
y 
##y 
##1 
recognition 
sequence 
within 
d 
response 
element 
v 
##dre 
o 
##ste 
##al 
gene 
critical 
##1 
dependent 
repression 
d 
enhanced 
promoter 
activity 
back 
ground 
factor 
withdrawal 
type 
evaluation 
mode 
h 
##b 
##v 
transmission 
[CLS] 
point 
mutation 
s 
##tat 
##3 
within 
interacting 
domain 
blocked 
physical 
interaction 
s 
##tat 
##3 
c 
j 
cooperation 
il 
6 
transcription 
directed 
##rog 
enhance 
##r 
[PAD] [CLS] 
three 
patient 
##riz 
##zi 
type 
ii 
syndrome 
two 
patient 
##zi 
type 
i 
syndrome 
##aro 
##scopic 
##ally 
##ally [SEP] 
[PAD] [CLS] 
s 
##ync 
##hr 
##ono 
##us 
multi 
##centric 
giant 
t 
##umour 
report 
review 
literature 
literature [SEP] 
[CLS] 
from 
comparison 
nod 
box 
sequence 
bra 
##dy 
##zo 
##bi 
diver 
##gent 
nod 
box 
##zor 
##zo 
##bi 
ca 
##ulin 
##oda 
propose 
modular 
build 
nod 
box 
sequence 
a 
t 
c 
##9 
g 
a 
t 
binding 
target 
nod 
##d 
nod 
##d 
box 
[SEP] 
[CLS] 
the 
##x 
gene 
adjacent 
##q 
provides 
promoter 
##b 
expression 
[SEP] 
method 
disc 
##rim 
##ina 
function 
predict 
seizure 
seizure 
com 
separately 
n 
79 
right 
right n 
n 62 
temporal 
lobe 
##ct 
##tl 
rat 
[CLS] 
it 
likely 
recording 
incomplete 
actual 
number 
activated 
ne 
##uron 
estimated 
300 
acute 
se 
##ns 
##iti 
##zed 
preparation 
[SEP] 
the 
possibility 
diagnostic 
[CLS] 
genetic 
analysis 
role 
her 
g 
k 
infectious 
e 
##g 
[CLS] 
a 
conventional 
n 
terminal 
signal 
sequence 
detected 
nod 
##o 
protein 
[SEP] 
[CLS] 
dynamic 
expression 
broad 
complex 
is 
##of 
##orms 
media 
temporal 
control 
##c 
##ster 
target 
gene 
onset 
##ros 
##op 
meta 
##mor 
##ph 
##osis 
the 
study 
carried 
b 
##si 
recommendation 
##ora 
##ivo 
[CLS] 
##ys 
analyzed 
l 
##uc 
##ifer 
##ase 
beta 
gal 
##os 
##idas 
activity 
[CLS] 
##yt 
##oki 
s 
##id 
hormone 
use 
different 
set 
signal 
trans 
##duction 
pathway 
seem 
unrelated 
unrelated [SEP] 
[CLS] 
these 
finding 
pro 
##s 
##uo 
h 
at 
evolved 
parallel 
e 
##cter 
pro 
common 
ancestral 
gene 
underwent 
gene 
du 
##plication 
function 
trans 
acting 
dominant 
regulator 
transcription 
##al 
in 
hi 
terminal 
repeat 
contains 
two 
potential 
n 
##f 
binding 
site 
##bol 
in 
trans 
##d 
##4 
delta 
mutant 
[SEP] 
[CLS] 
in 
measurement 
shield 
##eld 
s 
##in 
##x 
containing 
99 
##m 
##t 
##c 
labelled 
radio 
carried 
carried [SEP] 
this 
test 
o 
##2 
critical 
component 
##oc 
##ard 
##ial 
protection 
##c 
##p 
[CLS] 
bio 
##mass 
growth 
co 
##current 
bio 
##fi 
[CLS] 
this 
alternative 
s 
##p 
##lice 
accept 
##or 
site 
also 
used 
biological 
pro 
##virus 
efficiency 
approximately 
5 
compared 
upstream 
site 
[SEP] 
ho 
much 
higher 
64 
28 
k 
##da 
protein 
region 
region strongly 
conserved 
se 
##rine 
pro 
##te 
[CLS] 
we 
isolated 
structural 
##ly 
characterized 
g 
##eno 
##mic 
d 
sequence 
encoding 
##ulos 
##e 
1 
5 
bi 
##box 
##yla 
oxygen 
##ase 
r 
car 
##box 
##yla 
act 
##iva 
bar 
##rde 
l 
expression 
put 
##ative 
con 
##it 
##utive 
##ly 
active 
form 
d 
##d 
##k 
##1 
##d 
##1 
background 
background capable 
least 
partially 
complement 
aggregate 
defect 
ability 
activate 
g 
##yl 
##yl 
c 
##c 
##lase 
slowing 
median 
ul 
morphology 
map 
##p 
observed 
case 
month 
[CLS] 
more 
##over 
mutation 
lead 
dramatic 
transition 
##roma 
structure 
d 
##e 
i 
##sen 
region 
replaced 
two 
stable 
sequence 
positioned 
n 
##some 
##s 
[SEP] 
during 
chronic 
ca 
##ci 
##ton 
##pha 
##rina 
##ry 
##rol 
##ine 
50 
page 
paget 
disease 
[CLS] 
187 
200 
because 
structural 
similarity 
new 
gene 
termed 
##2 
experience 
##ya 
district 
hospital 
[CLS] 
the 
2 
3 
x 
10 
3 
base 
##12 
trans 
##cript 
contains 
open 
reading 
frame 
sufficient 
en 
88 
x 
10 
3 
m 
##r 
protein 
[SEP] 
[CLS] 
co 
##rt 
##ical 
so 
##mat 
##ose 
e 
median 
nerve 
revealed 
significantly 
delayed 
peak 
late 
##ncy 
n 
##20 
p 
p20 
p 
p25 
##26 
although 
late 
##ncy 
normal 
[CLS] 
family 
rate 
adaptive 
pace 
##maker 
accomplish 
circa 
##dian 
rate 
variation 
modeling 
patient 
sleep 
wake 
cycle 
time 
day 
clock 
inside 
device 
pro 
present 
future 
future [SEP] 
[CLS] 
bi 
##ru 
##bin 
red 
cell 
metabolism 
relation 
neon 
##ata 
##l 
##ndi 
[SEP] 
[CLS] 
material 
mean 
three 
different 
placement 
technique 
bulk 
pack 
horizontal 
layer 
##ing 
vertical 
layer 
class 
ii 
cavity 
extracted 
human 
m 
##olar 
[CLS] 
this 
pathway 
function 
another 
and 
##rogen 
promoter 
shown 
tumor 
##t 
cat 
reporter 
[CLS] 
stress 
induced 
suppression 
pro 
##ct 
##in 
afternoon 
o 
##ct 
est 
##rogen 
treated 
no 
##cturnal 
pseudo 
##p 
##gnant 
accompanied 
increase 
median 
em 
##inen 
di 
##dr 
acid 
concentration 
er 
##go 
##read 
75 
62 
respectively 
m 
##or 
##ph 
##gic 
re 
##nal 
ca 
##x 
p 
##vis 
control 
u 
##ret 
##eric 
activity 
rabbit 
child 
protein 
##uria 
higher 
path 
##olo 
##gic 
##ye 
##ram 
##ram [SEP] 
[CLS] 
par 
##ph 
##ost 
##rong 
##yl 
o 
##do 
##ei 
red 
##es 
##cribed 
worm 
collected 
type 
host 
o 
##do 
hem 
##ion 
co 
##bian 
ca 
##fo 
##rn 
##ia 
well 
material 
experimental 
##ly 
infected 
m 
##ule 
deer 
o 
o h 
hem 
al 
##a 
[CLS] 
the 
car 
##box 
##yl 
g 
##bula 
##r 
domain 
found 
encoded 
ex 
##on 
appear 
del 
##ate 
structural 
sub 
##dom 
##ain 
##s 
[SEP] 
expression 
##b 
mutation 
##b 
plasma 
membrane 
pm 
##37 
##3 
[PAD] [CLS] 
thus 
integration 
host 
factor 
required 
normal 
type 
1 
fi 
##ria 
phase 
variation 
e 
co 
##li 
[SEP] 
[CLS] 
insulin 
therapy 
expanded 
human 
insulin 
mode 
injection 
including 
insulin 
pump 
pump [SEP] 
because 
level 
##o 
##2 
##dir 
##o 
##2 
similar 
group 
pool 
data 
se 
##ptic 
[PAD] [CLS] 
further 
intervention 
##ph 
##re 
##rect 
##x 
re 
##section 
l 
##iga 
ca 
##va 
##va 1 
##x 
re 
##section 
replacement 
re 
vein 
1 
##x 
##x [SEP] 
[CLS] 
objective 
the 
present 
study 
tested 
hypothesis 
s 
##ti 
##mulating 
central 
nor 
##ad 
##rene 
##rg 
system 
nor 
##ad 
##rena 
up 
##take 
inhibitor 
re 
##eti 
##ne 
would 
result 
dose 
dependent 
enhance 
##ment 
memory 
emotional 
material 
man 
[SEP] 
[CLS] 
we 
mechanism 
two 
different 
type 
photo 
c 
gamma 
radiation 
activate 
transcription 
factor 
##f 
##ppa 
[CLS] 
however 
co 
##liga 
##tion 
gamma 
r 
##b 
##1 
cell 
a 
receptor 
##r 
in 
##hibit 
##r 
mediated 
signaling 
mechanism 
recruitment 
p 
##pha 
##tase 
s 
1 
s 
2 
##2 
containing 
in 
##os 
##tase 
ship 
p 
##lated 
gamma 
r 
##b 
##1 
im 
##ec 
##or 
##or t 
##os 
based 
inhibitor 
##y 
motif 
motif [SEP] 
using 
standard 
full 
##q 
84 
5 
year 
sensitivity 
54 
score 
3 
3 [SEP] 
11 
580 
##18 
##3 
protein 
co 
##loc 
##ali 
##zes 
##11 
protein 
c 
##oso 
face 
##uo 
membrane 
this 
patient 
treated 
1964 
1978 
age 
year 
required 
##9 
generator 
[CLS] 
br 
c 
early 
gene 
directly 
activate 
late 
gene 
transcription 
interacting 
late 
gene 
c 
##i 
acting 
regulatory 
element 
interaction 
responsible 
temporal 
link 
##age 
early 
late 
e 
gene 
expression 
[SEP] 
[CLS] 
specific 
limit 
detection 
0 
02 
micro 
##gram 
m 
##l 
0 
01 
0125 
##gram 
m 
##l 
f 
##ante 
meta 
##bol 
##ite 
respectively 
respectively sufficiently 
high 
character 
time 
course 
drug 
plasma 
oral 
administration 
therapeutic 
sheep 
[CLS] 
identified 
gene 
encoding 
si 
genetic 
screen 
designed 
designed is 
##olate 
trans 
acting 
mutation 
##bol 
##ish 
either 
h 
##po 
##hp 
##3 
two 
promoter 
recognized 
uniquely 
si 
containing 
r 
##na 
polymer 
##ase 
[SEP] 
[CLS] 
c 
##yt 
##oki 
##net 
##ics 
##bs 
car 
##cin 
##oma 
[SEP] 
through 
effective 
laboratory 
testing 
database 
possible 
away 
anal 
##ytic 
quality 
control 
far 
system 
based 
evaluation 
[CLS] 
these 
patient 
developed 
severe 
di 
##abe 
##tic 
s 
##ym 
##pt 
##om 
glucose 
into 
##ler 
weight 
loss 
impaired 
energy 
u 
##til 
##ization 
nerve 
brain 
disorder 
insulin 
insulin [SEP] 
[CLS] 
one 
promoter 
##53 
##1 
located 
100 
250 
b 
##p 
upstream 
218 
b 
##p 
non 
##co 
##ding 
first 
ex 
##on 
second 
stronger 
promoter 
map 
within 
first 
intro 
##n 
[SEP] 
[CLS] 
both 
gene 
product 
contain 
car 
##box 
##yl 
terminal 
sequence 
##l 
similar 
put 
##ative 
s 
##k 
##l 
per 
##ox 
##is 
sorting 
sequence 
go 
##uld 
s 
the 
likelihood 
death 
3 
time 
higher 
among 
era 
group 
3 
82 
95 
1 
48 
9 
9 84 
bar 
##ium 
##uc 
##osa 
##l 
coating 
judged 
member 
ma 
su 
##7 
immortal 
dip 
##lo 
##id 
w 
wt 
##av 
targeted 
integration 
ch 
19 
[SEP] 
[CLS] 
the 
corresponding 
te 
##tra 
##pe 
##pt 
##ide 
sequence 
s 
##d 
sat 
##d 
human 
e 
##ps 
##ilon 
respectively 
unusual 
##sp 
##ase 
3 
[SEP] 
the 
##hari 
binding 
secret 
class 
1 
acute 
whose 
gene 
transcription 
##ally 
activated 
##rf 
##tat 
3 
##oki 
in 
protein 
[CLS] 
t 
##rit 
found 
determined 
within 
25 
[CLS] 
this 
region 
contain 
consensus 
est 
##rogen 
element 
er 
binding 
d 
sequence 
observed 
[SEP] 
[CLS] 
protein 
called 
vs 
specific 
lo 
##cus 
vs 
gene 
expression 
site 
e 
the 
s 
##ng 
##ulated 
in 
##test 
##inal 
path 
##ology 
horse 
accompanied 
local 
activation 
ne 
##ut 
revealed 
t 
##ular 
en 
##zy 
##matic 
##matic activity 
activity g 
enzyme 
##elo 
##per 
##ox 
##idas 
##idase 
##po 
[CLS] 
del 
##eti 
analysis 
##as 
##1 
promoter 
in 
##os 
##olin 
element 
motif 
region 
n 
##leo 
##tide 
760 
850 
responsible 
remaining 
activation 
[SEP] 
[CLS] 
here 
fabric 
single 
molecule 
trans 
##ist 
based 
individual 
c 
##60 
molecule 
connected 
electro 
##de 
the 
home 
##od 
transcription 
factor 
##d 
cut 
interact 
cell 
cycle 
regulatory 
element 
his 
gene 
packaged 
##some 
##s 
they 
protein 
whose 
core 
region 
display 
great 
similarity 
as 
ha 
ha 
ha 
##pe 
known 
ha 
ho 
##mo 
organism 
[SEP] 
further 
##more 
co 
##gnate 
binding 
protein 
present 
rat 
human 
he 
##la 
nuclear 
extract 
[SEP] 
[CLS] 
trans 
co 
##ns 
##fect 
cooperative 
association 
il 
8 
promoter 
result 
s 
##rg 
##istic 
transcription 
##al 
activation 
[SEP] 
[CLS] 
heart 
rate 
behavioral 
avoid 
##ance 
test 
shown 
susceptible 
experimental 
demand 
study 
shown 
approach 
behavior 
influenced 
influenced [SEP] 
[CLS] 
function 
retained 
one 
copy 
sequence 
present 
sequence 
represents 
essential 
element 
[SEP] 
[CLS] 
decreased 
##th 
##rom 
##bin 
ii 
##i 
assumed 
one 
major 
factor 
underlying 
h 
##yper 
##gu 
state 
##ph 
##rot 
syndrome 
[CLS] 
no 
##2 
road 
frequently 
exceeded 
br 
union 
air 
particle 
lower 
lower [SEP] 
[CLS] 
co 
##tra 
##ns 
##fect 
247 
##3 
construct 
containing 
247 
##3 
base 
pair 
hi 
upstream 
sequence 
linked 
l 
##uc 
##ifer 
##ase 
##od 
transcription 
factor 
o 
oct 
##1 
o 
##2 
br 
##4 
##1 
##1 
##i 
result 
strong 
suppression 
basal 
promoter 
activity 
[SEP] 
87 
72 
##70 
[CLS] 
i 
[CLS] 
trans 
##cript 
in 
##iti 
##ating 
ca 
##gt 
motif 
pro 
##ximal 
trans 
abolished 
del 
##eti 
pro 
##ximal 
ta 
##ta 
box 
located 
29 
relative 
ca 
##gt 
[SEP] 
[CLS] 
##eno 
##mic 
d 
b 
##lot 
analysis 
l 
##2 
lo 
##cus 
cluster 
like 
organization 
similar 
l 
##1 
lo 
##cus 
i 
lo 
##cus 
several 
fish 
[SEP] 
[CLS] 
although 
energy 
d 
##ft 
affected 
##rote 
##ren 
6 
1 
1 
5 
6 
0 
1 
7 
j 
decreased 
3 
7 
1 
6 
j 
third 
stage 
in 
##40 
##31 
##rote 
##ren 
base 
##line 
##rote 
##ren 
go 
length 
4 
12 
cm 
dynamic 
interaction 
retention 
3 
##b 
##ut 
group 
group 20 
##rks 
35 
s 
1 
##r 
3 
##r 
##par 
3 
h 
an 
##est 
injected 
inn 
500 
##ci 
30 
min 
he 
##par 
##b 
roller 
pump 
o 
ox 
bent 
0 
m 
m2 
##2 a 
bent 
0 
0 25 
m 
5 
3 
6 
l 
min 
3 
##r 
[CLS] 
the 
region 
immediately 
following 
promoter 
5 
##f 
##1 
potential 
transcription 
term 
##inator 
sequence 
[SEP] 
[CLS] 
study 
re 
##rrence 
g 
##ival 
h 
##yper 
##p 
preface 
[CLS] 
c 
##lon 
##id 
3 
micro 
##gram 
produce 
se 
##dation 
comparable 
di 
##az 
##am 
0 
2 
mg 
in 
##tub 
##ation 
response 
incidence 
com 
##plication 
[CLS] 
##cre 
##atic 
expression 
g 
##lu 
##ca 
##gon 
gene 
depends 
multiple 
transcription 
factor 
interacting 
least 
three 
d 
##na 
control 
element 
g 
##1 
upstream 
promoter 
element 
g 
##2 
g 
##3 
two 
enhance 
##r 
like 
sequence 
[SEP] 
##3 
following 
order 
plate 
##let 
##3 
break 
cluster 
region 
like 
show 
bind 
bound 
##d 
conclusion 
men 
##hr 
peripheral 
blood 
pro 
##life 
##k 
p 
##d 
identified 
17 
94 
diagnosed 
depression 
e 
##p 
woman 
78 
b 
##di 
ii 
identified 
10 
##ych 
often 
wish 
element 
others 
[CLS] 
single 
amino 
acid 
substitution 
shown 
result 
mutation 
##dr 
##1 
2 
##30 
##i 
##dr 
##1 
3 
f 
f8 
##15 
##s 
##dr 
##1 
6 
k 
##30 
##q 
##1 
7 
7 p 
##29 
##298 
##1 
##1 8 
8 l 
##10 
##36 
whereas 
in 
##tra 
suppress 
##or 
mutant 
##1 
100 
deleted 
amino 
acid 
acid l 
l53 
##53 
[CLS] 
both 
gene 
consist 
40 
##8 
b 
##p 
or 
##f 
coding 
135 
amino 
acid 
[CLS] 
##nio 
##tic 
fluid 
ion 
##ic 
response 
f 
##etal 
##as 
##op 
in 
[CLS] 
the 
slice 
image 
##d 
three 
time 
sequence 
spatial 
pre 
##sat 
##uration 
##uration [SEP] 
[CLS] 
molecular 
c 
##lon 
alpha 
##bin 
transcription 
factor 
##2 
[CLS] 
the 
di 
##stal 
active 
site 
t 
##iga 
ex 
##cision 
66 
b 
##p 
intro 
##n 
[SEP] 
[CLS] 
##at 
##ores 
d 
dgg 
##e 
sequence 
analysis 
##4 
major 
member 
female 
ma 
##ry 
g 
##land 
sub 
##illa 
##ry 
la 
##ry 
##mal 
g 
sex 
counterpart 
male 
liver 
##agu 
found 
##1 
all 
possessed 
cut 
##aneous 
re 
##ceptive 
di 
##stal 
segment 
digit 
2 
3 
4 
[CLS] 
se 
seed 
also 
considered 
cause 
all 
##ergic 
reaction 
drug 
##etic 
##etic [SEP] 
l 
##igan 
##d 
binding 
receptor 
hem 
##ato 
##iet 
result 
rapid 
activation 
t 
##os 
##t 
##k 
dependent 
signalling 
molecule 
p 
3 
##i 
3 
kinase 
kinase [SEP] 
[CLS] 
the 
u 
##as 
##b 
reactor 
treated 
##fa 
mixture 
ace 
##tate 
##ate 
##yra 
##te 
ratio 
5 
3 
2 
co 
##d 
basis 
ace 
##tate 
sole 
substrate 
different 
co 
su 
##ate 
ratio 
[SEP] 
specific 
##aga 
involvement 
diagnosis 
ex 
##ti 
##rp 
mild 
operative 
course 
course [SEP] 
now 
pleasure 
[CLS] 
this 
article 
review 
current 
concept 
path 
##op 
##sio 
sum 
##mar 
##ises 
clinical 
feature 
natural 
history 
available 
treatment 
treatment [SEP] 
previous 
data 
subtle 
increase 
serum 
p 
time 
without 
##h 
reduces 
##r 
woman 
o 
i 
iv 
##f 
study 
compared 
##r 
recipient 
shared 
o 
program 
according 
donor 
level 
[CLS] 
ad 
##e 
ha 
##lda 
transformation 
com 
o 
o2 
man 
man [SEP] 
m 
m ad 
four 
##net 
cap 
association 
##ys 
##tein 
##che 
heart 
disease 
la 
[CLS] 
radio 
##logical 
imaging 
series 
c 
##t 
scan 
arrive 
accurate 
diagnosis 
diagnosis [SEP] 
architecture 
h 
##1 
domain 
close 
domain 
t 
##1 
##1 
##p 
##b 
80 
encoded 
amino 
acid 
located 
immediately 
et 
junction 
found 
translation 
product 
pro 
set 
cellular 
protein 
protein 64 
62 
60 
k 
##da 
related 
##eptide 
predicted 
protein 
product 
second 
m 
[CLS] 
because 
controlled 
release 
ni 
##ac 
seems 
potent 
crystal 
ni 
##ac 
product 
substitution 
dose 
adjustment 
avoided 
avoided [SEP] 
inter 
agreement 
not 
##ting 
his 
##to 
##rading 
scheme 
##fi 
##lt 
##rating 
duct 
##cin 
##oma 
breast 
[SEP] 
[CLS] 
this 
dose 
##3 
##rate 
suggest 
h 
##po 
##emia 
even 
though 
acid 
##rate 
de 
##x 
##tro 
ni 
formula 
formula a 
a 
ac 
##d 
identical 
condition 
reduce 
level 
total 
calcium 
serum 
con 
##com 
number 
reaction 
donor 
late 
##x 
glove 
balloon 
condom 
directly 
bound 
bound i 
ige 
patient 
[CLS] 
##6 
##9 
c 
newborn 
early 
late 
protein 
stimulate 
cellular 
promoter 
thus 
ex 
exert 
rather 
broad 
activation 
pattern 
[CLS] 
southern 
b 
##lot 
analysis 
##eno 
##mic 
d 
altered 
c 
##p 
met 
##hyl 
within 
intro 
##n 
1 
d 
b 
normal 
mortal 
human 
##ry 
e 
##c 
t 
##bet 
##a 
##1 
expression 
up 
##re 
##gu 
k 
##era 
r 
##tro 
although 
functional 
clear 
[CLS] 
an 
increased 
incidence 
at 
##n 
##los 
##por 
a 
[CLS] 
##p 
dependent 
br 
##ef 
##eld 
##in 
##it 
##ro 
1 
binding 
ass 
determined 
parameter 
1 
binding 
reaction 
[CLS] 
the 
overall 
rate 
bio 
##hy 
##dr 
##ogen 
2 
14 
3 
h 
declined 
1 
2 
h 
added 
substrate 
[SEP] 
[CLS] 
plasma 
enter 
##og 
##lu 
##ca 
##gon 
measured 
three 
hour 
standard 
meal 
##tre 
patient 
suspected 
co 
##eli 
##ac 
disease 
at 
##rop 
in 
##test 
##inal 
##uc 
ma 
##bs 
##or 
##ption 
nine 
control 
subject 
[SEP] 
[CLS] 
after 
mass 
trait 
anxiety 
predict 
di 
##ast 
##olic 
blood 
pressure 
woman 
[CLS] 
regulation 
human 
stress 
gene 
##ad 
##d 
##15 
##3 
expression 
role 
##1 
##i 
1 
gene 
product 
[CLS] 
##4 
sa 
##cc 
##har 
##omy 
##ces 
c 
##ere 
##vis 
part 
##4 
##6 
component 
m 
##rna 
s 
apparatus 
[SEP] 
132 
var 
##ix 
l 
##iga 
performed 
44 
separate 
separate e 
ev 
session 
[CLS] 
here 
r 
##f 
##x 
x 
##b 
##p 
d 
complex 
formed 
class 
ii 
is 
##otype 
##s 
regardless 
ability 
x 
box 
region 
bind 
either 
factor 
individually 
[SEP] 
[CLS] 
the 
ps 
##i 
z 
##eta 
gene 
nonsense 
mutation 
ex 
##on 
1 
identical 
promoter 
sequence 
r 
processing 
site 
z 
##eta 
gene 
raising 
possibility 
ps 
##i 
z 
##eta 
z 
##eta 
transcription 
##ally 
active 
[SEP] 
prospect 
ch 
##em 
##ost 
##eri 
##lant 
genetic 
control 
##nt 
serum 
##rl 
administration 
normal 
woman 
h 
##yper 
##rol 
##act 
##ine 
normal 
sell 
##a 
patient 
##no 
##roa 
##oma 
without 
su 
##pra 
##sel 
##lar 
expansion 
s 
##se 
##se [SEP] 
the 
id 
##4 
protein 
contains 
h 
domain 
highly 
conserved 
among 
d 
##ros 
[CLS] 
the 
coding 
region 
##fa 
determined 
translation 
##al 
la 
##cz 
fusion 
site 
directed 
m 
##uta 
identify 
four 
frame 
au 
##g 
co 
##don 
used 
[SEP] 
##eptide 
competition 
localized 
c 
##y 
##c 
##lin 
a 
interaction 
site 
l 
##ys 
##38 
##1 
##38 
##2 
##3 
##4 
sequence 
within 
terminal 
negative 
regulatory 
domain 
human 
p 
[CLS] 
he 
##tero 
##di 
##mer 
##ization 
##r 
failed 
alter 
##p 
##dr 
distribution 
activity 
like 
t 
##rop 
##oni 
##od 
##ulin 
##k 
contains 
four 
e 
##f 
hand 
binding 
motif 
a 
third 
group 
n 
10 
assigned 
canal 
##ith 
re 
##position 
maneuver 
without 
mast 
##oid 
vibration 
[CLS] 
upstream 
##fa 
3 
gene 
cluster 
1 
k 
##b 
region 
found 
96 
identical 
re 
##ib 
sequence 
one 
enter 
##oto 
co 
##mi 
##30 
common 
ancestor 
p 
##mi 
##d 
[SEP] 
the 
cat 
stage 
2 
l 
##ymph 
test 
negative 
best 
treatment 
treatment [SEP] 
[CLS] 
h 
##hes 
act 
##iva 
specifically 
interact 
multiple 
component 
transcription 
initiation 
complex 
likely 
dramatic 
functional 
s 
##rgy 
exhibited 
class 
activation 
domain 
v 
##ivo 
[SEP] 
two 
modified 
combined 
hole 
16 
3 
##pi 
r 
1 
##r 
radius 
one 
hole 
1971 
his 
##to 
##logical 
##not 
revealed 
large 
cell 
l 
##ymph 
b 
cell 
one 
t 
cell 
two 
small 
##ave 
##d 
cell 
l 
##ymph 
b 
cell 
five 
b 
cell 
##ymph 
three 
three f 
##icular 
mixed 
##ymph 
##oma 
##oma [SEP] 
[CLS] 
the 
de 
##viation 
site 
equivalent 
ex 
##on 
1 
ex 
##on 
2 
s 
##p 
##lice 
site 
mouse 
c 
subunit 
[SEP] 
[CLS] 
determination 
di 
##ace 
3 
##ed 
##ione 
##to 
##in 
performed 
two 
step 
[CLS] 
there 
may 
o 
##smo 
challenge 
##uc 
##osa 
##l 
cell 
function 
evidenced 
different 
reaction 
rate 
[CLS] 
##9 
prototype 
em 
##b 
##ryo 
expression 
h 
##st 
gene 
positively 
regulated 
downstream 
o 
##ame 
##r 
motif 
enhance 
##r 
[SEP] 
reading 
achievement 
disability 
reading 
instruction 
di 
##star 
program 
student 
using 
basal 
reader 
material 
[CLS] 
two 
put 
##ative 
at 
binding 
domain 
identified 
one 
amino 
terminal 
half 
a 
##rga 
encoded 
protein 
car 
##box 
##y 
terminal 
half 
[SEP] 
[PAD] [CLS] 
child 
child [SEP] 
[CLS] 
half 
life 
2 
5 
h 
reduced 
15 
min 
addition 
m 
##olar 
p 
c 
##op 
##las 
##mic 
region 
p 
[SEP] 
[CLS] 
this 
transformation 
suppression 
##b 
shown 
due 
transcription 
##al 
repression 
##u 
using 
r 
##b 
expressing 
effect 
##or 
p 
##mi 
##d 
##u 
promoter 
##lora 
##l 
##ty 
##lt 
##ran 
##s 
##fer 
##ase 
reporter 
gene 
[SEP] 
[CLS] 
therapy 
started 
bone 
alter 
##ation 
could 
observed 
typical 
page 
##t 
disease 
bone 
bulk 
##y 
t 
##ec 
##e 
increased 
re 
##mo 
##dell 
surface 
giant 
o 
##ste 
##oc 
##last 
t 
in 
##fest 
del 
##pont 
##ei 
##ei t 
##rov 
so 
##rdi 
##da 
##da t 
v 
##ice 
in 
##id 
##ip 
##ro 
##fa 
##cia 
terminal 
mutation 
disturb 
mit 
##osis 
produce 
cell 
##r 
approach 
isolated 
put 
##ative 
ho 
##mo 
##logue 
##4 
cell 
[CLS] 
1 
1 [SEP] 
[CLS] 
bio 
##chemical 
study 
il 
il 
t 
##yr 
##os 
activation 
initiate 
complex 
signaling 
ca 
##sca 
##de 
[CLS] 
background 
peripheral 
receptor 
ago 
##nist 
therapeutic 
approach 
treatment 
d 
##pe 
fourteen 
38 
9 
developed 
d 
e 
defect 
13 
time 
[CLS] 
the 
yeast 
genome 
contains 
single 
##d 
##1 
gene 
resides 
chromosome 
x 
##i 
the 
system 
unit 
##m 
##c 
at 
[CLS] 
n 
terminal 
sequence 
extra 
##cellular 
t 
##vas 
194 
198 
within 
or 
##f 
[SEP] 
##olate 
b 
b 
##dorf 
human 
rode 
i 
dam 
##mini 
##dis 
b 
b 
##dorf 
different 
major 
protein 
identified 
c 
##lon 
##ata 
binding 
regulate 
end 
##oth 
##elin 
1 
gene 
expression 
##oth 
##eli 
cell 
[CLS] 
the 
s 
gene 
##1 
encoding 
##1 
located 
1 
1 
k 
##b 
downstream 
##bb 
##codes 
##ys 
##80 
##op 
##in 
[SEP] 
[CLS] 
dimensional 
echo 
##card 
##io 
axis 
view 
graded 
bleeding 
rapid 
withdrawal 
blood 
art 
##erial 
##nu 
5 
30 
blood 
volume 
rate 
recovery 
##co 
##ba 
growth 
mg 
##it 
bi 
##pha 
se 
##pt 
ch 
##ek 
based 
og 
##awa 
medium 
[CLS] 
a 
in 
##p 
alpha 
p 
##mi 
##d 
op 
##eron 
trans 
##cribed 
bid 
##ire 
##ctional 
promoter 
region 
consisting 
t 
t 
op 
##eron 
##ap 
t 
##b 
##p 
t 
##rb 
op 
##eron 
[SEP] 
conclusion 
structural 
study 
th 
##rom 
##bus 
self 
sustaining 
significance 
path 
##op 
mechanism 
abdominal 
##ort 
an 
##eur 
##ys 
##m 
[CLS] 
the 
b 
bh 
1 
ul 
##24 
ul 
##25 
ul 
##26 
ul 
##26 
5 
trans 
##cript 
terminated 
common 
3 
site 
varied 
significantly 
relative 
abundance 
[CLS] 
electro 
##ore 
d 
complex 
formed 
protein 
i 
##3 
combination 
super 
##shi 
s 
##p 
##1 
s 
##p 
##1 
binding 
site 
##d 
promoter 
form 
specific 
i 
##3 
re 
##ons 
d 
protein 
complex 
contains 
s 
##1 
transcription 
factor 
[SEP] 
distinct 
d 
binding 
##rar 
ho 
##mo 
##di 
##mers 
se 
##x 
##r 
##rar 
molecular 
mechanism 
under 
path 
##l 
[CLS] 
the 
analysis 
showed 
morning 
active 
ma 
individual 
rose 
earlier 
went 
earlier 
evening 
active 
active e 
##a 
individual 
former 
longer 
sleep 
length 
latter 
day 
morning 
shift 
opposite 
true 
true afternoon 
night 
shift 
shift [SEP] 
[CLS] 
this 
er 
##d 
recorded 
con 
##tral 
##ater 
##al 
central 
region 
region [SEP] 
[CLS] 
del 
##eti 
##on 
mutation 
constructed 
removing 
residue 
2 
30 
31 
60 
61 
90 
49 
78 
n 
terminal 
c 
##op 
domain 
well 
miss 
##ense 
mutation 
di 
##uc 
motif 
[SEP] 
[CLS] 
k 
##y 
la 
b 
##uddin 
related 
##vis 
substrate 
show 
le 
sensitivity 
glucose 
repression 
##vis 
[SEP] 
low 
affinity 
e 
##2 
binding 
site 
media 
down 
##mo 
trans 
##act 
promoter 
##tra 
##formed 
3 
##t 
##3 
cell 
1 
9 
k 
##b 
ho 
##x 
1 
3 
r 
##cho 
##lant 
##hren 
transformed 
m 
##b 
##6 
##t 
##k 
3 
##t 
##3 
transformed 
on 
s 
##o 
level 
[CLS] 
although 
analysis 
similarity 
k 
co 
re 
protein 
show 
ho 
##mology 
revealed 
identity 
five 
amino 
acid 
residue 
involved 
formation 
e 
##pit 
recognized 
re 
##body 
subsequent 
e 
##pit 
binding 
protein 
u 
##rease 
shown 
identical 
enzyme 
fi 
##roma 
do 
electro 
correlated 
nickel 
content 
atomic 
absorption 
analysis 
de 
##rid 
suppression 
ma 
##rrow 
culture 
##cy 
an 
##mia 
##mia [SEP] 
[CLS] 
finally 
p 
##eptide 
corresponding 
mutant 
protein 
act 
substrate 
p 
##r 
these 
ps 
sponsored 
toxic 
program 
root 
surface 
car 
##ies 
in 
v 
##isco 
a 
v 
##isco 
plus 
differ 
[CLS] 
these 
result 
demonstrate 
entire 
##3 
##l 
gene 
required 
path 
##ogen 
##esis 
model 
[CLS] 
the 
development 
various 
path 
##ological 
les 
##ion 
thy 
##mus 
s 
##ple 
##en 
l 
##ymph 
node 
bone 
ma 
##rrow 
frequently 
observed 
observed [SEP] 
micro 
cell 
brain 
mac 
##rop 
15 
receptor 
[CLS] 
we 
analyzed 
role 
protein 
in 
invert 
##as 
assembly 
enhance 
##r 
located 
variable 
close 
one 
re 
##comb 
site 
[PAD] [CLS] 
the 
mode 
action 
often 
suggested 
explanation 
different 
slope 
concentration 
effect 
curve 
curve [SEP] 
example 
principle 
principle le 
le [SEP] 
wide 
conservation 
gene 
nature 
evidence 
participate 
mob 
iron 
sulfur 
nitrogen 
##ase 
specific 
iron 
sulfur 
cluster 
formation 
product 
gene 
could 
general 
formation 
repair 
iron 
sulfur 
cluster 
[CLS] 
transfer 
glucose 
su 
##nate 
ma 
medium 
##rate 
medium 
c 
es 
##cher 
##ichi 
co 
strain 
delay 
36 
48 
h 
growth 
[SEP] 
result 
resistance 
do 
##x 
cell 
due 
different 
mechanism 
top 
##ois 
##omer 
multi 
##dr 
##ug 
resistance 
[PAD] [CLS] 
j 
##val 
b 
b [SEP] 
[CLS] 
the 
pattern 
expression 
##i 
##26 
##33 
promoter 
e 
region 
contains 
c 
##i 
acting 
sequence 
activate 
transcription 
silence 
transcription 
leaf 
[SEP] 
[CLS] 
spontaneous 
co 
##rona 
##ry 
artery 
spa 
##rona 
##ry 
##gio 
exercise 
s 
##t 
segment 
elevation 
elevation [SEP] 
[CLS] 
four 
newborn 
group 
became 
h 
##bs 
##ag 
carrier 
carrier [SEP] 
[CLS] 
effectively 
upstream 
house 
##keeping 
type 
promoter 
responds 
##k 
positively 
regulate 
##s 
downstream 
si 
54 
type 
promoter 
[CLS] 
k 
we 
##i 
m 
m [SEP] 
new 
t 
##b 
re 
##sp 
##ira 
choice 
cost 
cost [SEP] 
[CLS] 
electro 
##ore 
o 
##gon 
##leo 
##tide 
##s 
derived 
site 
demonstrated 
specific 
d 
protein 
complex 
[SEP] 
[CLS] 
a 
##8 
##9 
n 
##leo 
##tide 
long 
e 
##cor 
##i 
fragment 
genome 
genome the 
##oto 
##rit 
cross 
hybrid 
##ization 
##ization l 
##11 
##11 l 
##1 
##1 l 
##10 
##10 l 
##12 
gene 
sequence 
##cher 
##ichi 
co 
clone 
##d 
sequence 
##d 
[SEP] 
[CLS] 
background 
reduction 
various 
agent 
prominent 
effect 
d 
##tin 
##1 
well 
99 
##m 
##t 
d 
##t 
##pa 
bio 
##dis 
##tribution 
##tribution [SEP] 
reduction 
p 
##ra 
contributed 
hem 
##ody 
##nam 
peak 
ii 
##i 
p 
inhibitor 
[CLS] 
the 
following 
parameter 
measured 
onset 
time 
time 
interval 
injection 
ma 
maximal 
total 
block 
t 
##12 
75 
time 
##1 
reach 
25 
75 
to 
tof 
##70 
to 
ratio 
reach 
70 
heart 
rate 
blood 
[CLS] 
[CLS] 
premature 
##ly 
in 
##act 
##ivating 
##k 
extract 
resulted 
corresponding 
has 
##ten 
##ing 
first 
mit 
##osis 
[CLS] 
the 
use 
##ad 
activity 
e 
##p 
lead 
suggested 
suggested [SEP] 
binding 
c 
##b 
##ps 
three 
2 
3 
3 
re 
##press 
##or 
site 
although 
rather 
weak 
confirmed 
electro 
reveal 
interaction 
liver 
nuclear 
protein 
##ro 
[SEP] 
cycle 
regulatory 
conserved 
however 
or 
##th 
##olo 
##gs 
neither 
##k 
##1 
##sk 
##1 
s 
##pec 
##ie 
date 
[CLS] 
in 
clone 
##d 
full 
length 
##4 
race 
rapid 
##p 
end 
r 
min 
##6 
cell 
insulin 
cell 
line 
[CLS] 
k 
##oh 
##tz 
j 
j [SEP] 
hence 
gap 
##1 
gene 
en 
characteristic 
typical 
trans 
l 
##igan 
cellular 
membrane 
[CLS] 
the 
pro 
##en 
##zy 
processing 
essential 
secret 
p 
##2 
p 
containing 
mutation 
affect 
ability 
prop 
##eptide 
c 
##lea 
##vage 
site 
fold 
within 
cat 
##alytic 
pocket 
transferred 
beyond 
early 
stage 
secret 
pathway 
[SEP] 
[CLS] 
these 
result 
transcription 
influence 
aspect 
gene 
conversion 
initiation 
strand 
invasion 
mm 
##r 
important 
pro 
##gno 
##stic 
factor 
result 
##sio 
c 
##lau 
##dication 
finally 
sample 
drug 
derived 
probe 
archive 
ma 
##rrow 
cell 
break 
##point 
occurred 
m 
##dr 
##1 
sequence 
500 
1000 
k 
##b 
te 
##lo 
##mer 
##ic 
m 
##dr 
##1 
random 
ch 
##rom 
##oso 
rear 
##rang 
##ement 
[CLS] 
application 
method 
11 
year 
micro 
##sei 
##smic 
record 
revealed 
systematic 
spatial 
temporal 
change 
slip 
rate 
s 
##ync 
##hr 
##ono 
##us 
earthquake 
activity 
independent 
measure 
fault 
zone 
slip 
slip [SEP] 
[CLS] 
p 
##c 
##12 
culture 
prime 
way 
accelerated 
differentiation 
[CLS] 
one 
clone 
en 
##codes 
x 
##eno 
n 
##a 
the 
m 
##olten 
imp 
case 
high 
eye 
eye [SEP] 
the 
10 
ng 
m 
inter 
m 
i 
m 
inter 
i 
m 
[PAD] [CLS] 
in 
91 
2 
##mona 
co 
##agu 
s 
##ta 
15 
s 
e 
23 
s 
au 
16 
co 
coryn 
##eb 
s 
##pec 
others 
seven 
isolated 
isolated [SEP] 
stamp 
card 
[CLS] 
factor 
nuclear 
extract 
potato 
tube 
found 
bind 
specifically 
n 
##uc 
##leo 
##tide 
located 
135 
105 
suggesting 
region 
contains 
important 
c 
##i 
regulatory 
element 
[SEP] 
[CLS] 
zipper 
at 
also 
similar 
##p 
1 
j 
transcription 
factor 
whose 
d 
binding 
site 
differs 
at 
binding 
site 
single 
position 
[SEP] 
[CLS] 
r 
##26 
##0 
mutant 
expected 
support 
m 
##rna 
synthesis 
##it 
##ro 
transcription 
re 
##con 
##itution 
reaction 
well 
transcription 
##ivo 
mini 
##gen 
reverse 
approach 
[SEP] 
higher 
id 
48 
7 
32 
6 
v 
u 
contraction 
began 
late 
min 
alpha 
woman 
u 
activity 
unchanged 
hypothesis 
correct 
requirement 
##4 
##rrel 
##ate 
degree 
m 
##rna 
secondary 
structure 
in 
physician 
real 
path 
##ology 
in 
population 
co 
##lo 
##mb 
well 
known 
known [SEP] 
[CLS] 
result 
demonstrate 
b 
##v 
coat 
protein 
sole 
translation 
product 
g 
##eno 
##mic 
r 
beta 
whereas 
s 
beta 
1 
se 
##rf 
messenger 
translation 
beta 
b 
protein 
protein s 
beta 
2 
function 
messenger 
translation 
beta 
c 
beta 
newly 
beta 
protein 
[SEP] 
retrospective 
study 
##za 
electro 
##pha 
abnormal 
##zo 
patient 
patient [SEP] 
[CLS] 
the 
concept 
developed 
mine 
##rey 
next 
10 
year 
year [SEP] 
[CLS] 
beta 
gal 
##os 
##idas 
trans 
cell 
normal 
##ized 
##11 
trans 
appropriate 
control 
##40 
early 
region 
promoter 
con 
##it 
##utive 
result 
promoter 
region 
gene 
contains 
information 
necessary 
initiation 
transcription 
##6 
cell 
specific 
manner 
[SEP] 
[CLS] 
exists 
three 
disc 
##ern 
form 
steady 
under 
form 
100 
k 
##da 
soluble 
c 
##oso 
##lated 
form 
k 
##da 
p 
de 
form 
k 
##da 
[SEP] 
[CLS] 
the 
p 
it 
compelled 
complex 
bind 
activate 
##s 
s 
2 
turn 
de 
##ph 
##lates 
ship 
##c 
probably 
substrate 
[SEP] 
[CLS] 
when 
##r 
used 
am 
##p 
##gar 
culture 
express 
fi 
##ria 
switch 
region 
off 
[SEP] 
mechanism 
action 
local 
an 
##ae 
student 
health 
health [SEP] 
[CLS] 
we 
##r 
mutation 
imp 
##air 
fix 
##ation 
##c 
re 
##t 
consequently 
prevent 
[SEP] 
different 
app 
##icit 
normal 
app 
##ix 
s 
an 
##ore 
##xia 
[SEP] 
propose 
##3 
involved 
##hyl 
g 
human 
28 
r 
##rna 
[CLS] 
at 
start 
performance 
ride 
plasma 
glucose 
4 
2 
0 
0 2 
5 
2 
0 
1 
5 
7 
0 
mm 
##ol 
l 
1 
con 
ch 
##o 
##o 
0 
21 
respectively 
different 
05 
05 [SEP] 
[PAD] [CLS] 
therefore 
pro 
e 
e2 
characterized 
relation 
pro 
alpha 
alpha stronger 
u 
effectiveness 
effectiveness also 
influence 
card 
##iovascular 
system 
system [SEP] 
copyright 
1999 
[CLS] 
##lion 
c 
##ys 
frequently 
occur 
proximity 
joint 
joint [SEP] 
##ys 
trans 
modified 
able 
h 
##ydro 
##ly 
te 
##a 
al 
##a 
as 
th 
##io 
##zy 
##er 
b 
##a 
as 
s 
##l 
trans 
##mo 
##dified 
inactive 
[CLS] 
protein 
##b 
1 
2 
bind 
two 
three 
promoter 
element 
try 
##omo 
se 
##ym 
##our 
##i 
##i [SEP] 
expression 
medical 
efficiency 
rational 
##til 
budget 
fund 
[CLS] 
the 
present 
study 
try 
associate 
cause 
hot 
is 
##emia 
agony 
corpse 
donor 
evaluate 
may 
caused 
sympathetic 
e 
##fference 
removal 
removal [SEP] 
[CLS] 
the 
enzyme 
encoded 
clone 
##d 
fragment 
equally 
active 
p 
##vate 
h 
##ydro 
##vate 
indicating 
enzyme 
d 
la 
##ct 
##ate 
d 
g 
##ly 
##ate 
de 
##hy 
##dr 
##ogen 
##ase 
activity 
[CLS] 
noise 
s 
##t 
##m 
atom 
moving 
tunnel 
space 
space [SEP] 
[CLS] 
the 
human 
sequence 
contains 
element 
t 
##ct 
also 
found 
m 
r 
##a 
re 
enhance 
##r 
[SEP] 
[CLS] 
there 
overall 
functional 
f 
##o 
promoter 
trans 
promoter 
d 
intact 
he 
cell 
m 
##od 
##ulates 
function 
he 
##tero 
promoter 
construct 
[SEP] 
[CLS] 
enhanced 
##ydro 
fatty 
th 
##rom 
##box 
##ane 
increased 
release 
ex 
##ci 
##tat 
amino 
decreased 
tissue 
ma 
##gnesium 
level 
worse 
##n 
secondary 
tissue 
damage 
dim 
##uro 
injury 
acute 
alcohol 
into 
##xi 
##cation 
[SEP] 
[CLS] 
trans 
##cript 
en 
active 
enzyme 
trans 
em 
##b 
##ryo 
ex 
##cision 
ass 
##ra 
co 
co injected 
r 
trans 
##cribed 
##it 
##ro 
c 
##a 
template 
##mi 
##d 
d 
harbor 
element 
del 
##eti 
trans 
##po 
coding 
region 
[SEP] 
the 
objective 
response 
##r 
50 
95 
29 
71 
including 
complete 
response 
response eight 
partial 
response 
response [SEP] 
[CLS] 
relatively 
small 
del 
##eti 
##on 
affect 
segment 
containing 
3 
gene 
gene important 
regulatory 
function 
loss 
lead 
al 
##hen 
##otype 
[SEP] 
[CLS] 
two 
s 
##h 
##2 
domain 
##12 
##0 
##a 
##pas 
act 
bind 
s 
##yne 
##rg 
##istic 
##ally 
##0 
[CLS] 
p 
##12 
##0 
g 
##pas 
act 
gap 
regulator 
##a 
function 
key 
relay 
point 
signal 
trans 
pathway 
control 
cell 
proliferation 
[PAD] [CLS] 
ho 
##mo 
##logue 
map 
er 
##k 
kinase 
gene 
expressed 
ve 
veget 
##ative 
female 
reproductive 
pet 
hybrid 
##a 
##a [SEP] 
[CLS] 
it 
pro 
##gno 
t 
##1 
2 
one 
r 
##r 
2 
9 
p 
##10 
[CLS] 
it 
en 
##codes 
sequence 
specific 
transcription 
factor 
control 
concert 
gene 
product 
different 
##ia 
pathway 
tissue 
##r 
expressed 
[SEP] 
[CLS] 
conclusion 
d 
detect 
regional 
##ly 
h 
##y 
##pop 
##er 
##fused 
my 
##oc 
##ard 
##ium 
agreement 
m 
##b 
##f 
fatty 
up 
de 
##ter 
##ior 
##ates 
effect 
absorption 
bio 
##tam 
composite 
[CLS] 
transcription 
inserted 
gene 
predicted 
sub 
##omi 
##c 
m 
r 
##na 
b 
hybrid 
analysis 
encoded 
protein 
detected 
enzyme 
[SEP] 
these 
result 
pan 
##ret 
##inal 
photo 
##coa 
##gu 
effective 
dealing 
early 
moderately 
advanced 
case 
angle 
neo 
##vas 
##cular 
##ization 
[CLS] 
n 
##bs 
##ii 
essential 
stimulate 
activity 
sixteen 
25 
rejection 
9 
5 
month 
range 
1 
63 
[CLS] 
al 
al 
##ani 
amino 
##fer 
##b 
hem 
##og 
predict 
efficacy 
the 
##op 
##hyl 
##id 
t 
##id 
bid 
q 
##d 
##d [SEP] 
a 
report 
24 
hour 
dos 
release 
the 
##op 
##hyl 
emphasis 
analysis 
data 
obtain 
food 
drug 
##o 
24 
##bro 
transformed 
activity 
extra 
##cellular 
signal 
regulated 
terminal 
moderately 
increased 
delta 
inhibitor 
j 
alleviate 
##d 
[CLS] 
time 
action 
he 
##nis 
[CLS] 
es 
##cher 
##ichi 
co 
cell 
mutant 
gene 
con 
##it 
##utive 
##hen 
##otype 
imp 
##lication 
mechanism 
underlying 
m 
##uta 
##ut 
##c 
m 
##uta 
effect 
[CLS] 
24 
h 
level 
target 
specific 
##2 
altered 
addition 
appropriate 
terminal 
extension 
thus 
select 
system 
here 
c 
##lon 
##ing 
hem 
gene 
##ero 
##bic 
cop 
##rop 
##or 
##rino 
ii 
##i 
o 
##das 
es 
##cher 
##ichi 
co 
functional 
complement 
##ation 
sa 
##har 
c 
##vis 
[SEP] 
this 
study 
undertaken 
##bul 
##ized 
##oso 
[CLS] 
the 
atop 
##ic 
skin 
reaction 
reaction i 
##body 
t 
etc 
br 
##ty 
##cho 
examined 
following 
three 
group 
1 
1 20 
adult 
history 
as 
##th 
s 
free 
free 4 
y 
##r 
2 
2 20 
current 
as 
##th 
3 
3 20 
healthy 
[CLS] 
previous 
study 
showed 
p 
##ali 
##nd 
##rom 
##ic 
sequence 
located 
159 
base 
pair 
essential 
induction 
cut 
##inas 
gene 
f 
so 
f 
[SEP] 
[CLS] 
s 
##ema 
type 
##i 
h 
cut 
50 
k 
##da 
nuclear 
bind 
promoter 
contains 
element 
this 
regional 
alter 
brain 
op 
dependence 
withdrawal 
we 
conclude 
belong 
novel 
class 
here 
##by 
designated 
ka 
##ppa 
subunit 
gene 
designated 
##1 
human 
gene 
called 
called h 
##1 
[CLS] 
based 
##r 
strategy 
expression 
g 
##eno 
##mic 
organization 
f 
##ut 
##b 
gene 
[SEP] 
[CLS] 
the 
present 
demonstrates 
pro 
on 
##co 
c 
j 
re 
##press 
##es 
transcription 
human 
alpha 
beta 
promoter 
[SEP] 
[CLS] 
c 
j 
re 
##pressed 
alpha 
promoter 
canonical 
camp 
response 
element 
c 
known 
bind 
j 
member 
b 
z 
transcription 
factor 
family 
[SEP] 
pulse 
monitor 
out 
##patient 
dental 
an 
##ae 
##hesia 
[CLS] 
previous 
study 
partial 
sequence 
suggested 
26 
large 
subunit 
p 
##hyl 
##ogen 
##y 
re 
##tri 
##eval 
tax 
##mic 
level 
investigated 
##a 
[SEP] 
[CLS] 
the 
sensitivity 
99 
##m 
##t 
i 
##gg 
s 
##ti 
ranged 
71 
100 
100 [SEP] 
[PAD] [CLS] 
the 
index 
patient 
10 
year 
boy 
present 
typical 
s 
op 
##d 
type 
i 
together 
bow 
bone 
abnormal 
th 
##orax 
spinal 
column 
column [SEP] 
the 
cause 
##p 
active 
phase 
remains 
determined 
[CLS] 
a 
g 
##eno 
##mic 
clone 
representing 
5 
part 
message 
also 
isolated 
[SEP] 
anti 
##biotic 
##d 
##ca 
media 
essential 
##oma 
therapy 
the 
main 
side 
##elo 
m 
##os 
##itis 
##uro 
common 
often 
severe 
severe [SEP] 
[CLS] 
the 
column 
density 
frozen 
hydrogen 
##han 
in 
inferred 
2 
5 
x 
10 
18 
3 
0 
19 
respectively 
respectively [SEP] 
similarly 
cat 
expression 
##l 
##cat 
##oa 
observed 
##2 
1 
cell 
1 
p 
##14 
24 
127 
determined 
blood 
donor 
146 
im 
disorder 
c 
##lon 
se 
##quencing 
in 
chain 
regulated 
expression 
development 
skeletal 
muscle 
contract 
o 
pro 
alpha 
combined 
human 
##ro 
[CLS] 
these 
1 
sub 
##c 
##lon 
promoter 
##less 
su 
##d 
fragment 
downstream 
la 
##c 
promoter 
m 
##10 
2 
precise 
s 
##p 
##licing 
su 
coding 
region 
efficient 
at 
##pe 
rib 
##oso 
binding 
site 
expression 
##oi 
##uc 
promoter 
##50 
##3 
vector 
[SEP] 
mutation 
prevent 
f 
##k 
##b 
binding 
##r 
hybrid 
system 
[CLS] 
transcription 
e 
##uka 
t 
gene 
dependent 
a 
b 
box 
internal 
control 
region 
i 
##c 
##rs 
upstream 
transcription 
m 
##od 
##ulatory 
region 
[SEP] 
failure 
major 
inflammatory 
to 
##ol 
supplement 
i 
##u 
day 
result 
am 
##io 
##dar 
##one 
prevention 
##ox 
##ys 
##f 
e 
##qui 
attributed 
difference 
##ox 
##ys 
##f 
high 
level 
expression 
s 
##b 
well 
s 
clone 
##d 
expression 
vector 
##j 
##70 
change 
growth 
morphology 
##ry 
s 
##ns 
[SEP] 
##po 
##9 
tumor 
ne 
##rosis 
receptor 
induce 
##pop 
[CLS] 
in 
##oes 
##hage 
echo 
##card 
##io 
variation 
wall 
thickness 
change 
global 
loading 
condition 
basal 
mid 
##wall 
compartment 
[CLS] 
we 
dog 
spontaneous 
##ly 
breathing 
room 
air 
in 
##hala 
##tion 
gas 
mixture 
containing 
10 
co 
##2 
20 
9 
o 
o2 
69 
1 
n 
n2 
determine 
role 
his 
se 
##rot 
##oni 
acid 
##ae 
h 
##yper 
##tens 
##yper 
##cap 
##nia 
[SEP] 
[CLS] 
se 
##quencing 
fragment 
showed 
##rp 
coding 
region 
s 
##pec 
##ifies 
##4 
amino 
acid 
basic 
protein 
calculated 
##r 
37 
36 
##6 
[CLS] 
viral 
complementary 
15 
s 
m 
##rna 
directs 
synthesis 
protein 
hybrid 
##izes 
predicted 
n 
gene 
d 
identified 
cell 
extract 
[SEP] 
##ore 
d 
i 
protection 
##p 
i 
bound 
transcription 
factor 
pu 
1 
s 
##pi 
1 
[SEP] 
[CLS] 
##tro 
cell 
population 
cell 
clone 
clone established 
##r 
vector 
capable 
high 
vector 
t 
##iter 
10 
5 
##8 
##r 
c 
m 
3 
##t 
##3 
[SEP] 
[CLS] 
however 
site 
genome 
e 
##c 
cell 
permit 
m 
m 
##v 
##o 
delta 
pro 
##vir 
##al 
expression 
[CLS] 
increasing 
insulin 
type 
i 
di 
##abe 
possibility 
g 
##lu 
##co 
##cor 
##tic 
##oid 
deficiency 
however 
differential 
u 
##til 
##ization 
de 
##ter 
##mina 
media 
r 
##ar 
##x 
##r 
he 
##tero 
##di 
##mer 
binding 
d 
##r 
2 
d 
##r 
5 
rare 
##s 
[SEP] 
[PAD] [CLS] 
gal 
##actor 
##r 
##hoe 
rare 
presentation 
sell 
##a 
syndrome 
syndrome [SEP] 
his 
##sta 
trans 
rate 
detection 
disease 
[CLS] 
several 
drug 
management 
mac 
drug 
interaction 
involving 
##yt 
##och 
##p 
enzyme 
system 
##erial 
compliance 
##kes 
patient 
isolated 
s 
##ys 
##to 
##yper 
##tens 
90 
29 
patient 
essential 
##yper 
di 
##ast 
blood 
##ote 
##ns 
rather 
blanket 
characterization 
id 
##io 
##m 
com 
##p 
secondary 
manifest 
##nis 
74 
##00 
preventing 
##uro 
d 
group 
##51 
74 
##00 
better 
vehicle 
preventing 
##uro 
d 
[CLS] 
the 
woman 
intermediate 
calcium 
group 
group approximately 
mean 
b 
##m 
##d 
value 
low 
calcium 
group 
[SEP] 
##em 
##oly 
condition 
present 
study 
meant 
contribution 
[CLS] 
the 
transition 
expression 
early 
##iot 
gene 
expression 
middle 
s 
##por 
gene 
occurs 
cell 
exit 
form 
##ios 
i 
spin 
##dle 
##dle [SEP] 
n 
##f 
d 
protein 
binding 
##cam 
1 
promoter 
activity 
enhanced 
1 
##bet 
effect 
in 
t 
##ph 
##ost 
98 
##0 
##5 
##9 
203 
##uro 
cherry 
red 
##lon 
si 
##ali 
##dos 
type 
i 
using 
hybrid 
additional 
component 
##t 
binding 
factor 
[SEP] 
my 
##b 
pro 
on 
product 
c 
##b 
transcription 
##al 
regulator 
expression 
tightly 
linked 
entry 
s 
phase 
d 
synthesis 
both 
##38 
kinase 
inhibitor 
##20 
##38 
kinase 
il 
1 
##bet 
stimulation 
promoter 
[CLS] 
clinical 
feature 
y 
##r 
##ra 
##vid 
v 
para 
para 0 
presented 
an 
##ae 
consultation 
clinic 
37 
##esta 
disc 
##us 
option 
labour 
delivery 
delivery [SEP] 
[CLS] 
the 
ta 
ha 
haei 
##l 
##ps 
tool 
genetic 
analysis 
##r 
##2 
effect 
##f 
##pop 
result 
strongly 
role 
p 
##k 
##pop 
[CLS] 
cognitive 
measure 
s 
##tro 
##op 
controlled 
oral 
word 
association 
test 
using 
letter 
c 
c f 
l 
cow 
##at 
##f 
##l 
version 
version [SEP] 
##x 
##1 
belongs 
expanding 
bi 
##co 
##id 
related 
##bra 
##ob 
gene 
[CLS] 
effect 
diet 
##ary 
##id 
whole 
body 
retention 
distribution 
in 
mercury 
mouse 
[SEP] 
[CLS] 
differential 
transcription 
p 
##ome 
encoded 
gene 
me 
##so 
##ll 
bundle 
ch 
##op 
mon 
##oc 
##ot 
##yle 
##don 
##ous 
##d 
##p 
enzyme 
type 
##4 
plant 
maize 
so 
##rg 
[SEP] 
##quential 
detect 
##24 
class 
transformed 
indeed 
wild 
type 
[CLS] 
tissue 
specific 
gene 
regulation 
large 
large extent 
mediated 
transcription 
factor 
interact 
##eno 
d 
sequence 
sequence 
specific 
manner 
[SEP] 
enhanced 
correlation 
bound 
higher 
so 
effect 
bound 
so 
drastically 
enhanced 
so 
the 
compromised 
fi 
##bri 
##no 
contributing 
factor 
development 
th 
##rom 
##bos 
patient 
l 
##gu 
the 
##e 
greater 
bee 
calculated 
energy 
expenditure 
[CLS] 
result 
e 
##60 
##10 
treatment 
co 
##rona 
##ry 
o 
##cc 
##lusion 
[CLS] 
relationship 
expression 
on 
instability 
cell 
activated 
human 
ha 
r 
##a 
control 
bacterial 
la 
##ose 
op 
##eron 
regulatory 
element 
change 
##hot 
di 
##of 
##olate 
red 
##uc 
d 
##f 
##r 
gene 
am 
##p 
##lification 
following 
mutant 
ha 
r 
##a 
induction 
on 
variety 
front 
chronic 
bacterial 
at 
##her 
##os 
##cle 
##rosis 
com 
##plication 
an 
##gin 
##oc 
##ard 
in 
##far 
##ction 
stroke 
stroke [SEP] 
long 
term 
result 
cu 
##rative 
##teral 
re 
##f 
##lux 
end 
##os 
injection 
[CLS] 
inspection 
x 
tropical 
##is 
mouse 
human 
d 
upstream 
sequence 
revealed 
presence 
ta 
##ta 
box 
well 
pro 
##ximal 
enhance 
##r 
o 
##ame 
##r 
motif 
element 
contained 
##rna 
gene 
trans 
##cribed 
r 
polymer 
##ase 
ii 
[SEP] 
[CLS] 
characterization 
unusual 
t 
##rna 
like 
sequence 
found 
inserted 
ne 
##uro 
##sp 
re 
##tro 
##mi 
##d 
[SEP] 
[CLS] 
repeated 
time 
course 
patient 
re 
absolute 
concentration 
showed 
variation 
variation [SEP] 
the 
present 
relative 
blood 
##test 
##inal 
f 
[CLS] 
the 
human 
p 
gene 
generates 
least 
five 
different 
alternatively 
s 
##lice 
##d 
trans 
##cript 
encoding 
different 
##of 
##orms 
[CLS] 
these 
show 
s 
##1 
s 
##3 
transcription 
factor 
up 
##re 
##gu 
##f 
promoter 
activity 
binding 
s 
##p 
##1 
binding 
site 
position 
31 
##8 
303 
b 
##p 
##f 
gene 
promoter 
[SEP] 
[CLS] 
1 
h 
rest 
t 
return 
base 
subject 
repeated 
5 
min 
protocol 
followed 
final 
m 
##ri 
m 
##r 
##r [SEP] 
[CLS] 
the 
cell 
arrest 
g 
##1 
cycle 
grow 
projection 
towards 
one 
another 
forming 
s 
##hm 
##oo 
projection 
[SEP] 
ma 
##mmal 
ho 
##mo 
##mologue 
##s 
##comb 
group 
enhance 
##r 
media 
gene 
si 
##ros 
##op 
he 
##tero 
##ch 
te 
##lo 
with 
show 
##lan 
nod 
##al 
meta 
##sta 
##sis 
s 
##ln 
his 
##tology 
reflective 
his 
##tology 
remainder 
nod 
##al 
basin 
conservative 
s 
##ln 
bio 
stage 
nod 
##ally 
patient 
##lan 
##oma 
the 
result 
obtained 
##30 
##4 
r 
structural 
change 
e 
co 
r 
vicinity 
he 
##lix 
distortion 
influence 
cat 
##alytic 
##zy 
[SEP] 
[CLS] 
c 
##lon 
##ing 
characterization 
5 
flank 
region 
human 
at 
##rate 
l 
##yas 
gene 
[SEP] 
##bul 
maintenance 
##od 
##ial 
relation 
he 
##pa 
infection 
the 
s 
##3 
protein 
contains 
d 
repair 
processing 
processing 8 
o 
d 
via 
##yla 
##id 
##yas 
activity 
[CLS] 
25 
patient 
received 
20 
mg 
h 
##cine 
n 
##yl 
br 
##omi 
##de 
rest 
5 
mg 
prop 
##ino 
##te 
v 
plus 
di 
##az 
##am 
[CLS] 
we 
statistical 
technique 
identify 
sequence 
element 
may 
responsible 
cycle 
regulation 
[CLS] 
com 
to 
c 
##t 
finding 
##cre 
##atic 
duct 
##al 
ad 
##eno 
##cin 
##oma 
studied 
combined 
method 
early 
enhance 
c 
##t 
high 
dose 
enhance 
72 
##cin 
##oma 
[SEP] 
[CLS] 
no 
trans 
##cript 
different 
length 
could 
detected 
prolonged 
exposure 
absence 
e 
##1 
##a 
##4 
trigger 
operate 
independently 
known 
##va 
ca 
yet 
##ter 
##ized 
mechanism 
used 
super 
##shi 
##fts 
##tero 
promoter 
protein 
complex 
gel 
shift 
experiment 
[CLS] 
the 
n 
##uc 
##leo 
##tide 
sequence 
est 
##rogen 
receptor 
gene 
ore 
##och 
##rom 
au 
##reus 
o 
##ae 
##r 
indicates 
hormone 
binding 
e 
domain 
composed 
4 
ex 
##on 
inter 
##spersed 
short 
intro 
##n 
0 
18 
1 
3 
k 
##b 
[SEP] 
[CLS] 
the 
expression 
##1 
mph 
##1 
well 
correlated 
tissue 
em 
##b 
##ryo 
##ryo [SEP] 
[CLS] 
the 
n 
gene 
##9 
rear 
##ranged 
several 
##uke 
trans 
##location 
within 
region 
we 
isolated 
sequence 
##d 
sequence 
corresponding 
two 
novel 
gene 
map 
##q 
##28 
a 
direct 
direct hem 
##rina 
##h 
compared 
serum 
[CLS] 
diffusion 
epidemic 
in 
##cu 
##bation 
c 
##ris 
##s 
##cross 
dynamic 
dynamic [SEP] 
[CLS] 
c 
##eri 
##p 
interaction 
interaction [SEP] 
the 
encoded 
##ido 
##3 
folded 
secondary 
structure 
similar 
##3 
r 
##zo 
[PAD] [CLS] 
therapy 
prevention 
##rre 
##versible 
shock 
co 
##rt 
##ico 
##ster 
##oid 
##oid [SEP] 
##rate 
0 
1 
m 
##l 
2 
##h 
##5 
f 
internal 
0 
0 05 
m 
##l 
100 
mg 
mg l 
extracted 
extracted to 
##xi 
tube 
to 
##roma 
##pect 
##rome 
##rometry 
##try [SEP] 
[PAD] [CLS] 
positive 
effect 
radioactive 
therapy 
[CLS] 
the 
l 
##t 
beta 
gene 
expressed 
l 
##ymph 
##oid 
cell 
organ 
little 
known 
in 
regulation 
[SEP] 
[CLS] 
##ro 
##f 
attained 
peak 
serum 
concentration 
1 
2 
mg 
l 
serum 
half 
life 
34 
min 
[CLS] 
d 
##d 
clone 
en 
##codes 
p 
##pt 
##ide 
33 
amino 
acid 
82 
identity 
my 
##od 
41 
amino 
acid 
put 
##ative 
he 
##lix 
loop 
he 
##lix 
region 
100 
identity 
13 
amino 
acid 
basic 
domain 
proposed 
contain 
essential 
recognition 
code 
muscle 
specific 
gene 
activation 
[SEP] 
[CLS] 
identification 
o 
##ste 
##al 
##cin 
gene 
promoter 
sequence 
bind 
##p 
##1 
treatment 
based 
##nga 
drug 
n 
##ys 
##tat 
am 
##oter 
k 
##le 
[CLS] 
mutation 
##bol 
ma 
##lk 
function 
result 
transport 
##lt 
##ose 
also 
cause 
con 
##it 
##utive 
expression 
ma 
##lt 
##ose 
re 
##lon 
[SEP] 
[CLS] 
d 
##ros 
case 
##in 
kinase 
d 
##cki 
##i 
composed 
cat 
##alytic 
alpha 
regulatory 
beta 
subunit 
associated 
alpha 
##a 
he 
##tero 
##te 
##tra 
##mer 
[SEP] 
the 
the aim 
study 
examine 
examine whether 
whether e 
research 
##l 
##30 
alone 
distinguish 
group 
design 
defined 
gas 
gastric 
variable 
variable [SEP] 
##gio 
##po 
##f 
les 
almost 
size 
light 
area 
dark 
center 
##co 
##id 
les 
##ion 
[CLS] 
we 
percentage 
o 
##3 
up 
##take 
30 
adult 
s 
##pra 
##gue 
da 
##wley 
rat 
nose 
1 
h 
##r 
0 
3 
0 
6 
1 
0 
o 
##3 
[SEP] 
[CLS] 
the 
signal 
noise 
ratio 
##r 
calculated 
t 
##2 
weighted 
sequence 
sequence [SEP] 
kinase 
##3 
##k 
lacking 
cluster 
kinase 
regulatory 
domain 
[CLS] 
three 
distinct 
human 
h 
##da 
##cs 
ho 
##mo 
##log 
##ous 
r 
##d 
##3 
yeast 
transcription 
##al 
regulator 
[SEP] 
[CLS] 
the 
4 
n 
##t 
sequence 
rot 
3 
te 
far 
shortest 
sequence 
enhance 
##r 
known 
stimulate 
translation 
[SEP] 
[PAD] [CLS] 
objective 
v 
associated 
ne 
##bro 
##mat 
##matosis 
type 
##2 
well 
characterized 
expression 
##em 
##oki 
require 
n 
##f 
element 
additional 
region 
ca 
##at 
enhance 
##r 
binding 
protein 
c 
e 
##b 
element 
il 
8 
promoter 
[CLS] 
hope 
health 
illness 
illness [SEP] 
assessment 
direct 
screening 
##rina 
p 
##or 
##ph 
##ob 
##ili 
##vation 
peripheral 
blood 
##ope 
first 
##po 
##cellular 
ma 
##rrow 
##rate 
therapy 
dose 
##ra 
c 
c ex 
exert 
main 
main activity 
suppression 
le 
##uka 
##em 
rather 
differentiation 
cell 
cell [SEP] 
all 
de 
##pressive 
showed 
improved 
error 
treatment 
t 
##ria 
##xial 
pro 
neutron 
##oso 
o 
6 
symmetry 
application 
a 
[CLS] 
the 
best 
sequence 
study 
experience 
##r 
short 
t 
##r 
spin 
echo 
t 
##1 
weighted 
image 
spin 
echo 
1200 
t 
##r 
t 
##2 
image 
image [SEP] 
[CLS] 
cell 
co 
infected 
simultaneously 
i 
ib 
##bv 
re 
containing 
d 
r 
##na 
sequence 
second 
r 
expressing 
expressing t 
r 
##na 
polymer 
##ase 
initial 
expression 
d 
r 
trans 
##cript 
subsequently 
rescued 
help 
##er 
i 
##b 
##v 
[SEP] 
[CLS] 
seasonal 
variation 
##d 
##mium 
content 
##d 
##mium 
poll 
##uted 
environment 
result 
relation 
##of 
##orm 
l 
diversity 
tissue 
cell 
[CLS] 
doctor 
given 
in 
##hot 
##xa 
##te 
20 
standard 
needle 
used 
the 
1 
1 recruited 
released 
go 
gol 
##gi 
membrane 
treatment 
1 
m 
t 
##ris 
re 
##in 
1 
1 recruited 
##utive 
##1 
##1 
remains 
bound 
[CLS] 
the 
formation 
tumor 
##like 
les 
##ion 
cock 
anal 
block 
##age 
fine 
tangled 
p 
##ili 
ha 
##em 
du 
novel 
class 
p 
[CLS] 
we 
remarkable 
difference 
expression 
pattern 
m 
##t 
##b 
##rna 
two 
hybrid 
##rna 
5 
##k 
##b 
##b 8 
k 
##b 
human 
brain 
primary 
brain 
tumor 
compared 
compared [SEP] 
[CLS] 
two 
red 
##ox 
center 
f 
##ad 
##ad 4 
##4 
##s 
2 
1 
cluster 
present 
64 
k 
##da 
mon 
##omer 
the 
gene 
g 
gt 
##pas 
belonging 
##pt 
r 
##ab 
expression 
regulated 
mediated 
##rome 
[CLS] 
car 
##ot 
##id 
body 
ch 
##em 
##ore 
##ceptor 
activity 
recorded 
##ros 
##al 
gang 
##lion 
cat 
human 
##oto 
se 
serine 
pro 
prote 
sub 
##site 
th 
##io 
##ester 
substrate 
in 
##oly 
[CLS] 
explore 
role 
car 
##box 
terminal 
domain 
determining 
cell 
cycle 
##d 
##c 
##c34 
characterized 
gene 
encoding 
##s 
incorporating 
sequence 
##d 
related 
functional 
distinct 
distinct e 
e2 
##ad 
##2 
[SEP] 
[CLS] 
map 
##k 
##k 
kinase 
##k 
p 
activate 
downstream 
protein 
kinase 
map 
##k 
kinase 
##k 
turn 
activate 
##k 
[CLS] 
k 
##ond 
##o 
effect 
cu 
f 
##e 
film 
[CLS] 
however 
ad 
##ar 
##1 
related 
de 
##ami 
##nas 
##ar 
##2 
showed 
expression 
region 
brain 
examined 
including 
cortex 
hip 
##po 
##cam 
##pus 
o 
##lf 
##actor 
##y 
s 
##tri 
##at 
##um 
5 
##t 
##r 
m 
##rna 
extensively 
edited 
[SEP] 
[CLS] 
to 
investigate 
transcription 
1 
1 
k 
##base 
##s 
5 
flank 
##ing 
sequence 
fused 
l 
##uc 
##ifer 
##ase 
reporter 
gene 
[SEP] 
[PAD] [CLS] 
influence 
copper 
addition 
0 
01 
inch 
flow 
##ire 
do 
signal 
[CLS] 
##os 
##ulf 
##ates 
oxygen 
##eton 
c 
##19 
s 
##tero 
##id 
adult 
human 
urine 
[SEP] 
[CLS] 
an 
##ae 
##ro 
##bic 
condition 
50 
day 
experiment 
organism 
de 
##graded 
15 
15 18 
te 
##m 
##m 20 
25 
al 
##kan 
in 
36 
368 
##9 
109 
##34 
##342 
168 
##64 
##3 
determine 
hem 
lethal 
further 
review 
evaluation 
survival 
rate 
9 
262 
patient 
1981 
1996 
1996 [SEP] 
36 
initial 
examination 
[CLS] 
co 
##rt 
##ico 
##tro 
##pin 
releasing 
##rf 
injected 
central 
suppression 
punished 
punished 
responding 
conflict 
##hes 
role 
media 
behavioral 
response 
stress 
[SEP] 
[CLS] 
temporal 
recruitment 
m 
msin 
##3 
core 
##press 
complex 
et 
##s 
domain 
transcription 
factor 
factor el 
##k 
1 
[SEP] 
[CLS] 
the 
cluster 
mapped 
n 
##uc 
##leo 
##tide 
46 
##4 
43 
##4 
relative 
##leo 
##tide 
a 
initiation 
co 
##don 
g 
##eno 
##mic 
d 
##na 
[SEP] 
in 
##r 
##1 
show 
con 
##it 
##utive 
p 
positive 
regulator 
translation 
p 
##70 
##6 
kinase 
p 
in 
##hibit 
##3 
kinase 
m 
##tor 
target 
inhibitor 
[CLS] 
the 
the author 
orbital 
cavern 
##ous 
hem 
##ang 
##io 
diagnosed 
t 
99 
r 
##b 
##c 
s 
##pect 
##pect [SEP] 
##ro 
##f 
level 
serum 
##er 
end 
dos 
interval 
8 
h 
superior 
superior almost 
superior 
organism 
pseudo 
##mona 
##ino 
anti 
##biotic 
##hyl 
##ax 
[CLS] 
identified 
clone 
ch 
##omo 
##eno 
##mic 
d 
rescued 
ca 
ca 2 
dependent 
a 
##xon 
##ema 
##l 
##ule 
se 
defect 
##1 
these 
change 
first 
week 
week [SEP] 
[CLS] 
##yper 
##lip 
recently 
child 
##gra 
alter 
##ation 
base 
disease 
disease [SEP] 
plasma 
hem 
##ope 
##xin 
home 
##ost 
acute 
phase 
[CLS] 
re 
##press 
##or 
element 
rare 
example 
naturally 
perfect 
##nd 
##rom 
binding 
motif 
n 
##f 
ka 
##ppa 
##l 
transcription 
factor 
[SEP] 
[CLS] 
try 
##pt 
induction 
prevents 
r 
##ho 
dependent 
transcription 
termination 
leader 
region 
op 
##eron 
[SEP] 
[CLS] 
remains 
physiological 
problem 
one 
always 
foremost 
m 
##or 
intrinsic 
regulation 
brain 
activity 
separate 
action 
different 
arousal 
system 
brought 
whole 
whole [SEP] 
[CLS] 
the 
gene 
comprised 
17 
ex 
##on 
span 
36 
k 
##b 
[CLS] 
the 
immune 
response 
seems 
partially 
protection 
destructive 
consequence 
infection 
[CLS] 
result 
he 
##pa 
h 
##yd 
##dos 
177 
patient 
patient [SEP] 
c 
##rea 
##tine 
p 
##hos 
##oki 
##nas 
release 
patient 
[CLS] 
the 
majority 
put 
##ative 
t 
mutation 
found 
s 
##poradic 
rather 
linked 
family 
[SEP] 
[CLS] 
m 
##am 
1 
encoded 
single 
copy 
gene 
spanning 
13 
k 
##b 
structural 
##ly 
organized 
14 
ex 
##on 
13 
intro 
##n 
similar 
human 
counterpart 
[SEP] 
bio 
specimen 
taken 
frontal 
branch 
right 
superficial 
segment 
##al 
in 
##ti 
thick 
consistent 
in 
##ti 
fi 
##bro 
##p 
type 
##m 
##d 
his 
thus 
study 
##it 
##ro 
directly 
evaluate 
##phe 
##nous 
respond 
##as 
##oc 
##ons 
##tric 
##erial 
level 
[PAD] [CLS] 
we 
found 
##20 
gene 
identical 
yeast 
##rm 
##1 
gene 
##k 
s 
##pra 
##gue 
1989 
1989 [SEP] 
[CLS] 
basal 
j 
map 
##k 
specifically 
delta 
##r 
correlated 
increased 
54 
k 
##da 
protein 
observed 
delta 
##r 
cell 
del 
##eti 
##on 
analysis 
distinct 
functional 
domain 
##f 
##1 
line 
1 
[CLS] 
##a 
similar 
result 
induction 
w 
wt 
##p 
##1 
j 
promoter 
cat 
p 
##mi 
##d 
smaller 
[SEP] 
##th 
##rom 
##bin 
ii 
##i 
at 
ii 
##i 
[CLS] 
one 
##f 
extends 
n 
##uc 
##leo 
415 
1620 
en 
##codes 
40 
amino 
acid 
preceded 
rib 
##oso 
binding 
site 
[CLS] 
glucose 
consumption 
human 
brain 
influence 
##ven 
##ous 
in 
##fusion 
glucose 
g 
##lu 
##ca 
##gon 
glucose 
insulin 
d 
hug 
##hes 
f 
[CLS] 
del 
##eti 
##c 
lethal 
resulted 
dumb 
##bell 
shaped 
terminal 
morphology 
nucleus 
almost 
divided 
still 
connected 
these 
##a 
found 
derived 
3 
region 
3 
met 
gene 
[CLS] 
a 
during 
o 
o2 
is 
##che 
extra 
##cellular 
k 
change 
sub 
##ep 
##rdi 
##um 
significantly 
le 
mid 
##oc 
##ard 
##ium 
[SEP] 
the 
generation 
do 
##rs 
##o 
ventral 
polar 
##ros 
##op 
##b 
##ryo 
regulated 
action 
12 
12 maternal 
maternally 
gene 
product 
dorsal 
group 
group [SEP] 
[CLS] 
ul 
##ti 
##mo 
##nch 
##ial 
body 
para 
##roid 
g 
##land 
freshwater 
na 
natri 
p 
##cat 
response 
d 
##3 
administration 
[CLS] 
these 
observation 
suggest 
##f 
1 
region 
##pha 
partially 
silence 
##d 
core 
##press 
##or 
protein 
might 
interact 
p 
##lation 
dependent 
manner 
[SEP] 
author 
title 
title two 
drug 
name 
name two 
c 
##ir 
##cum 
##stance 
condition 
data 
dial 
dim 
s 
variation 
ass 
pro 
##te 
##ase 
enzyme 
exhibited 
substantial 
level 
pro 
##ly 
is 
##omer 
##ase 
activity 
5 
20 
wild 
revealing 
mutation 
con 
##fer 
pro 
##te 
##ase 
dig 
##est 
classic 
##it 
##ro 
ass 
pro 
##ly 
is 
##omer 
##ase 
misleading 
[CLS] 
test 
hypothesis 
predicted 
altered 
class 
i 
gene 
product 
beta 
knockout 
beta 
would 
develop 
over 
##load 
[CLS] 
n 
##uc 
##leo 
##tide 
sequence 
gag 
gene 
gag 
p 
##ol 
junction 
f 
##elin 
##uke 
[SEP] 
based 
1 
r 
##na 
level 
based 
complete 
##iro 
suppression 
describes 
result 
trial 
tumor 
##b 
combination 
##i 
d 
##d 
##p 
5 
flu 
##oro 
##rist 
##ine 
[CLS] 
on 
basis 
physical 
interaction 
##x 
##l 
##f 
present 
model 
##x 
##l 
s 
##licing 
regulation 
[SEP] 
skin 
##fold 
ant 
##hr 
##op 
limitation 
der 
##iving 
total 
body 
fat 
fat t 
##b 
##bf 
possibility 
problem 
might 
related 
den 
##si 
addressed 
addressed [SEP] 
difference 
intermediate 
group 
11 
f 
##em 
##oral 
11 
l 
6 
total 
b 
##m 
##ds 
we 
clone 
##d 
b 
##hi 
f 
fragment 
##4 
##13 
1 
sa 
b 
##hi 
site 
order 
structural 
analysis 
##1 
##a 
region 
##4 
we 
reviewed 
81 
patient 
dem 
##ent 
auto 
##psy 
finding 
al 
##z 
##heimer 
disease 
ad 
identify 
patient 
seizure 
##oc 
##lon 
onset 
dem 
##ent 
##ia 
##ia [SEP] 
background 
lung 
ex 
##pi 
##rator 
slightly 
higher 
p 
##x 
air 
##way 
corresponding 
lower 
in 
##fle 
##ction 
lip 
ins 
##pi 
##rator 
p 
curve 
measured 
recommended 
recommended [SEP] 
[CLS] 
3 
3 [SEP] 
raw 
cell 
micro 
e 
##oc 
two 
if 
gamma 
activated 
transcription 
factor 
s 
##tat 
1 
##al 
##pha 
i 
##rf 
1 
bind 
gas 
i 
##rf 
element 
respectively 
[SEP] 
[CLS] 
thermal 
change 
b 
##ov 
u 
##ter 
##us 
following 
administration 
est 
##rad 
##iol 
17 
##bet 
##a 
[CLS] 
the 
starting 
dose 
dose 8 
m 
administered 
in 
##ven 
i 
##v 
short 
in 
##fusion 
daily 
5 
day 
repeated 
3 
dose 
adjustment 
depending 
tolerance 
tolerance [SEP] 
safe 
satisfactory 
result 
result [SEP] 
[CLS] 
in 
##hibition 
##oam 
##ine 
o 
##xi 
##xidas 
##gy 
##line 
10 
mg 
kg 
v 
effect 
t 
##yra 
##mine 
1000 
##gram 
injected 
he 
##pa 
potent 
he 
##lena 
trigger 
##d 
##9 
death 
##l 
x 
l 
##l 
2 
of 
##cus 
in 
##al 
invasive 
neo 
##p 
34 
95 
21 
49 
including 
9 
low 
high 
sq 
in 
les 
##ion 
1 
ad 
##eno 
##cin 
##oma 
##er 
##x 
3 
ad 
##eno 
##cin 
##x 
2 
ad 
##eno 
##cin 
end 
1 
ad 
##id 
basal 
car 
##cin 
##er 
##x 
[SEP] 
the 
d 
##3 
##1 
gene 
high 
over 
##ex 
##pressed 
transcription 
##al 
level 
breast 
cancer 
[CLS] 
the 
organization 
##b 
gene 
similar 
arrangement 
gene 
ho 
##mo 
##log 
##ous 
pulmonary 
surf 
##act 
although 
one 
intro 
##n 
position 
shifted 
single 
amino 
acid 
[CLS] 
hip 
fracture 
[CLS] 
these 
result 
indicate 
patient 
s 
evidence 
exercise 
s 
##t 
segment 
depression 
may 
decreased 
my 
##oc 
##ard 
##ial 
oxygen 
supply 
due 
hem 
##og 
##lo 
##bin 
level 
increased 
my 
##oc 
##ard 
##ial 
oxygen 
demand 
elevated 
double 
compared 
subject 
exercise 
s 
##t 
segment 
depression 
depression [SEP] 
although 
display 
display approximately 
75 
sequence 
identity 
rat 
##r 
receptor 
display 
different 
p 
##har 
profile 
especially 
respect 
analogue 
201 
99 
##5 
specific 
reduction 
##au 
peak 
echo 
e 
late 
component 
observed 
[CLS] 
em 
##bo 
e 
##ur 
[CLS] 
using 
o 
##gon 
##leo 
##tide 
probe 
probe 8 
k 
##ilo 
##base 
hind 
##ii 
##i 
fragment 
g 
##eno 
##mic 
d 
isolated 
subjected 
sang 
##er 
did 
##eo 
d 
se 
##quencing 
[SEP] 
130 
132 
167 
i 
top 
##ois 
##omer 
four 
c 
k 
##4 
##15 
identified 
match 
one 
g 
##eno 
##mic 
clone 
match 
confirmed 
##leo 
##tide 
sequence 
analysis 
[CLS] 
[CLS] 2 
prevalence 
##p 
##ride 
pro 
his 
pro 
##ram 
relax 
pro 
e 
e1 
##1 
##os 
men 
art 
##eri 
##ogenic 
imp 
##ote 
di 
##abe 
imp 
##ote 
##nous 
leak 
[CLS] 
prime 
##r 
extension 
experiment 
d 
##p 
differentiated 
##9 
##37 
single 
transcription 
##al 
initiation 
site 
[SEP] 
[CLS] 
in 
ii 
showed 
improvement 
peak 
v 
##o 
##2 
rate 
##v 
delay 
fixed 
##v 
delay 
05 
effect 
family 
visit 
blood 
heart 
##rona 
##ry 
unit 
[CLS] 
sequence 
analysis 
electro 
##ore 
experiment 
##nse 
element 
interact 
region 
region g 
##ata 
related 
factor 
respectively 
[SEP] 
[PAD] [CLS] 
co 
k 
##12 
strain 
co 
9 
##und 
##ii 
1 
1 
1 e 
c 
##aca 
##aca 2 
##art 
[CLS] 
wild 
##k 
##k 
##1 
enhance 
promoter 
activity 
activity 
in 
##hibit 
dominant 
##k 
##k 
##1 
##k 
##1 
##3 
##k 
c 
250 
302 
[PAD] [CLS] 
the 
study 
shift 
immunity 
system 
path 
##ogen 
chronic 
##tum 
##orous 
disease 
##id 
g 
##land 
##land [SEP] 
[PAD] [CLS] 
co 
##ex 
##ist 
turn 
##er 
syndrome 
##chi 
##zophrenia 
##zophrenia [SEP] 
[CLS] 
an 
promoter 
fragment 
dose 
contain 
sequence 
resembling 
o 
shifted 
fusion 
protein 
[SEP] 
conflict 
drinking 
test 
rat 
effect 
##sel 
##ec 
beta 
ad 
##ren 
##ept 
##or 
block 
##er 
pin 
##do 
##lo 
##op 
##olo 
bind 
##t 
##1 
##a 
##1 
receptor 
selective 
beta 
1 
beta 
ad 
##ren 
##or 
antagonist 
beta 
##x 
##olo 
i 
55 
##1 
##1 respectively 
respectively ne 
##t 
receptor 
receptor [SEP] 
[CLS] 
although 
signal 
contain 
tandem 
##ly 
occurring 
s 
##h 
##3 
##2 
domain 
function 
closely 
spaced 
domain 
well 
understood 
[SEP] 
bio 
##har 
##ces 
c 
##vis 
##29 
##eli 
##1 
defect 
initiation 
chain 
formation 
conclusion 
ul 
##cer 
co 
##lit 
increased 
promptly 
parent 
##eral 
##tero 
i 
##rre 
##spective 
outcome 
[CLS] 
the 
duration 
na 
##xon 
##e 
appears 
dose 
related 
statistical 
approximately 
1 
5 
h 
##r 
[CLS] 
but 
equal 
##izes 
upper 
limit 
normal 
common 
95 
specific 
t 
##umour 
indicating 
19 
9 
clearly 
##pass 
[CLS] 
these 
motion 
found 
n 
c 
terminal 
tail 
segment 
33 
35 
form 
turn 
beta 
strand 
s 
##1 
s 
##2 
residue 
47 
52 
located 
long 
loop 
preceding 
strand 
s 
##3 
[SEP] 
[CLS] 
##eno 
##mic 
southern 
analysis 
reveals 
10 
15 
hybrid 
fragment 
maize 
contains 
small 
gene 
family 
[CLS] 
custom 
made 
or 
##th 
##ose 
achieving 
wide 
therapeutic 
goal 
improving 
function 
pinch 
stab 
individual 
joint 
preventing 
position 
##al 
contract 
##ure 
joint 
trauma 
intrinsic 
muscle 
correct 
joint 
tissue 
contract 
##ure 
controlling 
inflammation 
inflammation [SEP] 
[PAD] [CLS] 
is 
patient 
c 
##ro 
##hn 
disease 
environmental 
factor 
developing 
disease 
disease [SEP] 
[CLS] 
the 
z 
##1 
##ro 
translation 
bind 
consensus 
target 
site 
recognized 
protein 
[SEP] 
[CLS] 
the 
##100 
c 
##i 
acting 
promoter 
con 
##it 
##utive 
mutation 
du 
##plication 
comprises 
two 
g 
##ata 
site 
suppress 
##es 
area 
zinc 
mutation 
alleviate 
need 
functional 
u 
area 
protein 
[SEP] 
[PAD] [CLS] 
pit 
##uit 
##ary 
thy 
##rot 
##eno 
associated 
##gen 
##ital 
h 
##roid 
##ism 
##ism [SEP] 
[CLS] 
region 
un 
##fa 
##vour 
##able 
due 
malaria 
past 
past [SEP] 
indeed 
single 
oral 
dose 
role 
m 
ago 
component 
anti 
tram 
##ado 
##l 
appears 
minor 
anal 
effect 
at 
##tri 
##but 
##able 
##op 
##io 
##id 
parent 
compound 
chief 
end 
##ol 
##umi 
pro 
##sta 
6 
##eto 
##1 
alpha 
th 
##rom 
##box 
pat 
e 
##c 
coverage 
[CLS] 
so 
##matic 
##cer 
##al 
input 
th 
spinal 
cat 
effect 
bi 
##lia 
##ry 
system 
##2 
high 
##cher 
##ichi 
co 
synthetic 
gene 
[CLS] 
##fect 
6 
3 
p 
resulted 
10 
fold 
induction 
human 
re 
##nin 
transcription 
##al 
containing 
native 
consensus 
c 
5 
fold 
activation 
containing 
##function 
##al 
##re 
[CLS] 
we 
we undertook 
study 
examine 
relationship 
systemic 
oxygen 
delivery 
do 
##2 
tissue 
oxygen 
t 
##po 
##2 
##vo 
white 
case 
likely 
1 
9 
95 
c 
##i 
1 
0 
3 
5 
5 [SEP] 
method 
deficit 
ad 
##h 
##d 
28 
sub 
year 
random 
90 
immediate 
release 
met 
##ni 
##date 
i 
##r 
mph 
3 
day 
t 
##id 
dose 
##d 
every 
4 
hour 
hour n 
97 
##os 
mph 
day 
q 
##d 
##d n 
95 
28 
day 
[CLS] 
im 
##mu 
tolerance 
rat 
13 
week 
in 
##hala 
##tion 
exposure 
##elli 
##ide 
[PAD] [CLS] 
they 
cause 
disability 
invalid 
mortality 
great 
part 
significantly 
damaging 
country 
country [SEP] 
[CLS] 
c 
##lon 
##ing 
sequence 
analysis 
ch 
##ot 
pro 
prote 
##ase 
t 
##po 
##ne 
den 
##tic 
##ola 
[CLS] 
and 
q 
##t 
##d 
j 
##t 
##d 
interval 
39 
child 
long 
q 
##t 
syndrome 
compared 
50 
normal 
age 
matched 
child 
[SEP] 
[CLS] 
v 
v er 
##bb 
mediated 
complex 
formation 
transformation 
shown 
occur 
independently 
##a 
activation 
[SEP] 
both 
parameter 
determined 
ion 
##ron 
##oro 
##oto 
excluded 
[CLS] 
organization 
ex 
##on 
suggests 
similar 
human 
gene 
alternative 
s 
##p 
##licing 
generates 
120 
164 
188 
amino 
is 
##of 
##orms 
predict 
fourth 
##of 
##orm 
corresponding 
##20 
##6 
electron 
##sco 
7 
t 
s 
extract 
10 
v 
##on 
complex 
##ed 
##oso 
10 
bound 
##oso 
confirming 
o 
##ga 
least 
##coat 
##ed 
[CLS] 
the 
sequence 
contained 
five 
repeat 
h 
##hetical 
zipper 
motif 
one 
n 
terminal 
g 
##bula 
##r 
domain 
four 
central 
alpha 
he 
##lica 
##l 
stalk 
[SEP] 
[CLS] 
post 
##he 
##par 
lip 
fat 
em 
substrate 
greater 
female 
rat 
male 
the 
author 
painful 
wrist 
related 
##ieu 
muscle 
dorsal 
hand 
hand [SEP] 
g 
##eno 
##mic 
organization 
human 
multi 
##dr 
##ug 
resistance 
m 
##dr 
##1 
gene 
origin 
[CLS] 
the 
response 
ni 
##tro 
##cer 
intact 
initial 
##per 
##fusion 
pressure 
[CLS] 
del 
##eti 
analysis 
revealed 
t 
domain 
required 
go 
gol 
##gi 
targeting 
targeting [SEP] 
[CLS] 
in 
addition 
put 
##ative 
binding 
site 
s 
##h 
##3 
s 
##h 
##2 
domain 
present 
amino 
terminal 
half 
molecule 
[SEP] 
[CLS] 
since 
nearly 
transform 
home 
##olo 
##go 
##us 
d 
carried 
single 
re 
##comb 
p 
##mi 
##d 
pm 
pm 
strain 
stable 
he 
##tero 
##du 
##plex 
d 
appears 
le 
likely 
ho 
##mo 
##log 
##ous 
d 
[SEP] 
right 
right reserved 
[CLS] 
one 
new 
##f 
##r 
##0 
##4 
detected 
coding 
protein 
91 
##8 
amino 
acid 
acid [SEP] 
sequence 
ready 
3 
m 
##b 
con 
##ti 
##g 
break 
##points 
##iri 
##da 
region 
human 
##13 
the 
map 
kinase 
kinase 
kinase 
m 
##lk 
co 
local 
##izes 
along 
##tub 
##ule 
associate 
kin 
##esi 
motor 
##3 
[CLS] 
bone 
s 
##ti 
excellent 
screening 
test 
bone 
les 
##ion 
##a 
67 
s 
##ti 
tool 
detect 
inflammatory 
les 
##ion 
##ion [SEP] 
[CLS] 
spontaneous 
fracture 
ta 
##rsa 
##rsal 
bone 
2 
case 
le 
##ros 
[CLS] 
they 
trans 
##duced 
t 
c 
##op 
##las 
portion 
c 
##olo 
##ops 
c 
terminal 
tail 
receptor 
transferred 
##op 
##las 
signaling 
molecule 
g 
protein 
[SEP] 
serum 
al 
##kal 
##pha 
##rea 
##tine 
increased 
##rae 
fed 
decreased 
na 
##o 
##4 
pig 
[CLS] 
this 
group 
showed 
presence 
bacteria 
in 
##fi 
##rated 
den 
##tina 
##l 
tub 
##ule 
co 
##rona 
##lly 
root 
canal 
[SEP] 
[CLS] 
seven 
z 
challenge 
time 
however 
scattering 
rate 
ta 
1 
plan 
##ck 
2 
##pi 
ta 
approximately 
6 
##t 
perpendicular 
implying 
bed 
t 
##t 
2 
##cu 
n 
2 
meet 
criterion 
inter 
##layer 
in 
[PAD] [CLS] 
the 
effect 
kidney 
length 
length considerably 
prolonged 
effect 
chain 
linked 
29 
implicated 
targeting 
pro 
##as 
[CLS] 
di 
##abe 
o 
##ste 
known 
chronic 
com 
diabetes 
alter 
##ation 
calcium 
vitamin 
d 
end 
##rine 
system 
##ro 
##af 
1 
kinase 
l 
##af 
1 
kinase 
activity 
cell 
raw 
cell 
r 
##af 
1 
kinase 
act 
##ivating 
component 
l 
signaling 
pathway 
regulating 
1 
promoter 
activity 
##a 
g 
##t 
##pas 
act 
gap 
##9 
##3 
f 
formation 
f 
complex 
via 
domain 
dependent 
mechanism 
[CLS] 
g 
##ival 
re 
##traction 
class 
v 
restoration 
method 
hem 
##og 
oxygen 
##per 
l 
##ymph 
flow 
##l 
increased 
4 
3 
3 8 
3 
m 
##l 
30 
##ymph 
ratio 
unchanged 
0 
6 
l 
##ymph 
protein 
increased 
increased 2 
6 
6 4 
6 
m 
##l 
30 
data 
micro 
##vas 
##cular 
per 
##me 
##ability 
[CLS] 
u 
s 
a 
[CLS] 
re 
##t 
p 
pt 
##c 
on 
##co 
##gene 
generated 
ch 
##rom 
##oso 
rear 
##rang 
##illa 
thy 
##roid 
con 
##it 
##utive 
##ly 
activated 
version 
pro 
##to 
re 
ret 
gene 
coding 
receptor 
type 
type t 
##os 
whose 
l 
##igan 
##d 
still 
unknown 
unknown [SEP] 
[CLS] 
p 
##cc 
680 
##3 
mutant 
impaired 
c 
##yt 
##och 
##rome 
c 
mat 
##uration 
[SEP] 
study 
objective 
character 
gas 
ma 
##ximal 
c 
exercise 
[CLS] 
in 
study 
show 
act 
##ivating 
effect 
mutation 
result 
creating 
ex 
##onic 
s 
##licing 
enhance 
##r 
es 
##e 
disrupt 
##ing 
put 
##ative 
secondary 
structure 
[SEP] 
[CLS] 
the 
kinase 
domain 
encoded 
co 
##oh 
terminal 
##ety 
94 
conserved 
n 
terminal 
##oi 
65 
ho 
##mo 
##log 
##ous 
suggesting 
region 
may 
en 
##code 
sequence 
con 
##fer 
##ferring 
differential 
regulation 
two 
kinase 
[SEP] 
[CLS] 
in 
rat 
c 
##d 
30 
level 
para 
##roid 
hormone 
##roid 
##x 
1 
alpha 
h 
##le 
##fer 
##ol 
1 
alpha 
oh 
d 
##3 
showed 
almost 
pattern 
control 
rat 
response 
camp 
influenced 
continuous 
continuous oral 
administration 
##d 
[SEP] 
[CLS] 
the 
goal 
investigation 
determine 
whether 
##mi 
up 
differentiate 
viable 
##oc 
##ard 
##ium 
scar 
tissue 
soon 
##rona 
##ry 
th 
##rom 
##bol 
##ys 
##oc 
##ard 
in 
##far 
[SEP] 
there 
three 
type 
problem 
problem 
enters 
body 
accept 
problem 
penetration 
drug 
body 
absorption 
barrier 
crossing 
duration 
action 
problem 
relating 
therapeutic 
target 
selective 
local 
delivery 
delivery [SEP] 
[PAD] [CLS] 
in 
shock 
se 
##psis 
##psis id 
cause 
acid 
##osis 
severe 
an 
##emia 
hem 
##og 
1 
2 
d 
appeared 
et 
##iol 
factor 
factor [SEP] 
transplant 
##los 
##por 
liver 
disease 
adult 
adult [SEP] 
[CLS] 
northern 
b 
##lot 
analysis 
muscle 
fat 
##uit 
##ary 
r 
d 
##d 
show 
major 
trans 
##cript 
4 
3 
##base 
k 
##b 
three 
minor 
trans 
##cript 
0 
0 8 
1 
7 
3 
2 
k 
##b 
correspond 
##r 
copyright 
1999 
concentration 
##roi 
t 
##umour 
evidence 
re 
##gression 
drug 
the 
##9 
gene 
en 
##1 
protein 
major 
partner 
ran 
g 
##t 
##pas 
[SEP] 
study 
design 
retrospective 
review 
review [SEP] 
[CLS] 
sequence 
diver 
transformation 
10 
fold 
fold [SEP] 
[CLS] 
study 
suggest 
he 
##lica 
assembly 
protein 
responsible 
loading 
t 
##4 
gene 
41 
he 
##lica 
specifically 
replication 
fork 
binding 
site 
arm 
must 
hold 
six 
12 
##tide 
[SEP] 
[CLS] 
during 
1st 
week 
treatment 
received 
either 
##ans 
##eri 
##n 
30 
mg 
c 
##mi 
##pra 
75 
mg 
daily 
c 
##b 
##d 
exploration 
patient 
normal 
the 
human 
pro 
##ximal 
promoter 
promoter analyzed 
d 
##nas 
##e 
i 
foot 
##print 
functional 
foot 
##print 
region 
##1 
##6 
within 
pro 
##ximal 
promoter 
studied 
he 
he 
[CLS] 
we 
do 
cross 
cross e 
120 
degree 
c 
60 
relative 
4 
degree 
90 
relative 
##read 
exercise 
1 
km 
h 
degree 
measured 
f 
##etal 
la 
e 
body 
temperature 
abdominal 
radio 
##em 
mutation 
variant 
within 
close 
coding 
region 
ex 
##on 
1 
h 
gene 
ex 
##on 
expressed 
solely 
##quito 
##of 
##orm 
[SEP] 
approach 
determination 
structure 
function 
##4 
isolated 
fifty 
all 
##4 
gene 
random 
site 
directed 
m 
##uta 
analyzed 
##hen 
many 
[CLS] 
over 
five 
training 
session 
2 
5 
day 
learned 
breathe 
number 
stimulus 
received 
session 
first 
session 
[CLS] 
the 
5 
flank 
##ing 
region 
gene 
approximately 
1 
1 
k 
##b 
##p 
long 
known 
regulatory 
element 
transcription 
g 
##c 
cc 
##aa 
##t 
box 
[SEP] 
[CLS] 
f 
##3 
##p 
k 
##1 
##p 
control 
##1 
arrest 
multiple 
function 
operate 
parallel 
far 
##1 
[CLS] 
tag 
expression 
##pop 
##ry 
e 
##pit 
late 
pregnancy 
the 
composition 
re 
##nal 
stone 
anal 
##ys 
infrared 
##pect 
[CLS] 
14 
9 
x 
109 
l 
1 
equal 
cc 
##i 
value 
higher 
bedside 
filtered 
p 
14 
1 
9 
5 
v 
v [SEP] 
[PAD] [CLS] 
in 
second 
he 
##pa 
##cin 
##oma 
year 
first 
tumor 
type 
reported 
reported [SEP] 
the 
time 
dependent 
change 
measured 
facility 
out 
##out 
appeared 
result 
gradual 
dissolution 
h 
##idas 
component 
barrier 
##ous 
out 
eye 
the 
factor 
defect 
##ive 
group 
c 
##ii 
##ta 
c 
##x 
d 
identified 
2 
4 
united 
kingdom 
24 
7 
##uga 
##l 
transmission 
7 
among 
ho 
##mo 
bisexual 
among 
in 
##ject 
drug 
among 
he 
##tero 
on 
approximately 
d 
##f 
##1 
million 
annually 
first 
40 
year 
prevent 
##ative 
strategy 
strategy [SEP] 
[CLS] 
by 
del 
##eti 
##on 
analysis 
identified 
region 
c 
j 
encoding 
transformation 
trans 
##act 
##ivation 
function 
[SEP] 
[PAD] [CLS] 
survey 
late 
detected 
case 
c 
##dh 
year 
1970 
74 
74 presented 
presented [SEP] 
[CLS] 
to 
test 
pro 
mediated 
activation 
transcription 
yeast 
reporter 
##mi 
##d 
constructed 
transform 
yeast 
cell 
p 
c 
##1 
##c 
receptor 
[SEP] 
fl 
##i 
1 
rear 
##ranged 
tumor 
three 
different 
re 
##tro 
ca 
br 
e 
f 
m 
##v 
##1 
[CLS] 
ion 
##ic 
composition 
na 
na k 
ca 
2 
mg 
##2 
##ere 
##bro 
fluid 
feeding 
behavior 
sheep 
[SEP] 
material 
m 
##or 
##phological 
##io 
t 
##nn 
medium 
[CLS] 
conclusion 
finding 
imply 
spinal 
cord 
simple 
command 
carrying 
medium 
brain 
limb 
implies 
computational 
activity 
take 
place 
spinal 
level 
level [SEP] 
the 
101 
##st 
annual 
meeting 
j 
##nese 
society 
[CLS] 
the 
result 
physiological 
function 
##oa 
##om 
##t 
el 
##icit 
cell 
may 
light 
se 
##quential 
action 
trans 
trans active 
factor 
regulation 
##ano 
gene 
[SEP] 
[CLS] 
s 
transformed 
gap 
he 
##tero 
##mer 
##ic 
complex 
notably 
highly 
p 
k 
##da 
##2 
[CLS] 
a 
study 
as 
##th 
##ns 
##nsiti 
cat 
dog 
all 
##er 
##gen 
[SEP] 
[CLS] 
p 
##p 
rapidly 
trans 
##ient 
##ly 
activated 
extra 
##cellular 
signal 
regulated 
protein 
kinase 
##k 
type 
cell 
[SEP] 
[CLS] 
co 
harbor 
##10 
##zy 
##matic 
c 
##lea 
34 
me 
o 
##leo 
containing 
single 
single 8 
o 
##x 
opposite 
##os 
##ine 
##ine 8 
o 
##x 
c 
[SEP] 
est 
##rogen 
cast 
##rated 
also 
showed 
my 
##oc 
##ard 
##ial 
blood 
beta 
est 
##rad 
##rona 
##ry 
decreased 
base 
##line 
1 
h 
200 
dose 
1 
69 
0 
61 
1 
41 
0 
##h 
##z 
di 
##ast 
##olic 
co 
##rona 
##ry 
resistance 
increased 
01 
compared 
time 
51 
15 
compared 
39 
##z 
re 
##nal 
vein 
th 
##rom 
##bos 
all 
##og 
##pp 
[CLS] 
several 
d 
##na 
clone 
obtained 
procedure 
one 
clone 
18 
reported 
characterized 
[CLS] 
long 
range 
mapping 
field 
gel 
electro 
##ores 
three 
m 
##dr 
gene 
closely 
linked 
g 
##eno 
##mic 
d 
segment 
approximately 
625 
k 
##ilo 
##base 
##s 
[SEP] 
[CLS] 
these 
sequence 
tested 
presence 
enhance 
##r 
element 
ability 
activate 
reporter 
gene 
consisting 
cat 
gene 
linked 
gamma 
##lo 
##bin 
gene 
promoter 
promoter er 
##yt 
##hr 
k 
er 
##hr 
he 
cell 
[SEP] 
[CLS] 
two 
si 
##b 
identical 
feature 
dwarf 
##ism 
normal 
skull 
face 
normal 
intelligence 
described 
[SEP] 
[CLS] 
this 
describes 
program 
resulted 
75 
reduction 
five 
year 
interval 
further 
comparative 
analysis 
para 
##log 
33 
identity 
46 
similarity 
gene 
belong 
novel 
family 
nine 
zinc 
motif 
followed 
##ob 
domain 
[SEP] 
all 
patient 
ma 
##rrow 
identical 
sibling 
donor 
underwent 
##elo 
##ab 
regime 
##tre 
##at 
characteristic 
characteristic [SEP] 
[CLS] 
in 
##ad 
b 
##uf 
b 
##uf 
feeding 
different 
rate 
##re 
value 
n 
0 
44 
metabolism 
growth 
k 
##j 
##j 
1 
1 [SEP] 
[CLS] 
method 
patient 
developed 
##er 
##vic 
##elo 
##adi 
manipulation 
therapy 
her 
##nia 
disc 
c 
##4 
c 
##5 
c 
##6 
respectively 
sub 
##lone 
stab 
alpha 
##1 
alpha 
##1 
##b 
alpha 
##1 
##d 
##r 
control 
promoter 
high 
receptor 
density 
isolated 
characterized 
[SEP] 
analysis 
w 
wt 
##1 
target 
gene 
trans 
cell 
line 
[CLS] 
soluble 
r 
##i 
soluble 
c 
alpha 
associate 
##ro 
activated 
c 
am 
##p 
[SEP] 
i 
##ris 
gas 
d 
formed 
number 
specific 
complex 
con 
##it 
##utive 
factor 
##b 
##b [SEP] 
[CLS] 
simulation 
based 
presented 
model 
experimental 
data 
type 
cm 
##uts 
literature 
[CLS] 
t 
##re 
exercise 
35 
w 
degree 
c 
correlated 
r 
70 
v 
##o 
##2 
##max 
0 
80 
exercise 
heat 
heat [SEP] 
electro 
##ore 
extract 
1 
cell 
trans 
s 
1 
5 
indicate 
s 
##3 
form 
complex 
migration 
##ogen 
t 
beta 
specific 
complex 
observed 
##bro 
extract 
[SEP] 
[CLS] 
the 
n 
##f 
ka 
enhance 
##r 
##r t 
##aa 
##att 
##cc 
bound 
t 
##n 
##f 
alpha 
appears 
key 
element 
rapid 
transcription 
induction 
##f 
alpha 
t 
trans 
##act 
##ivation 
element 
re 
##pressed 
bound 
##co 
##cor 
##tic 
receptor 
[SEP] 
[CLS] 
our 
result 
showed 
h 
##ydro 
##try 
##pta 
h 
content 
plate 
##let 
1 
increased 
subgroup 
anti 
social 
alcoholic 
2 
trans 
##ient 
##ly 
differently 
altered 
alcoholic 
compared 
op 
add 
##ict 
3 
lowered 
drinking 
alcoholic 
normal 
alcoholic 
drinking 
well 
smoking 
occur 
via 
via ma 
mao 
b 
in 
##hibition 
smoke 
smoke [SEP] 
in 
33 
36 
detected 
6 
level 
le 
25 
mg 
d 
3 
the 
p 
##pt 
##ide 
encoded 
contained 
amino 
acid 
calculated 
m 
r 
52 
05 
showed 
ho 
##d 
22 
[CLS] 
correlation 
alpha 
activity 
frontal 
o 
##pit 
##al 
cortex 
cortex [SEP] 
[CLS] 
sit 
local 
##1 
trans 
##cript 
revealed 
specifically 
pollen 
late 
bin 
##lea 
##te 
t 
stage 
development 
rather 
tape 
##tum 
previously 
taken 
principal 
source 
coat 
[SEP] 
##fo 
##ido 
##fo 
c 
##os 
##ino 
[CLS] 
the 
s 
##pec 
##ie 
composition 
abundance 
glass 
e 
natural 
in 
[CLS] 
however 
h 
##19 
i 
lie 
within 
larger 
imprint 
##ed 
domain 
specific 
##19 
e 
##pi 
##mu 
persistent 
question 
[CLS] 
here 
c 
##lon 
##ing 
either 
p 
##eptide 
se 
sequence 
human 
c 
##dn 
##ere 
##vis 
##iae 
gene 
##1 
##2 
##3 
##4 
##5 
it 
interest 
starvation 
nutrition 
cat 
##ast 
##rophe 
past 
including 
s 
##r 
##vy 
vitamin 
deficiency 
resulting 
lack 
fruit 
be 
##ber 
##i 
b 
##1 
deficiency 
consumption 
polished 
rice 
forgotten 
history 
[CLS] 
this 
sequence 
interact 
least 
protein 
fi 
##bro 
nuclear 
extract 
binding 
et 
##s 
serum 
response 
factor 
like 
[SEP] 
[PAD] [CLS] 
a 
th 
##rom 
##bin 
bypass 
pro 
##th 
##rom 
##bin 
activation 
fragment 
f 
##1 
2 
##rom 
##bin 
##rom 
##bin 
complex 
showing 
factor 
x 
##ii 
necessary 
th 
##rom 
##bin 
generation 
generation [SEP] 
[CLS] 
molecular 
event 
underlying 
specific 
receptor 
regulating 
native 
understood 
##1 
he 
hair 
he 
response 
##hyl 
d 
damage 
sa 
##ere 
##vis 
##iae 
treatment 
he 
inter 
##fer 
experience 
western 
country 
[CLS] 
several 
clone 
isolated 
encoded 
c 
terminal 
253 
amino 
acid 
put 
r 
he 
##lica 
##se 
dead 
box 
protein 
designated 
d 
##d 
##x 
##3 
[SEP] 
k 
##ers 
take 
medical 
education 
education [SEP] 
[CLS] 
binding 
n 
##f 
##50 
ho 
##mo 
##di 
##mer 
bind 
nuclear 
b 
site 
protein 
s 
gamma 
3 
tandem 
repeat 
[CLS] 
in 
initially 
expressed 
characterized 
expression 
paired 
box 
gene 
##3 
##3 [SEP] 
at 
##her 
##ogenic 
stimulation 
co 
##lla 
el 
##ast 
##in 
synthesis 
[CLS] 
these 
result 
1 
##x 
##r 
##r 
he 
##tero 
##di 
##mers 
play 
role 
basal 
trans 
##act 
##ivation 
##ivation t 
##3 
suppression 
negatively 
regulated 
gene 
2 
##x 
##rs 
increase 
dominant 
negative 
effect 
mutant 
mutant t 
##rs 
specific 
##res 
[SEP] 
[CLS] 
mutant 
including 
ex 
##o 
##1 
##rs 
##ad 
##5 
##dh 
##4 
strain 
role 
re 
##comb 
##al 
repair 
##j 
[CLS] 
further 
induction 
c 
##yt 
##och 
##rome 
450 
1 
##a 
##1 
observed 
##rm 
##oran 
indicates 
receptor 
mediated 
process 
t 
##c 
##dd 
related 
chemical 
chemical ex 
exert 
many 
toxicity 
activated 
[SEP] 
s 
a 
study 
34 
na 
##fare 
ace 
##tate 
1 
47 
40 
bus 
##ere 
##tate 
long 
i 
iv 
##f 
protocol 
68 
46 
##fare 
##tate 
3 
56 
39 
bus 
##ere 
##tate 
4 
short 
short i 
iv 
32 
##fare 
##tate 
5 
50 
30 
bus 
##tate 
i 
87 
60 
na 
##fare 
##tate 
81 
61 
bus 
##ere 
##tate 
short 
i 
protocol 
this 
##eas 
potential 
##gene 
b 
##m 
t 
##x 
##elo 
##ma 
##ma [SEP] 
5 
3 
6 
6 
r 
##per 
##ido 
determined 
sequence 
eight 
v 
##ir 
##f 
binding 
site 
four 
different 
gene 
d 
i 
##ydro 
foot 
##print 
[CLS] 
il 
##9 
##r 
gene 
gene approximately 
90 
identity 
none 
copy 
en 
##codes 
functional 
receptor 
none 
contains 
sequence 
ho 
##mo 
##log 
##ous 
5 
flank 
region 
ex 
##on 
1 
il 
##9 
##r 
gene 
remaining 
##fs 
inactivated 
various 
point 
mutation 
del 
##on 
[SEP] 
type 
ii 
ne 
##uro 
##pta 
##ges 
o 
##don 
s 
##ato 
##logy 
##3 
27 
##42 
##0 
##9 
put 
##ative 
per 
##is 
pro 
response 
element 
present 
47 
[PAD] [CLS] 
while 
reviewing 
gas 
##tric 
specimen 
215 
##ab 
found 
di 
##ff 
##use 
giant 
m 
##uc 
##osa 
##l 
fold 
2 
specimen 
multiple 
giant 
##uc 
##osa 
##l 
nod 
##ule 
another 
3 
3 [SEP] 
[CLS] 
to 
investigate 
whether 
two 
##g 
box 
media 
mediate 
transcription 
activation 
l 
##46 
##24 
gene 
two 
experimental 
strategy 
followed 
c 
##lon 
gene 
multi 
##copy 
vector 
construction 
fusion 
gene 
[SEP] 
[CLS] 
when 
op 
antagonist 
administered 
24 
h 
##r 
termination 
single 
multiple 
exposure 
restraint 
increase 
basal 
plasma 
l 
##h 
at 
chronic 
##ally 
stressed 
rat 
stress 
abstract 
t 
##runcated 
at 
250 
word 
the 
##cial 
feature 
self 
ignition 
suicide 
suicide 
[CLS] 
this 
trans 
##act 
##ivation 
fi 
##bro 
trans 
trans 
beta 
##lo 
##bin 
reporter 
gene 
absence 
presence 
##k 
##lf 
##a 
construct 
[SEP] 
colony 
s 
analysis 
[CLS] 
thus 
addition 
previously 
characterized 
f 
##a 
binding 
factor 
1 
interacting 
in 
##os 
##olin 
element 
motif 
second 
motif 
common 
promoter 
region 
f 
gene 
could 
identified 
[SEP] 
[PAD] [CLS] 
reconstruction 
x 
64 
matrix 
matrix approximately 
45 
trans 
##ax 
slice 
slice [SEP] 
sequence 
analysis 
##a 
ass 
##a 
like 
domain 
terminus 
band 
4 
1 
j 
##ef 
domain 
##rb 
10 
adapt 
[CLS] 
patient 
received 
b 
##p 
##b 
using 
b 
2 
mg 
1 
adrenaline 
1 
000 
either 
without 
without h 
##yal 
##uron 
##idas 
3000 
i 
iu 
volume 
0 
m 
##l 
per 
2 
54 
height 
height [SEP] 
[CLS] 
##hino 
2 
pro 
prote 
##ase 
foot 
mouth 
disease 
l 
pro 
##te 
##ase 
used 
analyze 
association 
e 
##if 
##4 
e 
##if 
##4 
##a 
e 
##if 
##if4 
e 
##if 
##3 
hundred 
clone 
sequence 
r 
##t 
##ks 
identified 
well 
r 
##t 
##ks 
se 
kinase 
[CLS] 
roller 
pump 
##rona 
##ry 
su 
card 
##iot 
further 
##b 
extended 
ne 
##uri 
##tes 
response 
e 
##pid 
[SEP] 
[CLS] 
level 
p 
##53 
substantially 
increased 
e 
##1 
##a 
expression 
infection 
in 
##sul 
pro 
level 
##static 
1 
4 
0 
0 8 
##gram 
l 
l [SEP] 
[CLS] 
healthy 
subject 
received 
following 
regime 
##n 
dose 
##d 
steady 
state 
t 
##af 
300 
mg 
24 
h 
c 
##ro 
##f 
400 
mg 
12 
h 
t 
##af 
300 
mg 
24 
h 
plus 
2 
g 
12 
h 
c 
##ro 
##f 
400 
mg 
12 
h 
plus 
c 
2 
g 
12 
h 
in 
in e 
mediated 
kinase 
##b 
a 
##kt 
mit 
##ogen 
c 
terminal 
function 
downstream 
3 
##i 
3 
kinase 
##os 
p 
##lated 
form 
mit 
##ogenic 
pathway 
protein 
s 
addition 
r 
mit 
pathway 
activated 
##d 
effect 
mediated 
action 
upstream 
c 
##y 
##c 
e 
##d 
##k 
via 
neutral 
##ization 
rather 
##d 
##c 
##c25 
[CLS] 
bi 
##le 
re 
##f 
##lux 
99 
di 
##so 
##in 
##in [SEP] 
[CLS] 
nuclear 
import 
ran 
t 
##4 
closely 
linked 
n 
##f 
##2 
transport 
step 
ran 
t 
##4 
[PAD] [CLS] 
almost 
image 
appears 
therapy 
session 
reveals 
symbolic 
symbol 
##gu 
position 
originated 
different 
area 
investigation 
mentioned 
mentioned ending 
description 
trait 
according 
writer 
writer best 
##ow 
symbolic 
image 
image [SEP] 
[CLS] 
the 
##ych 
##omo 
##tar 
##dation 
varied 
mild 
severe 
severe [SEP] 
both 
o 
##leo 
##tide 
cross 
competition 
super 
##shi 
experiment 
established 
double 
strand 
binding 
protein 
equivalent 
s 
##1 
[SEP] 
ha 
synthesis 
abnormal 
[CLS] 
although 
f 
##kh 
##2 
redundant 
##kh 
##1 
controlling 
pseudo 
##hy 
##pha 
##l 
growth 
gene 
different 
function 
si 
##ra 
[SEP] 
[CLS] 
molecular 
analysis 
in 
##act 
##l 
expression 
every 
null 
clone 
resulted 
apparent 
del 
##eti 
##on 
rear 
##rang 
##ement 
5 
flank 
5 
coding 
sequence 
break 
##points 
consistently 
mapping 
within 
550 
b 
##p 
g 
##c 
rich 
region 
ex 
##on 
1 
middle 
intro 
##n 
2 
[SEP] 
[CLS] 
however 
c 
##b 
beta 
stimulate 
transcription 
primarily 
camp 
re 
##sp 
element 
c 
##re 
map 
position 
77 
94 
5 
binding 
site 
[SEP] 
he 
##lio 
##liox 
pu 
##ls 
##dox 
ex 
##pi 
##uba 
patient 
severe 
as 
50 
fold 
increase 
ion 
##rns 
heating 
confinement 
##or 
to 
##ka 
[CLS] 
however 
molecular 
mechanism 
specific 
c 
##i 
trans 
acting 
factor 
control 
pro 
##dy 
##phi 
promoter 
clearly 
defined 
[CLS] 
finally 
mediated 
##k 
1 
decreased 
insulin 
increased 
pro 
##ct 
##in 
gene 
confirmed 
requirement 
##k 
1 
insulin 
increased 
pro 
##ct 
##in 
gene 
expression 
substitution 
##11 
led 
dominant 
lethal 
##ity 
three 
modern 
hem 
##ato 
analyze 
d 
##yn 
3000 
co 
##ulter 
s 
##t 
##ks 
##ys 
##me 
ne 
800 
through 
differential 
capability 
protocol 
designed 
team 
injected 
ant 
##ec 
##ubi 
##ubital 
7 
mg 
kg 
sodium 
25 
solution 
measurement 
taken 
1 
h 
##r 
##in 
##jection 
4 
5 
7 
re 
##tina 
[CLS] 
##ft 
wall 
lined 
highly 
residue 
##p 
bound 
along 
one 
wall 
[SEP] 
c 
##a 
c 
##lon 
se 
##quencing 
chromosome 
mapping 
er 
##hr 
##oid 
s 
##pect 
[CLS] 
##r 
transcription 
regulate 
drug 
meta 
##bol 
enzyme 
##press 
te 
##rato 
cell 
specific 
h 
##yper 
##p 
certain 
type 
ma 
##gna 
toxicity 
[PAD] [CLS] 
1996 
1996 j 
j [SEP] 
define 
molecular 
mechanism 
regulating 
##r 
1 
gene 
expression 
##life 
my 
##ob 
##last 
mit 
##otic 
muscle 
fiber 
isolated 
##r 
1 
gene 
[CLS] 
more 
fact 
specifically 
interact 
##leo 
##some 
##s 
h 
##b 
dim 
##er 
indicating 
may 
promoting 
##some 
di 
##sse 
##mb 
##ly 
upon 
transcription 
[SEP] 
[CLS] 
measure 
se 
##dation 
delta 
##bis 
absolute 
change 
bi 
painful 
stimulus 
memory 
drug 
concentration 
obtained 
target 
drug 
concentration 
er 
d 
##r 
correlated 
1 
l 
01 
05 
respectively 
r 
ri 
t 
##d 
te 
[CLS] 
linear 
correlation 
0 
12 
0 
68 
01 
maximum 
plasma 
concentration 
0 
34 
01 
minimum 
plasma 
0 
55 
01 
elimination 
t 
##1 
2 
r 
0 
46 
01 
##ressed 
age 
[PAD] [CLS] 
ps 
evidence 
given 
existence 
two 
distinct 
system 
human 
vision 
fast 
system 
extract 
##ing 
con 
##tour 
slower 
system 
assign 
surface 
color 
color [SEP] 
peripheral 
##ov 
center 
participated 
trial 
trial [SEP] 
[CLS] 
the 
program 
my 
##ogenic 
differentiation 
subject 
negative 
control 
factor 
product 
mutation 
##ally 
activated 
##a 
on 
##gene 
persistent 
activate 
in 
##tra 
##cellular 
ca 
##sca 
normally 
triggered 
specific 
factor 
[SEP] 
[CLS] 
te 
##tra 
ben 
##zo 
di 
##sso 
##cia 
##tes 
se 
##dation 
##zo 
activity 
activity [SEP] 
[CLS] 
the 
difference 
effect 
two 
dose 
level 
level z 
z [SEP] 
[CLS] 
mutation 
di 
##stal 
e 
##f 
binding 
site 
##d 
##c 
promoter 
promoter abolished 
repression 
whereas 
mutation 
pro 
##ximal 
e 
##f 
site 
site e 
##2 
site 
effect 
[SEP] 
[CLS] 
p 
##mi 
##d 
p 
pnk 
##21 
2 
05 
k 
##b 
sequence 
covering 
region 
encoding 
ni 
##tri 
##lase 
placed 
control 
la 
##c 
promoter 
directed 
##p 
en 
##zy 
ni 
##tri 
##lase 
response 
d 
th 
##rano 
##cher 
##ichi 
co 
[SEP] 
toxicity 
neutral 
##izer 
##bial 
##llan 
[CLS] 
expression 
decreased 
inclusion 
region 
upstream 
ex 
exting 
##uished 
inclusion 
first 
intro 
##n 
[SEP] 
[CLS] 
static 
dynamic 
##ri 
normal 
path 
##ological 
floor 
i 
density 
calf 
lower 
obtained 
pro 
##ximal 
site 
length 
depend 
fiber 
loss 
##uro 
these 
result 
specific 
association 
si 
hi 
2 
1 
t 
##rz 
##eta 
[CLS] 
insertion 
alternatively 
s 
##lice 
##d 
ex 
##on 
w 
##b 
m 
##rna 
##ato 
result 
p 
##oly 
##cist 
##ronic 
r 
en 
##codes 
two 
novel 
internally 
translated 
##b 
re 
##press 
##or 
##of 
##orms 
called 
i 
##bs 
consisting 
car 
##box 
##y 
terminal 
d 
binding 
domain 
devoid 
trans 
##act 
##ivation 
domain 
[SEP] 
[CLS] 
a 
continuous 
flow 
bi 
system 
consists 
high 
c 
system 
reservoir 
bag 
##umatic 
controlled 
membrane 
valve 
ex 
##pi 
##rator 
limb 
[CLS] 
older 
female 
0 
6 
1 
3 
t 
##b 
1 
1 
1 
1 
b 
##m 
##d 
z 
score 
greater 
0 
p 
00 
##1 
##1 [SEP] 
smooth 
gain 
percentage 
total 
eye 
due 
various 
##dic 
sub 
##type 
com 
##cu 
computer 
pattern 
recognition 
software 
[CLS] 
fraction 
m 
mg 
p 
##40 
protein 
p 
t 
##os 
##ine 
[SEP] 
consistent 
hypothesis 
alpha 
##1 
##x 
prevents 
c 
##lea 
##vage 
o 
translation 
p 
##53 
del 
##eti 
mutant 
delta 
pro 
lack 
entire 
pro 
rich 
domain 
deleted 
amino 
91 
created 
characterized 
variety 
p 
function 
##ort 
##ic 
th 
##rom 
##bus 
deficiency 
[CLS] 
our 
result 
suggest 
br 
##1 
s 
influence 
expression 
m 
##b 
s 
##b 
driven 
gene 
expression 
b 
##uddin 
yeast 
perhaps 
including 
gene 
involved 
cell 
wall 
metabolism 
via 
two 
component 
signal 
trans 
##duction 
pathway 
activate 
##s 
br 
##1 
response 
unidentified 
signal 
[SEP] 
[PAD] [CLS] 
1992 
1992 j 
j [SEP] 
a 
constructed 
phylogenetic 
tree 
##1 
member 
##2 
##s 
##let 
factor 
4 
level 
patient 
##rona 
##ry 
artery 
disease 
functional 
characterised 
##1 
interaction 
##oto 
##xin 
##mb 
also 
interaction 
small 
##1 
yeast 
hybrid 
system 
[PAD] [CLS] 
a 
backward 
look 
infection 
infection [SEP] 
[CLS] 
##r 
##14 
##b 
strongly 
impaired 
bar 
al 
##bino 
involvement 
p 
##id 
##ial 
factor 
control 
gene 
expression 
[SEP] 
[CLS] 
m 
##r 
differentiation 
following 
meta 
##bol 
5 
patient 
n 
ace 
as 
##a 
##rea 
##tine 
p 
##rea 
p 
##cho 
g 
##op 
##cho 
beta 
gamma 
g 
##lu 
[SEP] 
[CLS] 
overall 
free 
##lor 
0 
3 
1 
0 
mg 
showed 
lower 
he 
##tero 
##tro 
plate 
number 
without 
##lor 
##ine 
[CLS] 
s 
##1 
n 
##uc 
##lea 
##se 
protection 
mapping 
prime 
##r 
extension 
analysis 
u 
propose 
residue 
located 
19 
b 
##p 
upstream 
translation 
initiation 
co 
##don 
site 
transcription 
initiation 
[SEP] 
[CLS] 
various 
stimulus 
in 
##act 
##ivate 
i 
##ka 
alpha 
trigger 
n 
terminal 
residue 
se 
##r 
##32 
se 
##r 
##36 
[SEP] 
day 
cure 
64 
regime 
confirmed 
##eno 
[CLS] 
in 
suggest 
n 
region 
diversity 
d 
j 
junction 
within 
rear 
##ranged 
lo 
introduced 
generation 
rag 
cat 
##zed 
d 
##na 
double 
strand 
break 
e 
d 
end 
joining 
phase 
d 
j 
re 
##comb 
##ination 
reaction 
[SEP] 
[CLS] 
99 
##m 
##t 
##9 
##1 
marker 
##oc 
##ard 
##ial 
via 
##bility 
acute 
##per 
##fusion 
##fusion [SEP] 
three 
patient 
##ph 
##oter 
single 
course 
well 
multiple 
##nga 
##il 
##ba 
##mi 
re 
##sed 
month 
##gen 
##ital 
##lau 
##op 
##hil 
lost 
one 
eye 
due 
ha 
##em 
##or 
##r 
##tom 
hospital 
hospital [SEP] 
and 
hospital 
tumor 
ho 
houst 
30 
year 
1944 
1974 
minimum 
year 
major 
pro 
##gno 
##stic 
factor 
survival 
node 
we 
c 
##a 
in 
invert 
##rate 
##rch 
##b 
##ryo 
[CLS] 
to 
study 
structural 
diversity 
three 
ho 
##mo 
##log 
lo 
##1 
like 
##ob 
##xa 
##id 
wheat 
genome 
isolated 
clone 
c 
##a 
library 
young 
spike 
j 
##nese 
common 
wheat 
nor 
26 
[SEP] 
[CLS] 
novel 
repeated 
sequence 
throughout 
s 
region 
involved 
disease 
[CLS] 
thus 
regulate 
##s 
##ot 
##os 
signalling 
event 
complex 
e 
##ct 
##ode 
##rmal 
me 
##sen 
interaction 
regulate 
ma 
##mmal 
b 
##uddin 
##g 
m 
##or 
##ph 
##ogen 
##esis 
[SEP] 
[PAD] [CLS] 
m 
##oya 
##mo 
##ya 
intriguing 
controversial 
syndrome 
syndrome [SEP] 
however 
elimination 
kinase 
d 
##k 
##1 
detect 
effect 
##ule 
polymer 
[CLS] 
we 
thus 
clone 
##d 
two 
yeast 
ho 
##mo 
##log 
##s 
ma 
##mmal 
##0 
[CLS] 
the 
glucose 
effect 
##vate 
gene 
re 
##vers 
ant 
##agon 
agent 
increasing 
in 
camp 
an 
identical 
##pt 
##ide 
detected 
k 
##1 
##f 
##on 
[CLS] 
patient 
p 
show 
excessive 
daytime 
sleep 
##iness 
ins 
##nia 
##nia [SEP] 
[CLS] 
##b 
binding 
##b 
##30 
##0 
##p 
132 
add 
##itive 
effect 
promoter 
demonstrated 
physically 
[SEP] 
[CLS] 
it 
believed 
operation 
effective 
cut 
spin 
##oth 
##ala 
##mic 
tract 
s 
##tt 
primary 
pathway 
carrying 
no 
##ci 
information 
spinal 
brain 
human 
[CLS] 
##ala 
key 
anti 
##ero 
##bic 
organism 
toxic 
effect 
hydrogen 
per 
case 
post 
##ir 
##ule 
factor 
recovery 
rate 
energy 
level 
##tra 
stimulation 
100 
##h 
##z 
observed 
30 
##h 
##z 
exhaled 
no 
##em 
##ol 
air 
cavity 
sufficient 
##ala 
e 
##co 
77 
analyze 
recent 
study 
factor 
##rf 
so 
##mat 
[PAD] [CLS] 
new 
concept 
##ina 
##inata 
child 
this 
first 
due 
f 
##etal 
ka 
##bach 
pre 
##nat 
##ally 
diagnosed 
son 
blood 
sampling 
sampling [SEP] 
ace 
##to 
##tate 
de 
##car 
##yla 
##c 
##c 
##4 
1 
1 
4 
c 
##los 
##tri 
##dium 
ace 
##to 
##yl 
##ic 
79 
first 
25 
n 
terminal 
acid 
determined 
[SEP] 
transfer 
promise 
say 
sequence 
127 
residue 
m 
52 
striking 
strikingly 
similar 
##i 
protein 
##ula 
##ulatus 
##tus especially 
put 
##ative 
ha 
##em 
binding 
motif 
abstract 
t 
##runcated 
at 
400 
word 
[CLS] 
cat 
ass 
##x 
##ral 
##pha 
conferred 
best 
r 
##a 
response 
9 
c 
##i 
r 
##a 
potent 
trans 
##a 
in 
##f 
gene 
[SEP] 
[CLS] 
for 
rotating 
presented 
dominant 
eye 
class 
ne 
##uron 
responded 
best 
rotation 
world 
axis 
oriented 
near 
horizontal 
plane 
approximately 
45 
degree 
a 
##zi 
##th 
##th [SEP] 
none 
patient 
developed 
clinical 
event 
disappearance 
dependent 
inhibitor 
co 
##agu 
##lation 
##lation [SEP] 
in 
var 
d 
##d 
##9 
##5 
regard 
body 
weight 
recovery 
##mus 
three 
group 
comparable 
[CLS] 
we 
studied 
parameter 
governing 
promoter 
reporter 
incorporated 
type 
1 
[SEP] 
[CLS] 
relation 
r 
##oe 
##gen 
lung 
function 
##bro 
pulmonary 
x 
##13 
##3 
each 
fusion 
lead 
principle 
re 
##t 
t 
##yr 
##os 
un 
string 
physiological 
regulation 
replacement 
5 
end 
a 
##ber 
##rant 
activated 
5 
fused 
gene 
thy 
##ro 
##cy 
normally 
re 
ret 
t 
##yr 
##os 
##osine 
kinase 
[PAD] [CLS] 
he 
complained 
fever 
right 
h 
##po 
##cho 
##ndra 
##ndral 
##gia 
2 
month 
operated 
app 
##icit 
[CLS] 
in 
predicted 
amino 
acid 
sequence 
##1 
sequence 
ho 
##mo 
##log 
##ous 
cat 
##alytic 
domain 
protein 
kinase 
found 
[SEP] 
[CLS] 
##cin 
##oma 
related 
protein 
may 
may played 
role 
development 
observed 
re 
##nal 
les 
##ion 
##ion [SEP] 
these 
strong 
evidence 
conserved 
##ical 
packing 
interaction 
core 
de 
##ter 
##mina 
hi 
1 
entry 
[CLS] 
la 
##g 
phase 
14 
89 
hour 
0 
77 
13 
hour 
0 
50 
50 20 
20 22 
hour 
0 
76 
76 20 
00 
0 
79 
respectively 
##oth 
##eli 
##dl 
oxidation 
adult 
122 
f 
##etal 
sacrificed 
##esta 
##cas 
analyzed 
variety 
growth 
parameter 
[CLS] 
o 
##gon 
##leo 
##tide 
##s 
containing 
c 
##4 
##t 
sequence 
con 
##fer 
heat 
in 
reporter 
show 
presence 
two 
element 
add 
##itive 
effect 
induction 
[SEP] 
[CLS] 
the 
e 
##1 
e 
##2 
protein 
along 
cellular 
factor 
required 
replication 
genome 
genome [SEP] 
[CLS] 
the 
observed 
alter 
##ation 
lung 
function 
individual 
heavy 
exercise 
likely 
affected 
lower 
o 
##3 
level 
level [SEP] 
[CLS] 
end 
##oto 
##1 
in 
0 
25 
##gram 
kg 
1 
x 
min 
1 
begun 
pulmonary 
card 
##iovascular 
d 
##ys 
##function 
closer 
mimic 
use 
the 
main 
tidal 
p 
##o 
instead 
ins 
##pi 
##rator 
##o 
controller 
cap 
##nos 
o 
##sta 
proportional 
difference 
tidal 
##co 
##o 
like 
human 
er 
##hr 
##4 
er 
##oc 
##4 
contains 
region 
striking 
##ly 
ho 
##mo 
##log 
##ous 
trans 
t 
##gas 
protein 
although 
likely 
lack 
t 
##gas 
##e 
##link 
activity 
[CLS] 
it 
span 
span 20 
k 
##ilo 
##base 
##s 
consists 
7 
ex 
##on 
6 
intro 
##n 
contains 
ta 
##ta 
motif 
24 
n 
##leo 
##tide 
upstream 
transcription 
##al 
start 
site 
[SEP] 
nine 
##bs 
##ag 
level 
9 
4 
i 
1 
m 
se 
geometric 
mean 
i 
1 
nine 
patient 
patient [SEP] 
##ros 
##r 
difficult 
method 
method [SEP] 
post 
synthesis 
##ido 
##gly 
layer 
affected 
anti 
##ab 
##oli 
m 
##or 
effect 
striking 
c 
##aca 
di 
##so 
##eta 
plus 
l 
d 
##rap 
recognized 
c 
##d 
##9 
further 
el 
##ida 
subtle 
##cha 
##in 
correlation 
reveal 
detailed 
atomic 
structure 
low 
temperature 
temperature 8 
##x 
[CLS] 
control 
o 
##go 
##mers 
scrambled 
sequence 
identical 
base 
composition 
ineffective 
t 
##fo 
re 
##comb 
##ination 
seen 
control 
l 
##t 
##k 
cell 
carrying 
otherwise 
identical 
dual 
t 
##k 
gene 
construct 
lacking 
30 
b 
##p 
##pur 
target 
site 
[SEP] 
[CLS] 
to 
##uant 
normal 
coupling 
pattern 
##da 
##ver 
specimen 
l 
##1 
s 
##1 
used 
[CLS] 
one 
c 
##op 
##las 
##mic 
target 
reflects 
functional 
state 
p 
##id 
protein 
kinase 
c 
[SEP] 
these 
three 
chromosome 
share 
transfer 
##rin 
gene 
t 
##os 
3 
gene 
##3 
gene 
##h 
[CLS] 
several 
rib 
##oso 
protein 
synthesized 
substantial 
excess 
experience 
would 
home 
nutrition 
##al 
support 
disease 
relatively 
stable 
major 
organ 
failure 
present 
present [SEP] 
[CLS] 
based 
sequence 
data 
##olate 
excluding 
##1 
en 
##code 
t 
##runcated 
49 
a 
##a 
p 
##a 
frame 
stop 
co 
##don 
although 
##1 
##olate 
en 
##code 
202 
##a 
[CLS] 
in 
present 
study 
##ly 
side 
effect 
12 
patient 
first 
administration 
dose 
ok 
##t 
##3 
0 
mg 
twice 
daily 
induction 
therapy 
10 
patient 
treated 
dose 
ok 
##t 
##3 
daily 
acute 
rejection 
203 
sensitive 
map 
kinase 
involved 
mediated 
increase 
d 
binding 
trans 
##act 
##ivation 
[CLS] 
together 
result 
indicate 
##ts 
##1 
bi 
##function 
##al 
protein 
active 
s 
##licing 
protein 
synthesis 
[SEP] 
[CLS] 
o 
##s 
##cilla 
flow 
##esta 
##illa 
##ry 
##ere 
##illa 
##ry 
ve 
##nous 
interface 
[CLS] 
4 
one 
eight 
known 
gene 
coding 
la 
##rva 
##rval 
secret 
##ion 
d 
##ros 
##op 
##hil 
me 
##lan 
##oga 
[CLS] 
although 
g 
##3 
sequence 
contains 
two 
protein 
binding 
motif 
organization 
g 
##3 
enhance 
##r 
like 
element 
bi 
##par 
##tite 
[SEP] 
human 
##oto 
d 
##k 
member 
novel 
class 
##dom 
size 
shape 
variety 
organism 
[CLS] 
the 
human 
br 
##1 
promoter 
contains 
conserved 
e 
e2 
##f 
site 
similarly 
regulated 
e 
##f 
##1 
r 
##b 
[SEP] 
the 
translated 
sequence 
##i 
l 
associated 
flap 
protein 
represented 
data 
base 
##ster 
##dar 
l 
##ymph 
##p 
##hyl 
##ax 
op 
pulmonary 
infection 
infection [SEP] 
[CLS] 
in 
respect 
promoter 
structure 
co 
##x 
gene 
resemble 
many 
house 
keeping 
gene 
[SEP] 
##ro 
##oki 
##pox 
regulation 
expression 
associated 
r 
##t 
##c 
##pop 
[SEP] 
[CLS] 
the 
site 
##t 
mapped 
double 
##ys 
motif 
highly 
conserved 
region 
49 
##k 
##k 
##q 
54 
basic 
r 
binding 
motif 
ta 
tat 
[CLS] 
these 
result 
##b 
therapy 
sufficient 
cure 
case 
element 
bulk 
##y 
meta 
##sta 
##sis 
[SEP] 
[CLS] 
the 
k 
measurement 
show 
two 
model 
give 
improvement 
signal 
ratio 
approximately 
7 
d 
##b 
di 
##ff 
##use 
sound 
field 
field [SEP] 
[PAD] [CLS] 
indirect 
determination 
ma 
##ximal 
o 
##2 
consumption 
man 
man [SEP] 
[CLS] 
using 
un 
##id 
##ire 
##ctional 
p 
##r 
isolated 
36 
##1 
b 
##p 
5 
promoter 
region 
del 
intro 
##nic 
ex 
##onic 
boundary 
include 
non 
coding 
ex 
##on 
1 
single 
intro 
##n 
coding 
ex 
##on 
2 
structure 
typical 
gene 
r 
super 
##family 
[SEP] 
[CLS] 
when 
severe 
h 
##pox 
acute 
##ly 
produced 
ventilation 
low 
oxygen 
mixture 
experimental 
##ao 
23 
7 
1 
7 
to 
##rr 
control 
animal 
##ao 
26 
3 
1 
0 
to 
##rr 
plasma 
insulin 
response 
response marked 
in 
##hibit 
##ed 
##ed [SEP] 
[CLS] 
up 
required 
different 
domain 
ton 
##b 
m 
around 
residue 
160 
co 
i 
domain 
closer 
end 
[SEP] 
d 
when 
x 
combined 
t 
prolonged 
central 
treatment 
improve 
care 
fl 
whole 
fed 
level 
5 
15 
compared 
1 
5 
men 
oil 
typical 
layer 
ratio 
[CLS] 
it 
label 
secret 
since 
requirement 
defence 
ton 
[CLS] 
the 
complete 
n 
##leo 
##tide 
sequence 
o 
##to 
##um 
rings 
##pot 
##y 
1 
strain 
##eno 
##mic 
r 
##na 
[CLS] 
an 
enhance 
##ment 
ben 
liver 
tumor 
tumor 
##ige 
c 
##f 
##1 
male 
17 
56 
tested 
dose 
400 
v 
[CLS] 
cell 
co 
cotra 
##fected 
##mi 
##d 
appropriate 
respond 
##er 
p 
##mi 
##d 
c 
##lon 
##ies 
selected 
basis 
resistance 
genetic 
##in 
via 
neo 
##my 
##cos 
##ide 
##ot 
##ran 
##fer 
##ase 
gene 
[SEP] 
[CLS] 
this 
c 
terminal 
domain 
contains 
several 
##x 
##xi 
l 
motif 
reminiscent 
##a 
put 
##ative 
t 
##ra 
##f 
binding 
site 
##1 
[SEP] 
o 
##mit 
experimental 
no 
derived 
distance 
restraint 
violation 
lower 
r 
factor 
structural 
##m 
##d 
##fine 
[CLS] 
cardiac 
les 
##ion 
ex 
##oto 
##xi 
shock 
[CLS] 
risk 
factor 
at 
##os 
##rosis 
related 
nutrition 
h 
##tero 
h 
##yper 
##gly 
##ce 
##mia 
diabetes 
h 
##yper 
##tens 
o 
##besity 
high 
intake 
excessive 
alcohol 
[CLS] 
mutation 
absent 
t 
beta 
##i 
protein 
tumor 
tissue 
scan 
box 
gene 
##bank 
database 
also 
##rup 
##pel 
zinc 
lacking 
a 
domain 
zinc 
however 
resistance 
##olo 
##ne 
j 
##osa 
##cin 
t 
##yl 
##os 
##in 
seventy 
nine 
child 
screened 
91 
0 
10 
d 
##ic 
[CLS] 
normal 
dog 
either 
10 
15 
30 
g 
x 
ray 
single 
hemisphere 
gross 
his 
##ath 
##gic 
change 
##ly 
[CLS] 
ya 
##cs 
selected 
con 
##ti 
##g 
starting 
point 
c 
##lon 
##ing 
##d 
gene 
thereby 
establish 
biological 
basis 
form 
muscular 
d 
relationship 
##ir 
##dle 
muscular 
d 
##ys 
##cc 
##1 
detect 
group 
1 
group 
4 
x 
##p 
extract 
[CLS] 
in 
ma 
##late 
extension 
routing 
##bo 
##dies 
##dies since 
contains 
per 
##ox 
##is 
##oma 
##omal 
targeting 
signal 
se 
##r 
##y 
terminus 
[CLS] 
op 
##ti 
##mized 
d 
binding 
site 
differ 
n 
##leo 
##tide 
bordering 
##ot 
##ide 
box 
di 
##sp 
##lace 
##lace e 
##4 
factor 
competition 
efficiency 
efficiency e 
##4 
site 
[SEP] 
[CLS] 
screening 
human 
c 
library 
two 
different 
5 
terminus 
alternatively 
s 
##lice 
##d 
form 
human 
fl 
##i 
1 
gene 
##i 
1 
##b 
possible 
existence 
two 
independent 
promoter 
[SEP] 
a 
rate 
as 
##by 
##l 
radical 
directly 
o 
##rad 
abrupt 
fall 
super 
di 
##uta 
##utase 
switching 
radical 
dependent 
machinery 
formation 
##ct 
5 
h 
thermal 
carrying 
run 
##away 
re 
##comb 
p 
##bs 
##1 
protein 
b 
40 
protein 
fraction 
fraction cell 
[SEP] 
[CLS] 
a 
regulatory 
element 
empty 
s 
##rac 
##ob 
composed 
three 
distinct 
conserved 
region 
bind 
regulatory 
protein 
[SEP] 
[CLS] 
peak 
reactive 
h 
##yper 
m 
##l 
min 
1 
1 
determined 
forearm 
immediately 
12 
week 
training 
training [SEP] 
suit 
##44 
##1 
effective 
pro 
##dr 
##39 
##4 
##oro 
##zo 
r 
##iv 
##iz 
##or 
stereo 
inhibitor 
##roma 
end 
##oc 
effect 
i 
study 
[PAD] [CLS] 
in 
combined 
se 
##ns 
##iti 
##zation 
salt 
particularly 
gold 
sodium 
th 
##ios 
##ulf 
##ate 
g 
##st 
##adi 
chloride 
p 
##d 
##c 
observed 
[CLS] 
gene 
structure 
precursor 
processing 
processing [SEP] 
the 
content 
mon 
##oam 
meta 
##bol 
h 
acid 
hi 
##aa 
##mo 
h 
##va 
patient 
##ere 
determined 
one 
131 
29 
24 
83 
29 
normal 
serum 
t 
##4 
3 
10 
remained 
h 
##yper 
##ro 
##xin 
##em 
h 
##ro 
##xin 
##em 
[CLS] 
these 
finding 
t 
##3 
##r 
re 
##press 
activate 
transcription 
te 
##ther 
##ed 
lb 
##d 
gal 
##4 
##x 
##r 
he 
##tero 
##di 
##mer 
##ization 
occur 
v 
##ivo 
without 
stab 
##ilization 
hormone 
response 
element 
[SEP] 
[CLS] 
most 
effect 
##or 
##mi 
##d 
containing 
i 
##p 
##27 
gene 
little 
effect 
two 
different 
marked 
effect 
depending 
target 
observed 
i 
##p 
##27 
combined 
i 
##p 
##4 
##0 
[PAD] [CLS] 
re 
##nal 
vein 
th 
##rom 
##bos 
similar 
pattern 
acute 
tub 
##ular 
ne 
##c 
##rosis 
found 
r 
##i 
ve 
##no 
to 
##1 
en 
member 
he 
domain 
##3 
growth 
[CLS] 
##eno 
##mic 
clone 
containing 
c 
br 
##ae 
gene 
gene able 
completely 
rescue 
119 
trans 
c 
el 
##egan 
mutant 
[CLS] 
the 
rapid 
decrease 
plasma 
first 
two 
hour 
standard 
h 
##d 
cause 
membrane 
h 
##yper 
##pol 
##zation 
[SEP] 
[CLS] 
region 
specific 
enhance 
##r 
near 
two 
ma 
home 
##o 
box 
gene 
define 
adjacent 
r 
##ost 
##ro 
##ca 
##uda 
##l 
domain 
central 
nervous 
system 
[SEP] 
in 
c 
##lon 
se 
##quencing 
overlapping 
c 
##a 
encoding 
encoding approximately 
4 
1 
k 
##b 
human 
ho 
##mo 
sub 
##type 
response 
element 
dependent 
difference 
trans 
##is 
alpha 
gamma 
m 
##ri 
visual 
##og 
de 
cart 
in 
##ven 
##ous 
administration 
g 
##d 
d 
##t 
##pa 
[CLS] 
we 
developed 
artificial 
chromosome 
con 
##ti 
##g 
region 
[CLS] 
induction 
if 
##na 
promoter 
region 
requires 
cooperation 
alpha 
f 
##1 
binding 
protein 
i 
##rf 
1 
[SEP] 
[CLS] 
hybrid 
##12 
gene 
specific 
probe 
##ug 
revealed 
presence 
##12 
ho 
##mo 
##log 
##ous 
sequence 
within 
inverted 
repeat 
s 
##rod 
##ela 
##op 
##last 
d 
fragment 
b 
##am 
##hi 
v 
[SEP] 
[CLS] 
to 
investigate 
effect 
h 
##yper 
##roid 
##ism 
pattern 
time 
course 
o 
##2 
up 
##take 
##o 
transition 
rest 
exercise 
patient 
subject 
cycle 
exercise 
rate 
##r 
18 
18 20 
w 
respectively 
respectively [SEP] 
however 
##ro 
del 
##eti 
##on 
mutant 
##d 
reported 
[CLS] 
re 
##comb 
##ination 
occurred 
corresponding 
l 
##tr 
lo 
##cus 
quasi 
s 
##pec 
##ie 
present 
##olate 
described 
[SEP] 
[CLS] 
in 
stab 
trans 
##fected 
mutant 
del 
##eti 
##on 
second 
zinc 
finger 
d 
binding 
domain 
domain e 
h 
ht 
different 
effect 
effect e 
##p 
gene 
expression 
expression e 
##bb 
##p 
regulation 
regulation e 
e dramatically 
reduced 
effect 
augmented 
[SEP] 
[CLS] 
gene 
at 
subunit 
6 
mitochondrial 
f 
##0 
at 
complex 
normal 
og 
##ura 
male 
s 
##adi 
##op 
order 
determine 
at 
transcription 
##al 
difference 
could 
c 
##yt 
##op 
##mic 
s 
##ter 
[CLS] 
when 
single 
amino 
acid 
mutation 
directly 
introduced 
parental 
##b 
##a 
genome 
ch 
##ime 
##ric 
large 
wild 
like 
pattern 
obtained 
trans 
observation 
demonstrating 
point 
mutation 
alone 
drastic 
effect 
growth 
##b 
##4 
ch 
##ric 
virus 
[SEP] 
[CLS] 
gag 
variant 
efficiently 
localized 
cell 
nucleus 
[CLS] 
##r 
##1 
form 
together 
th 
##2 
##1 
th 
##2 
th 
##o 
complex 
control 
transcription 
el 
##ong 
##ation 
genome 
stability 
sa 
##vis 
##iae 
[SEP] 
up 
##r 
element 
present 
er 
gene 
yeast 
##r 
##2 
##p 
ma 
##ian 
##9 
function 
analogous 
manner 
##b 
##2 
[CLS] 
the 
objective 
research 
determine 
determine er 
##got 
##amine 
##amine er 
##go 
##pt 
##kal 
neo 
##ty 
##ph 
##od 
infected 
grass 
associated 
toxic 
##ose 
livestock 
altered 
hormone 
##icular 
he 
cow 
pro 
imp 
[CLS] 
acute 
spontaneous 
sub 
##du 
##ral 
ha 
##ema 
##a 
##a [SEP] 
[CLS] 
strain 
carrying 
##1 
mutation 
unable 
grow 
su 
##rose 
gal 
##act 
##ose 
ma 
##lt 
##ose 
##bio 
##fer 
##ment 
carbon 
source 
##til 
##ization 
carbon 
source 
regulated 
glucose 
repression 
[CLS] 
2 
depending 
structure 
certain 
compound 
se 
##ered 
##ea 
presumably 
s 
##trom 
##a 
form 
release 
system 
anterior 
a 
##que 
##ous 
neural 
network 
density 
mask 
threshold 
750 
300 
h 
radio 
[CLS] 
mechanism 
regulatory 
subunit 
m 
##od 
##ulate 
##i 
3 
kinase 
signal 
possibly 
sub 
local 
##ization 
cat 
##alytic 
subunit 
interaction 
additional 
signaling 
molecule 
[SEP] 
[CLS] 
these 
result 
##b 
therapy 
sufficient 
cure 
case 
element 
bulk 
##y 
meta 
##sta 
##sis 
[SEP] 
right 
sided 
##leg 
5 
year 
occurred 
remaining 
case 
case [SEP] 
##mi 
##d 
sub 
##lone 
##1 
containing 
hind 
##ii 
n 
fragment 
fragment examined 
replica 
s 
##po 
##do 
##rug 
##9 
cell 
stimulate 
transcription 
linked 
##i 
39 
##k 
gene 
promoter 
##ron 
##idas 
fusion 
co 
cotra 
along 
p 
##mi 
##d 
1 
containing 
gene 
encoding 
trans 
acting 
factor 
i 
ie 
1 
[SEP] 
##fect 
chain 
loss 
variant 
complete 
12 
k 
##b 
construct 
termed 
238 
##ro 
resulted 
secret 
i 
##g 
pairing 
238 
##da 
l 
chain 
however 
trans 
i 
lacked 
auto 
##rea 
path 
[PAD] [CLS] 
diver 
##gent 
region 
posterior 
left 
hemisphere 
hemisphere used 
de 
##co 
##ding 
storage 
information 
emerged 
working 
memory 
versus 
control 
task 
comparison 
comparison [SEP] 
[CLS] 
normal 
cell 
stimulate 
l 
il 
4 
new 
complex 
appear 
bind 
c 
e 
##b 
##p 
4 
element 
respectively 
located 
within 
125 
101 
region 
[SEP] 
[CLS] 
crystal 
structure 
2 
5 
a 
resolution 
fragment 
in 
##te 
r 
##ous 
residue 
49 
286 
containing 
conserved 
cat 
##alytic 
domain 
m 
##od 
##ulatory 
d 
binding 
domain 
c 
domain 
[CLS] 
vector 
##card 
##io 
##rona 
##ry 
electro 
##card 
##io 
segment 
##1 
lead 
[CLS] 
the 
b 
##dic 
##rg 
##s 
r 
d 
fragment 
fragment end 
##osy 
##ion 
s 
##pec 
##ie 
##phi 
promoter 
co 
##li 
ranged 
6 
135 
observed 
comparable 
d 
fragment 
co 
coli 
r 
##b 
[SEP] 
[CLS] 
the 
re 
##8 
re 
##8 
regulatory 
##iot 
effect 
##or 
cellular 
d 
replication 
cellular 
transformation 
cellular 
on 
##mo 
##molog 
##tero 
gene 
expression 
[CLS] 
role 
cc 
##aa 
##t 
enhance 
##r 
binding 
alpha 
transcription 
factor 
##cor 
##tic 
stimulation 
p 
##1 
##1 
gene 
promoter 
activity 
arrested 
he 
[CLS] 
long 
term 
##bula 
co 
##2 
##co 
test 
directly 
co 
occurrence 
panic 
##yper 
##ilation 
natural 
condition 
[SEP] 
[CLS] 
the 
highly 
conserved 
region 
##rna 
structural 
similarity 
cat 
##alytic 
domain 
strand 
satellite 
r 
##na 
tobacco 
ring 
spot 
s 
##v 
suggesting 
highly 
conserved 
region 
##rna 
form 
cat 
##alytic 
center 
one 
suppress 
##or 
suppress 
##c 
del 
##eti 
[CLS] 
cell 
10 
min 
t 
##f 
alpha 
resulted 
activation 
##44 
map 
##k 
##38 
j 
##nk 
this 
describes 
##comb 
clone 
encoding 
fourth 
member 
family 
[CLS] 
in 
pulmonary 
abnormal 
1 
carrier 
careful 
determining 
determining whether 
pulmonary 
involvement 
involvement et 
##iol 
##iological 
##ogically 
related 
1 
infection 
mit 
derivative 
208 
##3 
[CLS] 
excess 
re 
##comb 
p 
pt 
##b 
sq 
##uel 
s 
##licing 
switch 
re 
##esta 
##lish 
ex 
##on 
skip 
predominant 
s 
##licing 
pathway 
[SEP] 
child 
child presumed 
21 
h 
##ydro 
deficiency 
form 
con 
##gen 
##ital 
ad 
##rena 
##l 
h 
##yper 
##p 
studied 
extensively 
infant 
infant [SEP] 
six 
anniversary 
##gio 
##tens 
inability 
ni 
##ac 
##ivo 
##yper 
##ox 
##ro 
##so 
##id 
per 
[CLS] 
m 
##da 
46 
cell 
stab 
##ly 
trans 
##fected 
p 
##mi 
##d 
promoter 
driven 
beta 
##bin 
gene 
p 
##mi 
##d 
promoter 
driven 
ch 
##ime 
##ric 
##ad 
##d 
##45 
u 
beta 
##bin 
gene 
entire 
##ad 
##d 
##45 
1 
29 
298 
45 
b 
##p 
sub 
##fra 
##gment 
##ad 
##d 
##45 
u 
utr 
10 
55 
positioned 
end 
beta 
##bin 
gene 
[CLS] 
the 
university 
north 
car 
##olin 
car 
##ies 
risk 
assessment 
1986 
1989 
5000 
child 
initially 
1 
5 
##ori 
site 
##olin 
main 
##e 
[CLS] 
e 
##rk 
c 
##rk 
protein 
became 
t 
p 
##lated 
within 
1 
min 
[SEP] 
[CLS] 
b 
##r 
##b 
cross 
resistance 
multiple 
##eno 
##to 
##can 
drug 
in 
##hibition 
##pop 
d 
damage 
association 
cycle 
arrest 
##2 
m 
restriction 
point 
[CLS] 
result 
lava 
rapid 
decrease 
art 
##erial 
p 
##ao 
increase 
##aco 
animal 
animal [SEP] 
[CLS] 
conclusion 
elevation 
t 
##bar 
decrease 
show 
presence 
o 
##xi 
##da 
##f 
##d 
hem 
##od 
##fi 
s 
##3 
[SEP] 
oz 
##one 
up 
##take 
awake 
spontaneous 
##ly 
breathing 
##scher 
34 
##4 
s 
##pra 
##gue 
da 
##wley 
##van 
ha 
##rt 
##ley 
data 
dos 
##ime 
##3 
small 
laboratory 
animal 
e 
r 
c 
p 
[PAD] [CLS] 
important 
advance 
diagnosis 
diagnosis [SEP] 
[CLS] 
del 
##eti 
##on 
analysis 
3 
5 
##k 
##b 
d 
fragment 
revealed 
region 
125 
1 
containing 
single 
s 
##1 
binding 
site 
essential 
transcription 
##bi 
##gin 
gene 
[SEP] 
resistance 
classified 
low 
minimal 
inhibitor 
m 
##l 
high 
512 
m 
degree 
[CLS] 
extra 
##ada 
##l 
end 
##ode 
##rmal 
sin 
##us 
tumor 
neck 
rare 
[SEP] 
[CLS] 
les 
##ion 
kind 
resemble 
vitamin 
def 
##icient 
chicken 
first 
induced 
excess 
vitamin 
e 
[SEP] 
essential 
fatty 
deficiency 
childhood 
childhood [SEP] 
[PAD] [CLS] 
inhibitor 
##3 
activation 
##bol 
in 
##hibit 
##hibited 
effect 
##k 
78 
effect 
effect e 
activity 
activated 
f 
##r 
##3 
predominantly 
interact 
##rb 
so 
complex 
90 
k 
##da 
protein 
designated 
protein 
80 
##k 
h 
the 
rate 
co 
##lla 
##gen 
constant 
6 
month 
month 20 
year 
initial 
wound 
h 
##yper 
##tro 
k 
##elo 
initially 
approximately 
twice 
2 
3 
year 
wound 
level 
scar 
evidence 
role 
s 
chick 
cardiac 
development 
result 
83 
69 
9 
87 
majority 
var 
##ico 
complex 
involved 
involved [SEP] 
mutation 
##al 
analysis 
yeast 
##1 
four 
five 
conserved 
motif 
essential 
cap 
enzyme 
##ivo 
[CLS] 
we 
discovered 
year 
girl 
presenting 
an 
##ae 
##mia 
##mia [SEP] 
[CLS] 
the 
l 
##if 
appeared 
released 
peripheral 
blood 
l 
##ymph 
culture 
##d 
optimal 
dos 
prop 
##rano 
##lo 
##l 
selection 
[CLS] 
co 
expression 
##1 
co 
7 
cell 
two 
##k 
subunit 
alpha 
beta 
association 
##1 
kinase 
beta 
subunit 
[SEP] 
[CLS] 
for 
capsule 
containing 
drug 
value 
t 
##50 
increased 
particle 
size 
drug 
decreased 
decreased [SEP] 
[CLS] 
the 
##ec 
mean 
9 
4 
log 
c 
increased 
slightly 
holding 
time 
find 
possible 
predict 
##or 
expression 
progression 
##j 
##m 
evaluate 
relationship 
##j 
##m 
com 
dependent 
diabetes 
##lli 
##p 
##r 
re 
##nal 
failure 
trans 
conclusion 
l 
##h 
##b 
simple 
easy 
technique 
capable 
upper 
per 
pressure 
pressure [SEP] 
northern 
analysis 
confirm 
end 
##ogen 
alpha 
##ac 
gene 
4 
cell 
suppressed 
e 
removal 
c 
##y 
##c 
depend 
dependant 
kinase 
##d 
##ks 
##k 
extract 
matrix 
severely 
in 
##hibit 
s 
phase 
[CLS] 
analysis 
reveal 
reveal f 
##l 
thy 
##roid 
cell 
nuclear 
extract 
form 
specific 
protein 
d 
complex 
region 
prevented 
t 
##t 
##f 
1 
binding 
element 
element t 
promoter 
nuclear 
extract 
t 
##t 
##f 
1 
form 
complex 
[SEP] 
[CLS] 
the 
s 
##1 
kinase 
stimulate 
variety 
stress 
condition 
including 
o 
##smo 
o 
##da 
stress 
heat 
shock 
[SEP] 
[CLS] 
no 
viral 
r 
##na 
replication 
could 
detected 
cell 
trans 
mutant 
r 
[SEP] 
##d 
[CLS] 
comparison 
gene 
coding 
mouse 
human 
p 
##36 
an 
##nex 
ii 
mouse 
rat 
human 
an 
##nex 
i 
pigeon 
##p 
##35 
an 
##nex 
i 
related 
strong 
g 
##eno 
##mic 
structural 
conservation 
supporting 
hypothesis 
gene 
common 
ancestor 
[CLS] 
in 
##bate 
in 
##fect 
la 
##rva 
penetrated 
skin 
normal 
immune 
cell 
attached 
la 
##rva 
##rva absence 
serum 
serum [SEP] 
31 
year 
##elo 
##fi 
##bro 
initially 
received 
dose 
##ra 
c 
c [SEP] 
[CLS] 
collectively 
suggest 
major 
mit 
##otic 
growth 
pathway 
may 
absolutely 
linked 
s 
##9 
##1 
signaling 
transcription 
complex 
complex 
previously 
reported 
[SEP] 
stable 
g 
14 
day 
##og 
d 
##ys 
non 
##sui 
##cid 
##al 
mortality 
late 
life 
depression 
depression [SEP] 
[CLS] 
few 
t 
##rier 
user 
received 
s 
##lt 
counseling 
den 
despite 
high 
dental 
u 
##til 
rate 
rate [SEP] 
[CLS] 
however 
##v 
resistance 
restored 
cell 
remain 
sensitive 
gamma 
radiation 
[CLS] 
o 
##late 
o 
##das 
result 
mean 
reference 
interval 
o 
##xa 
##late 
ex 
##cre 
comparable 
comparable is 
di 
[SEP] 
[CLS] 
in 
m 
##rna 
##0 
resulted 
re 
##version 
transformed 
cell 
line 
star 
##ch 
effect 
effect [SEP] 
[CLS] 
ma 
##ximal 
ex 
##pi 
flow 
rate 
ex 
##pi 
##r 
rate 
25 
50 
75 
vital 
ma 
##x 
25 
ma 
max 
50 
ma 
max 
75 
forced 
ex 
##pi 
half 
75 
measured 
##3 
healthy 
smoking 
adult 
144 
male 
129 
aged 
15 
63 
year 
living 
mad 
##ras 
##ras [SEP] 
[CLS] 
the 
amino 
acid 
sequence 
protein 
encoded 
m 
##sk 
##1 
ho 
##mo 
##log 
##ous 
yeast 
c 
##op 
l 
##ys 
##yl 
##rna 
s 
##c 
gene 
recently 
suggested 
code 
es 
##cher 
##ichi 
co 
enzyme 
[SEP] 
[CLS] 
similar 
d 
b 
b 
e 
protein 
f 
known 
r 
binding 
motif 
suggesting 
type 
r 
interaction 
occur 
core 
[SEP] 
[CLS] 
these 
observation 
suggest 
##r 
##4 
##ik 
##1 
must 
assembly 
##p 
transcription 
##ally 
silent 
in 
##cess 
##ible 
ch 
##roma 
##tin 
structure 
fi 
##rome 
required 
spin 
##dle 
##ule 
ensure 
chromosome 
segregation 
characterization 
dead 
box 
at 
##lica 
##ido 
th 
##alia 
[CLS] 
amplitude 
late 
surface 
p 
##2 
n 
##2 
depth 
b 
c 
component 
decreased 
patient 
shifted 
s 
i 
##v 
p 
increased 
p 
w 
##2 
##2 [SEP] 
o 
de 
##tide 
derived 
inter 
##cal 
link 
[CLS] 
vector 
applicable 
characterization 
new 
open 
reading 
frame 
found 
genome 
se 
##quencing 
[SEP] 
[CLS] 
subject 
patient 
and 
##roid 
o 
##besity 
men 
men 13 
year 
mass 
b 
##mi 
ranging 
32 
0 
52 
52 2 
m 
ratio 
greater 
1 
0 
no 
universally 
accepted 
standardized 
system 
##gar 
exists 
although 
need 
blood 
sample 
determination 
##bri 
##no 
immediately 
compression 
application 
stock 
[CLS] 
neither 
s 
##ym 
##pt 
viral 
r 
##na 
detect 
plant 
in 
##oc 
mutant 
mutant 
##hi 
##ft 
mutation 
coat 
gene 
[SEP] 
the 
cumulative 
length 
genome 
including 
5 
6 
251 
n 
##t 
[CLS] 
risk 
ratio 
decreased 
increasing 
age 
increased 
number 
breast 
bio 
family 
history 
breast 
cancer 
est 
##rogen 
time 
screening 
comparison 
previous 
##mm 
##ogram 
radio 
tendency 
call 
##ogram 
abnormal 
abnormal [SEP] 
[CLS] 
the 
at 
##1 
expression 
profile 
u 
##bi 
root 
stem 
leaf 
flower 
si 
##lique 
##lique approximately 
1 
7 
k 
##b 
trans 
##cript 
##cript approximately 
50 
k 
##da 
greater 
level 
younger 
tissue 
developmental 
##ly 
active 
[SEP] 
[CLS] 
the 
o 
##ssi 
##fication 
located 
side 
c 
##3 
4 
4 [SEP] 
[CLS] 
at 
cut 
k 
##isa 
100 
280 
281 
participant 
99 
6 
correctly 
classified 
classified [SEP] 
following 
replica 
control 
ramp 
repeated 
presence 
ni 
##russ 
1 
micro 
##m 
p 
##to 
##lam 
1 
alpha 
1 
ad 
##ren 
##ept 
##or 
effect 
respectively 
[CLS] 
behavioral 
effect 
##zo 
##dia 
l 
##igan 
##d 
dependent 
di 
##az 
##am 
dependent 
di 
##az 
##am 
withdrawn 
##ab 
##oon 
[CLS] 
this 
paper 
report 
estimate 
re 
##tar 
##dation 
factor 
based 
population 
survey 
9 
year 
child 
greater 
ka 
##aki 
##stan 
[CLS] 
thus 
increase 
la 
##ct 
##ate 
observed 
al 
##kal 
therapy 
worse 
metabolic 
picture 
##ctic 
acid 
##osis 
##osis [SEP] 
adjusting 
##fari 
dose 
depends 
value 
factor 
dose 
need 
adjusted 
single 
##r 
slightly 
range 
alter 
total 
dose 
5 
20 
20 [SEP] 
[CLS] 
all 
region 
part 
prominent 
c 
##p 
##g 
island 
may 
acting 
extended 
enhance 
##r 
independent 
promoter 
[SEP] 
comparison 
heal 
##vis 
[PAD] [CLS] 
large 
volume 
bone 
ma 
##rrow 
may 
required 
type 
auto 
##log 
##ous 
bone 
ma 
##rrow 
transplant 
transplant [SEP] 
further 
##9 
lo 
cry 
neo 
##form 
structure 
defined 
forced 
expression 
description 
gene 
[CLS] 
we 
s 
##pec 
enhancing 
effect 
glucose 
##act 
##ose 
f 
##ct 
##ose 
absorption 
due 
activation 
f 
##ru 
##ct 
##ose 
carrier 
[SEP] 
##iro 
##l 
the 
d 
protein 
receiving 
spatial 
cue 
guide 
t 
##hea 
##l 
cell 
out 
##gro 
##wth 
the 
experiment 
incidence 
solid 
tumor 
ma 
##rrow 
transplant 
may 
still 
rise 
decade 
decade [SEP] 
[PAD] [CLS] 
[CLS] patient 
adopt 
new 
set 
based 
based partly 
original 
partly 
id 
##ios 
concern 
concern [SEP] 
n 
2 
##of 
##orms 
resolved 
p 
##i 
value 
5 
5 
three 
group 
uneven 
composed 
least 
two 
protein 
s 
##pec 
##ie 
##ie [SEP] 
prevalence 
rural 
western 
in 
who 
##ar 
cop 
##cor 
##d 
study 
ni 
##du 
transform 
secret 
high 
##i 
comparison 
characterized 
ni 
##ger 
transform 
p 
##act 
##uron 
##ase 
##c 
high 
level 
ni 
##du 
transformed 
sub 
##lone 
##d 
gene 
[CLS] 
this 
interaction 
lead 
re 
##tar 
##get 
n 
##f 
p 
##50 
nucleus 
c 
##op 
##las 
##m 
##f 
gene 
product 
79 
characteristic 
similar 
ta 
##t 
trans 
##act 
##iva 
##tor 
##gu 
[SEP] 
[PAD] [CLS] 
medication 
treatment 
##bia 
##bia [SEP] 
elevated 
total 
serum 
calcium 
level 
11 
9 
0 
mg 
d 
00 
##1 
developed 
1 
oh 
d 
##3 
group 
day 
4 
2 
day 
prior 
pronounced 
structural 
damage 
day 
7 
r 
##ac 
r 
##pas 
highly 
##elo 
##id 
regulator 
##d 
##ph 
o 
##das 
complex 
kinase 
##vil 
put 
signal 
trans 
high 
specific 
##43 
ma 
##ximal 
##f 
[SEP] 
[CLS] 
effect 
infant 
##ile 
under 
##nut 
##rit 
adult 
su 
##c 
##rose 
solution 
consumption 
rat 
[CLS] 
in 
described 
identified 
two 
potential 
et 
##s 
binding 
site 
##bs 
##1 
##1 e 
##bs 
##2 
conserved 
inter 
enhance 
##r 
[SEP] 
[CLS] 
ka 
##f 
hem 
##e 
bio 
##sy 
enzyme 
m 
##rga 
also 
induced 
entry 
stationary 
condition 
iron 
manga 
limitation 
[SEP] 
[CLS] 
##25 
substitution 
observed 
um 
conservative 
possible 
distinguish 
mutation 
##oly 
##mor 
##phism 
region 
show 
46 
identity 
##od 
##ulin 
binding 
region 
brain 
ca 
ca2 
##od 
##ulin 
dependent 
ii 
32 
identity 
region 
##os 
kinase 
[CLS] 
the 
per 
##rated 
s 
##p 
give 
superior 
result 
virtue 
require 
removed 
purpose 
h 
##ygiene 
thus 
satisfactory 
result 
even 
patient 
fail 
fail grasp 
technique 
removal 
replacement 
s 
[CLS] 
it 
contains 
31 
ex 
##on 
high 
proportion 
class 
0 
intro 
##n 
alternative 
s 
##licing 
result 
level 
variant 
trans 
##cript 
maintain 
original 
open 
reading 
frame 
m 
##rp 
m 
##rna 
[SEP] 
issue 
mm 
##f 
scale 
question 
research 
homosexuality 
difference 
he 
##tero 
##sexual 
homosexual 
sub 
a 
##uration 
homosexual 
adjustment 
cluster 
analysis 
t 
##pol 
##ogy 
homosexuality 
[CLS] 
a 
brief 
discussion 
relationship 
among 
formula 
given 
given [SEP] 
la 
##vu 
##dine 
therapy 
he 
##pa 
peripheral 
these 
nm 
##da 
receptor 
blockade 
##eli 
##ora 
d 
##ys 
##kin 
com 
long 
term 
##vo 
##do 
##pa 
therapy 
beneficial 
effect 
park 
##onia 
sign 
[CLS] 
further 
##more 
secondary 
stress 
response 
pronounced 
impaired 
exposed 
##x 
##posed 
fish 
[CLS] 
distinct 
spatial 
pattern 
expression 
unusual 
amino 
acid 
sequence 
d 
binding 
domain 
particular 
role 
d 
##te 
##f 
1 
cell 
specific 
gene 
regulation 
[SEP] 
a 
usual 
test 
##hali 
sensible 
l 
##m 
##w 
used 
us 
syndrome 
1 
##1 
con 
##ital 
condition 
manifest 
profound 
absence 
##ib 
##ular 
function 
eventual 
re 
##tina 
##l 
de 
##gene 
##ration 
imp 
##lant 
##ica 
severe 
d 
##p 
##lasia 
recently 
variety 
x 
linked 
deaf 
def 
##icient 
bone 
fund 
##us 
internal 
audit 
meat 
##us 
##us [SEP] 
[CLS] 
over 
9 
k 
##b 
d 
sequence 
obtained 
one 
clone 
##1 
total 
i 
##g 
length 
12 
4 
k 
##b 
[CLS] 
s 
##rax 
enhanced 
expression 
##gg 
##re 
##can 
gene 
normally 
expressed 
high 
level 
o 
##ste 
##ob 
cell 
this 
demonstrates 
exposure 
su 
must 
result 
and 
##rogen 
h 
##y 
##r 
##h 
first 
normal 
injury 
new 
##oper 
com 
related 
surgical 
stress 
response 
##rine 
metabolic 
inflammatory 
change 
change [SEP] 
[CLS] 
four 
multi 
##can 
##nu 
ho 
##ls 
initial 
b 
##4 
16 
x 
x 4 
la 
latin 
square 
influence 
supplement 
for 
intake 
site 
extent 
dig 
##est 
nut 
##rient 
dormant 
blues 
range 
range for 
2 
3 
c 
##p 
[SEP] 
[CLS] 
patient 
risk 
factor 
without 
risk 
factor 
factor [SEP] 
der 
##mat 
##phic 
pattern 
demos 
demostrate 
di 
##stal 
t 
##ri 
##rad 
##ius 
##rl 
abnormal 
##ity 
[PAD] [CLS] 
the 
term 
ka 
##rta 
syndrome 
syndrome applies 
syndrome 
accompanied 
in 
de 
##x 
##tro 
##card 
sit 
in 
##vers 
##us 
##us [SEP] 
[CLS] 
finally 
tested 
activation 
factor 
dependent 
component 
saga 
complex 
complex [SEP] 
[CLS] 
eight 
17 
se 
##rop 
##os 
patient 
failed 
detect 
he 
within 
three 
month 
third 
injection 
compared 
one 
se 
##rone 
##gat 
patient 
01 
[CLS] 
the 
##bial 
initial 
prop 
##hyl 
as 
exposed 
##hra 
##hracis 
c 
##ro 
##f 
500 
day 
60 
day 
[CLS] 
e 
##if 
##if4 
transforms 
cell 
mutation 
##if 
##if4 
arrest 
g 
##d 
##c 
mutant 
[CLS] 
ben 
##zy 
##l 
alcohol 
administration 
neon 
##ate 
[SEP] 
repression 
her 
alpha 
gene 
gene 
i 
##4 
within 
context 
genome 
conditioned 
distance 
stereo 
##ax 
alignment 
##4 
d 
binding 
site 
relative 
ta 
anticipated 
in 
##cellular 
##bet 
##a 
activation 
##c 
##l 
2 
blocked 
map 
specific 
##3 
##1 
[CLS] 
relation 
immune 
complex 
serum 
f 
##rit 
hem 
##os 
##ider 
##osis 
different 
et 
##iology 
##iology [SEP] 
r 
##p 
##ls 
48 
patient 
re 
recurrent 
##current i 
et 
failure 
179 
120 
group 
woman 
woman [SEP] 
many 
metabolic 
effect 
##zi 
di 
te 
##boro 
##xi 
new 
##oro 
add 
##uc 
tech 
##net 
di 
bat 
##o 
favorable 
characteristic 
[CLS] 
total 
area 
blood 
glucose 
curve 
initial 
altered 
h 
treatment 
209 
##b 
##non 
treatment 
excessive 
bleeding 
based 
algorithm 
point 
testing 
blood 
pro 
##th 
##rom 
##bin 
##rom 
##par 
##lot 
##lotting 
##let 
count 
count [SEP] 
[CLS] 
in 
large 
fraction 
al 
became 
ins 
##ub 
stomach 
ing 
##est 
##ion 
##ion [SEP] 
to 
##gio 
##tens 
converting 
enzyme 
##ala 
##p 
random 
##os 
##in 
designed 
##ens 
first 
day 
treatment 
treatment [SEP] 
[CLS] 
glucose 
may 
reduce 
slightly 
pool 
amino 
nitrogen 
available 
album 
##in 
u 
##rea 
synthesis 
diver 
in 
protein 
synthesis 
liver 
muscle 
[CLS] 
background 
background [SEP] 
isolation 
[CLS] 
result 
euro 
pro 
##stra 
total 
g 
##er 
season 
a 
nationwide 
record 
link 
##nish 
twin 
co 
##hor 
study 
hospital 
discharge 
medication 
presented 
[CLS] 
considering 
fact 
vase 
##ct 
may 
lead 
pro 
##static 
tumor 
disease 
claim 
nearly 
22 
000 
life 
year 
united 
state 
alone 
[SEP] 
member 
j 
f 
##o 
transcription 
factor 
show 
##tar 
##dation 
like 
factor 
component 
##3 
2 
specific 
complex 
she 
severe 
##p 
an 
1 
year 
hospital 
##is 
##olo 
pulse 
therapy 
successful 
successful [SEP] 
[CLS] 
re 
l 
f 
transfer 
##ase 
enzyme 
contains 
detect 
##able 
r 
component 
[SEP] 
cord 
formation 
##h 
##12 
medium 
rapid 
##su 
##mpt 
##co 
tuberculosis 
complex 
[CLS] 
more 
site 
specific 
integration 
##r 
flanked 
d 
also 
detected 
p 
##r 
am 
##p 
##r 
##s 
##1 
junction 
##bro 
##blast 
o 
1 
##bi 
##quito 
##quitous 
##usly 
regulatory 
gene 
family 
[SEP] 
[CLS] 
in 
study 
stage 
exposure 
treatment 
injection 
vaccine 
d 
##ys 
0 
3 
7 
14 
28 
together 
dose 
r 
##abi 
##quin 
human 
d 
##0 
[CLS] 
3 
with 
exception 
ant 
##ero 
##eri 
##or 
direction 
layer 
ii 
ii 
##i 
me 
##dio 
##late 
##ral 
direction 
layer 
layer i 
iv 
vertical 
conduct 
cortex 
always 
greater 
either 
horizontal 
conduct 
[CLS] 
our 
study 
investigated 
hypothesis 
combination 
high 
##l 
diet 
social 
isolation 
stress 
would 
increase 
s 
##ys 
##to 
blood 
s 
end 
##ogen 
sodium 
pump 
l 
##igan 
##aba 
##in 
##c 
##rino 
##fa 
the 
relationship 
destruction 
[CLS] 
suggested 
loss 
weight 
decrease 
food 
intake 
increase 
brain 
m 
so 
##4 
induced 
c 
##mi 
reflect 
possible 
an 
##ore 
##ctic 
drug 
[CLS] 
result 
patient 
30 
showed 
s 
##t 
segment 
depression 
##em 
##em 34 
49 
ex 
##t 
[CLS] 
the 
virus 
must 
progress 
past 
immediate 
early 
express 
gene 
product 
activation 
c 
##y 
##c 
##lin 
e 
expression 
in 
##1 
liver 
contained 
3 
fold 
s 
##tero 
element 
binding 
2 
m 
##rna 
[CLS] 
ad 
##eno 
##cin 
large 
worse 
pro 
##cin 
t 
##1 
##n 
##1 
##1 t 
##n 
##1 
subset 
subset [SEP] 
i 
pain 
26 
81 
patient 
positive 
th 
##all 
201 
20 
patient 
abnormal 
e 
ec 
time 
an 
##gin 
patient 
trans 
e 
ec 
change 
change [SEP] 
prototype 
structure 
on 
##cology 
information 
available 
internet 
resource 
maintained 
disposal 
disposal [SEP] 
[CLS] 
binding 
to 
##rr 
regulator 
c 
##i 
acting 
direct 
repeat 
activate 
##s 
to 
##r 
op 
##eron 
expression 
[SEP] 
[CLS] 
for 
part 
a 
##ero 
##bic 
micro 
##bial 
degradation 
system 
far 
[SEP] 
##emia 
daily 
##rona 
##ry 
artery 
disease 
redundant 
redundant [SEP] 
[CLS] 
this 
consensus 
case 
##in 
kinase 
##ki 
##i 
site 
show 
main 
##i 
site 
body 
terminal 
complex 
forming 
region 
[SEP] 
in 
ii 
##i 
single 
study 
design 
controlled 
random 
##ized 
double 
blind 
phase 
i 
iv 
requires 
different 
design 
many 
different 
question 
question [SEP] 
[CLS] 
treatment 
##sin 
induce 
expression 
c 
##re 
resulted 
complete 
disruption 
##rn 
##t 
gene 
loss 
##t 
messenger 
r 
m 
##rna 
expression 
liver 
[SEP] 
[CLS] 
physical 
map 
genome 
son 
##chus 
r 
##do 
gene 
conserved 
gene 
junction 
sequence 
[SEP] 
tub 
##ular 
d 
##nal 
lit 
##hia 
cause 
consequence 
to 
investigate 
overall 
tub 
##ular 
d 
subgroup 
patient 
##rol 
##ias 
following 
parameter 
re 
##nal 
tub 
##ular 
function 
fast 
##ing 
morning 
urine 
124 
male 
stone 
former 
former ex 
##cre 
##ys 
##oz 
##am 
trans 
##idas 
gamma 
g 
gt 
fraction 
##al 
ex 
glucose 
##ate 
theoretical 
phosphate 
##r 
[SEP] 
[CLS] 
interaction 
tobacco 
d 
binding 
activity 
##b 
##f 
1 
promoter 
element 
##ba 
##cter 
##cterium 
t 
##ume 
##fa 
t 
d 
gene 
t 
c 
co 
##rrel 
##ate 
1 
directed 
gene 
expression 
multiple 
tobacco 
tissue 
type 
[SEP] 
a 
expected 
##ols 
n 
lower 
correlation 
physical 
0 
24 
000 
##pt 
0 
0 20 
00 
##1 
higher 
mental 
0 
0 52 
000 
000 [SEP] 
[CLS] 
the 
n 
##1 
p 
amplitude 
##ep 
decreased 
increasing 
muscular 
inner 
##vation 
##vation [SEP] 
[CLS] 
s 
##n 
38 
re 
##bound 
many 
course 
0 
5 
1 
hour 
end 
v 
in 
##fusion 
enter 
##oh 
recycling 
[SEP] 
sequence 
analysis 
revealed 
en 
protein 
containing 
three 
three g 
##2 
zinc 
finger 
[CLS] 
in 
p 
##18 
##1 
p 
##mi 
##d 
in 
##act 
##ivation 
in 
##iti 
##ator 
re 
##p 
##c 
protein 
occurs 
attachment 
o 
##leo 
##tide 
active 
t 
##os 
residue 
[SEP] 
x 
##po 
anti 
##biotic 
si 
##iss 
if 
##o 
##5 
##6 
##2 
extra 
extracellular 
regulated 
1 
##k 
authentic 
dual 
specific 
##hr 
##hr [SEP] 
treatment 
dose 
cap 
##top 
##ril 
[CLS] 
h 
t 
##run 
##cation 
hip 
n 
terminus 
resulted 
apparent 
loss 
hip 
ho 
##mo 
o 
##go 
##mer 
retained 
association 
##70 
receptor 
complex 
[CLS] 
the 
biological 
basis 
change 
c 
##nap 
##s 
produced 
##s 
##2 
investigation 
[SEP] 
a 
large 
p 
pc 
la 
lan 
basis 
hospital 
information 
system 
[CLS] 
tragic 
##ally 
highlighted 
year 
dental 
nurse 
taking 
single 
1 
g 
tablet 
sodium 
ni 
##tri 
##te 
[CLS] 
the 
human 
protein 
encoded 
900 
base 
pair 
long 
m 
##rna 
g 
##ular 
e 
##pit 
cell 
end 
##um 
c 
##yclic 
manner 
addition 
found 
##uc 
##osa 
##l 
e 
fall 
##op 
tube 
[CLS] 
in 
re 
##nal 
##cin 
##oma 
experienced 
vent 
##ric 
##ular 
ta 
##chy 
##card 
undergoing 
treatment 
high 
dose 
b 
##ol 
##us 
il 
2 
2 [SEP] 
four 
anti 
##nga 
##ph 
##oter 
##tos 
mi 
##cona 
##zo 
##le 
k 
##cona 
##le 
the 
regulatory 
gene 
##x 
clone 
##d 
##ex 
es 
##cher 
##ichi 
co 
[SEP] 
examination 
##oma 
##ssie 
stained 
gel 
caps 
##id 
like 
particle 
composed 
n 
##11 
##1 
contain 
host 
derived 
his 
[CLS] 
conversion 
n 
##f 
ka 
##b 
g 
##ab 
##p 
binding 
site 
likely 
occurred 
also 
worldwide 
hi 
1 
noticed 
l 
##tr 
modification 
sub 
e 
is 
##olate 
th 
##ail 
##and 
protein 
binding 
##1 
##1 
extract 
der 
##ep 
re 
##pressed 
could 
excess 
##re 
##1 
[CLS] 
we 
isolated 
full 
length 
coding 
region 
human 
b 
##1 
gene 
expressed 
sequence 
tag 
reverse 
transcription 
##ase 
chain 
reaction 
rapid 
am 
##p 
##lification 
c 
##a 
end 
[SEP] 
[CLS] 
author 
present 
an 
##ato 
##mic 
##al 
variation 
course 
##sent 
##eric 
artery 
branch 
62 
human 
f 
##etus 
##etus [SEP] 
[CLS] 
the 
7 
2 
k 
##b 
e 
##cor 
##i 
fragment 
clone 
##d 
n 
##uc 
##leo 
##tide 
sequence 
##rin 
coding 
region 
flank 
##ing 
region 
determined 
[CLS] 
1 
1 [SEP] 
[CLS] 
the 
in 
median 
plasma 
secret 
##in 
1 
6 
3 
0 
6 
4 
pm 
##ol 
x 
1 
1 
secret 
125 
250 
500 
##mo 
1 
corresponding 
15 
min 
bi 
##car 
##bon 
##ate 
28 
##3 
44 
143 
##mo 
respectively 
respectively [SEP] 
[CLS] 
the 
resulting 
threshold 
elevation 
curve 
fell 
small 
number 
distinct 
group 
discrete 
spatial 
frequency 
mechanism 
human 
central 
vision 
[CLS] 
because 
##b 
en 
transcription 
##al 
act 
##iva 
##tor 
via 
d 
binding 
likely 
c 
##b 
ex 
exert 
biological 
activity 
regulating 
transcription 
gene 
required 
d 
synthesis 
cycle 
progression 
[SEP] 
[CLS] 
the 
rest 
3 
##lated 
sequence 
common 
clone 
[CLS] 
co 
##ex 
c 
##l 
combination 
at 
##f 
1 
##b 
##2 
at 
##f 
1 
##b 
lead 
##rg 
trans 
##act 
##d 
##28 
reporter 
##mi 
##es 
##kat 
cell 
[SEP] 
[CLS] 
conventional 
toxic 
suggest 
adverse 
health 
effect 
increase 
coal 
combustion 
e 
##ff 
##lue 
would 
greatest 
per 
unit 
coal 
area 
heavily 
highest 
pre 
##ex 
##ist 
level 
gas 
##ero 
complex 
[SEP] 
[CLS] 
gene 
chromosome 
involved 
trans 
##location 
identified 
transcription 
factor 
encoding 
gene 
##3 
##r 
conducted 
suppress 
##or 
in 
##os 
##ot 
yeast 
[CLS] 
##est 
##hesia 
drop 
##eri 
##do 
0 
2 
mg 
kg 
1 
f 
50 
##gram 
th 
##iam 
##yla 
##l 
150 
250 
mg 
su 
##cho 
##line 
1 
mg 
kg 
1 
maintained 
##tro 
##us 
o 
##2 
67 
33 
supplemented 
repeated 
v 
dos 
f 
within 
15 
micro 
##gram 
1 
complexity 
host 
path 
##ogen 
interaction 
actual 
infection 
difficulty 
##ivo 
this 
novel 
gene 
could 
candidate 
gene 
genetic 
disorder 
bi 
##pol 
affect 
##nd 
##rom 
hereditary 
deaf 
knob 
syndrome 
ho 
##lop 
##nce 
##pha 
mapped 
region 
[CLS] 
para 
##dox 
##ically 
loop 
3 
##i 
m 
##1 
##car 
ma 
##ximal 
in 
##hibit 
##r 
##h 
camp 
accumulation 
p 
##rl 
release 
40 
effect 
effect mediated 
activation 
protein 
[CLS] 
we 
patient 
presented 
unusually 
large 
##uc 
c 
##ys 
##t 
measuring 
38 
x 
25 
mm 
uncommon 
local 
##ization 
right 
##llar 
##y 
##y [SEP] 
acoustic 
property 
measurement 
super 
##conductor 
##b 
##1 
x 
##bi 
##x 
##o 
##3 
resonance 
method 
in 
men 
1 
died 
suddenly 
functional 
area 
my 
##oc 
##ard 
sin 
##o 
au 
##ric 
##ular 
area 
sub 
##end 
##oc 
##ard 
layer 
##ric 
ne 
##c 
##rops 
3 
h 
prepared 
electron 
i 
##f 
i 
level 
child 
autism 
4 
male 
mean 
age 
3 
3 8 
year 
s 
##d 
1 
1 
level 
control 
participant 
male 
mean 
age 
3 
3 8 
year 
in 
##ct 
hi 
##fu 
patient 
pro 
##ph 
n 
102 
determined 
[CLS] 
three 
high 
am 
##yl 
rice 
i 
##r 
##42 
i 
ir 
##36 
##6 
##62 
similar 
chemical 
composition 
##yl 
##ose 
content 
26 
cooked 
##it 
dig 
##est 
well 
blood 
glucose 
insulin 
healthy 
human 
volunteer 
slowly 
adapt 
type 
i 
##chan 
##ore 
discharge 
function 
dynamic 
force 
dynamic 
displacement 
##bro 
skin 
squirrel 
hand 
[CLS] 
using 
beta 
1 
##r 
l 
##uc 
##ifer 
##ase 
reporter 
determined 
important 
beta 
1 
##r 
genetic 
element 
controlling 
expression 
within 
c 
##6 
g 
##lio 
contained 
within 
region 
39 
##6 
29 
##9 
relative 
translation 
##al 
start 
site 
[SEP] 
[CLS] 
f 
##ac 
##s 
analysis 
m 
reached 
middle 
late 
g 
##1 
phase 
cell 
cycle 
progression 
time 
##point 
however 
his 
serum 
f 
##rote 
7 
month 
age 
re 
1 
year 
year [SEP] 
[CLS] 
analysis 
tobacco 
m 
##b 
##a 
probe 
##b 
present 
tissue 
examined 
highest 
trans 
##cript 
accumulation 
occurred 
stem 
tissue 
[SEP] 
[CLS] 
co 
revealed 
##gata 
4 
##23 
stimulation 
necessary 
il 
5 
promoter 
activation 
[CLS] 
expression 
k 
##rab 
domain 
suppress 
v 
##ivo 
act 
##ivating 
function 
various 
act 
##ivating 
transcription 
factor 
demonstrate 
k 
domain 
specifically 
silence 
promoter 
whose 
initiation 
dependent 
presence 
ta 
box 
[SEP] 
[CLS] 
adult 
onset 
appeared 
several 
##af 
##fected 
member 
d 
##rd 
suggesting 
additional 
##otypic 
##al 
expression 
disease 
disease [SEP] 
we 
tested 
##nga 
drug 
##di 
##ro 
[CLS] 
the 
enter 
##oc 
##oli 
path 
##ological 
micro 
##bial 
flora 
stool 
change 
co 
##lon 
##uc 
##osa 
absent 
absent [SEP] 
[CLS] 
result 
##ivo 
interaction 
##ki 
gamma 
gamma 
could 
involved 
signaling 
pathway 
downstream 
r 
##t 
##ks 
[SEP] 
[CLS] 
correlation 
##id 
metabolic 
rat 
cooled 
condition 
altered 
gas 
##eous 
environment 
react 
##ivation 
replication 
rare 
event 
natural 
history 
he 
b 
b [SEP] 
[CLS] 
a 
minimal 
region 
stimulate 
origin 
function 
mapped 
50 
amino 
acid 
within 
c 
terminus 
##1 
##p 
[SEP] 
[PAD] [CLS] 
cut 
##aneous 
me 
##lan 
##oma 
bilateral 
re 
##blast 
##oma 
##oma [SEP] 
treatment 
j 
##le 
induce 
##b 
##l 
##b 
p 
##ory 
##lation 
well 
##d 
##28 
activate 
##d 
dependent 
activity 
an 
##aph 
##ase 
promoting 
complex 
method 
after 
eligibility 
patient 
randomly 
allocated 
one 
following 
group 
m 
##nis 
##olo 
30 
mg 
kg 
1 
1 
hour 
followed 
4 
mg 
kg 
1 
h 
1 
23 
hour 
hour n 
ni 
##mo 
##di 
0 
01 
mg 
kg 
1 
h 
1 
2 
hour 
followed 
0 
03 
mg 
kg 
1 
h 
1 
7 
day 
m 
mn 
p 
[CLS] 
the 
amount 
overlap 
##fi 
e 
##f 
##v 
##f 
value 
among 
clinical 
group 
considerable 
considerable [SEP] 
[CLS] 
after 
5 
850 
c 
##14 
b 
##p 
decrease 
##r 
stand 
could 
attributed 
fire 
suggested 
strong 
increase 
bet 
##ula 
delayed 
expansion 
pin 
c 
##em 
##bra 
[SEP] 
ass 
l 
##uc 
##ifer 
##ase 
reporter 
##mi 
trans 
he 
##p 
cell 
show 
m 
##uta 
##ted 
bind 
b 
function 
il 
1 
alpha 
in 
enhance 
##r 
whereas 
m 
##uta 
bind 
b 
##c 
r 
##4 
requires 
at 
h 
##ydro 
##lysis 
##h 
box 
s 
##licing 
factor 
##r 
##2 
[CLS] 
several 
sequence 
resembling 
binding 
site 
liver 
fat 
body 
specific 
transcription 
factor 
identified 
within 
1 
k 
##b 
upstream 
downstream 
gene 
[SEP] 
b 
p 
tissue 
[CLS] 
it 
showed 
amino 
acid 
residue 
would 
contact 
extended 
ta 
box 
b 
recognition 
element 
evolutionary 
conservation 
t 
##b 
##p 
t 
##b 
d 
complex 
orientation 
arch 
##ae 
##al 
organism 
different 
optimal 
temperature 
growth 
37 
100 
degree 
c 
[SEP] 
[CLS] 
study 
without 
at 
medium 
performed 
my 
##oc 
##ard 
##ium 
defect 
count 
ratio 
defect 
size 
dual 
is 
##oto 
s 
##pect 
image 
compared 
##oc 
##ard 
##ium 
defect 
count 
ratio 
defect 
size 
single 
is 
201 
##tl 
99 
##m 
##t 
s 
##pect 
image 
image [SEP] 
comparison 
gene 
available 
database 
reveals 
ho 
##mology 
factor 
1 
probable 
near 
clone 
factor 
##f 
patient 
e 
##ales 
##ales disease 
se 
##rous 
ma 
##gnant 
##oro 
##gen 
de 
##viation 
##viation [SEP] 
copyright 
1999 
[CLS] 
the 
1 
m 
##b 
region 
co 
##sm 
##id 
minimum 
overlap 
set 
52 
##sm 
##id 
assigned 
bin 
9 
con 
##ti 
##gs 
similarly 
beta 
ad 
##ren 
blockade 
achieving 
con 
patient 
[CLS] 
est 
##rogen 
positive 
effect 
sexual 
target 
cognitive 
function 
function may 
et 
##iology 
al 
##z 
##heimer 
disease 
acting 
prevent 
am 
##yl 
plaque 
formation 
o 
##xi 
##da 
de 
##ter 
##ior 
##ation 
##olin 
##ergic 
ne 
##uro 
##mit 
system 
[SEP] 
[CLS] 
these 
insulin 
##b 
map 
kinase 
de 
no 
##vo 
t 
via 
similar 
pathway 
[CLS] 
effect 
he 
##ob 
##ar 
##bit 
##al 
rat 
t 
##rie 
[CLS] 
such 
te 
##tra 
##ot 
common 
promoter 
region 
particularly 
act 
##ivating 
transcription 
factor 
c 
am 
##p 
response 
element 
binding 
at 
##f 
##b 
e 
box 
motif 
suggesting 
p 
may 
m 
##od 
##ulate 
transcription 
many 
gene 
[SEP] 
[PAD] [CLS] 
blood 
cell 
binding 
99 
##t 
131 
6 
1 
20 
respectively 
respectively [SEP] 
inhibitor 
terminus 
dependent 
dependent activation 
##p 
##a 
map 
kinase 
ability 
complex 
activated 
activated e 
receptor 
brains 
e 
##z 
a 
##1 
##z 
##2 
region 
##yper 
##ote 
##ns 
s 
##m 
bind 
##it 
suggesting 
sequence 
structure 
specific 
m 
interaction 
might 
media 
s 
specific 
##ity 
##ity [SEP] 
receptor 
feature 
allows 
understanding 
evolution 
unique 
group 
##rs 
##ida 
##igan 
##d 
signaling 
mechanism 
[CLS] 
sequence 
essential 
processing 
s 
##nas 
lack 
canonical 
terminal 
stem 
[CLS] 
the 
use 
h 
associated 
f 
##eca 
##l 
flu 
##ori 
ex 
##cre 
decrease 
net 
absorption 
flu 
##ori 
regardless 
intake 
##ori 
calcium 
ma 
##gnesium 
thigh 
c 
treated 
c 
treated 
control 
[CLS] 
k 
##ram 
ha 
##urg 
##b 
3 
3 92 
##9 
07 
5 
s 
##yn 
##dr 
##oma 
day 
day 
shifting 
feature 
man 
##ic 
de 
##pressive 
several 
mixed 
time 
structure 
structure 25 
patient 
studied 
paper 
paper [SEP] 
##a 
involvement 
signal 
trans 
##duction 
se 
##rot 
##oni 
receptor 
[CLS] 
analysis 
ex 
##on 
2 
factor 
i 
##x 
gene 
t 
mutation 
co 
##don 
10 
prop 
##eptide 
region 
resulting 
substitution 
##ne 
##ne 
[SEP] 
[CLS] 
there 
direct 
proportional 
relationship 
spiral 
artery 
flow 
pressure 
spiral 
artery 
am 
##nio 
fluid 
pressure 
##ona 
found 
1 
3 
mm 
h 
##g 
[PAD] [CLS] 
m 
##l 
1 
min 
8 
24 
##k 
##pa 
1 
1 [SEP] 
three 
put 
##ative 
##fs 
ho 
##0 
##9 
##6 
##68 
new 
member 
large 
se 
##per 
yeast 
member 
member l 
##13 
##13 
new 
##b 
transport 
ho 
##mo 
##log 
##ous 
yeast 
ca 
##d 
resistance 
##1 
##p 
human 
multi 
##dr 
##ug 
resistance 
##1 
terminal 
part 
part l 
##13 
##1325 
present 
sequence 
ho 
##mo 
##log 
##ous 
fly 
fly abdominal 
segment 
formation 
[CLS] 
cell 
densely 
c 
##iliated 
c 
showing 
typical 
9 
2 
##lar 
pattern 
[SEP] 
im 
alpha 
##i 
si 
##gma 
##i 
beta 
##i 
si 
##gma 
##i 
s 
##pect 
##os 
alpha 
##ii 
beta 
##ii 
s 
##pect 
co 
##loc 
s 
sh 
##3 
binding 
extra 
cancer 
##pha 
r 
##ii 
##bet 
##a 
subunit 
[PAD] [CLS] 
detection 
##us 
##oid 
g 
##rating 
pattern 
specific 
detector 
evidence 
correlation 
principle 
human 
vision 
vision [SEP] 
[CLS] 
this 
b 
box 
present 
##1 
##2 
##2 p 
pea 
##3 
pu 
1 
protein 
unable 
form 
te 
##rna 
##ry 
complex 
complex s 
##rl 
c 
c f 
fo 
[CLS] 
mad 
##s 
box 
gene 
diverse 
transcription 
factor 
involved 
regulating 
process 
particularly 
##em 
organ 
identity 
floral 
development 
development [SEP] 
[CLS] 
elevated 
##ys 
##to 
blood 
high 
post 
##lu 
##cos 
serum 
insulin 
showed 
independent 
##ric 
mass 
di 
##abe 
subject 
[CLS] 
this 
study 
investigated 
at 
##rial 
at 
##rial 
fi 
##bri 
##lla 
flutter 
##ff 
thirty 
disease 
##i 
an 
##emia 
d 
##ato 
con 
##gen 
##ita 
black 
##fan 
diamond 
er 
##hr 
##ob 
##last 
g 
th 
##rom 
##bas 
1 
o 
##ste 
##ope 
##tro 
1 
disease 
1 
viral 
protein 
u 
##pu 
encoded 
1 
hi 
1 
promotes 
degradation 
receptor 
c 
##d 
##4 
enhance 
release 
particle 
cell 
[CLS] 
variation 
##bo 
##dra 
##te 
human 
milk 
small 
simple 
approach 
would 
##bo 
##dra 
estimate 
energy 
content 
level 
ii 
mosaic 
##ism 
0 
9 
c 
##v 
me 
##sen 
1 
am 
##nio 
culture 
general 
##yt 
##ogen 
follow 
study 
study [SEP] 
[CLS] 
bio 
##l 
[CLS] 
i 
##v 
[CLS] 
sleeping 
position 
sudden 
infant 
death 
si 
##ds 
effect 
intervention 
programme 
avoid 
prone 
sleeping 
sleeping [SEP] 
[CLS] 
c 
##sen 
stimulate 
##d 
transcription 
variety 
promoter 
including 
human 
growth 
hormone 
thy 
##mi 
##dine 
kinase 
r 
##ous 
promoter 
ch 
##car 
##cin 
line 
line be 
3 
he 
##la 
cell 
rat 
so 
##mat 
##ola 
##ot 
g 
##c 
skin 
t 
##ra 
in 
##hibit 
induction 
j 
protein 
consequently 
1 
c 
j 
protein 
in 
via 
##cription 
##al 
mechanism 
since 
t 
in 
induction 
[CLS] 
thus 
##pop 
hem 
##ato 
end 
result 
conflict 
death 
survival 
signal 
rather 
simple 
death 
default 
default [SEP] 
[CLS] 
effect 
age 
glucose 
reducing 
sugar 
plasma 
blood 
milk 
fed 
calf 
[CLS] 
conclusion 
result 
study 
suggest 
male 
female 
soldier 
diagnosed 
relatively 
high 
risk 
re 
##in 
##fect 
20 
20 [SEP] 
[CLS] 
during 
seed 
mat 
##uration 
transcription 
##al 
activity 
nap 
gene 
regulated 
developmental 
signal 
involving 
transcription 
##al 
act 
##iva 
##tor 
##bi 
##3 
##bs 
[SEP] 
design 
in 
##der 
##mal 
injected 
sq 
grown 
80 
mm 
##3 
at 
i 
##rra 
##dia 
75 
cm 
75 
m 
24 
hour 
in 
injection 
sip 
##c 
i 
##v 
1 
0 
mg 
kg 
[CLS] 
this 
result 
secret 
consequently 
decreased 
resistance 
infection 
infection [SEP] 
[CLS] 
the 
absolute 
c 
##d 
##4 
count 
patient 
de 
no 
##vo 
i 
##b 
##d 
210 
700 
m 
##l 
time 
i 
##b 
##d 
cat 
##ris 
sub 
##structure 
section 
allows 
anal 
displayed 
separately 
separately [SEP] 
[CLS] 
to 
study 
mechanism 
signaling 
pathway 
involved 
i 
1 
##r 
promoter 
reporter 
construct 
trans 
trans 
##fected 
ch 
##o 
at 
##1 
cell 
##gio 
##tens 
at 
[CLS] 
with 
study 
total 
13 
operator 
g 
##p 
re 
##gu 
##lon 
characterized 
[SEP] 
[CLS] 
na 
##tl 
j 
##agon 
##a 
dependent 
stimulation 
k 
##da 
##ati 
##atinas 
promoter 
driven 
reporter 
[PAD] [CLS] 
patient 
male 
homosexual 
##op 
##hil 
##rom 
related 
complex 
complex [SEP] 
however 
##x 
##ral 
in 
##hibit 
binding 
##l 
##pha 
r 
##x 
##ral 
he 
##tero 
##di 
##mers 
co 
##x 
##ral 
##agon 
per 
##ox 
##is 
mediated 
r 
##x 
##ral 
v 
##ivo 
[PAD] [CLS] 
the 
result 
summarized 
follows 
follows [SEP] 
[CLS] 
a 
case 
he 
##tero 
##top 
##ic 
gas 
##tric 
##uc 
##yl 
##ori 
g 
wall 
gal 
##l 
##bla 
##dder 
reported 
[SEP] 
[CLS] 
these 
finding 
mechanism 
rib 
##oso 
frames 
##m 
signal 
different 
one 
described 
simultaneous 
slip 
##page 
model 
string 
four 
ad 
##eno 
##sin 
represents 
slippery 
sequence 
involved 
1 
p 
site 
slip 
##page 
[SEP] 
c 
##t 
##d 
##k 
##1 
c 
##d 
##k 
differ 
protein 
substrate 
specific 
##ity 
this 
communication 
clinical 
massive 
p 
recent 
confirmed 
lung 
per 
single 
v 
dose 
30 
mg 
l 
p 
##min 
s 
##ac 
comparable 
1 
500 
000 
s 
followed 
systemic 
he 
##par 
7 
day 
[CLS] 
a 
laboratory 
manual 
2nd 
ed 
ed [SEP] 
engineering 
temperature 
sensitive 
s 
##h 
##3 
[PAD] [CLS] 
##1 
increased 
progression 
re 
##tino 
associated 
[PAD] [CLS] 
all 
detect 
detect [SEP] 
[CLS] 
at 
1 
min 
postal 
##fen 
##tani 
##l 
n 
##2 
##o 
caused 
rigid 
##ity 
100 
o 
o2 
[CLS] 
the 
pre 
##par 
##ative 
regime 
fraction 
##ated 
total 
body 
i 
##rra 
##diation 
t 
##bi 
c 
##mi 
##de 
c 
##y 
[CLS] 
ng 
also 
induced 
promoter 
repeated 
s 
##p 
##1 
site 
linked 
core 
promoter 
p 
##mi 
##d 
regulated 
ch 
##ime 
##ric 
trans 
##act 
##iva 
##tor 
gal 
##4 
d 
binding 
domain 
fused 
s 
##1 
trans 
##act 
##ivation 
domain 
indicating 
trans 
##act 
##ivation 
domain 
regulated 
ng 
##f 
[SEP] 
##lle 
##mbo 
##ols 
fi 
##met 
studied 
soil 
su 
##ate 
different 
period 
introduction 
##lle 
##mbo 
effect 
aging 
contamination 
toxicity 
the 
severe 
con 
heart 
failure 
kill 
ii 
##i 
##i i 
iv 
admission 
early 
presentation 
late 
presentation 
30 
7 
la 
##ate 
la 
solution 
showed 
net 
la 
solution 
peaked 
2 
h 
decreased 
significantly 
4 
h 
6 
the 
the g 
tumor 
##do 
##mentation 
##ssy 
g 
##t 
##ds 
disease 
specific 
system 
rubber 
late 
##x 
[CLS] 
co 
##tra 
fragment 
sin 
retaining 
s 
##3 
binding 
site 
one 
##os 
containing 
motif 
##rc 
activation 
measured 
transcription 
##al 
reporter 
[SEP] 
related 
tumor 
suppress 
##or 
##0 
also 
effect 
p 
##10 
level 
phase 
[CLS] 
p 
induction 
e 
d 
binding 
observed 
primarily 
s 
phase 
cell 
coincide 
increase 
protein 
level 
[CLS] 
both 
fl 
##av 
red 
##uc 
##tase 
media 
electron 
transfer 
resulting 
na 
##dh 
dependent 
reduction 
per 
##ene 
h 
##ydro 
[SEP] 
transcription 
##al 
regulation 
k 
gene 
[CLS] 
further 
cell 
co 
##tra 
##ns 
##fected 
promoter 
l 
##uc 
##ifer 
##ase 
1935 
##uf 
l 
reporter 
gene 
b 
##b 
expression 
vector 
2 
fold 
higher 
l 
activity 
##ns 
reporter 
3 
[SEP] 
e 
##vas 
host 
immunity 
immunity to 
##x 
##oc 
can 
in 
##fect 
la 
##rva 
mediated 
ne 
##mat 
surface 
coat 
shed 
response 
binding 
anti 
##body 
molecule 
effect 
##or 
cell 
cell [SEP] 
[CLS] 
f 
##rank 
vector 
##card 
##io 
##gram 
15 
30 
hour 
o 
##cc 
##lusion 
in 
agreement 
arch 
##ae 
lack 
e 
##if 
##5 
e 
##if 
##b 
##ys 
rich 
binding 
domain 
factor 
e 
##if 
ho 
##mo 
##log 
[CLS] 
##ep 
##ression 
r 
##ar 
signaling 
dominant 
core 
##press 
resulted 
em 
##b 
##ryo 
exhibited 
p 
##hen 
##otype 
similar 
treated 
[SEP] 
05 
bacterial 
##m 
##ns 
[CLS] 
last 
##ly 
several 
restriction 
length 
p 
##oly 
##mor 
##phism 
identified 
mapped 
within 
1 
k 
##b 
region 
located 
immediately 
upstream 
cluster 
[SEP] 
radio 
##graphic 
spatial 
essential 
diagnosis 
in 
##nt 
inter 
##ro 
##ximal 
les 
##ion 
[CLS] 
promoter 
region 
human 
alpha 
ad 
##rene 
gene 
[CLS] 
1982 
1982 [SEP] 
[CLS] 
99 
##ys 
##tein 
dim 
##er 
stable 
6 
##h 
contributed 
develop 
i 
##ct 
##al 
study 
evaluate 
location 
partial 
seizure 
seizure [SEP] 
l 
##if 
##if the 
##ol 
dos 
chip 
1 
eye 
skin 
thy 
##roid 
clothes 
breast 
o 
##vary 
female 
test 
##icle 
male 
patient 
patient [SEP] 
[CLS] 
thus 
##ivo 
function 
##p 
strictly 
coupled 
short 
g 
##bs 
within 
##p 
link 
m 
mrna 
transport 
factor 
p 
##ore 
d 
##m 
##t 
bind 
ad 
##oh 
##cy 
conform 
##ation 
m 
##tase 
d 
##m 
##t 
share 
sequence 
structural 
feature 
m 
##tase 
trans 
##met 
##hyl 
##ase 
[CLS] 
the 
structure 
m 
##uri 
d 
##t 
##k 
gene 
determined 
[SEP] 
[CLS] 
showed 
nuclear 
import 
occurs 
via 
direct 
interaction 
import 
beta 
domain 
[CLS] 
in 
##pa 
mean 
s 
##d 
1 
43 
0 
46 
m 
##l 
[SEP] 
in 
clone 
##d 
##1 
b 
##uke 
##h 
##3 
library 
[CLS] 
patient 
year 
year terminal 
##ej 
##uno 
##sto 
within 
first 
meter 
##un 
##um 
treated 
in 
elemental 
diet 
di 
##stal 
bow 
##el 
i 
##edd 
##s 
##b 
##b [SEP] 
s 
##ten 
d 
##p 
les 
##bro 
##mat 
digital 
radio 
heart 
##ort 
pulmonary 
vascular 
regulation 
##21 
activated 
kinase 
##a 
w 
repeat 
##1 
[CLS] 
other 
clinic 
##ath 
##ological 
feature 
definite 
influence 
survival 
expect 
##ancy 
##ancy [SEP] 
[CLS] 
these 
tandem 
alpha 
he 
##lix 
located 
near 
c 
terminus 
membrane 
binding 
extraction 
##lines 
[SEP] 
[CLS] 
striking 
similarity 
preference 
##tched 
weakly 
paired 
n 
##leo 
##tide 
binding 
ex 
##cision 
functional 
relationship 
binding 
c 
##lea 
##vage 
reaction 
[SEP] 
[CLS] 
interesting 
activation 
defect 
mutant 
segregated 
two 
class 
1 
unable 
form 
dim 
##er 
could 
still 
form 
higher 
order 
o 
##go 
##mers 
transform 
cell 
2 
defect 
##d 
binding 
transformation 
in 
[CLS] 
patient 
showed 
low 
yet 
level 
##em 
1 
m 
##rna 
bone 
ma 
##rrow 
[CLS] 
conclusion 
the 
result 
show 
in 
##nas 
##al 
challenge 
flu 
induce 
##s 
change 
##yte 
his 
##tamine 
release 
systemic 
immune 
inflammatory 
response 
[CLS] 
activation 
stimulate 
gas 
##tri 
gene 
expression 
##c 
rich 
element 
called 
g 
##ere 
[CLS] 
c 
rich 
sequence 
resembling 
c 
##p 
island 
associated 
many 
imprint 
gene 
often 
parental 
specific 
met 
##hyl 
could 
act 
common 
imprint 
##ing 
element 
the 
##rea 
##tine 
kinase 
##ric 
##ular 
fi 
##bri 
##lla 
ta 
##chy 
##card 
within 
first 
24 
hour 
death 
con 
##tive 
heart 
failure 
within 
30 
day 
follow 
30 
day 
##ric 
e 
##jection 
fraction 
fraction [SEP] 
[CLS] 
prevention 
g 
r 
is 
##zation 
##zation [SEP] 
[PAD] [CLS] 
re 
##lap 
within 
first 
year 
confined 
ii 
disease 
four 
site 
involvement 
involvement [SEP] 
[CLS] 
presence 
##k 
##c 
dependent 
pathway 
function 
independently 
map 
activation 
[CLS] 
this 
interesting 
ex 
##on 
junction 
resulted 
novel 
de 
##duced 
amino 
terminal 
open 
reading 
frame 
completely 
frame 
sequence 
located 
downstream 
[SEP] 
single 
amino 
substitution 
##box 
terminal 
as 
##d 
##2 
incapable 
avid 
regulation 
##r 
signaling 
##a 
treatment 
elevation 
camp 
level 
utilizes 
common 
structural 
element 
regulating 
##d 
##2 
avid 
[SEP] 
[CLS] 
12 
per 
observed 
te 
##tra 
##cy 
4 
e 
##pian 
##hy 
##dr 
##ote 
dos 
1000 
100 
##gam 
em 
##b 
##ryo 
respectively 
[CLS] 
present 
investigation 
undertaken 
el 
##uc 
##ida 
##te 
p 
##har 
##co 
##kin 
##etic 
parameter 
experiment 
could 
predictable 
human 
beta 
blocking 
agent 
[CLS] 
the 
at 
##pa 
reading 
end 
four 
tandem 
##ga 
co 
##don 
overlap 
four 
tandem 
tandem au 
co 
##don 
in 
##iti 
##ating 
unidentified 
reading 
frame 
##f 
##21 
##4 
[CLS] 
trans 
he 
##p 
lack 
c 
##b 
##p 
alpha 
o 
##b 
promoter 
weakly 
active 
[SEP] 
##as 
##od 
##ila 
##ens 
is 
##omer 
ni 
##card 
##ip 
##c 
93 
new 
ca 
##2 
antagonist 
between 
1988 
1995 
34 
##1 
##l 
treated 
##10 
##10 [SEP] 
[CLS] 
##tero 
promoter 
construct 
containing 
three 
repeat 
consensus 
s 
##1 
site 
clone 
##d 
upstream 
single 
copy 
z 
##ii 
c 
##b 
##p 
##1 
element 
b 
##1 
promoter 
linked 
beta 
##lo 
##bin 
##ta 
box 
exhibited 
##bol 
[SEP] 
[CLS] 
ni 
##cot 
receptor 
antagonist 
me 
##cam 
##yla 
##mine 
0 
5 
1 
mg 
kg 
he 
##xa 
##met 
##hon 
##ium 
5 
10 
mg 
kg 
reduced 
response 
induced 
ni 
##cot 
##ine 
0 
25 
mg 
kg 
[CLS] 
app 
##l 
[CLS] 
thus 
predicted 
m 
##3 
##f 
functional 
gene 
en 
abundant 
secret 
protein 
candidate 
interacting 
host 
cellular 
receptor 
##yt 
##oki 
##ne 
protein 
metabolism 
disorder 
burn 
[CLS] 
the 
cumulative 
dose 
week 
treatment 
dependent 
mobility 
estimated 
0 
0 08 
m 
##s 
self 
caring 
6 
3 
m 
##s 
totally 
1840 
##b 
##q 
group 
a 
a [SEP] 
j 
##ca 
##ho 
use 
##yx 
data 
##ine 
##l 
event 
[CLS] 
show 
##bt 
trans 
##cribed 
upstream 
##bb 
gene 
promoter 
m 
##rna 
target 
sequence 
##bb 
##1 
function 
[SEP] 
[CLS] 
to 
test 
c 
##d 
exposure 
would 
increase 
ca 
release 
bone 
la 
##ct 
##ation 
relation 
et 
##iol 
mechanism 
mechanism it 
##ai 
##ai it 
##ai 
disease 
45 
pre 
##la 
##bel 
skeleton 
##ci 
one 
round 
def 
##icient 
diet 
containing 
0 
0 5 
25 
c 
##d 
25 
32 
day 
conception 
day 
14 
o 
##5 
##25 
show 
ho 
##mology 
protein 
another 
yeast 
[CLS] 
principle 
thy 
##roid 
hormone 
treatment 
[CLS] 
significance 
es 
##op 
##ha 
##go 
##card 
##iac 
reflex 
in 
th 
##ora 
##c 
pain 
[CLS] 
the 
fate 
o 
##rato 
##xin 
ma 
##lt 
##ing 
brewing 
method 
measured 
method 
[CLS] 
messenger 
r 
##na 
ad 
##2 
d 
binding 
d 
sequence 
encoding 
first 
leader 
he 
##tero 
##gen 
m 
##rna 
5 
end 
[SEP] 
[CLS] 
consistent 
hypothesis 
stimulation 
a 
2 
r 
p 
enhanced 
nuclear 
##p 
##c 
activity 
[CLS] 
at 
##rial 
di 
##sso 
##ciation 
##ciation [SEP] 
the 
gene 
sequence 
predict 
##s 
150 
82 
m 
136 
##3 
n 
terminal 
h 
signal 
sequence 
17 
acid 
19 
linked 
linked g 
site 
h 
sequence 
approximately 
17 
amino 
acid 
near 
terminus 
h 
##tein 
rich 
terminus 
35 
acid 
[CLS] 
however 
depending 
promoter 
context 
observed 
cooperative 
interaction 
two 
domain 
con 
##fer 
high 
d 
binding 
affinity 
specific 
##ity 
[SEP] 
[CLS] 
a 
result 
relative 
biological 
##be 
2 
3 
2 
2 7 
straight 
line 
given 
modify 
least 
curve 
an 
##oma 
f 
##etus 
imp 
##lant 
em 
##b 
i 
##rra 
##dia 
120 
r 
##ad 
c 
##f 
252 
252 80 
220 
r 
##ad 
co 
60 
day 
day 8 
pregnancy 
pregnancy [SEP] 
sample 
1 
g 
extracted 
0 
5 
##c 
##l 
70 
##han 
m 
##l 
di 
##lut 
##ed 
subsequently 
give 
fold 
fold 
step 
wise 
di 
##lution 
containing 
0 
0 05 
t 
0 
2 
t 
b 
##sa 
knowledge 
108 
eat 
##bla 
e 
##ct 
##op 
##ic 
focus 
success 
[SEP] 
[CLS] 
following 
im 
hybrid 
molecule 
isolated 
b 
cell 
d 
contained 
trans 
re 
##comb 
##ined 
end 
##ogen 
##ous 
i 
lo 
##cus 
[SEP] 
[PAD] [CLS] 
it 
extra 
##py 
##ram 
##idal 
disturbance 
nearly 
every 
subject 
common 
aka 
##thi 
severe 
case 
one 
individual 
acute 
d 
##ys 
##ton 
##ia 
[CLS] 
northern 
b 
##lot 
human 
m 
##uri 
gene 
en 
##code 
approximately 
6 
k 
##b 
trans 
##cript 
[SEP] 
[CLS] 
transforming 
factor 
activate 
promoter 
c 
##y 
dependent 
inhibitor 
p 
p15 
##1 
consensus 
site 
[CLS] 
co 
##x 
proportional 
hazard 
analysis 
dial 
##ys 
m 
##oda 
##lity 
pre 
dial 
##ys 
le 
1 
000 
m 
##l 
m 
24 
h 
risk 
factor 
survival 
[SEP] 
the 
##yper 
linked 
presence 
numerous 
single 
me 
##lan 
##oso 
p 
##oly 
##mel 
##ano 
##some 
k 
level 
e 
der 
##mal 
factor 
x 
##ii 
##ia 
den 
##dr 
##ocytes 
[CLS] 
possible 
definite 
neglect 
abuse 
36 
correlated 
d 
##b 
##h 
activity 
activity [SEP] 
two 
s 
protein 
e 
form 
he 
##tero 
##di 
##mer 
##ic 
complex 
cell 
the 
alpha 
##b 
##1 
gene 
##ifies 
2 
68 
amino 
protein 
acid 
identity 
ho 
##mo 
##mologue 
##i 
##f 
##1 
[CLS] 
##hyl 
interference 
f 
##o 
j 
protein 
bind 
sequence 
specific 
manner 
##p 
1 
site 
within 
##dre 
box 
[SEP] 
##rina 
chest 
x 
p 
e 
##c 
##g 
hem 
##ato 
examination 
r 
##b 
##c 
##b 
##c 
h 
##lt 
##r 
bio 
##chemical 
test 
as 
al 
al 
gamma 
##t 
##dh 
##p 
##pk 
ch 
##ol 
t 
t 
b 
##r 
g 
ca 
c 
##rp 
both 
inactive 
domain 
ii 
lacking 
91 
243 
le 
inhibitor 
due 
reduced 
ability 
initiation 
factor 
alpha 
##ivo 
[CLS] 
all 
patient 
studied 
pregnant 
woman 
delivered 
child 
child [SEP] 
[CLS] 
current 
body 
size 
w 
##t 
##2 
di 
000 
0005 
mad 
##3 
##4 
interacting 
transcription 
##al 
##press 
suppress 
##c 
dependent 
transformation 
expressed 
neural 
e 
differentiation 
[SEP] 
conclusion 
attain 
##b 
mon 
##otherapy 
change 
test 
[CLS] 
the 
regulatory 
lo 
##cus 
found 
required 
induction 
gene 
within 
re 
##gu 
##lon 
##b 
##d 
##c 
##i 
##j 
##f 
##em 
##ota 
response 
bacteria 
##romatic 
compound 
[SEP] 
[CLS] 
further 
major 
open 
reading 
frame 
r 
##f 
##4 
2 
3 
k 
##b 
essential 
activation 
shown 
n 
##f 
ka 
s 
##1 
ta 
box 
motif 
l 
##tr 
required 
full 
induction 
promoter 
trans 
##act 
##iva 
[CLS] 
however 
mutation 
c 
rich 
element 
disrupted 
g 
##c 
box 
located 
inverse 
strand 
eliminated 
gel 
mobility 
eliminated 
binding 
##1 
[SEP] 
[CLS] 
t 
##ib 
##dr 
also 
interact 
directly 
factor 
s 
##rg 
media 
trans 
##act 
##ivation 
[SEP] 
[CLS] 
both 
algorithm 
implemented 
scan 
large 
a 
##xial 
30 
degree 
also 
e 
##cat 
##r 
e 
##cat 
##r 
scan 
##ner 
##ner [SEP] 
[CLS] 
the 
well 
trained 
measured 
re 
##spiration 
chamber 
36 
h 
according 
protocol 
sa 
##mar 
##ium 
153 
##vas 
##rra 
##diation 
therapy 
filled 
balloon 
rest 
##eno 
##sis 
term 
rest 
##eno 
only 
viable 
bacteria 
high 
pu 
o 
medium 
culture 
positive 
58 
day 
4 
[CLS] 
urine 
pregnancy 
[CLS] 
transfer 
f 
like 
p 
##las 
##mi 
##d 
regulated 
##op 
system 
control 
expression 
t 
##raj 
positive 
regulator 
transfer 
op 
##eron 
[SEP] 
1 
member 
hit 
shown 
sequence 
identity 
organism 
conversion 
glucose 
phosphate 
##c 
glucose 
passage 
brain 
##ivo 
simple 
technique 
section 
co 
##cci 
##dian 
o 
##ys 
reported 
[CLS] 
it 
21st 
day 
c 
##ime 
##ti 
##dine 
administration 
serum 
gas 
##tri 
##n 
level 
elevated 
[CLS] 
dual 
signal 
p 
##eptide 
media 
signal 
recognition 
se 
##c 
independent 
insertion 
thy 
##lak 
##oid 
membrane 
##by 
[SEP] 
score 
allowed 
disease 
effectively 
utilized 
see 
correlation 
severity 
co 
##rona 
##ry 
art 
##erial 
disease 
ca 
##d 
individual 
risk 
factor 
risk 
marker 
on 
g 
##uan 
##id 
##ine 
b 
##ot 
##uli 
##sm 
electronic 
structure 
si 
111 
##si 
##2 
111 
type 
b 
type 
interface 
[SEP] 
[CLS] 
in 
development 
tumor 
posterior 
side 
pro 
lack 
im 
##ea 
presence 
m 
##uc 
##ino 
##us 
g 
##land 
sometimes 
end 
##al 
like 
like could 
origin 
em 
##b 
##ryo 
m 
remnant 
pro 
u 
##tric 
rather 
u 
##ital 
sin 
##us 
[SEP] 
[CLS] 
ma 
##rang 
threshold 
initially 
stationary 
flow 
becomes 
quickly 
time 
dependent 
dependent [SEP] 
the 
result 
showed 
differential 
activation 
region 
verbal 
memory 
task 
side 
side activated 
shifted 
depending 
depending nature 
task 
employed 
increase 
##b 
##f 
##us 
##us associated 
re 
retri 
##eval 
strategy 
non 
matching 
increase 
##b 
##f 
right 
##us 
##us associated 
re 
retri 
##eval 
strategy 
matching 
matching [SEP] 
[CLS] 
maternal 
acquired 
throughout 
first 
year 
life 
demonstration 
change 
f 
##etal 
liver 
er 
##hr 
##op 
echo 
[CLS] 
the 
actual 
placement 
les 
##ion 
determined 
mapping 
##pi 
micro 
##re 
##cor 
##ding 
stimulation 
identify 
sensor 
##imo 
region 
so 
##mat 
##oto 
organization 
organization [SEP] 
effect 
pro 
e 
e2 
at 
##her 
##os 
##rosis 
[CLS] 
both 
art 
##erial 
ve 
##nous 
th 
##rom 
##bus 
clearly 
disc 
##ern 
2 
8 
h 
injection 
99 
##t 
##c 
##z 
51 
51 [SEP] 
[CLS] 
effect 
ed 
##as 
fur 
##ose 
##mi 
[CLS] 
however 
malaria 
vector 
an 
##op 
##hel 
an 
##bia 
become 
abundant 
1970s 
1980s 
##por 
##oz 
##oit 
positive 
specimen 
found 
##es 
##bro 
3 
fold 
higher 
kinase 
ex 
added 
liver 
40 
rib 
##oso 
p 
r 
##s 
##l 
##ra 
[SEP] 
[CLS] 
in 
gene 
encoding 
major 
p 
##id 
expressed 
partially 
totally 
s 
##p 
##lice 
##d 
trans 
##cript 
respectively 
##1 
[SEP] 
inhibitor 
characterized 
presence 
characteristic 
sequence 
known 
##ept 
t 
##os 
based 
inhibitor 
motif 
it 
##im 
##op 
tail 
##g 
##cs 
es 
##op 
##hage 
##al 
var 
##ix 
setting 
h 
##yper 
##dynamic 
portal 
circulation 
acceptable 
liver 
function 
function [SEP] 
candidate 
factor 
identified 
##cor 
##tic 
1 
cell 
could 
reproduced 
varying 
cellular 
level 
co 
##act 
##iva 
##tors 
transcription 
##al 
inter 
intermedia 
factor 
2 
t 
##if 
s 
##id 
receptor 
co 
##iva 
1 
s 
1 
1 am 
amplified 
breast 
cancer 
1 
##ib 
##1 
com 
##od 
##ulator 
##b 
binding 
##b 
##p 
core 
##press 
##or 
si 
##len 
media 
re 
##id 
thy 
##roid 
hormone 
##m 
without 
con 
##com 
##ita 
##itant 
increase 
g 
##r 
[CLS] 
act 
##iva 
function 
coincide 
selective 
removal 
c 
terminal 
domain 
c 
##t 
##d 
h 
##nap 
ii 
##o 
along 
n 
##2 
[SEP] 
[CLS] 
the 
n 
##uc 
##leo 
##tide 
sequence 
gene 
encoding 
product 
determined 
amino 
acid 
sequence 
de 
##duced 
[SEP] 
[CLS] 
at 
9 
month 
serum 
ft 
##4 
ft 
##3 
level 
low 
normal 
8 
0 
1 
1 7 
##ol 
respectively 
t 
##sh 
raised 
0 
0 4 
m 
##u 
l 
l [SEP] 
result 
three 
patient 
medication 
managed 
treatment 
type 
2 
his 
##tamine 
block 
[CLS] 
it 
considered 
therefore 
treating 
di 
##abe 
patient 
peripheral 
##uro 
assume 
diabetes 
cause 
case 
case [SEP] 
[CLS] 
t 
##ii 
##b 
assemble 
autonomous 
##ly 
upstream 
promoter 
yeast 
##r 
gene 
v 
##ro 
interaction 
t 
subunit 
consensus 
ta 
tata 
box 
located 
base 
pair 
30 
[CLS] 
mutation 
##al 
analysis 
reveals 
two 
critical 
sequence 
element 
g 
c 
rich 
sequence 
called 
##rs 
##1 
previously 
identified 
many 
##iot 
newly 
element 
t 
t4 
##c 
site 
found 
subset 
##iot 
gene 
[CLS] 
molecular 
analysis 
man 
##to 
op 
##eron 
##los 
##tri 
##dium 
ace 
##to 
##ic 
encoding 
p 
##ot 
##ran 
##s 
##fer 
##ase 
system 
put 
##ative 
p 
m 
##od 
##ulated 
regulator 
[SEP] 
[CLS] 
result 
show 
combination 
p 
ex 
##o 
prime 
##r 
extension 
step 
##r 
am 
##p 
##lification 
step 
d 
analysis 
d 
damage 
mapping 
l 
##r 
[SEP] 
effect 
t 
1 
6 
ten 
capsule 
fi 
##bro 
tissue 
culture 
[PAD] [CLS] 
est 
##r 
la 
##cz 
in 
t 
probe 
s 
##ple 
library 
trans 
trans 
##fected 
anti 
##gen 
isolated 
clone 
allowed 
m 
mh 
##c 
complex 
end 
##oto 
##xe 
##mia 
b 
##ere 
se 
##psis 
intensive 
unit 
unit [SEP] 
[CLS] 
[CLS] early 
attempt 
modify 
growth 
function 
annual 
variation 
dating 
back 
2 
decade 
application 
showing 
rather 
different 
degree 
approximation 
a 
reduction 
total 
cellular 
p 
protein 
level 
moderate 
reduction 
p 
m 
##rna 
observed 
change 
c 
##d 
##k 
regulatory 
occur 
[CLS] 
genetic 
link 
##age 
mapping 
##a 
##1 
gene 
encoding 
ch 
##ole 
##ster 
##ol 
side 
chain 
##0s 
close 
##1 
##1 
gene 
d 
d15 
##20 
##4 
chromosome 
chromosome 15 
##22 
33 
##23 
region 
[CLS] 
genetic 
physiological 
experiment 
close 
relationship 
##d 
##c 
##c 
gene 
key 
regulator 
mit 
##osis 
yeast 
also 
cell 
[SEP] 
the 
study 
100 
##r 
##iculate 
extra 
##ne 
##ous 
source 
[CLS] 
the 
clone 
##d 
op 
##eron 
trans 
##cribed 
##it 
##ro 
##rified 
r 
##na 
polymer 
##ase 
es 
##cher 
##ichi 
co 
##li 
[SEP] 
##f 
tested 
tested 24 
oxygen 
0 
84 
0 
34 
24 
0 
0 
1 
##ol 
min 
s 
##d 
##d n 
n 8 
[CLS] 
the 
sequence 
gene 
upstream 
cap 
site 
contains 
characteristic 
r 
##na 
polymer 
##ase 
ii 
promoter 
binding 
site 
put 
##ative 
ta 
box 
position 
29 
s 
1 
binding 
site 
site g 
##gg 
##aga 
position 
48 
[SEP] 
[CLS] 
the 
kinetic 
##c 
ng 
blood 
dose 
followed 
[CLS] 
these 
clone 
contain 
ex 
##on 
c 
##y 
##c 
##lin 
d 
except 
ex 
##on 
5 
[CLS] 
one 
48 
hour 
cycle 
24 
hour 
cycle 
action 
could 
##agon 
##llin 
competitive 
##1 
##rino 
##ceptor 
[CLS] 
evidence 
##r 
##1 
##p 
##r 
##p 
interaction 
presented 
supported 
isolation 
mutation 
##r 
##1 
##p 
suppress 
##r 
assessed 
growth 
enzyme 
[SEP] 
key 
used 
identifying 
s 
##pec 
##ie 
us 
##r 
##tan 
[CLS] 
promoter 
mutation 
p 
##tre 
sequence 
selective 
selectively 
abolished 
binding 
either 
one 
complex 
ex 
exert 
##erted 
opposite 
effect 
transcription 
##al 
activity 
##ps 
g 
##bia 
##biae 
##e a 
##ede 
##edes 
##s a 
##pt 
cell 
line 
[SEP] 
the 
re 
##8 
protein 
##av 
contains 
amino 
acid 
sequence 
motif 
common 
rolling 
circle 
replication 
r 
##c 
##r 
in 
##iti 
##ator 
protein 
plasma 
pro 
##ct 
##in 
patient 
##ec 
##tal 
cancer 
reality 
preparation 
[CLS] 
the 
extent 
##oc 
##ard 
##ial 
is 
##che 
##rona 
##ry 
sin 
##us 
study 
##rona 
##ry 
diameter 
pro 
##ximal 
middle 
segment 
ram 
##us 
inter 
##ric 
##ular 
##is 
anterior 
middle 
segment 
##us 
##fle 
##x 
0 
0 87 
p 
02 
[SEP] 
plane 
orientation 
##al 
##b 
film 
grown 
un 
##id 
##ire 
##ctional 
photo 
##riz 
substrate 
considerably 
intrinsic 
surface 
orientation 
substrate 
weak 
alignment 
layer 
[CLS] 
nuclear 
transcription 
c 
##ys 
3 
sulfur 
regulated 
transcription 
##al 
control 
3 
transcription 
con 
##it 
##utive 
sulfur 
controller 
negative 
regulator 
mutant 
[SEP] 
[CLS] 
r 
replication 
suggests 
either 
tertiary 
initiation 
novel 
mode 
initiation 
[CLS] 
p 
##har 
##kin 
##etics 
skin 
penetration 
[CLS] 
further 
##more 
regulation 
conferred 
reporter 
gene 
d 
##ros 
##op 
three 
closely 
sequence 
demonstrates 
even 
subtle 
sequence 
change 
within 
e 
box 
flank 
##ing 
base 
dramatic 
consequence 
overall 
repertoire 
protein 
bind 
##ivo 
[SEP] 
bus 
##pi 
##rone 
therapy 
type 
behavior 
hostility 
stress 
cardiac 
patient 
patient [SEP] 
detailed 
analysis 
specific 
ne 
##uron 
population 
affected 
mutation 
role 
##ro 
##x 
20 
segment 
##ation 
physiological 
in 
##ivation 
[CLS] 
a 
s 
##pec 
##ie 
comparison 
sequence 
isolation 
##eno 
##mic 
clone 
[SEP] 
[CLS] 
in 
##oam 
o 
ma 
mao 
t 
##ran 
##yl 
##rom 
volunteer 
given 
increasing 
dos 
10 
15 
20 
25 
mg 
day 
4 
week 
period 
[CLS] 
del 
##eti 
##uta 
promoter 
positive 
regulatory 
element 
pre 
likely 
exist 
downstream 
ul 
##9 
##4 
m 
##rna 
start 
site 
negative 
regulatory 
element 
n 
##re 
present 
upstream 
ta 
box 
[SEP] 
[CLS] 
expression 
##lio 
detected 
earliest 
hem 
##ato 
##po 
##iet 
site 
em 
##b 
##ryo 
hem 
##ato 
##iet 
stem 
cell 
adult 
subsequently 
restricted 
subset 
cell 
t 
cell 
lineage 
lineage [SEP] 
meta 
##chia 
term 
born 
necessity 
design 
hit 
##her 
un 
interface 
##ia 
##stic 
effect 
negative 
p 
##i 
me 
##son 
bone 
ma 
##rrow 
cell 
[CLS] 
probe 
containing 
c 
##b 
##p 
binding 
site 
in 
gene 
revealed 
binding 
different 
complex 
strongly 
in 
camp 
also 
il 
1 
##bet 
##a 
[SEP] 
[CLS] 
the 
p 
##i 
signal 
conveyed 
##ho 
##8 
binding 
##ho 
##4 
protein 
regulatory 
factor 
promoter 
region 
##ho 
##ho8 
##p 
influence 
##ho 
regulatory 
circuit 
[SEP] 
[CLS] 
thus 
end 
linear 
##ized 
d 
fragment 
initiate 
new 
d 
synthesis 
bi 
##r 
newly 
synthesized 
d 
displaced 
subsequently 
form 
circle 
n 
##j 
[SEP] 
[CLS] 
would 
seem 
value 
index 
##ntal 
function 
[PAD] [CLS] 
a 
case 
acquired 
immune 
deficiency 
syndrome 
1980 
1980 [SEP] 
[CLS] 
these 
multiple 
genetic 
re 
##comb 
##ination 
among 
b 
##act 
##eri 
##op 
different 
immunity 
took 
place 
generate 
prop 
##1 
##kai 
[SEP] 
##1 
##b 
19 
000 
19 
##k 
##pop 
cooperate 
##1 
des 
hormone 
kinase 
kinase 2 
##ak 
2 
trans 
s 
requires 
synthesis 
two 
separate 
specimen 
##liva 
individual 
year 
76 
year 
37 
year 
year 
examined 
concentration 
concentration i 
##ga 
function 
volume 
total 
content 
h 
transformation 
requires 
trans 
activation 
domain 
domain e 
e2 
##uc 
dim 
##eri 
##zation 
domain 
h 
[SEP] 
[CLS] 
two 
adjacent 
highly 
ho 
##mo 
##log 
##ous 
end 
##og 
##can 
##ase 
gene 
c 
##eld 
c 
##ele 
fi 
##bro 
##ba 
su 
##no 
##gene 
separated 
at 
rich 
223 
n 
##leo 
##tide 
inter 
##genic 
region 
characterized 
[SEP] 
se 
difficult 
j 
87 
##9 
##9 30 
[CLS] 
screened 
th 
##alia 
library 
whose 
insert 
control 
##act 
##ose 
in 
gal 
##10 
promoter 
##a 
enabled 
grow 
restrict 
temperature 
signature 
o 
##leo 
##tide 
##s 
##dr 
##3 
##r 
##plified 
ka 
product 
##yn 
##ov 
##ium 
##b 
##ls 
patient 
##b 
##ls 
s 
##ple 
individual 
without 
r 
disease 
[CLS] 
one 
major 
trans 
##cript 
en 
33 
##9 
amino 
b 
protein 
ho 
##mo 
##log 
j 
f 
##o 
transcription 
factor 
class 
competitive 
nm 
##da 
receptor 
antagonist 
ex 
exem 
##4 
##9 
candidate 
[CLS] 
an 
em 
##ended 
diagnosis 
t 
##yl 
##oc 
excluding 
feature 
along 
distribution 
test 
pre 
##ova 
##rian 
field 
c 
##cum 
##med 
##ull 
##ary 
distribution 
##llin 
##e 
f 
##icle 
[SEP] 
[CLS] 
induction 
inter 
##fer 
##pha 
gene 
expression 
requires 
induced 
activation 
transcription 
factor 
i 
##rf 
##3 
##rf 
##7 
method 
j 
west 
ni 
den 
den 
den 2 
test 
determine 
infection 
virus 
virus [SEP] 
[CLS] 
more 
integrated 
transforming 
d 
altered 
lost 
expression 
##b 
##cs 
a 
##ada 
##b 
##cs 
gene 
appears 
re 
##pressed 
[SEP] 
done 
##how 
[CLS] 
tendency 
ho 
##mo 
##tero 
##di 
##mer 
complex 
[SEP] 
[CLS] 
further 
liver 
disease 
led 
differential 
alter 
##ation 
c 
##yt 
##och 
##rome 
regard 
protein 
content 
activity 
[PAD] [CLS] 
apparent 
bus 
##ch 
##ke 
lo 
##ew 
##enstein 
t 
##umour 
penis 
penis [SEP] 
[PAD] [CLS] 
this 
effect 
stronger 
multiple 
pre 
##dos 
##rt 
##ral 
im 
##ram 
0 
in 
infinity 
increased 
39 
68 
68 respectively 
respectively [SEP] 
[CLS] 
mutation 
##r 
##1 
##c 
##r 
##4 
r 
##po 
##n 
encoding 
si 
##4 
influence 
x 
##dh 
gene 
expression 
[CLS] 
we 
propose 
##r 
true 
human 
ho 
##mo 
##log 
mph 
[SEP] 
[PAD] [CLS] 
s 
##warm 
m 
##orax 
##ella 
##ella [SEP] 
bio 
[CLS] 
in 
v 
##rel 
strong 
c 
terminal 
gene 
activation 
function 
since 
le 
##xa 
fusion 
protein 
containing 
c 
terminal 
v 
##rel 
sequence 
alone 
weakly 
activated 
transcription 
[SEP] 
crystal 
structure 
yeast 
t 
##phe 
te 
##rna 
##ry 
complex 
the 
##rm 
##us 
aquatic 
e 
ef 
##d 
##p 
t 
determined 
representative 
general 
disc 
##rim 
complex 
formation 
[SEP] 
[CLS] 
##ov 
su 
se 
##rone 
##gat 
cow 
infected 
herd 
experimental 
infection 
##ap 
marginal 
##e 
[SEP] 
[CLS] 
because 
gut 
f 
##er 
##mentation 
substantial 
portion 
16 
80 
n 
absorbed 
am 
##monia 
n 
##h 
##3 
##n 
[SEP] 
quantitative 
measurement 
factor 
ne 
comparison 
late 
latex 
wa 
rose 
test 
the 
density 
ranged 
2 
39 
##7 
ne 
##uri 
mm 
skin 
without 
p 
small 
[CLS] 
zoo 
##not 
co 
infection 
sand 
become 
co 
infected 
individual 
[SEP] 
##th 
##rom 
##bin 
ii 
##i 
at 
ii 
##i 
[CLS] 
the 
kinetic 
er 
##omy 
##air 
##nal 
single 
in 
##ven 
##ous 
dose 
dose [SEP] 
[CLS] 
base 
substitution 
within 
n 
##l 
6 
site 
resulted 
virtual 
elimination 
l 
induced 
il 
1 
beta 
gene 
transcription 
mortality 
rate 
##i 
##2 
0 
0 02 
##9 
##98 
the 
ma 
##i 
to 
##f 
experiment 
proved 
superior 
g 
##c 
experiment 
regard 
base 
resolution 
##sat 
acid 
acid [SEP] 
[PAD] [CLS] 
modern 
aspect 
shock 
burn 
of 
accredited 
au 
##gus 
1995 
40 
participated 
participated [SEP] 
[CLS] 
a 
##ros 
##op 
##hil 
sub 
##ob 
##s 
g 
##eno 
##mic 
fragment 
containing 
ex 
##on 
late 
early 
pro 
##moto 
##rs 
##l 
gene 
d 
me 
##lan 
##oga 
isolated 
[SEP] 
[CLS] 
collectively 
unique 
mechanism 
involving 
appears 
regulate 
type 
specific 
activation 
dependent 
expression 
##m 
1 
gene 
[SEP] 
[CLS] 
the 
sensitivity 
central 
do 
##pa 
receptor 
assessed 
hormone 
response 
##mor 
##phine 
application 
[CLS] 
oral 
basal 
body 
temperature 
##bt 
donor 
ins 
##ute 
##ini 
establish 
feature 
associated 
optimal 
cycle 
[SEP] 
[CLS] 
our 
result 
admit 
rib 
##oso 
##me 
scanning 
mechanism 
m 
##p 
gene 
expression 
i 
2 
s 
##rna 
operates 
concurrently 
concurrently [SEP] 
[CLS] 
the 
three 
dimensional 
structure 
co 
##li 
##r 
domain 
sequence 
conservation 
likely 
result 
conserved 
structural 
motif 
[SEP] 
o 
##tos 
mon 
##oz 
##got 
##ic 
twin 
clinical 
genetic 
##al 
analysis 
analysis [SEP] 
[CLS] 
a 
d 
fragment 
complement 
mutation 
sub 
##lone 
##d 
monitoring 
ability 
transform 
mutant 
resistance 
[SEP] 
[CLS] 
the 
human 
human lb 
on 
product 
g 
n 
exchange 
factor 
specifically 
activate 
r 
small 
binding 
thus 
resulting 
biological 
##t 
bound 
turn 
media 
act 
c 
##os 
##etal 
reorganization 
gene 
transcription 
entry 
mit 
mitotic 
s 
phase 
[SEP] 
[CLS] 
insulin 
auto 
##ph 
specific 
site 
t 
domain 
receptor 
beta 
correlated 
kinetic 
##ally 
activation 
kinase 
cat 
p 
model 
substrate 
reduced 
car 
l 
##ys 
##oz 
r 
##cam 
l 
##ys 
##oz 
##yme 
[SEP] 
[CLS] 
critical 
obstacle 
modeling 
disorder 
limited 
information 
origin 
underlying 
neural 
mechanism 
mechanism [SEP] 
[CLS] 
background 
all 
r 
##hino 
common 
disorder 
affecting 
people 
socio 
s 
##tra 
##tum 
##tum [SEP] 
[CLS] 
the 
result 
study 
1 
structural 
ho 
##mo 
simple 
simplex 
suggest 
e 
##pit 
containing 
terminal 
amino 
acid 
sequence 
sequence her 
##pes 
undergone 
extensive 
evolutionary 
diver 
##gence 
c 
terminal 
sequence 
sequence [SEP] 
[CLS] 
within 
final 
11 
amino 
acid 
5 
a 
##romatic 
2 
basic 
residue 
proposed 
residue 
stack 
electro 
kin 
##ked 
d 
site 
##id 
##ine 
dim 
##er 
[SEP] 
by 
contrast 
foot 
##print 
ii 
position 
125 
he 
##3 
extract 
##lies 
15 
base 
pair 
sequence 
found 
member 
hormone 
significance 
determination 
ton 
differential 
art 
##eri 
##os 
##rot 
les 
heart 
vessel 
elderly 
person 
##bri 
##lla 
##rr 
##th 
the 
gene 
responsible 
end 
1 
men 
##1 
her 
##ita 
##itable 
##dis 
t 
##umour 
identified 
identified [SEP] 
[CLS] 
toxic 
diet 
##ary 
mail 
##lard 
reaction 
product 
rat 
[CLS] 
as 
##t 
activity 
##ns 
significantly 
low 
approximately 
2 
observed 
hp 
##lf 
##s 
specifically 
engineered 
two 
ch 
##ime 
##ra 
terminal 
lobe 
##h 
##1 
domain 
c 
##b 
swap 
bio 
##chemical 
analysis 
revealed 
nor 
##ep 
##ph 
reduced 
significantly 
cortex 
hip 
##po 
##cam 
##pus 
o 
##lf 
##actor 
##y 
bulb 
region 
do 
##pa 
se 
##rot 
##oni 
##n 
level 
altered 
brain 
region 
examined 
[CLS] 
the 
contains 
reading 
frame 
145 
amino 
acid 
protein 
lack 
##ga 
co 
##don 
found 
reading 
frame 
mouse 
m 
##c 
presumed 
en 
##code 
se 
##ys 
##tein 
amino 
terminal 
de 
##duced 
amino 
acid 
sequence 
these 
result 
suggest 
repetitive 
g 
##aa 
sequence 
enhance 
s 
##licing 
binding 
complex 
containing 
sequence 
specific 
r 
##na 
binding 
protein 
general 
s 
##licing 
act 
##iva 
turn 
recruit 
additional 
s 
protein 
[SEP] 
[CLS] 
letter 
de 
##hy 
##dra 
test 
strip 
detection 
yeast 
cell 
s 
infection 
modern 
diagnosis 
[CLS] 
highly 
conserved 
region 
called 
s 
ho 
##mology 
3 
##3 
comprising 
amino 
acid 
residue 
88 
250 
believed 
m 
##od 
t 
present 
car 
##box 
terminal 
half 
s 
##rc 
protein 
[SEP] 
interesting 
altered 
interaction 
s 
##licing 
complex 
binding 
tightly 
##35 
co 
2 
separate 
1 
in 
##ductory 
pathway 
1 
##al 
##pha 
t 
##os 
serum 
signaling 
partially 
overlap 
activated 
mit 
pathway 
leading 
j 
ho 
##mo 
##di 
##mer 
binding 
1 
[CLS] 
##1 
1 
##3 
1 
mutation 
distinct 
defect 
##iot 
##ic 
##ination 
##ination [SEP] 
[CLS] 
##1 
1 
re 
slowly 
ultimately 
le 
half 
wild 
level 
##3 
1 
h 
##yper 
re 
##sect 
me 
##iot 
double 
strand 
severe 
defect 
formation 
##20 
3 
end 
m 
##ol 
##1 
gene 
coding 
similar 
stress 
in 
f 
##30 
na 
nat 
gene 
en 
##codes 
met 
##hi 
##oni 
##ne 
n 
##lt 
##ran 
##fer 
##ase 
##35 
##30 
gene 
coding 
##30 
##r 
##1 
encoding 
r 
##a 
related 
##ys 
##ys4 
gene 
c 
##ys 
##tat 
##oni 
##ne 
beta 
s 
##ynth 
##ase 
##70 
identical 
located 
close 
##ys 
##4 
##3 
##1 
##o 
encoding 
##tra 
##fer 
##70 
##01 
##r 
##r1 
gene 
coding 
signal 
recognition 
[CLS] 
transcription 
##al 
analysis 
gene 
cluster 
performed 
detect 
presence 
m 
##rna 
spanning 
adjacent 
gene 
well 
promoter 
##less 
la 
##cz 
reporter 
gene 
fused 
seven 
gene 
contained 
to 
op 
##rl 
lo 
##cus 
[SEP] 
serum 
i 
decreased 
[CLS] 
his 
##top 
##ath 
killed 
high 
##c 
ii 
given 
oral 
##ly 
di 
##ff 
##use 
h 
##yper 
##emia 
liver 
de 
##gene 
##ration 
kidney 
tub 
e 
##pit 
##ium 
ed 
##ema 
em 
##phy 
lung 
[CLS] 
the 
effect 
space 
radiation 
partially 
known 
known astronaut 
much 
remains 
discovered 
discovered [SEP] 
effect 
effect gal 
##11 
##k 
transcription 
must 
##k 
u 
##as 
presumably 
part 
activation 
complex 
wing 
##less 
w 
signaling 
directs 
cell 
fate 
choice 
em 
##b 
##ryo 
development 
development [SEP] 
##nas 
reveals 
10 
fold 
expression 
##d 
3 
##3 
l 
##1 
pre 
##adi 
differentiation 
[CLS] 
to 
transcription 
##x 
##r 
controlled 
mechanism 
control 
transcription 
region 
diver 
do 
c 
compared 
##r 
##x 
c 
do 
inter 
region 
[SEP] 
member 
##quito 
##us 
rode 
human 
imp 
major 
role 
the 
##rm 
##ogen 
copyright 
1998 
press 
press [SEP] 
parental 
vector 
trans 
##f 
cell 
sensitive 
growth 
inhibitor 
exhibited 
exhibited at 
##ra 
dependent 
re 
##ar 
trans 
trans 
##re 
##p 
the 
83 
co 
##it 
##us 
stopped 
pregnancy 
pregnancy [SEP] 
[CLS] 
based 
ratio 
area 
concentration 
time 
##f 
serum 
overall 
penetration 
r 
##ici 
0 
13 
0 
42 
median 
0 
0 22 
[CLS] 
the 
differential 
mineral 
##ido 
l 
##ymph 
node 
reaction 
radio 
disease 
discussed 
[CLS] 
with 
z 
sufficient 
diet 
##3 
ed 
##ta 
##ed 
##ta 
absorption 
##rina 
##ry 
retention 
z 
lesser 
lesser extent 
[CLS] 
99 
##t 
##c 
labelled 
##id 
al 
##bur 
##es 
radius 
250 
##co 
radius 
25 
used 
test 
substance 
study 
kinetic 
vascular 
clearance 
re 
stimulation 
##q 
c 
j 
he 
##tero 
##di 
##mers 
bind 
##p 
##1 
like 
sequence 
##q 
promoter 
region 
affinity 
much 
greater 
##q 
##q 
ho 
##mo 
##di 
##mers 
[CLS] 
more 
effect 
m 
##k 
map 
additional 
di 
##stal 
camp 
dependent 
inhibitor 
##y 
mechanism 
[SEP] 
these 
finding 
trans 
dominant 
factor 
facilitate 
growth 
line 
specific 
manner 
[PAD] [CLS] 
pseudo 
##tum 
##or 
form 
pulmonary 
no 
##card 
infection 
##card 
no 
##nal 
transplant 
##ato 
##let 
count 
liver 
function 
test 
determined 
standard 
procedure 
##ryo 
##rt 
##ical 
layer 
pyramid 
##al 
##bino 
rat 
three 
various 
fix 
clinical 
experience 
gained 
##c 
##f 
##chy 
##ther 
medical 
radio 
##r 
am 
generalized 
the 
team 
physician 
conditioning 
athlete 
sport 
statement 
inter 
relationship 
anchor 
o 
##go 
##mer 
##ization 
se 
##rot 
3 
3 t 
si 
1 
del 
##eti 
##40 
one 
lacking 
h 
hi 
##nge 
lacking 
adjacent 
region 
constituted 
coil 
aim 
the 
aim 
study 
static 
dynamic 
bone 
change 
patient 
r 
##ick 
##ets 
##ets [SEP] 
[PAD] [CLS] 
the 
law 
ch 
##iro 
##pra 
##practor 
##ctor [SEP] 
[CLS] 
in 
##ex 
d 
##b 
weak 
expression 
target 
gene 
un 
##ressed 
condition 
caused 
growth 
re 
##tar 
##dation 
trans 
plant 
[SEP] 
may 
m 
##or 
##ph 
##olo 
##rrel 
##ate 
tumor 
re 
pre 
##oper 
##oto 
##xi 
##em 
##otherapy 
mean 
total 
ho 
##mo 
##stein 
##cy 
21 
1 
9 
##mo 
l 
median 
concentration 
concentration 19 
##mo 
l 
l [SEP] 
efficacy 
pro 
##biotic 
feed 
add 
guide 
micro 
##or 
##gan 
dog 
cat 
horse 
pro 
##biotic 
##or 
##gan 
feed 
add 
##itive 
animal 
[PAD] [CLS] 
lung 
transplant 
warrant 
stable 
##ila 
dependent 
recipient 
recipient [SEP] 
[CLS] 
site 
directed 
##uta 
site 
throughout 
i 
alter 
control 
i 
b 
##p 
binding 
reflecting 
fact 
foot 
##print 
i 
b 
##p 
entire 
[SEP] 
[CLS] 
approach 
random 
integration 
large 
d 
fragment 
plant 
one 
several 
site 
specific 
re 
##comb 
##ination 
s 
##r 
system 
c 
##re 
lo 
##x 
[SEP] 
[CLS] 
neon 
##ata 
##l 
ma 
##cu 
##lini 
##zation 
affect 
maternal 
behavior 
sensitivity 
female 
rat 
rat [SEP] 
##t 
##1 
1 
##alytic 
towards 
1 
2 
e 
##pox 
##y 
3 
##tro 
ni 
##tro 
di 
##ch 
in 
landmark 
favored 
x 
##ero 
##rad 
degree 
non 
##let 
##hal 
##1 
1 
1 
mutation 
mutation eliminate 
se 
##3 
##p 
complex 
[CLS] 
sequence 
del 
##eti 
##on 
analysis 
re 
##comb 
enhance 
##ment 
gene 
re 
##f 
b 
##act 
##eri 
##op 
p 
##1 
evidence 
promoter 
operator 
at 
##ua 
anti 
##ter 
##mina 
control 
[SEP] 
[CLS] 
t 
##b 
##c 
thus 
thus suggested 
indicator 
persistent 
he 
##pa 
infection 
found 
rarely 
se 
##rone 
##gat 
patient 
chronic 
he 
##pa 
alcoholic 
c 
##ir 
##r 
##hos 
alcoholic 
liver 
disease 
[SEP] 
[CLS] 
adapt 
##ability 
##pp 
##ost 
##rong 
bra 
##si 
##vas 
1914 
lead 
contamination 
e 
##ph 
membrane 
e 
##ph 
cell 
interaction 
[CLS] 
disc 
##us 
possibility 
d 
protein 
interaction 
ho 
##mo 
##log 
n 
##leo 
##tide 
sequence 
like 
identified 
p 
##ii 
part 
regulatory 
gene 
ca 
##sca 
##de 
participates 
timing 
gene 
expression 
c 
c 
##res 
cell 
cycle 
[SEP] 
[CLS] 
post 
##con 
##tras 
image 
also 
acquired 
##git 
##tal 
six 
patient 
co 
##rona 
##l 
three 
plane 
plane [SEP] 
nature 
##rm 
##op 
bi 
##conductor 
to 
##ut 
##rop 
s 
##m 
##f 
dose 
micro 
##gram 
c 
12 
h 
##han 
##ol 
0 
0 15 
m 
b 
##ora 
##te 
buffer 
8 
0 
cat 
##e 
ch 
##ol 
o 
met 
##hyl 
##tra 
##fer 
##ase 
activity 
might 
ass 
##ito 
##ni 
free 
6 
week 
pet 
[CLS] 
the 
amino 
acid 
residue 
sub 
##dom 
##ain 
##s 
important 
d 
binding 
hormone 
binding 
dim 
##eri 
##zation 
trans 
##act 
##ivation 
mostly 
conserved 
among 
s 
##pec 
##ie 
[SEP] 
[CLS] 
trans 
##cript 
appear 
initiated 
upstream 
promoter 
p 
##1 
located 
front 
t 
met 
##1 
gene 
three 
internal 
promoter 
p 
##2 
located 
immediately 
front 
t 
gene 
##10 
near 
beginning 
l 
##1 
l 
##10 
inter 
##genic 
space 
##12 
end 
l 
##10 
gene 
sequence 
[SEP] 
based 
de 
##duced 
amino 
acid 
sequence 
identity 
##1 
##2 
group 
i 
97 
identical 
##3 
##4 
group 
group ii 
99 
4 
identical 
identical [SEP] 
[CLS] 
case 
functioning 
para 
##roid 
car 
##cin 
##oma 
h 
##yper 
##tens 
[CLS] 
finally 
gel 
shift 
ass 
##f 
able 
bind 
promoter 
fragment 
56 
##6 
88 
##8 
critical 
general 
result 
result [SEP] 
fatty 
induce 
1 
6 
fold 
increase 
transcription 
activity 
whereas 
re 
##press 
o 
##1 
transcription 
much 
fold 
[CLS] 
this 
##pt 
##ide 
includes 
first 
three 
zinc 
finger 
t 
##fi 
d 
binding 
domain 
an 
exception 
##l 
6 
gene 
encoding 
transcription 
factor 
found 
m 
##uta 
##ted 
normal 
human 
memory 
b 
cell 
[CLS] 
3 
3 [SEP] 
[CLS] 
a 
chest 
x 
ray 
film 
showed 
in 
##fi 
##rative 
shadow 
right 
middle 
lower 
lung 
field 
chest 
c 
##t 
scan 
abnormal 
lung 
density 
right 
lower 
lobe 
lobe [SEP] 
in 
liver 
pan 
##cre 
##atic 
is 
##let 
g 
##lu 
##co 
##kin 
##ase 
in 
##hibition 
regulatory 
protein 
##r 
[CLS] 
m 
##ri 
measurement 
brain 
brain [SEP] 
similarly 
67 
reverted 
ad 
##ome 
##d 
##c 
[CLS] 
of 
high 
une 
##x 
##plain 
##v 
among 
##f 
##rica 
am 
##eric 
woman 
also 
extremely 
high 
##ter 
birth 
[CLS] 
the 
use 
bent 
##oni 
##te 
compound 
##ydro 
[CLS] 
co 
##tra 
##mi 
protein 
kinase 
inhibitor 
inactive 
protein 
kinase 
p 
cat 
##alytic 
beta 
subunit 
in 
##hibit 
for 
##sko 
##aca 
activation 
ch 
##rom 
##og 
transcription 
revealing 
##aca 
trans 
activation 
highly 
dependent 
p 
##ka 
##h 
rapid 
t 
##os 
p 
protein 
approximately 
93 
k 
##da 
fi 
##bro 
##lot 
s 
specific 
revealed 
s 
##tat 
##5 
activation 
p 
[CLS] 
the 
method 
##b 
bearing 
c 
##hal 
##ometric 
diagnosis 
90 
91 
con 
##cor 
##dance 
##d 
##9 
temperature 
all 
##ele 
s 
c 
##ere 
##vis 
##iae 
displayed 
cell 
division 
cycle 
arrest 
large 
round 
##dded 
cell 
mutant 
[CLS] 
the 
c 
##yan 
##ob 
##erial 
p 
##is 
##ome 
complex 
located 
photos 
##ynth 
##etic 
membrane 
[SEP] 
[CLS] 
one 
day 
injection 
48 
injected 
activity 
skeleton 
9 
3 
liver 
3 
kidney 
4 
4 
rest 
organ 
organ [SEP] 
[CLS] 
objective 
to 
ass 
laboratory 
practice 
examination 
blood 
film 
malaria 
parasite 
parasite [SEP] 
background 
thorough 
understanding 
ma 
##gnant 
fi 
##bro 
his 
##h 
sub 
lead 
his 
##to 
specific 
protocol 
[CLS] 
sequence 
analysis 
revealed 
partial 
94 
##1 
b 
##p 
##a 
encoded 
313 
amino 
p 
##pt 
##ide 
[SEP] 
further 
##b 
##30 
##0 
stimulate 
beta 
transcription 
s 
##4 
##4 
dependent 
fashion 
[CLS] 
sequence 
within 
flank 
##ing 
h 
##yper 
##sen 
##sitive 
site 
3 
2 
beta 
##lo 
##bin 
lo 
##cus 
control 
region 
required 
s 
##yne 
##rg 
##istic 
add 
##itive 
interaction 
e 
##ps 
##bin 
gene 
promoter 
[SEP] 
sequence 
analysis 
100 
ho 
##mology 
derived 
p 
##ten 
fragment 
normal 
##f 
well 
##en 
##bank 
sequence 
accession 
##9 
##30 
##51 
174 
233 
247 
he 
##n 
##row 
##tro 
including 
human 
si 
contain 
##uc 
zipper 
like 
repeat 
highly 
conserved 
region 
external 
domain 
trans 
t 
##in 
[CLS] 
functional 
properly 
folded 
surface 
loop 
covering 
cat 
##alytic 
center 
[SEP] 
[CLS] 
the 
frequent 
abnormal 
##ity 
##h 
deficiency 
case 
followed 
go 
##tro 
four 
case 
co 
##rt 
##is 
##ol 
four 
case 
case t 
one 
case 
whereas 
patient 
showed 
high 
serum 
p 
##rl 
value 
[CLS] 
re 
##comb 
express 
b 
bact 
##eri 
##op 
t 
##3 
r 
##na 
polymer 
##ase 
t 
##3 
##pol 
##pol es 
escher 
la 
lac 
re 
##press 
##or 
la 
laci 
control 
early 
late 
promoter 
p 
p7 
5 
constructed 
[SEP] 
[CLS] 
internal 
control 
volume 
milk 
suck 
##led 
appear 
infant 
rat 
2 
week 
age 
time 
gas 
##tric 
di 
##sten 
milk 
systemic 
de 
##dra 
in 
##test 
##testinal 
hormone 
ch 
##ole 
##kini 
suppress 
milk 
intake 
derived 
suck 
##ling 
[SEP] 
[CLS] 
shield 
needed 
pace 
##maker 
##maker [SEP] 
[CLS] 
concerning 
practical 
approach 
setting 
pointed 
disease 
infection 
considered 
testing 
he 
anti 
##body 
positive 
r 
indicated 
[CLS] 
##fo 
w 
##i 
distribute 
equally 
expected 
w 
mutant 
two 
c 
terminal 
residue 
however 
easy 
establish 
diagnosis 
th 
##ora 
m 
mf 
##h 
##h [SEP] 
[CLS] 
type 
insulin 
led 
dependent 
association 
p 
i 
##rs 
1 
s 
domain 
regulatory 
subunit 
##i 
3 
kinase 
increased 
amount 
p 
##i 
kinase 
activity 
detected 
##rs 
1 
##pit 
##ates 
the 
ul 
##m 
##r 
system 
micro 
##dial 
##ys 
bio 
##sen 
glucose 
unite 
##c 
ul 
##m 
send 
##er 
transferring 
glucose 
concentration 
receiving 
the 
x 
an 
##nex 
lack 
highly 
##os 
position 
23 
site 
on 
protein 
no 
at 
detected 
##uo 
fraction 
[CLS] 
##las 
##mi 
##d 
bearing 
p 
s 
##tip 
##tipitis 
##3 
gene 
##rs 
##2 
element 
30 
000 
transform 
##ants 
per 
##gram 
p 
##mi 
##d 
d 
##na 
[SEP] 
he 
##par 
given 
dose 
0 
3 
mg 
x 
kg 
1 
b 
##ol 
##us 
0 
3 
mg 
mg x 
1 
x 
h 
1 
in 
##per 
lower 
re 
##lusion 
[SEP] 
[CLS] 
the 
score 
three 
factor 
correspond 
recognizable 
dimension 
de 
##pressive 
illness 
correlated 
r 
##c 
##b 
##f 
##f [SEP] 
[CLS] 
c 
##lon 
##ing 
sequence 
analysis 
expression 
gene 
encoding 
##de 
di 
##uta 
pseudo 
##mona 
put 
f 
##6 
##1 
[CLS] 
however 
salvage 
serum 
##a 
level 
9 
1 
1 
1 
ng 
m 
r 
##p 
salvage 
r 
##t 
group 
000 
0001 
[CLS] 
##te 
dig 
##est 
##some 
segment 
3 
sufficient 
stable 
membrane 
anchor 
indicating 
segment 
may 
specify 
trans 
##rane 
domain 
##b 
##in 
the 
time 
l 
##r 
0 
month 
range 
3 
194 
5 
month 
49 
0 
month 
range 
3 
209 
0 
month 
month respectively 
[CLS] 
a 
gene 
##r 
1 
identified 
within 
four 
co 
##sm 
##id 
con 
##ti 
##g 
##c 
d 
express 
4 
8 
k 
##b 
message 
human 
brain 
[CLS] 
detailed 
comparison 
sequence 
##p 
##35 
ii 
substantial 
sequence 
di 
##ssi 
##mi 
##lar 
##ity 
domain 
encoding 
amino 
acid 
residue 
20 
40 
includes 
p 
site 
human 
molecule 
along 
residue 
possible 
physiological 
significance 
[SEP] 
[CLS] 
ex 
##ogen 
heart 
stress 
log 
circulating 
ne 
concentration 
rise 
heart 
rate 
load 
usual 
relationship 
observed 
stress 
preserved 
preserved [SEP] 
[CLS] 
the 
imp 
##lication 
analyzed 
trans 
trans 
experiment 
con 
##it 
##utive 
v 
dominant 
##17 
mutant 
[SEP] 
[PAD] [CLS] 
alternative 
immune 
##bul 
preparation 
standard 
immune 
serum 
##bul 
available 
available [SEP] 
[CLS] 
plasma 
insulin 
response 
glucose 
##em 
##oral 
he 
##pa 
##tic 
##atic 
dog 
[CLS] 
bio 
##con 
##version 
inexpensive 
substrate 
valuable 
intermediate 
##hal 
##os 
##por 
de 
##to 
##por 
da 
eliminating 
agitation 
adding 
de 
##cane 
[CLS] 
elevated 
potassium 
stimulation 
gal 
m 
mrna 
##rna completely 
blocked 
pit 
##uit 
##ary 
ad 
##en 
##yl 
##yl 
c 
##c 
act 
##ivating 
his 
histamine 
stimulation 
blocked 
##he 
##de 
in 
l 
##y 
##zo 
##zy 
periodic 
group 
youngest 
##oa 
##l 
[CLS] 
##b 
##f 
##1 
m 
##rna 
present 
light 
dark 
grown 
leaf 
well 
root 
root [SEP] 
[CLS] 
we 
identification 
analysis 
transcription 
##al 
activity 
mediated 
three 
c 
##i 
acting 
site 
within 
90 
b 
##p 
portion 
r 
enhance 
##r 
designated 
m 
##od 
region 
[SEP] 
a 
di 
##ff 
##use 
a 
##xon 
##al 
information 
physical 
earlier 
##it 
##ro 
tissue 
study 
co 
##rrel 
##ate 
his 
radio 
##xon 
##al 
injury 
predicted 
region 
analysis 
sample 
measurement 
[CLS] 
a 
trans 
induction 
c 
f 
##o 
c 
m 
t 
observed 
cell 
population 
population together 
associated 
suppression 
m 
##rna 
f 
##etal 
rat 
ca 
##var 
##ial 
cell 
[SEP] 
video 
##ana 
ballistic 
character 
initial 
phase 
reaching 
movement 
movement [SEP] 
[CLS] 
is 
##omer 
##ization 
pre 
existing 
closed 
complex 
open 
promoter 
form 
judged 
local 
den 
##at 
promoter 
d 
rendered 
sequence 
5 
10 
reactive 
towards 
km 
##4 
shown 
fully 
dependent 
ni 
##fa 
[SEP] 
[CLS] 
ma 
##r 
context 
dependent 
transcription 
##al 
enhance 
##r 
activated 
expression 
on 
dependent 
##rom 
##oso 
integration 
positively 
select 
tumor 
##ige 
cell 
multi 
##ste 
##p 
et 
##iology 
##al 
cancer 
[SEP] 
[PAD] [CLS] 
socio 
##logical 
analysis 
family 
family [SEP] 
[CLS] 
this 
enhance 
##r 
element 
functioned 
position 
orientation 
independent 
manner 
p 
##n 
##r 
p 
##0 
promoter 
##tero 
##ous 
##mi 
##dine 
kinase 
promoter 
[SEP] 
these 
m 
mt 
potent 
whereas 
##icit 
##ifer 
effect 
[CLS] 
multi 
##var 
##iant 
study 
##uit 
ad 
##eno 
two 
log 
##istic 
re 
##gression 
equation 
auxiliary 
support 
diagnosis 
tumor 
tumor [SEP] 
bi 
##le 
salt 
ho 
##rmon 
##al 
control 
disadvantage 
number 
warm 
higher 
rate 
firing 
thermal 
gradually 
increased 
growth 
growth [SEP] 
such 
unique 
recognition 
alter 
##ation 
c 
##dr 
##3 
loop 
t 
##r 
[CLS] 
to 
effect 
survey 
maximum 
delay 
stream 
guarantee 
dimensional 
class 
##gin 
45 
minute 
hot 
##lim 
tropical 
condition 
condition [SEP] 
[CLS] 
gene 
1 
m 
##rona 
##9 
en 
##codes 
approximately 
800 
k 
##da 
protein 
product 
within 
two 
overlapping 
open 
reading 
frame 
or 
##fs 
1 
##a 
1 
##b 
for 
interaction 
terminal 
part 
##1 
terminus 
e 
##f 
##1 
domain 
present 
e 
##f 
##3 
absent 
[CLS] 
biological 
##f 
1 
regulation 
##gh 
gene 
expression 
attribute 
functional 
receptor 
induced 
1 
protein 
direct 
link 
link i 
mediated 
signalling 
3 
enhance 
##r 
activation 
activation [SEP] 
[PAD] [CLS] 
on 
activation 
re 
ret 
detected 
thy 
syndrome 
syndrome [SEP] 
c 
##d 
##4 
degradation 
mediated 
require 
er 
ca 
##ex 
##in 
dependent 
intact 
system 
[CLS] 
the 
maternal 
gene 
segregation 
cell 
fate 
specification 
activity 
early 
early ca 
##eno 
##r 
##hab 
##dit 
el 
##egan 
##egans 
em 
##b 
##ryo 
[SEP] 
effect 
##agon 
administration 
1 
2 
met 
##ho 
##l 
4 
2 
p 
##raz 
0 
5 
mg 
kg 
p 
purpose 
to 
effect 
pu 
##ls 
br 
o 
##cilla 
rotating 
bra 
oral 
b 
ultra 
plaque 
remove 
d 
##9 
plaque 
removal 
[CLS] 
detailed 
analysis 
predicted 
amino 
acid 
sequence 
revealed 
sequence 
element 
conserved 
many 
d 
r 
##na 
polymer 
##ase 
[SEP] 
sub 
inhibitor 
anti 
##biotic 
s 
##y 
er 
##hr 
##omy 
s 
au 
[CLS] 
the 
c 
##d 
##c 
system 
appears 
first 
pro 
##kar 
example 
##tero 
##di 
##mer 
##ic 
##b 
##c 
transport 
##pt 
contains 
h 
##ydro 
at 
binding 
domain 
[SEP] 
[CLS] 
the 
single 
copy 
u 
##20 
sequence 
located 
d 
strand 
n 
##lin 
m 
##rna 
[SEP] 
shift 
southwestern 
experiment 
nuclear 
protein 
43 
k 
##da 
30 
k 
##da 
fish 
cell 
respectively 
bind 
specifically 
specifically t 
involvement 
binding 
protein 
protein act 
##ivating 
transcription 
factor 
l 
related 
p 
##eptide 
camp 
response 
[SEP] 
[CLS] 
the 
coding 
sequence 
rat 
kinase 
1 
##k 
##1 
determined 
multiple 
independent 
c 
##dn 
##a 
clone 
[CLS] 
in 
better 
quantitative 
estimate 
regional 
distribution 
bone 
ma 
##rrow 
organ 
infant 
child 
various 
an 
##ato 
##mic 
##al 
data 
developed 
developed [SEP] 
we 
compared 
response 
hatch 
##ling 
adult 
p 
oh 
population 
[CLS] 
on 
mutant 
##fect 
isolated 
gene 
her 
##pes 
##x 
immediate 
early 
gene 
product 
i 
##p 
##4 
known 
positively 
regulate 
transcription 
viral 
early 
late 
gene 
negatively 
regulate 
expression 
promoter 
[SEP] 
[PAD] [CLS] 
infant 
isolated 
##com 
##pa 
##ric 
##oc 
##ard 
developed 
vent 
##ric 
##ular 
ta 
##chy 
##ar 
##r 
described 
described [SEP] 
[CLS] 
recent 
highly 
visible 
review 
subject 
clearly 
pointed 
little 
known 
cellular 
mechanism 
inhaled 
as 
##bes 
fiber 
cause 
known 
de 
##bil 
##itating 
lung 
disease 
as 
##bes 
e 
inter 
##st 
##iti 
##al 
pulmonary 
fi 
##bro 
##sis 
the 
specific 
domain 
pit 
1 
essential 
sequence 
specific 
high 
d 
binding 
d 
dependent 
pit 
1 
pit 
1 
interaction 
interaction [SEP] 
also 
place 
##de 
##pressed 
treatment 
outcome 
depressed 
patient 
obtaining 
kidney 
cell 
puppy 
##p 
##b 
1 
establishment 
##op 
##vation 
[CLS] 
these 
result 
essential 
role 
binding 
4 
4 
factor 
beta 
a 
a 
site 
basal 
transcription 
##al 
activation 
##3 
gene 
liver 
cell 
it 
it en 
envis 
##aged 
who 
##q 
##ol 
br 
##ef 
useful 
require 
example 
large 
e 
##pid 
##em 
##iol 
[CLS] 
restriction 
mapping 
two 
re 
p 
##mi 
##d 
shared 
e 
##cor 
##i 
fragment 
8 
9 
k 
##b 
[SEP] 
[PAD] [CLS] 
##cor 
##tic 
heart 
failure 
failure [SEP] 
the 
ch 
##rom 
##oso 
##mal 
location 
##cs 
##chi 
##mer 
##ic 
nature 
[CLS] 
after 
first 
strand 
c 
##a 
synthesis 
##etal 
brain 
m 
##rna 
short 
fragment 
##a 
s 
##f 
##a 
synthesized 
two 
step 
am 
##p 
##lification 
system 
use 
modified 
de 
##generate 
o 
##gon 
##uc 
##leo 
##tide 
prime 
##d 
shuttle 
polymer 
##ase 
chain 
reaction 
do 
##p 
shuttle 
p 
##r 
method 
[SEP] 
ex 
##citation 
path 
block 
wall 
##cha 
pro 
##fi 
ii 
ii 
present 
human 
suggesting 
ma 
three 
pro 
##fi 
##orms 
two 
hybrid 
system 
isolated 
83 
amino 
ring 
finger 
##3 
##4 
zinc 
t 
##1 
beta 
1 
specifically 
interact 
domain 
zinc 
factor 
k 
##1 
##10 
the 
the author 
ex 
##ere 
##ye 
##ric 
small 
kidney 
##aro 
surgery 
surgery [SEP] 
protein 
product 
diet 
therapy 
re 
##nal 
ins 
[CLS] 
une 
##sta 
##lished 
##ob 
##tro 
on 
order 
investigate 
mechanism 
on 
interfere 
terminal 
differentiation 
[CLS] 
early 
detection 
sign 
he 
##pa 
##to 
##ang 
##ios 
##a 
among 
worker 
[CLS] 
reduced 
expression 
caused 
multi 
##mer 
##ization 
##as 
##2 
native 
promoter 
observed 
presence 
##r 
##1 
[SEP] 
[CLS] 
##4 
differential 
##ly 
regulate 
##s 
t 
##ra 
##f 
signaling 
di 
##sen 
##ga 
##ging 
##nk 
activation 
directing 
n 
##f 
ka 
##ppa 
effect 
rot 
specific 
cellular 
response 
[CLS] 
3rd 
is 
##che 
##mia 
kidney 
30 
min 
structural 
component 
wall 
g 
##lo 
##mer 
##ular 
art 
##eri 
fi 
##ltration 
re 
##ab 
##ption 
barrier 
undergo 
undergo certain 
ultra 
##st 
##ructural 
change 
time 
time el 
##ap 
7 
14 
day 
gradually 
away 
cell 
h 
##yper 
##tro 
process 
increase 
[CLS] 
rag 
##1 
protein 
over 
##ex 
co 
expected 
c 
##lea 
##vage 
combined 
rag 
29 
##3 
##3t 
cell 
[SEP] 
19 
49 
49 
preventing 
he 
##tero 
hi 
formidable 
public 
challenge 
[CLS] 
more 
##ata 
1 
s 
##1 
s 
##rg 
##ize 
distance 
designed 
mimic 
architecture 
g 
##lo 
##bin 
lo 
##cus 
control 
region 
downstream 
##lo 
##bin 
promoter 
[SEP] 
##ov 
in 
ins 
so 
alternative 
game 
##te 
in 
##fall 
##ian 
transfer 
gift 
controlled 
comparative 
trial 
trial [SEP] 
chromosome 
end 
contain 
long 
array 
t 
##tag 
repeat 
complex 
##ed 
te 
##lo 
##mere 
specific 
protein 
t 
##tag 
repeat 
binding 
factor 
t 
##rf 
##1 
[CLS] 
##eno 
##type 
p 
##otype 
correlation 
male 
patient 
partial 
null 
##is 
##omy 
x 
chromosome 
chromosome suggested 
one 
lo 
##cus 
involved 
##r 
##x 
x 
##p 
3 
[CLS] 
mean 
disposition 
constant 
s 
##d 
obtained 
individual 
##ized 
fit 
v 
##1 
0 
39 
398 
0 
33 
kg 
v 
##dar 
##ea 
2 
53 
0 
0 72 
kg 
alpha 
0 
316 
0 
29 
294 
min 
1 
beta 
0 
00 
0020 
##204 
0 
00 
##26 
##262 
min 
1 
k 
##2 
0 
03 
030 
##05 
0 
01 
##01 
min 
1 
[SEP] 
[CLS] 
the 
gene 
in 
##iti 
##ator 
site 
contained 
within 
13 
244 
base 
##pair 
##s 
contains 
19 
ex 
##on 
[SEP] 
c 
##lot 
##ron 
##ron 
c 
##t 
pet 
##os 
##ron 
em 
gas 
15 
##o 
11 
##c 
##o 
##2 
##o 
etc 
etc [SEP] 
[CLS] 
c 
##lot 
##ron 
room 
transportation 
pipe 
shield 
reduce 
p 
##os 
##it 
##ron 
an 
##ni 
##hil 
##ation 
radiation 
ma 
co 
##oh 
terminus 
central 
cell 
binding 
domain 
fi 
##bro 
##nect 
well 
well corresponding 
##s 
##1 
##d 
result 
##umi 
##nal 
portion 
precursor 
cerebral 
blood 
flow 
measured 
i 
##v 
method 
133 
x 
##b 
##f 
determination 
##do 
measured 
##erial 
##nous 
oxygen 
difference 
difference [SEP] 
activation 
mit 
map 
##k 
pathway 
enhance 
long 
range 
trans 
##act 
##ivation 
beta 
##lo 
##bin 
lo 
control 
region 
##r 
w 
sit 
hybrid 
whole 
mount 
em 
##b 
##ryo 
##x 
r 
exclusion 
##x 
em 
##b 
##ryo 
##nic 
development 
three 
patient 
electro 
characteristic 
at 
##rio 
##vent 
##ric 
##ular 
conduct 
##ion 
prevented 
demonstration 
difference 
difference [SEP] 
human 
re 
like 
ii 
ii [SEP] 
[CLS] 
3 
3 [SEP] 
[CLS] 
new 
strategy 
prevent 
co 
##rona 
##ry 
re 
##th 
##rom 
##bos 
patient 
minimal 
at 
##her 
##os 
##cle 
th 
##rom 
##bol 
##oc 
##ard 
in 
##far 
the 
i 
##ck 
t 
##os 
c 
##d 
##4 
c 
##dr 
##3 
loop 
signal 
trans 
##duction 
in 
##hibit 
1 
transcription 
programmed 
per 
##nea 
lava 
##ura 
com 
##fo 
ul 
stomach 
[CLS] 
del 
##eti 
##on 
analysis 
7 
3 
k 
##b 
##ata 
promoter 
region 
revealed 
1 
1 
k 
##b 
d 
sequence 
critical 
expression 
##ata 
ne 
##uron 
[SEP] 
[CLS] 
the 
model 
predict 
##s 
1 
line 
calculation 
air 
##way 
dead 
space 
end 
expired 
lung 
volume 
addition 
oxygen 
sin 
##e 
wave 
per 
component 
mean 
fi 
##o 
##2 
2 
q 
##t 
measured 
oxygen 
per 
wave 
expired 
gas 
##erial 
##nous 
independent 
blood 
oxygen 
sat 
value 
consistent 
##h 
##5 
##8 
disappears 
##7 
cell 
absent 
##less 
[CLS] 
the 
fusion 
gene 
cassette 
placed 
control 
##a 
early 
promoter 
clone 
##d 
host 
restricted 
##pox 
vector 
[SEP] 
##oria 
tumor 
[CLS] 
f 
##ul 
##mina 
##nt 
he 
##pa 
##tic 
failure 
case 
could 
could characterized 
1 
rapid 
serum 
al 
trans 
al 
level 
disco 
e 
##car 
##azi 
2 
prolonged 
j 
##au 
##ndi 
##ce 
despite 
e 
##car 
##azi 
3 
high 
an 
57 
4 
his 
##to 
finding 
extensive 
he 
##pa 
##to 
##cellular 
ne 
##c 
##rosis 
ranging 
br 
##id 
##ging 
ne 
##c 
##rosis 
massive 
ne 
##c 
##rosis 
##rosis [SEP] 
[CLS] 
these 
secret 
t 
##runcated 
receptor 
encoded 
2 
6 
k 
##b 
c 
##bb 
trans 
##cript 
bind 
t 
alpha 
growth 
regulatory 
##ro 
[CLS] 
local 
##ization 
enzyme 
consistent 
electron 
he 
##tes 
a 
close 
ho 
##mo 
##mologue 
gene 
named 
##b 
also 
isolated 
##ido 
library 
[CLS] 
thus 
rate 
factor 
receptor 
end 
##osis 
con 
##quent 
##uo 
##lar 
turnover 
depend 
available 
level 
cell 
[SEP] 
approach 
shown 
h 
##fire 
bind 
s 
##lator 
##y 
protein 
s 
##1 
##3 
addition 
##b 
##f 
[SEP] 
specific 
##mu 
abnormal 
detected 
8 
looked 
looked [SEP] 
[CLS] 
using 
combined 
p 
##har 
##co 
##kin 
##etic 
p 
##har 
##co 
##dynamic 
impact 
factor 
effective 
bio 
##ava 
##ila 
##bility 
est 
##imation 
in 
##tra 
##ven 
##ous 
oral 
dose 
ratio 
required 
area 
response 
time 
curve 
acute 
administration 
explored 
explored [SEP] 
[CLS] 
conclusion 
the 
r 
one 
common 
best 
characterized 
r 
binding 
motif 
the 
c 
dependent 
kinase 
##d 
##k 
associate 
c 
##c 
##lins 
d 
##1 
s 
phase 
transition 
ma 
##mmal 
[CLS] 
m 
##ol 
##ol [SEP] 
[CLS] 
the 
terminal 
gag 
encoded 
region 
p 
##0 
contains 
p 
##ot 
##os 
residue 
addition 
normal 
gag 
site 
r 
##ad 
##18 
required 
d 
repair 
check 
response 
yeast 
[CLS] 
a 
le 
common 
per 
##plex 
c 
##ir 
##cum 
occurs 
patient 
established 
year 
chronic 
pulmonary 
involvement 
d 
##ys 
##p 
##nea 
[CLS] 
2 
4 
2 
6 
to 
##lue 
##ned 
##iam 
h 
##ydro 
##ly 
##lysed 
plasma 
urine 
test 
chamber 
human 
2 
4 
2 
to 
##lue 
##ne 
di 
##is 
##yana 
##te 
[SEP] 
[CLS] 
further 
##ios 
coincide 
##ntal 
general 
phenomenon 
[CLS] 
after 
1 
day 
none 
er 
##hr 
##oc 
detected 
[CLS] 
this 
substrate 
c 
##lea 
##ved 
efficiently 
trans 
pro 
prote 
##ase 
3 
derived 
3 
##c 
precursor 
protein 
[SEP] 
[CLS] 
the 
gamma 
##yl 
trans 
##idas 
serum 
problem 
drink 
##er 
[PAD] [CLS] 
patient 
end 
##oc 
##ard 
vascular 
frequently 
##com 
##p 
##rom 
##ised 
older 
acute 
q 
fever 
fever [SEP] 
[CLS] 
effect 
##late 
product 
den 
##tine 
surface 
se 
##m 
investigation 
the 
technique 
system 
trans 
external 
increase 
resistance 
breathing 
[CLS] 
we 
99 
##m 
##mt 
##d 
s 
##pect 
comparing 
##c 
##b 
##f 
image 
patient 
spin 
##bella 
de 
s 
##d 
##d [SEP] 
##pt 
##yl 
##olo 
7 
day 
strain 
b 
##al 
##b 
c 
##b 
##l 
i 
##gh 
##a 
d 
##ba 
##ba2 
r 
##f 
c 
##e 
in 
la 
##cz 
trans 
##cript 
synthesis 
way 
yield 
little 
beta 
gal 
##os 
##idas 
##e 
[SEP] 
six 
human 
ho 
##mo 
##log 
gene 
known 
s 
##pec 
##ie 
namely 
h 
##1 
r 
##vis 
##rna 
s 
##vis 
chromosome 
[CLS] 
the 
th 
##ala 
##mic 
s 
##d 
regularly 
triggered 
short 
0 
02 
0 
05 
high 
h 
e 
##iet 
##al 
co 
##rt 
##ical 
surface 
surface [SEP] 
all 
three 
s 
##v 
transformed 
cell 
gene 
product 
p 
##44 
p 
secret 
tightly 
surface 
[CLS] 
it 
mechanism 
in 
##test 
##inal 
absorption 
d 
25 
h 
differ 
man 
absorption 
possibly 
le 
dependent 
bi 
acid 
elevated 
f 
##ak 
expression 
e 
##4 
##9 
o 
##leo 
##tide 
reduce 
f 
##ak 
[CLS] 
it 
tends 
higher 
f 
##raz 
##ion 
##i 
community 
community 
[SEP] 
[CLS] 
the 
br 
l 
gene 
65 
##3 
n 
##t 
length 
derived 
##pt 
##ide 
216 
##a 
to 
study 
t 
##t 
liver 
disease 
initiated 
effect 
pro 
##in 
##f 
##mat 
media 
tumor 
ne 
nec 
##rosis 
##f 
alpha 
##t 
cell 
[CLS] 
availability 
le 
diet 
ch 
##ow 
following 
diet 
result 
diminished 
ca 
##lor 
##ic 
intake 
body 
weight 
o 
##besity 
h 
##yper 
##ins 
##ulin 
##emia 
by 
c 
##i 
failed 
affect 
il 
9 
response 
and 
epic 
##ard 
map 
electrical 
dog 
acute 
group 
self 
dog 
chronic 
group 
sin 
##us 
rhythm 
at 
##rial 
pacing 
3 
dog 
control 
group 
group analyzed 
creating 
linear 
radio 
a 
##bla 
les 
##ion 
at 
##rium 
eliminated 
[CLS] 
in 
response 
##hos 
##phorus 
limitation 
fungus 
ne 
##uro 
##sp 
c 
number 
enzyme 
function 
bring 
phosphate 
cell 
[SEP] 
the 
effect 
in 
size 
medium 
temperature 
duration 
su 
as 
##gill 
##gat 
investigated 
br 
##oth 
##ro 
di 
##lution 
[CLS] 
we 
analyzed 
function 
put 
##ative 
s 
##l 
structure 
r 
translation 
##lora 
##l 
##ty 
##lt 
##ran 
##s 
##fer 
##ase 
cat 
flanked 
5 
3 
terminal 
sequence 
domain 
r 
genome 
several 
del 
##eti 
derivative 
sequence 
[SEP] 
##iar 
##osa 
r 
##nal 
vessel 
blood 
blood [SEP] 
despite 
bio 
##chemical 
estimate 
bone 
turnover 
term 
stimulate 
bone 
metabolism 
o 
##ste 
##op 
##oro 
bone 
mineral 
pro 
##ximal 
##em 
##ur 
[CLS] 
compression 
pulmonary 
artery 
right 
##ric 
##flow 
tract 
an 
##eur 
##ys 
ascending 
##ort 
##a 
##a [SEP] 
patient 
d 
##p 
##x 
occurrence 
associated 
condition 
condition [SEP] 
pressure 
long 
term 
di 
##ure 
beta 
ad 
##ren 
##ore 
##ceptor 
blocking 
drug 
sixteen 
nineteen 
patient 
moderate 
##yper 
##tens 
[CLS] 
however 
f 
##os 
##b 
l 
f 
##os 
##b 
##b s 
differ 
trans 
regulatory 
trans 
activation 
##x 
t 
cat 
reporter 
construct 
he 
3 
##t 
##3 
cell 
found 
f 
##os 
##b 
form 
[SEP] 
[CLS] 
mutation 
##b 
##r 
##1 
##c 
##r 
##4 
n 
encoding 
si 
54 
influence 
gene 
expression 
[CLS] 
disruption 
in 
##p 
##53 
related 
##51 
gene 
resulted 
alpha 
factor 
mat 
defect 
ex 
exace 
##rb 
##ated 
alpha 
factor 
defect 
combined 
##c 
##1 
52 
##1 
impact 
##yt 
##oki 
gene 
##mor 
##phism 
outcome 
##rona 
##ry 
artery 
bypass 
g 
surgery 
[CLS] 
regardless 
muscle 
tension 
ma 
treatment 
aging 
24 
h 
h t 
##1 
##1 t 
##2 
##2 t 
##3 
lower 
shear 
hot 
bone 
##d 
t 
##4 
##4 t 
##5 
##5 [SEP] 
blood 
whole 
brain 
mercury 
concentration 
pu 
p 
0 
birth 
21 
we 
[CLS] 
sub 
##tract 
##ive 
differential 
screening 
clone 
##d 
12 
sequence 
2 
c 
##o 
##ro 
##x 
24 
[SEP] 
s 
##ti 
value 
34 
34 
##esta 
difference 
l 
s 
lb 
34 
##b 
stimulate 
basal 
alpha 
i 
co 
##lla 
promoter 
93 
fold 
##ath 
##ione 
red 
##uc 
##ob 
##eri 
an 
##aba 
##cc 
71 
[PAD] [CLS] 
additional 
interaction 
spatial 
stimulus 
duration 
effect 
adaptation 
property 
residual 
trace 
opposed 
per 
##sistence 
##sistence [SEP] 
[CLS] 
fraction 
##al 
ca 
retention 
measured 
72 
h 
##dos 
##b 
##r 
divided 
##b 
##r 
time 
0 
0 [SEP] 
method 
the 
acute 
co 
##rona 
##ry 
acute 
##oc 
##ard 
in 
##far 
##gin 
##ector 
patient 
##gin 
##ector 
75 
[CLS] 
further 
rub 
##body 
never 
detected 
woman 
ha 
##i 
negative 
la 
positive 
pregnancy 
pregnancy [SEP] 
disease 
free 
greater 
node 
##1 
00 
007 
##7 t 
presentation 
[CLS] 
5 
del 
##eti 
##on 
s 
##tat 
binding 
site 
abolished 
promoter 
reporter 
activity 
response 
p 
##rl 
[SEP] 
a 
treated 
department 
1960 
1991 
89 
1 
superficial 
t 
##1 
disease 
remaining 
9 
presented 
invasive 
disease 
plasma 
beta 
th 
##rom 
##bo 
##bul 
beta 
beta t 
##let 
##vas 
##cular 
plate 
##let 
de 
##gra 
[PAD] [CLS] 
j 
##oh 
w 
##ort 
[CLS] 
design 
setting 
and 
subject 
the 
analysis 
data 
collected 
first 
two 
round 
nationally 
representative 
g 
##hana 
survey 
held 
1987 
88 
g 
##ls 
i 
1988 
89 
##ls 
ii 
survey 
3000 
household 
household [SEP] 
[CLS] 
the 
d 
##na 
binding 
protein 
without 
effect 
transcription 
p 
##mi 
##d 
lacking 
binding 
site 
binding 
site 
located 
upstream 
[SEP] 
gas 
##tro 
##est 
##estinal 
tumor 
##its 
protocol 
##i 
71 
random 
##ized 
1975 
1980 
1980 following 
stage 
b 
##2 
re 
##ct 
##al 
four 
1 
therapy 
2 
ch 
##em 
##otherapy 
3 
radio 
##ther 
##ap 
4 
radio 
##ther 
##ap 
##em 
##otherapy 
combined 
##oda 
##lity 
[SEP] 
[CLS] 
the 
r 
##ti 
##40 
gene 
span 
35 
##base 
pair 
contains 
6 
ex 
##on 
least 
6 
id 
repetitive 
element 
[CLS] 
the 
d 
element 
element e 
##b 
3 
activate 
1 
promoter 
includes 
s 
##pi 
1 
s 
##pi 
b 
binding 
site 
previously 
characterized 
important 
e 
##b 
2 
response 
element 
[SEP] 
d 
1 
d 
2 
en 
maternal 
##ly 
trans 
##cript 
expressed 
early 
development 
development [SEP] 
[CLS] 
further 
##more 
del 
##eti 
##on 
two 
potential 
s 
ste 
##11 
recognition 
site 
f 
##us 
##1 
promoter 
region 
abolished 
transcription 
expression 
could 
restored 
inserted 
different 
s 
ste 
##11 
site 
mat 
##1 
p 
promoter 
[SEP] 
however 
analogous 
##yla 
derived 
yes 
also 
inhibitor 
[CLS] 
the 
oral 
movement 
occur 
ha 
##l 
treated 
rat 
slower 
normal 
finally 
animal 
mutation 
convert 
bi 
##function 
##al 
protein 
u 
##1 
specific 
protein 
viable 
[CLS] 
these 
sequence 
difference 
reflected 
difference 
gene 
expression 
three 
cell 
line 
[SEP] 
[CLS] 
pathway 
reported 
media 
##di 
##mer 
regulator 
bad 
[CLS] 
##uta 
base 
142 
151 
a 
##bol 
formation 
complex 
##ii 
partially 
in 
##hibit 
complex 
i 
iv 
protein 
forming 
complex 
bind 
neighboring 
segment 
d 
##na 
[SEP] 
d 
##fa 
slide 
prepared 
thin 
##p 
d 
##fa 
sample 
end 
s 
m 
##be 
##mi 
tolerate 
alternative 
##de 
##press 
long 
term 
efficacy 
method 
auto 
##cap 
device 
pace 
##sett 
##r 
re 
##r 
pace 
##sett 
so 
soln 
s 
##tero 
##uti 
epic 
##ard 
pacing 
##dt 
e 
epi 
103 
##6 
##dt 
m 
mn 
imp 
child 
child [SEP] 
##rmon 
##al 
replacement 
therapy 
personal 
history 
breast 
cancer 
cancer [SEP] 
recently 
also 
directly 
associate 
##3 
##l 
##oz 
##n 
transcription 
##al 
re 
##press 
involved 
path 
##ogen 
ho 
##d 
##g 
##kin 
##ymph 
##oma 
[CLS] 
using 
reporter 
gene 
construct 
driven 
c 
##d 
##4 
promoter 
report 
h 
6 
efficiently 
trans 
##act 
##ivate 
genetic 
element 
[SEP] 
characterization 
##a 
encoding 
predict 
##s 
structural 
three 
##uc 
motif 
several 
domain 
domain exhibiting 
limited 
ho 
##mology 
##os 
[CLS] 
pre 
##formed 
s 
##b 
1 
##p 
d 
complex 
bound 
##b 
contained 
terminal 
portion 
c 
##b 
##p 
[SEP] 
[CLS] 
##ido 
##st 
##ig 
##at 
two 
dos 
anti 
##do 
combination 
t 
##m 
b 
consisting 
0 
05 
mg 
kg 
at 
##rop 
2 
24 
mg 
kg 
t 
4 
0 
4 
mg 
kg 
ben 
##act 
##zine 
following 
three 
separate 
exposure 
exposure 10 
l 
##d 
##50 
so 
##man 
ta 
##1 
protein 
p 
##lated 
exclusively 
se 
identified 
se 
##r 
##12 
substrate 
mit 
1 
rapid 
gas 
##roma 
##to 
analysis 
8 
met 
##ho 
human 
plasma 
if 
c 
##ys 
liver 
les 
exclude 
refuse 
##em 
##otherapy 
##ben 
##zo 
[CLS] 
co 
##tra 
##ns 
##fected 
hi 
l 
##tr 
cat 
c 
##v 
1 
cell 
p 
##d 
##41 
##d 
##41 
clone 
trans 
activated 
l 
##tr 
[SEP] 
[CLS] 
induction 
composite 
##k 
tag 
s 
##k 
tag 
trans 
##dra 
##te 
rich 
diet 
liver 
similar 
end 
##ogen 
l 
##k 
gene 
patient 
patient advanced 
##ian 
##cin 
ii 
##i 
i 
iv 
random 
##ized 
##em 
do 
##x 
##or 
##ubi 
##p 
##xa 
##ap 
exit 
mit 
##osis 
d 
##ros 
##op 
s 
##ial 
em 
##b 
requires 
pro 
##te 
##oly 
c 
##y 
##c 
##lin 
degradation 
associated 
localized 
de 
##lation 
[CLS] 
cough 
c 
##p 
##r 
deep 
rhythmic 
force 
##ful 
cough 
repeated 
30 
60 
time 
minute 
effective 
re 
##sus 
technique 
emergency 
[CLS] 
to 
dramatic 
effect 
examined 
local 
##r 
protein 
##35 
shifted 
c 
##op 
##las 
sky 
##1 
##del 
##ta 
yeast 
although 
phenomenon 
obvious 
as 
nuclear 
import 
##r 
protein 
may 
differential 
##ly 
regulated 
[SEP] 
##biotic 
##biotics 
reducing 
salmon 
##ella 
[CLS] 
on 
contrary 
administration 
ca 
##ton 
in 
##tra 
##lor 
##ic 
pressure 
via 
v 
##aga 
##l 
nerve 
at 
##rop 
gal 
##lam 
animal 
presence 
fatty 
medium 
transcription 
##19 
directly 
regulated 
##p 
##1 
##p 
##r 
##1 
[CLS] 
gas 
exchange 
measured 
breath 
breath 
we 
premature 
##las 
##min 
thus 
defense 
in 
##tra 
##ve 
##olar 
fi 
##bri 
##n 
deposition 
trauma 
reduced 
reduced [SEP] 
[CLS] 
analysis 
n 
##t 
sequence 
carried 
three 
15 
region 
present 
mouse 
genome 
study 
reaction 
##och 
##rome 
c 
co 
##rt 
##ico 
##ster 
##oid 
[CLS] 
however 
##ar 
r 
##x 
##r 
specific 
l 
##igan 
##d 
increase 
ca 
##ski 
number 
20 
[SEP] 
[CLS] 
also 
patient 
my 
##d 
decrease 
art 
##erial 
p 
##o 
##o2 
seated 
posture 
su 
##pine 
posture 
without 
change 
##erial 
the 
primary 
structure 
human 
##b 
cell 
##r 
##b 
##1 
f 
##olate 
receptor 
human 
##r 
##r 
protein 
cellular 
##olate 
de 
##duced 
c 
##a 
sequence 
general 
rare 
c 
##lea 
##vage 
mapping 
well 
limitation 
discussed 
discussed [SEP] 
investigate 
role 
##r 
transcription 
##al 
signaling 
wild 
human 
##r 
cat 
##alytic 
dominant 
##r 
pre 
b 
l 
70 
##z 
3 
[CLS] 
selective 
upper 
abdominal 
s 
##ym 
##tom 
increased 
basal 
acid 
output 
rat 
effect 
stimulate 
##d 
acid 
output 
serum 
gas 
##tri 
##n 
concentration 
gas 
##tric 
##uc 
##osa 
##l 
his 
##ti 
##dine 
de 
##car 
##box 
##yla 
##ylase 
activity 
[SEP] 
reason 
presented 
support 
contention 
increase 
part 
real 
patient 
##hal 
##oth 
in 
##tra 
##ven 
##ously 
procedure 
additional 
dos 
[CLS] 
in 
b 
up 
##take 
directly 
proportional 
##i 
67 
1 
activity 
number 
mit 
##ose 
tumor 
tissue 
[PAD] [CLS] 
heating 
effect 
force 
decline 
relaxation 
##uing 
contraction 
[CLS] 
binding 
transformed 
receptor 
complex 
di 
transcription 
##al 
enhance 
evidence 
two 
distinct 
he 
##tero 
##mer 
##ic 
d 
binding 
form 
[SEP] 
[CLS] 
interesting 
##dr 
able 
bind 
##s 
high 
fully 
activate 
transcription 
intact 
yeast 
cell 
presence 
re 
##tino 
##id 
receptor 
r 
##x 
##r 
[SEP] 
m 
anti 
##biotic 
infection 
[CLS] 
a 
fine 
structure 
radiation 
hybrid 
map 
region 
extends 
d 
d8 
##20 
di 
##stal 
d 
d8 
##9 
pro 
##ximal 
prepared 
followed 
construction 
single 
integrated 
##c 
b 
##ac 
con 
##ti 
##g 
interval 
protein 
contains 
s 
##ha 
amino 
acid 
signature 
motif 
second 
##b 
like 
repeat 
highly 
conserved 
number 
related 
thus 
defining 
class 
d 
binding 
[CLS] 
i 
##v 
shown 
re 
##nin 
secret 
stimulate 
end 
##oth 
discovered 
p 
strong 
v 
##as 
##oc 
##ons 
##tric 
s 
##ti 
##mulating 
effect 
re 
##nin 
secret 
here 
c 
##lon 
novel 
human 
gene 
predict 
k 
##el 
protein 
ho 
##mo 
##log 
##ous 
i 
gene 
previously 
k 
##el 
member 
[SEP] 
[CLS] 
the 
encoded 
260 
amino 
h 
##1 
i 
240 
##1 
##pt 
typical 
trip 
##art 
##ite 
organization 
animal 
##1 
c 
terminal 
domain 
flank 
##bula 
d 
binding 
domain 
[SEP] 
instead 
large 
difference 
s 
binding 
loss 
he 
##xa 
##mer 
##ization 
ability 
suggesting 
form 
in 
##tra 
##xa 
##mer 
s 
##rg 
##ism 
co 
##oper 
##ati 
binding 
site 
within 
he 
##xa 
##mer 
lead 
high 
observed 
##a 
seen 
found 
group 
degree 
##oper 
de 
##ior 
##io 
##ry 
[CLS] 
the 
p 
##k 
domain 
showed 
pair 
##wise 
##ro 
binding 
interaction 
pseudo 
##ase 
his 
##rs 
c 
term 
domain 
additionally 
##rs 
domain 
interact 
##ed 
term 
region 
[SEP] 
effect 
er 
##hr 
##os 
red 
3 
ben 
red 
105 
##roid 
##ec 
##tom 
development 
thy 
##roid 
tumor 
male 
w 
##ista 
##r 
rat 
bi 
##tro 
d 
[CLS] 
the 
am 
##yi 
specific 
3 
characterized 
absence 
i 
##r 
sequence 
presence 
put 
##ative 
a 
##ata 
##aa 
##lation 
signal 
[SEP] 
[CLS] 
to 
initiate 
analysis 
factor 
required 
##if 
2 
alpha 
expression 
selected 
cap 
pro 
##ximal 
element 
shown 
##ivo 
met 
##hyl 
##ation 
protection 
analysis 
potential 
regulatory 
factor 
[SEP] 
further 
n 
##f 
ya 
subunit 
restore 
re 
##versible 
pressure 
am 
##or 
solid 
##70 
##an 
photo 
[CLS] 
alternative 
role 
d 
motif 
act 
##iva 
early 
m 
##rna 
transcription 
in 
##iti 
##ator 
element 
late 
m 
##rna 
transcription 
explain 
gene 
regulated 
l 
##ytic 
growth 
provides 
cellular 
transcription 
development 
[SEP] 
[CLS] 
s 
##p 
##1 
binding 
site 
function 
distinct 
t 
##f 
beta 
element 
t 
##f 
beta 
mediated 
promoter 
expression 
##p 
##1 
per 
se 
media 
##te 
response 
[SEP] 
effect 
br 
##omo 
##cript 
##ram 
serum 
pro 
##ct 
##in 
level 
##yo 
##tro 
phase 
i 
study 
##oro 
14 
day 
circa 
##dian 
in 
##static 
the 
result 
study 
demonstrate 
release 
single 
repair 
tend 
area 
gliding 
ex 
##cursion 
tend 
##on 
reduced 
resistance 
motion 
repaired 
tend 
##on 
provide 
support 
partial 
##2 
pull 
in 
repair 
area 
##ey 
[CLS] 
heart 
rate 
oxygen 
consumption 
increased 
75 
4 
b 
##pm 
26 
3 
1 
1 4 
m 
##l 
o 
o2 
x 
min 
1 
su 
##pine 
resting 
respectively 
respectively [SEP] 
effect 
th 
##rom 
##box 
blockade 
##let 
react 
##ctor 
an 
##gin 
04 
##6 
600 
mg 
day 
p 
administered 
patient 
re 
##gin 
therapy 
therapy [SEP] 
pro 
##long 
pro 
##th 
##rom 
##bin 
time 
due 
de 
dependent 
co 
##agu 
##lation 
factor 
manifest 
fi 
##bri 
##no 
due 
presence 
##bri 
##no 
fi 
##bri 
##n 
##mon 
##omer 
##d 
##p 
complex 
[CLS] 
effect 
g 
##ly 
##co 
##gen 
liver 
in 
##test 
##inal 
micro 
##f 
##lora 
mouse 
[PAD] [CLS] 
a 
case 
report 
report [SEP] 
mutation 
k 
##3 
##rf 
major 
target 
##ro 
##fers 
strong 
synthetic 
defect 
on 
v 
##3 
value 
degree 
t 
##rem 
##or 
se 
##bor 
##r 
##hea 
illness 
illness [SEP] 
patient 
##a 
level 
0 
1 
ng 
m 
##l 
[CLS] 
in 
trans 
##act 
##ivation 
mediated 
et 
1 
##r 
enhance 
##r 
sequence 
specifically 
in 
##hibit 
##k 
##r 
trans 
trans 
[CLS] 
treatment 
ace 
inhibitor 
##oc 
##ard 
in 
##far 
##ction 
##ction [SEP] 
[CLS] 
con 
4 
##ime 
##ra 
isolated 
##z 
##3 
b 
##c 
##l 
##6 
b 
##t 
##b 
p 
##oz 
domain 
nearly 
efficient 
entire 
protein 
in 
transcription 
##al 
repression 
[SEP] 
[CLS] 
new 
my 
##oc 
##yte 
specific 
enhance 
##r 
binding 
factor 
recognizes 
conserved 
element 
associated 
multiple 
specific 
gene 
di 
##lo 
##fen 
##ac 
sodium 
blood 
concentration 
slow 
release 
metabolism 
[CLS] 
the 
l 
gene 
promoter 
sequence 
ho 
##mology 
##mology es 
##ichi 
co 
coli 
promoter 
sequence 
term 
##inator 
sequence 
capable 
forming 
stem 
loop 
structure 
[SEP] 
we 
synthetic 
imaging 
[CLS] 
either 
s 
##1 
p 
##b 
trans 
transactivated 
##ga 
promoter 
dose 
dependent 
##ly 
co 
transcription 
factor 
resulted 
add 
additive 
##ga 
promoter 
response 
[SEP] 
[CLS] 
##ga 
92 
64 
b 
##p 
comprising 
s 
##1 
e 
##r 
1 
site 
c 
##re 
motif 
conferred 
gas 
##tri 
##n 
thy 
##mi 
##dine 
promoter 
system 
therefore 
function 
true 
enhance 
##r 
element 
[SEP] 
[CLS] 
together 
regulation 
camp 
response 
element 
m 
##od 
m 
##rna 
protein 
level 
##b 
regulation 
##b 
beta 
compensation 
within 
##b 
##b at 
##f 
transcription 
factor 
##b 
delta 
##b 
alpha 
absent 
[SEP] 
[CLS] 
the 
data 
obtained 
cellular 
r 
cell 
demonstrated 
transcription 
initiated 
89 
##1 
base 
upstream 
translation 
start 
site 
p 
##lation 
site 
located 
550 
base 
downstream 
stop 
co 
##don 
[SEP] 
[CLS] 
finally 
recognition 
pivotal 
b 
##p 
reduction 
##all 
pressure 
related 
card 
##iovascular 
com 
##plication 
even 
among 
high 
person 
diabetes 
##lli 
re 
##nal 
ins 
[SEP] 
individual 
combined 
effect 
f 
##oni 
b 
##1 
present 
f 
mon 
culture 
material 
di 
##to 
##ci 
##cirp 
##rato 
[CLS] 
it 
h 
##y 
##hes 
occurs 
ant 
##agon 
##ism 
##ar 
alpha 
action 
##uke 
cell 
[CLS] 
13 
96 
##1 
96 
##9 
1993 
t 
could 
media 
transcription 
##al 
activation 
interaction 
ta 
##ta 
binding 
protein 
well 
upstream 
bound 
transcription 
factor 
[SEP] 
##rb 
s 
##3 
c 
binding 
region 
##ab 
##1 
ho 
##mology 
region 
adapt 
76 
inter 
##fer 
re 
##nal 
pro 
##te 
##ase 
[CLS] 
activation 
##ota 
promoter 
##ob 
containing 
gene 
gene e 
ev 
##x 
1 
[CLS] 
conclusion 
interpretation 
increased 
hip 
fracture 
woman 
75 
year 
type 
i 
diabetes 
type 
ii 
diabetes 
duration 
duration [SEP] 
[CLS] 
maternal 
behavior 
assessed 
observation 
##al 
technique 
rat 
p 
p8 
discovered 
strong 
activation 
##as 
acute 
phase 
##ati 
l 
##v 
compliance 
slope 
end 
di 
##ast 
##olic 
##ved 
v 
v [SEP] 
[CLS] 
ache 
level 
acute 
poisoning 
limited 
limited [SEP] 
##as 
##od 
heart 
[CLS] 
the 
co 
##lli 
##cular 
label 
found 
injection 
within 
m 
##st 
area 
exhibited 
distribution 
deep 
s 
##c 
subdivision 
whereas 
spared 
superficial 
layer 
deep 
so 
[SEP] 
[CLS] 
alone 
introduced 
delta 
lung 
moderately 
increased 
suggesting 
fur 
##a 
could 
regulate 
gene 
involved 
path 
##ogen 
##esis 
the 
c 
##az 
##olin 
ii 
##i 
##ric 
different 
studied 
##aba 
content 
g 
##ad 
##aba 
t 
brain 
stem 
[CLS] 
sub 
##lone 
##s 
r 
##15 
reverted 
ka 
##ppa 
light 
chain 
contained 
g 
##eno 
##mic 
del 
##eti 
##on 
r 
##15 
##ns 
surrounding 
intro 
##n 
[CLS] 
the 
disorder 
accompanied 
re 
##versible 
electro 
##ence 
##pha 
change 
change [SEP] 
[CLS] 
the 
delayed 
activation 
pro 
##ynth 
promoter 
g 
##ran 
associated 
regulation 
upstream 
s 
factor 
2 
trans 
##ami 
missing 
re 
examine 
pro 
##tracted 
he 
##pa 
late 
##ncy 
29 
6 
among 
ins 
35 
among 
43 
he 
##tero 
##gene 
group 
various 
46 
4 
##building 
49 
4 
51 
51 7 
among 
history 
domestic 
as 
##bes 
people 
trade 
trade [SEP] 
[CLS] 
the 
strategy 
us 
r 
l 
##iga 
add 
d 
o 
##leo 
##tide 
p 
##rim 
##ing 
site 
r 
subsequent 
reverse 
transcription 
##r 
r 
l 
##iga 
reverse 
transcription 
##r 
r 
##l 
r 
##t 
##r 
[SEP] 
we 
analyzed 
effect 
tub 
##ulin 
m 
##rna 
##ido 
r 
##na 
gel 
b 
##lot 
hybrid 
probe 
[SEP] 
[CLS] 
more 
l 
##igan 
##d 
activated 
insulin 
i 
i 
receptor 
p 
##late 
##c 
protein 
##it 
##ro 
indicating 
s 
##c 
protein 
could 
direct 
substrate 
insulin 
i 
##f 
i 
receptor 
[SEP] 
[CLS] 
ch 
##ime 
##ra 
trans 
il 
4 
signal 
binding 
dramatically 
enhanced 
type 
type 2 
response 
il 
##it 
##ro 
t 
##c 
##r 
stimulation 
##ivo 
anti 
challenge 
[CLS] 
a 
distinct 
5 
sequence 
clone 
alternative 
upstream 
transcription 
initiation 
site 
[SEP] 
two 
human 
beta 
1 
6 
##cos 
##ran 
##s 
##fer 
core 
2 
##can 
branch 
##gn 
##t 
i 
i anti 
##gn 
ho 
##mo 
##log 
three 
region 
region cat 
##alytic 
domain 
c 
gene 
reside 
lo 
chromosome 
9 
band 
q 
##21 
bi 
##zen 
m 
f 
mat 
##te 
##i 
m 
g 
f 
##uku 
##da 
gene 
de 
dev 
46 
##8 
47 
1993 
[CLS] 
higher 
level 
vitamin 
cat 
##ala 
##se 
##get 
##arian 
c 
63 
6 
86 
mum 
##ol 
l 
149 
131 
m 
##l 
male 
female 
respectively 
compared 
##get 
##arians 
c 
41 
3 
3 54 
mum 
##ol 
##ol l 
119 
108 
m 
[CLS] 
cutting 
in 
##tra 
##bit 
##al 
nerve 
re 
##tri 
##eval 
imp 
##air 
##ment 
in 
##dis 
in 
lid 
##oc 
##aine 
injection 
[CLS] 
developmental 
regulation 
expression 
ma 
##late 
s 
##ynth 
##ase 
gene 
trans 
plant 
[SEP] 
in 
level 
##53 
activation 
m 
##d 
##m 
protein 
p 
##53 
observed 
##ms 
##1 
cell 
exposure 
[CLS] 
day 
1 
350 
r 
##i 
showed 
fall 
body 
weight 
respect 
s 
##l 
a 
maintained 
[CLS] 
transcription 
##al 
activation 
pro 
##op 
##io 
##mel 
##cor 
##tin 
gene 
am 
##p 
element 
binding 
[CLS] 
the 
n 
##f 
##1 
member 
interact 
##ed 
overlapping 
sequence 
l 
ii 
element 
wherein 
5 
half 
site 
critical 
n 
##1 
binding 
3 
site 
important 
##4 
binding 
[SEP] 
rap 
shown 
useful 
vaccine 
target 
site 
rip 
inhibitor 
therapeutic 
au 
infection 
insulin 
di 
##abe 
##tic 
level 
h 
##ba 
##1 
[CLS] 
the 
la 
##of 
gene 
promoter 
active 
human 
end 
##um 
car 
##cin 
95 
cell 
rat 
##6 
cell 
[CLS] 
the 
1 
year 
2 
year 
survival 
rate 
rate patient 
n 
##0 
3 
exceeded 
n 
##4 
patient 
patient [SEP] 
[CLS] 
measurement 
spectral 
sensitivity 
sensitivity er 
thus 
help 
diagnosis 
three 
hereditary 
disease 
disease [SEP] 
##r 
##1 
distortion 
d 
##po 
monitored 
systematically 
three 
group 
group 
unique 
incorporated 
repeated 
exposure 
tone 
[CLS] 
lung 
vent 
##ilated 
##2 
##o 
o 
fi 
##o 
0 
3 
end 
tidal 
co 
##2 
present 
an 
##est 
##b 
##f 
##xe 
ten 
counter 
five 
cerebral 
hemisphere 
hemisphere [SEP] 
[CLS] 
this 
change 
all 
##er 
##gy 
b 
##c 
##g 
##g [SEP] 
[CLS] 
analysis 
1 
m 
##b 
published 
sequence 
region 
conserved 
##yn 
##ten 
human 
chromosome 
##31 
q 
##33 
identified 
45 
gene 
candidate 
including 
35 
expressed 
gene 
human 
il 
##yt 
##oki 
gene 
cluster 
[CLS] 
there 
indication 
experiment 
link 
##er 
his 
##tone 
bind 
fundamental 
differently 
5 
s 
bulk 
##some 
##s 
[CLS] 
km 
value 
##l 
glucose 
ranged 
0 
5 
2 
5 
mm 
order 
magnitude 
higher 
normal 
##l 
[CLS] 
c 
##yt 
##och 
##rome 
b 
##d 
bio 
##sy 
es 
##cher 
##ichi 
co 
coli 
sequence 
##c 
##d 
gene 
suggest 
en 
component 
##b 
##c 
membrane 
transport 
##er 
[SEP] 
##k 
##k 
kinase 
98 
##0 
##9 
kinase 
def 
map 
##ks 
activated 
basal 
##r 
##h 
##r 
l 
activity 
[CLS] 
the 
influence 
gas 
composition 
air 
cell 
p 
liver 
metabolism 
em 
##b 
##ryo 
chick 
[SEP] 
historically 
first 
ability 
bind 
im 
##mu 
##nos 
##pressive 
agent 
##c 
##los 
##por 
c 
##idy 
pro 
trans 
is 
##omer 
##e 
cat 
##aly 
folding 
o 
##pt 
pro 
p 
##ro 
may 
folding 
[CLS] 
thus 
o 
##r 
mutant 
locked 
##43 
expression 
whereas 
mutant 
locked 
##43 
expression 
[CLS] 
a 
rare 
t 
##rna 
cc 
regulate 
t 
##1 
element 
rib 
##oso 
##mal 
frames 
##fting 
essential 
t 
##1 
re 
##tro 
##ns 
##position 
sa 
##har 
##ces 
c 
##ere 
##vis 
several 
35 
mm 
slide 
d 
##tro 
section 
my 
##of 
##iber 
section 
##al 
area 
technique 
setting 
image 
capture 
system 
##cho 
##ydro 
trans 
##location 
new 
selective 
##ech 
##ol 
##fer 
disease 
further 
furthermore 
learning 
learning theory 
depression 
described 
described [SEP] 
laser 
ex 
fi 
##bri 
##no 
##al 
c 
##lot 
##ting 
bursting 
we 
##ast 
##omo 
result 
##rok 
##inas 
##bri 
##no 
cross 
linking 
intensity 
variation 
t 
##r 
removed 
data 
correlation 
lateral 
##ized 
stimulus 
stimulus [SEP] 
[CLS] 
routine 
imaging 
total 
79 
meta 
##sta 
##sis 
##sis [SEP] 
anal 
##ges 
##or 
##phine 
hem 
##or 
##r 
##hage 
##eu 
##ers 
sire 
##c 
shock 
29 
300 
1986 
s 
##tat 
related 
factor 
##9 
##3 
##43 
extract 
appears 
absent 
b 
##ov 
fi 
##bro 
##blast 
if 
gamma 
tumor 
ne 
alpha 
cell 
[CLS] 
p 
##9 
##3 
appears 
##ally 
related 
##9 
##1 
p 
e 
m 
##1 
ne 
kinase 
undergo 
different 
mit 
##otic 
response 
e 
eg 
##f 
[CLS] 
in 
in addition 
addition f 
##c 
e 
##ps 
##ilon 
r 
##1 
linking 
activate 
##i 
3 
kinase 
kinase [SEP] 
when 
single 
point 
mutation 
introduced 
g 
##c 
box 
e 
##b 
##t 
box 
##9 
3 
fold 
cat 
activity 
observed 
c 
##8 
cell 
[CLS] 
association 
kinase 
translation 
##al 
act 
##iva 
##4 
gene 
sa 
##har 
c 
##ere 
##erevis 
[SEP] 
[CLS] 
treatment 
affect 
mediated 
immediate 
event 
t 
p 
##ak 
##1 
##ak 
##3 
insulin 
receptor 
substrate 
i 
##rs 
1 
i 
##rs 
2 
p 
d 
binding 
s 
##tat 
##6 
[CLS] 
thus 
s 
##t 
##k 
##1 
likely 
human 
ho 
##mo 
##logue 
m 
mo 
##15 
[SEP] 
background 
sequence 
alignment 
k 
##da 
belongs 
##aa 
class 
at 
[CLS] 
when 
##b 
1 
protein 
solely 
located 
c 
##op 
##las 
##m 
local 
##ize 
nucleus 
[SEP] 
consistent 
experiment 
compound 
cocaine 
potent 
group 
[CLS] 
the 
significance 
change 
relation 
control 
##hos 
##phorus 
balance 
##umi 
discussed 
[SEP] 
[CLS] 
trans 
##fect 
first 
600 
b 
##p 
upstream 
n 
##uc 
##leo 
##tide 
sequence 
indicated 
region 
75 
120 
necessary 
al 
##dh 
gene 
expression 
especially 
n 
##f 
##p 
##1 
binding 
site 
92 
96 
##aa 
##t 
box 
important 
expression 
gene 
[SEP] 
this 
distinct 
bio 
##chemical 
difference 
s 
s 
activated 
s 
##tat 
[CLS] 
the 
result 
show 
##in 
##fected 
3 
##t 
##3 
cell 
##varo 
##l 
cause 
50 
reduction 
growth 
rate 
high 
concentration 
29 
6 
##m 
ii 
accumulated 
c 
##op 
##m 
close 
nucleus 
nucleus [SEP] 
[CLS] 
blood 
co 
##agu 
factor 
x 
activated 
form 
factor 
x 
play 
essential 
role 
mid 
##lot 
##de 
##de [SEP] 
the 
ex 
##on 
sequence 
determined 
##eno 
##mic 
d 
se 
##quencing 
difference 
published 
rat 
g 
##lut 
##2 
##a 
[SEP] 
[CLS] 
in 
##tra 
##cular 
interaction 
believed 
result 
formation 
m 
##xa 
mon 
##omer 
whereas 
inter 
interaction 
may 
induce 
formation 
large 
m 
##xa 
o 
##go 
##mers 
##mers [SEP] 
[CLS] 
the 
gene 
en 
d 
##1 
protein 
photos 
##ys 
ii 
synthesized 
high 
rate 
light 
order 
replace 
photo 
##dam 
protein 
[SEP] 
the 
three 
slower 
mi 
s 
##b 
band 
observed 
response 
contain 
residue 
[CLS] 
the 
maximum 
reporter 
protein 
attained 
transformed 
prolonged 
1 
7 
total 
cellular 
protein 
[SEP] 
[CLS] 
specifically 
demonstrate 
25 
base 
pair 
region 
media 
##tes 
regulatory 
effect 
beta 
co 
##l 
##1 
##a 
promoter 
activity 
allows 
antagonist 
##ic 
alpha 
alpha t 
beta 
effect 
[SEP] 
[CLS] 
sin 
##4 
##10 
component 
specific 
r 
##na 
polymer 
##ase 
ii 
sub 
complex 
required 
##6 
t 
##1 
repression 
activity 
found 
required 
##1 
repression 
function 
function [SEP] 
[CLS] 
translation 
m 
##ok 
tightly 
regulated 
so 
##k 
r 
so 
##k 
r 
thus 
regulate 
##s 
ho 
hok 
translation 
indirectly 
m 
##ok 
[SEP] 
depending 
body 
position 
c 
##s 
##f 
pressure 
varied 
20 
##h 
##o 
erect 
15 
##h 
su 
##pine 
position 
[CLS] 
one 
hour 
##3 
##2 
personal 
measured 
sample 
##r 
developed 
laboratory 
short 
term 
pm 
pm2 
5 
co 
v 
##oc 
##s 
exposure 
measured 
currently 
monitor 
monitor [SEP] 
these 
t 
##r 
family 
member 
unlike 
others 
date 
identified 
within 
##eno 
##mic 
database 
[CLS] 
we 
h 
##y 
##pot 
##hes 
subject 
would 
p 
##kar 
hop 
stepping 
p 
##kar 
central 
##ly 
adaptation 
general 
##com 
##oto 
trajectory 
specific 
##com 
##otion 
used 
rotating 
disk 
disk [SEP] 
[CLS] 
in 
study 
transcription 
##al 
fusion 
constructed 
x 
##c 
##pp 
x 
##r 
gene 
la 
##cz 
reporter 
[SEP] 
[CLS] 
mechanism 
insulin 
receptor 
##3 
##t 
##3 
trans 
receptor 
one 
ch 
##ric 
receptor 
composed 
extra 
##cellular 
domain 
human 
e 
##g 
receptor 
c 
##oso 
domain 
human 
insulin 
beta 
subunit 
second 
kinase 
def 
insulin 
receptor 
path 
##ogen 
##etic 
proved 
##th 
##rom 
ii 
##i 
concentrate 
d 
##ag 
##gat 
##bro 
##nect 
##ras 
##yl 
##ol 
complex 
##oper 
[CLS] 
stimulation 
end 
##ost 
##eal 
bone 
formation 
rate 
mainly 
impaired 
d 
depleted 
resulting 
t 
##rab 
##ec 
##ular 
bone 
loss 
d 
mother 
rat 
associated 
decreased 
bone 
ash 
total 
bone 
calcium 
hem 
##ato 
pro 
1 
##k 
##1 
member 
mit 
##ogen 
map 
map4 
##k 
upstream 
upstream act 
##iva 
terminal 
terminal kinase 
signaling 
[CLS] 
we 
##ico 
##l 
##ty 
##lt 
##ran 
##s 
##fer 
##ase 
cat 
reporter 
gene 
system 
study 
effect 
t 
terminal 
repeat 
l 
##s 
large 
human 
end 
##ogen 
##tro 
like 
sequence 
r 
##l 
h 
[SEP] 
to 
investigate 
possibility 
split 
visual 
study 
manipulated 
stimulus 
set 
recognition 
task 
exposure 
duration 
duration [SEP] 
effect 
##rine 
stress 
e 
##pid 
an 
##est 
finally 
conservation 
residue 
sensitive 
mutation 
##9 
##4 
##9 
##9 
##53 
##11 
ho 
##mo 
##log 
residue 
domain 
play 
important 
role 
structural 
##chan 
##istic 
aspect 
common 
protein 
based 
requirement 
c 
##rem 
##r 
r 
##ad 
##b 
protein 
sperm 
##ato 
##genesis 
determined 
expression 
##d 
##c 
##c34 
##ad 
##r 
is 
##of 
##orms 
s 
##1 
subunit 
##l 
1 
##l 
2 
associated 
activity 
test 
##icular 
development 
[CLS] 
the 
en 
##igma 
aging 
bone 
loss 
loss [SEP] 
[CLS] 
transcription 
factor 
ii 
##ic 
t 
##fi 
##ii 
required 
assembly 
pre 
##tia 
complex 
r 
t 
r 
gene 
contains 
two 
se 
##able 
component 
t 
##fi 
##ii 
##1 
t 
tfi 
##2 
recognizing 
key 
component 
receptor 
pathway 
including 
e 
receptor 
p 
##d 
receptor 
beta 
##rs 
1 
[CLS] 
these 
two 
enhance 
##r 
element 
also 
enhanced 
transcription 
fused 
separately 
basal 
promoter 
region 
chicken 
v 
##iment 
##in 
gene 
[SEP] 
[CLS] 
when 
exposed 
intermittent 
schedule 
punishment 
fixed 
interval 
fi 
120 
fi 
300 
si 
##b 
1 
participant 
increased 
level 
similar 
observed 
base 
##line 
##line [SEP] 
deep 
bite 
c 
##l 
ii 
di 
div 
[PAD] [CLS] 
patient 
bin 
##ular 
patient 
balanced 
bin 
##ular 
##ulate 
loss 
without 
rap 
##d 
patient 
mon 
pupil 
age 
matched 
control 
control [SEP] 
protein 
se 
##quencing 
electro 
##4 
##47 
48 
member 
nuclear 
factor 
3 
##3 
transcription 
[CLS] 
p 
##4 
belongs 
subfamily 
##n 
##f 
##3 
beta 
##47 
48 
binding 
includes 
##f 
##3 
gamma 
in 
cross 
controlled 
male 
volunteer 
donated 
one 
unit 
red 
one 
unit 
whole 
blood 
manual 
3 
month 
apart 
[CLS] 
promoter 
activity 
trans 
trans 
l 
##uc 
##ifer 
##ase 
reporter 
containing 
nest 
##ed 
del 
##eti 
##on 
upstream 
sequence 
##pe 
cell 
##40 
well 
s 
28 
he 
[SEP] 
[CLS] 
this 
system 
exploit 
late 
transcription 
termination 
signal 
sufficiently 
weak 
allow 
many 
multi 
##gen 
##ome 
length 
primary 
trans 
##cript 
repeating 
intro 
##n 
ex 
##on 
p 
##oly 
site 
[SEP] 
plan 
##llar 
region 
according 
lit 
##tman 
method 
312 
##ec 
chronic 
125 
age 
re 
matched 
disk 
photograph 
[CLS] 
although 
eliminated 
del 
##p 
component 
downstream 
##p 
growth 
m 
##or 
abnormal 
cell 
##r 
##1 
##p 
rescued 
del 
known 
p 
##omo 
response 
pathway 
component 
southern 
hybrid 
##eno 
d 
w 
l 
l 
##b 
##ryo 
specific 
rear 
##rang 
##ement 
near 
##1 
lo 
##cus 
northern 
r 
##na 
b 
##lot 
r 
##t 
##r 
evaluation 
##1 
##1 
m 
w 
l 
l 
em 
##b 
in 
##dis 
[SEP] 
in 
in addition 
##17 
1 
combination 
mutation 
affecting 
mitochondrial 
caused 
defect 
##ive 
p 
##hen 
##otype 
[CLS] 
expression 
characterization 
g 
##eno 
##mic 
##ak 
##1 
kinase 
gene 
[SEP] 
[CLS] 
significantly 
p 
gene 
several 
feature 
found 
human 
gene 
[CLS] 
fluorescent 
sit 
hybrid 
fish 
analysis 
region 
involved 
##k 
##b 
rear 
##rang 
##ement 
originated 
##q 
##34 
thus 
implying 
occurrence 
7 
10 
q 
##34 
q 
##24 
re 
##p 
##ro 
##cal 
ch 
##rom 
##oso 
##mal 
trans 
##location 
[SEP] 
[CLS] 
trans 
expression 
sub 
##lone 
##i 
g 
localized 
trans 
active 
factor 
3 
0 
k 
##ilo 
##base 
##ba 
##i 
fragment 
[SEP] 
mg 
##f 
member 
##oki 
regulated 
transcription 
factor 
##h 
domain 
##rs 
protein 
function 
dominant 
in 
##hibit 
insulin 
signaling 
[CLS] 
a 
29 
425 
k 
##b 
segment 
arm 
yeast 
contains 
twice 
many 
unknown 
known 
open 
reading 
frame 
[CLS] 
##rra 
##nged 
ka 
##ppa 
gene 
transcription 
##ally 
silent 
structural 
feature 
ka 
##ppa 
lo 
##cus 
contribute 
transcription 
##al 
efficiency 
rear 
##ranged 
ka 
gene 
[SEP] 
[CLS] 
the 
first 
270 
b 
##p 
promoter 
region 
sequence 
##d 
contain 
cat 
##aa 
box 
rather 
ta 
tata 
##a 
box 
several 
d 
motif 
found 
activation 
gene 
[SEP] 
[CLS] 
c 
g 
##bra 
cell 
containing 
##b 
##f 
##1 
gene 
influence 
shut 
promoter 
te 
##cho 
arrested 
growth 
5 
h 
cultivation 
drug 
do 
##cline 
[CLS] 
##1 
utilizes 
ma 
##xi 
k 
ho 
##mology 
##mology ma 
##xi 
##h 
domain 
recognition 
stranded 
b 
##ps 
requires 
cooperative 
interaction 
##licing 
factor 
##65 
bound 
adjacent 
##id 
tract 
pp 
high 
binding 
[CLS] 
an 
x 
linked 
zinc 
gene 
mapping 
x 
##q 
##21 
1 
q 
##21 
3 
closely 
related 
##x 
z 
##fy 
possible 
origin 
common 
ancestral 
gene 
[SEP] 
validity 
form 
q 
##if 
correlation 
motor 
using 
analysis 
variance 
motor 
level 
motor 
grouping 
grouping [SEP] 
[PAD] [CLS] 
juvenile 
an 
##gio 
##bro 
##mas 
comment 
critical 
behavior 
binary 
mixture 
protein 
the 
pine 
##al 
hormone 
me 
##oni 
##n 
m 
##lt 
able 
on 
##cos 
##tat 
action 
amount 
##12 
##0 
specific 
##pas 
gap 
associated 
##0 
additional 
trans 
##ec 
##n 
eliminated 
remaining 
si 
##g 
##mo 
##idal 
correlation 
map 
r 
##s 
##na 
increase 
resting 
map 
r 
##s 
##na 
[PAD] [CLS] 
pregnancy 
ensued 
4 
case 
group 
i 
i [SEP] 
[CLS] 
the 
1 
3 
k 
##b 
d 
placed 
upstream 
ch 
##lora 
##l 
ace 
##ty 
##lt 
##ran 
##s 
##fer 
##ase 
gene 
shown 
functional 
active 
[CLS] 
controversy 
regarding 
natural 
life 
cycle 
parasite 
well 
s 
##pec 
##ie 
identity 
op 
sa 
##rc 
##oc 
##ys 
##tis 
[SEP] 
the 
mean 
66 
mm 
laser 
group 
63 
mm 
control 
group 
p 
##os 
##in 
high 
blood 
pressure 
[CLS] 
5 
##3 
antagonist 
on 
##dan 
##set 
##ron 
reduced 
alcohol 
intake 
medium 
high 
alcohol 
rat 
dos 
0 
01 
0 
0 16 
mg 
kg 
[CLS] 
oral 
h 
##gly 
##ce 
[CLS] 
1 
1 [SEP] 
[CLS] 
in 
system 
enhance 
##r 
act 
primarily 
increase 
rapid 
efficient 
transcription 
complex 
formation 
initiation 
[SEP] 
relationship 
donor 
b 
##tra 
##ns 
he 
6 
5 
surgery 
[CLS] 
by 
se 
##quencing 
ex 
##on 
##uc 
##lea 
ii 
##i 
del 
##eti 
##on 
clone 
open 
reading 
frame 
405 
n 
##leo 
##tide 
found 
coding 
protein 
135 
amino 
molecular 
15 
k 
##da 
[SEP] 
[CLS] 
the 
##i 
gene 
over 
##ex 
es 
##cher 
##ichi 
co 
##li 
treatment 
##tero 
rejection 
##t 
##3 
[CLS] 
the 
level 
transcription 
act 
##iva 
##tor 
greater 
level 
individual 
factor 
phenomenon 
transcription 
##al 
s 
##yne 
##rgy 
[SEP] 
conservation 
zinc 
finger 
motif 
yeast 
human 
implies 
functional 
importance 
[CLS] 
this 
nuclear 
organ 
##ella 
##r 
gene 
transfer 
event 
striking 
similar 
experimental 
accessible 
nuclear 
integration 
introduced 
##log 
##ous 
d 
##na 
[SEP] 
[CLS] 
result 
data 
set 
single 
sample 
model 
confirmed 
give 
excellent 
est 
##imation 
mg 
m 
##l 
x 
min 
0 
93 
x 
c 
##3 
##h 
0 
0 47 
m 
##pe 
##pe 4 
4 4 
r 
##ms 
##mse 
##e 8 
9 
9 [SEP] 
s 
##3 
##a 
competes 
##3 
domain 
##rb 
binding 
##1 
inter 
##sect 
##in 
m 
##1 
complex 
comparison 
r 
therapeutic 
tech 
ii 
division 
i 
mm 
##alo 
##cc 
##lusion 
[PAD] [CLS] 
this 
shift 
c 
##1 
c 
##2 
effect 
co 
##lla 
pronounced 
ma 
##ximal 
##1 
##2 
134 
##p 
ma 
##ximal 
##1 
##2 
79 
[SEP] 
[CLS] 
we 
exercise 
s 
##t 
segment 
elevation 
history 
##oc 
##ard 
in 
##far 
##ric 
an 
##eur 
##ys 
caused 
co 
##rona 
##ry 
spa 
##sm 
major 
co 
##rona 
##ry 
vessel 
vessel [SEP] 
[CLS] 
x 
##r 
##3 
transcription 
##ally 
activated 
w 
signaling 
gas 
##tr 
##ulation 
x 
##eno 
em 
##b 
##ryo 
[SEP] 
for 
for economical 
could 
send 
question 
##naire 
35 
77 
##9 
individual 
based 
investigation 
s 
4 
000 
men 
s 
##tra 
##ti 
##fied 
high 
risk 
low 
risk 
group 
group [SEP] 
several 
wave 
##mat 
##ose 
n 
##20 
n 
30 
##20 
##0 
brains 
e 
ii 
iii 
##i i 
demonstrated 
shorter 
0 
05 
late 
##ncy 
growth 
re 
##tar 
##ded 
f 
##etus 
normal 
sized 
f 
##etus 
##etus [SEP] 
effect 
ch 
##olin 
ma 
##ris 
pro 
[CLS] 
sequence 
two 
known 
tail 
gene 
r 
s 
temperate 
b 
bact 
##op 
p 
p2 
sequence 
additional 
open 
reading 
frame 
or 
##f 
30 
located 
s 
determined 
[SEP] 
[CLS] 
the 
high 
at 
##rial 
se 
##pta 
##ptal 
defect 
te 
##tral 
fall 
##ot 
cited 
possible 
analogy 
right 
##ric 
##ular 
pressure 
high 
right 
compliance 
low 
birth 
birth [SEP] 
[CLS] 
the 
stress 
1 
resulted 
mild 
respiratory 
infection 
calf 
difference 
observed 
treatment 
group 
[CLS] 
solution 
bolt 
##zman 
equation 
random 
magnetic 
##h 
signal 
interacting 
receptor 
[CLS] 
##link 
experiment 
element 
b 
revealed 
specific 
binding 
two 
protein 
approximately 
43 
80 
k 
##da 
[CLS] 
result 
at 
short 
dwell 
time 
##re 
##cted 
whole 
d 
u 
higher 
corrected 
plasma 
value 
5 
7 
5 
9 
9 [SEP] 
[CLS] 
the 
recovery 
x 
##nin 
75 
9 
averaged 
41 
coefficient 
variation 
25 
the 
extraordinary 
high 
substrate 
specific 
##pu 
together 
enzyme 
good 
candidate 
star 
##ch 
[SEP] 
relationship 
##mu 
##munological 
change 
disease 
stage 
3 
##h 
##mi 
##dine 
incorporation 
9 
stage 
disease 
ex 
##ace 
##rb 
##ation 
208 
8 
stage 
re 
##mission 
complement 
t 
reached 
46 
64 
5 
28 
0 
unit 
m 
##l 
##l [SEP] 
do 
s 
##d 
##d page 
band 
22 
k 
##da 
[CLS] 
consistent 
effect 
transcription 
p 
##21 
localized 
nucleus 
trans 
cell 
[CLS] 
analysis 
pseudo 
gene 
segment 
re 
##comb 
##ination 
product 
reveals 
bias 
d 
gene 
segment 
reading 
frame 
u 
##til 
##ization 
[SEP] 
[CLS] 
plasma 
pro 
##ct 
##in 
##bation 
25 
8 
2 
3 
ng 
m 
##l 
decreased 
base 
level 
10 
8 
1 
9 
ng 
m 
within 
24 
h 
##r 
nest 
##box 
removal 
removal [SEP] 
30 
week 
am 
##if 
##ost 
therapy 
m 
##d 
switched 
##m 
##l 
like 
appearance 
##if 
##ost 
1 
month 
month exclude 
exclude possible 
side 
effect 
##if 
##ost 
##ine 
[CLS] 
heart 
disease 
disease [SEP] 
[CLS] 
a 
new 
b 
cell 
specific 
enhance 
##r 
element 
identified 
3 
3 e 
##4 
o 
##ame 
##rl 
##ike 
motif 
enhance 
##r 
conclusion 
experience 
middle 
term 
efficiency 
g 
##ks 
treat 
m 
[CLS] 
case 
poisoning 
##con 
##vat 
origin 
described 
genetic 
mutation 
loss 
t 
receptor 
function 
shown 
l 
##ymph 
breast 
color 
##ec 
##ectal 
##p 
##1 
##o 
est 
##er 
designed 
combined 
o 
##cular 
delivery 
de 
##xa 
##has 
sodium 
phosphate 
5 
release 
[CLS] 
we 
describe 
cell 
##in 
beta 
subunit 
##a 
k 
##b 
containing 
96 
base 
5 
##tra 
##ns 
##lated 
sequence 
sequence 64 
##5 
base 
open 
reading 
frame 
1832 
base 
3 
##tra 
##lated 
sequence 
two 
consensus 
signal 
sequence 
two 
stretch 
[CLS] 
[CLS] br 
##ome 
polymer 
##ase 
like 
2 
##a 
directed 
end 
##op 
re 
he 
##lica 
like 
1 
##a 
[CLS] 
diagnostic 
importance 
determining 
##uc 
amino 
##fer 
##cre 
##ati 
[CLS] 
therapeutic 
i 
##od 
125 
##yper 
##roid 
special 
radio 
##bio 
effect 
f 
##oll 
##icular 
cell 
cell [SEP] 
maintenance 
meta 
##bol 
energy 
energy me 
31 
0 
k 
##cal 
kg 
[PAD] [CLS] 
this 
finding 
importance 
complete 
completes 
##s explanation 
central 
near 
location 
error 
partial 
report 
bar 
probe 
task 
task [SEP] 
d 
binding 
identified 
bind 
two 
target 
like 
sequence 
5 
flank 
site 
break 
##point 
chromosome 
chromosome 8 
patient 
t 
l 
##ymph 
##uke 
14 
q 
##24 
q 
##11 
rear 
##rang 
##ement 
ii 
chromosome 
1 
three 
five 
1 
14 
p 
q 
##11 
rear 
##rang 
##ement 
[CLS] 
ne 
##do 
##rom 
##il 
shifted 
early 
all 
##ergic 
reaction 
ear 
mean 
34 
8 
6 
9 
in 
##hibit 
##ed 
later 
reaction 
30 
0 
0 4 
the 
##r 
##1 
protein 
contains 
k 
motif 
found 
r 
binding 
r 
##r 
##1 
bind 
specifically 
##r 
##2 
r 
[SEP] 
[CLS] 
result 
obtained 
t 
##rit 
##ium 
test 
direct 
chemical 
analysis 
compared 
[SEP] 
[CLS] 
we 
an 
##est 
paralyzed 
e 
##p 
dependent 
delta 
c 
pattern 
transition 
ending 
contrast 
level 
level [SEP] 
experiment 
clinical 
bio 
##chemical 
his 
##to 
12 
day 
period 
z 
##osa 
given 
[CLS] 
direct 
sat 
##uration 
analysis 
analysis [SEP] 
[CLS] 
from 
as 
##ym 
previously 
##4 
interact 
##valent 
possibly 
overlapping 
half 
site 
at 
at 
different 
affinity 
further 
al 
##dos 
##tero 
##ne 
s 
##ti 
sodium 
diet 
child 
severe 
prolonged 
vomit 
child 
synthetic 
act 
child 
studied 
modified 
method 
method [SEP] 
[PAD] [CLS] 
a 
case 
control 
study 
1 
2 
182 
pair 
he 
##pa 
a 
##p 
##ril 
1988 
1988 [SEP] 
[CLS] 
the 
mutant 
strain 
carry 
three 
tandem 
copy 
18 
b 
##p 
sequence 
du 
##plicate 
##d 
##di 
##6 
##6 
mutation 
[SEP] 
although 
c 
##a 
encoding 
human 
form 
##yl 
binding 
##ou 
##lay 
ta 
m 
br 
##cho 
v 
##ais 
p 
3 
##t 
##3 
##bro 
high 
##r 
bearing 
del 
##eti 
##on 
region 
rich 
acidic 
amino 
acid 
acidic 
region 
il 
##r 
beta 
chain 
induce 
t 
p 
map 
kinase 
well 
expression 
three 
[SEP] 
molecule 
il 
inhibitor 
suppress 
##k 
##r 
47 
##3 
##r 
308 
site 
[CLS] 
the 
car 
##cin 
contains 
hybrid 
gene 
delta 
gag 
m 
##ht 
con 
##ti 
##guous 
open 
reading 
frame 
26 
##8 
base 
pair 
well 
my 
##c 
a 
help 
##er 
related 
sequence 
delta 
gag 
partial 
re 
##al 
core 
protein 
gene 
v 
m 
##ht 
cell 
drive 
##d 
sequence 
[SEP] 
the 
result 
##tre 
##ated 
patient 
demonstrate 
primary 
bulk 
reduction 
initial 
##aro 
##tom 
##y 
[CLS] 
of 
38 
##41 
serum 
sample 
received 
##ness 
##ee 
state 
diagnostic 
laboratory 
1991 
1992 
113 
##0 
positive 
positive to 
##x 
##op 
anti 
##body 
[SEP] 
[CLS] 
these 
excluded 
factor 
protein 
likely 
located 
along 
length 
na 
##scent 
trans 
##cript 
group 
patient 
9 
3 
9 
i 
##u 
l 
sex 
hormone 
binding 
##bul 
54 
9 
nm 
##ol 
concentration 
7 
1 
11 
##u 
##u l 
26 
0 
0 7 
0 
nm 
##ol 
respectively 
[CLS] 
we 
completed 
primary 
structure 
##bri 
##uc 
ex 
##on 
intro 
##n 
organization 
gene 
derived 
physical 
map 
genetic 
lo 
##cus 
b 
##c 
##l 
p 
##oz 
domain 
##oz 
domain 
interact 
co 
re 
##press 
##or 
n 
##r 
s 
##m 
##rt 
##oki 
##cam 
##1 
##oth 
##eli 
utilizes 
interaction 
##tero 
##di 
##mer 
##ic 
##rf 
1 
[CLS] 
m 
##f 
male 
receiving 
either 
5 
0 
mg 
kg 
c 
##d 
##p 
dose 
3 
0 
mg 
kg 
r 
##o 
dose 
explored 
object 
often 
mm 
male 
male abstract 
abstract t 
##runcated 
##runcated at 
250 
word 
[CLS] 
insight 
novel 
check 
characterized 
##vi 
lo 
##cus 
sequence 
similarity 
##hesion 
##go 
implicated 
process 
##elin 
question 
localized 
bi 
##uda 
##l 
c 
en 
protein 
containing 
k 
domain 
r 
binding 
motif 
##r 
##1 
##2 
encoding 
member 
ma 
maf 
##k 
##g 
[CLS] 
indigenous 
micro 
##bial 
flora 
large 
in 
##test 
##ine 
ta 
##d 
##pole 
copyright 
1998 
association 
behaviour 
behaviour [SEP] 
in 
tissue 
##tro 
##na 
thy 
##roid 
respectively 
##4 
diverse 
tissue 
including 
o 
ovary 
test 
ad 
##rena 
place 
##nta 
thy 
##mus 
spinal 
cord 
##roid 
whereas 
whereas l 
muscle 
##nta 
spinal 
brain 
substantially 
reduce 
case 
he 
##pa 
framework 
successful 
introduction 
future 
adolescent 
au 
##lia 
##lia [SEP] 
technique 
identification 
phase 
contained 
polymer 
blend 
paper 
radioactive 
hem 
##ody 
##nam 
ni 
##russ 
s 
##n 
##p 
##tro 
n 
nt 
deep 
en 
##f 
##rane 
control 
[CLS] 
their 
central 
projection 
##xon 
four 
t 
##em 
sub 
##i 
[SEP] 
the 
##k 
act 
##iva 
mixed 
lineage 
kinase 
3 
m 
##3 
transforms 
3 
##t 
##3 
cell 
fashion 
decision 
support 
system 
network 
core 
reaching 
diagnosis 
optimal 
reach 
diagnosis 
diagnosis [SEP] 
[CLS] 
in 
d 
replication 
substitution 
large 
prevent 
complex 
formation 
h 
##70 
##b 
protein 
[CLS] 
to 
explore 
effect 
persistent 
card 
##io 
##gal 
##y 
##iovascular 
newborn 
rat 
inhaled 
500 
pp 
##m 
co 
33 
day 
development 
continued 
ambient 
air 
[CLS] 
bandwidth 
audit 
unit 
##bra 
##in 
field 
l 
##v 
complex 
measured 
is 
##oint 
##ens 
tone 
stimulus 
[CLS] 
member 
s 
##id 
hormone 
regulate 
target 
gene 
transcription 
via 
recognition 
association 
specific 
c 
##i 
acting 
sequence 
d 
called 
hormone 
element 
h 
##res 
[SEP] 
[CLS] 
indeed 
de 
##x 
enhanced 
r 
##a 
dependent 
increase 
r 
##ar 
##bet 
##a 
m 
##rna 
manner 
[CLS] 
the 
highest 
concentration 
mineral 
found 
overhaul 
truck 
as 
##bes 
ins 
reached 
value 
5 
f 
cm 
##3 
total 
dust 
value 
value 80 
m 
##3 
em 
19 
day 
##ryo 
##ort 
blood 
[CLS] 
c 
##51 
##1 
96 
5 
identical 
human 
##51 
coding 
sequence 
interrupted 
intro 
##n 
six 
frame 
stop 
co 
##don 
resulting 
point 
mutation 
[CLS] 
we 
ache 
decrease 
individual 
sampled 
tank 
sa 
30 
temperature 
increase 
three 
##40 
differ 
ability 
bind 
##a 
effect 
##or 
##al 
##0 
subunit 
##i 
3 
n 
##r 
cell 
mutant 
transform 
3 
##3 
[CLS] 
mating 
response 
f 
corpus 
l 
size 
g 
##esta 
##estation 
length 
rate 
la 
##mb 
##ing 
rate 
la 
birth 
recorded 
recorded [SEP] 
membrane 
a 
difference 
distribution 
anti 
##body 
thy 
##rog 
##bul 
thy 
##roid 
per 
##ox 
##idas 
found 
subgroup 
2 
here 
t 
##r 
##d 
##48 
##d 
##28 
##im 
l 
s 
3 
##3 
[SEP] 
##3 
##gam 
skeletal 
tissue 
drove 
investigate 
differentiation 
in 
##ob 
showed 
increased 
##a 
expression 
differentiation 
induction 
[CLS] 
the 
rate 
ii 
##i 
ca 
##f 
therapy 
61 
5 
32 
52 
little 
higher 
two 
two [SEP] 
[CLS] 
these 
result 
induce 
put 
##ative 
ta 
##ta 
box 
in 
##iti 
##ator 
involved 
promoter 
activity 
##it 
##rone 
##ct 
##in 
promoter 
lack 
ta 
box 
in 
##iti 
##ator 
##c 
box 
interaction 
trap 
candidate 
protein 
bind 
##op 
region 
##r 
trans 
##rane 
##ase 
isolated 
##a 
encoding 
286 
##1 
amino 
protein 
termed 
trio 
contains 
three 
enzyme 
domain 
two 
functional 
functional g 
##ef 
domain 
protein 
se 
th 
##k 
domain 
[SEP] 
we 
isolated 
two 
##19 
e 
contain 
##f 
##4 
correspond 
incomplete 
copy 
unique 
2 
3 
k 
##b 
r 
##na 
combined 
##it 
##ro 
effect 
ethanol 
##ih 
##lone 
p 
##ob 
##ar 
##bit 
##al 
##zo 
di 
##sul 
##fi 
##ram 
brain 
micro 
##so 
beta 
##1 
in 
inte 
##teg 
stimulation 
cell 
bind 
##0 
##cas 
[CLS] 
earlier 
localized 
mutation 
affect 
processing 
transport 
her 
1 
region 
located 
gene 
specify 
b 
major 
d 
binding 
beta 
8 
[CLS] 
these 
result 
b 
##p 
##a 
en 
##codes 
functional 
f 
##elin 
l 
b 
k 
type 
expressed 
cell 
via 
g 
##ly 
##can 
link 
##age 
[SEP] 
t 
weight 
choice 
recognition 
##c 
##rosis 
##unate 
##unate [SEP] 
[CLS] 
analysis 
he 
##t 
mutation 
s 
##p 
strain 
71 
##20 
##lica 
secondary 
meta 
##bol 
##ite 
regulation 
he 
##tero 
##st 
spa 
##cing 
[SEP] 
[CLS] 
here 
component 
r 
map 
##k 
pathway 
con 
##it 
##utive 
l 
transformed 
im 
##mat 
thy 
##mo 
##s 
[SEP] 
p 
utilizes 
##rb 
adapt 
##or 
media 
activation 
p 
##21 
##a 
thy 
##mo 
##blast 
line 
promoting 
##c 
protein 
con 
##utive 
interaction 
##rb 
re 
##8 
##10 
##11 
gene 
gene fi 
yeast 
s 
##chi 
##zo 
##sa 
##cc 
##har 
specific 
##iot 
##ic 
re 
##comb 
##8 
required 
ch 
co 
##mo 
pairing 
[SEP] 
based 
result 
analysis 
predict 
b 
##uddin 
yeast 
a 
##rsen 
##ate 
resistance 
##r 
##3 
p 
cat 
##alytic 
similar 
##c 
[CLS] 
first 
in 
injection 
3 
75 
mg 
pro 
served 
injected 
con 
[CLS] 
we 
h 
##v 
achieve 
value 
co 
##2 
elimination 
close 
estimated 
metabolic 
co 
##2 
normal 
##int 
##uba 
subject 
short 
period 
time 
[SEP] 
[CLS] 
the 
p 
##ho 
##5 
gene 
activated 
##4 
##p 
transcription 
factor 
negatively 
regulated 
product 
p 
##ho 
##80 
[SEP] 
although 
authoritative 
way 
determine 
effect 
diet 
##h 
feeding 
protocol 
measuring 
##rina 
##ry 
[CLS] 
analysis 
d 
sequence 
upstream 
gene 
en 
##codes 
second 
ni 
##trate 
re 
sensor 
transmitter 
protein 
es 
##cher 
##ichi 
co 
##li 
revealed 
open 
reading 
frame 
##f 
whose 
product 
show 
high 
degree 
similarity 
number 
iron 
sulfur 
well 
beta 
subunit 
subunit g 
##ama 
##te 
s 
##ynth 
##ase 
##d 
co 
[SEP] 
##oth 
##eli 
##al 
pu 
##rine 
content 
[CLS] 
suggest 
response 
type 
i 
ii 
co 
##lla 
##gen 
caused 
cross 
reaction 
type 
ii 
##i 
co 
##lla 
##gen 
p 
##eptide 
##eptide [SEP] 
possibility 
l 
##im 
laboratory 
diagnosis 
r 
##abi 
##es 
the 
5 
half 
e 
gene 
fused 
3 
region 
gene 
encoding 
d 
binding 
domain 
transcription 
##al 
regulator 
including 
at 
##f 
##1 
1 
1 er 
human 
tumor 
p 
##d 
stimulate 
c 
##d 
##k 
me 
##sang 
##ial 
decreased 
level 
p 
##1 
inhibitor 
protein 
##po 
95 
the 
influence 
different 
temperature 
degree 
c 
degree 
c 
##agu 
##ro 
studied 
##lot 
time 
time 
[CLS] 
on 
r 
##c 
##l 
value 
23 
control 
region 
studied 
greatest 
difference 
posterior 
brain 
region 
association 
cortex 
primary 
cortex 
##iet 
##al 
cortex 
th 
##ala 
##mus 
##mus [SEP] 
[CLS] 
thus 
trans 
##gene 
expression 
directed 
human 
r 
##b 
promoter 
restricted 
subset 
tissue 
r 
##b 
normally 
em 
##b 
##ryo 
##genesis 
[SEP] 
[CLS] 
thus 
tax 
##1 
activate 
##s 
mediated 
transcription 
without 
mit 
signal 
interaction 
binding 
factor 
p 
##s 
##rf 
[SEP] 
[CLS] 
in 
experiment 
1 
subject 
required 
disc 
##rim 
male 
female 
face 
hem 
##is 
##pheric 
as 
##ym 
found 
found [SEP] 
[CLS] 
membrane 
de 
##pol 
critical 
element 
ne 
##uron 
signaling 
[SEP] 
[CLS] 
the 
transcription 
start 
site 
localized 
224 
b 
##p 
upstream 
at 
##g 
co 
##don 
r 
##nas 
##e 
protection 
prime 
##r 
extension 
mapping 
[SEP] 
[CLS] 
all 
co 
##gnate 
gene 
clone 
constructed 
using 
either 
p 
##r 
product 
am 
##plified 
g 
##eno 
##mic 
d 
gap 
repair 
[SEP] 
rising 
##tro 
one 
child 
i 
##g 
##m 
serum 
serum [SEP] 
effect 
##ob 
##ari 
electro 
##card 
##io 
##yper 
[CLS] 
although 
r 
##ad 
##17 
##ad 
##24 
##3 
required 
cell 
cycle 
arrest 
s 
phase 
in 
##hibit 
contribute 
yeast 
cell 
possibly 
required 
d 
damage 
[CLS] 
##a 
important 
intermediate 
degradation 
synthesis 
well 
function 
regulation 
inter 
##media 
##ry 
metabolism 
gene 
expression 
[CLS] 
##1 
la 
##cz 
study 
p 
##1 
spatial 
##ly 
localized 
pre 
##stal 
##k 
anterior 
like 
cell 
type 
type [SEP] 
[CLS] 
when 
translated 
frame 
##k 
z 
##eta 
stop 
co 
##don 
located 
28 
amino 
acid 
towards 
terminus 
diver 
##gence 
point 
inter 
##vening 
sequence 
lack 
expected 
in 
##iti 
##ating 
ps 
##i 
##k 
z 
##eta 
functional 
term 
protein 
synthesis 
##lot 
directed 
c 
terminus 
z 
reveal 
protein 
smaller 
synthetic 
ps 
r 
failed 
support 
protein 
synthesis 
translation 
system 
##ro 
[SEP] 
w 
##uster 
o 
o [SEP] 
electrical 
und 
competition 
convection 
[CLS] 
the 
sequence 
immediately 
upstream 
translation 
start 
site 
g 
c 
rich 
greater 
75 
contained 
consensus 
##aa 
##t 
sequence 
despite 
absence 
ta 
box 
[SEP] 
[CLS] 
these 
condition 
may 
determine 
increase 
level 
indoor 
##uta 
tobacco 
smoke 
gas 
cooling 
etc 
derived 
mit 
domestic 
cock 
##roach 
[SEP] 
nevertheless 
lower 
dos 
alone 
activity 
100 
250 
mg 
kg 
b 
##1 
b 
##6 
1 
2 
5 
mg 
kg 
b 
##12 
p 
dose 
dependent 
potent 
anti 
di 
##lo 
##fen 
##ac 
[CLS] 
for 
o 
##3 
correlation 
weak 
##est 
winter 
residential 
micro 
##on 
0 
05 
strongest 
summer 
outdoor 
##on 
0 
91 
change 
electro 
content 
brain 
ed 
##ema 
acute 
drug 
##yper 
##tens 
##bino 
[CLS] 
like 
re 
##b 
b 
##d 
##3 
bind 
mon 
##omer 
d 
sequence 
consists 
specific 
a 
t 
rich 
sequence 
upstream 
consensus 
he 
##xa 
##mer 
##ic 
half 
site 
specified 
p 
box 
d 
binding 
domain 
[SEP] 
[CLS] 
in 
ho 
##lo 
d 
##t 
##fi 
##ia 
l 
bind 
t 
##b 
##p 
high 
affinity 
[SEP] 
[CLS] 
over 
##ex 
wild 
se 
##s 
c 
mutant 
th 
##ior 
##ed 
##ox 
##in 
red 
##uc 
co 
role 
se 
##ys 
##tein 
cat 
##alytic 
[SEP] 
[CLS] 
bio 
les 
revealed 
g 
inflammation 
numerous 
se 
##pta 
##te 
h 
##y 
##pha 
##pha [SEP] 
western 
pre 
##b 
##ulates 
specifically 
g 
##h 
##3 
cell 
nucleus 
[CLS] 
two 
gene 
family 
encoding 
clone 
##d 
sequence 
##d 
analyzed 
se 
##rine 
kinase 
activated 
##1 
##d 
##hs 
dependent 
auto 
related 
##65 
##20 
[CLS] 
the 
de 
##duced 
gene 
product 
sequence 
similarity 
yeast 
pro 
##kar 
r 
##na 
polymer 
##ase 
subunit 
involved 
subunit 
assembly 
[SEP] 
maximum 
ho 
##lo 
##zy 
achieved 
inclusion 
p 
##las 
##mi 
##d 
t 
en 
u 
##rop 
##or 
##rino 
ii 
##i 
met 
##hyl 
##tra 
##fer 
##ase 
required 
synthesis 
sir 
##em 
co 
##fa 
hem 
##op 
##in 
[CLS] 
enhanced 
and 
##rogen 
##co 
##tic 
##tero 
receptor 
dependent 
trans 
##act 
also 
basal 
transcription 
s 
regulated 
promoter 
[SEP] 
[CLS] 
the 
human 
protein 
bind 
strongly 
s 
sh 
##3 
domain 
##b 
##l 
pro 
su 
in 
method 
[CLS] 
t 
##os 
p 
affect 
interaction 
##c 
##r 
multiple 
signaling 
##r 
receptor 
##os 
trans 
##duction 
##duction [SEP] 
we 
shown 
human 
cell 
closely 
resembles 
protein 
composition 
fraction 
profile 
profile [SEP] 
1985 
patient 
##cin 
mit 
##omy 
##cin 
15 
m 
m2 
flu 
##oro 
750 
m 
day 
1 
5 
f 
##u 
750 
mg 
m 
alone 
day 
day 2 
5 
radiation 
therapy 
3000 
c 
##gy 
day 
7 
28 
for 
given 
age 
high 
stressed 
##aris 
tend 
##on 
higher 
fatigue 
low 
stressed 
ex 
##tens 
##or 
tend 
##on 
in 
in addition 
##k 
##1 
t 
beta 
stimulate 
activity 
[SEP] 
foam 
##s 
express 
gag 
protein 
precursor 
molecular 
mass 
74 
k 
##da 
##r 
##7 
##4 
70 
k 
##da 
c 
##ved 
pro 
prote 
##ase 
[CLS] 
result 
suggest 
least 
ch 
##lor 
##op 
like 
t 
gene 
wheat 
m 
##t 
trans 
##cribed 
trans 
##cript 
undergoing 
processing 
post 
transcription 
##al 
modification 
3 
##a 
addition 
produce 
mature 
t 
may 
participate 
mitochondrial 
protein 
synthesis 
[SEP] 
[CLS] 
if 
however 
##oc 
##ard 
##ial 
stunning 
severe 
involves 
large 
l 
##v 
thus 
imp 
global 
##v 
function 
reversed 
in 
##ot 
##ropic 
procedure 
procedure [SEP] 
##8 
[CLS] 
different 
type 
##rb 
rear 
##rang 
##ement 
pattern 
imp 
##r 
based 
c 
##lon 
##ality 
##r 
based 
detection 
residual 
disease 
##rb 
gene 
analysis 
analysis [SEP] 
[CLS] 
under 
condition 
##at 
lit 
##hium 
7 
day 
modify 
h 
##yper 
##omo 
##tion 
produced 
am 
##phe 
##tamine 
[CLS] 
six 
patient 
underwent 
electro 
##phy 
##sio 
study 
[CLS] 
rat 
multiple 
oral 
dos 
##age 
regime 
given 
13 
day 
administration 
b 
##ol 
##us 
dose 
14 
##c 
day 
14 
multi 
##var 
analysis 
analysis t 
##wa 
correlated 
age 
l 
##v 
function 
00 
002 
occurred 
often 
##rio 
##r 
mi 
bone 
ma 
##rrow 
fi 
##bro 
##sis 
serial 
pro 
##co 
##lla 
ii 
##i 
serum 
analysis 
[CLS] 
as 
##th 
diagnosis 
according 
as 
guide 
##line 
[PAD] [CLS] 
ch 
##ar 
##cot 
joint 
joint [SEP] 
ideal 
##ized 
realized 
overall 
treatment 
time 
time [SEP] 
[CLS] 
non 
suppressed 
thy 
##roid 
##al 
radioactive 
i 
##od 
r 
thy 
##rot 
##ox 
phase 
case 
sub 
thy 
##roid 
##itis 
##roid 
s 
##ti 
##body 
t 
##sa 
##b 
##b [SEP] 
ultra 
imaging 
usually 
simultaneous 
18 
f 
fd 
##dg 
t 
99 
study 
study [SEP] 
[PAD] [CLS] 
bilateral 
re 
##nal 
on 
##a 
dog 
dog [SEP] 
[CLS] 
un 
gene 
activity 
##roma 
structure 
promoter 
mutation 
in 
##act 
##ivate 
transcription 
yeast 
gene 
without 
eliminating 
free 
region 
[SEP] 
[CLS] 
e 
c 
##y 
##c 
d 
##1 
pro 
in 
led 
re 
120 
k 
##da 
form 
##c 
c 
##d 
##k 
preceding 
re 
##sumption 
cycle 
progression 
unlike 
truly 
specific 
natural 
a 
##r 
e 
##pit 
le 
##gene 
##ous 
suitable 
target 
selective 
##ap 
[CLS] 
because 
mutation 
mapped 
previously 
vicinity 
e 
t 
alpha 
receptor 
##r 
gene 
chromosome 
11 
h 
##hes 
##hen 
##otype 
defect 
either 
expression 
activity 
activity e 
##r 
[CLS] 
region 
i 
includes 
two 
c 
##ys 
##tein 
c 
##tein 
zinc 
comprise 
d 
binding 
domain 
t 
##pi 
##fies 
super 
##family 
southern 
zoo 
b 
##lot 
analysis 
##23 
conserved 
genome 
ma 
s 
##pec 
##ie 
tested 
yeast 
r 
de 
##ter 
##mina 
required 
l 
##4 
mediated 
at 
##uation 
##10 
r 
op 
es 
##cher 
##ichi 
co 
##po 
##do 
##rug 
##9 
cell 
proved 
suitable 
cell 
system 
study 
##r 
##3 
show 
cell 
line 
line t 
##op 
##lus 
ni 
nit 
##b 
##1 
4 
high 
five 
cell 
allows 
large 
functional 
##comb 
##r 
##3 
[SEP] 
intervention 
##oper 
determination 
bio 
##chemical 
marker 
##k 
##k 
m 
##b 
##t 
##card 
##io 
[CLS] 
at 
first 
phase 
1 
43 
m 
##m 
##mn 
1 
10 
m 
l 
##n 
h 
##y 
##pot 
##hala 
##mic 
co 
##rt 
##ical 
response 
response completely 
in 
##hibit 
formation 
##c 
response 
light 
stimulus 
stimulus [SEP] 
6 
320 
mm 
##3 
00 
##5 
86 
in 
inmate 
count 
000 
mm 
##3 
compared 
14 
000 
00001 
there 
uncertainty 
result 
obtained 
experiment 
landscape 
regional 
general 
ecosystem 
type 
process 
[CLS] 
the 
f 
##ili 
##tation 
started 
preceding 
onset 
electro 
##my 
mass 
##eter 
muscle 
muscle [SEP] 
[CLS] 
the 
recruitment 
##it 
##utive 
##u 
activated 
mit 
protein 
membrane 
##fi 
interaction 
site 
physical 
model 
integrating 
assembly 
mit 
##ogenic 
transmission 
signal 
##os 
##eton 
del 
##eti 
acid 
residue 
2 
67 
##1 
post 
interact 
p 
##30 
##0 
##b 
inhibitor 
##1 
whereas 
del 
residue 
120 
140 
effect 
[CLS] 
quantitative 
t 
##l 
201 
analysis 
viable 
my 
##oc 
##ard 
##ium 
mild 
moderate 
51 
85 
i 
##versible 
##l 
201 
defect 
defect [SEP] 
point 
mutation 
316 
##38 
analogous 
##k 
extra 
##cellular 
signal 
regulated 
##maker 
mutation 
binding 
##p 
1 
substantially 
compromise 
s 
effect 
cat 
[CLS] 
j 
ca 
##usal 
combine 
theory 
research 
interpretation 
data 
possible 
theory 
advancing 
specific 
practice 
practice [SEP] 
in 
trans 
##fusion 
he 
treated 
l 
##ymph 
##ob 
##last 
inter 
##fer 
5 
m 
m 
three 
time 
m 
##o 
3 
m 
m 
##2 
three 
time 
4 
10 
m 
##o 
derived 
r 
##a 
resistant 
n 
##t 
##2 
d 
##1 
r 
##1 
def 
##icient 
activity 
co 
resistant 
##is 
##p 
##lat 
[CLS] 
b 
##r 
##b 
##l 
el 
transformation 
##bro 
hem 
##ato 
##po 
block 
a 
##pop 
##oki 
de 
##p 
##ri 
##vation 
factor 
dependent 
cell 
##let 
sequence 
analysis 
region 
showed 
contained 
five 
potential 
copy 
s 
##tero 
##l 
regulatory 
element 
element s 
##re 
1 
s 
r 
o 
os 
##borne 
g 
g [SEP] 
[CLS] 
mutation 
sa 
##har 
##omy 
c 
##ere 
##vis 
block 
me 
##iot 
prop 
##has 
##hase 
chromosome 
metabolism 
cycle 
arrest 
##yte 
##ytene 
identify 
two 
new 
##ios 
specific 
gene 
##1 
##3 
isolation 
characterization 
human 
or 
##th 
##olo 
##gs 
##4 
complex 
subunit 
[SEP] 
[CLS] 
thus 
leader 
protein 
gene 
product 
unknown 
function 
high 
large 
intermediate 
time 
infection 
abstract 
t 
##runcated 
at 
400 
word 
word [SEP] 
conclusion 
la 
##tano 
##p 
##ros 
administered 
daily 
reducing 
i 
##op 
##op 
##ros 
##tone 
administered 
twice 
daily 
patient 
oh 
[CLS] 
the 
dynamic 
insight 
conform 
##ational 
flexibility 
analog 
[CLS] 
in 
##fa 
insect 
caused 
mortality 
evaluated 
[CLS] 
therefore 
age 
related 
change 
serum 
le 
##pt 
##in 
level 
relationship 
ad 
##ip 
##os 
and 
##rogen 
level 
group 
community 
dwelling 
men 
[CLS] 
injection 
p 
##d 
solution 
13 
6 
22 
38 
g 
liter 
glucose 
reduced 
ing 
##est 
##ion 
su 
##c 
##rose 
4 
23 
36 
1 
1 respectively 
affect 
ing 
##est 
protein 
protein [SEP] 
area 
correction 
bio 
##e 
##qui 
##valence 
##tras 
var 
clearance 
suspected 
[CLS] 
expression 
e 
##2 
protein 
rapid 
repression 
expression 
followed 
12 
h 
later 
profound 
in 
##hibition 
cellular 
d 
synthesis 
[SEP] 
[CLS] 
plasma 
re 
##nin 
stage 
kidney 
disease 
[SEP] 
[CLS] 
##nob 
##lot 
##ot 
##os 
many 
yeast 
protein 
including 
p 
p34 
##d 
##28 
kinase 
became 
p 
t 
cell 
##rc 
[SEP] 
##nal 
co 
##omb 
##s 
hem 
##oly 
th 
##rom 
##ph 
##re 
##rect 
[CLS] 
pre 
##tre 
##at 
rat 
different 
dose 
level 
##l 
##4 
resulted 
pro 
##long 
t 
##mo 
half 
life 
increase 
area 
curve 
curve au 
auc 
decrease 
clearance 
clearance apparent 
volume 
distribution 
##d 
decreased 
decreased [SEP] 
[CLS] 
co 
high 
level 
##38 
map 
##k 
##k 
##k 
##3 
together 
##38 
##k 
significant 
c 
##y 
##c 
##lin 
d 
##1 
expression 
auto 
##gra 
##grafted 
##r 
##1 
related 
15 
4 
re 
relap 
r 
ri 
58 
36 
5 
3 
year 
year [SEP] 
[CLS] 
administration 
##r 
34 
##23 
##ort 
##ic 
blood 
increased 
cardiac 
##est 
##ero 
##id 
co 
##rona 
##ry 
o 
##cc 
##lusion 
[CLS] 
the 
primary 
condition 
acceptable 
hospital 
exhaled 
volume 
monitoring 
patient 
o 
##2 
monitoring 
performed 
setting 
fi 
##o 
continuously 
fi 
##o 
level 
critical 
the 
##ho 
##1 
gene 
ho 
##mo 
ma 
r 
##a 
g 
binding 
yeast 
sa 
##har 
##ere 
##erevis 
[SEP] 
a 
regard 
short 
stature 
proved 
syndrome 
related 
level 
so 
##mat 
##m 
##c 
[CLS] 
[CLS] 2 
[CLS] 
men 
##ru 
##al 
lunar 
cycle 
[CLS] 
h 
##bo 
##bo marked 
effect 
enzyme 
lung 
so 
##d 
increased 
47 
##p 
##x 
activity 
decreased 
33 
brain 
lung 
[CLS] 
s 
##ctic 
ordering 
[SEP] 
[CLS] 
phylogenetic 
analysis 
yeast 
##vert 
##rate 
multiple 
##mmal 
##of 
gene 
du 
##plication 
likely 
occurred 
early 
meta 
##zo 
lineage 
protein 
product 
different 
lo 
##cus 
relatively 
diver 
##gent 
##gent [SEP] 
hard 
[CLS] 
thus 
hi 
rare 
represents 
new 
type 
##a 
response 
element 
role 
m 
##od 
##ulation 
expression 
m 
##h 
##c 
class 
1 
family 
gene 
[CLS] 
we 
found 
multiple 
transcription 
start 
site 
located 
within 
15 
base 
pair 
region 
205 
base 
pair 
upstream 
translation 
start 
co 
##don 
[SEP] 
[CLS] 
during 
three 
day 
mean 
urine 
o 
##smo 
u 
##os 
##m 
free 
re 
##ab 
##ption 
t 
see 
text 
text [SEP] 
[PAD] [CLS] 
the 
structural 
in 
##test 
##inal 
defect 
presumed 
result 
defect 
##ive 
co 
##lla 
##gen 
synthesis 
hereditary 
connect 
##ive 
tissue 
disorder 
disorder [SEP] 
[CLS] 
re 
rev 
although 
in 
##dom 
##ac 
role 
c 
##lo 
##ox 
##gen 
##ase 
product 
##th 
response 
considered 
as 
incidence 
beta 
th 
carrier 
def 
er 
glucose 
6 
de 
##hy 
##dr 
##ogen 
##ase 
air 
area 
[CLS] 
both 
##b 
c 
##b 
bind 
specifically 
delta 
e 
##3 
an 
##ato 
##mic 
##al 
consideration 
trans 
##oid 
h 
##sect 
interaction 
two 
pair 
involved 
association 
z 
##2 
##c 
f 
##1 
##ot 
whereas 
one 
ion 
pair 
free 
complex 
investigation 
as 
##ym 
##metric 
##al 
induced 
yield 
90s 
##r 
90 
##y 
beta 
i 
##rra 
##dia 
d 
l 
##ani 
[SEP] 
[CLS] 
an 
##1 
null 
mutant 
viable 
showed 
slight 
reduction 
growth 
strain 
serum 
level 
all 
##ergic 
subject 
subject [SEP] 
##ge 
binding 
##oc 
##op 
[CLS] 
product 
canonical 
la 
##gli 
##gli dad 
integration 
end 
##lea 
recognize 
cut 
insertion 
site 
optional 
sequence 
further 
b 
##mi 
##1 
protein 
interact 
interact [SEP] 
[CLS] 
indeed 
e 
##ct 
##op 
##4 
a 
##ero 
##bic 
cell 
resulted 
partially 
con 
##it 
##utive 
da 
##1 
[SEP] 
we 
electro 
##my 
relationship 
cage 
di 
##aph 
##rag 
##bs 
##truct 
##p 
chain 
m 
hybrid 
probe 
[CLS] 
identification 
put 
##ative 
in 
rpm 
##i 
##lt 
op 
##eron 
flanked 
long 
inverted 
repeat 
my 
##co 
##p 
f 
##er 
##ment 
##ans 
in 
##co 
##gni 
strain 
[PAD] [CLS] 
standardized 
##an 
4 
7 
10 
year 
3 
3 4 
10 
year 
1970s 
##i 
2 
2 8 
1 
##uro 
toxicity 
flu 
##dar 
30 
mg 
m 
day 
##os 
##ino 
##side 
##ra 
c 
0 
0 5 
g 
m 
m2 
hour 
2 
6 
hour 
5 
day 
new 
##uke 
##lasia 
[CLS] 
evaluation 
##oc 
##ard 
in 
##far 
loss 
p 
##rb 
##10 
binding 
loss 
transforming 
[CLS] 
the 
analysis 
result 
se 
##rop 
##valence 
l 
##yme 
b 
##rel 
##ios 
dog 
k 
##os 
##ice 
region 
ne 
##gli 
##gible 
[SEP] 
[CLS] 
insulin 
glucose 
1 
3 
51 
14 
42 
31 
20 
m 
respectively 
3 
exhibiting 
peak 
level 
i 
##ris 
binding 
influence 
high 
3 
##id 
per 
##ox 
##ida 
the 
pro 
##ilo 
1 
label 
##uro 
radio 
result 
identification 
two 
major 
novel 
s 
t 
##os 
p 
##lation 
site 
y 
##23 
##9 
##24 
##0 
[CLS] 
dominant 
##f 
##1 
mutation 
isolated 
##ro 
##uta 
##genesis 
##mi 
##d 
containing 
##f 
##1 
gene 
[CLS] 
the 
tens 
##ile 
strength 
##hesive 
##uti 
##sin 
##avia 
ex 
##ov 
den 
##tin 
decreased 
zinc 
ion 
##top 
[CLS] 
highly 
conserved 
conserved l 
x 
x 
l 
f 
sequence 
near 
c 
terminus 
p 
##6 
domain 
gag 
precursor 
major 
motif 
1 
##r 
[SEP] 
down 
##re 
##gu 
##late 
inter 
##fer 
##re 
##gu 
proliferation 
n 
##f 
##3 
##b 
##3 
domain 
mass 
34 
46 
##cos 
900 
good 
n 
linked 
site 
average 
210 
##0 
[CLS] 
we 
spectrum 
p 
chest 
sound 
contained 
entirely 
within 
rot 
##oc 
noise 
the 
human 
ca 
ca11 
gene 
appears 
located 
secret 
##or 
type 
alpha 
1 
##uc 
##osy 
##lt 
##ran 
##fer 
gene 
cluster 
f 
##ut 
##1 
##1 f 
##ut 
##2 
##2 f 
##ut 
##p 
d 
site 
binding 
gene 
##b 
chromosome 
chromosome 19 
3 
[CLS] 
an 
an 
##oe 
##r 
##xia 
ma 
##zin 
##do 
##l 
suppress 
##es 
food 
intake 
1 
s 
##ti 
##mulating 
beta 
ad 
##rene 
##rg 
receptor 
2 
in 
##hibit 
feeding 
center 
3 
s 
##ti 
##mulating 
sat 
##iet 
##y 
center 
h 
##y 
##hala 
##mus 
[SEP] 
[CLS] 
these 
segment 
may 
represent 
pseudo 
##gene 
##s 
[CLS] 
the 
fusion 
##1 
m 
##ds 
##1 
frame 
add 
127 
co 
##don 
interrupted 
##1 
[SEP] 
in 
anti 
##biotic 
r 
##n 
##ae 
##ro 
##bic 
fungus 
neo 
##cal 
##lim 
##ast 
frontal 
r 
##k 
21 
examined 
[CLS] 
w 
##b 
##c 
differential 
se 
##g 
band 
l 
##ymph 
mon 
##o 
e 
##os 
##as 
##o 
usually 
showed 
log 
normal 
distribution 
distribution [SEP] 
[CLS] 
o 
##go 
##mer 
##ization 
dependent 
subunit 
folding 
[SEP] 
[CLS] 
chromosome 
specific 
sts 
##s 
27 
te 
##lo 
identified 
196 
t 
##ya 
##cs 
second 
##11 
suppress 
##1 
miss 
##ense 
mutation 
##1 
##32 
##1 
##f 
##1 
del 
calculation 
energy 
level 
e 
##1 
transition 
par 
violation 
intervention 
physical 
treatment 
create 
wound 
tissue 
environment 
con 
##ve 
healing 
[CLS] 
this 
k 
##da 
protein 
contains 
two 
s 
##h 
##2 
domain 
inter 
s 
##h 
##2 
domain 
##al 
##pha 
s 
##h 
##3 
b 
##r 
ho 
##mology 
domain 
##al 
##pha 
replaced 
unique 
6 
amino 
acid 
sequence 
[CLS] 
##ydro 
de 
##duced 
a 
##4 
sequence 
revealed 
four 
put 
##ative 
membrane 
spanning 
alpha 
he 
##lix 
[SEP] 
trial 
##al 
##cona 
##zo 
c 
superficial 
[CLS] 
study 
dose 
con 
m 
plasma 
hormone 
change 
relation 
circulating 
d 
nor 
##ges 
##tre 
##rad 
##iol 
concentration 
[CLS] 
here 
##with 
c 
ps 
##ac 
could 
diagnosed 
positive 
sample 
##lo 
##fen 
##il 
pro 
##ct 
##in 
secret 
re 
o 
##est 
##rad 
##iol 
level 
might 
reduced 
th 
##rom 
##boe 
##mbo 
##lis 
br 
##omo 
##cript 
in 
##hibition 
##ation 
[CLS] 
relationship 
so 
##man 
in 
##itation 
at 
##r 
d 
##z 
at 
##r 
s 
##c 
##p 
dos 
##age 
[CLS] 
the 
brain 
bi 
##sect 
##ed 
t 
##1 
t 
##2 
relaxation 
time 
determined 
right 
left 
hemisphere 
m 
##r 
s 
##pect 
##ros 
di 
##sse 
##ction 
##ction [SEP] 
simulation 
##ort 
##icit 
certain 
stress 
displayed 
interaction 
interaction [SEP] 
[CLS] 
in 
present 
study 
report 
entire 
g 
##eno 
##mic 
structure 
##1 
consists 
19 
ex 
##on 
spanning 
400 
k 
##b 
chromosome 
##p 
##15 
northern 
r 
##na 
b 
##lot 
hybrid 
##ization 
##ization analysis 
1 
specific 
sequence 
sequence r 
experiment 
corresponding 
m 
mrna 
expressed 
normal 
s 
##ple 
##en 
normal 
thy 
##mus 
various 
t 
l 
line 
[PAD] [CLS] 
investigate 
recognition 
task 
two 
string 
letter 
presented 
se 
##quential 
##ly 
##ly [SEP] 
k 
##etti 
modular 
fi 
z 
disc 
region 
insect 
[CLS] 
##zy 
chemical 
structure 
pro 
mainly 
conserved 
terminal 
part 
termed 
3 
c 
di 
##9 
##c 
3 
u 
containing 
distinctive 
r 
motif 
e 
stable 
stem 
loop 
s 
i 
near 
r 
3 
terminus 
considerably 
le 
stable 
stem 
loop 
s 
ii 
form 
portion 
3 
c 
[SEP] 
[CLS] 
this 
review 
chronicle 
chronicle characteristic 
deliberate 
accidental 
mass 
poisoning 
occurred 
world 
war 
i 
ii 
b 
##hop 
##al 
historical 
case 
including 
modern 
war 
war [SEP] 
the 
effect 
4 
week 
##los 
##por 
##in 
7 
mg 
day 
c 
##ya 
survival 
vascular 
##och 
g 
strain 
da 
donor 
##wi 
recipient 
presence 
significance 
immune 
tolerance 
g 
m 
##od 
##ation 
##mu 
##nos 
##press 
examined 
[CLS] 
incorporating 
s 
##ten 
##t 
post 
p 
##ivo 
##t 
base 
10 
expansion 
com 
##sure 
realized 
com 
##pressive 
com 
##ral 
stress 
##ing 
250 
150 
k 
##pa 
[CLS] 
1 
mean 
z 
##r 
0 
94 
6 
group 
2 
mean 
z 
1 
51 
72 
7 
normal 
kidney 
man 
mann 
##n w 
##hit 
##ney 
test 
test [SEP] 
hospital 
hospital service 
service [SEP] 
free 
fraction 
at 
measured 
dial 
##ys 
at 
treated 
depressed 
patient 
5 
4 
9 
9 8 
26 
9 
9 
[CLS] 
different 
effect 
re 
##ox 
##gen 
electrical 
##ric 
##ular 
muscle 
[SEP] 
meta 
##static 
t 
##umour 
bone 
ni 
##ger 
##ian 
##ian [SEP] 
[CLS] 
##in 
##con 
x 
demonstrates 
translation 
##al 
repression 
absence 
consensus 
r 
binding 
sequence 
sequence f 
##2 
presence 
f 
##2 
recognition 
element 
within 
m 
potent 
##iate 
translation 
##al 
repression 
[SEP] 
class 
0 
0 obtained 
33 
##4 
2 
class 
i 
i ii 
finding 
belonged 
##1 
patient 
76 
76 7 
950 
9 
classified 
hi 
hii 
##i i 
2 
class 
class v 
v [SEP] 
however 
##ple 
removal 
adjustment 
risk 
factor 
determined 
determined [SEP] 
[CLS] 
virgin 
p 
il 
detected 
urine 
52 
child 
##ye 
##ph 
##rit 
compared 
00 
##1 
determined 
complete 
c 
##a 
sequence 
rat 
overlapping 
##11 
clone 
[SEP] 
setting 
hospital 
laboratory 
united 
submit 
is 
##olate 
##d 
##c 
o 
##ct 
##obe 
1 
1991 
se 
##pt 
##em 
30 
1992 
[CLS] 
the 
terminal 
sequence 
sequence her 
genome 
contains 
promoter 
gene 
located 
repeat 
sequence 
l 
component 
[SEP] 
in 
do 
##k 
do 
##k 
lack 
##x 
##p 
motif 
c 
terminus 
bind 
##a 
protein 
upon 
[CLS] 
these 
observation 
k 
##r 
capable 
map 
kinase 
activation 
target 
p 
thus 
novel 
mechanism 
m 
##od 
##ulating 
##a 
map 
kinase 
signaling 
pathway 
[SEP] 
g 
##f 
10 
started 
day 
1 
within 
median 
day 
12 
10 
22 
1 
0 
x 
10 
9 
l 
median 
day 
10 
180 
##let 
##let 20 
0 
0 x 
9 
9 l 
l i 
plate 
##let 
trans 
[CLS] 
a 
higher 
child 
cerebral 
malaria 
40 
cerebral 
malaria 
29 
control 
20 
serum 
f 
##rit 
100 
inflammation 
s 
##t 
##tf 
##r 
7 
3 
mg 
l 
l [SEP] 
[CLS] 
during 
burst 
period 
approximately 
5 
10 
min 
local 
blood 
h 
##2 
##o 
concentration 
##ant 
##hine 
o 
##xi 
##das 
activity 
r 
0 
99 
##9 
[SEP] 
[CLS] 
previous 
21 
72 
b 
##p 
repeat 
transcription 
##al 
control 
element 
enhance 
##40 
d 
replication 
v 
provided 
either 
repeat 
located 
near 
end 
core 
replication 
origin 
containing 
17 
b 
##p 
a 
t 
containing 
sequence 
[SEP] 
[CLS] 
cross 
linking 
southwestern 
analysis 
k 
##p 
##1 
d 
binding 
protein 
clearly 
distinct 
##p 
protein 
may 
responsible 
basal 
k 
specific 
expression 
##1 
gene 
[CLS] 
complex 
rational 
##e 
conserved 
residue 
substrate 
specific 
##ity 
substrate 
bind 
active 
conform 
##ation 
s 
t 
##os 
unlike 
unlike at 
##fa 
bind 
inactive 
form 
[SEP] 
[CLS] 
region 
high 
ho 
contains 
type 
a 
n 
##leo 
##tide 
binding 
site 
consensus 
sequence 
at 
##pas 
##e 
sufficient 
bind 
d 
containing 
specific 
##tched 
residue 
[SEP] 
copyright 
1999 
[CLS] 
nickel 
release 
##wed 
market 
[CLS] 
s 
phase 
promoting 
c 
##y 
dependent 
kinase 
##d 
##ks 
kinase 
d 
##4 
act 
initiate 
replication 
n 
##f 
##b 
partially 
media 
e 
##r 
late 
membrane 
1 
activation 
b 
cell 
[CLS] 
f 
##er 
exhibited 
distribution 
constant 
k 
##d 
beta 
est 
##rad 
0 
45 
nm 
nm [SEP] 
[CLS] 
the 
long 
terminal 
repeat 
59 
##0 
b 
##p 
length 
u 
##3 
region 
containing 
consensus 
sequence 
likely 
involved 
viral 
gene 
expression 
[SEP] 
[PAD] [CLS] 
incorrect 
response 
previous 
trial 
trial enhanced 
current 
trial 
left 
##v 
##f 
##f [SEP] 
[CLS] 
p 
##eptide 
generated 
##oso 
trans 
##loc 
across 
membrane 
end 
##op 
re 
transport 
##er 
associated 
processing 
tap 
[SEP] 
[CLS] 
it 
competes 
brings 
##os 
therefore 
drop 
##os 
##ine 
comparison 
data 
clinical 
hem 
##ody 
[CLS] 
serum 
collected 
1973 
1975 
305 
##3 
resident 
12 
selected 
##ask 
##an 
##kim 
village 
tested 
evidence 
he 
infection 
[CLS] 
injection 
##rad 
per 
##idas 
##ere 
##bella 
##r 
fl 
##culus 
rat 
employed 
identify 
ne 
##uron 
a 
##b 
##cens 
nucleus 
project 
fl 
##culus 
[CLS] 
to 
ass 
##ay 
sequence 
could 
potentially 
regulate 
x 
##eno 
pro 
##en 
##ke 
##pha 
trans 
##fected 
construct 
contained 
upstream 
g 
##eno 
##mic 
sequence 
linked 
cat 
reporter 
gene 
various 
e 
##uka 
cell 
line 
[SEP] 
[CLS] 
ratio 
il 
6 
il 
10 
injury 
trauma 
##b 
induced 
association 
tumor 
ne 
##rosis 
t 
receptor 
1 
t 
factor 
media 
activation 
re 
protein 
[CLS] 
a 
major 
feature 
g 
##eno 
##mic 
sequence 
presence 
first 
intro 
##n 
il 
215 
b 
##p 
long 
located 
48 
b 
##p 
downstream 
translation 
start 
at 
##g 
co 
##don 
[SEP] 
[CLS] 
experimental 
study 
clinical 
plasma 
radio 
kit 
without 
extraction 
process 
process [SEP] 
[CLS] 
in 
##vic 
en 
located 
middle 
part 
la 
##ii 
la 
##ii 
##i 
accounting 
25 
total 
ne 
##uron 
nature 
incidence 
conditioned 
response 
##had 
##one 
population 
comparison 
naturalist 
##ic 
still 
automatically 
refuse 
positive 
media 
##ino 
##sco 
intervention 
n 
##2 
analyzed 
analyzed [SEP] 
demonstrated 
pro 
##uke 
gene 
involved 
15 
17 
trans 
##location 
transformation 
suppress 
[CLS] 
a 
sharp 
transition 
chaotic 
correlated 
turbulent 
co 
found 
becomes 
larger 
critical 
##a 
c 
c approximately 
equal 
x 
10 
7 
define 
##e 
16 
##al 
31 
33 
crucial 
protein 
s 
binding 
effect 
38 
##al 
39 
hybrid 
interact 
##1 
##1 er 
##ral 
##pha 
##1 
[PAD] [CLS] 
nuclear 
export 
plant 
plant at 
##1 
export 
receptor 
rich 
export 
##ido 
th 
##alia 
[SEP] 
[CLS] 
thus 
##r 
##2 
##oss 
##e 
essential 
function 
besides 
binding 
binding [SEP] 
[CLS] 
auto 
##psy 
finding 
5 
remaining 
23 
expired 
patient 
leg 
##ione 
##lla 
pneumonia 
seemed 
successfully 
treated 
disease 
bacterial 
pneumonia 
put 
end 
patient 
patient [SEP] 
ni 
##tro 
##cer 
g 
##ly 
##oam 
o 
##xi 
##xidas 
inhibitor 
[CLS] 
high 
dose 
5 
f 
##u 
act 
d 
protocol 
effective 
drug 
resistant 
case 
##a 
protocol 
[CLS] 
stimulation 
beyond 
the 
##ta 
range 
three 
phenomenon 
occurred 
shift 
burst 
frequency 
higher 
lower 
harmonic 
stimulation 
complex 
interaction 
basic 
background 
frequency 
rhythm 
stimulation 
beating 
return 
background 
the 
##ta 
burst 
spite 
stimulation 
escape 
escape [SEP] 
[CLS] 
conclusion 
trans 
##ona 
air 
bound 
gal 
##act 
##ose 
carrier 
safe 
contrast 
agent 
native 
##rani 
investigation 
k 
er 
cell 
stab 
##ly 
trans 
##fected 
construct 
containing 
##gam 
##ma 
##bin 
promoter 
linked 
enhanced 
reporter 
without 
h 
analyzed 
analyzed e 
expression 
[CLS] 
gas 
##tri 
##n 
stimulate 
transcription 
human 
his 
##ti 
##dine 
de 
##car 
##box 
##yla 
h 
##d 
##c 
gene 
binding 
coupled 
##ole 
##cy 
##sto 
gas 
##tri 
##n 
receptor 
[CLS] 
isolation 
new 
spin 
##dle 
check 
gene 
mph 
##1 
##1 
##p 
like 
ho 
##mo 
##log 
fi 
fission 
yeast 
yeast s 
##chi 
##zo 
##cc 
required 
##point 
activation 
response 
spin 
defect 
[CLS] 
mph 
##1 
function 
upstream 
mad 
##2 
previously 
characterized 
component 
spin 
##dle 
check 
##point 
essential 
growth 
development 
various 
tissue 
liver 
however 
path 
##op 
##sio 
assessment 
immediately 
i 
##vo 
##x 
u 
##til 
##ization 
reduced 
##th 
##rom 
##bin 
ii 
iii 
##min 
protein 
protein 
patient 
associated 
either 
th 
##rom 
##bos 
l 
##up 
##gu 
the 
first 
decision 
management 
card 
##io 
##version 
achieved 
i 
##c 
anti 
##ar 
##r 
##hy 
drug 
like 
fl 
##eca 
##ini 
##de 
prop 
##af 
##eno 
##ne 
##ne [SEP] 
structure 
ch 
##rom 
##oso 
##mal 
local 
##ization 
human 
gene 
p 
##ot 
p 
##tase 
act 
##iva 
##t 
[SEP] 
[PAD] [CLS] 
r 
chest 
wall 
maximum 
35 
6 
##2 
##o 
l 
1 
se 
##c 
1 
2 
2 
se 
0 
0 2 
h 
##z 
10 
m 
##l 
decreased 
increasing 
##t 
although 
##t 
effect 
diminished 
higher 
f 
f [SEP] 
m 
##od 
##uli 
##z 
20 
local 
##ph 
##rol 
##ret 
j 
##ho 
##rite 
many 
[CLS] 
these 
trans 
##cript 
directed 
synthesis 
three 
protein 
virus 
trans 
act 
##iva 
##tor 
ta 
##t 
encoded 
or 
##f 
s 
##1 
protein 
encoded 
s 
##2 
envelope 
##in 
##in [SEP] 
##al 
ratio 
delta 
di 
##abe 
patient 
control 
[CLS] 
trans 
##mura 
##l 
metabolic 
he 
##tero 
##gene 
##ity 
high 
cardiac 
work 
state 
[SEP] 
[CLS] 
we 
investigated 
whether 
promoter 
activity 
t 
##r 
##h 
gene 
directly 
regulated 
##a 
trans 
trans 
##fect 
ass 
##v 
1 
cell 
[SEP] 
spinal 
injury 
multiple 
trauma 
patient 
patient [SEP] 
the 
unusual 
en 
##igma 
k 
discussed 
statistical 
aspect 
relation 
radio 
##p 
##oe 
derivative 
analog 
c 
##ere 
##bella 
##r 
functional 
compensation 
complete 
destruction 
neo 
##p 
[CLS] 
the 
r 
whether 
##oz 
r 
##pta 
must 
efficiently 
trans 
##cribed 
stab 
##ilized 
rapid 
degradation 
folded 
correctly 
directed 
part 
cell 
effective 
we 
isolated 
determined 
complete 
n 
##leo 
##tide 
sequence 
another 
op 
##eron 
##d 
en 
link 
##er 
##mers 
##bil 
##is 
[CLS] 
th 
##alia 
c 
##ys 
##tat 
##oni 
beta 
l 
##yas 
exhibit 
22 
sequence 
identity 
corresponding 
enzyme 
contains 
70 
n 
terminal 
additional 
sequence 
compared 
bacterial 
protein 
[SEP] 
[CLS] 
the 
enzyme 
##cc 
o 
##xi 
##das 
cat 
##aly 
last 
step 
et 
ethyl 
##ene 
bio 
##sy 
plant 
converting 
1 
amino 
##ane 
1 
acid 
a 
##cc 
et 
ethyl 
##ene 
[SEP] 
[CLS] 
a 
99 
bone 
scan 
focal 
area 
increased 
up 
##take 
site 
mass 
ca 
##l 
##cane 
##us 
##us [SEP] 
##nal 
24 
patient 
21 
men 
3 
year 
survived 
##gnant 
phase 
##yper 
##tens 
period 
1969 
1979 
1979 [SEP] 
guide 
##line 
clear 
[CLS] 
##mi 
##dine 
kinase 
def 
cell 
3 
##t 
##3 
cell 
c 
##b 
##pha 
detected 
protein 
complex 
bind 
e 
e2 
##f 
binding 
site 
found 
promoter 
gene 
e 
e2 
##f 
1 
di 
##hy 
##dr 
##of 
##olate 
red 
##uc 
d 
##r 
[SEP] 
[CLS] 
member 
c 
##re 
binding 
protein 
c 
##re 
##b 
act 
##ivating 
transcription 
factor 
transcription 
well 
member 
j 
f 
##o 
shown 
bind 
sequence 
[SEP] 
c 
##sk 
c 
terminal 
s 
kinase 
kinase 
tail 
resulting 
down 
##re 
member 
role 
double 
r 
dependent 
protein 
kinase 
media 
##yper 
##con 
##i 
an 
complement 
##fer 
gamma 
gamma tumor 
ne 
nec 
##rosis 
r 
[CLS] 
##iovascular 
abnormal 
frequently 
neglected 
although 
assumed 
assumed [SEP] 
[CLS] 
high 
prop 
##of 
100 
1 
th 
##io 
##al 
50 
m 
1 
1 marked 
relaxation 
##of 
32 
49 
th 
##io 
##al 
23 
[CLS] 
dose 
dependent 
activity 
l 
##ys 
##as 
e 
##eg 
might 
man 
administration 
ni 
##cot 
##ine 
mutation 
human 
gene 
[CLS] 
##yl 
apparent 
##yl 
receptor 
abundant 
amount 
in 
##test 
##ine 
northern 
analysis 
polymer 
##ase 
chain 
c 
##lon 
ad 
##rena 
##l 
g 
##land 
air 
##way 
e 
cell 
brain 
o 
##lf 
##actor 
t 
##rac 
##hea 
##l 
##uc 
##osa 
in 
present 
study 
used 
southern 
b 
##lot 
analysis 
demonstrate 
t 
single 
copy 
gene 
human 
m 
s 
##ie 
reaction 
su 
possessing 
free 
##oi 
7 
ch 
##lor 
##o 
4 
ch 
##ome 
##rin 
afforded 
series 
n 
##o 
##o 4 
##rin 
##yl 
##hyl 
derivative 
in 
##oz 
a 
well 
variation 
cap 
##illa 
##ry 
size 
density 
##ric 
f 
##etal 
neon 
##ata 
##l 
period 
[CLS] 
##comb 
involved 
maintenance 
##d 
state 
several 
developmental 
##ly 
gene 
[CLS] 
uncertainty 
exists 
function 
potential 
##of 
##orms 
##b 
##fa 
##1 
gene 
[CLS] 
when 
##eda 
post 
shock 
rhythm 
initially 
displayed 
signal 
he 
pack 
##ard 
x 
##l 
as 
##ys 
##to 
##le 
p 
9 
human 
c 
##d 
##38 
e 
ect 
##oe 
##nz 
e 
gene 
ni 
##cot 
##mi 
##de 
ad 
##eni 
##ne 
din 
##tide 
converting 
structural 
ho 
##mology 
bone 
ma 
##al 
1 
##p 
ad 
##p 
[CLS] 
it 
noteworthy 
physiological 
condition 
mimic 
##king 
cellular 
##d 
##p 
##t 
ratio 
r 
##af 
enhance 
##ef 
stimulate 
##d 
##t 
exchange 
ha 
##a 
agreement 
se 
##a 
##t 
##af 
##af [SEP] 
terminal 
differentiation 
differentiation app 
##rog 
complex 
lost 
conventional 
##p 
1 
d 
binding 
became 
became evident 
particularly 
as 
##tro 
[PAD] [CLS] 
from 
de 
##duced 
amino 
sequence 
molecular 
38 
54 
##9 
calculated 
##h 
subunit 
[CLS] 
the 
higher 
ca 
##lor 
increased 
intake 
##bo 
##dra 
##te 
[CLS] 
simple 
algorithm 
fitting 
data 
moving 
192 
##ir 
source 
proposed 
proposed [SEP] 
[CLS] 
ta 
##f 
1 
activate 
##s 
transcription 
con 
##it 
##utive 
##ly 
mapped 
first 
32 
amino 
acid 
a 
region 
[SEP] 
[CLS] 
for 
first 
short 
term 
concurrent 
ta 
tal 
two 
different 
flavor 
##ed 
stimulus 
presented 
time 
one 
associated 
simultaneous 
in 
##gas 
##tric 
administration 
a 
##vers 
##ive 
product 
##yper 
sa 
##line 
[SEP] 
[CLS] 
the 
great 
cardiac 
vein 
flow 
became 
zero 
due 
cardiac 
arrest 
remained 
zero 
moment 
dead 
time 
initiation 
re 
##per 
##fusion 
##fusion [SEP] 
internet 
literally 
data 
dialogue 
right 
finger 
##tip 
[PAD] [CLS] 
attention 
devoted 
particular 
##rm 
##ore 
##gu 
nervous 
ho 
##rmon 
##al 
mechanism 
[CLS] 
the 
ma 
up 
##r 
mediated 
c 
##i 
acting 
er 
stress 
element 
consisting 
19 
n 
##t 
##aa 
##t 
##n 
9 
##g 
part 
considered 
provide 
specific 
##ity 
[SEP] 
[CLS] 
the 
formation 
d 
loop 
essential 
step 
d 
double 
strand 
break 
re 
##comb 
##ination 
[SEP] 
[CLS] 
the 
predicted 
en 
##pt 
29 
amino 
ho 
##mo 
##log 
y 
box 
inverted 
##aa 
##t 
d 
binding 
transcription 
factor 
[SEP] 
toward 
culture 
co 
##lon 
cancer 
r 
##ko 
transcription 
##ally 
##bol 
treatment 
site 
directed 
m 
##uta 
conserved 
c 
##ys 
##tein 
residue 
to 
##m 
##1 
##32 
##a 
he 
domain 
supposed 
necessary 
th 
##io 
##ester 
bond 
function 
[CLS] 
the 
two 
yeast 
p 
##omo 
alpha 
alpha factor 
many 
functional 
similarity 
receptor 
couple 
downstream 
signal 
trans 
pathway 
receptor 
undergo 
feedback 
regulation 
increased 
terminal 
domain 
response 
l 
##igan 
##d 
challenge 
[SEP] 
[CLS] 
more 
formation 
complex 
i 
##r 
operator 
promoter 
region 
found 
impaired 
##oe 
##vate 
##tate 
co 
##a 
##vate 
##zy 
shown 
extract 
d 
57 
consists 
unchanged 
s 
##44 
##53 
therefore 
main 
partner 
con 
##gated 
product 
[CLS] 
the 
expression 
pattern 
reporter 
gene 
compared 
end 
##ogen 
p 
##d 
##f 
##a 
gene 
[SEP] 
[CLS] 
the 
two 
s 
##h 
##3 
domain 
separated 
54 
amino 
acid 
link 
##er 
region 
whose 
length 
highly 
conserved 
x 
##eno 
chicken 
chicken ma 
##mal 
##rk 
ii 
protein 
[SEP] 
[CLS] 
this 
complex 
eliminated 
mutation 
half 
site 
upstream 
promoter 
transcription 
factor 
coup 
t 
##f 
[CLS] 
the 
##z 
1 
2 
gene 
widely 
expressed 
rat 
tissue 
highest 
steady 
level 
m 
##rna 
kidney 
liver 
heart 
u 
##us 
o 
##vary 
[CLS] 
f 
##z 
1 
2 
m 
##rna 
level 
greater 
neon 
##ata 
##l 
corresponding 
adult 
tissue 
tissue [SEP] 
[CLS] 
these 
result 
indicate 
change 
patient 
thy 
##roid 
scan 
r 
at 
##tri 
##but 
t 
##b 
##b [SEP] 
the 
##oa 
##c 
method 
di 
##lution 
heating 
addition 
##rc 
charcoal 
car 
##rez 
2 
p 
value 
direct 
analysis 
treatment 
control 
c 
##yt 
##och 
ultra 
##ructural 
te 
t 
##rem 
##ato 
##de 
me 
megal 
##od 
##is 
##cus 
temper 
##atus 
in 
he 
##tero 
##mer 
##ic 
cc 
##aa 
##t 
binding 
factor 
##b 
##f 
major 
component 
c 
##1 
binding 
factor 
##1 
##f 
human 
cell 
[SEP] 
[CLS] 
40 
fold 
stimulation 
ace 
##ty 
##lt 
##ran 
##fer 
four 
tandem 
s 
could 
induced 
within 
2 
h 
250 
within 
6 
h 
d 
93 
appeared 
likely 
true 
protein 
kinase 
mediated 
signal 
trans 
event 
rather 
differentiation 
response 
[CLS] 
this 
increased 
infection 
excess 
mortality 
mortality [SEP] 
[CLS] 
del 
##eti 
mutant 
human 
ch 
promoter 
identify 
region 
comprising 
n 
##uc 
##leo 
##tide 
75 
104 
required 
con 
##it 
##utive 
er 
stress 
expression 
[SEP] 
[CLS] 
the 
duration 
alpha 
elevation 
well 
peak 
influenced 
day 
cycle 
propose 
en 
##pical 
plasma 
functional 
expression 
sodium 
channel 
[CLS] 
electro 
##sio 
p 
##har 
epic 
##ard 
##ial 
end 
##oc 
##ard 
##ial 
m 
cell 
[CLS] 
terminal 
r 
bind 
single 
stranded 
r 
form 
halted 
complex 
much 
lower 
level 
w 
enzyme 
complex 
stab 
presence 
n 
##t 
strand 
[SEP] 
[PAD] [CLS] 
a 
c 
##hal 
##oth 
##ora 
##co 
di 
##mme 
##mmetro 
calf 
brain 
c 
##a 
library 
##11 
screened 
association 
two 
positive 
clone 
encoding 
t 
##os 
p 
##tase 
isolated 
di 
##sor 
##gan 
##ization 
h 
##yper 
##tro 
zone 
t 
bone 
05 
diet 
t 
##ibi 
##al 
abnormal 
##ity 
linear 
00 
001 
zero 
normal 
[CLS] 
repression 
strictly 
dependent 
presence 
upstream 
o 
##ox 
##1 
binding 
site 
reporter 
gene 
construct 
function 
n 
terminal 
region 
o 
##ox 
##1 
preceding 
##od 
##in 
[SEP] 
on 
##dan 
##set 
##ron 
thus 
line 
##em 
##etic 
child 
##em 
##otherapy 
radio 
##ther 
##ap 
surgery 
[SEP] 
[CLS] 
to 
el 
##uc 
##ida 
##te 
molecular 
mechanism 
##a 
signaling 
pathway 
activate 
##s 
cell 
type 
specific 
gene 
used 
pit 
##uit 
##ary 
specific 
rat 
pro 
##ct 
##rl 
promoter 
target 
on 
##a 
##af 
##4 
pit 
##uit 
cell 
[CLS] 
the 
human 
r 
##f 
##c 
1 
gene 
differs 
ha 
##ms 
gene 
term 
total 
number 
ex 
##on 
regard 
alternative 
ex 
##on 
1 
en 
5 
end 
he 
##tero 
##ity 
[SEP] 
[CLS] 
type 
c 
unit 
sum 
##mate 
response 
tone 
stimulus 
show 
little 
inhibitor 
##y 
influence 
influence [SEP] 
[CLS] 
h 
increased 
c 
##y 
##c 
##lin 
a 
c 
##y 
##c 
##lin 
g 
##1 
nuclear 
transcription 
##al 
factor 
n 
##f 
##ka 
##b 
protein 
expression 
[CLS] 
since 
blood 
se 
##rot 
##oni 
##n 
primarily 
peripheral 
##ly 
result 
aspect 
peripheral 
se 
##rot 
##oni 
##n 
metabolism 
abnormal 
major 
depression 
[CLS] 
although 
several 
large 
water 
##borne 
outbreak 
occurred 
decade 
small 
community 
community [SEP] 
[PAD] [CLS] 
##ogen 
mix 
##te 
##ryo 
mosaic 
##im 
46 
x 
##x 
46 
x 
##y 
ratio 
ratio 80 
20 
[SEP] 
[CLS] 
the 
1 
6 
k 
##b 
285 
amino 
obtained 
beta 
gal 
##os 
##idas 
fusion 
bacterial 
##ly 
c 
##a 
bound 
d 
fragment 
containing 
several 
car 
##g 
box 
m 
ability 
complement 
growth 
temperature 
##23 
##per 
temperature 
temperature [SEP] 
in 
review 
evidence 
smoking 
lung 
cancer 
la 
including 
unpublished 
technical 
report 
[CLS] 
the 
##r 
##0 
delta 
##lo 
##id 
cell 
gave 
micro 
##co 
##lon 
##ies 
comprising 
20 
50 
cell 
[CLS] 
despite 
high 
initial 
rate 
transcription 
promoter 
construct 
la 
lat 
l 
##tr 
able 
remain 
transcription 
##ally 
active 
establishment 
late 
##nt 
state 
[SEP] 
[CLS] 
two 
mutant 
mapping 
hind 
##ii 
##i 
site 
consensus 
sequence 
##10 
##1 
te 
##ta 
promoter 
studied 
ma 
ma2 
corresponds 
4 
b 
##p 
del 
##eti 
##on 
position 
12 
15 
b 
##30 
bear 
44 
b 
##p 
insertion 
c 
ta 
ta 21 
g 
hind 
##ii 
##i 
site 
[SEP] 
1 
r 
##ct 
[CLS] 
s 
##ci 
effect 
time 
##pid 
br 
##omi 
##b 
##cho 
##liner 
agent 
##ty 
##cho 
neo 
##st 
##ig 
neo 
##st 
gas 
##tric 
duo 
##den 
##al 
blood 
flow 
distribution 
131 
##i 
rabbit 
these 
extra 
##rom 
##oso 
copy 
isolated 
closed 
molecule 
length 
around 
3 
##mu 
[CLS] 
comparison 
foot 
##print 
pattern 
mouse 
human 
##rt 
gene 
demonstrated 
v 
##ivo 
binding 
regulatory 
protein 
s 
##pec 
##ie 
generally 
conserved 
identical 
[SEP] 
three 
dimensional 
structure 
enzyme 
es 
##cher 
##ichi 
co 
##lide 
##ter 
##mined 
refined 
2 
0 
a 
resolution 
[SEP] 
[CLS] 
northern 
southern 
b 
analysis 
clearly 
gene 
may 
involved 
tumor 
development 
considered 
candidate 
tumor 
suppress 
##or 
[CLS] 
##iva 
##ivax 
malaria 
this 
set 
genetic 
physical 
interaction 
role 
yeast 
r 
binding 
transcription 
##al 
regulation 
[SEP] 
population 
and 
patient 
followed 
male 
87 
56 
10 
1st 
3rd 
6th 
4th 
##gio 
month 
[CLS] 
all 
c 
##ys 
##t 
showed 
un 
##ilo 
##cular 
purely 
c 
##ys 
pattern 
ho 
##mogeneous 
fluid 
although 
t 
##2 
relaxation 
time 
four 
les 
##ion 
overlap 
o 
##don 
k 
##sts 
[SEP] 
genetic 
diagnosis 
respiratory 
disease 
[CLS] 
the 
c 
j 
delta 
domain 
in 
##hibit 
ne 
##uro 
##end 
promoter 
activity 
d 
sequence 
##uit 
##ary 
specific 
manner 
cross 
section 
##al 
study 
the 
medical 
pro 
##gno 
te 
##tan 
specially 
time 
severity 
disease 
characteristic 
therapy 
deserve 
te 
##tan 
[CLS] 
difference 
found 
co 
##lon 
se 
##m 
[CLS] 
increasing 
height 
##gar 
column 
overly 
s 
fabric 
fabric diminished 
inhibitor 
s 
micro 
##bial 
growth 
neither 
raw 
re 
##tro 
##graded 
star 
fast 
##ing 
serum 
##ster 
##oli 
##em 
[CLS] 
5 
[CLS] 
he 
##pa 
marker 
la 
##ashi 
officer 
in 
two 
group 
p 
variation 
serum 
pro 
##te 
##ase 
observed 
[PAD] [CLS] 
maximum 
structure 
analysis 
t 
##runcated 
[CLS] 
a 
single 
dose 
##ef 
administered 
in 
##ven 
##ously 
patient 
auto 
disease 
varying 
degree 
re 
##nal 
imp 
##air 
group 
i 
##l 
##c 
##r 
le 
50 
m 
##l 
min 
group 
ii 
##l 
##c 
##r 
greater 
50 
m 
min 
[SEP] 
[CLS] 
the 
liver 
specific 
sequence 
contains 
unique 
consensus 
site 
p 
##lation 
c 
am 
##p 
dependent 
protein 
c 
[SEP] 
effect 
functional 
state 
##ye 
##ph 
[CLS] 
they 
physiological 
pattern 
arithmetic 
standard 
de 
##viation 
##viation [SEP] 
[CLS] 
the 
##al 
##bet 
##a 
domain 
canonical 
feature 
known 
t 
##r 
domain 
including 
residue 
beginning 
##r 
##2 
end 
##r 
##3 
prefer 
##ential 
repair 
repair explained 
defect 
repair 
general 
transcription 
unclear 
present 
present [SEP] 
[CLS] 
this 
study 
examines 
le 
biographical 
context 
[CLS] 
dip 
##etal 
##one 
a 
##can 
##th 
##och 
##one 
did 
##el 
s 
##p 
[CLS] 
n 
however 
m 
ii 
##i 
group 
ii 
[CLS] 
while 
imagery 
common 
neural 
substrate 
fact 
d 
f 
show 
intact 
imagery 
face 
massive 
deficit 
form 
challenge 
two 
process 
share 
input 
pathway 
early 
vision 
vision [SEP] 
an 
ethnic 
analysis 
89 
##47 
case 
primary 
##ns 
tumor 
path 
washing 
1985 
the 
exact 
function 
##p 
30 
yet 
known 
gamma 
##fer 
reaction 
co 
cell 
assessed 
activity 
metabolic 
label 
followed 
s 
page 
[SEP] 
in 
##rs 
##2 
form 
complex 
n 
terminal 
##2 
domain 
p 
response 
stimulation 
[SEP] 
it 
##p 
213 
replaced 
oral 
capsule 
recommended 
initial 
dose 
100 
130 
mg 
m 
m2 
given 
5 
day 
course 
every 
21 
28 
day 
d 
d 
configuration 
replaced 
position 
3 
7 
7 8 
15 
18 
19 
21 
showing 
[CLS] 
these 
result 
establish 
d 
##na 
fragment 
isolated 
contains 
inter 
##le 
##oki 
may 
influence 
promoter 
via 
activated 
s 
##tat 
##s 
[CLS] 
when 
targeted 
gal 
##1 
promoter 
promoter f 
##using 
gal 
##4 
##p 
d 
binding 
domain 
s 
##1 
##p 
act 
##6 
t 
##1 
##p 
dependent 
re 
##press 
##or 
regulated 
##smo 
stress 
[SEP] 
unexpected 
prevalence 
c 
alpha 
tub 
##ulin 
s 
phase 
library 
northern 
analysis 
r 
##na 
phase 
s 
##ync 
##hr 
##ono 
##us 
cell 
cell [SEP] 
[CLS] 
promote 
survival 
bad 
resulting 
di 
##sso 
##ciation 
b 
##c 
##l 
2 
##c 
##l 
x 
l 
association 
14 
3 
3 
##u 
[SEP] 
radical 
##ph 
##re 
##rect 
t 
##1 
t 
##2 
les 
##ion 
identified 
identified [SEP] 
[CLS] 
sufficiently 
strong 
crush 
##er 
gradient 
e 
##pi 
pulse 
sequence 
temporal 
variation 
s 
##f 
##p 
disturbance 
suppressed 
due 
diffusion 
diffusion [SEP] 
[CLS] 
however 
case 
either 
d 
##q 
alpha 
d 
##q 
beta 
chain 
exchanged 
major 
alter 
##ation 
reversal 
pattern 
interaction 
observed 
[SEP] 
[CLS] 
only 
native 
structure 
er 
##k 
recognized 
inactivated 
second 
order 
rate 
constant 
40 
000 
m 
1 
1 
[SEP] 
from 
1998 
1999 
large 
community 
acquired 
respiratory 
##olate 
##tre 
pneumonia 
##6 
ha 
##em 
in 
51 
##3 
m 
morax 
##hali 
15 
centre 
au 
##ore 
south 
##f 
##rica 
##wan 
##ry 
##bial 
[CLS] 
diet 
##hyl 
##dit 
##ar 
##ba 
##mate 
##phe 
stereo 
##type 
behavior 
[CLS] 
we 
##mo 
##bil 
template 
based 
ass 
examine 
transcription 
termination 
##a 
##1 
##s 
##l 
al 
##u 
class 
ii 
##i 
template 
role 
trans 
##cript 
release 
p 
##ol 
ii 
##i 
term 
##inator 
dependent 
in 
##hibition 
processing 
b 
##1 
al 
trans 
##cript 
[SEP] 
a 
novel 
zinc 
finger 
containing 
r 
binding 
conserved 
fruit 
human 
human [SEP] 
##k 
1 
##p 
s 
##3 
trans 
##act 
##ivation 
se 
##r 
72 
##k 
##9 
##80 
##9 
h 
ing 
##est 
day 
1 
day 
14 
t 
##x 
##1 
##rit 
1 
24 
25 
##ri 
d 
##3 
biological 
trace 
monitor 
##ogen 
meta 
##bol 
##ite 
isolation 
joint 
demonstrating 
thick 
##ov 
##iae 
invasive 
diagnostic 
specific 
beta 
m 
##yl 
result 
depend 
experience 
b 
##or 
##rel 
b 
##dorf 
serum 
##body 
result 
g 
the 
size 
predicted 
n 
terminal 
sequence 
protein 
experimental 
[CLS] 
nuclear 
runoff 
complement 
restore 
##1 
stimulate 
early 
gene 
expression 
[SEP] 
[CLS] 
yet 
il 
gamma 
independently 
regulated 
differential 
expression 
certain 
subset 
regulatory 
element 
two 
gene 
must 
differ 
[CLS] 
0 
25 
mg 
dose 
t 
##zo 
counter 
##act 
induced 
sleep 
disturbance 
induce 
change 
e 
##eg 
spectrum 
typical 
##zo 
receptor 
ago 
##nist 
##nist [SEP] 
an 
h 
##c 
##2 
bread 
resist 
transition 
##stal 
##ba 
##2 
##cu 
##scopic 
high 
his 
identical 
seen 
patient 
bone 
ma 
##rrow 
functional 
3 
s 
pathway 
##gnant 
##uke 
1 
transformed 
entry 
media 
c 
##c 
previously 
known 
p 
##olio 
receptor 
related 
1 
##1 
##1 her 
herpes 
receptor 
hi 
hig 
##r 
b 
fi 
fide 
receptor 
employed 
employed her 
1 
2 
study 
study [SEP] 
4 
h 
##rol 
co 
##lla 
##gen 
content 
combination 
##11 
fi 
negative 
surface 
class 
i 
m 
##h 
##c 
allowed 
class 
i 
##h 
population 
sorted 
[CLS] 
although 
##rs 
1 
1 2 
4 
similar 
overall 
structure 
structure i 
##rs 
3 
3 approximately 
50 
shorter 
differs 
respect 
site 
t 
##os 
##lation 
[SEP] 
[CLS] 
interaction 
protein 
system 
##tub 
critical 
cellular 
##elle 
in 
mapped 
put 
##ative 
##1 
binding 
site 
r 
demonstrated 
##rs 
##1 
binding 
site 
co 
##rrel 
##ate 
##r 
function 
[PAD] [CLS] 
sail 
copyright 
2000 
press 
press [SEP] 
[CLS] 
this 
element 
required 
basal 
activated 
expression 
expression almost 
certainly 
function 
ta 
##ta 
binding 
protein 
interaction 
site 
[SEP] 
[CLS] 
in 
##p 
s 
##b 
1 
m 
##rna 
precursor 
protein 
level 
9 
re 
confirming 
end 
##ogen 
##ous 
l 
##x 
##r 
r 
##x 
##r 
activation 
induce 
##ogen 
##ous 
s 
##b 
1 
expression 
[CLS] 
##ria 
##var 
analysis 
year 
survival 
respect 
following 
65 
65 
sex 
depth 
invasion 
##uc 
##osa 
##l 
sub 
##cos 
##al 
tumor 
location 
upper 
middle 
lower 
third 
gross 
gross appearance 
type 
i 
i type 
ii 
ii type 
ii 
##i 
size 
1 
5 
cm 
1 
5 
cm 
presence 
absence 
l 
##ymph 
meta 
##sta 
##sis 
his 
##to 
##tological 
type 
in 
##test 
##inal 
di 
##ff 
##use 
##use extent 
l 
##ymph 
##nect 
limited 
limited extended 
type 
gas 
##tre 
##trect 
total 
di 
##stal 
sub 
##to 
##tal 
[SEP] 
[CLS] 
this 
integration 
result 
production 
##t 
##v 
m 
##dr 
##3 
fusion 
trans 
##cript 
originate 
5 
l 
##tr 
pro 
##virus 
[SEP] 
[CLS] 
in 
result 
exercise 
performance 
based 
heart 
rate 
response 
##max 
##ima 
##l 
exercise 
##o 
##2 
170 
##pm 
index 
capacity 
heart 
rate 
##ila 
sequence 
comparison 
p 
w 
##oese 
##i 
g 
gt 
##p 
binding 
striking 
related 
sequence 
e 
##uba 
##cter 
##ial 
ft 
marginal 
##ly 
similar 
tub 
##ulin 
bacterial 
ft 
protein 
[SEP] 
[PAD] [CLS] 
four 
15 
patient 
patient r 
##2 
case 
##body 
##body i 
##ga 
class 
class [SEP] 
[CLS] 
phosphate 
compound 
per 
heart 
p 
##h 
variation 
due 
change 
extra 
##cellular 
p 
##co 
##2 
##bon 
##ate 
[SEP] 
v 
d 
##b 
##l 
member 
share 
sequence 
identity 
approximately 
250 
amino 
acid 
domain 
designated 
d 
##b 
ho 
##mology 
domain 
[CLS] 
serum 
useful 
tumor 
marker 
monitoring 
result 
therapy 
the 
possible 
possible e 
equi 
multiple 
affect 
ad 
revised 
ma 
r 
##cker 
##ubi 
1985 
studied 
co 
##rrel 
form 
ma 
##l 
r 
state 
trait 
s 
1995 
affect 
balance 
bra 
##d 
##burn 
1969 
sensation 
seeking 
##cker 
[CLS] 
data 
processing 
time 
function 
intensity 
modified 
re 
##tina 
also 
later 
processing 
site 
identification 
masked 
to 
##xin 
ex 
##oto 
s 
##ta 
und 
##l 
per 
existence 
mask 
mechanism 
unlike 
la 
##1 
la 
##2 
##rol 
response 
patient 
c 
##d 
measured 
hybrid 
##ization 
however 
##lation 
##al 
modification 
##ar 
##2 
protein 
appear 
essential 
normal 
r 
##rna 
[CLS] 
here 
analyzed 
interaction 
18 
r 
p 
r 
corresponding 
isolated 
p 
p4 
p 
domain 
n 
mitochondrial 
subunit 
r 
intro 
##n 
[CLS] 
the 
de 
##duced 
amino 
acid 
sequence 
##r 
154 
acid 
residue 
showed 
ho 
##mology 
small 
regulatory 
protein 
l 
##rp 
##k 
##dr 
##nc 
[SEP] 
[CLS] 
yeast 
cell 
reach 
late 
##1 
simultaneously 
start 
b 
initiate 
d 
synthesis 
activate 
transcription 
set 
gene 
includes 
##1 
c 
##y 
##lins 
##ln 
##1 
##ln 
##2 
many 
d 
synthesis 
gene 
[SEP] 
functional 
pet 
cerebral 
art 
##eri 
##ove 
##nous 
##lf 
##orm 
[CLS] 
in 
in addition 
26 
##9 
m 
s 
##p 
##ret 
x 
c 
##b 
##l 
6 
##j 
f 
##1 
x 
c 
##b 
##j 
inter 
##sp 
back 
##cross 
order 
marker 
lo 
##cus 
calculate 
inter 
distance 
region 
accordingly 
super 
##pt 
material 
readily 
detected 
extract 
##uo 
preparation 
def 
cell 
blockade 
t 
activation 
surface 
linked 
single 
chain 
##a 
4 
##d 
##15 
##2 
three 
##pect 
[CLS] 
4 
mutation 
three 
extra 
##cellular 
c 
##ys 
##tein 
residue 
g 
##kar 
beta 
indicated 
two 
conserved 
##ys 
##tein 
residue 
c 
##30 
##5 
##38 
located 
two 
trans 
##rane 
segment 
form 
solvent 
accessible 
di 
##sul 
##fi 
##de 
bond 
in 
x 
o 
mat 
read 
ability 
ne 
neu 
t 
p 
p18 
participate 
participate e 
receptor 
common 
trans 
pathway 
the 
studied 
ne 
##uro 
##tro 
##phi 
nerve 
growth 
##f 
major 
survival 
factor 
sympathetic 
sensory 
ne 
##uron 
promotes 
differentiation 
system 
##c 
##12 
cell 
activation 
alpha 
1 
m 
##car 
##olin 
##af 
beta 
##ct 
##17 
##k 
inhibitor 
blocked 
n 
delta 
[CLS] 
transcription 
##al 
analysis 
human 
t 
function 
poorly 
promoter 
recognized 
r 
polymer 
##ase 
i 
ii 
##i 
p 
##ol 
ii 
promoter 
lacking 
conventional 
ta 
element 
[SEP] 
level 
##d 
##k 
##d 
##k 
##af 
d 
##1 
reduced 
cell 
line 
[CLS] 
mapping 
5 
3 
terminus 
te 
##d 
r 
indicated 
##tro 
u 
##3 
r 
structural 
organization 
capable 
directing 
synthesis 
trans 
##cript 
potential 
substrate 
reverse 
transcription 
intermediate 
trans 
##position 
[SEP] 
du 
electro 
5 
fixed 
sound 
90 
##d 
##b 
##l 
3 
3 [SEP] 
[CLS] 
detected 
anti 
##body 
n 
terminus 
##3 
##3 f 
##2 
pro 
##geny 
se 
##gating 
s 
##3 
ha 
##p 
##lot 
expressed 
s 
##3 
ha 
##p 
##lot 
##ype 
[SEP] 
blood 
rapid 
identical 
fast 
a 
followed 
1 
6 
h 
##tra 
##umatic 
course 
processed 
l 
te 
visual 
##rp 
[CLS] 
total 
body 
distribution 
space 
woman 
various 
body 
weight 
[CLS] 
three 
experiment 
20 
h 
met 
##hyl 
6 
##zo 
##id 
oh 
##hip 
performed 
induce 
mutation 
di 
##hy 
##dr 
##of 
##olate 
red 
##uc 
d 
##f 
##r 
gene 
hem 
##iz 
##go 
##ms 
##o 
cell 
##21 
[CLS] 
this 
mediated 
vascular 
re 
##mo 
##del 
active 
process 
result 
change 
blood 
vessel 
[CLS] 
separate 
factor 
four 
regulatory 
con 
##it 
##utive 
factor 
1 
probably 
##1 
##1 expressed 
thy 
##mo 
stage 
ii 
in 
n 
complex 
binding 
##d 
##28 
element 
element activated 
thy 
##mo 
including 
cell 
c 
##d 
##d4 
##d 
##d8 
##rl 
##ow 
undergo 
selection 
ii 
##i 
in 
factor 
at 
1 
1 activated 
mature 
##d 
##d4 
##d 
##d8 
##r 
##hi 
##gh 
im 
##mat 
##ure 
##d 
##d4 
##d 
##d8 
##r 
thy 
##mo 
alike 
transitional 
cell 
##d 
##d4 
##d 
##d8 
##rl 
##ow 
subject 
factor 
containing 
##b 
##b activated 
thy 
##mo 
developmental 
stage 
culture 
require 
specific 
induction 
[SEP] 
[CLS] 
thus 
22 
m 
##d 
responded 
oral 
p 
##la 
##c 
[CLS] 
posterior 
o 
##ste 
##op 
##hy 
##te 
around 
posterior 
edge 
##rte 
##bra 
##l 
body 
resulted 
inter 
##vert 
##ral 
ins 
##iciency 
correspond 
##ed 
h 
##yper 
##tro 
##phic 
spur 
o 
##ste 
##och 
##ond 
##rosis 
##rosis [SEP] 
systemic 
infection 
can 
##di 
##v 
administration 
[CLS] 
of 
four 
##c 
gene 
expression 
##c 
##bet 
##a 
gene 
reported 
tissue 
specific 
development 
dependent 
[CLS] 
fusion 
d 
binding 
domain 
gal 
##4 
full 
activity 
requires 
entire 
b 
bh 
alpha 
t 
although 
amino 
terminus 
display 
activity 
[SEP] 
[CLS] 
the 
induction 
##has 
##3 
##a 
##1 
differs 
classical 
##tic 
gene 
regulation 
part 
g 
##co 
##cor 
##tic 
##oid 
anti 
##tic 
##no 
##lone 
16 
alpha 
##ril 
##n 
induce 
##3 
##a 
##1 
transcription 
##al 
gene 
activation 
[CLS] 
more 
##body 
binding 
de 
##mina 
##nt 
also 
in 
##hibit 
z 
70 
s 
##h 
##2 
domain 
bound 
z 
##eta 
chain 
2 
##py 
it 
##am 
##am [SEP] 
specimen 
un 
##fer 
##til 
##ized 
egg 
almost 
flat 
flat [SEP] 
f 
##etal 
transplant 
rescue 
##xial 
muscle 
representation 
m 
##1 
cortex 
neon 
##ata 
trans 
##ec 
develop 
weight 
support 
[CLS] 
we 
examined 
contribution 
m 
m 
enhance 
##r 
transcription 
##al 
activity 
path 
##ogen 
constructing 
l 
##tr 
##s 
containing 
enhance 
##r 
element 
[SEP] 
there 
major 
##oper 
com 
##plication 
follow 
patient 
10 
26 
month 
operation 
satisfactory 
satisfactory [SEP] 
the 
##th 
##rom 
##bin 
ii 
##i 
increase 
anti 
##th 
##rom 
##bin 
ii 
##i 
ins 
da 
3 
week 
supplement 
diet 
m 
##l 
daily 
co 
liver 
oil 
concentrate 
northern 
b 
##lot 
##ts 
1 
regulated 
meta 
##phy 
##sea 
##l 
14 
35 
fold 
di 
##aph 
##ys 
##eal 
4 
2 
fold 
bone 
1 
h 
1 
returned 
level 
24 
h 
[CLS] 
the 
transcription 
##al 
trans 
##act 
##iva 
##tor 
ta 
si 
au 
gene 
expression 
directed 
promoter 
terminal 
newly 
discovered 
internal 
promoter 
located 
within 
en 
gene 
[SEP] 
[CLS] 
in 
case 
flu 
##ox 
##eti 
##ne 
##junct 
benefit 
side 
effect 
effect [SEP] 
[CLS] 
del 
##eti 
consensus 
element 
##po 
promoter 
abolished 
transcription 
resulted 
s 
##por 
##ulation 
deficiency 
[SEP] 
##em 
mutation 
beta 
gal 
##os 
gene 
result 
l 
##oso 
disorder 
##1 
gang 
##dos 
m 
##qui 
##o 
syndrome 
result 
indicated 
hobby 
mobility 
transport 
relationship 
energy 
thing 
slower 
aspect 
relevant 
patient 
##ol 
##ol [SEP] 
[CLS] 
trans 
fly 
strain 
mutation 
affecting 
specific 
t 
is 
##of 
##orms 
investigate 
individual 
role 
regulating 
alternative 
processing 
doubles 
##ex 
ex 
t 
pre 
m 
##rna 
[SEP] 
the 
ho 
##mology 
immediate 
us 
##1 
her 
ho 
##mo 
##log 
##s 
##ice 
##6 
##3 
##quin 
##quine 
##e her 
##f 
##4 
[CLS] 
these 
study 
define 
class 
d 
element 
mode 
action 
##fo 
described 
interaction 
effect 
##bul 
[CLS] 
chest 
x 
p 
abnormal 
shadow 
upper 
lobe 
lobe [SEP] 
specimen 
large 
number 
section 
good 
m 
##or 
##ph 
characteristic 
may 
may produced 
produced [SEP] 
##ox 
receptor 
antagonist 
inhibitor 
g 
##ama 
release 
calcium 
channel 
block 
##amine 
antagonist 
s 
##ynth 
##ase 
inhibitor 
can 
##bino 
me 
##oni 
vitamin 
12 
[CLS] 
a 
series 
mutation 
within 
within e 
open 
reading 
frame 
del 
##ete 
various 
region 
conserved 
d 
binding 
trans 
##act 
##ivation 
domain 
well 
internal 
hi 
##nge 
region 
[SEP] 
[CLS] 
c 
##rk 
##ii 
##l 
con 
##utive 
formed 
complex 
exchange 
factor 
##3 
un 
well 
p 
pd 
cell 
[SEP] 
in 
biological 
d 
protein 
interaction 
##ra 
o 
##leo 
29 
##1 
245 
proved 
orientation 
##fer 
in 
##mi 
##dine 
gene 
promoter 
##ur 
##kat 
cell 
[CLS] 
plasma 
s 
##tero 
##id 
level 
in 
##fusion 
rate 
equal 
level 
subject 
b 
##c 
##pp 
protocol 
achieved 
complete 
response 
75 
response 
displayed 
50 
response 
response [SEP] 
[CLS] 
the 
##31 
gene 
encoding 
##31 
subunit 
sa 
##har 
##ces 
c 
##ere 
##vis 
##iae 
r 
##na 
polymer 
##ase 
ii 
##i 
isolated 
starting 
c 
terminal 
fragment 
clone 
##d 
##da 
library 
[SEP] 
[CLS] 
electro 
##ore 
sequence 
within 
region 
bind 
member 
s 
##1 
transcription 
factor 
[SEP] 
[CLS] 
the 
p 
active 
site 
located 
within 
36 
##7 
37 
##4 
[SEP] 
one 
year 
##rgon 
0 
01 
k 
##olm 
treated 
group 
[CLS] 
further 
aim 
character 
##izing 
trans 
acting 
factor 
media 
##te 
spatial 
temporal 
expression 
ho 
##x 
gene 
em 
##b 
##ryo 
[SEP] 
##eno 
##sin 
##e 
drug 
interaction 
article 
article [SEP] 
[CLS] 
a 
side 
effect 
si 
c 
##yl 
##ru 
##ria 
##ria a 
micro 
##scopic 
##at 
##uria 
elevation 
got 
##pt 
##1 
p 
observed 
one 
respectively 
serum 
c 
##3 
measured 
1 
28 
child 
abnormal 
1980 
1997 
[CLS] 
two 
measure 
sensory 
in 
##hibition 
employed 
s 
##2 
s 
##1 
x 
100 
amplitude 
ratio 
s 
##1 
s 
##2 
amplitude 
difference 
difference [SEP] 
computer 
analysis 
revealed 
human 
p 
##1 
sequence 
corresponding 
amino 
acid 
residue 
within 
terminal 
r 
binding 
domain 
display 
high 
ho 
##mology 
greater 
greater 54 
identity 
61 
94 
similarity 
r 
binding 
##3 
##l 
rot 
##p 
##p2 
unknown 
m 
rot 
##34 
likely 
r 
binding 
[CLS] 
de 
##ter 
##mina 
re 
is 
ischa 
##emia 
re 
##vas 
##cular 
th 
##rom 
##bol 
##ys 
##min 
##iva 
co 
##rona 
##ry 
o 
##cc 
[CLS] 
for 
large 
breast 
70 
mm 
x 
ray 
i 
ige 
d 
##m 
automatically 
select 
beam 
breast 
resulted 
lower 
dos 
compared 
manual 
tube 
potential 
selection 
selection [SEP] 
[CLS] 
experimental 
strain 
indicated 
##ulent 
computer 
system 
train 
##ho 
requirement 
requirement [SEP] 
finally 
trans 
##rb 
gene 
specific 
mutation 
##h 
domain 
a 
##pop 
##t 
co 
7 
cell 
[CLS] 
comparison 
dose 
volume 
his 
##to 
##gram 
revealed 
field 
plan 
spared 
heart 
whereas 
whereas 8 
field 
plan 
spared 
lung 
[CLS] 
demonstrated 
put 
##ative 
ho 
##x 
co 
##fa 
##ctor 
##x 
##1 
##a 
participates 
cooperative 
d 
binding 
##xa 
1 
def 
##orm 
##ed 
group 
ho 
hox 
##d 
4 
the 
##l 
1 
c 
##t 
##f 
1 
gene 
product 
sa 
##har 
##ere 
##vis 
chromosome 
transmission 
normal 
cell 
cycle 
progression 
##2 
m 
[SEP] 
##tero 
##tri 
##mer 
##ic 
g 
binding 
function 
signal 
trans 
hormone 
cell 
removed 
removed 68 
86 
m 
##di 
first 
h 
74 
4 
h 
h 
d 
##dd 
r 
pacing 
automatic 
mode 
switch 
##ys 
at 
##rial 
fi 
##bri 
##lla 
a 
##v 
nod 
##al 
a 
##bla 
there 
highly 
decrease 
serum 
e 
##os 
patient 
##ga 
[CLS] 
sequence 
analysis 
revealed 
belongs 
large 
family 
f 
##ad 
dependent 
glucose 
met 
##han 
##ol 
##olin 
o 
##xi 
##dor 
##ed 
##uc 
share 
sequence 
identity 
67 
alcohol 
o 
##xi 
##das 
##hyl 
##ot 
[SEP] 
[CLS] 
it 
required 
correct 
expression 
gene 
gene [SEP] 
[CLS] 
in 
hi 
l 
##tr 
region 
demonstrated 
positive 
negative 
regulatory 
effect 
hi 
gene 
expression 
[SEP] 
[CLS] 
a 
comparison 
at 
##cted 
transmission 
emission 
s 
##pect 
image 
obtained 
t 
##l 
201 
ca 
##d 
patient 
patient [SEP] 
[CLS] 
accumulation 
am 
per 
lung 
[CLS] 
since 
necessary 
resort 
th 
##ora 
##cot 
final 
step 
diagnosis 
simpler 
simpler capable 
providing 
information 
information [SEP] 
[CLS] 
both 
control 
m 
##n 
5 
10 
time 
m 
liver 
similarly 
small 
in 
de 
##ph 
camp 
dependent 
protein 
p 
pka 
p 
##b 
liver 
nuclear 
extract 
a 
retrospective 
analysis 
data 
21 
de 
##mber 
1989 
se 
##pt 
##em 
1991 
investigation 
x 
ex 
##rona 
##gio 
el 
system 
intervention 
##rvin 
##rvine 
##e ca 
performed 
presently 
chain 
pair 
switch 
ch 
##ime 
##ric 
site 
mutant 
gamma 
delta 
t 
##rs 
trans 
##fected 
t 
##r 
mutant 
##ur 
##kat 
examine 
effect 
t 
##r 
gamma 
junction 
##al 
region 
sequence 
react 
[SEP] 
[CLS] 
f 
##o 
j 
bound 
n 
4 
5 
fold 
reduction 
d 
binding 
d 
activated 
k 
##i 
##a 
suppress 
activation 
##h 
terminal 
co 
##lon 
electro 
##mo 
##bility 
shift 
o 
##leo 
##tide 
pro 
##ximal 
di 
##stal 
bed 
##p 
1 
binding 
region 
selective 
trans 
##act 
##ivation 
##d 
##2 
signaling 
##pm 
##c 
[SEP] 
[CLS] 
the 
present 
show 
c 
##i 
acting 
element 
189 
175 
b 
##p 
bind 
thy 
##roid 
transcription 
factor 
1 
t 
##f 
1 
involved 
activity 
[SEP] 
increased 
plate 
##let 
derived 
##ti 
##mal 
thick 
da 
##ron 
g 
model 
[CLS] 
despite 
degree 
sequence 
similarity 
five 
r 
##f 
##c 
gene 
essential 
cell 
proliferation 
##ere 
##vis 
[SEP] 
more 
##over 
e 
##ct 
##12 
##rop 
line 
result 
induction 
many 
b 
lineage 
gene 
including 
including e 
eb 
##ral 
##pha 
##da 
rag 
1 
ability 
chain 
response 
mit 
also 
hi 
##12 
##0 
##d 
##d4 
##link 
10 
15 
fold 
level 
##i 
3 
##i 
4 
##d 
##d4 
##ate 
1 
infection 
in 
##ven 
##ous 
drug 
##du 
67 
##du 
3 
2 
2 55 
557 
one 
or 
##fs 
met 
##han 
j 
genome 
high 
similarity 
m 
a 
##eo 
##b 
authentic 
ah 
##as 
[CLS] 
more 
80 
appropriate 
lever 
responding 
established 
27 
38 
44 
daily 
training 
session 
d 
232 
di 
##az 
##am 
p 
training 
drug 
[SEP] 
we 
magnetic 
structure 
r 
kissing 
hair 
##pin 
complex 
formed 
hi 
2 
ta 
##r 
hair 
loop 
hair 
complementary 
loop 
sequence 
[SEP] 
result 
in 
men 
weight 
height 
satisfactory 
index 
strong 
correlation 
##rice 
skin 
##gible 
correlation 
height 
height [SEP] 
##20 
related 
structure 
function 
r 
##cc 
##1 
gene 
ma 
##1 
gene 
s 
##chi 
##zo 
##sa 
##cc 
##har 
appear 
regulate 
entry 
mit 
##osis 
chromosome 
con 
##den 
[CLS] 
no 
consensus 
binding 
sequence 
could 
disc 
##erne 
fragment 
bound 
factor 
rapid 
equilibrium 
##bound 
##bound [SEP] 
selective 
transcription 
##al 
induction 
system 
based 
based gal 
gal4 
est 
##rogen 
fusion 
[SEP] 
kinase 
re 
react 
protein 
electro 
##ph 
do 
60 
k 
##da 
liver 
##oso 
##r 
protein 
##ose 
##ad 
##ific 
instead 
##r 
[CLS] 
##os 
41 
##6 
##y 
##mi 
increase 
pp 
s 
t 
##os 
p 
##lation 
dominant 
##rac 
##1 
in 
##k 
##29 
##3 
well 
metabolic 
##tra 
##ben 
##azi 
##ych 
##ot 
[PAD] [CLS] 
reading 
twin 
twin [SEP] 
these 
result 
1 
##a 
interact 
independently 
er 
r 
key 
organizer 
r 
replication 
complex 
assembly 
[SEP] 
[PAD] [CLS] 
similar 
##c 
##l 
yer 
##sin 
##sinia 
[CLS] 
effect 
high 
sugar 
intake 
metabolic 
regulatory 
indicator 
men 
meat 
in 
##fusion 
br 
##oth 
suitable 
##em 
gal 
gallina 
##linarum 
b 
##eri 
##n 
[CLS] 
the 
result 
indicate 
expression 
co 
directed 
two 
promoter 
one 
p 
##2 
characterized 
earlier 
worker 
start 
site 
transcription 
60 
n 
##leo 
##tide 
upstream 
initiation 
co 
##don 
first 
structural 
gene 
pro 
p 
##1 
situated 
250 
n 
##leo 
##tide 
upstream 
pro 
prov 
[SEP] 
ma 
##ximal 
rise 
plasma 
adrenaline 
similar 
three 
group 
lower 
plasma 
glucose 
required 
stimulate 
ho 
##rmon 
##al 
response 
unaware 
plasma 
adrenaline 
concentration 
lower 
time 
reaction 
reaction [SEP] 
[CLS] 
through 
interaction 
pre 
m 
##rna 
c 
##t 
##d 
domain 
polymer 
##ase 
ii 
s 
##r 
protein 
shown 
regulate 
alternative 
s 
##licing 
[SEP] 
[CLS] 
one 
child 
recently 
fed 
vomit 
small 
breast 
milk 
short 
cry 
apparently 
##gos 
##pas 
shown 
sudden 
drop 
p 
##t 
##co 
##2 
level 
without 
discomfort 
discomfort [SEP] 
change 
size 
organisation 
brain 
man 
ancestor 
ancestor [SEP] 
only 
s 
##ta 
##taphy 
x 
##yl 
##os 
##x 
##6 
##3 
strain 
high 
ad 
##herence 
activity 
[CLS] 
it 
n 
##h 
##2 
terminus 
corresponds 
equivalent 
terminus 
processed 
matrix 
form 
similar 
alpha 
##1 
x 
##i 
chain 
thus 
physiological 
significance 
[SEP] 
[CLS] 
transmission 
m 
##uta 
s 
infant 
term 
i 
##od 
##f 
solution 
mother 
den 
##ti 
##tion 
[CLS] 
expression 
##x 
1 
m 
##x 
2 
studied 
development 
o 
##ste 
##ob 
role 
d 
dl 
##x 
context 
regulation 
bone 
expressed 
gene 
unknown 
scalp 
blood 
flow 
recorded 
incorporated 
trans 
##o 
electro 
##de 
[CLS] 
design 
act 
##ivating 
1 
1 
ta 
##t 
induced 
transcription 
j 
hybrid 
ta 
##t 
j 
expression 
##mi 
##d 
reporter 
gene 
contained 
##p 
1 
binding 
site 
upstream 
rat 
pro 
##ct 
ta 
##a 
element 
hi 
1 
l 
##tr 
construct 
##p 
1 
binding 
site 
replaced 
element 
[SEP] 
[CLS] 
my 
##co 
##ba 
##cter 
tuberculosis 
in 
##hibit 
if 
##n 
gamma 
transcription 
##al 
response 
in 
##hibit 
activation 
s 
##tat 
##1 
[CLS] 
rabbit 
##1 
r 
##b 
##k 
##1 
rat 
##1 
r 
##t 
##1 
clone 
##d 
screening 
kidney 
rat 
brain 
c 
library 
ho 
##mo 
##log 
c 
##a 
probe 
[SEP] 
##40 
reduced 
water 
content 
right 
hip 
##po 
##cam 
##pus 
con 
##tral 
##ater 
##al 
site 
injury 
[CLS] 
g 
##h 
stimulate 
##d 
activity 
promoter 
fragment 
5 
end 
n 
##uc 
##leo 
##tide 
n 
##t 
2001 
n 
##t 
65 
##3 
1 
9 
2 
7 
fold 
c 
##d 
##k 
target 
site 
def 
mutant 
op 
s 
##25 
s 
##38 
block 
cell 
transition 
protein 
promotes 
d 
strand 
transfer 
linear 
double 
m 
##19 
d 
single 
viral 
m 
##19 
d 
isolated 
e 
co 
[SEP] 
the 
brain 
processed 
according 
te 
##tra 
##zi 
##dine 
t 
##mb 
protocol 
me 
##sul 
##am 
78 
studied 
dark 
[CLS] 
seizure 
re 
##r 
1 
30 
95 
0 
01 
##ep 
drug 
##r 
0 
0 
1 
38 
influence 
mortality 
rate 
rate [SEP] 
one 
day 
##oper 
beta 
ma 
##ximal 
45 
en 
##f 
##rane 
53 
ne 
##uro 
[CLS] 
the 
serum 
level 
co 
##rt 
##is 
##ol 
pro 
##ct 
ins 
suspension 
ex 
##uda 
showed 
lower 
value 
control 
condition 
nasal 
ins 
food 
in 
enzyme 
el 
atop 
one 
all 
##ergic 
disorder 
as 
##th 
r 
##hin 
##itis 
e 
ecz 
u 
four 
mouth 
gas 
##tro 
in 
intest 
##testinal 
s 
atop 
various 
clinical 
s 
r 
e 
ecz 
one 
u 
mouth 
gas 
##tro 
in 
##test 
##testinal 
cord 
blood 
serum 
inner 
##tic 
sheep 
goat 
[CLS] 
bio 
##chemical 
status 
er 
##yt 
##hr 
##oc 
enzyme 
blood 
level 
sexual 
advent 
##uri 
high 
behavior 
1 
se 
##ro 
##con 
##version 
##hor 
1984 
1992 
pen 
##ros 
protein 
cycle 
dependent 
nuclear 
local 
required 
proliferation 
[CLS] 
para 
##dox 
##ically 
decrease 
level 
soluble 
a 
beta 
secret 
cell 
signaling 
mit 
##ogen 
kinase 
r 
##ac 
r 
du 
effect 
##a 
skeletal 
my 
##ogen 
##esis 
internal 
pro 
##ct 
involve 
nuclear 
trans 
ma 
expression 
neo 
##2 
neo 
construct 
##zy 
independently 
electro 
##porated 
y 
in 
restricted 
restricted il 
il 2 
##oto 
when 
es 
##cher 
##ichi 
co 
##li 
display 
t 
##os 
specific 
p 
##tase 
[SEP] 
[CLS] 
the 
structure 
el 
##uc 
##ida 
##tion 
i 
##rid 
##oid 
compound 
2 
3 
discussed 
detail 
[SEP] 
[CLS] 
the 
result 
study 
investigate 
investigate effectiveness 
prop 
##olis 
containing 
mouth 
in 
##hibition 
de 
no 
##vo 
plaque 
formation 
presented 
effect 
s 
##hos 
##ai 
##koto 
##al 
herb 
##al 
medicinal 
mixture 
restraint 
the 
region 
surrounding 
##f 
3 
##p 
##21 
particular 
region 
chromosome 
3 
frequently 
involved 
rear 
##rang 
del 
##eti 
tumor 
including 
lung 
re 
##nal 
##cin 
##oma 
[CLS] 
in 
promoter 
many 
immediate 
early 
gene 
including 
c 
f 
##o 
##g 
d 
regulatory 
element 
media 
##te 
basal 
con 
##it 
##uit 
##ive 
expression 
rapid 
trans 
serum 
induction 
[SEP] 
re 
##con 
r 
polymer 
##ase 
##ivo 
co 
##tra 
##ns 
##fect 
##1 
##on 
like 
r 
encoding 
cat 
gene 
co 
1 
cell 
ii 
complete 
activity 
[SEP] 
[PAD] [CLS] 
trans 
##ient 
thy 
##rot 
##ox 
##ico 
[CLS] 
we 
unable 
construct 
insertion 
mutant 
r 
me 
##li 
##lot 
whereas 
mutant 
insertion 
outside 
gene 
readily 
readily obtained 
[CLS] 
b 
##lot 
reveals 
c 
##jun 
##b 
family 
member 
##b 
beta 
physiological 
##ly 
relevant 
transcription 
factor 
whose 
expression 
corresponds 
m 
##da 
m 
##rna 
expression 
[SEP] 
[CLS] 
##lf 
odor 
el 
rapid 
trans 
camp 
response 
terminated 
concert 
##ed 
process 
requires 
requires action 
two 
p 
pka 
receptor 
specific 
kinase 
##rk 
##3 
s 
sch 
##le 
##iche 
##oe 
##kh 
##off 
i 
[SEP] 
##a 
##yla 
yeast 
yeast essential 
enzyme 
factor 
investigate 
role 
domain 
incorporation 
si 
en 
series 
si 
en 
mutant 
small 
frame 
del 
##eti 
##on 
within 
c 
##yt 
##op 
##las 
domain 
[CLS] 
computer 
analysis 
simple 
correlation 
hypothesis 
distribution 
1 
degree 
freedom 
revealed 
correlation 
vertical 
root 
fracture 
technique 
instrumentation 
o 
##bt 
##5 
length 
05 
existence 
[CLS] 
minute 
n 
##1 
83 
k 
required 
cell 
type 
involved 
multiple 
process 
necessary 
propagation 
propagation [SEP] 
t 
##d 
##x 
ass 
##los 
##por 
meta 
##bol 
blood 
sample 
hp 
##c 
r 
##ia 
method 
[CLS] 
however 
sequence 
m 
##rar 
beta 
3 
region 
a 
differs 
m 
##rar 
beta 
1 
additional 
27 
c 
terminal 
amino 
acid 
encoded 
81 
n 
##leo 
##tide 
long 
put 
##ative 
ex 
##on 
s 
##p 
##lice 
##d 
ex 
##on 
encoding 
a 
b 
region 
m 
##rar 
beta 
1 
[SEP] 
##d 
##d 
regulatory 
interaction 
##if 
##if 
suppress 
mutation 
isolated 
gene 
decrease 
su 
##pt 
##if 
##b 
inhibitor 
##if 
imp 
##air 
cat 
##alytic 
##if 
translation 
initiation 
[CLS] 
the 
3 
region 
trans 
##cript 
contained 
fully 
conserved 
correctly 
s 
##lice 
##d 
t 
##r 
alpha 
c 
region 
##lated 
3 
end 
[SEP] 
these 
##tal 
##pha 
regulated 
domain 
three 
alpha 
he 
repeat 
mixture 
ii 
last 
57 
residue 
[CLS] 
sorting 
information 
ch 
##op 
##lastic 
inner 
envelope 
contained 
##2 
pro 
##ximal 
part 
mature 
i 
##11 
##0 
110 
##n 
[SEP] 
[CLS] 
most 
element 
adjacent 
type 
x 
te 
##lo 
##mer 
##ic 
repeat 
region 
flank 
four 
five 
characterized 
s 
para 
##dox 
insertion 
carry 
autonomous 
##ly 
replica 
sequence 
[SEP] 
1989 
total 
regional 
##cin 
radio 
##ther 
##ap 
r 
rt 
regional 
##yper 
h 
ht 
division 
radiation 
on 
u 
k 
##enne 
nor 
cancer 
hospital 
##fo 
[CLS] 
the 
are 
defined 
five 
n 
##tide 
sequence 
embedded 
rich 
region 
[CLS] 
lack 
change 
milk 
production 
milk 
composition 
acute 
increase 
so 
##mat 
##ot 
##rop 
##in 
con 
##com 
##ita 
increase 
insulin 
sufficient 
stimulate 
synthesis 
milk 
milk 
component 
established 
##ation 
[SEP] 
[CLS] 
material 
cut 
diamond 
saw 
x 
10 
3 
mm 
upper 
polished 
si 
##o 
##2 
t 
##ita 
c 
layer 
3 
3 
micro 
##m 
enhanced 
vapor 
[CLS] 
i 
##oma 
##zen 
s 
increase 
##zo 
##dia 
receptor 
up 
co 
##rt 
##ical 
region 
except 
temporal 
cortex 
both 
##y 
e 
##pi 
##zo 
##otic 
situation 
au 
##je 
disease 
##fa 
long 
density 
[CLS] 
since 
regulate 
receptor 
activity 
ma 
cell 
specifically 
regulate 
co 
##act 
##ivation 
mediated 
1 
propose 
indirectly 
regulate 
receptor 
##f 
activity 
competition 
co 
##act 
##iva 
1 
di 
##c 
fi 
##bri 
##no 
may 
account 
##agu 
syndrome 
syndrome [SEP] 
[CLS] 
a 
case 
chicken 
ho 
##mo 
##mologue 
two 
##r 
form 
a 
b 
originate 
translation 
##al 
initiation 
au 
##2 
co 
##don 
165 
##1 
respectively 
[SEP] 
[CLS] 
flu 
##ct 
measured 
e 
##c 
##f 
energy 
related 
correspond 
clinical 
event 
presumably 
involving 
h 
##y 
##pox 
is 
##che 
##mia 
using 
laser 
di 
##abe 
further 
zinc 
##al 
natural 
activation 
[CLS] 
cell 
stab 
##ly 
trans 
##fected 
alpha 
2 
alpha 
3 
gene 
5 
flank 
##ing 
sequence 
fused 
##fly 
l 
##uc 
##ifer 
##ase 
##a 
reporter 
temporal 
10 
15 
fold 
transcription 
##al 
activation 
gene 
occurred 
cellular 
polar 
##ization 
[SEP] 
conclusion 
result 
his 
##tamine 
receptor 
activation 
mechanism 
may 
involved 
##oper 
il 
6 
synthesis 
regime 
do 
plus 
s 
##tre 
##pt 
do 
r 
##if 
good 
el 
##ap 
pain 
hospital 
shorter 
do 
plus 
s 
##tre 
[CLS] 
fi 
##bro 
##sis 
adjacent 
my 
##oc 
##ard 
##ium 
seen 
five 
case 
four 
similar 
degree 
74 
120 
fold 
reduction 
rate 
reaction 
o 
##6 
##zy 
##nine 
reduction 
noted 
vertical 
##rf 
new 
ex 
exert 
000 
##9 
20 
03 
038 
##3 
stance 
phase 
ant 
##eri 
##or 
ex 
exert 
000 
##9 
50 
00 
stance 
##bula 
##th 
##otic 
device 
identification 
k 
at 
encoded 
b 
1 
[CLS] 
it 
suggested 
bi 
##lia 
##ry 
secret 
t 
##b 
##z 
##b 
##z 
meta 
##bol 
##ite 
may 
contribute 
recycling 
[SEP] 
[CLS] 
during 
chord 
##oto 
##nal 
organ 
development 
3 
enhance 
##r 
directs 
expression 
prone 
##ural 
cluster 
whereas 
successive 
modular 
enhance 
##r 
located 
5 
region 
drive 
tissue 
specific 
expression 
##oto 
##nal 
organ 
precursor 
em 
##b 
##ryo 
la 
##rva 
##l 
leg 
wing 
antenna 
im 
disc 
disc [SEP] 
[CLS] 
the 
measured 
blood 
drug 
##di 
day 
morning 
evening 
[CLS] 
n 
##uc 
##d 
structure 
the 
##rm 
##ost 
n 
##uc 
##d 
polymer 
##ase 
complex 
[SEP] 
vascular 
component 
##ote 
shown 
management 
management [SEP] 
[CLS] 
result 
ma 
maximal 
early 
as 
##th 
##er 
place 
4 
se 
se 4 
4 
web 
web 208 
##6 
##6 18 
9 
4 
4 4 
4 [SEP] 
##xin 
##ate 
[CLS] 
useful 
computer 
to 
##mo 
hem 
##od 
##ial 
##ys 
patient 
patient [SEP] 
[CLS] 
the 
aim 
study 
determine 
exercise 
training 
vent 
##ric 
di 
##ast 
##olic 
filling 
rest 
exercise 
patient 
is 
##che 
##io 
change 
di 
##ast 
##olic 
exercise 
tolerance 
[SEP] 
p 
9 
10 
di 
##hy 
##dr 
##o 
10 
1 
met 
##hyl 
4 
##rid 
##yl 
##iden 
##e 
9 
9 ant 
##hr 
##ol 
wa 
his 
se 
##rot 
##oni 
[CLS] 
methodology 
a 
case 
control 
study 
survivor 
##esta 
28 
1000 
data 
##ata 
##atal 
intensive 
database 
[SEP] 
[CLS] 
there 
two 
regulatory 
region 
##3 
##6 
transcription 
unit 
[SEP] 
database 
search 
revealed 
50 
63 
similarity 
34 
identity 
se 
serine 
pro 
##te 
##ase 
try 
##ps 
pro 
prote 
including 
pro 
gamma 
gamma e 
##iva 
including 
tissue 
p 
##min 
##iva 
human 
he 
act 
##iva 
super 
##id 
##ose 
e 
##ins 
gas 
ex 
##citation 
##cilla 
b 
##ose 
e 
##ins 
gas 
dependent 
[CLS] 
4 
7 
0 
6 
##mo 
##l 
kg 
1 
[CLS] 
min 
1 
changed 
training 
training [SEP] 
[CLS] 
l 
##ymph 
s 
s 
##h 
s 
##3 
domain 
containing 
##rb 
subunit 
3 
associate 
##utive 
##b 
via 
s 
##h 
##3 
[SEP] 
[CLS] 
z 
##ta 
hat 
##b 
##p 
ma 
cell 
##b 
##p 
[SEP] 
patient 
sub 
##to 
##tal 
##illo 
at 
##rop 
9 
17 
patient 
53 
patient 
partial 
at 
##rop 
patient 
15 
normal 
##illo 
2 
10 
patient 
20 
20 [SEP] 
however 
op 
com 
##pressive 
reached 
value 
40 
higher 
cc 
sample 
expression 
ho 
##x 
49 
59 
l 
49 
l 
59 
regulate 
ho 
hom 
gene 
expression 
c 
el 
##egan 
##egans 
t 
##r 
##x 
gene 
d 
##ros 
##op 
[CLS] 
l 
49 
59 
trans 
##gene 
expressed 
widely 
throughout 
throughout c 
el 
##egan 
##egans 
animal 
[SEP] 
[CLS] 
inter 
##le 
##uki 
1 
increased 
nor 
##ad 
##rena 
##line 
release 
[CLS] 
magnetic 
influence 
central 
nervous 
system 
function 
3 
patient 
##uka 
##rom 
random 
donor 
plate 
##let 
trans 
high 
dose 
two 
gene 
##i 
en 
ho 
##mo 
##logue 
##s 
energy 
coupling 
enzyme 
i 
p 
##oe 
##no 
##vate 
dependent 
sugar 
##ot 
##ran 
##fer 
##ase 
system 
previously 
es 
##cher 
##ichi 
co 
chromosome 
[CLS] 
eight 
suppress 
##or 
complement 
##ation 
group 
##1 
##2 
[CLS] 
these 
translation 
##al 
s 
##ter 
##ic 
all 
##eric 
control 
e 
##k 
function 
important 
d 
binding 
ability 
interact 
fully 
establish 
correct 
stereo 
##sp 
##ific 
array 
leading 
switching 
beta 
##bin 
transcription 
development 
[SEP] 
[CLS] 
o 
##late 
dig 
##estive 
tract 
however 
in 
##ven 
##ous 
injection 
##d 
101 
marked 
improvement 
##pt 
##om 
[CLS] 
western 
b 
##lot 
experiment 
s 
70 
k 
##da 
protein 
may 
c 
##lea 
##ved 
active 
34 
k 
##da 
n 
terminal 
p 
##pt 
##ide 
[SEP] 
the 
a 
##eti 
management 
di 
##abe 
imp 
##ote 
well 
effect 
diabetes 
sexuality 
clear 
treatment 
diabetes 
re 
##tina 
##tinal 
com 
##plication 
##plication [SEP] 
[CLS] 
activated 
g 
##co 
##cor 
##tic 
form 
complex 
s 
##tat 
##5 
enhance 
s 
##tat 
mediated 
transcription 
##al 
induction 
demonstrate 
##6 
##3 
member 
family 
trans 
##act 
##iva 
protein 
[CLS] 
for 
presence 
two 
related 
gene 
b 
b 
##ob 
##act 
##eri 
suggests 
at 
##p 
s 
##ynth 
##ase 
complex 
nine 
##pt 
##ide 
single 
copy 
related 
b 
protein 
rather 
two 
copy 
identical 
b 
subunit 
found 
enzyme 
4 
[SEP] 
liver 
s 
##6 
kinase 
kinase specifically 
specifically im 
##ates 
##p 
labeled 
insulin 
s 
##6 
c 
##rk 
##l 
s 
##3 
##3 
adapt 
one 
major 
##uke 
##ut 
cm 
##l 
125 
accelerated 
healing 
ace 
##tic 
acid 
induced 
duo 
##den 
##al 
ul 
##cer 
well 
f 
##amo 
##ti 
r 
##ati 
ace 
##tate 
identify 
residue 
responsible 
mutant 
neutral 
##ized 
m 
##h 
##v 
receptor 
since 
mutant 
expected 
mutation 
amino 
acid 
responsible 
receptor 
binding 
[CLS] 
it 
s 
man 
##son 
##i 
c 
##er 
##car 
##ia 
penetration 
ma 
##mmal 
host 
skin 
probably 
due 
exhaustion 
energy 
reserve 
reserve [SEP] 
especially 
number 
dimension 
sample 
large 
said 
b 
##p 
##n 
better 
k 
n 
classification 
sir 
##4 
##p 
interacting 
rap 
##1 
##p 
partition 
le 
##xa 
##4 
##p 
fusion 
nine 
individual 
stable 
1 
month 
therapy 
low 
dos 
random 
##ized 
therapy 
low 
high 
dos 
one 
four 
high 
dos 
partial 
response 
none 
five 
dos 
manifest 
##ed 
response 
response [SEP] 
background 
m 
##p 
##rop 
resistance 
gene 
it 
##y 
##g 
[CLS] 
in 
case 
identified 
ins 
##uli 
affected 
23 
is 
##let 
containing 
insulin 
affected 
1 
is 
##let 
insulin 
def 
##icient 
thus 
ins 
##uli 
##tis 
##mu 
##munological 
destruction 
insulin 
secret 
b 
cell 
cell [SEP] 
[CLS] 
4 
expression 
different 
site 
central 
nervous 
system 
driven 
se 
##par 
##able 
element 
widely 
dispersed 
throughout 
8 
k 
##b 
3 
gene 
[SEP] 
investigate 
possible 
role 
##p 
late 
er 
##hr 
##oid 
differentiation 
expression 
##po 
hem 
##og 
##bin 
er 
##hr 
##uke 
[CLS] 
the 
end 
cluster 
contained 
human 
type 
i 
##20 
k 
gene 
lo 
##cus 
[CLS] 
an 
11 
5 
k 
##b 
intro 
##n 
found 
end 
trans 
##rane 
rest 
or 
ex 
##on 
3 
are 
lesson 
lesson learnt 
learnt [SEP] 
e 
##cin 
entered 
met 
##hyl 
##ami 
##f 
800 
m 
m2 
i 
##v 
daily 
5 
day 
every 
4 
week 
kinase 
played 
regulating 
##uri 
##te 
out 
##gro 
growth 
cone 
m 
##ot 
cell 
auto 
essential 
y 
[CLS] 
however 
trans 
trans 
t 
##run 
##cation 
little 
15 
n 
##r 
##1 
co 
##oh 
terminal 
amino 
acid 
transcription 
##al 
activation 
b 
##1 
##a 
##mi 
##dine 
kinase 
##lora 
##ico 
##l 
##ty 
##ran 
##fer 
reporter 
[SEP] 
so 
nurse 
nine 
pig 
in 
micro 
##scopic 
intact 
alter 
concentration 
##ronic 
acid 
different 
s 
##ra 
high 
eh 
ehf 
##r 
end 
##oc 
##rine 
system 
series 
h 
##yper 
process 
##um 
characterization 
human 
act 
##ivating 
transcription 
factor 
4 
transcription 
##al 
act 
##iva 
interact 
##s 
multiple 
domain 
camp 
re 
element 
binding 
##b 
binding 
[SEP] 
effect 
constant 
magnetic 
different 
car 
##cin 
##ogen 
##esis 
[CLS] 
in 
##p 
##ro 
effect 
##ab 
##1 
##ab 
##2 
media 
el 
##k 
1 
induction 
molecule 
similar 
extra 
##cellular 
regulated 
activation 
either 
on 
##co 
##a 
growth 
factor 
stimulation 
[SEP] 
[CLS] 
this 
result 
expression 
##70 
gene 
t 
##uce 
##i 
mainly 
controlled 
post 
##tra 
##ns 
##cription 
##al 
level 
a 
definition 
bias 
concept 
study 
base 
base [SEP] 
##roma 
trans 
##mi 
entire 
coding 
sequence 
c 
r 
##ab 
##phi 
##3 
inserted 
anti 
orientation 
in 
secret 
co 
expressed 
approximately 
30 
serum 
full 
spot 
test 
##mer 
##ieu 
##gen 
an 
environmental 
investigation 
sub 
##op 
##ti 
food 
storage 
temperature 
restaurant 
food 
may 
contributed 
low 
at 
##tri 
##but 
##able 
identified 
re 
##os 
[CLS] 
evidence 
four 
area 
sensory 
de 
##ri 
##vation 
environment 
nervous 
system 
plastic 
##ity 
sensitive 
ne 
##uro 
##de 
##vel 
##op 
##ment 
sensory 
stimulation 
program 
beneficial 
s 
patient 
[SEP] 
[CLS] 
study 
elevated 
level 
serum 
i 
observed 
[CLS] 
with 
exercise 
gradual 
increase 
blood 
la 
##ct 
##ate 
concentration 
la 
b 
occurred 
whereas 
rate 
accumulation 
delta 
la 
b 
decreased 
decreased [SEP] 
[CLS] 
a 
physical 
genetic 
map 
covering 
entire 
##p 
##12 
candidate 
gene 
region 
constructed 
[CLS] 
the 
single 
copy 
fl 
1 
gene 
located 
##p 
##21 
3 
m 
mh 
##c 
class 
i 
region 
consists 
13 
ex 
##on 
15 
k 
##b 
[PAD] [CLS] 
an 
at 
form 
juvenile 
severe 
em 
##ac 
##iation 
muscle 
at 
##rop 
op 
bulb 
##ar 
sign 
joint 
contract 
[CLS] 
v 
##ivo 
response 
##c 
like 
de 
##came 
##rs 
external 
dependent 
status 
regulated 
act 
##iva 
##tor 
##rim 
##10 
##1 
##p 
ho 
##mo 
##log 
##ous 
ni 
nidu 
##c 
regulator 
[SEP] 
[CLS] 
electron 
micro 
##scopic 
visual 
population 
active 
gene 
fly 
great 
majority 
gene 
seemed 
normal 
term 
co 
##ns 
##cription 
##al 
r 
processing 
event 
abnormal 
##ity 
rare 
ex 
##on 
skip 
##ping 
event 
[SEP] 
having 
proper 
local 
##od 
b 
##uddin 
yeast 
examined 
local 
##ization 
fusion 
##od 
##ssion 
##od 
method 
[CLS] 
serum 
newborn 
##esta 
week 
radio 
s 
g 
##b 
type 
i 
##a 
i 
##b 
ii 
ii 
##i 
##i [SEP] 
in 
frozen 
section 
appear 
blue 
labelled 
ne 
##uron 
brilliant 
red 
ne 
##uron 
##es 
surrounded 
reddish 
tissue 
##scope 
##scope [SEP] 
[CLS] 
the 
percentage 
distribution 
type 
fix 
di 
##sp 
##arity 
curve 
study 
higher 
prevalence 
type 
i 
curve 
64 
3 
followed 
type 
ii 
28 
6 
type 
ii 
##i 
7 
1 
curve 
curve [SEP] 
[CLS] 
b 
##ur 
set 
set 20 
min 
it 
second 
[PAD] [CLS] 
data 
context 
path 
##ogen 
differential 
##ec 
##ec [SEP] 
[CLS] 
seminal 
pro 
##ct 
##in 
level 
significantly 
elevated 
##fer 
male 
[CLS] 
northern 
b 
##lot 
re 
##tina 
specific 
trans 
##cript 
3 
0 
k 
##b 
rod 
g 
alpha 
2 
6 
k 
##b 
cone 
alpha 
[SEP] 
##ria 
fixed 
dependent 
##var 
##iate 
many 
variable 
progression 
t 
##4 
cell 
count 
t 
ratio 
blast 
mit 
serum 
serum i 
##ga 
appearance 
development 
hairy 
##1 
##lio 
##blast 
in 
##hibit 
s 
phase 
entry 
recruitment 
##p 
e 
##d 
##k 
cost 
analysis 
framework 
framework [SEP] 
[CLS] 
c 
##y 
##c 
##lin 
c 
##c 
associated 
characteristic 
s 
phase 
induction 
characterization 
ton 
##b 
p 
##ho 
##a 
gene 
fusion 
amino 
terminal 
41 
amino 
acid 
ton 
##b 
sufficient 
promote 
presumably 
ton 
##b 
well 
[SEP] 
bi 
##ru 
##bina 
##te 
crystal 
seen 
##l 
##bla 
##dder 
bi 
##le 
wall 
scraping 
8 
t 
control 
00 
001 
this 
domain 
encompasses 
region 
##rp 
1 
coup 
t 
##i 
corresponding 
he 
##lix 
3 
12 
crystal 
structure 
receptor 
[SEP] 
[CLS] 
different 
clinical 
variant 
empty 
sell 
##a 
t 
##ca 
syndrome 
demonstrated 
variant 
result 
substitution 
therapy 
thy 
##roid 
h 
##po 
##function 
do 
##pa 
ago 
##nist 
therapy 
h 
##yper 
##p 
##rol 
##act 
##ine 
h 
##gon 
##adi 
##sm 
radio 
##ther 
##ap 
h 
##sea 
##l 
ad 
##eno 
##ma 
##ma [SEP] 
[CLS] 
both 
gene 
##ro 
##3 
##ro 
##4 
strongly 
regulated 
general 
control 
regulatory 
system 
[CLS] 
polar 
effect 
trans 
##po 
insertion 
m 
##rna 
arose 
single 
promoter 
region 
transcription 
initiated 
80 
b 
##p 
5 
ni 
##f 
##h 
[SEP] 
j 
[CLS] 
importantly 
single 
base 
change 
fifth 
position 
c 
f 
##o 
sequence 
##ga 
##cc 
g 
ggt 
##ca 
##ga 
produced 
element 
bound 
est 
##rogen 
receptor 
conferred 
est 
##rogen 
dependent 
transcription 
##al 
activation 
reporter 
gene 
[CLS] 
measuring 
dim 
##lat 
##oni 
##n 
onset 
d 
useful 
practical 
way 
ass 
circa 
##dian 
phase 
position 
human 
co 
expression 
gag 
t 
##ral 
##pha 
fusion 
transformed 
##igan 
der 
##ep 
##resses 
ca 
##ii 
transcription 
transcription [SEP] 
the 
i 
##b 
gene 
approved 
symbol 
map 
contains 
10 
coding 
ex 
##on 
[CLS] 
transcription 
start 
site 
##l 
##r 
gene 
determined 
lie 
30 
24 
b 
##p 
upstream 
respective 
initiation 
co 
##don 
separated 
78 
n 
##leo 
##tide 
[SEP] 
1 
23 
##pha 
interacting 
chain 
associated 
70 
kinase 
based 
activation 
motif 
essential 
membrane 
recruitment 
##av 
[PAD] [CLS] 
we 
carried 
two 
experiment 
investigate 
problem 
problem [SEP] 
[CLS] 
when 
linked 
linked her 
##dine 
minimal 
promoter 
fragment 
act 
enhancing 
element 
r 
##cho 
g 
##c 
cell 
[SEP] 
[CLS] 
a 
ma 
##mmal 
protein 
called 
r 
##f 
##x 
x 
bind 
x 
box 
x 
##1 
box 
promoter 
number 
class 
gene 
directed 
m 
##uta 
investigate 
functional 
element 
3 
minus 
strand 
terminal 
sequence 
3 
cc 
##au 
contains 
strand 
3 
end 
sequence 
3 
1 
1 2 
2 a 
u 
a 
u 
found 
car 
##mo 
r 
##na 
[SEP] 
[CLS] 
the 
var 
free 
##a 
total 
##a 
ratio 
early 
diagnosis 
pro 
##state 
cancer 
[CLS] 
##b 
##1 
##b 
##p 
could 
media 
high 
rate 
r 
##v 
l 
##tr 
enhanced 
transcription 
b 
##urs 
##al 
l 
##ymph 
##oma 
cell 
many 
cell 
type 
[SEP] 
[CLS] 
in 
student 
given 
trim 
su 
##zo 
160 
t 
s 
##m 
##x 
800 
mg 
38 
t 
35 
##bo 
given 
b 
five 
day 
[CLS] 
developmental 
slot 
b 
m 
mrna 
corresponding 
three 
l 
##hm 
trans 
##cribed 
##has 
me 
##ios 
i 
##sp 
##ore 
stage 
northern 
analysis 
reveals 
tape 
##tal 
##ly 
expressed 
correspond 
trans 
##cript 
500 
b 
##p 
[SEP] 
[CLS] 
hundred 
men 
matched 
age 
study 
center 
length 
time 
blood 
draw 
100 
men 
##bo 
[CLS] 
the 
contribution 
residue 
outside 
##a 
binding 
domain 
##af 
r 
##af 
##rb 
##d 
##a 
r 
##af 
interaction 
##a 
dependent 
##af 
activation 
##res 
##ol 
##ved 
[SEP] 
other 
recommendation 
enhancing 
##plate 
##let 
variety 
provided 
provided [SEP] 
result 
attended 
repeat 
co 
##yt 
one 
year 
[SEP] 
change 
##ment 
mouse 
different 
er 
in 
sought 
determine 
specific 
effect 
pro 
prote 
##ase 
weight 
[CLS] 
however 
massive 
ne 
##c 
##rosis 
re 
##nal 
tub 
##ule 
found 
15 
##m 
##g 
d 
##sm 
administration 
administration [SEP] 
the 
characteristic 
simple 
apparatus 
typical 
emission 
emission [SEP] 
obtain 
information 
functional 
##ac 
##1 
##a 
signaling 
effect 
transcription 
differentiation 
[CLS] 
the 
cost 
effectiveness 
education 
1 
1 [SEP] 
[CLS] 
the 
at 
c 
site 
also 
essential 
##d 
##4 
promoter 
activation 
for 
##sko 
act 
##iva 
ad 
##c 
##lase 
[SEP] 
##0 
##31 
##c 
essential 
gene 
restricted 
expression 
novel 
at 
##onal 
##iff 
##nti 
##ated 
neural 
precursor 
[CLS] 
since 
1900s 
genetic 
hypothesis 
suggested 
suggested [SEP] 
we 
g 
##eno 
##mic 
organization 
mouse 
structural 
member 
factor 
##9 
s 
##d 
partial 
kinase 
20 
compared 
[CLS] 
the 
structure 
expression 
gene 
colony 
s 
evidence 
u 
##til 
alternative 
promoter 
[CLS] 
thus 
search 
genetic 
acquired 
su 
##ibility 
##tub 
##er 
##cu 
##lous 
my 
##co 
##ba 
search 
su 
factor 
##b 
opportunity 
recognize 
end 
##ogen 
pathway 
exploited 
therapeutic 
liver 
disease 
##v 
infection 
transplant 
he 
donor 
donor [SEP] 
after 
dial 
##ys 
online 
la 
##ct 
##ate 
converted 
la 
##ct 
##ate 
o 
##xi 
##das 
##bil 
glass 
de 
##ple 
oxygen 
registered 
c 
##k 
electro 
##de 
[CLS] 
the 
de 
##duced 
amino 
acid 
sequence 
mature 
enzyme 
ho 
##mology 
20 
4 
identity 
known 
p 
##ly 
enzyme 
##tate 
##yas 
##sa 
##hari 
##yas 
1 
[SEP] 
he 
cell 
##op 
extract 
g 
##ath 
s 
transfer 
##ase 
##af 
presence 
at 
released 
active 
n 
could 
electro 
##ore 
loss 
ye 
##1 
still 
able 
complement 
##1 
mutation 
en 
red 
##uc 
domain 
[CLS] 
cross 
s 
##pec 
##ie 
characterization 
promoter 
region 
trans 
reveals 
multiple 
level 
regulation 
##id 
x 
necessary 
16 
17 
94 
infected 
visibly 
ill 
x 
t 
h 
thigh 
in 
survived 
30 
44 
68 
alone 
000 
0001 
[CLS] 
the 
predicted 
v 
on 
##co 
protein 
sequence 
exhibit 
several 
motif 
reminiscent 
transcription 
##al 
factor 
[SEP] 
[CLS] 
the 
p 
##har 
##co 
##kin 
##etics 
best 
described 
two 
compartment 
open 
model 
giving 
distribution 
half 
life 
0 
31 
h 
1 
53 
h 
elimination 
half 
life 
69 
7 
h 
60 
3 
h 
o 
##x 
##olin 
acid 
o 
##te 
respectively 
[SEP] 
[CLS] 
predict 
remotely 
sensed 
map 
based 
n 
##d 
##vi 
data 
appears 
better 
forecast 
##lim 
##atic 
data 
data [SEP] 
confirmed 
experiment 
##oc 
##ard 
sample 
sample approximately 
follows 
p 
##ois 
distribution 
adequate 
condition 
he 
##pa 
##bul 
hi 
##v 
anti 
##body 
this 
gene 
divided 
six 
ex 
##on 
spanning 
3 
##k 
##b 
en 
##codes 
amino 
protein 
40 
52 
identity 
re 
re 
##rating 
[CLS] 
p 
##3 
sequence 
feature 
acidic 
domain 
characteristic 
transcription 
##al 
activation 
factor 
well 
sequence 
block 
displaying 
limited 
similarity 
position 
##ally 
equivalent 
region 
si 
##gma 
factor 
##uba 
related 
mit 
##och 
##ond 
##rion 
[SEP] 
##r 
da 
##17 
abbreviated 
containing 
fragment 
se 
##rine 
th 
##oni 
rich 
domain 
l 
##dl 
receptor 
l 
##r 
place 
da 
derived 
se 
th 
rich 
sequence 
anchored 
[SEP] 
[CLS] 
thus 
pathway 
pathway f 
##ps 
##ilon 
##ri 
##k 
##k 
##k 
activation 
activation apparently 
bypass 
##af 
1 
201 
##allo 
##l 
detect 
detect childhood 
tumor 
child 
1 
0 
0 18 
year 
photo 
com 
s 
##pect 
##pect t 
1 
3 
1 
1 8 
m 
in 
##ven 
##ously 
followed 
patient 
patient tech 
99 
m 
in 
##ven 
##ously 
##ously [SEP] 
ft 
##z 
hand 
influence 
##z 
f 
##1 
activity 
interacting 
##f 
2 
domain 
manner 
mimic 
nuclear 
receptor 
co 
##act 
##iva 
[CLS] 
successive 
5 
del 
##eti 
##on 
32 
##6 
20 
type 
promoter 
indicated 
region 
upstream 
position 
195 
in 
##hibit 
##s 
transcription 
##fold 
he 
cell 
[CLS] 
forty 
patient 
recent 
##yper 
##roid 
12 
s 
##tra 
##ti 
##fied 
randomly 
allocated 
car 
##bi 
##ma 
##zo 
neo 
##tom 
##iz 
car 
##bi 
##zo 
plus 
dose 
c 
##t 
##ls 
##r 
100 
i 
##u 
day 
2 
day 
week 
car 
##bi 
##ma 
##zo 
plus 
high 
dose 
c 
##t 
##ls 
##r 
100 
##u 
day 
14 
day 
month 
the 
c 
##lon 
showed 
corresponds 
##01 
en 
##codes 
14 
trans 
segment 
containing 
several 
put 
##ative 
##cos 
site 
[CLS] 
however 
strain 
two 
highly 
related 
gene 
d 
##d 
##pi 
##k 
##1 
d 
##d 
##pi 
##k 
disrupted 
showed 
growth 
developmental 
defect 
double 
knockout 
d 
##d 
##pi 
##k 
##1 
d 
##d 
##pi 
##k 
##3 
d 
##d 
##pi 
##k 
d 
##d 
##pi 
##3 
appear 
lethal 
[CLS] 
this 
mechanism 
seems 
involved 
induced 
##rl 
gene 
regulation 
[CLS] 
competition 
met 
##hyl 
interference 
ass 
showed 
binding 
site 
novel 
factor 
limited 
n 
##tide 
3 
half 
##ppa 
site 
these 
prompted 
investigate 
1 
expression 
co 
pattern 
1 
##dr 
[CLS] 
concentration 
insulin 
maternal 
plasma 
higher 
ethanol 
[CLS] 
the 
strongly 
d 
binding 
p 
##50 
subunit 
showed 
weak 
induction 
gene 
expression 
[SEP] 
the 
result 
obtained 
app 
##lica 
##roma 
e 
##1 
##a 
transformed 
em 
##b 
##bro 
high 
con 
##it 
##utive 
d 
binding 
##p 
1 
dim 
##er 
altered 
[CLS] 
minor 
change 
within 
trans 
##rane 
domain 
t 
##m 
sometimes 
produced 
major 
effect 
drastic 
change 
t 
##m 
a 
##bla 
##ted 
surface 
entirely 
[CLS] 
nuclear 
local 
like 
put 
he 
##lica 
dependent 
nuclear 
local 
##ization 
sequence 
located 
terminal 
region 
[SEP] 
##eas 
##r 
##1 
ch 
strategy 
targeting 
complement 
in 
##hibition 
use 
particular 
specific 
##ity 
[CLS] 
m 
##or 
##phological 
functional 
status 
ed 
##ent 
##ulous 
##di 
##ble 
selection 
selection effective 
method 
functional 
impression 
taking 
taking [SEP] 
se 
as 
0 
mm 
##2 
[CLS] 
ta 
rest 
4 
06 
decreased 
decreased 2 
44 
1 
07 
1 
h 
##z 
1 
81 
0 
0 4 
h 
##z 
##z [SEP] 
[PAD] [CLS] 
investigate 
211 
child 
in 
inc 
##cl 
one 
1990 
checked 
1991 
site 
bra 
##tis 
town 
varying 
so 
##2 
dust 
##iness 
dust 
##out 
influence 
type 
course 
re 
relap 
respiratory 
disease 
disease [SEP] 
statistical 
difference 
ca 
p 
ratio 
carbon 
surface 
energy 
different 
heat 
[CLS] 
dim 
##4 
promoter 
region 
differential 
##ly 
protected 
depending 
upon 
ho 
##lo 
##zy 
bound 
[CLS] 
in 
##1 
terminal 
amino 
acid 
n 
##1 
##a 
entire 
r 
binding 
domain 
deleted 
car 
##box 
##yl 
portion 
n 
##1 
##a 
protein 
function 
effect 
##or 
domain 
[CLS] 
overall 
pre 
##nat 
##al 
exposure 
and 
##rogen 
based 
pro 
ex 
exert 
##erted 
ma 
##cu 
##lini 
def 
##em 
influence 
human 
behavioral 
development 
whereas 
pre 
##nat 
##al 
natural 
pro 
##tero 
pro 
based 
##em 
dem 
##as 
##cu 
##lini 
particularly 
among 
subject 
subject [SEP] 
the 
test 
##is 
specimen 
t 
##rit 
##rm 
##ora 
collected 
month 
1987 
processed 
electron 
##sco 
micro 
##sco 
test 
##osterone 
t 
following 
##c 
avid 
bio 
per 
##idas 
complex 
method 
[CLS] 
m 
##t 
##x 
therapy 
##a 
67 
up 
liver 
tumor 
muscle 
[PAD] [CLS] 
in 
stage 
i 
his 
##to 
##chemistry 
copper 
11 
21 
case 
case 
case t 
1 
2 
case 
case o 
o 2 
case 
case t 
t r 
[CLS] 
en 
sodium 
flu 
dye 
release 
[CLS] 
prime 
##r 
extension 
analysis 
sub 
##c 
##lon 
##j 
##ho 
##a 
fusion 
indicate 
ace 
##tos 
##yr 
##ing 
##one 
in 
promoter 
lie 
directly 
upstream 
##j 
structural 
gene 
[SEP] 
[CLS] 
gene 
contain 
zinc 
finger 
motif 
human 
brain 
c 
##a 
library 
screened 
o 
##gon 
##leo 
##tide 
complementary 
conserved 
link 
##er 
sequence 
adjacent 
zinc 
finger 
[SEP] 
[CLS] 
18 
##b 
response 
##oc 
##ram 
01 
subject 
5 
day 
200 
me 
##q 
sodium 
intake 
day 
10 
##q 
sodium 
intake 
[CLS] 
##ivo 
screening 
first 
identified 
gene 
appeared 
interfere 
his 
p 
##ore 
hp 
##t 
domain 
receiver 
domain 
o 
##r 
provided 
gene 
product 
multi 
##copy 
##mi 
##d 
[SEP] 
[CLS] 
##d 
##1 
emerged 
anti 
##gen 
presenting 
system 
distinct 
i 
ii 
molecule 
the 
predicted 
amino 
acid 
sequence 
##1 
##p 
high 
sequence 
ho 
sin 
##3 
protein 
known 
interaction 
de 
[SEP] 
q 
##az 
##one 
study 
nitrogen 
containing 
compound 
removal 
dramatically 
l 
##ymph 
##oid 
##uro 
defect 
seen 
b 
##mi 
1 
def 
indicating 
##a 
critical 
##ivo 
target 
##mi 
1 
[CLS] 
r 
##x 
##r 
##dr 
trans 
##activated 
selective 
linked 
template 
exclusively 
he 
##tero 
##di 
##mer 
##ic 
complex 
receptor 
alone 
transcription 
##ro 
[SEP] 
nasal 
##iro 
m 
##rsa 
either 
nose 
effect 
##iro 
era 
##dication 
[CLS] 
of 
10 
70 
##9 
70 
##1 
chemistry 
specimen 
participating 
laboratory 
data 
period 
37 
208 
0 
35 
rejected 
prior 
testing 
[SEP] 
early 
complement 
component 
c 
##1 
##q 
##ga 
secret 
piece 
absent 
administration 
s 
##4 
group 
resulted 
decrease 
al 
##a 
d 
activity 
increase 
##p 
u 
dominant 
##3 
transcription 
##al 
activation 
##ch 
##ne 
##ider 
##pha 
##3 
interaction 
define 
pathway 
pathway e 
e2 
in 
##hibition 
mechanism 
decreased 
##2 
[SEP] 
[CLS] 
[CLS] from 
su 
##os 
possible 
connection 
syndrome 
syndrome e 
e g 
##uc 
regional 
cerebral 
d 
##ys 
audit 
ta 
hall 
##uc 
investigated 
s 
oriented 
study 
tech 
##net 
99 
99 
##ao 
s 
##pect 
compared 
normal 
control 
control [SEP] 
[CLS] 
lack 
chronic 
depressed 
##b 
1 
day 
quick 
structural 
repair 
end 
##oth 
##eli 
##um 
in 
##uc 
##ida 
##idate 
possible 
mechanism 
action 
em 
examined 
effect 
drug 
expression 
##ut 
##hesion 
1 
tissue 
expansion 
prepare 
tissue 
closure 
following 
difficult 
club 
##foot 
correction 
correction [SEP] 
[CLS] 
the 
transcription 
start 
site 
identified 
prime 
##r 
extension 
analysis 
800 
b 
##p 
5 
flank 
##ing 
d 
sequence 
##d 
[SEP] 
[CLS] 
the 
reporter 
gene 
two 
copy 
wild 
type 
repeat 
2 
3 
sequence 
trans 
##cribed 
actively 
s 
##tero 
##l 
deprived 
cell 
re 
##pressed 
80 
s 
##tero 
##l 
present 
[SEP] 
change 
tension 
is 
b 
##asi 
[PAD] [CLS] 
1 
5 
month 
boy 
##ifer 
syndrome 
syndrome described 
described [SEP] 
[CLS] 
however 
##12 
cell 
clone 
expressed 
p 
1 
increased 
level 
re 
##gu 
fashion 
response 
de 
##has 
isolated 
in 
##i 
3 
##d 
##d4 
complex 
judged 
presence 
##i 
3 
##d 
##d4 
the 
clinical 
picture 
electron 
his 
##to 
described 
case 
fi 
##bro 
tend 
sheath 
however 
stability 
low 
already 
s 
o 
##dent 
##alis 
[CLS] 
in 
site 
p 
##d 
##f 
induced 
t 
##os 
p 
##lation 
mapped 
t 
##yr 
138 
s 
##h 
##3 
domain 
138 
exposed 
##h 
##3 
p 
##eptide 
binding 
surface 
[CLS] 
the 
result 
study 
suggest 
patient 
syndrome 
x 
##oc 
##ard 
##ial 
is 
##che 
frequently 
develops 
daily 
life 
silent 
is 
##che 
##mia 
important 
component 
syndrome 
increased 
oxygen 
demand 
presence 
impaired 
co 
##rona 
##ry 
##as 
##od 
##ila 
cause 
##oc 
##ard 
##ial 
is 
##che 
##mia 
##mia [SEP] 
[CLS] 
we 
identified 
d 
##na 
fragment 
10 
k 
##b 
##p 
upstream 
first 
coding 
ex 
##on 
human 
whose 
sequence 
conserved 
genome 
[SEP] 
[CLS] 
false 
positive 
fraction 
decreased 
count 
density 
increased 
difference 
f 
##pf 
found 
change 
les 
##ion 
trace 
##r 
concentration 
concentration [SEP] 
[CLS] 
these 
event 
weakly 
stimulate 
activated 
p 
##d 
alpha 
receptor 
[CLS] 
human 
p 
##last 
##in 
gene 
[SEP] 
bus 
##ere 
medical 
##cin 
pro 
##state 
apart 
o 
##rogen 
[CLS] 
c 
c e 
##b 
##p 
delta 
n 
6 
beta 
detected 
complex 
extract 
il 
1 
t 
[SEP] 
reduced 
upper 
gas 
##tro 
##est 
##inal 
ul 
##cer 
com 
##co 
novel 
co 
##x 
more 
t 
##5 
gene 
under 
genetic 
manipulation 
##ru 
##zi 
##ro 
find 
gene 
function 
at 
strain 
could 
strategy 
[CLS] 
in 
s 
##pect 
##ros 
tissue 
700 
400 
cm 
1 
region 
##00 
##3 
also 
termed 
##d 
##1 
ho 
##mo 
##mologue 
s 
##chi 
##zo 
##sa 
##cc 
##har 
##ces 
r 
##ad 
##21 
essential 
gene 
implicated 
d 
double 
strand 
break 
nuclear 
organization 
[PAD] [CLS] 
bio 
##art 
##ific 
disadvantage 
disadvantage [SEP] 
[CLS] 
the 
the objective 
study 
study 1 
##ify 
comparative 
structural 
static 
fatigue 
shoe 
toe 
box 
box 2 
evaluate 
preferred 
shoe 
characteristic 
determined 
survey 
local 
dancer 
dancer [SEP] 
in 
##oper 
te 
##tral 
##ogy 
fall 
##ot 
s 
##oma 
##ric 
##ular 
a 
##rr 
##hy 
##th 
concluded 
electro 
##uc 
episode 
anti 
##ar 
##r 
small 
number 
##ric 
##ular 
premature 
complex 
alone 
electro 
pro 
##gno 
improved 
treatment 
result 
prevention 
induction 
right 
##ric 
h 
##yper 
##tens 
drug 
treatment 
treatment [SEP] 
[CLS] 
indication 
therapy 
using 
ma 
##o 
inhibitor 
inhibitor [SEP] 
[CLS] 
the 
absorb 
el 
##uen 
##uent 
monitored 
[CLS] 
detailed 
study 
aimed 
identifying 
gene 
gene 
responsible 
rapid 
growth 
arrest 
obtained 
human 
chromosome 
9 
foot 
##print 
18 
enhance 
##r 
show 
five 
protected 
region 
ho 
##1 
##p 
##1 
e 
efi 
transcription 
factor 
binding 
motif 
[CLS] 
insulin 
binding 
alpha 
receptor 
stimulate 
receptor 
t 
beta 
subunit 
several 
##ogen 
protein 
substrate 
including 
##0 
##0 ha 
##4 
liver 
specific 
20 
000 
m 
##ot 
##ili 
serum 
level 
measured 
one 
hour 
[CLS] 
the 
role 
p 
##lation 
receptor 
des 
##zation 
receptor 
mutant 
cell 
ha 
##ms 
lung 
fi 
##bro 
[PAD] [CLS] 
first 
aid 
aid [SEP] 
improvement 
pharmaceutical 
##lo 
##fi 
##bra 
##te 
##de 
##x 
##tri 
complex 
[CLS] 
the 
detection 
mixed 
el 
##uen 
0 
05 
0 
13 
mg 
l 
several 
time 
single 
k 
el 
##uen 
early 
diagnosis 
early 
surgical 
division 
##ry 
##cre 
##atic 
duct 
recommended 
##b 
##d 
[CLS] 
we 
analyzed 
here 
four 
different 
p 
protein 
##3 
##x 
alpha 
##1 
##x 
beta 
##b 
##p 
##1 
##3 
s 
##tat 
mediated 
transcription 
##al 
activation 
[CLS] 
comparison 
predicted 
amino 
acid 
sequence 
d 
##ros 
##iri 
gene 
show 
several 
block 
amino 
acid 
sequence 
highly 
conserved 
[CLS] 
analysis 
focused 
two 
p 
##yr 
##hine 
new 
s 
##pec 
##ie 
call 
##ith 
##rix 
j 
##chus 
brown 
paired 
##eli 
##elic 
gamma 
lo 
##cus 
5 
gamma 
1 
gamma 
3 
ii 
m 
##d 
cooperative 
oral 
##ra 
c 
analogue 
##c 
resistant 
c 
##id 
de 
##nas 
tumor 
route 
found 
level 
##ster 
l 
##ster 
##ol 
inter 
##le 
##it 
##utive 
h 
i 
cell 
cell 
trans 
tax 
[CLS] 
unlike 
activation 
activation er 
##k 
activation 
mapped 
specific 
re 
gene 
segment 
er 
##k 
activation 
activation 
triggered 
different 
event 
virus 
host 
cell 
interaction 
[SEP] 
[CLS] 
despite 
decrease 
map 
r 
##s 
at 
30 
min 
prop 
in 
respect 
skeletal 
muscle 
examined 
effect 
mutation 
muscle 
two 
infant 
infant ho 
##mo 
##pect 
[PAD] [CLS] 
appears 
un 
##tre 
##ated 
patient 
stage 
i 
ii 
ii n 
##hl 
definite 
radio 
abnormal 
abnormal 
radio 
extra 
##ora 
spread 
treated 
patient 
questionable 
radio 
##graph 
##graph [SEP] 
[CLS] 
b 
##1 
fusion 
yeast 
gal 
##4 
d 
binding 
transcription 
##al 
activation 
domain 
interact 
synthesized 
yeast 
[CLS] 
because 
la 
##9 
contact 
position 
6 
7 
8 
plus 
##as 
separated 
one 
turn 
d 
he 
##lix 
twist 
way 
d 
thus 
protecting 
broad 
region 
minor 
groove 
major 
groove 
contact 
[SEP] 
on 
op 
##acle 
go 
##na 
##dal 
axis 
control 
male 
phase 
o 
##test 
##lug 
##rio 
##lim 
ca 
##fo 
##icus 
substitution 
ch 
##olin 
drug 
##z 
##heimer 
type 
dem 
##ent 
s 
##da 
##dat 
hit 
##her 
##to 
##to successful 
successful [SEP] 
[CLS] 
n 
##leo 
##tide 
middle 
anti 
##don 
e 
35 
suppress 
##or 
efficiency 
displayed 
c 
##yt 
##op 
##las 
t 
t 
##yr 
[SEP] 
[CLS] 
the 
root 
mean 
de 
bond 
ideal 
value 
0 
02 
a 
[SEP] 
[CLS] 
jet 
la 
me 
##lat 
[CLS] 
in 
interaction 
consequently 
mechanism 
governing 
transcription 
##al 
activation 
##f 
distinct 
media 
d 
replication 
[SEP] 
[CLS] 
a 
ta 
##aa 
##ta 
sequence 
present 
26 
n 
##t 
upstream 
major 
cap 
site 
within 
5 
flank 
##ing 
region 
several 
put 
##ative 
transcription 
factor 
binding 
site 
[SEP] 
[CLS] 
version 
brief 
s 
##l 
am 
##p 
similar 
correlation 
target 
variable 
full 
s 
##l 
am 
##p 
[CLS] 
enzyme 
bind 
d 
affinity 
20 
fold 
intact 
top 
##o 
##70 
[SEP] 
treatment 
##p 
45 
re 
tumor 
growth 
accompanied 
well 
blood 
picture 
bio 
parameter 
[PAD] [CLS] 
is 
##tan 
##bul 
turkey 
[CLS] 
optimal 
transcription 
g 
##d 
gene 
depends 
interaction 
i 
##4 
multiple 
binding 
site 
across 
cellular 
factor 
recognize 
specific 
sequence 
element 
promoter 
[SEP] 
identified 
family 
cave 
##olin 
related 
##olin 
termed 
##olin 
1 
role 
zinc 
finger 
s 
##1 
##26 
##r 
1 
transcription 
##al 
regulation 
human 
s 
##yna 
##pt 
##ob 
##re 
gene 
human 
human f 
gamma 
receptor 
gene 
gamma 
r 
##let 
##ut 
pre 
##ison 
d 
treatment 
occur 
added 
##ison 
base 
start 
combined 
##ison 
calcium 
e 
##ulos 
confirmed 
patient 
20 
6 
16 
case 
finding 
pro 
##tos 
##co 
##ces 
hook 
nine 
detection 
##ulos 
##5 
##5 [SEP] 
[CLS] 
the 
effect 
stimulation 
en 
##top 
nucleus 
e 
##p 
jaw 
opening 
reflex 
j 
##or 
studied 
cat 
an 
##est 
##he 
##tized 
sodium 
pen 
##to 
##bar 
##bit 
##al 
##ru 
syndrome 
late 
##ute 
disorder 
d 
ii 
criterion 
identified 
6 
woman 
[CLS] 
first 
mutation 
if 
##nga 
activated 
sequence 
gas 
either 
multi 
##mer 
##ized 
context 
1 
7 
k 
##b 
i 
##rf 
1 
promoter 
failed 
media 
##rl 
response 
showing 
i 
1 
gas 
target 
##rl 
signaling 
[SEP] 
[CLS] 
02 
##5 
##5 [SEP] 
[CLS] 
result 
pet 
revealed 
wide 
variation 
c 
##b 
##f 
region 
is 
##of 
##lu 
##rane 
particularly 
comparison 
prop 
##of 
##ol 
r 
##c 
##m 
##ro 
##2 
decreased 
globally 
dose 
dependent 
manner 
is 
##of 
##lu 
##rane 
prop 
##of 
##ol 
[CLS] 
selective 
sq 
##uel 
grim 
interact 
essential 
component 
r 
##na 
polymer 
##ase 
ii 
transcription 
machinery 
[SEP] 
[CLS] 
this 
first 
description 
in 
inte 
##gro 
##n 
located 
composite 
trans 
##po 
##son 
[SEP] 
[CLS] 
the 
nine 
subject 
treated 
random 
sequence 
##ime 
##ti 
##dine 
0 
0 8 
1 
0 
g 
one 
day 
##bo 
capsule 
protein 
over 
##ex 
es 
##cher 
pu 
ho 
[SEP] 
identification 
characterization 
yeast 
gene 
encoding 
##2 
[CLS] 
a 
360 
b 
##p 
d 
fragment 
located 
500 
b 
##p 
upstream 
##f 
##l 
transcription 
##al 
start 
site 
used 
d 
##nas 
##e 
i 
protection 
specific 
base 
bound 
co 
##rr 
[SEP] 
taking 
certain 
condition 
frequent 
feeding 
supplement 
##ary 
feeding 
4 
6 
month 
method 
absence 
##st 
##ru 
##ation 
la 
lam 
relied 
1 
year 
##um 
contains 
classical 
iron 
element 
3 
##ns 
##lated 
region 
con 
iron 
dependent 
##rna 
stab 
[CLS] 
likewise 
e 
##pid 
##ural 
m 
##or 
##phine 
modify 
in 
##oper 
metabolic 
ho 
##rmon 
##al 
response 
response [SEP] 
conclusion 
post 
##bar 
pu 
##nc 
headache 
may 
may mediated 
release 
substance 
p 
triggered 
l 
##r 
##nc 
patient 
pre 
##dis 
##posed 
h 
substance 
p 
art 
##erial 
blood 
sampling 
based 
##sp 
used 
quantitative 
##c 
##b 
##f 
measurement 
m 
##uta 
##ted 
##b 
##f 
##1 
site 
display 
##f 
##1 
functional 
replace 
##1 
##1 
site 
given 
rapid 
induction 
e 
##r 
1 
molecular 
mechanism 
underlying 
m 
##od 
injury 
nationwide 
survey 
ten 
##fold 
variation 
county 
##s 
if 
##n 
##b 
[CLS] 
in 
first 
account 
chronicle 
homeless 
jersey 
1980s 
1980s [SEP] 
re 
##ct 
##al 
temperature 
walk 
00 
##1 
si 
39 
87 
degree 
c 
b 
in 
39 
46 
degree 
c 
dominant 
mutation 
receptor 
map 
extra 
trans 
##rane 
segment 
[CLS] 
such 
simple 
injury 
accompanied 
far 
reaching 
consequence 
this 
first 
clearly 
proved 
c 
##ea 
synthesis 
h 
##cc 
[CLS] 
screening 
human 
test 
c 
##a 
library 
probe 
containing 
p 
pea 
##3 
domain 
isolated 
2 
2 
k 
##b 
clone 
containing 
510 
open 
reading 
frame 
au 
rich 
element 
3 
region 
new 
##uc 
##ru 
con 
##fers 
m 
##od 
translation 
efficiency 
[CLS] 
these 
1 
r 
##ho 
dependent 
c 
##os 
##kel 
##etal 
reorganization 
cluster 
specific 
architecture 
necessary 
persistent 
cell 
activation 
chronic 
disease 
[SEP] 
[CLS] 
change 
test 
##icular 
test 
##osterone 
test 
##is 
access 
sex 
induction 
var 
##ico 
##cel 
##e 
rat 
[SEP] 
m 
apps 
d 
[CLS] 
these 
data 
weight 
gain 
increased 
ca 
##lor 
##ic 
intake 
contrast 
large 
effect 
peripheral 
thy 
##roid 
function 
function relatively 
little 
effect 
##ns 
t 
##r 
##h 
activity 
[SEP] 
[CLS] 
##fa 
p 
##hos 
##phorus 
release 
kinetic 
high 
bacterial 
p 
##hos 
contamination 
[SEP] 
quantitative 
1 
alpha 
ace 
##ado 
##l 
principal 
meta 
##bol 
##ite 
ion 
[CLS] 
clinical 
tentative 
suggestion 
possible 
additional 
risk 
cigarette 
smoking 
b 
avoid 
##ance 
ve 
##no 
##graphy 
c 
avoid 
##ance 
var 
##ico 
##se 
vein 
surgery 
surgery [SEP] 
in 
##hibition 
116 
is 
##op 
circulation 
organ 
metabolic 
sky 
[CLS] 
in 
sa 
##cc 
##har 
##vis 
##iae 
act 
intro 
##n 
silent 
branch 
point 
like 
sequence 
u 
##ag 
located 
7 
n 
##t 
upstream 
canonical 
sequence 
[SEP] 
[CLS] 
the 
requirement 
essential 
interaction 
i 
##4 
##l 
explanation 
observed 
restriction 
transcription 
termination 
early 
viral 
gene 
[SEP] 
significantly 
higher 
increase 
increase i 
##ga 
##ga i 
##pra 
serum 
taken 
3 
6 
month 
group 
1 
2 
2 i 
##ga 
##ga i 
serum 
taken 
showed 
increase 
group 
[CLS] 
relation 
change 
bone 
density 
level 
blood 
calcium 
blood 
##p 
metabolism 
studied 
[SEP] 
[CLS] 
these 
result 
ho 
##mology 
sequence 
among 
i 
ka 
##m 
##m line 
gene 
##ib 
expressed 
phylogenetic 
response 
self 
anti 
part 
selection 
process 
auto 
response 
regulated 
in 
showed 
total 
bilateral 
s 
##tri 
##ate 
##ct 
##omi 
require 
execute 
accurate 
guided 
reach 
[CLS] 
comparison 
sequence 
alpha 
like 
d 
polymer 
##ase 
including 
co 
d 
polymer 
##ase 
ii 
showed 
nine 
highly 
conserved 
region 
constructed 
##root 
phylogenetic 
tree 
d 
polymer 
based 
difference 
conserved 
region 
[SEP] 
[CLS] 
before 
6 
12 
month 
h 
##yl 
##or 
##us 
era 
##dication 
fast 
##ing 
gas 
##trine 
##mia 
p 
##ep 
##sin 
i 
basal 
peak 
acid 
detailed 
his 
##to 
including 
e 
##c 
##l 
cell 
pro 
##life 
pattern 
[CLS] 
four 
experiment 
examined 
role 
ch 
##olin 
projection 
se 
##pt 
vertical 
limb 
nucleus 
diagonal 
band 
br 
##oc 
##d 
##b 
acquisition 
performance 
conditional 
discrimination 
[CLS] 
trans 
activation 
hi 
1 
l 
##tr 
1 
ta 
tat 
h 
i 
tax 
protein 
mediated 
different 
c 
##i 
acting 
sequence 
[SEP] 
defect 
##ive 
##ava 
suppression 
ban 
##croft 
fi 
##lar 
##ias 
[CLS] 
for 
detailed 
mapping 
##9 
cell 
containing 
##fs 
derived 
human 
chromosome 
chromosome 2 
tag 
##t 
##o 
different 
region 
##31 
q 
##ter 
##ric 
ins 
requires 
s 
patient 
81 
p 
cent 
cent [SEP] 
[CLS] 
however 
cow 
fail 
adequate 
1 
25 
di 
##hy 
##dr 
##in 
d 
onset 
##ation 
acidic 
car 
##box 
terminal 
domain 
gene 
protein 
##act 
##op 
protein 
protein 
interaction 
[SEP] 
[CLS] 
##rra 
##nged 
ka 
##ppa 
gene 
transcription 
##ally 
silent 
structural 
feature 
ka 
##ppa 
lo 
##cus 
contribute 
transcription 
##al 
efficiency 
rear 
##ranged 
ka 
gene 
[SEP] 
a 
10 
76 
##3 
men 
3 
3 118 
studied 
97 
89 
respectively 
traced 
36 
16 
died 
died [SEP] 
n 
##d 
##1 
contains 
set 
domain 
multiple 
##h 
##d 
finger 
em 
##g 
based 
measure 
fatigue 
##ua 
exercise 
we 
introduced 
change 
yeast 
t 
t 
gene 
demonstrated 
t 
act 
efficient 
amber 
suppress 
##or 
##ivo 
this 
ass 
##ga 
##ga i 
##g 
##m 
##yt 
##oi 
##ob 
##ar 
##bit 
##al 
[CLS] 
these 
result 
##ra 
involved 
triple 
##t 
repeat 
instability 
cell 
among 
factor 
inverse 
income 
a 
kinase 
interacting 
identified 
regulatory 
domain 
##k 
beta 
i 
bait 
conclusion 
the 
##ja 
country 
intermediate 
intermediate position 
one 
repeating 
domain 
##b 
##1 
consisting 
amino 
clone 
co 
##ela 
##r 
67 
ability 
##rk 
p 
membrane 
membrane incorporated 
receptor 
substrate 
dramatically 
at 
##bet 
mediated 
activation 
enzyme 
[CLS] 
method 
c 
##d 
##4 
cell 
count 
data 
survey 
patient 
attending 
community 
hospital 
based 
hi 
out 
##patient 
clinic 
[CLS] 
bio 
##l 
##ogen 
c 
##d 
##k 
dominant 
c 
##d 
##k 
##r 
##44 
##r 
##4 
##90 
##r 
##r4 
##9 
effect 
##r 
##5 
##1 
##3 
domain 
bacterial 
the 
##ta 
fragment 
specifically 
##da 
##kat 
##ates 
his 
##to 
##logical 
variable 
loss 
motor 
ne 
##uron 
limited 
injection 
site 
this 
northern 
largest 
epidemic 
28 
year 
[CLS] 
s 
##pt 
skin 
##rick 
environmental 
##t 
salt 
total 
serum 
serum i 
lung 
function 
##chia 
##chial 
##res 
##po 
standard 
procedure 
procedure [SEP] 
[CLS] 
binding 
site 
mapped 
factor 
complementary 
d 
library 
liver 
o 
im 
##mat 
screened 
ho 
##mo 
##log 
##ous 
era 
##l 
##pha 
probe 
[SEP] 
[CLS] 
the 
binding 
p 
##t 
##b 
antagonist 
##ic 
binding 
enhance 
##r 
located 
##id 
tract 
[SEP] 
in 
inte 
##p 
1 
induce 
tissue 
factor 
expression 
mechanism 
mit 
[CLS] 
however 
study 
promoter 
demonstrated 
l 
##1 
transcription 
##ally 
activate 
##s 
##20 
gene 
c 
##i 
acting 
ka 
##ppa 
site 
[CLS] 
southern 
b 
##lot 
analysis 
##k 
encoded 
single 
gene 
[SEP] 
[PAD] [CLS] 
surgical 
method 
##hino 
##phy 
##az 
##oly 
##6 
##p 
##d 
deficiency 
finally 
although 
d 
binding 
domain 
##b 
required 
differentiation 
block 
shift 
cell 
cycle 
##a 
treatment 
p 
##in 
kinase 
mit 
position 
11 
12 
53 
##b 
respectively 
activation 
##f 
dependent 
reporter 
transcription 
##1 
##a 
potent 
suppressed 
##1 
##b 
##b 19 
k 
##da 
19 
##k 
[CLS] 
our 
result 
showed 
direct 
en 
##anti 
##omer 
##ic 
separation 
##to 
##in 
##ira 
##iral 
##ry 
column 
retention 
time 
s 
r 
##to 
##in 
25 
5 
26 
min 
respectively 
detection 
limit 
le 
50 
ng 
m 
##l 
##to 
##in 
my 
##elo 
zinc 
gene 
1 
##1 
c 
h 
zinc 
transcription 
regulate 
g 
##ran 
##ulo 
##po 
##ies 
regulatory 
cellular 
proliferation 
on 
##co 
##genesis 
##genesis [SEP] 
[CLS] 
snail 
infected 
three 
five 
mi 
##id 
##ia 
produced 
meta 
##cer 
##car 
##iae 
infected 
single 
##id 
##ium 
##ium [SEP] 
##1 
form 
ho 
##mo 
##tero 
o 
##go 
##mers 
via 
d 
##h 
domain 
mutation 
##al 
in 
o 
##go 
##mer 
##1 
associated 
impaired 
29 
##3 
cell 
##1 
media 
mediates 
least 
pathway 
##af 
activation 
one 
con 
mainly 
dependent 
one 
signal 
cooperate 
au 
augment 
##a 
[CLS] 
for 
target 
stimulus 
p 
##3 
amplitude 
late 
correlated 
tightly 
coupled 
frontal 
central 
right 
medial 
lateral 
recording 
site 
site [SEP] 
mit 
##ox 
##rone 
plus 
##ra 
combination 
therapy 
am 
##l 
[CLS] 
in 
re 
##nal 
cortex 
s 
##ple 
di 
##stal 
co 
##lon 
il 
##eum 
gal 
##l 
##bla 
stomach 
body 
regional 
o 
##2 
delivery 
hem 
##od 
group 
a 
short 
account 
ka 
to 
##uto 
life 
historical 
concept 
giant 
cell 
current 
interpretation 
nature 
unit 
##arian 
view 
##oly 
##kar 
##yon 
favored 
x 
##as 
giant 
to 
##uto 
characteristic 
demons 
##id 
c 
##op 
##m 
[CLS] 
chronic 
active 
he 
##pa 
pregnancy 
pregnancy [SEP] 
in 
induced 
n 
##f 
dependent 
gene 
expression 
protein 
involves 
o 
##xi 
##da 
radical 
activation 
i 
kinase 
these 
observed 
change 
found 
level 
[CLS] 
re 
##versible 
topology 
bi 
##function 
trans 
depends 
upon 
charge 
balance 
around 
trans 
domain 
[SEP] 
kinase 
##c 
activation 
treatment 
ne 
##uro 
##blast 
cell 
##a 
found 
enhance 
transcription 
human 
do 
##pa 
beta 
h 
##ydro 
d 
##b 
[CLS] 
the 
second 
control 
group 
case 
diagnosed 
h 
##si 
##yt 
##ology 
[PAD] [CLS] 
the 
ill 
##umi 
##nat 
##or 
us 
light 
adjust 
bulb 
holder 
fashioned 
bent 
paper 
clip 
clip [SEP] 
##ime 
##imex 
n 
##ymph 
##gor 
star 
##ved 
central 
security 
ward 
colony 
ground 
el 
he 
together 
27 
##6 
serum 
sample 
recruit 
ward 
the 
g 
##eno 
##mic 
organization 
region 
similar 
similar neural 
restricted 
member 
##1 
##1 el 
##l 
##2 
m 
##hu 
##d 
##d el 
##4 
##4 [SEP] 
s 
##yne 
##rg 
##uke 
##9 
br 
1 
##as 
d 
##re 
##gu 
map 
##k 
##sca 
##de 
with 
partially 
overlapping 
##mat 
##ous 
su 
##ture 
different 
re 
##nal 
segment 
de 
##vi 
##tal 
##ized 
[CLS] 
promoter 
element 
transcription 
##al 
control 
mouse 
ace 
##ty 
##cho 
##lines 
##tera 
gene 
[SEP] 
[CLS] 
the 
cumulative 
u 
dose 
65 
cm 
cm2 
patient 
received 
200 
cm 
##2 
[PAD] [CLS] 
ma 
##lf 
##orm 
op 
te 
##ct 
la 
##gy 
##pt 
b 
##uf 
regular 
[CLS] 
these 
m 
##or 
##phological 
change 
marked 
induction 
p 
##45 
##0 
##m 
gene 
expression 
[CLS] 
the 
im 
##mu 
##p 
##fi 
adult 
patient 
pulmonary 
tuberculosis 
studied 
control 
ve 
##nous 
related 
readily 
diagnosed 
comparing 
simultaneous 
blood 
sample 
via 
peripheral 
vein 
[CLS] 
the 
role 
as 
##xia 
mechanism 
ii 
acute 
drowning 
hanging 
[PAD] [CLS] 
processing 
large 
bit 
manipulation 
manipulation heavy 
memory 
storage 
requirement 
requirement [SEP] 
[CLS] 
thus 
##r 
l 
##iga 
##tion 
initiate 
##i 
3 
##kt 
##sk 
3 
signaling 
pathway 
c 
##a 
c 
##lon 
transcription 
##al 
property 
g 
##c 
box 
binding 
protein 
b 
##b 
[CLS] 
this 
activity 
creates 
4 
b 
##p 
staggered 
cut 
3 
oh 
over 
##hang 
within 
specific 
sequence 
21 
r 
##rna 
gene 
o 
##ga 
strain 
[SEP] 
the 
two 
or 
replication 
##mi 
##d 
p 
##k 
##12 
th 
##io 
##ba 
##llus 
inter 
##med 
##ius 
co 
##ie 
##2 
related 
##mi 
##d 
[SEP] 
[CLS] 
in 
s 
sf 
g 
##m 
il 
3 
induced 
t 
p 
gamma 
plc 
gamma 
[SEP] 
phase 
i 
combination 
##hot 
##omy 
replacement 
##al 
##20 
##21 
dim 
##eric 
r 
##ii 
beta 
protein 
bind 
##p 
##75 
approximately 
avid 
##ly 
r 
##ii 
beta 
[CLS] 
the 
temporal 
expression 
##b 
##p 
similar 
photo 
##re 
##ceptor 
differentiation 
complete 
[CLS] 
i 
[CLS] 
in 
two 
signal 
pathway 
critical 
inter 
##le 
production 
production [SEP] 
replacement 
##6 
domain 
##1 
##a 
##par 
acid 
found 
c 
1 
##k 
1 
net 
te 
##rna 
##ry 
complex 
formation 
60 
effect 
direct 
direct action 
da 
##zo 
##l 
end 
##osis 
in 
in 
[CLS] 
the 
n 
##f 
re 
##l 
transcription 
factor 
participate 
activation 
immune 
system 
regulatory 
gene 
viral 
early 
gene 
including 
1 
terminal 
repeat 
a 
4 
91 
child 
examined 
question 
##naire 
sat 
##is 
##fa 
##factor 
completed 
relative 
guardian 
usually 
mother 
mother 4 
65 
##1 
##1 [SEP] 
c 
##a 
c 
##lon 
##ing 
reveals 
two 
in 
inte 
trans 
##cript 
distinct 
c 
##op 
##las 
##mic 
domain 
result 
alternative 
s 
##licing 
[CLS] 
earlier 
##op 
portion 
film 
contained 
##uc 
##us 
[CLS] 
objective 
to 
##mar 
##marise 
quantitative 
association 
moderate 
alcohol 
co 
##rona 
##ry 
heart 
disease 
predict 
[CLS] 
like 
known 
##d 
gene 
##d 
##14 
##d 
##15 
probably 
required 
general 
translation 
initiation 
addition 
role 
##4 
specific 
translation 
##al 
control 
[CLS] 
highly 
correlated 
frequency 
strong 
medium 
frequency 
pattern 
generator 
operative 
beyond 
neon 
##ata 
##l 
period 
[CLS] 
this 
gene 
named 
##x 
##1 
human 
no 
##menclature 
committee 
differentiation 
##or 
simple 
##roma 
[PAD] [CLS] 
hi 
##v 
2 
spa 
##in 
##in [SEP] 
no 
effect 
effect 4 
beta 
observed 
expression 
h 
patient 
external 
frame 
cum 
##bers 
##ome 
d 
the 
at 
##1 
gene 
gene s 
##chi 
##zo 
##sa 
##cc 
##har 
##ces 
##omb 
##ombe 
b 
##zi 
##p 
transcription 
factor 
strong 
ho 
##mology 
ma 
factor 
at 
2 
[SEP] 
the 
effect 
source 
commercial 
ratio 
humor 
##al 
new 
newcastle 
disease 
[SEP] 
[CLS] 
multiple 
attempt 
aimed 
disruption 
ch 
##rom 
##oso 
##mal 
f 
gene 
unsuccessful 
primary 
t 
##j 
##rs 
degree 
##ste 
##rosis 
[CLS] 
radiation 
i 
##rra 
##dia 
h 
##pox 
##ia 
p 
##min 
##iva 
tissue 
section 
modified 
to 
technique 
complexity 
report 
v 
##ac 
opposed 
est 
##rogen 
true 
[CLS] 
thus 
mutant 
def 
##icient 
o 
anti 
##gen 
polymer 
##ase 
termed 
##c 
mutant 
[PAD] [CLS] 
up 
1988 
145 
case 
reported 
literature 
32 
case 
country 
country [SEP] 
[CLS] 
focal 
g 
##lo 
##mer 
##ulos 
##cle 
##rosis 
like 
disease 
##ph 
##rot 
syndrome 
horse 
horse [SEP] 
##hy 
##pert 
##ens 
di 
##ure 
inter 
##con 
##version 
##s 
ha 
##eri 
##do 
reduced 
ha 
##eri 
##do 
##chi 
##zo 
##ren 
steady 
study 
the 
eating 
dark 
meat 
fish 
positively 
serum 
e 
do 
##3 
serum 
s 
effect 
food 
hem 
##ody 
##nam 
##ics 
d 
##44 
##3 
substitution 
act 
##ivating 
mutation 
render 
resistant 
h 
##cho 
[CLS] 
central 
heart 
rate 
##o 
##2 
local 
muscle 
blood 
la 
##ct 
##ate 
ad 
##eno 
##sin 
trip 
##rea 
##tine 
##nas 
g 
##ly 
##co 
##gen 
cue 
highlighted 
complexity 
effort 
need 
better 
understanding 
physiological 
component 
upon 
based 
[CLS] 
the 
gene 
predicted 
en 
##code 
88 
amino 
protein 
contains 
two 
c 
##h 
zinc 
finger 
nuclear 
local 
##ization 
sequence 
two 
transcription 
##al 
activation 
domain 
[SEP] 
[CLS] 
examination 
base 
##line 
factor 
well 
effect 
change 
mile 
##age 
occurrence 
problem 
occurrence 
another 
health 
problem 
rate 
##out 
##out [SEP] 
[CLS] 
micro 
##uria 
marker 
systemic 
disease 
[CLS] 
regulation 
act 
##ivating 
transcription 
factor 
1 
camp 
element 
binding 
protein 
protein ca 
ca2 
##od 
##ulin 
dependent 
protein 
type 
i 
ii 
i 
iv 
[SEP] 
[CLS] 
##rona 
##ry 
bio 
tissue 
30 
76 
39 
formed 
study 
group 
serum 
##yl 
##a 
disease 
am 
##yl 
##hr 
at 
##os 
##pa 
cell 
implicated 
path 
##ogen 
disease 
[PAD] [CLS] 
p 
##ace 
##ph 
##rit 
##is 
[CLS] 
we 
digital 
flu 
##oro 
imaging 
system 
replace 
portal 
film 
verify 
positioning 
radio 
##ther 
##ap 
treatment 
treatment [SEP] 
the 
human 
p 
gene 
span 
least 
7 
5 
k 
##b 
composed 
three 
ex 
##on 
two 
en 
##code 
p 
protein 
[CLS] 
serum 
##rea 
##tin 
kinase 
7 
800 
17 
500 
u 
making 
acute 
muscle 
damage 
likely 
probably 
r 
##hab 
##dom 
##yo 
##lysis 
##lysis [SEP] 
[CLS] 
highly 
specific 
event 
merely 
consequence 
decreased 
stability 
e 
##c 
like 
m 
##d 
##d 
##x 
##x able 
bind 
in 
##hibit 
##53 
trans 
##act 
##ivation 
however 
##d 
##m 
##x 
de 
##grade 
##53 
yet 
examined 
[PAD] [CLS] 
purpose 
second 
s 
##m 
##mns 
rare 
occurrence 
successful 
treatment 
treatment childhood 
cancer 
cancer [SEP] 
[CLS] 
recent 
geological 
study 
focusing 
da 
##vie 
fracture 
zone 
m 
##oz 
##am 
##bi 
##que 
channel 
resolution 
situation 
presence 
land 
bridge 
mid 
e 
##ocene 
##ocene 
interval 
match 
age 
##r 
group 
[CLS] 
the 
n 
##uc 
##leo 
##tide 
sequence 
##r 
am 
##plified 
s 
##m 
##t 
##3 
##eno 
##mic 
d 
fragment 
identical 
##t 
##3 
##a 
absence 
intro 
##n 
protein 
coding 
region 
[SEP] 
mutant 
p 
##53 
d 
clone 
co 
##lon 
car 
##cin 
##a 
transforming 
comparison 
hot 
spot 
mutant 
gas 
##roma 
discharge 
trim 
##eth 
##yla 
11 
sample 
fish 
odor 
sample 
[CLS] 
standing 
##bo 
114 
79 
b 
##ht 
93 
##3 
92 
67 
67 [SEP] 
[CLS] 
i 
##x 
##odes 
1971 
show 
following 
trend 
h 
pu 
##tata 
##tata r 
t 
t 
##ick 
prefer 
preferably 
##si 
##tis 
increase 
relative 
share 
[SEP] 
[CLS] 
the 
se 
gene 
clone 
##d 
sequence 
predict 
99 
4 
k 
##da 
protein 
45 
sequence 
identity 
beta 
cop 
[SEP] 
[CLS] 
study 
f 
##etal 
maturity 
maturity [SEP] 
[CLS] 
f 
##etal 
art 
##erial 
##git 
##tal 
sin 
base 
##o 
##2 
oxygen 
sat 
decreased 
hydrogen 
##co 
##co2 
increased 
as 
##phy 
##xia 
alone 
as 
##phy 
##xia 
plus 
is 
##of 
##lu 
##rane 
oxygen 
[SEP] 
therefore 
appears 
##n 
kinase 
function 
stimulate 
##d 
##lation 
##ally 
amino 
star 
##ved 
cell 
[SEP] 
[CLS] 
##el 
alone 
##38 
##k 
activation 
subsequent 
##d 
##9 
##80 
##9 
dramatic 
increase 
##38 
##k 
[CLS] 
in 
3 
5 
patient 
##n 
##rt 
##j 
##r 
junction 
##al 
beat 
served 
trigger 
re 
##entry 
##entry [SEP] 
[CLS] 
the 
three 
respective 
time 
control 
group 
c 
injected 
sa 
solution 
[CLS] 
sequence 
analysis 
##a 
clone 
encoding 
human 
gamma 
revealed 
open 
reading 
frame 
predict 
protein 
29 
##9 
amino 
acid 
approximately 
32 
k 
##da 
half 
size 
b 
##ov 
##ovine 
gamma 
subunit 
[CLS] 
a 
positive 
##b 
19 
##m 
test 
indicates 
necessity 
treatment 
[CLS] 
our 
data 
suggest 
defect 
observed 
b 
w 
r 
##ts 
consequence 
##rain 
re 
##comb 
##ination 
[SEP] 
[CLS] 
the 
promoter 
##a 
s 
##ynth 
##ase 
contains 
two 
binding 
site 
s 
##tero 
regulatory 
element 
binding 
protein 
s 
##b 
##ps 
[CLS] 
these 
data 
ch 
##romatic 
processing 
area 
v 
##1 
##2 
normal 
##4 
les 
##ion 
together 
behaviour 
area 
sufficient 
basic 
basic aspect 
colour 
perception 
perception [SEP] 
[PAD] [CLS] 
the 
curse 
##hara 
##haraoh 
co 
##var 
##iate 
##s 
##tre 
range 
sensory 
characterization 
targeted 
disruption 
##1 
p 
##ore 
complex 
p 
##1 
member 
##y 
dependent 
##d 
##k 
inhibitor 
##y 
##d 
##k 
complex 
in 
cat 
response 
##ifer 
[CLS] 
p 
##1 
regulated 
##cription 
##al 
mechanism 
including 
sub 
local 
##ization 
therefore 
##1 
protein 
d 
g 
##cos 
##yla 
l 
##yas 
[PAD] [CLS] 
one 
patient 
d 
##ph 
##oria 
##oria one 
toxic 
##a 
##a [SEP] 
[CLS] 
al 
##ve 
##ol 
##us 
cap 
##illa 
##ry 
diffusion 
[SEP] 
mutation 
sin 
##4 
r 
##3 
##8 
##9 
##10 
##rb 
##11 
two 
novel 
gene 
nut 
##1 
nut 
##2 
relieve 
requirement 
##p 
expression 
reporter 
reporter [SEP] 
ca 
##cula 
hp 
98 
##45 
hp 
85 
##a 
for 
the 
##rm 
##us 
strain 
z 
##o 
##5 
di 
##hy 
##dr 
##ota 
d 
##ho 
##ase 
encoded 
##c 
highest 
similarity 
identity 
d 
##ho 
##ases 
ca 
##ldo 
b 
##us 
sub 
[SEP] 
[CLS] 
precision 
data 
model 
sodium 
kinetic 
hem 
##od 
##ial 
##ys 
[SEP] 
these 
fi 
##bri 
##no 
gamma 
region 
##0 
##20 
function 
minimal 
recognition 
sequence 
in 
inte 
##teg 
##d 
##d11 
##18 
[CLS] 
at 
serum 
co 
##rt 
##is 
##ol 
response 
found 
patient 
despite 
act 
##h 
test 
isolation 
##to 
##xi 
n 
##t 
##12 
##3 
2 
point 
mutation 
e 
##17 
active 
site 
site a 
##bol 
en 
##zy 
##matic 
n 
##t 
##12 
##4 
3 
nonsense 
mutation 
result 
del 
##eti 
##on 
c 
terminal 
25 
##23 
##stop 
toxicity 
##zo 
##yl 
2 
4 
##rich 
##raz 
##ami 
meta 
##bol 
two 
##sp 
spider 
mit 
liver 
mon 
##oam 
##ine 
o 
[CLS] 
screen 
mutant 
whose 
growth 
depends 
high 
gene 
gene [SEP] 
the 
gene 
expressed 
em 
##b 
##ryo 
z 
##eta 
f 
##etal 
adult 
stage 
alpha 
alpha 
1 
modified 
point 
mutation 
affect 
either 
processing 
translation 
make 
##ide 
chain 
extremely 
unstable 
[SEP] 
[CLS] 
in 
##ore 
ma 
in 
pulmonary 
tuberculosis 
received 
2 
month 
daily 
treatment 
s 
r 
##ami 
##de 
followed 
daily 
is 
##d 
r 
either 
##ami 
s 
##z 
##rz 
without 
s 
##z 
##r 
allocated 
random 
[CLS] 
##f 
##50 
gene 
product 
contains 
c 
terminal 
activation 
domain 
activate 
gene 
expression 
via 
specific 
target 
sequence 
[CLS] 
n 
##sai 
##d 
micro 
##rc 
stomach 
[CLS] 
the 
efficiency 
normal 
relative 
net 
amount 
p 
##mi 
##d 
actually 
trans 
cell 
determined 
modified 
southern 
hybrid 
procedure 
[SEP] 
[CLS] 
##eno 
##mic 
southern 
b 
human 
ha 
##p 
##id 
genome 
contains 
single 
g 
alpha 
gene 
[CLS] 
evaluation 
effect 
ch 
##ela 
##tion 
therapy 
time 
s 
##tron 
##tium 
exposure 
mouse 
[CLS] 
in 
present 
study 
found 
##d 
##34 
down 
##re 
##gu 
hem 
##ato 
##po 
##ies 
occur 
##ed 
level 
transcription 
##al 
initiation 
all 
##er 
stimulate 
##d 
##d2 
##4 
56 
146 
1468 
67 
##9 
##ison 
likewise 
he 
hete 
95 
l 
lte 
##te4 
54 
54 20 
91 
51 
51 15 
he 
hete 
##te 63 
25 
[CLS] 
foreign 
d 
##na 
insert 
contained 
within 
f 
##pox 
sequence 
transferred 
viral 
genome 
ho 
##mo 
##log 
##ous 
re 
##comb 
##ination 
occurring 
cell 
infected 
f 
##pox 
temperature 
sensitive 
mutant 
trans 
##fected 
wild 
viral 
d 
p 
##mi 
##d 
d 
##na 
[SEP] 
although 
evidence 
cone 
ratio 
determine 
colour 
appearance 
many 
condition 
site 
site 
com 
further 
1 
form 
specific 
slowly 
complex 
pu 
##f 
binding 
##m 
##f 
promoter 
1 
site 
site [SEP] 
[CLS] 
several 
component 
##yt 
##oki 
signaling 
remain 
unidentified 
this 
first 
demonstrating 
specific 
##ity 
level 
energy 
coupling 
p 
[CLS] 
in 
stem 
loop 
structure 
2 
3 
4 
3 
domain 
showed 
great 
variation 
size 
sequence 
structure 
[SEP] 
s 
##pect 
##hot 
micro 
##det 
##er 
##mination 
##ate 
[CLS] 
result 
followed 
1 
early 
cancer 
like 
advanced 
cancer 
consisted 
les 
##ion 
128 
les 
##ion 
96 
2 
p 
##ept 
##ic 
ul 
##cer 
cancer 
##ous 
les 
##ion 
73 
les 
##ion 
active 
stage 
55 
les 
##ion 
scar 
##ring 
stage 
stage [SEP] 
[CLS] 
effect 
##ae 
##all 
201 
red 
##but 
normal 
can 
my 
##oc 
##ard 
##ium 
[SEP] 
1 
404 
p 
1 
50 
p 
recognized 
95 
##j 
##10 
per 
##le 
##can 
24 
404 
p 
##cher 
##ichi 
[CLS] 
the 
an 
cardiac 
surgeon 
[CLS] 
to 
gain 
insight 
event 
alpha 
3 
gene 
minimal 
promoter 
characterized 
found 
67 
base 
pair 
upstream 
major 
transcription 
start 
site 
[SEP] 
[CLS] 
f 
##d 
##p 
1 
1 
in 
##cor 
##ona 
injection 
co 
##lla 
##teral 
flow 
reduced 
systemic 
artery 
resistance 
co 
##rona 
##ry 
s 
##ys 
##to 
in 
##far 
##cted 
region 
area 
in 
##far 
##ction 
decreased 
decreased 28 
9 
1 
3 
15 
3 
1 
2 
p 
p 0 
0 01 
n 
n 6 
6 [SEP] 
[PAD] [CLS] 
path 
##op 
##sio 
mechanism 
underlying 
spatial 
di 
##ient 
##ation 
patient 
al 
##z 
##heimer 
disease 
disease [SEP] 
[CLS] 
many 
ma 
cell 
lack 
met 
##hyl 
##thi 
##os 
p 
m 
##p 
enzyme 
activity 
40 
min 
is 
##che 
recovered 
trans 
##mura 
##l 
conduct 
##ion 
block 
##1 
group 
4 
min 
le 
0 
05 
##2 
23 
min 
##runcated 
250 
word 
[CLS] 
the 
novel 
gene 
span 
16 
7 
k 
##b 
g 
##eno 
##mic 
sequence 
formed 
11 
ex 
##on 
10 
inter 
##vening 
intro 
##n 
[SEP] 
[CLS] 
g 
box 
binding 
factor 
##b 
##fs 
constitute 
d 
binding 
bind 
box 
motif 
regulatory 
c 
##i 
element 
present 
many 
gene 
p 
##nd 
##rom 
d 
motif 
##gt 
##g 
[SEP] 
[CLS] 
conclusion 
acute 
can 
l 
##c 
##x 
co 
##rona 
##ry 
s 
##ten 
c 
##f 
##r 
impaired 
is 
##che 
##mic 
remote 
##ische 
##mic 
region 
association 
mild 
moderate 
is 
##che 
##mic 
induced 
regional 
my 
##oc 
##ard 
##ial 
d 
##ys 
##function 
[SEP] 
[CLS] 
a 
third 
order 
p 
##oly 
##l 
fit 
showed 
good 
correlation 
parameter 
q 
m 
##tt 
whereas 
t 
si 
##max 
found 
poor 
correlation 
correlation [SEP] 
[CLS] 
late 
result 
treatment 
u 
##rot 
##rc 
##ulos 
[CLS] 
change 
frequency 
x 
ch 
##roma 
woman 
pre 
##dn 
##ison 
therapy 
other 
toxicity 
11 
de 
##hy 
##dra 
nausea 
vomit 
as 
##the 
##nia 
##nia [SEP] 
proceeding 
influence 
ha 
##lot 
he 
##3 
##uke 
result 
high 
dose 
05 
result 
am 
##nio 
fluid 
sample 
stored 
strict 
change 
occur 
in 
progression 
certain 
##p 
1 
transcription 
[CLS] 
the 
pattern 
net 
r 
expression 
adult 
tissue 
different 
[SEP] 
spin 
##op 
##hil 
ne 
brain 
extract 
##1 
##gam 
##ma 
1 
##1 
##a 
[PAD] [CLS] 
the 
the author 
patient 
ma 
##gnant 
tumor 
routine 
x 
ray 
study 
##r 
to 
##mo 
##graphy 
patient 
investigated 
way 
plus 
c 
ct 
##t [SEP] 
[CLS] 
reduction 
p 
##53 
protein 
detected 
1 
day 
treatment 
reached 
ma 
##ximal 
suppression 
10 
20 
control 
3 
day 
h 
##39 
##22 
40 
control 
4 
day 
##f 
7 
cell 
association 
s 
t 
##os 
occurs 
two 
##os 
##os 
based 
activation 
motif 
h 
##y 
##hes 
##ized 
l 
associate 
associate ye 
##ea 
acid 
motif 
##os 
112 
##11 
##2 
##cor 
##tic 
##nos 
##press 
noticeable 
level 
t 
##3 
e 
r 
##c 
##f 
##f [SEP] 
four 
##bro 
clone 
infected 
##tro 
containing 
##a 
encoding 
##od 
pu 
selection 
marker 
[CLS] 
serum 
est 
##rio 
##l 
level 
beta 
receptor 
ago 
third 
trim 
pregnancy 
[CLS] 
in 
investigated 
mechanism 
tax 
activate 
gene 
expression 
conjunction 
member 
at 
##f 
##b 
family 
[SEP] 
[CLS] 
four 
12 
patient 
33 
initially 
diagnosed 
ben 
##ign 
disease 
false 
negative 
[SEP] 
[CLS] 
however 
observed 
storage 
time 
affected 
bio 
##chemical 
change 
occurring 
constituent 
##rot 
gamma 
i 
##rra 
##diation 
[CLS] 
suppression 
##1 
delta 
mutant 
p 
##hen 
##otype 
occurs 
interaction 
c 
##b 
##1 
defect 
##ive 
encoded 
cat 
##alytic 
subunit 
[CLS] 
the 
median 
cumulative 
incidence 
rate 
found 
34 
##1 
per 
male 
29 
##6 
female 
female [SEP] 
th 
##oma 
similarly 
t 
##f 
beta 
ii 
##go 
##de 
##leo 
##tide 
micro 
resulted 
58 
increase 
branching 
##sma 
##tched 
sequence 
control 
t 
##f 
beta 
m 
protein 
expression 
level 
suppressed 
84 
respectively 
secret 
cut 
dome 
##d 
cell 
lead 
honey 
##comb 
like 
structure 
give 
superficial 
war 
like 
mit 
##otic 
clone 
adult 
adult [SEP] 
[CLS] 
taken 
result 
i 
pu 
1 
critical 
element 
il 
18 
gene 
expression 
[SEP] 
based 
result 
concluded 
i 
##sa 
promote 
healing 
process 
a 
##vas 
##cular 
zone 
torn 
men 
##is 
##cus 
rabbit 
systemic 
vascular 
s 
##yn 
##ov 
##ium 
##is 
##cus 
essential 
healing 
occur 
na 
##sa 
##r 
122 
##3 
[CLS] 
the 
magnitude 
four 
parameter 
increased 
ex 
##po 
##nent 
##ial 
fashion 
increasing 
400 
x 
10 
6 
e 
##culate 
we 
studied 
his 
##to 
##logical 
finding 
kidney 
in 
##fi 
mac 
##rop 
one 
hour 
transplant 
##ation 
kidney 
bio 
one 
hour 
bio 
bio 
patient 
[CLS] 
an 
additional 
stimulation 
d 
##1 
receptor 
giving 
s 
##38 
##39 
##3 
30 
min 
almost 
continuous 
pattern 
jaw 
opening 
le 
closure 
movement 
rest 
position 
opening 
accompanied 
frequent 
tongue 
pro 
##trusion 
##trusion [SEP] 
[CLS] 
control 
heart 
[CLS] 
the 
0 
0 
0 2 
di 
##ff 
##raction 
ha 
crystal 
##l 
fiber 
showed 
around 
60 
arch 
angle 
ch 
##s 
fiber 
showed 
around 
10 
degree 
[SEP] 
[CLS] 
during 
4 
o 
ventilation 
base 
##line 
pulmonary 
vascular 
##r 
di 
##lator 
s 
##n 
##p 
greater 
lung 
lung [SEP] 
determine 
role 
trans 
##rane 
h 
fusion 
h 
protein 
biological 
to 
nurse 
[CLS] 
trans 
trans 
45 
##51 
##1 
cat 
construct 
containing 
5 
regulatory 
region 
rat 
1 
gene 
activated 
##pha 
co 
trans 
##fect 
dose 
dependent 
manner 
activation 
potent 
##3 
re 
alpha 
synthesis 
2 
2 
th 
##zo 
##kan 
##eb 
##zi 
##zo 
ant 
##min 
human 
##r 
##2 
restricted 
cellular 
distribution 
expressed 
l 
##ymph 
den 
##dr 
s 
##ge 
##al 
e 
##pit 
cell 
low 
level 
##ymph 
##yte 
[CLS] 
##r 
##1 
extract 
made 
glucose 
##ep 
bound 
##1 
d 
similar 
greatly 
different 
activate 
##h 
##2 
gene 
expression 
##ivo 
[SEP] 
further 
ago 
##nist 
##t 
##1 
receptor 
antagonist 
action 
##t 
receptor 
appear 
contribute 
anti 
##de 
##press 
d 
##rl 
72 
schedule 
[CLS] 
gene 
put 
##ative 
function 
prevention 
d 
damage 
include 
complete 
base 
ex 
##cision 
pathway 
##il 
d 
g 
##cos 
##yla 
##lea 
d 
polymer 
##ase 
beta 
na 
##d 
dependent 
d 
l 
##iga 
##se 
photo 
##rea 
##ivation 
pathway 
c 
##lo 
##but 
##ane 
p 
##id 
dim 
##er 
photo 
##lya 
line 
type 
reverse 
trans 
##cript 
##ase 
m 
ho 
##mo 
##logue 
three 
group 
m 
##od 
discharge 
motor 
ii 
transitional 
phase 
s 
para 
##dox 
##ical 
sleep 
ii 
##i 
rapid 
eye 
following 
electrical 
##bra 
re 
##ular 
formation 
m 
##rf 
##rf [SEP] 
[CLS] 
likewise 
consensus 
signal 
believed 
involved 
terminating 
early 
gene 
transcription 
t 
##tt 
##tt 
evident 
3 
boundary 
n 
##2 
m 
##1 
or 
##fs 
suggesting 
gene 
may 
early 
gene 
[SEP] 
[CLS] 
this 
radio 
900 
b 
##p 
am 
##p 
##lic 
hybrid 
##ization 
screen 
c 
##a 
library 
constructed 
r 
##na 
isolated 
induced 
tax 
cell 
full 
length 
trans 
sequence 
obtained 
[SEP] 
[CLS] 
low 
temperature 
temperature 8 
degree 
c 
imp 
##air 
secret 
independently 
photo 
##per 
##io 
##d 
selected 
[CLS] 
##ric 
co 
##rona 
##ry 
sin 
##us 
fist 
##ula 
##ula [SEP] 
[CLS] 
in 
structure 
d 
##na 
sequence 
transcription 
##al 
control 
region 
human 
w 
##ista 
##r 
single 
functional 
culture 
[SEP] 
ma 
##gnesium 
content 
could 
medium 
[CLS] 
the 
sequence 
three 
revealed 
pure 
ca 
##g 
stretch 
stretch [SEP] 
[CLS] 
further 
mutation 
element 
ii 
result 
change 
r 
##na 
structure 
near 
element 
ii 
##i 
consistent 
long 
range 
interaction 
may 
promote 
translation 
[SEP] 
although 
q 
##t 
duration 
higher 
beat 
beat 
var 
interval 
lower 
domain 
decreased 
de 
domain 
decreased 
00 
004 
chaotic 
domain 
tighter 
cluster 
[CLS] 
the 
rat 
surf 
a 
o 
##go 
##mer 
##ide 
subunit 
derived 
single 
gene 
dependent 
intact 
di 
##sul 
##fi 
bond 
##1 
mutant 
##ivo 
11 
14 
n 
terminal 
amino 
acid 
altered 
viable 
s 
##ym 
##pt 
typical 
wild 
infection 
[CLS] 
this 
take 
nuclear 
compartment 
normal 
##i 
s 
##licing 
proceeds 
y 
branched 
intermediate 
analogous 
la 
##ria 
formed 
s 
##licing 
[SEP] 
##b 
##d 
##p 
alone 
th 
##rom 
##bol 
[PAD] [CLS] 
chronic 
re 
multi 
##fo 
o 
##ste 
##eli 
maximum 
bar 
##ore 
slope 
curve 
reduced 
at 
##her 
##os 
##cle 
##rot 
425 
34 
72 
##1 
30 
spike 
6 
2 
0 
0 
0 8 
spike 
[PAD] [CLS] 
a 
path 
##ogen 
##etic 
relation 
##ise 
[CLS] 
co 
##rona 
##ry 
##as 
##oc 
##tric 
caused 
end 
##oth 
##elin 
1 
enhanced 
##che 
##per 
nor 
##ep 
##ph 
##rine 
present 
concentration 
typically 
observed 
neon 
##ata 
##atal 
[SEP] 
[CLS] 
located 
3 
trans 
s 
##lice 
##d 
leader 
accept 
##or 
site 
translation 
##al 
initiation 
co 
##don 
##6 
##3 
gene 
area 
conserved 
##ot 
##ide 
direct 
repeat 
##t 
##c 
##cc 
vary 
number 
according 
s 
##pec 
##ie 
[SEP] 
##luk 
plasma 
##raw 
10 
h 
[CLS] 
insulin 
secret 
is 
##let 
t 
##umour 
##cre 
##as 
##as [SEP] 
disruption 
reconstruction 
narrative 
insight 
illness 
[CLS] 
the 
result 
posterior 
wall 
com 
##pliant 
anterior 
wall 
difference 
trans 
##mura 
##l 
pressure 
local 
segment 
length 
change 
posterior 
wall 
greater 
[SEP] 
p 
diesel 
exhaust 
de 
##p 
j 
c 
##edar 
pollen 
all 
##er 
##a 
in 
##lly 
partial 
characterization 
cc 
##aa 
##t 
box 
promoter 
1 
gene 
interaction 
negatively 
acting 
transcription 
factor 
de 
##cid 
##ual 
##ized 
##al 
s 
##al 
cell 
[CLS] 
transcription 
s 
##d 
##1 
##d 
##2 
gene 
re 
cellular 
s 
##tero 
##l 
level 
level 
nuclear 
##b 
##1 
transcription 
##al 
induction 
requires 
three 
spatial 
conserved 
c 
##i 
element 
bind 
##b 
y 
[SEP] 
[CLS] 
three 
transcription 
##al 
control 
element 
within 
300 
base 
pair 
5 
flank 
##ing 
region 
rat 
g 
##lu 
##ca 
##gon 
gene 
interact 
regulatory 
cellular 
protein 
direct 
transcription 
g 
##lu 
##ca 
##gon 
producing 
is 
##let 
cell 
[SEP] 
a 
role 
p 
3 
regulation 
beta 
1 
in 
inte 
##d 
[CLS] 
relationship 
age 
associated 
end 
##rine 
deficiency 
muscle 
elderly 
cross 
section 
##al 
study 
study [SEP] 
[CLS] 
in 
sequence 
essential 
transcription 
transcription e 
eft 
##1 
localized 
region 
start 
at 
##g 
stop 
co 
##don 
##17 
gene 
terminate 
##s 
26 
##7 
n 
##t 
upstream 
strand 
[SEP] 
[CLS] 
exposure 
r 
##aft 
culture 
act 
##iva 
##bol 
result 
induction 
late 
gene 
expression 
well 
v 
##iri 
##on 
assembly 
[CLS] 
a 
case 
2 
cancer 
co 
##lon 
##lon [SEP] 
[CLS] 
the 
g 
gre 
##gg 
phenomenon 
##oc 
##ard 
function 
oxygen 
consumption 
##vo 
increase 
co 
##rona 
##ry 
per 
##fusion 
enhanced 
within 
auto 
range 
range [SEP] 
mapped 
specific 
domain 
within 
protein 
responsible 
interaction 
[CLS] 
in 
studied 
type 
two 
c 
##d 
##p 
cut 
binding 
site 
##m 
overlap 
known 
presumed 
binding 
site 
replication 
in 
##iti 
##ator 
protein 
e 
##1 
[SEP] 
reduced 
cell 
number 
72 
h 
ins 
##no 
[CLS] 
h 
##ydro 
radical 
##print 
d 
complex 
et 
domain 
pu 
1 
comparison 
crystal 
structure 
at 
formulated 
pro 
##th 
##rom 
##bin 
p 
fi 
##bri 
##no 
transformation 
##r 
representation 
th 
##rom 
##bin 
##bri 
##no 
##g 
blood 
plasma 
[PAD] [CLS] 
[CLS] l 
p 
in 
##af 
1 
interfere 
##af 
1 
activation 
##k 
substrate 
binding 
##hen 
molecular 
partial 
chromosome 
21 
##oso 
enabled 
u 
define 
region 
spanning 
2 
4 
m 
##b 
d 
##21 
##s 
##19 
##0 
d 
##22 
##6 
associated 
##po 
re 
##tar 
##dation 
##yper 
##ton 
several 
facial 
an 
##oma 
##ly 
##ly [SEP] 
[CLS] 
the 
classic 
s 
##tero 
##l 
regulatory 
c 
##i 
element 
s 
1 
##dl 
receptor 
promoter 
media 
##tes 
s 
regulatory 
element 
binding 
##b 
##p 
binding 
effect 
insulin 
##let 
derived 
##d 
##f 
[CLS] 
the 
ca 
##2 
concentration 
serum 
in 
##gas 
##tric 
##ally 
f 
##rim 
##ol 
administration 
dos 
1 
40 
1 
20 
1 
10 
l 
##d 
##50 
5 
day 
investigated 
investigated [SEP] 
[CLS] 
co 
7 
cell 
trans 
##1 
camp 
accumulation 
highest 
##rf 
utilized 
100 
[SEP] 
[CLS] 
##yk 
##not 
o 
##ste 
##oc 
increased 
12 
h 
01 
2 
day 
00 
##1 
is 
##che 
##mia 
the 
right 
rat 
ca 
##uter 
drop 
1 
5 
n 
h 
##c 
##1 
30 
one 
served 
control 
is 
##op 
##rote 
##ren 
in 
heart 
rate 
30 
beat 
min 
base 
[CLS] 
this 
probably 
v 
##ivo 
bacteria 
perhaps 
dormant 
form 
entirely 
dependent 
upon 
u 
##rease 
survival 
[SEP] 
[CLS] 
the 
system 
consists 
##com 
##pute 
analyze 
##r 
blood 
gas 
analyze 
##r 
flame 
photo 
##meter 
ion 
t 
##rator 
blood 
sugar 
analyze 
##r 
hem 
##og 
sat 
##uration 
meter 
his 
##to 
bio 
##ific 
one 
concluded 
frontal 
bio 
high 
pro 
##gno 
claimed 
report 
[SEP] 
[PAD] [CLS] 
abdominal 
pain 
hem 
##ato 
fall 
fall [SEP] 
[CLS] 
fusion 
c 
##d 
##d8 
class 
i 
restricted 
b 
##51 
##47 
thy 
##mo 
in 
##var 
##d 
##d8 
hybrid 
##oma 
r 
trans 
##cribed 
##d 
##d8 
alpha 
l 
gene 
und 
##ete 
##able 
[SEP] 
plasma 
act 
##h 
patient 
group 
[CLS] 
for 
p 
trans 
##cript 
p 
g 
orientation 
full 
termination 
activity 
required 
region 
containing 
stem 
loop 
structure 
upstream 
sequence 
[SEP] 
development 
neural 
control 
##iment 
##ary 
motor 
##te 
[CLS] 
cell 
expressed 
three 
##r 
related 
m 
trans 
##cript 
2 
5 
3 
0 
10 
k 
##b 
[CLS] 
these 
##1 
##c 
c 
##op 
##las 
##mic 
component 
machinery 
responsible 
returning 
##1 
kinase 
basal 
level 
re 
##esta 
##lishing 
glucose 
repression 
however 
blend 
meta 
##ni 
ii 
1 
1 
resulted 
d 
##1 
50 
value 
288 
min 
[CLS] 
the 
majority 
cell 
also 
##4 
positive 
help 
##er 
induce 
##r 
minority 
positive 
suppress 
##or 
##oto 
##xi 
##yte 
aim 
post 
##he 
##cha 
##em 
oxygen 
metabolic 
effect 
##oc 
##ard 
via 
in 
##hibition 
car 
##ni 
##tine 
##tra 
##fer 
##ase 
1 
##em 
patient 
severe 
##ort 
s 
##ten 
##osis 
##osis [SEP] 
the 
if 
##nar 
chain 
interact 
##s 
if 
alpha 
2 
beta 
demonstrated 
cross 
linking 
[CLS] 
to 
clone 
c 
beta 
subunit 
amino 
acid 
sequence 
data 
first 
obtained 
design 
redundant 
o 
##leo 
prime 
##r 
use 
p 
##r 
[SEP] 
[CLS] 
we 
c 
##lon 
##ing 
##1 
gene 
4 
4 
k 
##b 
##3 
##a 
insert 
yeast 
shuttle 
vector 
##5 
[CLS] 
ni 
##mo 
##di 
##pine 
5 
micro 
##gram 
followed 
in 
##fusion 
0 
75 
min 
blood 
pressure 
##ote 
##ns 
##yper 
dose 
schedule 
ni 
##fe 
##di 
##pine 
map 
##it 
##ro 
study 
may 
relevant 
path 
##ogen 
al 
##ve 
##oli 
dust 
induced 
lung 
disease 
the 
atop 
time 
higher 
ratio 
ratio 7 
0 
95 
1 
6 
31 
1 
01 
influence 
age 
[CLS] 
a 
select 
##able 
marker 
transformation 
constructed 
transcription 
##al 
fusion 
##til 
may 
maydis 
heat 
gene 
promoter 
h 
##ot 
##ran 
##fer 
##ase 
gene 
es 
##cher 
##ichi 
co 
##li 
[CLS] 
the 
structure 
##r 
or 
##f 
confirmed 
sequence 
analysis 
fragment 
obtained 
##r 
am 
##p 
##lification 
test 
c 
##r 
specific 
prime 
##r 
[SEP] 
the 
aim 
study 
determine 
response 
human 
cortex 
ch 
##romatic 
magnet 
##oe 
##pha 
the 
role 
##1 
regulation 
nitrogen 
metabolism 
disease 
process 
path 
[CLS] 
these 
three 
phase 
##c 
##roma 
diverse 
##c 
c 
##d 
##k 
in 
replication 
blocking 
re 
##re 
##plication 
allowing 
re 
##sett 
origin 
mit 
##osis 
[SEP] 
[PAD] [CLS] 
##ort 
related 
der 
##mat 
##th 
inter 
##le 
##leuki 
il 
acquisition 
il 
il 2 
[PAD] [CLS] 
enter 
##oto 
##xin 
##rance 
##rance [SEP] 
[CLS] 
measurement 
given 
##rano 
in 
##hibit 
increase 
q 
i 
##bat 
indicated 
decline 
##bat 
at 
##tri 
##but 
q 
rather 
rather increasing 
sat 
##uration 
up 
##take 
##take mechanism 
mechanism [SEP] 
[CLS] 
plasma 
l 
##h 
pro 
##tero 
##ne 
level 
single 
multiple 
injection 
synthetic 
synthetic l 
r 
an 
##oes 
##tro 
##us 
e 
comparison 
level 
o 
##rous 
cycle 
material 
and 
and method 
[CLS] 
but 
mate 
##d 
male 
built 
nest 
absence 
young 
t 
level 
higher 
condition 
though 
early 
br 
##ood 
##ood [SEP] 
[CLS] 
prime 
##r 
developed 
specific 
am 
##p 
##lification 
98 
##0 
##4 
gene 
fragment 
interact 
##1 
in 
##hibit 
trans 
##act 
e 
promoter 
promoter [SEP] 
mutant 
retained 
parental 
participate 
inter 
co 
##ag 
human 
oral 
act 
##ino 
specific 
##ity 
mutation 
in 
##tra 
co 
##ag 
##s 
[SEP] 
[CLS] 
the 
sa 
##cc 
##har 
##omy 
##ces 
c 
##vis 
target 
rap 
##r 
##1 
to 
##r 
##2 
signal 
activation 
cell 
growth 
response 
nut 
##rient 
availability 
[SEP] 
biology 
an 
##op 
##hel 
condition 
central 
fl 
##da 
correspond 
s 
##ti 
1 
vaccine 
th 
##rom 
##bol 
##ys 
##oc 
##ard 
in 
##far 
t 
##i 
ii 
random 
##ized 
3 
33 
patient 
in 
inv 
##v n 
1 
68 
##1 
conservative 
1 
type 
p 
##las 
##min 
##iva 
r 
##oc 
##ard 
in 
##far 
##ction 
[SEP] 
[CLS] 
in 
in addition 
mutation 
within 
##b 
##x 
unit 
ex 
##on 
known 
behave 
null 
all 
##ele 
[CLS] 
taken 
s 
##3 
s 
##4 
complex 
least 
se 
##able 
nuclear 
function 
form 
rapid 
yet 
trans 
sequence 
specific 
d 
binding 
complex 
potent 
##p 
##1 
dependent 
transcription 
##al 
activation 
[SEP] 
[CLS] 
when 
p 
##hen 
##ter 
##mine 
mixed 
re 
ma 
##o 
inhibitor 
inhibitor e 
e g 
pseudo 
##ep 
##rine 
e 
##dr 
nor 
est 
##rad 
##iol 
ben 
##zo 
##ate 
degree 
ma 
##o 
in 
##hibition 
add 
##itive 
##itive [SEP] 
[CLS] 
here 
point 
mutation 
##b 
##d 
b 
gene 
trans 
suppress 
##ab 
7 
##hen 
##otype 
pairing 
dependent 
manner 
thus 
represent 
type 
trans 
##ve 
##ction 
[SEP] 
4 
38 
new 
mother 
examined 
retrospective 
##ly 
##ly enzyme 
el 
cm 
##v 
pregnancy 
[CLS] 
also 
residue 
27 
##3 
287 
identical 
sequence 
15 
acid 
segment 
near 
car 
##box 
terminus 
si 
transcription 
##al 
act 
##iva 
##f 
independently 
enhance 
minimal 
act 
##iva 
region 
[SEP] 
[CLS] 
analogue 
calcium 
s 
##tron 
##tium 
s 
##r 
89 
rapidly 
cleared 
blood 
v 
injection 
[PAD] [CLS] 
effect 
##um 
##oper 
di 
##sse 
##mination 
scar 
imp 
##lant 
abdominal 
tumor 
cell 
nine 
d 
score 
observed 
##ita 
park 
##ins 
##onia 
whereas 
full 
park 
akin 
##dl 
administration 
administration [SEP] 
alter 
t 
##r 
m 
##c 
contact 
recognition 
class 
i 
m 
mh 
##c 
sing 
substituted 
variant 
two 
patient 
patient e 
##wing 
re 
##lap 
##sed 
1 
local 
distant 
failure 
26 
disease 
free 
body 
i 
##rra 
##diation 
##em 
##otherapy 
##otherapy [SEP] 
[CLS] 
the 
c 
##lon 
human 
##po 
100 
provided 
insight 
structure 
p 
##po 
100 
facilitate 
factor 
m 
##od 
##po 
100 
bio 
##sy 
##synt 
##hesis 
##po 
100 
gene 
patient 
d 
##ys 
##gio 
92 
patient 
primary 
##gio 
accept 
home 
monitoring 
[CLS] 
repeated 
inter 
##fer 
beta 
if 
##n 
beta 
silence 
##r 
b 
motif 
l 
##oz 
silence 
##r 
1 
motif 
found 
##d 
##9 
gene 
approximately 
1 
600 
1 
100 
respectively 
action 
##rio 
ch 
o 
o1 
to 
##x 
chemical 
lemon 
patient 
chronic 
photos 
##iti 
der 
##mat 
act 
##ini 
re 
##ulo 
##id 
high 
total 
serum 
i 
concentration 
concentration [SEP] 
[CLS] 
the 
sequence 
25 
k 
##da 
chain 
alpha 
subunit 
found 
##a 
clone 
amino 
acid 
sequence 
de 
##duced 
##a 
establishes 
complete 
amino 
acid 
sequence 
25 
k 
##da 
chain 
[SEP] 
characterization 
chromosome 
19 
break 
##point 
region 
revealed 
transcription 
factor 
encoding 
gene 
affected 
tax 
active 
tax 
mutant 
##1 
arrest 
effect 
co 
##rrel 
altered 
local 
##ization 
nuclear 
##53 
disruption 
##53 
d 
complex 
patient 
admitted 
within 
one 
week 
onset 
dark 
urine 
urine 45 
ha 
hav 
whereas 
specimen 
admitted 
week 
contained 
virus 
[CLS] 
bio 
##chemical 
identified 
cellular 
element 
encoded 
d 
binding 
termed 
inverted 
repeat 
binding 
i 
##rb 
##p 
specifically 
interact 
outer 
half 
31 
b 
##p 
terminal 
inverted 
repeat 
[SEP] 
[CLS] 
three 
##fold 
observed 
men 
highest 
intensity 
highest 
heavy 
risk 
risk [SEP] 
spontaneous 
level 
lower 
normal 
higher 
control 
[CLS] 
we 
sequence 
79 
##41 
b 
##p 
d 
fragment 
arm 
chromosome 
v 
##vis 
contains 
four 
open 
reading 
frame 
or 
##fs 
greater 
100 
amino 
acid 
residue 
[SEP] 
[CLS] 
a 
4 
0 
k 
##b 
n 
message 
also 
present 
em 
##b 
##ryo 
##genesis 
detect 
##able 
day 
e 
##10 
##10 [SEP] 
[CLS] 
promoting 
fat 
u 
##til 
##isation 
reducing 
car 
##bo 
##dra 
##te 
fat 
ratio 
t 
##p 
reduces 
radical 
similar 
fat 
exclusion 
exclusion [SEP] 
[CLS] 
cell 
infected 
##v 
structural 
core 
e 
##1 
e 
##2 
d 
##d 
##x 
##3 
core 
co 
##loc 
##zed 
distinct 
spot 
per 
##r 
region 
c 
##op 
##m 
[SEP] 
[CLS] 
m 
##uta 
sequence 
eliminated 
complex 
formation 
marked 
basal 
camp 
dependent 
promoter 
trans 
reporter 
gene 
[SEP] 
the 
lowest 
p 
##aco 
lower 
m 
f 
w 
d 
d 
group 
control 
[CLS] 
the 
translation 
##al 
product 
ul 
##26 
5 
infected 
cell 
35 
i 
f 
[CLS] 
the 
tap 
gene 
mapped 
70 
##base 
h 
##2 
k 
cent 
##rome 
end 
mouse 
##c 
[CLS] 
due 
significant 
ho 
##mology 
c 
terminus 
m 
##uta 
trans 
##po 
##sa 
alternative 
gene 
product 
named 
trap 
trans 
##po 
associated 
[SEP] 
[CLS] 
nonetheless 
majority 
located 
within 
three 
short 
sequence 
n 
terminus 
middle 
c 
terminus 
phylogenetic 
##ally 
conserved 
known 
e 
##cter 
##ial 
ch 
##op 
##last 
version 
protein 
[SEP] 
[CLS] 
the 
c 
##af 
1 
pro 
cellular 
ho 
##mo 
##logue 
r 
##af 
on 
acute 
##ly 
transforming 
36 
##11 
##v 
[CLS] 
##tar 
##dation 
four 
binding 
site 
rap 
##1 
##p 
identified 
within 
promoter 
rap 
##1 
gene 
in 
extract 
potent 
photo 
##ta 
suppression 
alcohol 
abuse 
treatment 
resistance 
skin 
disease 
[CLS] 
the 
mean 
serum 
c 
##dt 
5 
s 
##d 
u 
l 
16 
s 
##d 
u 
l 
p 
00 
001 
[SEP] 
[CLS] 
subsequent 
analysis 
revealed 
unique 
modular 
structure 
consists 
terminal 
death 
domain 
similar 
in 
##tra 
##cellular 
segment 
t 
##f 
receptor 
1 
1 f 
##a 
c 
terminal 
region 
related 
##op 
##las 
##mic 
domain 
d 
##ros 
##op 
m 
##or 
##ph 
##ogen 
toll 
1 
receptor 
[SEP] 
r 
##t 
##r 
analysis 
3 
m 
presence 
s 
##p 
##lice 
variant 
ex 
##on 
7 
8 
deleted 
##x 
##rom 
##oso 
rear 
##rang 
##ement 
lead 
fusion 
growth 
arrest 
d 
damage 
in 
transcription 
factor 
ch 
##op 
##ad 
##d 
##15 
##3 
p 
##eptide 
fragment 
encoded 
t 
##l 
gene 
[CLS] 
show 
m 
ma 
##oe 
##nse 
isolated 
environment 
may 
source 
infection 
infection [SEP] 
[CLS] 
the 
administered 
common 
lead 
is 
##oto 
mix 
rate 
1300 
##gram 
kg 
w 
wt 
day 
age 
10 
month 
start 
study 
up 
##re 
##gu 
m 
##t 
anti 
##rod 
limb 
regeneration 
characterized 
m 
mt 
anti 
310 
325 
k 
##da 
##roi 
core 
protein 
285 
300 
k 
##da 
[CLS] 
analysis 
##v 
1 
##po 
##1 
revealed 
high 
amino 
acid 
ho 
##mology 
corresponding 
##pt 
var 
##iol 
virus 
[SEP] 
[CLS] 
the 
effect 
do 
##pa 
do 
##pa 
d 
receptor 
block 
ha 
##do 
activity 
##ot 
ch 
##em 
##ore 
studied 
studied 24 
an 
##est 
##tized 
vent 
##ilated 
newborn 
kit 
0 
17 
day 
patient 
abnormal 
##s 
##f 
[CLS] 
control 
##ych 
gave 
remarkably 
result 
[CLS] 
patient 
treated 
either 
either 4 
4 8 
million 
unit 
pro 
1 
##ne 
##cid 
3 
5 
4 
5 
g 
1 
##ne 
9 
5 
te 
##cy 
given 
4 
day 
[CLS] 
the 
result 
study 
improved 
crest 
complete 
longer 
rip 
br 
superior 
05 
inter 
##p 
##ro 
##ximal 
penetration 
gum 
co 
##gate 
total 
oral 
b 
advantage 
brush 
[SEP] 
cardiac 
ne 
higher 
base 
healthy 
re 
##nal 
##nal whole 
body 
ne 
similar 
##let 
factor 
4 
healthy 
high 
newborn 
plasma 
re 
##nin 
activity 
essential 
##erial 
h 
##yper 
##tens 
observed 
increased 
g 
##raft 
half 
life 
era 
2 
p 
n 
protein 
encoded 
gene 
called 
protein 
participate 
d 
complex 
show 
60 
identity 
conserved 
distributed 
protein 
referred 
3 
3 
protein 
[CLS] 
pits 
##re 
beta 
1 
protein 
super 
related 
master 
mit 
##otic 
protein 
##c 
[CLS] 
ma 
##ximal 
exercise 
duration 
peak 
oxygen 
consumption 
changed 
changed [SEP] 
in 
n 
##f 
b 
activation 
observed 
cell 
stimulation 
p 
##t 
##din 
##s 
4 
5 
p 
synthesis 
hand 
moderately 
affected 
even 
##1 
##del 
##ta 
mutant 
procedure 
accurate 
##ii 
##i 
inhibitor 
48 
patient 
##ora 
blood 
supply 
based 
r 
##adi 
##los 
lowest 
t 
##12 
second 
higher 
one 
t 
t 
##10 
serum 
c 
##3 
value 
observed 
11 
child 
stage 
illness 
the 
brought 
ho 
##ust 
laboratory 
measured 
analyzed 
l 
##ign 
##in 
protein 
content 
##yla 
am 
##monia 
l 
##yas 
per 
##idas 
activity 
p 
##ax 
6 
lacking 
c 
terminal 
activation 
domain 
re 
##pressed 
beta 
##b 
##1 
crystal 
promoter 
activity 
effectively 
full 
length 
protein 
alone 
##ax 
##a 
s 
##p 
##lice 
variant 
altered 
p 
affecting 
d 
binding 
specific 
##ity 
[CLS] 
a 
re 
##gression 
analysis 
showed 
86 
variance 
weight 
predicted 
two 
leading 
indicator 
middle 
treatment 
treatment [SEP] 
[CLS] 
objective 
respiratory 
related 
electro 
##my 
superior 
##al 
##ric 
analyzed 
early 
stage 
forced 
breathing 
breathing [SEP] 
[CLS] 
the 
predicted 
amino 
acid 
sequence 
contained 
consensus 
region 
s 
ad 
##eno 
met 
##tra 
##fer 
##ases 
presented 
26 
identity 
sa 
##cc 
##har 
##ces 
c 
##ere 
##vis 
##iae 
d 
##b 
met 
##tra 
##fer 
##ase 
##ase 38 
identity 
rat 
protein 
well 
bacterial 
bacterial es 
##cher 
##tra 
##ns 
##fer 
encoded 
##g 
gene 
letter 
ball 
##ist 
##oc 
##ard 
##io 
##graphy 
the 
introduction 
##1 
promotes 
degradation 
i 
##ka 
concert 
i 
kinase 
resulting 
nuclear 
trans 
##f 
##ppa 
##b 
f 
##os 
blood 
pressure 
101 
h 
149 
patient 
di 
##ast 
h 
##yper 
##tens 
86 
151 
80 
patient 
is 
ish 
although 
##b 
4 
is 
##olate 
le 
resistant 
##lor 
##b 
##olate 
1 
000 
min 
contact 
0 
01 
input 
infectious 
infectious [SEP] 
[CLS] 
the 
su 
##de 
at 
##rop 
upper 
sympathetic 
blockade 
to 
th 
##rom 
##bus 
growth 
##ret 
125 
fi 
##bri 
##no 
auto 
##log 
th 
##rom 
##bus 
pre 
##formed 
##ug 
rabbit 
rabbit [SEP] 
[CLS] 
th 
##all 
201 
s 
##cin 
##ti 
dip 
in 
low 
level 
exercise 
exercise [SEP] 
[CLS] 
kinetic 
model 
99 
##m 
##t 
##c 
d 
##a 
rat 
rat [SEP] 
crude 
drug 
plant 
[CLS] 
yet 
test 
##osterone 
predominant 
type 
ii 
male 
m 
##or 
##ph 
neither 
court 
nest 
nest instead 
instead para 
##si 
type 
i 
male 
sneak 
satellite 
spa 
tactic 
tactic [SEP] 
comparison 
therapeutic 
##phere 
terminal 
##mor 
##phism 
beta 
ad 
##rene 
ago 
regulatory 
[CLS] 
hence 
perhaps 
necessary 
perform 
spinal 
pu 
##nc 
purpose 
determine 
##f 
serum 
ratio 
[SEP] 
[CLS] 
##mi 
##d 
one 
containing 
terminus 
fused 
d 
binding 
domain 
yeast 
trans 
##act 
##iva 
gal 
##4 
containing 
n 
fused 
fused her 
trans 
##act 
##iva 
trans 
co 
1 
cell 
along 
##ran 
##fer 
##ase 
cat 
reporter 
##mi 
##d 
containing 
gal 
##4 
d 
binding 
site 
[SEP] 
[CLS] 
bio 
##chemical 
experiment 
genome 
se 
##quencing 
shown 
despite 
pro 
##kar 
##yo 
cell 
genome 
organization 
basal 
transcription 
##al 
element 
member 
domain 
arch 
##ae 
e 
ta 
##ta 
box 
like 
sequence 
r 
##na 
polymer 
##ase 
transcription 
factor 
t 
##b 
##p 
t 
t 
##fi 
##is 
e 
##ryo 
type 
[SEP] 
humor 
##al 
immunity 
altered 
drop 
level 
[CLS] 
for 
second 
phase 
12 
5 
w 
wk 
r 
##ir 
10 
w 
##l 
male 
whereas 
r 
##ir 
w 
##l 
female 
[CLS] 
modified 
##cott 
quick 
stain 
##um 
car 
##ini 
##i 
additionally 
v 
##ah 
##s 
often 
fatal 
im 
[PAD] [CLS] 
result 
##rot 
##rotising 
f 
##ci 
##erial 
p 
##o 
rose 
7 
fold 
##erial 
increased 
slightly 
exposure 
5 
5 absolute 
atmosphere 
atmosphere at 
oxygen 
[CLS] 
we 
43 
old 
male 
br 
##cho 
c 
##ys 
di 
##stal 
es 
##op 
mi 
##dia 
ma 
##gnant 
es 
##op 
##hage 
##hageal 
tumor 
based 
pre 
level 
tumor 
marker 
ca 
19 
9 
ca 
125 
125 [SEP] 
100 
51 
p 
[CLS] 
a 
plasma 
cell 
rich 
in 
##fi 
##lt 
##rate 
present 
connect 
##ive 
tissue 
core 
p 
##illa 
[CLS] 
during 
norm 
##ox 
exercise 
o 
##2 
up 
##take 
##o 
##o2 
4 
0 
l 
min 
al 
##mit 
##rine 
increased 
art 
##erial 
p 
##o 
05 
##o 
##o2 
01 
ve 
decreased 
art 
##erial 
##co 
##co2 
01 
affecting 
pulmonary 
hem 
##ody 
ventilation 
per 
distribution 
distribution [SEP] 
[CLS] 
gene 
##r 
51 
localized 
radiation 
hybrid 
chromosome 
9 
4 
81 
c 
##r 
w 
##i 
86 
##8 
##4 
marker 
pro 
##ximal 
hereditary 
1 
lo 
##cus 
[CLS] 
outcome 
patient 
u 
##m 
##t 
mainly 
influenced 
initial 
stage 
type 
e 
component 
component [SEP] 
regulated 
246 
s 
##d 
page 
b 
[CLS] 
other 
fi 
##scher 
34 
rat 
also 
1 
h 
##r 
0 
0 
0 
6 
pp 
o 
##3 
computer 
##ized 
database 
veteran 
discharged 
military 
1967 
selected 
contains 
50 
total 
v 
##iet 
era 
population 
reasonably 
##bia 
method 
twin 
[CLS] 
to 
examine 
functional 
relationship 
distinct 
c 
##i 
active 
element 
within 
di 
##stal 
enhance 
##r 
region 
rat 
p 
##rl 
gene 
del 
##eti 
##onal 
mutation 
##al 
analysis 
region 
trans 
trans 
##3 
##uit 
cell 
[SEP] 
the 
entire 
coding 
region 
region o 
end 
##al 
o 
##cin 
c 
##r 
sub 
##lone 
##d 
##40 
major 
late 
promoter 
expression 
vector 
##j 
trans 
co 
7 
cell 
[CLS] 
alcohol 
stomach 
disease 
[CLS] 
these 
op 
##eron 
en 
##code 
subunit 
photos 
##ys 
##tem 
i 
##a 
ii 
ps 
##b 
c 
##yt 
##och 
##rome 
##f 
complex 
pet 
p 
##id 
##d 
p 
h 
de 
##hy 
##dr 
##ogen 
##ase 
##dh 
unidentified 
open 
reading 
frame 
##f 
##9 
[SEP] 
[PAD] [CLS] 
the 
p 
p 
transfer 
new 
new original 
transfer 
##p 
de 
##uter 
##ce 
##te 
as 
or 
##za 
##zae 
[CLS] 
transcription 
##al 
m 
##od 
anti 
b 
##l 
x 
paired 
box 
transcription 
factor 
##3 
##3 
##r 
[CLS] 
the 
level 
p 
##de 
protein 
monitored 
two 
specific 
camp 
##al 
##body 
p 
activity 
[CLS] 
b 
##lot 
in 
##test 
r 
hybrid 
##lot 
##box 
##b 
probe 
single 
15 
k 
##b 
hybrid 
##ization 
band 
hybrid 
terminal 
probe 
probe produced 
two 
hybrid 
##ization 
band 
15 
k 
##b 
since 
##ud 
protein 
pro 
##te 
##oly 
processed 
active 
form 
##ud 
re 
dependent 
fashion 
amino 
acid 
ho 
##mology 
##mology um 
examined 
whether 
similarly 
processed 
cell 
la 
##cz 
fusion 
[CLS] 
influence 
long 
term 
z 
##ime 
##lid 
l 
##s 
##d 
induced 
behaviour 
##al 
effect 
[CLS] 
we 
determined 
molecular 
organization 
transcription 
start 
t 
gene 
encoding 
thy 
##mi 
##dine 
kinase 
[SEP] 
together 
number 
ii 
i 
es 
##cal 
dos 
##bo 
##p 
##lat 
factor 
support 
increase 
dose 
intensity 
achieved 
it 
##test 
argument 
conventional 
beta 
ad 
##ren 
unwanted 
metabolic 
effect 
counter 
cardiac 
benefit 
[CLS] 
genetic 
##mor 
##phism 
5 
flank 
##ing 
region 
change 
transcription 
##al 
regulation 
human 
##yt 
##och 
##rome 
##e 
##1 
gene 
[SEP] 
##ric 
##ular 
e 
##ct 
##op 
##ic 
activity 
higher 
00 
##1 
co 
##rona 
##ry 
heart 
disease 
disease 86 
90 
compared 
12 
[CLS] 
increased 
t 
##ec 
spa 
##cing 
occurs 
##ste 
##op 
##oro 
reduces 
spatial 
field 
thus 
pro 
##long 
t 
##2 
shown 
##it 
##ro 
##ivo 
[CLS] 
healthy 
##ter 
##m 
g 
##esta 
26 
29 
showed 
mature 
pattern 
per 
birth 
followed 
period 
enhanced 
per 
3 
4 
life 
[CLS] 
these 
reveal 
##rem 
tissue 
specific 
factor 
regulated 
predominant 
##rem 
trans 
##cript 
en 
re 
##press 
##or 
##r 
##r 
capable 
in 
##hibit 
expression 
in 
##hi 
##bin 
alpha 
subunit 
gene 
[SEP] 
[CLS] 
the 
b 
##th 
##1 
gene 
may 
correspond 
##ido 
th 
1 
gene 
[SEP] 
[CLS] 
the 
pattern 
firing 
seen 
sa 
##cca 
##de 
light 
complete 
darkness 
darkness [SEP] 
chronic 
he 
se 
##rol 
test 
he 
becomes 
becomes available 
available [SEP] 
a 
##can 
##tham 
##os 
i 
kinase 
p 
##os 
i 
increasing 
##in 
activated 
at 
activity 
[CLS] 
mutation 
h 
##3 
element 
promoter 
activity 
##p 
whereas 
element 
isolation 
conferred 
##3 
promoter 
[SEP] 
[CLS] 
mitochondrial 
t 
##osy 
##rna 
s 
##eta 
pod 
##os 
##por 
an 
##ser 
bi 
##function 
##al 
enzyme 
synthesis 
r 
s 
##licing 
[CLS] 
cell 
1 
con 
##dict 
observation 
system 
1 
active 
line 
line [SEP] 
the 
t 
gene 
es 
##cher 
##ichi 
co 
k 
12 
factor 
f 
one 
numerous 
protein 
required 
con 
##gat 
##ive 
transfer 
##mi 
##d 
[SEP] 
mi 
##be 
##fra 
##di 
r 
##o 
40 
59 
##6 
##di 
##hy 
##dr 
antagonist 
[CLS] 
however 
technical 
advance 
shown 
limitation 
test 
test 
##m 
positive 
residual 
specific 
##m 
even 
subject 
free 
acute 
infection 
existence 
natural 
interfering 
interfering i 
##m 
##m [SEP] 
[CLS] 
##cin 
ground 
##nut 
meal 
containing 
rat 
1991 
##bo 
j 
j [SEP] 
[CLS] 
we 
trans 
trans 
mutation 
analysis 
electro 
##mo 
test 
hypothesis 
expression 
##pha 
gene 
controlled 
part 
binding 
three 
trans 
acting 
nuclear 
factor 
s 
##p 
##1 
##2 
##3 
[SEP] 
[CLS] 
am 
##p 
##k 
he 
##tero 
##tri 
##mer 
composed 
cat 
##alytic 
subunit 
alpha 
two 
regulatory 
subunit 
beta 
gamma 
[SEP] 
[CLS] 
the 
evolutionary 
similarity 
intro 
##n 
secondary 
structure 
open 
reading 
frame 
n 
##d 
##3 
4 
at 
gene 
discussed 
including 
possible 
separate 
evolution 
structural 
coding 
sequence 
[SEP] 
##cle 
##ar 
reactive 
serum 
con 
[CLS] 
the 
destruction 
me 
##some 
##sometri 
##um 
length 
o 
##rous 
cycle 
concentration 
plate 
##let 
ni 
##tri 
##te 
total 
ni 
##trate 
ni 
##tri 
##te 
determined 
sensitive 
ni 
##trate 
ni 
##tri 
##te 
##oro 
[CLS] 
power 
br 
modeled 
scheme 
based 
##aus 
##rat 
accommodate 
deposition 
rate 
whose 
spatial 
variation 
highly 
##uni 
##form 
[CLS] 
the 
sulfur 
s 
##pec 
could 
within 
le 
4 
min 
c 
##ze 
##yr 
electro 
3 
5 
5 
0 
[CLS] 
propose 
37 
may 
regulated 
4 
[CLS] 
##eno 
cell 
in 
##hibit 
##ed 
transcription 
p 
##oe 
##no 
##vate 
car 
##box 
##inas 
##p 
##c 
4 
1 
1 
32 
##ck 
gene 
virtually 
eliminated 
transcription 
##ime 
##ric 
gene 
contained 
##ck 
promoter 
linked 
structural 
gene 
ace 
##ran 
##fer 
##ase 
cat 
[PAD] [CLS] 
lands 
positive 
positive [SEP] 
[CLS] 
the 
second 
intro 
##n 
smallest 
intro 
##n 
116 
b 
##p 
[SEP] 
[CLS] 
expression 
gene 
encoding 
transcription 
factor 
c 
ad 
##eno 
##sin 
3 
camp 
response 
element 
binding 
##b 
regulation 
f 
##icle 
s 
##mulating 
hormone 
induced 
camp 
signaling 
se 
##rt 
##oli 
cell 
[CLS] 
efficacy 
24 
patient 
eight 
received 
r 
##d 
16 
s 
##d 
[CLS] 
a 
si 
##lica 
based 
flu 
##ori 
free 
place 
##bo 
containing 
##pp 
containing 
si 
##lica 
based 
##pas 
used 
positive 
##pas 
respectively 
[PAD] [CLS] 
the 
overall 
response 
rate 
including 
c 
##r 
p 
##r 
23 
4 
17 
17 [SEP] 
high 
path 
##ai 
1 
##o 
test 
defect 
##ive 
fi 
##bri 
##no 
##ly 
due 
inhibitor 
##y 
effect 
1 
##min 
activation 
[CLS] 
during 
he 
##xa 
##ami 
##mba 
differentiation 
er 
##hr 
##ole 
##uke 
cell 
er 
##hr 
transcription 
##ally 
activated 
c 
##b 
several 
regulated 
[CLS] 
##sto 
extra 
##cor 
##pore 
##al 
fi 
##ltration 
[SEP] 
to 
##rs 
##ion 
con 
##tral 
##ater 
##al 
test 
5 
year 
##ope 
##xy 
[SEP] 
frequency 
median 
year 
range 
21 
[CLS] 
ch 
##olin 
##fer 
##his 
re 
##tro 
##grade 
transport 
##rad 
per 
##idas 
re 
##tic 
##ular 
me 
##dio 
##dor 
##sal 
th 
##ala 
##mic 
nucleus 
cat 
receive 
important 
input 
ch 
##olin 
##ergic 
ch 
##olin 
##ergic 
ne 
##uron 
sub 
##ia 
inn 
##a 
adjacent 
structure 
basal 
fore 
##bra 
##in 
[SEP] 
[CLS] 
the 
ch 
##ime 
##ric 
gene 
consisting 
coding 
5 
##tra 
##ns 
##lated 
leader 
region 
t 
##k 
gene 
fused 
portion 
domain 
alpha 
gene 
0 
extending 
largely 
upstream 
site 
initiation 
transcription 
alpha 
gene 
0 
regulated 
fashion 
alpha 
4 
alpha 
27 
t 
##k 
ch 
##ime 
##ra 
[SEP] 
[CLS] 
ethanol 
preference 
strain 
rat 
selective 
##ly 
bred 
behavioral 
characteristic 
characteristic [SEP] 
[CLS] 
for 
al 
##bino 
s 
##t 
##1 
s 
##t 
##2 
spatial 
peak 
around 
0 
3 
cycle 
de 
1 
curve 
displaced 
considerably 
spatial 
side 
normal 
s 
##t 
##2 
spatial 
response 
[SEP] 
nuclear 
protein 
bound 
##d 
55 
75 
element 
cycle 
dependent 
electro 
##mo 
specific 
ma 
##x 
blocked 
d 
binding 
different 
growth 
regulated 
d 
complex 
[CLS] 
thus 
##mo 
##dified 
th 
position 
169 
##28 
important 
interaction 
g 
##1 
##c 
##lins 
[CLS] 
additional 
genetic 
analysis 
##b 
##1 
component 
morphology 
control 
branch 
##a 
signaling 
ca 
##sca 
##de 
s 
p 
pomb 
##ombe 
positively 
m 
##od 
##ulates 
##1 
function 
[SEP] 
method 
preparation 
coffee 
country 
country 
ch 
##rom 
##oso 
co 
##sm 
##id 
library 
s 
##rg 
m 
##t 
##m 
clone 
co 
cosar 
##7 
isolated 
ho 
##mology 
act 
##i 
ii 
##i 
region 
s 
s co 
##eli 
##color 
s 
##tr 
##trde 
##m 
gene 
##us 
in 
investigated 
whether 
c 
##lea 
##vage 
r 
##r 
motif 
m 
go 
gol 
##gi 
associated 
fur 
##in 
##in analogous 
enzyme 
activation 
mechanism 
observed 
s 
##ely 
3 
[CLS] 
co 
c 
##b 
alpha 
cell 
specific 
##ity 
##m 
formula 
traditional 
corn 
m 
mct 
blend 
containing 
38 
m 
mcts 
m 
mct 
group 
fat 
blend 
designed 
resemble 
human 
milk 
6 
m 
mcts 
l 
group 
thirty 
three 
small 
g 
##lot 
car 
##cin 
t 
##1 
small 
t 
##2 
u 
##ic 
##c 
1978 
examined 
ma 
g 
using 
using 8 
factor 
system 
proposed 
j 
##ob 
et 
al 
##yla 
t 
##os 
##ami 
9 
glucose 
55 
infant 
given 
##ami 
##yr 
##os 
limit 
target 
range 
[CLS] 
we 
we sought 
test 
prolonged 
in 
ma 
##gnesium 
su 
##lf 
##ate 
mg 
##so 
4 
40 
mm 
##ol 
24 
hour 
normal 
q 
##t 
interval 
var 
compensate 
heart 
failure 
failure [SEP] 
[CLS] 
es 
##cher 
##ichi 
co 
strain 
carrying 
##30 
all 
##ele 
dramatic 
increase 
so 
dependent 
spontaneous 
m 
##uta 
activity 
[CLS] 
outlook 
oral 
cut 
##aneous 
##oma 
[CLS] 
we 
report 
complete 
n 
##uc 
##leo 
##tide 
sequence 
gene 
along 
155 
base 
pair 
5 
175 
base 
pair 
3 
flank 
##ing 
sequence 
[SEP] 
[CLS] 
however 
loosely 
associated 
associated 
viral 
particle 
[CLS] 
##17 
alternatively 
s 
##p 
##lice 
##d 
en 
m 
##rna 
using 
s 
##p 
##lice 
donor 
s 
##p 
##lice 
accept 
##or 
pair 
localized 
within 
en 
open 
reading 
frame 
or 
##f 
normally 
used 
generate 
bell 
bet 
trans 
##cript 
derived 
internal 
promoter 
within 
en 
or 
##f 
[SEP] 
[CLS] 
##17 
##0 
expressed 
level 
30 
50 
precursor 
##0 
##0 [SEP] 
[CLS] 
in 
marked 
human 
c 
##d 
##6 
sequence 
mouse 
sequence 
predict 
##s 
long 
c 
##op 
tail 
closely 
related 
protein 
two 
pro 
rich 
motif 
containing 
s 
##h 
##3 
domain 
binding 
consensus 
sequence 
three 
protein 
kinase 
p 
##lation 
site 
motif 
nine 
case 
##in 
p 
site 
motif 
se 
th 
rich 
motif 
repeated 
three 
time 
[SEP] 
[CLS] 
et 
1 
limited 
electro 
##card 
##io 
sub 
##end 
##oc 
##ard 
##ial 
##che 
##mia 
contract 
##ile 
d 
##ys 
##function 
compared 
s 
##ten 
co 
##rona 
##ry 
even 
though 
la 
##ct 
##ate 
flux 
similar 
[CLS] 
result 
consistent 
##f 
##1 
mutation 
leading 
t 
##rea 
co 
##llin 
##hen 
##otype 
##otype [SEP] 
[CLS] 
experimental 
syndrome 
analogous 
h 
##yd 
##ram 
##nio 
rat 
f 
##etus 
[CLS] 
cross 
electron 
scattering 
co 
##2 
molecule 
energy 
range 
400 
5000 
e 
##v 
[CLS] 
thus 
cognitive 
performance 
elderly 
subject 
could 
trained 
large 
extent 
extent [SEP] 
partial 
al 
##bin 
##ism 
##de 
##em 
##op 
ma 
##last 
one 
[CLS] 
residue 
affect 
plc 
##bet 
ad 
opposite 
side 
central 
tunnel 
plc 
ad 
##yl 
like 
alpha 
make 
many 
contact 
top 
surface 
[CLS] 
the 
dynamic 
pro 
##to 
##zo 
group 
r 
##n 
fist 
basal 
diet 
m 
##ola 
l 
##ib 
##af 
##f 
given 
6 
18 
g 
weight 
the 
##bs 
1 
gene 
mapped 
human 
chromosome 
10 
##p 
##12 
marker 
85 
##35 
47 
##24 
tightly 
linked 
two 
marker 
d 
##s 
##17 
##178 
##9 
d 
##55 
##0 
[CLS] 
blood 
am 
##monia 
significantly 
higher 
male 
70 
80 
90 
v 
##o 
##2 
peak 
[SEP] 
[CLS] 
value 
bone 
s 
##cin 
##ti 
##9 
##9 
##d 
##p 
early 
diagnosis 
mob 
##ilization 
total 
hip 
pro 
[PAD] [CLS] 
you 
##uf 
[CLS] 
the 
dip 
##per 
r 
##on 
##f 
b 
##p 
##r 
10 
2 
2 [SEP] 
in 
present 
investigated 
effect 
s 
##d 
##z 
71 
##3 
spatial 
learning 
deficit 
[CLS] 
material 
and 
domain 
perform 
##r 
measurement 
breast 
pre 
64 
year 
ya 
##cs 
b 
##ac 
##s 
co 
##sm 
##id 
sts 
##s 
defined 
aid 
gene 
[CLS] 
##v 
##r 
l 
d 
##vas 
d 
##co 
4 
9 
0 
to 
[CLS] 
me 
##f 
transcription 
##al 
act 
##iva 
type 
[SEP] 
[CLS] 
the 
f 
##ric 
up 
##take 
regulation 
gene 
product 
participates 
regulating 
expression 
manga 
##nese 
iron 
containing 
super 
di 
##uta 
gene 
##cher 
##ichi 
co 
##li 
to 
date 
6 
ma 
##mmal 
g 
##rks 
identified 
molecular 
##lon 
op 
2 
##cu 
protection 
c 
alpha 
he 
inter 
##dom 
##ain 
hi 
##nge 
beta 
strand 
2 
7 
the 
aim 
present 
study 
investigate 
term 
##ous 
administration 
##id 
##ro 
du 
##so 
##dr 
##ha 
##rz 
##n 
twice 
daily 
dose 
dose 200 
mg 
continuous 
4 
hour 
in 
m 
##l 
0 
9 
art 
o 
##cc 
##lus 
##ao 
special 
##po 
r 
lo 
##p 
class 
polymer 
ii 
trans 
gene 
lack 
in 
##tra 
control 
region 
i 
##r 
element 
hat 
trans 
##po 
family 
maize 
act 
##iva 
##c 
discovered 
large 
s 
##ie 
[SEP] 
judge 
ch 
##rist 
##d 
##bi 
protocol 
##b 
##ryo 
##ryo [SEP] 
correlation 
coefficient 
s 
##f 
thickness 
##r 
optical 
reading 
94 
o 
##d 
##1 
950 
##d 
##2 
r 
0 
30 
sub 
r 
0 
67 
bi 
##ceps 
o 
##d 
##1 
r 
0 
39 
a 
axi 
##lla 
r 
0 
0 68 
bi 
##ceps 
o 
##d 
##2 
plc 
ins 
stimulation 
##let 
derived 
##d 
##f 
[CLS] 
analysis 
domain 
del 
##eti 
mutant 
demonstrated 
strong 
s 
##yne 
##rgy 
##rm 
central 
de 
##generate 
r 
##rm 
repeat 
binding 
r 
##na 
[SEP] 
[CLS] 
sequence 
analysis 
cat 
intro 
##n 
several 
sequence 
present 
appear 
similar 
important 
transcription 
##al 
regulatory 
element 
found 
within 
intro 
##n 
higher 
[SEP] 
31 
di 
##io 
h 
##yper 
##tro 
##io 
38 
##oc 
##ard 
in 
##far 
##gin 
##ector 
disease 
100 
however 
##3 
2 
mutation 
##hen 
##otype 
induced 
20 
s 
pro 
##as 
mutation 
##ept 
##idy 
##am 
##eptide 
h 
##ydro 
fulfill 
rescue 
function 
[CLS] 
whereas 
s 
##pra 
##gue 
da 
##wley 
##s 
displayed 
light 
light 
peak 
ing 
##estive 
activity 
minority 
34 
##4 
##s 
displayed 
consistent 
light 
peak 
ing 
##estive 
activity 
result 
35 
##1 
patient 
24 
different 
regime 
##n 
drop 
##eri 
##do 
##l 
[CLS] 
the 
##ro 
op 
##eron 
flanked 
ho 
##lli 
##day 
structure 
d 
he 
##lica 
ho 
##mo 
##log 
upstream 
two 
##fs 
representing 
pu 
##rine 
ho 
##mo 
##15 
characterized 
gene 
encoding 
membrane 
downstream 
[SEP] 
we 
nine 
consecutive 
case 
##b 
occurred 
male 
female 
detected 
11 
159 
routine 
spiral 
##t 
examination 
chest 
performed 
1994 
1998 
1998 [SEP] 
[CLS] 
in 
search 
mutation 
multi 
##copy 
gene 
might 
in 
sequence 
data 
reported 
c 
##a 
clone 
determine 
intro 
##n 
ex 
##on 
boundary 
1 
gene 
[SEP] 
98 
93 
98 
[CLS] 
study 
ex 
##cre 
##tion 
se 
##len 
urine 
f 
##ec 
##es 
distribution 
organ 
rat 
method 
radio 
##act 
measurement 
[SEP] 
[CLS] 
use 
two 
p 
##har 
##co 
##kin 
##etic 
parameter 
t 
##1 
2 
c 
##lt 
##p 
drug 
elimination 
ability 
discussed 
[CLS] 
gas 
##tric 
secret 
in 
##hibition 
three 
met 
pro 
e 
e2 
administered 
in 
##gas 
##tric 
##ally 
man 
by 
r 
##t 
##r 
different 
level 
e 
##75 
expression 
detected 
e 
nerve 
cord 
eyes 
##tal 
##k 
early 
m 
shrimp 
[CLS] 
vicinity 
large 
##b 
b 
concentration 
usually 
twice 
high 
ka 
##to 
##hip 
[CLS] 
forty 
dose 
ex 
##cre 
##ted 
met 
##hyl 
##do 
##pa 
opposed 
18 
normally 
seen 
oral 
met 
##hyl 
##do 
##pa 
dos 
##age 
[CLS] 
no 
c 
##vage 
##p 
130 
observed 
analogous 
chase 
##b 
fi 
##bro 
per 
##c 
replication 
process 
native 
##b 
molecule 
[SEP] 
phylogenetic 
32 
s 
##pec 
##ie 
showed 
difference 
##b 
m 
##rna 
sequence 
##b 
m 
##rna 
31 
s 
##pec 
##ro 
[CLS] 
the 
five 
within 
s 
##ro 
may 
entrance 
point 
c 
##lon 
candidate 
gene 
ne 
##uro 
##blast 
##oma 
[CLS] 
sugar 
analysis 
alpha 
investigate 
possible 
bio 
##sy 
##hetic 
mechanism 
part 
time 
p 
##gs 
p 
##ediatric 
handle 
care 
care [SEP] 
these 
und 
##ef 
##ined 
1 
##d 
##1 
##d 
##2 
##d 
##3 
coding 
unknown 
function 
gene 
encoding 
new 
##rup 
##pel 
put 
##ative 
transcription 
factor 
fly 
ho 
##mo 
##mologue 
##s 
ma 
##mmal 
mitochondrial 
##ri 
##function 
##al 
enzyme 
th 
##iol 
##ase 
##r 
d 
binding 
43 
first 
##rate 
member 
trans 
gene 
new 
##od 
gene 
gene 
coding 
nuclear 
binding 
##b 
ho 
##mo 
##log 
##ous 
male 
##less 
cop 
like 
element 
[CLS] 
t 
##f 
previously 
demonstrated 
activate 
transcription 
factor 
nuclear 
factor 
n 
##f 
##ka 
c 
j 
terminal 
stress 
protein 
kinase 
##p 
##k 
pathway 
turn 
stimulate 
##s 
transcription 
factor 
factor act 
1 
##p 
##1 
mainly 
via 
p 
j 
component 
[CLS] 
a 
pro 
##car 
##yo 
regulatory 
factor 
his 
##1 
like 
car 
##box 
terminal 
domain 
c 
##lon 
##al 
variation 
repeat 
within 
gene 
involved 
regulation 
m 
##uc 
##oid 
##y 
##mona 
[SEP] 
[CLS] 
the 
host 
h 
thought 
primarily 
determined 
surface 
molecule 
function 
##olio 
receptor 
##r 
since 
shown 
trans 
sensitive 
introducing 
human 
##r 
gene 
genome 
[CLS] 
human 
alcohol 
de 
##hy 
##dr 
##ogen 
##ase 
exists 
he 
##tero 
##gene 
##ous 
group 
##oz 
##yme 
o 
##xi 
##di 
##hat 
alcohol 
[SEP] 
[CLS] 
the 
control 
human 
a 
##roma 
##tase 
complex 
several 
promoter 
drive 
##tase 
tissue 
specific 
manner 
[SEP] 
in 
re 
##nal 
sympathetic 
activity 
measured 
separate 
rat 
[CLS] 
this 
in 
##com 
requires 
global 
transcription 
##al 
re 
##press 
##or 
##or 
##b 
target 
in 
##cc 
mediated 
in 
##com 
##or 
##b 
binding 
site 
o 
b 
[SEP] 
[PAD] [CLS] 
bodily 
refer 
affect 
affect [SEP] 
[CLS] 
the 
effect 
negative 
regulatory 
element 
ne 
##gated 
viral 
i 
##e 
##2 
protein 
l 
[SEP] 
r 
##x 
##ral 
##pha 
r 
##tero 
##di 
##mers 
ho 
##mo 
##di 
##mers 
bind 
d 
##r 
1 
motif 
element 
b 
i 
##4 
[CLS] 
evidence 
involvement 
protein 
h 
##u 
r 
##po 
##s 
transcription 
pro 
op 
##eron 
##cher 
##ichi 
co 
##li 
[SEP] 
[CLS] 
however 
lesser 
lesser extent 
effect 
##p 
##gnant 
seen 
rat 
[CLS] 
m 
##or 
##phine 
administration 
acute 
##ly 
reduced 
plasma 
clearance 
su 
##lf 
##ob 
##rom 
##op 
##hale 
b 
##sp 
mouse 
increased 
he 
##pa 
##tic 
retention 
dye 
b 
l 
l [SEP] 
[CLS] 
in 
##tras 
##pina 
##l 
media 
##inal 
fore 
##gu 
##t 
c 
##ys 
##t 
com 
##pressing 
cord 
[SEP] 
nut 
##race 
##utical 
specific 
##rogen 
fatty 
risk 
reduction 
program 
characterization 
unique 
protein 
component 
yeast 
r 
m 
##rp 
r 
##na 
binding 
zinc 
cluster 
domain 
the 
present 
study 
high 
dose 
5 
regime 
show 
activity 
##cre 
##atic 
seems 
[CLS] 
like 
nuclear 
in 
##tra 
##ar 
double 
membrane 
lame 
##lla 
defined 
c 
##ister 
interrupted 
p 
##ore 
unlike 
nuclear 
##ore 
lacked 
##c 
[SEP] 
22 
orbital 
flight 
co 
##smos 
60 
bio 
##elli 
followed 
in 
er 
##yt 
##hr 
##ob 
##last 
##osis 
alter 
##ation 
morphology 
me 
##ga 
##kar 
stimulation 
##elo 
##po 
##is 
[CLS] 
an 
o 
##d 
650 
greater 
0 
15 
rapid 
reliable 
indicator 
##etal 
lung 
maturity 
port 
n 
##2 
t 
##umour 
clear 
[CLS] 
r 
##x 
##r 
gamma 
terminal 
differentiation 
s 
##cc 
tumor 
suppress 
##or 
function 
transcription 
factor 
[SEP] 
residue 
subsequently 
identified 
se 
des 
s 
##i 
m 
degradation 
[CLS] 
the 
infection 
m 
##olo 
##ney 
m 
m 
m 
cause 
increase 
specific 
cellular 
gene 
product 
including 
m 
mh 
##c 
class 
i 
i anti 
##gen 
[CLS] 
these 
o 
##sin 
gene 
transcription 
regulated 
tissue 
specific 
temporal 
regulated 
manner 
clearly 
o 
##sin 
protein 
expression 
co 
or 
##dina 
##dinated 
primarily 
transcription 
##al 
level 
[CLS] 
##oc 
##ard 
##ial 
##ial tech 
##net 
99 
##boro 
up 
##eno 
##sin 
##yper 
dog 
critical 
mild 
co 
##rona 
##ry 
s 
##ten 
comparison 
comparison th 
##all 
201 
regional 
blood 
flow 
flow [SEP] 
u 
criterion 
35 
although 
##rp 
an 
##emia 
##emia obviously 
improved 
hem 
##og 
##lo 
level 
increasing 
4 
4 8 
d 
8 
d 
##l 
side 
effect 
effect [SEP] 
[CLS] 
di 
##k 
##zan 
s 
##ar 
experience 
r 
1 
surgical 
su 
##ura 
wound 
[CLS] 
at 
d 
##28 
149 
38 
patient 
49 
episode 
automatic 
mode 
switch 
prompted 
at 
##rial 
a 
##rr 
##hy 
##th 
##mia 
##mia [SEP] 
[CLS] 
together 
result 
##lica 
f 
##al 
##1 
##p 
18 
r 
##rna 
mat 
##uration 
pathway 
rather 
translation 
initiation 
[CLS] 
most 
difference 
two 
le 
##por 
located 
te 
##lo 
##mere 
[CLS] 
we 
rag 
r 
##w 
all 
hay 
dos 
rag 
extract 
investigate 
relationship 
early 
er 
late 
late l 
##r 
re 
reaction 
##c 
##rs 
nasal 
challenge 
challenge [SEP] 
expression 
second 
protein 
involved 
calcium 
metabolism 
moderately 
do 
##x 
##or 
##cin 
cell 
[CLS] 
the 
central 
region 
##rc 
##omer 
##e 
coincide 
##nt 
m 
line 
selective 
labeled 
##body 
c 
terminal 
form 
[CLS] 
despite 
depend 
##ency 
however 
b 
j 
##apon 
fix 
##k 
mutant 
p 
##hen 
##otypic 
characteristic 
b 
j 
##apon 
fix 
##l 
fix 
mutant 
mutant 
neither 
fix 
s 
##ym 
##bio 
##sis 
so 
plant 
defect 
##ive 
##ive an 
##ae 
##ro 
##bic 
re 
##spiration 
ni 
##trate 
terminal 
electron 
accept 
[SEP] 
an 
##l 
75 
##35 
the 
q 
##cs 
appears 
comparable 
mm 
##se 
quicker 
administer 
administer [SEP] 
[CLS] 
we 
ultra 
character 
##ndi 
ant 
##ral 
ex 
##cursion 
characteristic 
15 
healthy 
volunteer 
copyright 
1998 
press 
press [SEP] 
human 
##3 
##lio 
pro 
u 
##us 
al 
##iment 
##ary 
tract 
[CLS] 
e 
##pit 
cell 
abnormal 
accelerated 
ex 
##folia 
resulted 
multi 
##fo 
##cal 
e 
##ial 
defect 
defect [SEP] 
[CLS] 
tight 
binding 
band 
structure 
calculation 
beta 
m 
##nx 
m 
##r 
x 
c 
##l 
br 
m 
h 
##f 
x 
c 
##l 
##rc 
##l 
y 
2 
c 
2 
br 
2 
reported 
[SEP] 
[CLS] 
screening 
human 
foe 
##tal 
brain 
##eno 
d 
library 
e 
##cor 
##i 
e 
##cor 
##i 
fragment 
containing 
6 
k 
##b 
5 
flank 
##ing 
open 
reading 
frame 
4 
k 
##b 
3 
flank 
region 
##4 
gene 
[CLS] 
##oso 
approach 
##hr 
##osis 
[CLS] 
the 
rate 
decrease 
re 
##m 
onset 
est 
##ra 
half 
life 
suggests 
re 
##m 
onset 
##ation 
re 
##nin 
production 
production [SEP] 
[CLS] 
similarly 
interfering 
##k 
##k 
lie 
upstream 
##1 
dominant 
vector 
reduced 
##p 
9 
promoter 
activity 
concentration 
range 
re 
##pressed 
##p 
1 
thy 
##mi 
##dine 
kinase 
cat 
reporter 
construct 
[CLS] 
there 
serum 
transfer 
##rin 
level 
pre 
level 
group 
fed 
early 
desirable 
control 
group 
15 
8 
2 
5 
mg 
d 
##l 
28 
9 
3 
8 
mg 
d 
v 
18 
0 
0 2 
0 
mg 
d 
##l 
25 
9 
3 
9 
mg 
d 
##l 
[CLS] 
the 
repeat 
highly 
conserved 
within 
element 
well 
different 
le 
10 
diver 
##gence 
[SEP] 
[PAD] [CLS] 
utility 
##all 
201 
s 
##ti 
right 
##ric 
##ular 
d 
##ys 
##function 
em 
##bol 
##ism 
##ism [SEP] 
conclusion 
system 
developed 
study 
detect 
air 
trapping 
trapping t 
##gi 
##gi [SEP] 
[CLS] 
the 
car 
##box 
##yl 
terminal 
75 
amino 
acid 
two 
protein 
contain 
b 
##hl 
##h 
motif 
differ 
three 
conservative 
amino 
acid 
change 
amino 
terminal 
portion 
marked 
diver 
##gent 
[SEP] 
rat 
model 
assessed 
##bb 
change 
mean 
quantitative 
##c 
alpha 
amino 
##ob 
##yric 
[PAD] [CLS] 
poll 
##ino 
[CLS] 
b 
##lot 
red 
##uc 
m 
steady 
level 
seed 
development 
increase 
enzyme 
activity 
phase 
storage 
regulated 
level 
gene 
expression 
[CLS] 
time 
test 
le 
one 
year 
affect 
correlation 
##pi 
response 
set 
variable 
l 
f 
k 
f 
k 
k [SEP] 
[CLS] 
difference 
binding 
k 
##da 
##pp 
incorporation 
extension 
kinetic 
o 
##x 
##o 
d 
##p 
d 
##p 
incorporation 
template 
template 8 
o 
##o 
##uc 
polymer 
##ase 
fi 
overall 
geometry 
wa 
##ts 
c 
##rick 
base 
pair 
reflects 
as 
##metry 
enzyme 
active 
site 
this 
constant 
profile 
m 
##3 
au 
##1 
s 
##r 
em 
##b 
fi 
##bro 
re 
transformation 
m 
##3 
##a 
limiting 
factor 
regulation 
super 
function 
[CLS] 
the 
sequence 
10 
35 
relative 
transcription 
##al 
starting 
site 
showed 
ho 
##mology 
consensus 
es 
##cher 
##ichi 
co 
coli 
si 
##gma 
70 
type 
promoter 
[SEP] 
the 
result 
23 
auto 
into 
##ani 
##oid 
method 
de 
##uts 
diabetes 
dial 
##ys 
random 
hypothesis 
at 
##tat 
red 
##uc 
card 
##iovascular 
##fa 
##fatal 
##oc 
##ard 
in 
##far 
diabetes 
hem 
##od 
##ial 
##ys 
[CLS] 
there 
correlation 
serum 
am 
##io 
##dar 
##one 
des 
##eth 
##mio 
##dar 
##one 
level 
dos 
##age 
##io 
##dar 
##one 
the 
effect 
mon 
##ral 
middle 
destruction 
##nat 
##al 
development 
mouse 
##culus 
unusual 
behaviour 
may 
explained 
18 
amino 
acid 
long 
c 
##dr 
##3 
could 
design 
single 
domain 
anti 
##body 
question 
must 
mortality 
risk 
##rom 
##bol 
##ys 
electro 
##card 
##io 
##far 
initiated 
early 
onset 
s 
##pt 
regime 
##can 
##ali 
pat 
##far 
##ct 
parameter 
l 
##p 
treatment 
s 
b 
cell 
at 
result 
decrease 
m 
encoding 
alpha 
class 
amongst 
53 
##oper 
t 
##4 
n 
##0 
n 
##1 
t 
n 
##2 
n 
##3 
case 
5 
10 
positive 
scan 
doubtful 
scan 
[SEP] 
anti 
##biotic 
83 
##7 
as 
##pi 
##rin 
is 
conventional 
sperm 
analysis 
use 
use [SEP] 
the 
computer 
##ised 
record 
86 
couple 
investigate 
pro 
##gno 
se 
##men 
volume 
m 
##ot 
morphology 
morphology [SEP] 
muscle 
in 
##far 
i 
##p 
24 
2 
pre 
##ische 
##m 
##k 
21 
2 
group 
control 
42 
2 
binding 
s 
domain 
s 
f 
possibility 
protein 
interaction 
various 
member 
c 
p 
##t 
##k 
family 
[SEP] 
[CLS] 
mutation 
##al 
analysis 
put 
##ative 
effect 
##or 
domain 
##p 
binding 
##1 
protein 
yeast 
specific 
regulation 
novel 
gap 
activity 
[SEP] 
[CLS] 
interaction 
obtained 
d 
##b 
##m 
score 
qualified 
three 
interaction 
limited 
pattern 
participant 
higher 
self 
deception 
deception [SEP] 
t 
##yr 
##stein 
p 
3 
##ort 
29 
##40 
##400 
##02 
2 
2 4 
m 
##or 
##ph 
##olin 
##yl 
##yl 8 
##yl 
##h 
1 
##zo 
4 
blocked 
ad 
##eno 
##sin 
##3 
map 
##k 
[CLS] 
surprisingly 
##1 
bind 
e 
box 
v 
##1 
protein 
functional 
transcription 
activation 
domain 
[SEP] 
ex 
##r 
form 
he 
##tero 
##di 
##mers 
end 
##ogen 
##r 
result 
obtained 
functional 
##r 
taken 
caution 
[SEP] 
##at 
specific 
lip 
##ase 
##air 
fat 
absorption 
thereby 
reducing 
fat 
up 
##take 
metal 
##rote 
##inas 
media 
c 
##lea 
##vage 
##vage specifically 
in 
##hibit 
tissue 
inhibitor 
metal 
##rote 
##roteinas 
3 
3 t 
1 
1 t 
[CLS] 
relative 
independence 
s 
##ync 
##hr 
rhythmic 
tissue 
level 
influence 
higher 
regulatory 
center 
[SEP] 
[CLS] 
it 
con 
##ce 
elevated 
insulin 
may 
cause 
h 
##yper 
##tri 
##gly 
##cer 
##mia 
possibly 
abnormal 
##ity 
lip 
##id 
metabolism 
[CLS] 
flicker 
threshold 
measured 
1 
40 
h 
##z 
vertical 
line 
target 
as 
threshold 
threshold [SEP] 
[CLS] 
the 
c 
##r 
##1 
lo 
##cus 
regulate 
expression 
cry 
##ptic 
mating 
type 
lo 
##cus 
fi 
yeast 
[SEP] 
use 
el 
elisa 
diagnosis 
can 
atop 
##y 
##y [SEP] 
[CLS] 
a 
clinical 
study 
[CLS] 
method 
[CLS] 
instead 
##x 
shown 
activate 
c 
##y 
##c 
##lin 
promoter 
induce 
c 
##y 
##c 
##lin 
a 
c 
##y 
dependent 
kinase 
complex 
promote 
cycling 
growth 
arrested 
cell 
g 
##1 
pathway 
involving 
activation 
kinase 
[CLS] 
growth 
hormone 
ex 
exert 
effect 
o 
##ian 
f 
##icular 
cycle 
directly 
local 
production 
insulin 
1 
i 
1 
the 
the aim 
study 
type 
i 
insulin 
dependent 
diabetes 
##lli 
the 
subject 
started 
in 
##ac 
25 
mg 
th 
##rice 
daily 
[PAD] [CLS] 
a 
b 
##udd 
##his 
##t 
view 
abortion 
##erial 
blood 
measured 
method 
##est 
animal 
15 
min 
hem 
##or 
##r 
##hage 
star 
##ved 
45 
min 
striking 
difference 
observed 
de 
##cid 
##ual 
t 
##ho 
##blast 
pro 
##ct 
##in 
characterization 
gene 
structure 
cell 
specific 
expression 
[CLS] 
flu 
##ores 
sit 
hybrid 
investigate 
physical 
distribution 
revealed 
re 
##tro 
##tra 
##ns 
##po 
family 
present 
sugar 
bee 
chromosome 
largely 
excluded 
ch 
##rom 
##oso 
##mal 
region 
harbour 
##ing 
##ing 18 
5 
8 
25 
r 
##rna 
gene 
[SEP] 
[CLS] 
plasma 
ne 
ne e 
increased 
significantly 
higher 
15 
min 
young 
1 
68 
0 
18 
v 
v [SEP] 
[CLS] 
an 
insertion 
sequence 
element 
is 
##11 
##70 
identified 
upstream 
ni 
##m 
##c 
gene 
[SEP] 
[CLS] 
organ 
##elle 
s 
##ze 
set 
f 
##e 
s 
protein 
initiate 
generation 
extra 
##mit 
##och 
##ond 
##rial 
f 
##e 
s 
protein 
[SEP] 
[CLS] 
##c 
##d 
complex 
ma 
##ximal 
active 
##1 
s 
transition 
##c 
decrease 
take 
complete 
##1 
enter 
s 
phase 
phase [SEP] 
[CLS] 
##eno 
##mic 
clone 
chicken 
o 
##ste 
encoding 
op 
isolated 
found 
organized 
follows 
##lated 
5 
ex 
##on 
signal 
p 
recognition 
sequence 
p 
case 
##in 
kinase 
domain 
containing 
possible 
link 
##age 
site 
g 
##cos 
##tion 
second 
case 
##in 
site 
ex 
##on 
containing 
three 
functional 
region 
as 
sequence 
consecutive 
residue 
residue r 
##g 
##d 
in 
inte 
##teg 
recognition 
site 
n 
##age 
site 
g 
##cos 
large 
c 
terminal 
ex 
##on 
also 
contains 
n 
##age 
site 
##cos 
however 
neither 
s 
sf 
1 
alone 
binding 
mon 
##omer 
transcription 
satisfactory 
correlation 
result 
[CLS] 
structural 
organization 
human 
el 
##k 
##1 
gene 
processed 
pseudo 
##gene 
##gene el 
##k 
##2 
[SEP] 
o 
##cc 
15 
30 
45 
90 
min 
##mura 
bio 
##che 
analyzed 
ad 
##eni 
##rea 
ultra 
##ructural 
change 
the 
##cular 
ad 
##nex 
##al 
s 
significantly 
greater 
hair 
bay 
brown 
01 
[CLS] 
patient 
without 
s 
##yn 
##dr 
##omi 
##omic 
diagnosis 
diagnosis [SEP] 
[CLS] 
in 
r 
##1 
r 
##2 
feed 
restricted 
with 
##holding 
concentrate 
3 
4 
5 
m 
##o 
respectively 
respectively [SEP] 
in 
##1 
required 
##ivo 
##if 
alpha 
extract 
##1 
delta 
strain 
contained 
wild 
type 
level 
##if 
alpha 
kinase 
activity 
[SEP] 
[CLS] 
s 
##co 
##f 
1 
localized 
nucleus 
bind 
directly 
either 
c 
repeat 
de 
##dra 
c 
d 
a 
##ba 
re 
element 
element a 
##bre 
c 
##i 
acting 
d 
regulatory 
element 
present 
co 
##r 
gene 
promoter 
[SEP] 
[CLS] 
on 
basis 
accept 
p 
bind 
transfer 
##ase 
beta 
like 
conform 
##ation 
##imate 
residue 
chain 
s 
##ter 
##ic 
interaction 
determining 
extent 
given 
se 
##r 
th 
##r 
g 
##cos 
##yla 
##ted 
[SEP] 
the 
concentration 
vitamin 
b 
##1 
b 
##2 
b 
##6 
9 
96 
9 
92 
3 
01 
mg 
respectively 
240 
mg 
capsule 
powder 
standard 
name 
due 
due secrecy 
purpose 
purpose [SEP] 
##oly 
##mor 
##phism 
##r 
gene 
##f 
##rica 
mouse 
amino 
acid 
infection 
si 
[CLS] 
further 
detect 
##2 
three 
overlapping 
##cs 
contain 
one 
marker 
linked 
d 
##f 
##9 
m 
##co 
##b 
##2 
genetically 
mapped 
chromosome 
12 
region 
ho 
##mo 
##log 
##ous 
##yn 
##ten 
##y 
human 
##q 
##11 
contains 
##1 
audio 
seizure 
lo 
mouse 
[CLS] 
absence 
ni 
##tro 
##so 
formation 
14 
##c 
##hom 
##yl 
ni 
##tri 
##te 
stomach 
condition 
##b 
##1 
mutation 
create 
protein 
isolated 
previously 
gene 
##6 
two 
new 
s 
s 
##2 
am 
amt 
9 
6 
10 
s 
sbt 
##l 
##l 
9 
1 
1 10 
s 
st 
##t 13 
b 
bnt 
##nt 14 
c 
##pt 
1 
1 0 
3 
b 
##dt 
##dt 19 
19 0 
3 
3 33 
33 [SEP] 
[CLS] 
anti 
dose 
response 
curve 
drawn 
cumulative 
dose 
required 
35 
reduction 
specific 
air 
##way 
calculated 
designated 
pro 
##vocation 
dose 
p 
##d 
##35 
[SEP] 
[CLS] 
cross 
talk 
transcription 
factor 
n 
##f 
c 
##b 
transcription 
##al 
regulation 
gene 
[SEP] 
[PAD] [CLS] 
elect 
##ive 
replacement 
root 
ma 
##rf 
##an 
syndrome 
syndrome [SEP] 
complex 
o 
##xi 
##di 
##zes 
ca 
##lda 
##riel 
##uin 
##ol 
high 
rate 
completely 
in 
##hibit 
##olo 
analog 
inhibitor 
##uin 
##ol 
o 
##xi 
##das 
##e 
[CLS] 
characterized 
new 
##k 
6 
potentially 
encoding 
tobacco 
33 
k 
##da 
ch 
##op 
##last 
r 
##p 
##33 
ho 
##mo 
##logue 
[SEP] 
[CLS] 
the 
region 
encoding 
mature 
protein 
##ase 
clone 
##d 
expression 
vector 
re 
##comb 
protein 
produced 
es 
##cher 
##ichi 
co 
##li 
[SEP] 
further 
##more 
##l 
##100 
suppress 
##es 
##12 
activation 
map 
cell 
system 
##yte 
the 
x 
##eno 
##ob 
gene 
twin 
media 
mediates 
induction 
##co 
##id 
establishment 
s 
##pe 
##pemann 
organizer 
[SEP] 
1988 
1994 
data 
3 
site 
revealed 
3 
5 
fold 
##de 
##press 
at 
treatment 
year 
[CLS] 
the 
##a 
d 
##r 
open 
reading 
frame 
en 
subunit 
he 
##tero 
##di 
##mer 
##ic 
v 
early 
transcription 
factor 
##t 
##f 
activate 
transcription 
early 
gene 
##ro 
[SEP] 
se 
##rop 
##cc 
##ls 
likely 
mixed 
infection 
[CLS] 
recognition 
d 
single 
chain 
derivative 
43 
##4 
re 
##press 
##or 
high 
affinity 
binding 
depends 
contacted 
contacted 
base 
pair 
[SEP] 
[CLS] 
the 
call 
standardized 
question 
format 
centralized 
monitor 
change 
parameter 
sexual 
behaviour 
[CLS] 
##f 
bind 
one 
two 
d 
##ro 
sequence 
##rm 
##1 
promoter 
d 
##ro 
sequence 
##rm 
promoter 
specific 
manner 
[SEP] 
139 
##r 
relaxation 
z 
do 
effect 
la 
##2 
##o 
##4 
[CLS] 
the 
gamma 
ca 
##c 
box 
binding 
factor 
media 
l 
##r 
gamma 
interaction 
normally 
enhance 
gamma 
##lo 
##bin 
suppress 
beta 
##lo 
##bin 
gene 
expression 
##etal 
er 
##hr 
cell 
[SEP] 
##ivo 
attachment 
2 
1 
ha 
coated 
o 
##ct 
##ame 
##r 
recognition 
mediated 
domain 
structural 
motif 
like 
zinc 
defines 
transcription 
factor 
[SEP] 
all 
test 
##osterone 
plasma 
test 
##osterone 
concentration 
control 
pre 
level 
test 
##osterone 
##yn 
##ove 
test 
##osterone 
##yn 
##ove 
05 
[CLS] 
lifestyle 
characteristic 
as 
##cer 
##tain 
self 
administered 
question 
##naire 
##naire [SEP] 
[CLS] 
the 
major 
promoter 
element 
x 
##eno 
5 
r 
gene 
located 
within 
trans 
##cribed 
region 
gene 
form 
binding 
site 
transcription 
initiation 
factor 
t 
##fi 
##ii 
##a 
[SEP] 
[CLS] 
during 
step 
pulse 
in 
o 
##ste 
##al 
response 
##i 
general 
parallel 
r 
0 
46 
462 
inverse 
correlated 
r 
0 
0 56 
562 
00 
003 
[SEP] 
[CLS] 
the 
gamma 
gene 
expressed 
u 
##bi 
##quito 
##quitous 
induced 
coordinate 
p 
##uin 
##one 
o 
##dor 
##ed 
##uc 
##tase 
1 
##o 
##1 
g 
##ath 
##ione 
s 
transfer 
##ase 
ya 
ya 
response 
interesting 
id 
##rt 
##oli 
detect 
camp 
camp [SEP] 
[CLS] 
we 
determined 
n 
terminal 
amino 
acid 
sequence 
found 
p 
##pt 
##ide 
co 
##tt 
##ek 
##e 
co 
cot 
##f 
##a 
31 
45 
k 
##da 
s 
##po 
##iva 
respectively 
respectively [SEP] 
[CLS] 
the 
effect 
beta 
##has 
duo 
##den 
##al 
calcium 
absorption 
1 
25 
di 
##dr 
##y 
vitamin 
d 
##3 
chick 
[CLS] 
further 
established 
se 
p 
##lation 
s 
trans 
##act 
##ivation 
domain 
via 
map 
##k 
pathway 
mean 
modify 
transcription 
##al 
activation 
[SEP] 
e 
cell 
gene 
er 
##hr 
##oid 
transcription 
factor 
1 
disrupted 
mature 
er 
##hr 
##oid 
cell 
either 
##ivo 
##ro 
conserved 
motif 
##9 
##9 
##4 
##k 
##1 
seemed 
addressing 
[CLS] 
it 
predominant 
action 
l 
##s 
##d 
cop 
mediated 
increased 
do 
##pa 
##mine 
receptor 
activity 
activity l 
##s 
##d 
effect 
might 
m 
##od 
##ulated 
decreased 
do 
##pa 
##mine 
##rg 
activity 
activity [SEP] 
[CLS] 
therefore 
##dr 
mediated 
transcription 
##al 
activation 
1 
25 
oh 
2d 
##3 
binding 
##dr 
alter 
##s 
conform 
##ation 
l 
##igan 
##d 
binding 
domain 
engages 
strong 
he 
##tero 
##di 
##mer 
##ization 
##x 
##r 
facilitate 
##dre 
binding 
ii 
influence 
##x 
##r 
##d 
binding 
domain 
resistant 
binding 
9 
c 
##i 
##i r 
##a 
active 
recruiting 
co 
##act 
##iva 
##tor 
ii 
##i 
present 
##f 
2 
region 
##dr 
co 
##act 
##iva 
##tor 
association 
[SEP] 
[CLS] 
750 
m 
##l 
sa 
d 
##l 
co 
co 8 
01 
base 
d 
m 
10 
01 
base 
al 
##dos 
##tero 
29 
01 
base 
re 
##nin 
01 
base 
hem 
##ato 
05 
base 
increased 
c 
c 20 
01 
base 
without 
##pp 
lit 
##1 
paternal 
##ly 
r 
within 
##1 
lo 
##cus 
position 
##al 
screening 
approach 
human 
mon 
##och 
##rom 
##oso 
hybrid 
a 
series 
del 
##eti 
##on 
mutant 
trans 
two 
[CLS] 
the 
predicted 
amino 
acid 
sequence 
##ab 
##pt 
##ide 
92 
identical 
t 
p 
##id 
fl 
##ab 
76 
identity 
n 
##leo 
##tide 
level 
[SEP] 
[CLS] 
comparative 
analysis 
5 
peripheral 
domain 
exhibit 
75 
b 
##p 
length 
p 
##oly 
##mor 
##phism 
near 
sequence 
associated 
termination 
h 
strand 
replication 
the 
bow 
even 
need 
long 
term 
parent 
##eral 
nutrition 
good 
good [SEP] 
thus 
cross 
resistance 
##oro 
shown 
enter 
##rsa 
[SEP] 
[CLS] 
the 
5 
end 
p 
gene 
m 
##rna 
separated 
109 
n 
##uc 
##leo 
##tide 
pair 
d 
##na 
template 
[SEP] 
using 
community 
development 
approach 
[CLS] 
bio 
##l 
[CLS] 
we 
clone 
##d 
##b 
human 
frog 
yeast 
three 
hybrid 
system 
along 
##aru 
group 
group 2 
don 
3 
##ac 
##don 
15 
##ac 
##don 
##don f 
f ch 
##os 
##por 
type 
t 
##oth 
##ene 
derivative 
semi 
##tec 
often 
associated 
[CLS] 
t 
beta 
##1 
induced 
s 
s 
##3 
##1 
##lu 
##k 
lung 
e 
cell 
there 
little 
ace 
inhibitor 
##top 
en 
##ala 
##ril 
te 
##rato 
[CLS] 
thus 
induction 
rear 
##rang 
##1 
##a 
gene 
therapy 
unlikely 
treatment 
advanced 
ma 
##gnant 
disease 
[CLS] 
although 
hybrid 
##ize 
several 
similar 
structural 
feature 
open 
reading 
frame 
comprises 
23 
trans 
##cript 
5 
un 
##tra 
##ns 
##lated 
region 
region extremely 
g 
gc 
rich 
3 
##ns 
##lated 
region 
region unusually 
long 
at 
rich 
identification 
23 
k 
##d 
protein 
z 
sad 
1992 
[PAD] [CLS] 
##una 
##l 
done 
kind 
flap 
##fa 
j 
##una 
##l 
inter 
##position 
flap 
without 
need 
need complex 
##rger 
##y 
##y [SEP] 
in 
high 
binding 
at 
2 
low 
binding 
##b 
observed 
extract 
tissue 
low 
at 
opposite 
extract 
tissue 
high 
at 
level 
[SEP] 
activation 
t 
##yr 
##os 
##tero 
##tri 
##mer 
##ic 
g 
enhanced 
29 
##3 
##c 
cell 
[CLS] 
the 
##ug 
##rip 
##ug 
gene 
fragment 
used 
is 
##olate 
gene 
##ug 
g 
##eno 
##mic 
library 
[CLS] 
##ro 
glass 
stomach 
containing 
various 
volume 
h 
##ydro 
##ch 
acid 
##c 
##l 
am 
##mon 
n 
##h 
##4 
##c 
##l 
used 
evaluate 
increasing 
gas 
##tric 
##h 
##h 
##4 
##h 
##3 
transition 
occurs 
9 
24 
[SEP] 
##lov 
##ir 
3 
o 
topic 
##ally 
one 
five 
time 
day 
acute 
o 
##cular 
h 
##v 
infection 
gave 
beneficial 
result 
reduction 
##eal 
involvement 
con 
##iv 
##itis 
##rit 
##eal 
##ing 
[CLS] 
previously 
g 
##co 
##cor 
##tic 
##oid 
hormone 
m 
##od 
post 
##lation 
##al 
local 
tumor 
mm 
mmt 
##tv 
##1 
54 
##t 
he 
[CLS] 
partial 
pro 
##te 
##oly 
##od 
b 
g 
molecule 
generates 
extremely 
similar 
pattern 
spot 
within 
ha 
##p 
##lot 
##ype 
setting 
university 
research 
there 
57 
reduction 
##f 
m 
##rna 
##9 
confluence 
##10 
[CLS] 
o 
##go 
##mers 
corresponding 
region 
m 
1 
3 
enhance 
##r 
encompasses 
conserved 
sequence 
bound 
me 
##f 
competed 
binding 
m 
##ck 
enhance 
##r 
[SEP] 
[CLS] 
similar 
tissue 
specific 
pattern 
observed 
fusion 
ca 
cauf 
##ufli 
35 
35s 
r 
pro 
##moto 
##r 
##u 
gene 
[SEP] 
[CLS] 
this 
difference 
1 
p 
due 
differential 
up 
##take 
since 
since approximately 
100 
time 
2 
p 
##eptide 
could 
found 
c 
##yt 
##op 
##las 
extract 
s 
1 
p 
experiment 
radio 
p 
##eptide 
[SEP] 
[CLS] 
one 
function 
##53 
regulating 
cell 
cycle 
control 
d 
damage 
[CLS] 
we 
related 
##ri 
cue 
##d 
spatial 
task 
di 
##sso 
##cia 
##te 
brain 
activity 
related 
attention 
##al 
control 
target 
stimulus 
stimulus [SEP] 
background 
extract 
containing 
##n 
contraction 
effect 
human 
gal 
##l 
bladder 
##pop 
triggered 
##hibit 
##rma 
##35 
##l 
x 
[CLS] 
the 
product 
one 
gene 
##80 
single 
diver 
##gent 
copy 
sequence 
149 
amino 
acid 
approx 
[SEP] 
[CLS] 
the 
103 
##1 
b 
##p 
wild 
hit 
##1 
d 
contained 
open 
reading 
frame 
encoding 
protein 
164 
amino 
acid 
##gg 
##rg 
t 
gene 
complement 
hit 
##1 
1 
mutant 
##hen 
##otype 
mutant 
p 
##hen 
##otype 
caused 
del 
##eti 
##on 
gene 
[SEP] 
eating 
disorder 
5 
9 
lifetime 
prevalence 
10 
i 
##rre 
##spective 
type 
diabetes 
4 
1 
whole 
##olo 
##l 
cm 
##c 
used 
op 
drug 
polymer 
respectively 
[CLS] 
these 
result 
discussed 
context 
model 
my 
##ogenic 
lineage 
based 
expression 
des 
##min 
[CLS] 
identified 
two 
potential 
p 
site 
se 
##9 
se 
##3 
seem 
necessary 
##f 
5 
[CLS] 
we 
constructed 
series 
ch 
##ime 
##ric 
gene 
containing 
part 
first 
ex 
##on 
increasingly 
longer 
5 
flank 
##ing 
sequence 
o 
##d 
##c 
gene 
fused 
either 
bacterial 
ch 
##lora 
##l 
ace 
##ty 
##lt 
##ran 
##s 
##fer 
##ase 
cat 
l 
##uc 
##ifer 
##ase 
reporter 
gene 
[SEP] 
[CLS] 
##vo 
##2 
sat 
detect 
blood 
loss 
the 
gene 
encoding 
ne 
neisse 
##isseria 
la 
lact 
ii 
##i 
d 
met 
##hyl 
##tra 
##ns 
##fer 
##ase 
m 
n 
##lai 
##ii 
recognizes 
sequence 
##g 
clone 
##d 
expressed 
es 
##cher 
co 
##li 
[SEP] 
[CLS] 
this 
latter 
complex 
react 
serum 
response 
factor 
exhibit 
binding 
##rf 
[SEP] 
patient 
in 
##ven 
##ous 
pro 
alpha 
p 
alpha 
alpha [SEP] 
[CLS] 
alignment 
rat 
human 
win 
comparison 
##eno 
##mic 
sequence 
revealed 
win 
d 
binding 
domain 
encoded 
four 
ex 
##on 
two 
ex 
##on 
4 
6 
alternatively 
s 
##lice 
##d 
generate 
least 
three 
class 
m 
trans 
##cript 
[SEP] 
[CLS] 
dog 
given 
parent 
##eral 
r 
operation 
g 
##lot 
blood 
contained 
r 
slight 
increase 
in 
##hibition 
24 
hour 
93 
flow 
direct 
blood 
##ral 
devised 
[CLS] 
here 
interaction 
la 
la 
lact 
ll 
l 
##b 
intro 
##n 
end 
##lea 
d 
target 
site 
d 
foot 
##print 
modification 
[SEP] 
[CLS] 
clinical 
bring 
information 
p 
##har 
e 
##pid 
##em 
##iology 
##iology [SEP] 
[CLS] 
in 
several 
step 
converted 
re 
##id 
specific 
response 
element 
re 
beta 
promoter 
d 
re 
response 
element 
human 
o 
##ste 
promoter 
[CLS] 
the 
immediate 
5 
flank 
##ing 
region 
g 
##c 
rich 
3 
s 
##p 
1 
like 
2 
a 
##p 
2 
site 
identified 
close 
proximity 
transcription 
start 
site 
[SEP] 
a 
##kt 
dependent 
far 
##tra 
##fer 
##d 
##35 
##00 
91 
s 
##t 
##ks 
##35 
76 
s 
##t 
##ks 
73 
s 
##t 
##ks 
specific 
control 
o 
##vu 
##lation 
mare 
early 
o 
##ian 
s 
pro 
reason 
suggesting 
t 
##l 
join 
calcium 
antagonist 
agent 
[PAD] [CLS] 
##nous 
o 
##2 
sat 
pulmonary 
fat 
em 
##bol 
##ism 
##ism [SEP] 
two 
protein 
##rf 
1 
2 
apparently 
pro 
##te 
##oly 
##tic 
degradation 
product 
1 
bind 
##ef 
##ficient 
unable 
c 
##c 
##1 
identification 
domain 
media 
transcription 
activation 
repression 
in 
##hibition 
paired 
related 
##x 
method 
spatial 
counting 
location 
s 
##tra 
pyramid 
##ale 
sector 
##1 
4 
control 
s 
##z 
matched 
##mor 
interval 
well 
well 4 
man 
de 
m 
##d 
matched 
age 
[CLS] 
analytical 
scanning 
scanning is 
##oe 
##ro 
[CLS] 
upstream 
s 
##ti 
##mu 
##lator 
##y 
factor 
##f 
human 
transcription 
##al 
activation 
factor 
us 
he 
he 
b 
ho 
##mo 
##di 
##mer 
##ize 
recognize 
specific 
sequence 
promoter 
region 
nuclear 
gene 
trans 
r 
##na 
polymer 
ii 
[SEP] 
43 
6 
14 
01 
##3 
##cc 
sample 
##hl 
##hyl 
mutation 
3 
##p 
##14 
p 
p21 
##h 
differ 
##p 
##p25 
p 
p26 
72 
18 
25 
[CLS] 
sequence 
ho 
##mo 
##log 
##ous 
consensus 
t 
##uf 
binding 
##as 
box 
present 
5 
flank 
##ing 
region 
gene 
[SEP] 
[CLS] 
the 
analysis 
serum 
##tin 
as 
##par 
##tate 
trans 
##ami 
##nas 
reduction 
clearance 
[CLS] 
result 
although 
low 
##ir 
##f 
m 
##rna 
8 
b 
##b 
##l 
1 
tumor 
12 
0 
te 
t 
stimulate 
expression 
##f 
gene 
together 
primary 
l 
##ytic 
cycle 
gene 
[CLS] 
central 
projection 
gas 
##tric 
##ffer 
v 
##aga 
input 
[SEP] 
d 
sequence 
ul 
##6 
ul 
##20 
gene 
infectious 
la 
##ryn 
##got 
##itis 
characterization 
ul 
##10 
gene 
product 
##cos 
protein 
[CLS] 
co 
likely 
contribute 
multi 
##mer 
##ization 
function 
required 
ho 
##mo 
##mer 
##ic 
complex 
formation 
he 
##tero 
##mer 
##ic 
complex 
formation 
##50 
association 
p 
##65 
delta 
p 
##50 
evident 
[SEP] 
##ost 
##atic 
essential 
[CLS] 
a 
yeast 
mitochondrial 
translation 
initiation 
co 
##don 
mutation 
affecting 
gene 
c 
##yt 
##och 
##rome 
o 
##xi 
##das 
subunit 
ii 
##i 
co 
##x 
##3 
suppressed 
spontaneous 
nuclear 
mutation 
[SEP] 
only 
27 
k 
protein 
detected 
##cos 
##p 
h 
##in 
more 
##over 
studied 
relationship 
initial 
ma 
##rrow 
pro 
##sis 
these 
result 
##ase 
i 
inhibitor 
arrest 
g 
##0 
##1 
induce 
manner 
manner ft 
##ase 
inhibitor 
interfere 
cycle 
event 
mechanism 
involves 
neither 
##p 
[CLS] 
we 
year 
boy 
first 
acute 
in 
##vas 
##cular 
hem 
##oly 
##ph 
##oter 
##ici 
##b 
subsequently 
delayed 
hem 
##oly 
trans 
reaction 
due 
##oan 
##body 
##body [SEP] 
[CLS] 
temporal 
sequence 
organ 
failure 
lung 
c 
##lot 
##lotting 
system 
kidney 
liver 
liver [SEP] 
the 
biological 
structural 
motif 
shared 
##r 
##5 
##r 
##3 
##r 
##b 
##rs 
discussed 
analysis 
rat 
brain 
heart 
lung 
liver 
kidney 
skeletal 
muscle 
revealed 
##i 
##k 
##c 
z 
##eta 
m 
##rna 
brain 
the 
provide 
broad 
perspective 
m 
##pas 
management 
patient 
e 
##wing 
reference 
need 
achieve 
local 
result 
radiation 
therapy 
patient 
long 
term 
survival 
survival [SEP] 
[CLS] 
further 
rapid 
light 
mediated 
##rf 
protein 
transcription 
##al 
inhibitor 
post 
transcription 
##al 
mechanism 
control 
##rf 
accumulation 
[SEP] 
[PAD] [CLS] 
transplant 
se 
##rol 
received 
##v 
i 
igg 
positive 
donor 
incidence 
disease 
highest 
highest [SEP] 
since 
combination 
##lora 
##mb 
10 
mg 
daily 
initially 
six 
week 
alternating 
fort 
12 
week 
inter 
##fer 
alpha 
s 
p 
2 
x 
10 
6 
m 
m2 
three 
time 
sub 
injection 
injection 18 
week 
random 
##ised 
alone 
##tre 
stage 
ii 
##i 
i 
iv 
##v f 
##oll 
##icular 
l 
##ymph 
##oma 
the 
b 
##du 
ne 
##uron 
touch 
ne 
##uron 
line 
##al 
sister 
a 
##b 
lineage 
##a 
##b 
motor 
ne 
line 
##al 
sister 
##b 
lineage 
we 
retrospective 
s 
##f 
alone 
##em 
plus 
##d 
##34 
patient 
[CLS] 
serum 
concentration 
hormone 
patient 
classified 
c 
characteristic 
##ally 
inclined 
h 
##yper 
##ado 
##tro 
##rogen 
##ic 
##ic [SEP] 
[CLS] 
c 
##er 
##vic 
c 
##t 
revealed 
irregular 
low 
density 
periphery 
##vic 
##al 
##bra 
c 
##2 
##4 
level 
[SEP] 
incorporation 
information 
data 
brought 
revised 
year 
survival 
estimate 
percent 
[CLS] 
these 
motif 
co 
##gnate 
transcription 
factor 
appear 
act 
concert 
partial 
red 
##unda 
discrete 
mutation 
effective 
reducing 
transcription 
##al 
activity 
[SEP] 
we 
show 
c 
induce 
binding 
activity 
termed 
si 
si 
in 
factor 
[SEP] 
conservation 
turbulent 
transport 
[CLS] 
expression 
b 
##act 
##op 
t 
t4 
d 
term 
##inas 
##e 
gene 
16 
17 
multiple 
protein 
[SEP] 
[PAD] [CLS] 
er 
##dheim 
chest 
##er 
disease 
distinct 
##oid 
part 
spectrum 
his 
[CLS] 
er 
##dheim 
chest 
##er 
disease 
always 
considered 
distinct 
##oid 
##osis 
based 
clinical 
radio 
criterion 
criterion [SEP] 
surface 
electronic 
structure 
1 
x 
2 
reconstructed 
110 
[CLS] 
p 
##mi 
##d 
con 
##fer 
drug 
resistance 
specifically 
l 
##mb 
[SEP] 
[CLS] 
two 
p 
##har 
##ma 
##co 
##kin 
##etic 
model 
compared 
a 
higher 
median 
##ro 
##cha 
site 
o 
##cular 
injury 
an 
##est 
81 
girl 
cured 
re 
5 
s 
##oma 
p 
##ye 
##ph 
##rit 
3 
c 
##ys 
##titis 
##titis [SEP] 
the 
performance 
test 
pro 
##sta 
##a 
test 
detect 
cancer 
protein 
encoded 
gene 
similarity 
e 
##z 
##rin 
r 
##adi 
##xin 
m 
##m 
link 
##os 
##eton 
patient 
125 
s 
##oma 
bacterial 
##nosis 
[CLS] 
in 
healing 
tend 
##on 
rate 
co 
##lla 
##gen 
synthesis 
decreased 
rate 
##co 
##lla 
##gen 
protein 
synthesis 
remained 
unchanged 
[CLS] 
from 
##han 
smallest 
signal 
ratio 
delta 
s 
min 
delta 
r 
obtained 
determines 
minimal 
contrast 
given 
film 
property 
film 
response 
s 
film 
gradient 
gamma 
amount 
s 
##cat 
##ter 
[SEP] 
[CLS] 
however 
one 
activity 
bind 
prefer 
##ential 
##ly 
g 
c 
rich 
promoter 
another 
activity 
appears 
bind 
prefer 
##ential 
##ly 
two 
promoter 
tested 
[SEP] 
card 
##iovascular 
effect 
in 
##ous 
##id 
h 
s 
92 
##65 
##pert 
center 
disease 
control 
prevention 
[CLS] 
expression 
c 
##a 
clone 
yeast 
containing 
large 
portion 
open 
reading 
frame 
camp 
p 
##se 
activity 
identical 
property 
d 
##ros 
##op 
enzyme 
mutation 
[CLS] 
f 
##ds 
##r 
ho 
##ex 
f 
##ds 
##r 
co 
k 
##da 
ho 
##mote 
##tra 
##mer 
binding 
f 
##ds 
control 
region 
located 
f 
##ds 
##r 
f 
##ds 
##g 
gene 
[SEP] 
z 
mm 
range 
h 
##ydro 
##tric 
radical 
dependent 
manner 
[CLS] 
the 
or 
##th 
##olo 
1 
2 
sub 
display 
high 
amino 
acid 
sequence 
identity 
pig 
human 
92 
94 
sub 
display 
identity 
76 
87 
87 [SEP] 
binding 
70 
notable 
high 
co 
##oper 
##ati 
two 
s 
##h 
##2 
domain 
individually 
affinity 
interaction 
##igan 
##d 
[SEP] 
##zo 
##one 
drug 
##nal 
##ot 
considerable 
protein 
concentration 
air 
space 
inter 
##st 
##iti 
##al 
tissue 
o 
##ede 
radiation 
single 
4 
m 
##j 
pulse 
##se 
##con 
##d 
duration 
mean 
articulated 
##ir 
##con 
flu 
[CLS] 
perception 
sweetness 
cannot 
used 
accurately 
meter 
meta 
##bol 
energy 
nut 
##rit 
food 
[CLS] 
the 
leader 
p 
##eptide 
##hes 
in 
##hibit 
rib 
##oso 
release 
t 
##nac 
stop 
co 
##don 
thereby 
blocking 
r 
##ho 
access 
trans 
##cript 
[SEP] 
[CLS] 
response 
property 
single 
unit 
access 
op 
dark 
reared 
cat 
[CLS] 
ex 
##cre 
breast 
milk 
milk [SEP] 
influence 
h 
##uang 
combination 
##uang 
##yt 
##hr 
o 
f 
de 
##dr 
##ogen 
##ase 
deficiency 
rat 
objective 
to 
study 
influence 
common 
combination 
cop 
##hr 
de 
##ogen 
##p 
##d 
deficiency 
receptor 
antagonist 
##hibit 
sulfur 
dioxide 
br 
##on 
##con 
##ric 
patient 
as 
[CLS] 
this 
sequence 
sufficient 
con 
##fer 
##53 
dependent 
activation 
##tero 
promoter 
##53 
capable 
binding 
sequence 
assessed 
gel 
shift 
analysis 
[SEP] 
[CLS] 
the 
em 
##b 
##ryo 
##bra 
##l 
column 
reviewed 
briefly 
origin 
an 
##oma 
c 
##2 
##bra 
traced 
one 
two 
early 
stage 
development 
follows 
1 
formation 
me 
##sen 
##chy 
ve 
##rte 
##bra 
2 
induction 
cart 
##ge 
##ge [SEP] 
two 
three 
group 
##pox 
##o 
0 
05 
##5 
##o 
0 
1 
third 
norm 
##ox 
##o 
0 
21 
group 
group f 
##21 
environment 
[CLS] 
para 
##thy 
##roid 
hormone 
am 
##p 
serum 
##bol 
reporter 
##ste 
##ob 
um 
##r 
106 
cell 
[CLS] 
result 
strongly 
activation 
beta 
origin 
distant 
replication 
enhance 
##r 
element 
requires 
small 
target 
sequence 
essential 
in 
##iti 
##ator 
protein 
mediated 
d 
##na 
loop 
##ing 
[SEP] 
[CLS] 
h 
m 
##rna 
to 
##tip 
##ote 
em 
##b 
##ryo 
stem 
cell 
##ici 
##ty 
##cho 
receptor 
magnetic 
torque 
1 
5 
t 
di 
##lo 
##dge 
result 
per 
##c 
##f 
[CLS] 
l 
##1 
identical 
r 
##dl 
gene 
known 
g 
##aba 
receptor 
subunit 
gene 
d 
me 
##lan 
##oga 
whereas 
l 
##3 
novel 
d 
sequence 
sequence exhibited 
structural 
similarity 
member 
l 
##igan 
gate 
channel 
family 
[CLS] 
a 
increase 
gas 
##tric 
##uc 
##osa 
##l 
per 
##me 
##ability 
observed 
six 
subject 
ins 
ethanol 
20 
v 
v 
using 
simulated 
cough 
effect 
adding 
tens 
so 
##l 
phase 
si 
clearance 
gel 
m 
##uc 
##us 
si 
[CLS] 
first 
amino 
terminal 
regulatory 
arm 
##di 
bind 
switch 
i 
ii 
domain 
leading 
in 
##hibition 
##d 
##p 
di 
##sso 
##ciation 
##p 
h 
##ydro 
##lysis 
[SEP] 
combination 
alternative 
promoter 
usage 
ex 
##on 
s 
##licing 
r 
##or 
gene 
generates 
several 
is 
##of 
##orms 
differ 
terminus 
[SEP] 
[CLS] 
electro 
##ore 
rapid 
induction 
protein 
bound 
consensus 
##ppa 
motif 
[SEP] 
analysis 
larger 
clone 
demonstrates 
least 
two 
is 
##of 
##orms 
differ 
n 
terminal 
a 
b 
hi 
##nge 
d 
domain 
[CLS] 
multiple 
copy 
binding 
site 
found 
viral 
genome 
[SEP] 
[CLS] 
during 
subsequent 
c 
alone 
trial 
response 
m 
##k 
80 
##1 
injected 
ex 
exting 
##uished 
easily 
sa 
injected 
mouse 
[SEP] 
[CLS] 
in 
de 
##via 
##ted 
i 
##ps 
##ila 
##teral 
##ly 
cat 
hem 
##ise 
##ction 
##ro 
##fle 
##xed 
trans 
##ec 
##tion 
[CLS] 
the 
major 
open 
reading 
frame 
predict 
##s 
protein 
59 
k 
##d 
##uc 
situated 
adjacent 
##c 
related 
motif 
proposed 
he 
##lix 
he 
##lix 
structure 
[SEP] 
residue 
although 
located 
55 
rather 
35 
terminal 
essential 
undoubtedly 
second 
##par 
35 
motif 
member 
in 
in addition 
digit 
identity 
varying 
##oly 
##da 
##ct 
##yl 
##y 
pro 
##ximal 
skeletal 
element 
severely 
shortened 
x 
##t 
l 
##d 
double 
##mo 
limb 
[CLS] 
the 
##4 
gene 
isolated 
##eno 
##mic 
d 
library 
complement 
##ation 
3 
mutation 
gene 
high 
degree 
sequence 
identity 
ma 
ad 
##rf 
believed 
##si 
shell 
effect 
r 
##yd 
##kal 
scattering 
short 
term 
growth 
rhythm 
chaos 
noise 
noise [SEP] 
[CLS] 
association 
di 
##aph 
##rag 
use 
as 
##pt 
##oma 
b 
##act 
##eri 
##uria 
[CLS] 
effect 
to 
##xi 
##rio 
ch 
##ole 
##rae 
[CLS] 
the 
ta 
##t 
protein 
coded 
hi 
strong 
act 
##iva 
terminal 
repeat 
l 
##tr 
is 
time 
wine 
wine trial 
trial [SEP] 
the 
coefficient 
variation 
##roma 
5 
8 
radio 
3 
coefficient 
variation 
within 
##roma 
4 
9 
radio 
9 
mac 
##rop 
m 
##od 
##ulator 
immunity 
##h 
terminal 
fragment 
tested 
su 
modification 
##pha 
3 
male 
##p 
attach 
bio 
group 
c 
##ys 
##tein 
su 
##yl 
##s 
production 
retrospective 
co 
##rot 
##11 
di 
eight 
25 
moderate 
##rot 
##ox 
1 
despite 
several 
year 
##ro 
[CLS] 
serum 
pit 
##uit 
##ary 
s 
##tero 
##id 
hormone 
level 
male 
one 
value 
good 
mean 
three 
three [SEP] 
section 
anti 
##oth 
##eli 
##al 
e 
##os 
##in 
mapping 
region 
##p 
1 
required 
##1 
interaction 
showed 
amino 
substitution 
##bol 
##1 
binding 
##it 
##ro 
reduce 
1 
repression 
##ivo 
[SEP] 
[CLS] 
the 
flank 
##ing 
open 
reading 
frame 
##2 
showed 
ho 
##mology 
##rg 
##ini 
##ne 
bio 
gene 
[SEP] 
promoter 
activity 
pro 
in 
c 
##re 
binding 
inter 
method 
level 
##r 
measured 
simultaneously 
plasma 
##ural 
fluid 
111 
##ural 
e 
##ff 
##usion 
unknown 
cause 
[CLS] 
the 
g 
##i 
software 
program 
##view 
used 
spatial 
analysis 
distance 
calculation 
[CLS] 
ch 
##i 
##2 
test 
compare 
distribution 
characteristic 
mid 
##block 
collision 
collision [SEP] 
combination 
pure 
##omer 
5 
along 
e 
##bic 
##cre 
##atic 
cancer 
result 
3 
week 
therapy 
increase 
plate 
##let 
count 
base 
##line 
5 
000 
8 
000 
##r 
ma 
##ximal 
level 
33 
##r 
[CLS] 
the 
specific 
##ity 
transcription 
##al 
activation 
is 
##3 
mediated 
specific 
element 
termed 
if 
##n 
s 
##ti 
##lator 
##y 
response 
element 
is 
##re 
located 
promoter 
region 
if 
in 
gene 
[SEP] 
k 
##b 
##c 
test 
evaluation 
##f 
re 
##ret 
living 
related 
re 
##nal 
g 
6 
transplant 
[CLS] 
these 
mutant 
injection 
x 
del 
##im 
##it 
promoter 
36 
b 
##p 
d 
upstream 
cap 
site 
73 
b 
##p 
un 
##ns 
m 
##rna 
leader 
[SEP] 
[CLS] 
upstream 
tissue 
inhibitor 
1 
element 
1 
novel 
essential 
regulatory 
d 
##na 
motif 
human 
t 
1 
gene 
promoter 
directly 
interact 
##s 
30 
k 
##da 
nuclear 
protein 
[CLS] 
the 
result 
experiment 
experiment indicated 
charcoal 
im 
##ber 
be 
an 
re 
do 
x 
##fs 
##fs 40 
##22 
do 
s 
##r 
c 
##1 
would 
useful 
agent 
amount 
die 
##rin 
eliminated 
via 
f 
##ec 
dropping 
[CLS] 
the 
receptor 
##f 
1 
##ste 
##oss 
intrinsic 
t 
kinase 
via 
rapid 
p 
selected 
protein 
[SEP] 
[CLS] 
adaptive 
effect 
repeated 
##mers 
exposure 
human 
body 
body [SEP] 
[CLS] 
to 
end 
generated 
detailed 
physical 
map 
##eno 
##mic 
region 
spanning 
sequence 
tag 
##ged 
site 
marker 
d 
##51 
##8 
d 
##51 
##6 
spin 
##op 
1 
binding 
den 
##dr 
##itic 
spine 
[CLS] 
pro 
2 
initially 
form 
two 
di 
##sul 
##fi 
##de 
is 
##omer 
undergo 
rear 
##rang 
##ement 
single 
conform 
##ation 
v 
##ivo 
[PAD] [CLS] 
while 
war 
gas 
gas [SEP] 
formulated 
ha 
##ber 
rule 
c 
x 
t 
constant 
order 
toxicity 
##hala 
[CLS] 
the 
existence 
t 
##fi 
##ii 
assembly 
pathway 
leading 
transcription 
natural 
##ryo 
t 
gene 
absence 
t 
insight 
functional 
flexibility 
t 
gene 
transcription 
machinery 
evolution 
ancestral 
r 
##na 
polymer 
ii 
##i 
system 
relying 
upstream 
ta 
centered 
control 
element 
[SEP] 
[CLS] 
e 
##ct 
##op 
x 
##bra 
induce 
x 
##r 
1 
transcription 
indirect 
mechanism 
appears 
primary 
activation 
fi 
##bro 
##blast 
factor 
secret 
##ion 
[SEP] 
rapid 
mixing 
device 
##ela 
react 
system 
[CLS] 
the 
major 
transcription 
start 
site 
designated 
1 
determined 
race 
rapid 
##a 
end 
analysis 
human 
liver 
found 
located 
50 
b 
##p 
upstream 
translation 
start 
site 
[SEP] 
[CLS] 
these 
residue 
correspond 
co 
##don 
59 
108 
p 
d 
##h 
##f 
##r 
active 
site 
similar 
substitution 
c 
a 
59 
se 
108 
associated 
##yr 
##tham 
resistance 
of 
ya 
##r 
syndrome 
highest 
stability 
depressed 
scale 
scale [SEP] 
[CLS] 
here 
investigate 
mechanism 
t 
induction 
##p 
gene 
expression 
me 
me 180 
##cc 
cell 
line 
[CLS] 
between 
r 
##na 
initiation 
site 
coding 
region 
g 
##c 
rich 
hair 
##pin 
structure 
followed 
8 
t 
residue 
look 
like 
r 
##ho 
independent 
transcription 
term 
##inator 
[SEP] 
[CLS] 
con 
converse 
rate 
bio 
##ava 
patch 
release 
rate 
fast 
first 
24 
h 
leading 
e 
##2 
peak 
8 
h 
cm 
##ax 
average 
23 
h 
h [SEP] 
3 
progress 
fi 
##bri 
##no 
##lysis 
serial 
fluid 
side 
ear 
case 
17 
case 
much 
activity 
fi 
##bri 
##n 
degradation 
lowering 
fi 
##bri 
revealed 
4 
5 
case 
result 
result [SEP] 
[CLS] 
thus 
target 
f 
##o 
promoter 
##g 
sequence 
via 
r 
##ho 
a 
dependent 
pathway 
r 
##ho 
a 
appears 
role 
regulation 
t 
##17 
[SEP] 
the 
##90 
##b 
##k 
co 
##agu 
i 
strain 
rather 
12 
m 
##l 
[CLS] 
in 
m 
##b 
##f 
##uant 
three 
major 
vascular 
anterior 
descending 
##fle 
##flex 
co 
##rona 
##ry 
territory 
right 
co 
##rona 
##ry 
artery 
control 
region 
territory 
[CLS] 
these 
result 
m 
receptor 
couple 
alpha 
i 
##2 
alpha 
i 
##3 
v 
##ivo 
interaction 
integral 
positive 
negative 
regulatory 
pathway 
leading 
activation 
plc 
des 
##ens 
##iti 
##zation 
receptor 
signaling 
[SEP] 
##let 
higher 
group 
b 
[CLS] 
the 
f 
gene 
seven 
ex 
##on 
spanning 
15 
k 
##b 
encoding 
two 
trans 
##cript 
or 
##fs 
84 
##1 
69 
amino 
acid 
[SEP] 
h 
to 
##xin 
ex 
exert 
c 
##yt 
##ost 
##atic 
effect 
in 
##hibit 
his 
##tone 
de 
[CLS] 
the 
human 
r 
gene 
mapping 
human 
##31 
1 
##eno 
##mic 
organization 
alternative 
trans 
##cript 
[CLS] 
the 
delta 
mean 
##af 
delta 
##b 
##p 
varied 
value 
##af 
##b 
##p 
respectively 
respectively [SEP] 
##zo 
##os 
##per 
way 
adequate 
sperm 
##ato 
##zo 
a 
##1 
low 
scan 
##ty 
rare 
sperm 
##ato 
##zo 
##2 
sperm 
##ati 
arrest 
b 
##1 
sperm 
##ato 
arrest 
b 
##2 
se 
##rt 
##oli 
cell 
pattern 
s 
##cle 
##rosis 
d 
d [SEP] 
